Citrus Sinensis ID: 043285
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 414 | 2.2.26 [Sep-21-2011] | |||||||
| O81833 | 815 | G-type lectin S-receptor- | yes | no | 0.990 | 0.503 | 0.583 | 1e-132 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.985 | 0.48 | 0.544 | 1e-128 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.985 | 0.481 | 0.538 | 1e-127 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 1.0 | 0.491 | 0.550 | 1e-125 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.922 | 0.487 | 0.566 | 1e-124 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.997 | 0.484 | 0.513 | 1e-123 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 1.0 | 0.491 | 0.517 | 1e-123 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.987 | 0.490 | 0.507 | 1e-120 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.980 | 0.480 | 0.514 | 1e-120 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.983 | 0.496 | 0.525 | 1e-119 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 471 bits (1213), Expect = e-132, Method: Compositional matrix adjust.
Identities = 242/415 (58%), Positives = 309/415 (74%), Gaps = 5/415 (1%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKIVVIVISSAALLAVLLIAGYLIR 60
+WFGDL+D+R + GQD+YIRM +++E KG +VV + + A++ V++ A + +
Sbjct: 405 LWFGDLVDMREYSSFGQDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKK 464
Query: 61 KRRRNIAEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQ 120
+R E I+ DL+LP+F+ TI AT++FS LG+GGFGPVYKGKL DGQ
Sbjct: 465 IMKRYRGENFRKG-IEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQ 523
Query: 121 EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 180
EIAVKRLS S QG++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+MPNKSLD
Sbjct: 524 EIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDF 583
Query: 181 FIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 240
FIFD+ R LDW KR +II G ARG+LYLHQDSRLRIIHRDLKA NVLLD DMNPKISD
Sbjct: 584 FIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISD 643
Query: 241 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 300
FGLA++FGGD++E +TNRVVGTYGYM PEYA DG FSVKSDVFSFG+L+LEI++GK NRG
Sbjct: 644 FGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRG 703
Query: 301 FYHSDNNLNLIGHAWKLWNEGMP-SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRP 359
F H+D++LNL+GH WK+W E + +++ + EV+RCIH+ LLCVQQ PEDRP
Sbjct: 704 FRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRP 763
Query: 360 SMPSVILMLGSETVLPQPKQPGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
+M SV+LM GS++ LP P QPG+ +R D SS + S N ++++ L+GR
Sbjct: 764 TMASVVLMFGSDSSLPHPTQPGFFTNRNVP--DISSSLSLR-SQNEVSITMLQGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1175), Expect = e-128, Method: Compositional matrix adjust.
Identities = 245/450 (54%), Positives = 300/450 (66%), Gaps = 42/450 (9%)
Query: 2 WFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKIVVIVISSAALLAVLLIAGYLIRK 61
W G+L DIR + GGQDLY+R++A++LE K + KI+ I + LL + I +L ++
Sbjct: 406 WTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKR 465
Query: 62 R------------------------------RRNIAEKTENDQIQNIDLELPLFELATIV 91
+ RR+I+ + D DLELPL E +
Sbjct: 466 KQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTD-----DLELPLMEFEEVA 520
Query: 92 SATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR 151
ATNNFS KLGQGGFG VYKGKL+DGQE+AVKRLSK S QG E KNEV L ++LQH
Sbjct: 521 MATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHI 580
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
NLV+LL CC+ EK+LIYE++ N SLDS +FD+ R L+W RF II G ARGLLYLH
Sbjct: 581 NLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLH 640
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
QDSR RIIHRDLKASN+LLD+ M PKISDFG+AR FG DETE NT +VVGTYGYM+PEYA
Sbjct: 641 QDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYA 700
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331
DG FS+KSDVFSFG+LLLEI+S K+N+GFY+SD +LNL+G W+ W EG ++ID
Sbjct: 701 MDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPII 760
Query: 332 QDS---FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE-TVLPQPKQPGYLADRK 387
DS F E++RCI IGLLCVQ+ EDRP+M VILMLGSE T +PQPK PGY +R
Sbjct: 761 TDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERS 820
Query: 388 STRRDYSSIMP---ESCSTNTITVSGLEGR 414
D SS ES + N ITVS L+ R
Sbjct: 821 LLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-127, Method: Compositional matrix adjust.
Identities = 243/451 (53%), Positives = 307/451 (68%), Gaps = 43/451 (9%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKIVVIVIS-SAALLAVLLIAGYLI 59
+W G L DIR + GGQDLY+R++A +LE K + KI+ I S LL +I +
Sbjct: 403 IWSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWK 462
Query: 60 RKRRRNIAEKTE-NDQIQNID----------------------LELPLFELATIVSATNN 96
RK++R+I +T D +++ D LELPL E + ATNN
Sbjct: 463 RKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNN 522
Query: 97 FSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 156
FS + KLGQGGFG VYKG L+DG+EIAVKRLSK+S QG E NEV L +KLQH NLV+L
Sbjct: 523 FSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRL 582
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRL 216
LGCC+ EK+LIYE++ N SLDS +FDQ R L+W KRF II G ARGLLYLHQDSR
Sbjct: 583 LGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRC 642
Query: 217 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF 276
RIIHRDLKASNVLLD++M PKISDFG+AR FG +ETE NT RVVGTYGYM+PEYA DG F
Sbjct: 643 RIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIF 702
Query: 277 SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS-- 334
S+KSDVFSFG+LLLEI+SGK+N+GFY+S+ +LNL+G W+ W EG +++D D+
Sbjct: 703 SMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALS 762
Query: 335 --FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV-LPQPKQPGYLADR----- 386
F E++RCI IGLLCVQ+ EDRP M SV++MLGSET +PQPK+PG+ R
Sbjct: 763 SEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEV 822
Query: 387 ---KSTRRDYSSIMPESCSTNTITVSGLEGR 414
ST+RD + C+ N +T+S ++ R
Sbjct: 823 DSSSSTQRD------DECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 449 bits (1156), Expect = e-125, Method: Compositional matrix adjust.
Identities = 245/445 (55%), Positives = 311/445 (69%), Gaps = 31/445 (6%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKIVVIVIS-SAALLAVLLIAGYLI 59
+W +++D+R + GGQDLY+R++A+ELE K KI+ I S LL +I +
Sbjct: 399 IWTREILDMRNYAKGGQDLYVRLAAAELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWK 458
Query: 60 RKRRRNIAEKTEN-DQIQNID----------------------LELPLFELATIVSATNN 96
RK++R+I +T N DQ+++ D LELPL EL + +ATNN
Sbjct: 459 RKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLLELEALATATNN 518
Query: 97 FSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 156
FS + KLGQGGFG VYKG+L+DG+EIAVKRLSK+S QG E NEV L +KLQH NLV+L
Sbjct: 519 FSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRL 578
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRL 216
LGCC+ EK+LIYE++ N SLDS +FDQ R L+W KRF II G ARGLLYLHQDSR
Sbjct: 579 LGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRC 638
Query: 217 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF 276
RIIHRDLKASNVLLD++M PKISDFG+AR FG +ETE NT RVVGTYGYM+PEYA DG F
Sbjct: 639 RIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIF 698
Query: 277 SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS-- 334
S+KSDVFSFG+LLLEI+SGK+N+GFY+S+ +LNL+G W+ W EG +++D DS
Sbjct: 699 SMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLS 758
Query: 335 --FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV-LPQPKQPGYLADRKSTRR 391
F E++RCI IGLLCVQ+ EDRP M SV++MLGSET +PQPK+PG+ R
Sbjct: 759 SKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEA 818
Query: 392 DYSSIMP--ESCSTNTITVSGLEGR 414
D SS + C+ N IT+S ++ R
Sbjct: 819 DSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 445 bits (1145), Expect = e-124, Method: Compositional matrix adjust.
Identities = 235/415 (56%), Positives = 292/415 (70%), Gaps = 33/415 (7%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKIVVIVISSAALLAVLLIAGYLIR 60
+WFGDLIDIR + + GQDLY+R+++SE+E L R
Sbjct: 401 LWFGDLIDIREYNENGQDLYVRLASSEIET---------------------------LQR 433
Query: 61 KRRRNIAEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQ 120
+ R + K E + DLELP +L T+ AT+ FS KLGQGGFGPVYKG L GQ
Sbjct: 434 ESSRVSSRKQEEE-----DLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQ 488
Query: 121 EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 180
E+AVKRLS+ S QG++E KNE+ L +KLQHRNLVK+LG C+ EE++LIYE+ PNKSLDS
Sbjct: 489 EVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDS 548
Query: 181 FIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 240
FIFD+ER LDW KR II G ARG+LYLH+DSRLRIIHRDLKASNVLLD DMN KISD
Sbjct: 549 FIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISD 608
Query: 241 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 300
FGLAR GGDETE NT RVVGTYGYM+PEY DG FS+KSDVFSFG+L+LEIVSG++NRG
Sbjct: 609 FGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRG 668
Query: 301 FYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS-FNLAEVIRCIHIGLLCVQQHPEDRP 359
F + ++ LNL+GHAW+ + E ++ID +S +++EV+R IHIGLLCVQQ P+DRP
Sbjct: 669 FRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRP 728
Query: 360 SMPSVILMLGSETVLPQPKQPGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
+M V+LML SE +L P+QPG+ +R D SI E S N T+S ++ R
Sbjct: 729 NMSVVVLMLSSEMLLLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-123, Method: Compositional matrix adjust.
Identities = 232/452 (51%), Positives = 308/452 (68%), Gaps = 39/452 (8%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASEL------------EAKGEPTTKIVVIVISSAAL 48
+W DL +++ G ++++IR++ ++ EAK P I+V+ +SAA+
Sbjct: 402 IWLEDLNNLKEGYLGSRNVFIRVAVPDIGSHVERGRGRYGEAK-TPVVLIIVVTFTSAAI 460
Query: 49 LAVLL-IAGYLIRKRR-------------------RNIAEKTENDQIQNID---LELPLF 85
L VL A Y+ +RR R+I E E+ + + D +++P F
Sbjct: 461 LVVLSSTASYVFLQRRKVNKELGSIPRGVHLCDSERHIKELIESGRFKQDDSQGIDVPSF 520
Query: 86 ELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILF 145
EL TI+ AT+NFS KLGQGGFGPVYKG QEIAVKRLS+ S QGL+E KNEV+L
Sbjct: 521 ELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAVKRLSRCSGQGLEEFKNEVVLI 580
Query: 146 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTAR 205
+KLQHRNLV+LLG C+ GEEKLL+YE+MP+KSLD FIFD++ C LDW R +II G AR
Sbjct: 581 AKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRKLCQRLDWKMRCNIILGIAR 640
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
GLLYLHQDSRLRIIHRDLK SN+LLD++MNPKISDFGLAR FGG ET NTNRVVGTYGY
Sbjct: 641 GLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGSETSANTNRVVGTYGY 700
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325
M+PEYA +G FS KSDVFSFG++++E +SGK+N GF+ + +L+L+GHAW LW +
Sbjct: 701 MSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLSLLGHAWDLWKAERGIE 760
Query: 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE--TVLPQPKQPGYL 383
L+D Q+S ++C+++GLLCVQ+ P DRP+M +V+ MLGS LP PKQP ++
Sbjct: 761 LLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFMLGSSEAATLPTPKQPAFV 820
Query: 384 ADR-KSTRRDYSSIMPESCSTNTITVSGLEGR 414
R S+ + SS PE+CS N +T++ +GR
Sbjct: 821 LRRCPSSSKASSSTKPETCSENELTITLEDGR 852
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-123, Method: Compositional matrix adjust.
Identities = 223/431 (51%), Positives = 301/431 (69%), Gaps = 17/431 (3%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKIVVIVISSAALLAV-LLIAGYLI 59
+W GDL+D++ F G DL+IR++ SEL+ I VI + AV +L+A
Sbjct: 412 LWSGDLVDMQSFLGSGIDLFIRVAHSELKTHSNLAVMIAAPVIGVMLIAAVCVLLACRKY 471
Query: 60 RKR-------------RRNIAEKTENDQIQN-IDL-ELPLFELATIVSATNNFSINKKLG 104
+KR +R A ++N+ N I L ELPLFE + ++T++FS+ KLG
Sbjct: 472 KKRPAPAKDRSAELMFKRMEALTSDNESASNQIKLKELPLFEFQVLATSTDSFSLRNKLG 531
Query: 105 QGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 164
QGGFGPVYKGKL +GQEIAVKRLS+ S QGL+EL NEV++ SKLQHRNLVKLLGCCI+GE
Sbjct: 532 QGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGE 591
Query: 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 224
E++L+YE+MP KSLD+++FD + ILDW RF+I+ G RGLLYLH+DSRL+IIHRDLK
Sbjct: 592 ERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLK 651
Query: 225 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFS 284
ASN+LLD+++NPKISDFGLAR F +E E NT RVVGTYGYM+PEYA +G FS KSDVFS
Sbjct: 652 ASNILLDENLNPKISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFS 711
Query: 285 FGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCI 344
G++ LEI+SG++N + +NNLNL+ +AWKLWN+G + L D D E+ +C+
Sbjct: 712 LGVIFLEIISGRRNSSSHKEENNLNLLAYAWKLWNDGEAASLADPAVFDKCFEKEIEKCV 771
Query: 345 HIGLLCVQQHPEDRPSMPSVILMLGSETV-LPQPKQPGYLADRKSTRRDYSSIMPESCST 403
HIGLLCVQ+ DRP++ +VI ML +E + L PKQP ++ R ++ + S + S
Sbjct: 772 HIGLLCVQEVANDRPNVSNVIWMLTTENMSLADPKQPAFIVRRGASEAESSDQSSQKVSI 831
Query: 404 NTITVSGLEGR 414
N ++++ + GR
Sbjct: 832 NDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 433 bits (1113), Expect = e-120, Method: Compositional matrix adjust.
Identities = 223/439 (50%), Positives = 307/439 (69%), Gaps = 30/439 (6%)
Query: 2 WFGDLIDIRYFQDGGQDLYIRMSASEL---EAKGEPTTKIVVIVISS--AALLAVLLIAG 56
W G ++D R + + GQD YIR+ EL G + V++++ S AA++ + +I
Sbjct: 399 WHGGMLDARTYLNSGQDFYIRVDKEELARWNRNGLSGKRRVLLILISLIAAVMLLTVILF 458
Query: 57 YLIRKRRRNIAEKT------------------ENDQIQNIDLELPLFELATIVSATNNFS 98
++R+RR++ ++ E D+ +N ELPLF+L TIV+ATNNFS
Sbjct: 459 CVVRERRKSNRHRSSSANFAPVPFDFDESFRFEQDKARN--RELPLFDLNTIVAATNNFS 516
Query: 99 INKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 158
KLG GGFGPVYKG L + EIAVKRLS+ S QG++E KNEV L SKLQHRNLV++LG
Sbjct: 517 SQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILG 576
Query: 159 CCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRI 218
CC++ EEK+L+YE++PNKSLD FIF +E+ LDW KR I+ G ARG+LYLHQDSRLRI
Sbjct: 577 CCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRI 636
Query: 219 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSV 278
IHRDLKASN+LLD +M PKISDFG+AR FGG++ EG T+RVVGT+GYMAPEYA +GQFS+
Sbjct: 637 IHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSI 696
Query: 279 KSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF-QDSFNL 337
KSDV+SFG+L+LEI++GKKN F+ + NL+GH W LW G +++ID+ Q++++
Sbjct: 697 KSDVYSFGVLMLEIITGKKNSAFHEESS--NLVGHIWDLWENGEATEIIDNLMDQETYDE 754
Query: 338 AEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG-SETVLPQPKQPGYLADRKSTRRDYSSI 396
EV++CI IGLLCVQ++ DR M SV++MLG + T LP PK P + + R+ + + +
Sbjct: 755 REVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLPNPKHPAFTSARRRGGENGACL 814
Query: 397 MPES-CSTNTITVSGLEGR 414
++ S N +T S ++GR
Sbjct: 815 KGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 432 bits (1112), Expect = e-120, Method: Compositional matrix adjust.
Identities = 232/451 (51%), Positives = 315/451 (69%), Gaps = 45/451 (9%)
Query: 2 WFGDLIDIRYFQDGGQDLYIRMSASELE------AKGEPTTKIVVIVISSAALLAVLLIA 55
W G+++D R + GQD Y+R+ SEL A G+ ++V+I+IS A++ +LLI+
Sbjct: 402 WHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNGASGK--KRLVLILISLIAVVMLLLIS 459
Query: 56 GYLIRKRRRNIAEKTENDQIQ---------NIDLE----------------LPLFELATI 90
+ ++RR ++T++++++ + DLE LPLFEL+TI
Sbjct: 460 FHCYLRKRR---QRTQSNRLRKAPSSFAPSSFDLEDSFILEELEDKSRSRELPLFELSTI 516
Query: 91 VSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 150
+ATNNF+ KLG GGFGPVYKG L +G EIAVKRLSK S QG++E KNEV L SKLQH
Sbjct: 517 ATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKSSGQGMEEFKNEVKLISKLQH 576
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
RNLV++LGCC++ EEK+L+YE++PNKSLD FIF +E+ LDW KR II G RG+LYL
Sbjct: 577 RNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMGIIRGIGRGILYL 636
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
HQDSRLRIIHRDLKASNVLLD +M PKI+DFGLAR FGG++ EG+TNRVVGTYGYM+PEY
Sbjct: 637 HQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGNQIEGSTNRVVGTYGYMSPEY 696
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330
A DGQFS+KSDV+SFG+L+LEI++GK+N FY + +LNL+ H W W G ++ID
Sbjct: 697 AMDGQFSIKSDVYSFGVLILEIITGKRNSAFY--EESLNLVKHIWDRWENGEAIEIIDKL 754
Query: 331 F-QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV-LPQPKQPGYLADRKS 388
+++++ EV++C+HIGLLCVQ++ DRP M SV+ MLG + LP PK P + A R+
Sbjct: 755 MGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVFMLGHNAIDLPSPKHPAFTAGRRR 814
Query: 389 TRRD--YSSIMP--ESCST-NTITVSGLEGR 414
+ S P E+ ST N +T++ ++GR
Sbjct: 815 NTKTGGSSDNWPSGETSSTINDVTLTDVQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 428 bits (1100), Expect = e-119, Method: Compositional matrix adjust.
Identities = 224/426 (52%), Positives = 288/426 (67%), Gaps = 19/426 (4%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKIVVI------VISSAALLAVLLI 54
+W G L+D + G DLYIR++ SE++ K + I I V+++ LLA ++
Sbjct: 402 IWNGSLVDSQELSASGLDLYIRLAHSEIKTKDKRPILIGTILAGGIFVVAACVLLARRIV 461
Query: 55 AGYLIRKRRRN---IAEKTENDQIQNIDL--ELPLFELATIVSATNNFSINKKLGQGGFG 109
+K+ R+ I E+ E N ELPLFE + +ATNNFS+ KLGQGGFG
Sbjct: 462 MKKRAKKKGRDAEQIFERVEALAGGNKGKLKELPLFEFQVLAAATNNFSLRNKLGQGGFG 521
Query: 110 PVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169
PVYKGKL +GQEIAVKRLS+ S QGL+EL NEV++ SKLQHRNLVKLLGCCI GEE++L+
Sbjct: 522 PVYKGKLQEGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLV 581
Query: 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 229
YEFMP KSLD ++FD R +LDW RF+II G RGLLYLH+DSRLRIIHRDLKASN+L
Sbjct: 582 YEFMPKKSLDYYLFDSRRAKLLDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNIL 641
Query: 230 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 289
LD+++ PKISDFGLAR F G+E E NT RVVGTYGYMAPEYA G FS KSDVFS G++L
Sbjct: 642 LDENLIPKISDFGLARIFPGNEDEANTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVIL 701
Query: 290 LEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLL 349
LEI+SG++N +N L+ + W +WNEG + L+D D E+ +CIHIGLL
Sbjct: 702 LEIISGRRN-------SNSTLLAYVWSIWNEGEINSLVDPEIFDLLFEKEIHKCIHIGLL 754
Query: 350 CVQQHPEDRPSMPSVILMLGSETV-LPQPKQPGYLADRKSTRRDYSSIMPESCSTNTITV 408
CVQ+ DRPS+ +V ML SE +P+PKQP +++ + S S N +T+
Sbjct: 755 CVQEAANDRPSVSTVCSMLSSEIADIPEPKQPAFISRNNVPEAESSENSDLKDSINNVTI 814
Query: 409 SGLEGR 414
+ + GR
Sbjct: 815 TDVTGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 414 | ||||||
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 1.0 | 0.504 | 0.661 | 1e-156 | |
| 449458261 | 814 | PREDICTED: receptor-like serine/threonin | 1.0 | 0.508 | 0.659 | 1e-154 | |
| 449476944 | 1267 | PREDICTED: receptor-like serine/threonin | 1.0 | 0.326 | 0.657 | 1e-154 | |
| 224113157 | 786 | predicted protein [Populus trichocarpa] | 0.910 | 0.479 | 0.664 | 1e-151 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 0.908 | 0.478 | 0.659 | 1e-151 | |
| 224122810 | 810 | predicted protein [Populus trichocarpa] | 1.0 | 0.511 | 0.612 | 1e-149 | |
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.925 | 0.467 | 0.665 | 1e-149 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.997 | 0.508 | 0.635 | 1e-148 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 1.0 | 0.498 | 0.613 | 1e-147 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 1.0 | 0.495 | 0.614 | 1e-147 |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1432), Expect = e-156, Method: Compositional matrix adjust.
Identities = 278/420 (66%), Positives = 325/420 (77%), Gaps = 6/420 (1%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKIVV-IVISSAALLAVLLIAGYLI 59
+WFGDLIDIR F GQ++YIR++ASE AK K+ V +S +LL+A Y+
Sbjct: 401 VWFGDLIDIRQFSAAGQEIYIRLNASESRAKAASKIKMTVGSALSIFVACGILLVAYYIF 460
Query: 60 RKRRRNIA-EKTENDQIQN---IDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGK 115
+++ ++I + ENDQI + DLELPLF+ TI ATN FS N KLG+GGFGPVYKG
Sbjct: 461 KRKAKHIGGNREENDQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGT 520
Query: 116 LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175
L DGQEIA K LS+ S QGL E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPN
Sbjct: 521 LEDGQEIAAKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPN 580
Query: 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 235
KSLDSFIFDQ R +LDWSKRF IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMN
Sbjct: 581 KSLDSFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMN 640
Query: 236 PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 295
PKISDFGLAR FGGD+TEGNT RVVGTYGYMAPEYA+DG FSVKSDVFSFGIL+LEI+SG
Sbjct: 641 PKISDFGLARMFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISG 700
Query: 296 KKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVI-RCIHIGLLCVQQH 354
KK+RGF H D++L+LIGHAW+LW +G P LI++ +S NL+EVI RCI+I LLCVQQH
Sbjct: 701 KKSRGFCHPDHSLSLIGHAWRLWKDGKPLGLIEAFPGESCNLSEVIMRCINISLLCVQQH 760
Query: 355 PEDRPSMPSVILMLGSETVLPQPKQPGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
P+DRPSM +V+ MLG E LPQPK+PG+ R SS E S N IT S L R
Sbjct: 761 PDDRPSMATVVWMLGGENTLPQPKEPGFFKGSGPFRPSSSSKNTELFSNNEITSSLLYPR 820
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458261|ref|XP_004146866.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1419), Expect = e-154, Method: Compositional matrix adjust.
Identities = 275/417 (65%), Positives = 330/417 (79%), Gaps = 3/417 (0%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKIVVIVISSAALLAVLLIAG-YLI 59
+WFG+L+DI+ + GGQDLY+RM ASELE K + + VIV ++A L+ LL+ G Y+I
Sbjct: 398 IWFGELVDIKVVRRGGQDLYVRMLASELETKKTSSVAVGVIVGAAALLILGLLLIGFYVI 457
Query: 60 RKRRRNIAEKTENDQI--QNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLV 117
R +RR + + Q DLELPLF LATI +AT+NFS KLG+GGFG V++G+L
Sbjct: 458 RSKRRKLEATGAGKDLEGQEDDLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLT 517
Query: 118 DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 177
DG+EIAVKRLS S QG E KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE+MPNKS
Sbjct: 518 DGKEIAVKRLSSYSRQGTDEFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKS 577
Query: 178 LDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 237
LDSFIFD R +LDWSKRF+IICG ARG+LYLHQDSRLRIIHRDLKASNVLLD D+NPK
Sbjct: 578 LDSFIFDSARKKLLDWSKRFNIICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPK 637
Query: 238 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 297
ISDFG+AR FGGD+TEGNT RVVGTYGYMAPEYA DGQFS+KSDVFSFGIL+LEI+SG+K
Sbjct: 638 ISDFGMARTFGGDQTEGNTRRVVGTYGYMAPEYAIDGQFSIKSDVFSFGILMLEIISGEK 697
Query: 298 NRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPED 357
NRGF+ ++ LNLIGHAWKLWNEG P +LID+ +S+ L+EV+RCIH+ LLC+QQ PED
Sbjct: 698 NRGFFRPNHALNLIGHAWKLWNEGKPLELIDASIGESYALSEVLRCIHVSLLCLQQLPED 757
Query: 358 RPSMPSVILMLGSETVLPQPKQPGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
RP+M +V+LML SE L QPKQPG+ +R S S ES TN +T++ LE R
Sbjct: 758 RPTMSNVVLMLSSEGSLAQPKQPGFYMERDSLEVFSVSGKNESSITNELTITLLEAR 814
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449476944|ref|XP_004154883.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1418), Expect = e-154, Method: Compositional matrix adjust.
Identities = 274/417 (65%), Positives = 331/417 (79%), Gaps = 3/417 (0%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKIVVIVISSAALLAVLLIAG-YLI 59
+WFG+L+DI+ + GGQDLY+RM ASELE K + + VIV ++A L+ LL+ G Y+I
Sbjct: 398 IWFGELVDIKVVRRGGQDLYVRMLASELETKKTSSVAVGVIVGAAALLILGLLLIGFYVI 457
Query: 60 RKRRRNIAEKTENDQI--QNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLV 117
R +RR + + Q DLELPLF LATI +AT+NFS KLG+GGFG V++G+L
Sbjct: 458 RSKRRKLEATGAGKDLEGQEDDLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLT 517
Query: 118 DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 177
DG+EIAVKRLS S QG E KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE+MPNKS
Sbjct: 518 DGKEIAVKRLSSYSRQGTDEFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKS 577
Query: 178 LDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 237
LDSFIFD R +LDWSKRF+IICG ARG+LYLHQDSRLRIIHRDLKASNVLLD D+NPK
Sbjct: 578 LDSFIFDSARKKLLDWSKRFNIICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPK 637
Query: 238 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 297
ISDFG+AR FGGD+TEGNT RVVGTYGYMAPEYA DGQFS+KSDVFSFGIL+LEI+SG+K
Sbjct: 638 ISDFGMARTFGGDQTEGNTRRVVGTYGYMAPEYAIDGQFSIKSDVFSFGILMLEIISGEK 697
Query: 298 NRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPED 357
NRGF+ ++ LNLIGHAWKLWNEG P +LID+ +S+ L+EV+RCIH+ LLC+QQ PED
Sbjct: 698 NRGFFRPNHALNLIGHAWKLWNEGKPLELIDASIGESYALSEVLRCIHVSLLCLQQLPED 757
Query: 358 RPSMPSVILMLGSETVLPQPKQPGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
RP+M +V+LML SE L QPKQPG+ +R S S ES +TN +T++ LE +
Sbjct: 758 RPTMSNVVLMLSSEGSLAQPKQPGFYMERDSLEVFSVSGKNESSTTNELTITLLEAK 814
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1397), Expect = e-151, Method: Compositional matrix adjust.
Identities = 277/417 (66%), Positives = 319/417 (76%), Gaps = 40/417 (9%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKIVVIVISSAALLAVLLIAGYLIR 60
+W+GDLIDIR F GGQ+LYIRM+ SE SA +
Sbjct: 407 IWYGDLIDIRQFPAGGQELYIRMNPSE-----------------SAEM------------ 437
Query: 61 KRRRNIAEKTENDQI---QNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLV 117
+NDQI +N DLELP FE A IV+ATNNFSI KLGQGGFGPVYKG L
Sbjct: 438 --------DQQNDQITDGENEDLELPQFEFAKIVNATNNFSIKNKLGQGGFGPVYKGTLE 489
Query: 118 DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 177
DGQEIAVKRLS S QG KE KNEVIL +KLQHRNLVKLLGC IQ EE+LL+YE+MPNKS
Sbjct: 490 DGQEIAVKRLSMSSRQGSKEFKNEVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKS 549
Query: 178 LDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 237
LDSF+FDQ + +LDWSKRF+IICG ARGLLYLHQDSRLRIIHRDLK+SNVLLD+DMNPK
Sbjct: 550 LDSFLFDQTKSKLLDWSKRFNIICGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPK 609
Query: 238 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 297
ISDFGLAR FGGD+TEGNT+RVVGTYGYMAPEYA+DG FSVKSDVFSFGI+LLEIV+GKK
Sbjct: 610 ISDFGLARTFGGDQTEGNTSRVVGTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIVTGKK 669
Query: 298 NRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPED 357
+RGFYH DN+L+LIG+AW+LW EG P +L+D ++S+NL+EV++CIHI LLCVQQ+PED
Sbjct: 670 SRGFYHPDNSLSLIGYAWRLWKEGKPLELVDGLAEESWNLSEVMKCIHISLLCVQQYPED 729
Query: 358 RPSMPSVILMLGSETVLPQPKQPGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
RPSM SV+LMLG E LP+PK+PG+ DR SS ES STN I+ S LE R
Sbjct: 730 RPSMASVVLMLGGERTLPKPKEPGFFKDRGPVEAYSSSSKVESSSTNEISTSVLEPR 786
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1390), Expect = e-151, Method: Compositional matrix adjust.
Identities = 275/417 (65%), Positives = 316/417 (75%), Gaps = 41/417 (9%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKIVVIVISSAALLAVLLIAGYLIR 60
+W+G LIDIR F GGQ+LYIRM+ SE E
Sbjct: 407 IWYGGLIDIRQFPAGGQELYIRMNPSESEMD----------------------------- 437
Query: 61 KRRRNIAEKTENDQI---QNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLV 117
+NDQI +N DLELP FE A IV+ATNNFSI KLGQGGFGPVYKG L
Sbjct: 438 ---------QQNDQITDGENEDLELPQFEFAKIVNATNNFSIENKLGQGGFGPVYKGTLE 488
Query: 118 DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 177
DGQEIAVKRLS S QG KE KNEVIL +KLQHRNLVKLLGC IQ EE+LL+YE+MPNKS
Sbjct: 489 DGQEIAVKRLSMSSGQGSKEFKNEVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKS 548
Query: 178 LDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 237
LDSF+FDQ + +LDWSKRF+IICG ARGLLYLHQDSRLRIIHRDLK+SNVLLD+DMNPK
Sbjct: 549 LDSFLFDQTKSKLLDWSKRFNIICGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPK 608
Query: 238 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 297
ISDFGLAR FGGD+TEGNT+RVVGTYGYMAPEYA+DG FSVKSDVFSFGI+LLEIV+GKK
Sbjct: 609 ISDFGLARTFGGDQTEGNTSRVVGTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIVTGKK 668
Query: 298 NRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPED 357
+RGFYH DN+L+LIG+AW+LW EG P +L+D ++S+NL+EV++CIHI LLCVQQ+PED
Sbjct: 669 SRGFYHPDNSLSLIGYAWRLWKEGKPLELVDGLAEESWNLSEVMKCIHISLLCVQQYPED 728
Query: 358 RPSMPSVILMLGSETVLPQPKQPGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
RPSM SV+LMLG E LP+PK+PG+ DR SS ES STN I+ S LE R
Sbjct: 729 RPSMASVVLMLGGERTLPKPKEPGFFKDRGPVEAYSSSSKVESSSTNEISTSVLEPR 785
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122810|ref|XP_002330369.1| predicted protein [Populus trichocarpa] gi|222871754|gb|EEF08885.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 534 bits (1376), Expect = e-149, Method: Compositional matrix adjust.
Identities = 256/418 (61%), Positives = 328/418 (78%), Gaps = 4/418 (0%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEP---TTKIVVIVISSAALLAV-LLIAG 56
+WFGDLID+R GQD+Y+R++ASEL A + +TK+ +I+SAA L + +L+AG
Sbjct: 393 IWFGDLIDMRRSTGDGQDVYVRVAASELGANAKKRNLSTKLKAGIIASAAALGMGMLLAG 452
Query: 57 YLIRKRRRNIAEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKL 116
+ +RRRN+ + ++++ D+ELP+ +L+TI AT+NFS + KLG+GGFGPVYKG L
Sbjct: 453 MMFCRRRRNLGKNDRLEEVRKEDIELPIVDLSTIAHATDNFSSSNKLGEGGFGPVYKGIL 512
Query: 117 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 176
++GQEIAVK LSK S QG+ E KNEV +KLQHRNLVKLLG CIQ +E +LIYE+MPNK
Sbjct: 513 IEGQEIAVKSLSKSSVQGMDEFKNEVKFIAKLQHRNLVKLLGYCIQEDENMLIYEYMPNK 572
Query: 177 SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 236
SLD FIFDQ R +LDW+KR +II G ARGLLYLHQDSRLR+IHRD+KASN+LLD ++NP
Sbjct: 573 SLDFFIFDQARRKLLDWTKRMNIIGGIARGLLYLHQDSRLRVIHRDIKASNILLDNELNP 632
Query: 237 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
KISDFGLAR F GDETE NT+RV+GTYGYM+PEYAS+G FSVK+DVFSFG+L+LEIVSGK
Sbjct: 633 KISDFGLARMFRGDETEANTHRVIGTYGYMSPEYASNGHFSVKTDVFSFGVLILEIVSGK 692
Query: 297 KNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPE 356
KNRGF H D NLNL+GHAW LW +G PS+LID C N +EV+RCIH+ LLCVQQ PE
Sbjct: 693 KNRGFRHPDRNLNLLGHAWILWIKGTPSELIDECLGYLSNTSEVLRCIHVALLCVQQRPE 752
Query: 357 DRPSMPSVILMLGSETVLPQPKQPGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
DRP+MP+V+ +L +E LPQPKQPG+ + ++ SS E+CS+N ++++ LE R
Sbjct: 753 DRPNMPTVVQILCNENPLPQPKQPGFFMGKNPLEQEGSSNQMEACSSNEMSLTLLEAR 810
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 534 bits (1376), Expect = e-149, Method: Compositional matrix adjust.
Identities = 263/395 (66%), Positives = 308/395 (77%), Gaps = 12/395 (3%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKIVVIVISSAALLAVLLIAGYLIR 60
+WFGDLIDI GQ++YIRM+ASE V I +S +LL+A Y+ +
Sbjct: 395 IWFGDLIDITQLPAAGQEIYIRMNASESSECLSLVLMAVGIALSIFVACGILLVAYYIFK 454
Query: 61 KRRRNIAEKT--------ENDQIQN---IDLELPLFELATIVSATNNFSINKKLGQGGFG 109
++ + I + T ENDQI + DLELPLF+ TI ATN FS N KLG+GGFG
Sbjct: 455 RKAKLIGKVTLTAFSNREENDQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFG 514
Query: 110 PVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169
PVYKG L DGQEIA K S+ S QG+ E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+
Sbjct: 515 PVYKGTLEDGQEIAAKTHSRSSGQGINEFKNEVILITKLQHRNLVKLLGCCIQGEEKILV 574
Query: 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 229
YE+MPNKSLDSFIFDQ R +LDWSKRF IICG ARGLLYLHQDSRLRI+HRDLKASNVL
Sbjct: 575 YEYMPNKSLDSFIFDQTRGELLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVL 634
Query: 230 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 289
LD+DMNPKISDFGLAR FGGD+TEGNT RVVGTYGYMAPEYA+DG FSVKSDVFSFGIL+
Sbjct: 635 LDKDMNPKISDFGLARMFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILM 694
Query: 290 LEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVI-RCIHIGL 348
LEI+SGKK+RGFYH D++L+LIGHAW+LW +G P LI++ +S NL+EVI RCI+I L
Sbjct: 695 LEIISGKKSRGFYHPDHSLSLIGHAWRLWKDGKPLDLIEAFPGESRNLSEVIMRCINISL 754
Query: 349 LCVQQHPEDRPSMPSVILMLGSETVLPQPKQPGYL 383
LCVQQHP+DRPSM +V+ MLG E LPQP +PG+
Sbjct: 755 LCVQQHPDDRPSMATVVWMLGCENTLPQPNEPGFF 789
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 531 bits (1367), Expect = e-148, Method: Compositional matrix adjust.
Identities = 265/417 (63%), Positives = 315/417 (75%), Gaps = 4/417 (0%)
Query: 2 WFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPT--TKIVVIVISSAALL-AVLLIAGYL 58
WFGDLID R +GGQD+YIR++AS+ GE K VI A +L + +LI G +
Sbjct: 396 WFGDLIDTRRLAEGGQDIYIRLAASQSGVTGEKKRKKKTHAGVIGGAVILGSSILILGIV 455
Query: 59 IRKRRRNIAEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVD 118
RRR + + + ++ELP+ +L TI AT+NFS +KKLG+GGFG VYKG+L++
Sbjct: 456 FCIRRRKHRKNGNFEDRKEEEMELPMLDLTTIEHATDNFSSSKKLGEGGFGAVYKGELIE 515
Query: 119 GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 178
GQEIAVKRLSK S QGL E KNEV+L +KLQHRNLVKLLGCCI +EK+LIYE+MPN+SL
Sbjct: 516 GQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDEKMLIYEYMPNRSL 575
Query: 179 DSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 238
DSFIFD R LDWSKR HII G ARGLLYLHQDSRLRIIHRD+KASN+LLD ++NPKI
Sbjct: 576 DSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKASNILLDNELNPKI 635
Query: 239 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 298
SDFGLAR FGGD+TE NT RVVGTYGYM+PEYA DG FSVKSDVFSFG+L+LEIVSGKKN
Sbjct: 636 SDFGLARMFGGDQTEANTKRVVGTYGYMSPEYALDGHFSVKSDVFSFGVLVLEIVSGKKN 695
Query: 299 RGFYHSD-NNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPED 357
RGF H D N NL+GHAW LW G+P +LID CF DS +E +RCIH+ LLCVQQ PED
Sbjct: 696 RGFCHPDYNQKNLLGHAWMLWFNGIPLELIDECFADSCTPSEALRCIHVALLCVQQRPED 755
Query: 358 RPSMPSVILMLGSETVLPQPKQPGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
RP+M SV+LMLGSE LPQPKQPG+ +D SS +S S N +TV+ L+ R
Sbjct: 756 RPNMSSVVLMLGSENPLPQPKQPGFFMGSNPPEKDTSSNKHQSHSANEVTVTLLQAR 812
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 529 bits (1362), Expect = e-147, Method: Compositional matrix adjust.
Identities = 263/429 (61%), Positives = 328/429 (76%), Gaps = 15/429 (3%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSAS----ELEAKGEPTTKIVVIVISSAA--LLAVLLI 54
+WFGDLIDIR + + GQD+YIR++AS ++++G+ +I+VI +S A LLA+ L
Sbjct: 403 LWFGDLIDIRQYNENGQDIYIRIAASVIDKPVKSRGKKRVRIIVIPVSLVAFSLLALCLF 462
Query: 55 AGYLIRKRRR------NIAEKTENDQIQ---NIDLELPLFELATIVSATNNFSINKKLGQ 105
+L + +++ N+ E D+ + N DLELPLF+LAT+ ATN FSIN KLGQ
Sbjct: 463 LRFLRKNKQQQLTREGNVVTNPEQDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQ 522
Query: 106 GGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 165
GGFGPVYKG L DGQEIAVKRLSK S QG+ E +NEV+ +KLQHRNLVKLLGCCI+ EE
Sbjct: 523 GGFGPVYKGILQDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEE 582
Query: 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKA 225
++LIYE+MPNKSLDSFIFD+ R M+LDW+KRF II G ARGLLYLHQDSRLRIIHRDLKA
Sbjct: 583 RMLIYEYMPNKSLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKA 642
Query: 226 SNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSF 285
SN+LLD +MNPKISDFG+AR+FGGDET NT+R+VGTYGYM+PEYA DG FSVKSDVFSF
Sbjct: 643 SNILLDYEMNPKISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSF 702
Query: 286 GILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIH 345
G+L+LEIVSG+KNRGF H+++ LNL+GHAW L EG P LID D+ ++EV+R I
Sbjct: 703 GVLVLEIVSGRKNRGFRHAEHKLNLLGHAWMLHKEGRPLDLIDESIVDTCIISEVLRSIE 762
Query: 346 IGLLCVQQHPEDRPSMPSVILMLGSETVLPQPKQPGYLADRKSTRRDYSSIMPESCSTNT 405
+ LLCVQ+ PEDRP M V+LML S+ VLPQPK+PG+ +R + S+I E S N
Sbjct: 763 VALLCVQKSPEDRPKMSIVVLMLSSDIVLPQPKEPGFFTERDLSNDSSSTIKHEISSVNE 822
Query: 406 ITVSGLEGR 414
+T + LE R
Sbjct: 823 LTSTLLEAR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 529 bits (1362), Expect = e-147, Method: Compositional matrix adjust.
Identities = 271/441 (61%), Positives = 320/441 (72%), Gaps = 27/441 (6%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKIVVIVISSAALLAVLLIAGYLIR 60
+WFGDLIDIR F DGGQ++YIRM+ASE + I +S +LL+A Y+ +
Sbjct: 396 IWFGDLIDIRQFPDGGQEIYIRMNASESSECLSLIKMEMGIALSIFVACGMLLVAYYIFK 455
Query: 61 KRRRN------------------IAEKT-----ENDQIQN---IDLELPLFELATIVSAT 94
+ + ++EKT ENDQI + D+ELPLF+ TI AT
Sbjct: 456 RTEKLKAHYSFLLVYHVCDSHSLLSEKTGGNREENDQIDSGPMEDMELPLFQFTTIAKAT 515
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
N FS+N K+G+GGFGPVYKG L DGQEIAVK LS+ S QGL E KNEVIL +KLQHRNLV
Sbjct: 516 NGFSLNNKIGEGGFGPVYKGTLEDGQEIAVKTLSRSSGQGLNEFKNEVILITKLQHRNLV 575
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
KLLGCCIQGEEK+L+YE+MPN+SLDSFIFDQ R +LDWSKRF IICG ARGLLYLHQDS
Sbjct: 576 KLLGCCIQGEEKILVYEYMPNRSLDSFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDS 635
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
RLRI+HRDLKASNVLLD+DMNPKISDFGLAR GGD+TEGNT RV+GTYGYMAPEYA+DG
Sbjct: 636 RLRIVHRDLKASNVLLDKDMNPKISDFGLARMVGGDQTEGNTTRVIGTYGYMAPEYATDG 695
Query: 275 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334
FSVKSDVFSFGIL+LEI+SGKK+RGFYH D +L+L HAW+LW +G P LI++ +S
Sbjct: 696 LFSVKSDVFSFGILMLEIISGKKSRGFYHPDRSLSLTAHAWRLWKDGKPLDLIEAFPGES 755
Query: 335 FNLAEVI-RCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLPQPKQPGYLADRKSTRRDY 393
NL+EVI RCI+I LLCVQ HP+DRPSM +V+ MLG E LPQP +PG+
Sbjct: 756 RNLSEVIMRCINISLLCVQHHPDDRPSMATVVWMLGGENTLPQPNEPGFFKGSGPFGPSS 815
Query: 394 SSIMPESCSTNTITVSGLEGR 414
SS E S N T S L R
Sbjct: 816 SSSNIELYSNNEFTASLLYPR 836
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 414 | ||||||
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.990 | 0.503 | 0.571 | 1.2e-122 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.811 | 0.429 | 0.629 | 1.2e-119 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.838 | 0.408 | 0.615 | 4.1e-119 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.809 | 0.397 | 0.625 | 6.7e-119 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.809 | 0.395 | 0.616 | 3.3e-117 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.806 | 0.393 | 0.579 | 1.2e-110 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.818 | 0.402 | 0.556 | 2.5e-104 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.804 | 0.401 | 0.583 | 3.7e-103 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.985 | 0.515 | 0.501 | 1.4e-101 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.811 | 0.497 | 0.560 | 2.3e-101 |
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1206 (429.6 bits), Expect = 1.2e-122, P = 1.2e-122
Identities = 237/415 (57%), Positives = 299/415 (72%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKXXXXXXXXXXXXXXXXXXGYLIR 60
+WFGDL+D+R + GQD+YIRM +++E KG + +
Sbjct: 405 LWFGDLVDMREYSSFGQDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKK 464
Query: 61 KRRRNIAEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQ 120
+R E I+ DL+LP+F+ TI AT++FS LG+GGFGPVYKGKL DGQ
Sbjct: 465 IMKRYRGENFRKG-IEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQ 523
Query: 121 EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 180
EIAVKRLS S QG++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+MPNKSLD
Sbjct: 524 EIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDF 583
Query: 181 FIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 240
FIFD+ R LDW KR +II G ARG+LYLHQDSRLRIIHRDLKA NVLLD DMNPKISD
Sbjct: 584 FIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISD 643
Query: 241 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 300
FGLA++FGGD++E +TNRVVGTYGYM PEYA DG FSVKSDVFSFG+L+LEI++GK NRG
Sbjct: 644 FGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRG 703
Query: 301 FYHSDNNLNLIGHAWKLWNEGMPSQLIDS-CFQDSFNLAEVIRCIHIGLLCVQQHPEDRP 359
F H+D++LNL+GH WK+W E ++ + +++ + EV+RCIH+ LLCVQQ PEDRP
Sbjct: 704 FRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRP 763
Query: 360 SMPSVILMLGSETVLPQPKQPGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
+M SV+LM GS++ LP P QPG+ +R D SS + S N ++++ L+GR
Sbjct: 764 TMASVVLMFGSDSSLPHPTQPGFFTNRNVP--DISSSLSLR-SQNEVSITMLQGR 815
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1085 (387.0 bits), Expect = 1.2e-119, Sum P(2) = 1.2e-119
Identities = 212/337 (62%), Positives = 258/337 (76%)
Query: 79 DLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKEL 138
DLELP +L T+ AT+ FS KLGQGGFGPVYKG L GQE+AVKRLS+ S QG++E
Sbjct: 447 DLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEF 506
Query: 139 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFH 198
KNE+ L +KLQHRNLVK+LG C+ EE++LIYE+ PNKSLDSFIFD+ER LDW KR
Sbjct: 507 KNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVE 566
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
II G ARG+LYLH+DSRLRIIHRDLKASNVLLD DMN KISDFGLAR GGDETE NT R
Sbjct: 567 IIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTR 626
Query: 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318
VVGTYGYM+PEY DG FS+KSDVFSFG+L+LEIVSG++NRGF + ++ LNL+GHAW+ +
Sbjct: 627 VVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQF 686
Query: 319 NEGMPSQLIDSCFQDSF-NLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLPQP 377
E ++ID +S +++EV+R IHIGLLCVQQ P+DRP+M V+LML SE +L P
Sbjct: 687 LEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDP 746
Query: 378 KQPGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
+QPG+ +R D SI E S N T+S ++ R
Sbjct: 747 RQPGFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1085 (387.0 bits), Expect = 4.1e-119, Sum P(2) = 4.1e-119
Identities = 221/359 (61%), Positives = 261/359 (72%)
Query: 63 RRNIAEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEI 122
RR+I+ + D DLELPL E + ATNNFS KLGQGGFG VYKGKL+DGQE+
Sbjct: 497 RRHISRENNTD-----DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEM 551
Query: 123 AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 182
AVKRLSK S QG E KNEV L ++LQH NLV+LL CC+ EK+LIYE++ N SLDS +
Sbjct: 552 AVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHL 611
Query: 183 FDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 242
FD+ R L+W RF II G ARGLLYLHQDSR RIIHRDLKASN+LLD+ M PKISDFG
Sbjct: 612 FDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFG 671
Query: 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 302
+AR FG DETE NT +VVGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+S K+N+GFY
Sbjct: 672 MARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFY 731
Query: 303 HSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS---FNLAEVIRCIHIGLLCVQQHPEDRP 359
+SD +LNL+G W+ W EG ++ID DS F E++RCI IGLLCVQ+ EDRP
Sbjct: 732 NSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRP 791
Query: 360 SMPSVILMLGSE-TVLPQPKQPGYLADRKSTRRDYSSIMP---ESCSTNTITVSGLEGR 414
+M VILMLGSE T +PQPK PGY +R D SS ES + N ITVS L+ R
Sbjct: 792 TMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1087 (387.7 bits), Expect = 6.7e-119, Sum P(2) = 6.7e-119
Identities = 214/342 (62%), Positives = 260/342 (76%)
Query: 80 LELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELK 139
LELPL EL + +ATNNFS + KLGQGGFG VYKG+L+DG+EIAVKRLSK+S QG E
Sbjct: 502 LELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFM 561
Query: 140 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHI 199
NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +FDQ R L+W KRF I
Sbjct: 562 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 621
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 259
I G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG+AR FG +ETE NT RV
Sbjct: 622 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 681
Query: 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN 319
VGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+SGK+N+GFY+S+ +LNL+G W+ W
Sbjct: 682 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWK 741
Query: 320 EGMPSQLIDSCFQDS----FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV-L 374
EG +++D DS F E++RCI IGLLCVQ+ EDRP M SV++MLGSET +
Sbjct: 742 EGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAI 801
Query: 375 PQPKQPGYLADRKSTRRDYSSIMP--ESCSTNTITVSGLEGR 414
PQPK+PG+ R D SS + C+ N IT+S ++ R
Sbjct: 802 PQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1080 (385.2 bits), Expect = 3.3e-117, Sum P(2) = 3.3e-117
Identities = 211/342 (61%), Positives = 256/342 (74%)
Query: 80 LELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELK 139
LELPL E + ATNNFS + KLGQGGFG VYKG L+DG+EIAVKRLSK+S QG E
Sbjct: 506 LELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFM 565
Query: 140 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHI 199
NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +FDQ R L+W KRF I
Sbjct: 566 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 625
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 259
I G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG+AR FG +ETE NT RV
Sbjct: 626 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 685
Query: 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN 319
VGTYGYM+PEYA DG FS+KSDVFSFG+LLLEI+SGK+N+GFY+S+ +LNL+G W+ W
Sbjct: 686 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWK 745
Query: 320 EGMPSQLID----SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV-L 374
EG +++D F E++RCI IGLLCVQ+ EDRP M SV++MLGSET +
Sbjct: 746 EGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAI 805
Query: 375 PQPKQPGYLADRKSTRRDYSSIMP--ESCSTNTITVSGLEGR 414
PQPK+PG+ R S D SS + C+ N +T+S ++ R
Sbjct: 806 PQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 1035 (369.4 bits), Expect = 1.2e-110, Sum P(3) = 1.2e-110
Identities = 194/335 (57%), Positives = 257/335 (76%)
Query: 81 ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKN 140
EL ++ L I +AT+NFS + KLG+GGFGPVY G L G+E+AVKRL + S QGL+E KN
Sbjct: 514 ELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKN 573
Query: 141 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHII 200
EVIL +KLQHRNLV+LLGCCI EEK+L+YE+MPNKSLD+F+F+ E+ +LDW KRF II
Sbjct: 574 EVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDII 633
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
G ARGLLYLH+DSRLR++HRDLKASN+LLD DM PKISDFG+AR FGGD+ + NTNRVV
Sbjct: 634 EGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVV 693
Query: 261 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE 320
GT+GYM+PEYA +G FSVKSDV+ FG+L+LEI++GK+ F+ +++LN+ G+AW+ WNE
Sbjct: 694 GTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNE 753
Query: 321 GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV-LPQPKQ 379
++LID + S ++ +V+RCIHI LLCVQ H ++RP +P+VILML +++ LP P+
Sbjct: 754 DNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRP 813
Query: 380 PGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
P + + SS S S T+T++ L GR
Sbjct: 814 PTLMLRGREIESSKSSEKDRSHSIGTVTMTQLHGR 848
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 2.5e-104, Sum P(2) = 2.5e-104
Identities = 191/343 (55%), Positives = 252/343 (73%)
Query: 73 DQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISE 132
DQ+ DL P+F ++ SAT +F+ KLGQGGFG VYKG +G+EIAVKRLS S+
Sbjct: 503 DQVDTPDL--PIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSK 560
Query: 133 QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILD 192
QGL+E KNE++L +KLQHRNLV+LLGCCI+ EK+L+YE+MPNKSLD F+FD+ + LD
Sbjct: 561 QGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLD 620
Query: 193 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252
W KR+ +I G ARGLLYLH+DSRL+IIHRDLKASN+LLD +MNPKISDFG+AR F +
Sbjct: 621 WRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQD 680
Query: 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIG 312
NT RVVGTYGYMAPEYA +G FS KSDV+SFG+L+LEIVSG+KN F +D+ +LIG
Sbjct: 681 HANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHG-SLIG 739
Query: 313 HAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372
+AW LW++G ++ID +D+ ++ E +RCIH+G+LC Q RP+M SV+LML S+T
Sbjct: 740 YAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQT 799
Query: 373 V-LPQPKQPGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
LP P+QP + + S + + + S N +T + + GR
Sbjct: 800 SQLPPPRQPTFHSFLNSGDIELNFDGHDVASVNDVTFTTIVGR 842
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1022 (364.8 bits), Expect = 3.7e-103, P = 3.7e-103
Identities = 196/336 (58%), Positives = 250/336 (74%)
Query: 81 ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKN 140
ELPLFE + ATNNFSI KLGQGGFG VYKG+L +G +IAVKRLS+ S QG++E N
Sbjct: 496 ELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVN 555
Query: 141 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHII 200
EV++ SKLQHRNLV+LLG CI+GEE++L+YEFMP LD+++FD + +LDW RF+II
Sbjct: 556 EVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNII 615
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
G RGL+YLH+DSRL+IIHRDLKASN+LLD+++NPKISDFGLAR F G+E E +T RVV
Sbjct: 616 DGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVV 675
Query: 261 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE 320
GTYGYMAPEYA G FS KSDVFS G++LLEIVSG++N FY+ N NL +AWKLWN
Sbjct: 676 GTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNT 735
Query: 321 GMPSQLIDSC-FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV-LPQPK 378
G L+D F++ F E+ RC+H+GLLCVQ H DRPS+ +VI ML SE LP+PK
Sbjct: 736 GEDIALVDPVIFEECFE-NEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPK 794
Query: 379 QPGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
QP ++ R ++ + S S N ++++ + GR
Sbjct: 795 QPAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1007 (359.5 bits), Expect = 1.4e-101, P = 1.4e-101
Identities = 208/415 (50%), Positives = 271/415 (65%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIRMSASELEAKGEPTTKXXXXXXXXXXXXXXXXXXGYLIR 60
MW DL+D F GG+ L IR++ SEL+ T G+ R
Sbjct: 384 MWSKDLMDTMQFSAGGEILSIRLAHSELDVHKRKMTIVASTVSLTLFVILGFATFGFW-R 442
Query: 61 KRRRNIAEKTENDQIQNIDLE-LPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDG 119
R ++ + ND +Q+ D+ L FE+ TI +AT+NFS++ KLG GGFG VYKGKL DG
Sbjct: 443 NRVKH-HDAWRND-LQSQDVPGLEFFEMNTIQTATSNFSLSNKLGHGGFGSVYKGKLQDG 500
Query: 120 QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 179
+EIAVKRLS SEQG +E NE++L SKLQHRNLV++LGCC++G+EKLLIYEFM NKSLD
Sbjct: 501 REIAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGKEKLLIYEFMKNKSLD 560
Query: 180 SFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 239
+F+F + + LDW KRF II G RGLLYLH+DSRLR+IHRDLK SN+LLD+ MNPKIS
Sbjct: 561 TFVFGSRKRLELDWPKRFDIIQGIVRGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKIS 620
Query: 240 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNR 299
DFGLAR F G + + T RVVGT GYM+PEYA G FS KSD++SFG+LLLEI+SG+K
Sbjct: 621 DFGLARLFQGSQYQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGEKIS 680
Query: 300 GFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRP 359
F + + L+ + W+ W E L+D DS + AEV RC+ IGLLCVQ P DRP
Sbjct: 681 RFSYGEEGKALLAYVWECWCETRGVNLLDQALDDSSHPAEVGRCVQIGLLCVQHQPADRP 740
Query: 360 SMPSVILMLGSETVLPQPKQPGYLADRKSTRRDYSSIMPESCSTNTITVSGLEGR 414
+ ++ ML + + LP PKQP + ++ + +M + N +T S + GR
Sbjct: 741 NTLELLSMLTTTSDLPLPKQPTFAVHTRNDEPPSNDLM---ITVNEMTESVILGR 792
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1005 (358.8 bits), Expect = 2.3e-101, P = 2.3e-101
Identities = 190/339 (56%), Positives = 252/339 (74%)
Query: 57 YLIRKRRRN-IAEKTEN-DQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKG 114
+L+ +RR N ++ +TE+ D+ E F+ + I +ATN FS + KLG GGFG VYKG
Sbjct: 305 WLLARRRNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKG 364
Query: 115 KLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174
+L+ G+ +A+KRLS+ S QG +E KNEV + +KLQHRNL KLLG C+ GEEK+L+YEF+P
Sbjct: 365 QLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVP 424
Query: 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 234
NKSLD F+FD E+ +LDW +R+ II G ARG+LYLH+DSRL IIHRDLKASN+LLD DM
Sbjct: 425 NKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADM 484
Query: 235 NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+PKISDFG+AR FG D+T+ NT R+VGTYGYM+PEYA G++SVKSDV+SFG+L+LE+++
Sbjct: 485 HPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELIT 544
Query: 295 GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQH 354
GKKN FY D +L+ + WKLW E P +L+D + +F EVIRCIHI LLCVQ+
Sbjct: 545 GKKNSSFYEEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQED 604
Query: 355 PEDRPSMPSVILMLGSETV-LPQPKQPGYLADRKSTRRD 392
+RPSM +++M+ S TV LP PK+ G+L RD
Sbjct: 605 SSERPSMDDILVMMNSFTVTLPIPKRSGFLLRTMKDSRD 643
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.254.15.1 | annotation not avaliable (816 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 414 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-57 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-56 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-55 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-42 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-36 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-32 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-31 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-31 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-30 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-29 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-27 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-27 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-26 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-25 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-24 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-24 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-15 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-13 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-08 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 6e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 3e-57
Identities = 97/281 (34%), Positives = 144/281 (51%), Gaps = 35/281 (12%)
Query: 98 SINKKLGQGGFGPVYKGKLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 151
++ KKLG+G FG VYKGKL E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
N+VKLLG C + E ++ E+M L S++ ++ L S ARG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAP 268
IHRDL A N L+ +++ KISDFGL+R D + + R G +MAP
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAP 172
Query: 269 EYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327
E +G+F+ KSDV+SFG+LL EI + G++ Y +N ++ + L N Q
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQ---PYPGMSNEEVLEY---LKNGYRLPQ-P 225
Query: 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+C + ++L L C + PEDRP+ ++ +L
Sbjct: 226 PNCPPELYDLM---------LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 2e-56
Identities = 95/274 (34%), Positives = 139/274 (50%), Gaps = 34/274 (12%)
Query: 98 SINKKLGQGGFGPVYKGKLVDG-----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 151
++ KKLG+G FG VYKG L E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
N+VKLLG C + E +++ E+MP L ++ R L S ARG+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE 120
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAP 268
IHRDL A N L+ +++ KISDFGL+R D + + +V G +MAP
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAP 173
Query: 269 EYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327
E +G+F+ KSDV+SFG+LL EI + G++ Y +N ++ + K +P
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEE---PYPGMSNAEVLEYLKK--GYRLPK--P 226
Query: 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361
+C + + L L C + PEDRP+
Sbjct: 227 PNCPPELYKLM---------LQCWAEDPEDRPTF 251
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 2e-55
Identities = 93/290 (32%), Positives = 129/290 (44%), Gaps = 51/290 (17%)
Query: 101 KKLGQGGFGPVYKGKLVDGQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 155
KKLG+G FG VYKGKL E+AVK L + SE+ K+ E + KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSFI------FDQERCMILDWSKRFHIICGTARGLLY 209
LLG C + E L+ E+M L ++ F L A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTNRVVGTYGYMAP 268
L + +HRDL A N L+ +D+ KISDFGL+R + D T + +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 269 EYASDGQFSVKSDVFSFGILLLEIVS-------GKKN---RGFYHSDNNLNLIGHAWKLW 318
E DG F+ KSDV+SFG+LL EI + G N + L
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP--------- 227
Query: 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
P + C + L E++ C Q PEDRP+ ++ L
Sbjct: 228 ---KP----EYCPDE---LYELMLS------CWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 2e-52
Identities = 77/210 (36%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 97 FSINKKLGQGGFGPVYKGKLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQH 150
+ KKLG+G FG VYKG L ++AVK L + SE+ +E E + KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
N+V+LLG C QGE ++ E+MP L F+ L + A+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIAKGMEYL 118
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY----- 265
+HRDL A N L+ +++ KISDFGL+R D+ G
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-----RKRGGGKLPIKW 170
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSG 295
MAPE DG+F+ KSDV+SFG+LL EI +
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-50
Identities = 73/266 (27%), Positives = 121/266 (45%), Gaps = 24/266 (9%)
Query: 97 FSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 154
+ I +KLG+G FG VY + G+ +A+K + K + +E + E+ + KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+L ++ L+ E+ L + + + D ++ + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEAR--FYLRQILSALEYLHS-- 115
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
I+HRDLK N+LLD+D + K++DFGLAR E VGT YMAPE
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171
Query: 275 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334
+ D++S G++L E+++GK + D+ L + P D S
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKP---PFPGDDQLLELFKKIGKPKPPFPPPEWDI----S 224
Query: 335 FNLAEVIRCIHIGLLCVQQHPEDRPS 360
++IR + + PE R +
Sbjct: 225 PEAKDLIRK------LLVKDPEKRLT 244
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 5e-50
Identities = 72/194 (37%), Positives = 102/194 (52%), Gaps = 11/194 (5%)
Query: 103 LGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 160
LG+GGFG VY + G+++A+K + K L E L E+ + KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 161 IQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIH 220
L+ E+ SL + + E L + I+ GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 221 RDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YASDGQFSV 278
RDLK N+LLD D K++DFGL++ D++ T +VGT YMAPE G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 279 KSDVFSFGILLLEI 292
KSD++S G++L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 4e-48
Identities = 75/252 (29%), Positives = 112/252 (44%), Gaps = 26/252 (10%)
Query: 97 FSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 153
+ + +KLG G FG VYK K G+ +AVK L K + + + E+ + +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
V+L+ + L+ E+ L ++ L + I RGL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLH-- 115
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YAS 272
IIHRDLK N+LLD++ KI+DFGLA+ + + VGT YMAPE
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLG 172
Query: 273 DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN-----LNLIGHA-----WKLWNEGM 322
+ K DV+S G++L E+++GK F + + I W+ G
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPP--FSGENILDQLQLIRRILGPPLEFDEPKWSSGS 230
Query: 323 PS--QLIDSCFQ 332
LI C
Sbjct: 231 EEAKDLIKKCLN 242
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 5e-47
Identities = 82/279 (29%), Positives = 138/279 (49%), Gaps = 43/279 (15%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVD-GQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 152
++ + LG+G FG VY D G+ +AVK LS SE+ L+ L+ E+ + S LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 153 LVKLLGCCIQGEEK-LLIY-EFMPNKSLDSFIFDQERCMILDWSKRF-----HIICGTAR 205
+V+ G E+ L I+ E++ SL S + K+F +I R
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL------------KKFGKLPEPVIRKYTR 108
Query: 206 ----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 261
GL YLH I+HRD+K +N+L+D D K++DFG A+ G ET T V G
Sbjct: 109 QILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG 321
T +MAPE ++ +D++S G ++E+ +GK + N + + +K+ + G
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK--PPWSELGNPMAAL---YKIGSSG 220
Query: 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
P ++ + ++ + +R C+++ P+ RP+
Sbjct: 221 EPPEIPEHLSEE---AKDFLRK------CLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-42
Identities = 80/265 (30%), Positives = 127/265 (47%), Gaps = 23/265 (8%)
Query: 97 FSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 155
F I +K+G+GGFG VYK + G+E+A+K + S++ +++ NE+ + K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSR 215
G ++ +E ++ EF SL + + L S+ ++ +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS--- 116
Query: 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 275
IIHRD+KA+N+LL D K+ DFGL+ N +VGT +MAPE +
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKP 173
Query: 276 FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335
+ K+D++S GI +E+ GK L I G P + D F
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT------NGPPGLRNPEKWSDEF 227
Query: 336 NLAEVIRCIHIGLLCVQQHPEDRPS 360
C+Q++PE RP+
Sbjct: 228 K--------DFLKKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 6e-38
Identities = 88/268 (32%), Positives = 129/268 (48%), Gaps = 29/268 (10%)
Query: 97 FSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 156
F++ +KLG G FG V++G + +A+K L ++ + EV +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRL 216
C GE +I E M SL +F+ E +L + + C A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 217 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF 276
IHRDL A N+L+ +D+ K++DFGLAR D + ++ Y + APE AS G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 277 SVKSDVFSFGILLLEIVSGKKNRGF--YHSDNNLNLIGHAWKLWNEG--MPSQLIDSCFQ 332
S KSDV+SFGILL E+ + G Y NN + G MP C Q
Sbjct: 182 STKSDVWSFGILLYEMFT----YGQVPYPGMNN----HEVYDQITAGYRMPCPA--KCPQ 231
Query: 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
+ + + L C PEDRPS
Sbjct: 232 EIYKIM---------LECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 69/213 (32%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 96 NFSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRN 152
N+ + +G+G FG VYKG L G +A+K++S KI E+ LK + E+ L L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFH------IICGTA-- 204
+VK +G + +I E+ N SL I K+F +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII------------KKFGPFPESLVAVYVYQV 108
Query: 205 -RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
+GL YLH+ +IHRD+KA+N+L +D K++DFG+A + + VVGT
Sbjct: 109 LQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTP 163
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
+MAPE S SD++S G ++E+++G
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 27/205 (13%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 159
+K+G+G G VYK G+E+A+K++ ++ +Q + + NE+++ +H N+V
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDS 83
Query: 160 CIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF----HI--ICG-TARGLLYLHQ 212
+ G+E ++ E+M SL I+ + I +C +GL YLH
Sbjct: 84 YLVGDELWVVMEYMDGGSLTD---------IITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR--VVGTYGYMAPEY 270
+IHRD+K+ N+LL +D + K++DFG F T+ + R VVGT +MAPE
Sbjct: 135 ---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGTPYWMAPEV 187
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSG 295
+ K D++S GI+ +E+ G
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 103 LGQGGFGPVYKGKLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 158
LG+G FG V + D G+ A+K L K I + ++ E + S++ H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 159 CCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLR 217
Q EEKL L+ E+ P L S + +E + ++ + L YLH L
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFY--AAEIVLALEYLH---SLG 113
Query: 218 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFS 277
II+RDLK N+LLD D + K++DFGLA+ + + NT GT Y+APE +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYG 171
Query: 278 VKSDVFSFGILLLEIVSGKKNRGFYHSDNNL 308
D +S G+LL E+++GK FY D
Sbjct: 172 KAVDWWSLGVLLYEMLTGK--PPFYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 127 bits (323), Expect = 3e-34
Identities = 82/275 (29%), Positives = 131/275 (47%), Gaps = 37/275 (13%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 152
+ I K++G+G FG VY + DG+ +K LS +SE+ ++ NEV + KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERC-------MILDWSKRFHIICGTAR 205
++K + + ++ E+ L I Q++ ILDW F +C
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FVQLC---L 114
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
L YLH SR +I+HRD+K N+ L + K+ DFG+++ T VVGT Y
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYY 169
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325
++PE + ++ KSD++S G +L E+ + K F NL+ A K+ P
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLK--HPFEGE----NLLELALKILKGQYPP- 222
Query: 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
I S + S L ++ +Q+ PE+RPS
Sbjct: 223 -IPSQY--SSELRNLVS------SLLQKDPEERPS 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 83/269 (30%), Positives = 124/269 (46%), Gaps = 27/269 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ + +KLG G FG V+ G ++AVK L K + E + KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+L C + E ++ E+M SL F+ E L + + A G+ YL
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLE--- 120
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTNRVVGTYGYMAPEYA 271
IHRDL A N+L+ +++ KI+DFGLAR DE EG + T APE A
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAA 176
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331
+ G+F++KSDV+SFGILL EIV+ R Y N ++ + + P + +
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVT--YGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY 234
Query: 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
+ L C + PE+RP+
Sbjct: 235 D-------------LMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 6e-32
Identities = 82/329 (24%), Positives = 133/329 (40%), Gaps = 25/329 (7%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH-R 151
++ I +KLG+G FG VY + D + +A+K L+K + ++ E+ + + L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
N+VKL L+ E++ SL+ + R L S+ I+ L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 212 QDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLARAFGGDETEGN----TNRVVGTYGYM 266
IIHRD+K N+LLD+D K+ DFGLA+ + + + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 267 APEYA---SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323
APE S S SD++S GI L E+++G + + + + P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK--IILELPTP 233
Query: 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLPQPKQPGYL 383
S S + + + P++R S S + S +L K
Sbjct: 234 SLASP--LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL----SHDLLAHLKLKESD 287
Query: 384 ADRKSTRRDYSSIMPESCSTNTITVSGLE 412
D + + + +S L
Sbjct: 288 LSDLLKPDDSAPLRLSLPPSLEALISSLN 316
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 68/234 (29%), Positives = 110/234 (47%), Gaps = 47/234 (20%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-Q 149
++F K +G+G F V K +E A+K L K I E+ +K +K E + ++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 150 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI-----FDQERCMILDWSKRFH---II 200
H ++KL Q EE L + E+ PN L +I D++ RF+ I+
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT-------RFYAAEIL 112
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV- 259
L YLH IIHRDLK N+LLD+DM+ KI+DFG A+ + + +
Sbjct: 113 LA----LEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165
Query: 260 -----------------VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
VGT Y++PE ++ SD+++ G ++ ++++GK
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-31
Identities = 71/215 (33%), Positives = 111/215 (51%), Gaps = 25/215 (11%)
Query: 101 KKLGQGGFGPVYKGKLV------DGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNL 153
++LG+G FG VYKG+L +A+K L + +E ++ E + E L S LQH N+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------------DQERCMILDWSKRFHII 200
V LLG C + + +++E++ + L F+ D+ LD S HI
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTNRV 259
A G+ YL S +HRDL A N L+ + + KISDFGL+R + D + +
Sbjct: 131 IQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+ +M PE G+F+ +SD++SFG++L EI S
Sbjct: 188 LPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 151
++ K LGQG G VYK + G+ A+K++ E+ K+L E+ L S +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESP 59
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ----ERCM------ILDWSKRFHIIC 201
+VK G + E ++ E+M SL + E + IL
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILK--------- 110
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 261
GL YLH IIHRD+K SN+L++ KI+DFG+++ + T N VG
Sbjct: 111 ----GLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVG 162
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
T YM+PE +S +D++S G+ LLE GK
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-31
Identities = 71/195 (36%), Positives = 103/195 (52%), Gaps = 17/195 (8%)
Query: 103 LGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 162
+G+G FG V G GQ++AVK L K + E + + L+H NLV+LLG +Q
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 163 GEEKLLIYEFMPNKSLDSFIFDQERCMI-LDWSKRFHIICGTARGLLYLHQDSRLRIIHR 221
G ++ E+M SL ++ + R +I L F + G+ YL + +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL--DVCEGMEYLEEK---NFVHR 126
Query: 222 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYASDGQFSVK 279
DL A NVL+ +D+ K+SDFGLA+ E + + G + APE + +FS K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTK 179
Query: 280 SDVFSFGILLLEIVS 294
SDV+SFGILL EI S
Sbjct: 180 SDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 8e-31
Identities = 67/197 (34%), Positives = 105/197 (53%), Gaps = 8/197 (4%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 158
+K+G+G FG VYKG L E+AVK R + + K L+ IL + H N+VKL+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIG 59
Query: 159 CCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRI 218
C+Q + ++ E +P SL +F+ ++ + + K + A G+ YL +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESKN---C 114
Query: 219 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSV 278
IHRDL A N L+ ++ KISDFG++R G + + APE + G+++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 279 KSDVFSFGILLLEIVSG 295
+SDV+S+GILL E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 70/201 (34%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 101 KKLGQGGFGPVYKGKLV--DGQEI--AVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 155
K+LG G FG V KG + G+E+ AVK L + K E E + ++L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSR 215
L+G C +GE +L+ E P L ++ + + D + H + A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV---AMGMAYLESK-- 114
Query: 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYASD 273
+HRDL A NVLL KISDFG++RA G G + + APE +
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-YRATTAGRWPLKWYAPECINY 172
Query: 274 GQFSVKSDVFSFGILLLEIVS 294
G+FS KSDV+S+G+ L E S
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 101 KKLGQGGFGPVYKGK---LVDGQ--EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLV 154
K+LG+G FG V + L D ++AVK L+ EQ + + E+ + L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 155 KLLGCC--IQGEEKLLIYEFMPNKSLDSFI-FDQERCMILDWSKRFHIICGTARGLLYLH 211
K G C G LI E++P+ SL ++ +++ ++ + +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKGMDYLG 126
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTNRVVGTYGYMAPE 269
R IHRDL A N+L++ + KISDFGLA+ D + Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 270 YASDGQFSVKSDVFSFGILLLEIVS 294
+FS SDV+SFG+ L E+ +
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 69/197 (35%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 160
+KLG G FG V++G + +AVK L K K+ E + KL+H L++L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 161 IQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIH 220
E ++ E M SL ++ L + + A G+ YL + IH
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 221 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPEYASDGQFS 277
RDL A NVL+ ++ K++DFGLAR D E G + APE A +FS
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFS 182
Query: 278 VKSDVFSFGILLLEIVS 294
+KSDV+SFGILL EIV+
Sbjct: 183 IKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-30
Identities = 93/282 (32%), Positives = 129/282 (45%), Gaps = 49/282 (17%)
Query: 103 LGQGGFGPVYKGKLVD-------GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRN 152
LG G FG VY+G D +AVK L K E+ KE E L S H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCM----ILDWSKRFHIICGTARGLL 208
+VKLLG C+ E + +I E M L S++ D +L + I A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 209 YLHQDSRLRIIHRDLKASNVLL-----DQDMNPKISDFGLARAFGGDETEGNTNRVVG-- 261
YL Q + IHRDL A N L+ D D KI DFGLAR D + + R G
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEGEG 173
Query: 262 --TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLW 318
+MAPE DG+F+ +SDV+SFG+L+ EI++ G++ Y + NN ++ H
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP---YPALNNQEVLQHV---- 226
Query: 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
G Q ++C + L C Q P +RP+
Sbjct: 227 TAGGRLQKPENCPDKIYQLM---------TNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 61/201 (30%), Positives = 105/201 (52%), Gaps = 10/201 (4%)
Query: 97 FSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 155
F I +KLG+G +G VYK GQ +A+K + E+ L+E+ E+ + + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSR 215
G + + ++ E+ S+ + + L + I+ T +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 275
+ IHRD+KA N+LL+++ K++DFG++ T N V+GT +MAPE +
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 276 FSVKSDVFSFGILLLEIVSGK 296
++ K+D++S GI +E+ GK
Sbjct: 176 YNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 89/269 (33%), Positives = 132/269 (49%), Gaps = 28/269 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ KKLG G FG V+ G ++A+K L K + E L +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+L Q E +I E+M N SL F+ E + L +K + A G+ ++
Sbjct: 65 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIE--- 119
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTNRVVGTYGYMAPEYA 271
R IHRDL+A+N+L+ + + KI+DFGLAR +E EG + T APE
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAI 175
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331
+ G F++KSDV+SFGILL EIV+ R Y N +I + + + MP D+C
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVT--YGRIPYPGMTNPEVIQNLERGYR--MPRP--DNCP 229
Query: 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
++ + L LC ++ PE+RP+
Sbjct: 230 EELYELM---------RLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 29/226 (12%)
Query: 103 LGQGGFGPVYKGK---LVDGQE---IAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 155
LG+G FG V+ G+ L + +AVK L + + ++ + E L + QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSF---------IFDQER--CMILDWSKRFHIICGTA 204
G C +G+ ++++E+M + L+ F L S+ I A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT-- 262
G++YL + +HRDL N L+ D+ KI DFG++R D + RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 263 --YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306
+M PE +F+ +SDV+SFG++L EI + K + S+
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 66/208 (31%), Positives = 112/208 (53%), Gaps = 21/208 (10%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQ----EIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLV 154
K LG G FG VYKG + +G+ +A+K L + S + KE+ +E + + + H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCM----ILDWSKRFHIICGTARGLLYL 210
+LLG C+ + LI + MP L ++ + + + +L+W + A+G+ YL
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL 125
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
+ R++HRDL A NVL+ + KI+DFGLA+ DE E + +MA E
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 271 ASDGQFSVKSDVFSFGILLLEIVS-GKK 297
++ KSDV+S+G+ + E+++ G K
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 65/205 (31%), Positives = 108/205 (52%), Gaps = 10/205 (4%)
Query: 95 NNFSINKKLGQGGFGPVYKG--KLVDGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 149
+ +I K +G G FG V +G KL +EI A+K L + S++ + E + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209
H N+++L G + ++I E+M N SLD F+ +E + ++ G A G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKY 121
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 269
L S + +HRDL A N+L++ ++ K+SDFGL+R E T + APE
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178
Query: 270 YASDGQFSVKSDVFSFGILLLEIVS 294
+ +F+ SDV+SFGI++ E++S
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 72/252 (28%), Positives = 123/252 (48%), Gaps = 21/252 (8%)
Query: 96 NFSINKKLGQGGFGPVYKG-KLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 152
+F I K+G+G FG V+K + D + A+K+ LSK++ + +E +E + +KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLH 211
+++ + + ++ E+ N L + Q R + D RF I GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLH 118
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
+I+HRD+K+ N+ LD N KI D G+A+ + NT +VGT Y++PE
Sbjct: 119 SK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELC 173
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP-------S 324
D ++ KSDV++ G++L E +GK + ++N LI + + +
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHP---FDANNQGALILKIIRGVFPPVSQMYSQQLA 230
Query: 325 QLIDSCFQDSFN 336
QLID C +
Sbjct: 231 QLIDQCLTKDYR 242
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 85/266 (31%), Positives = 123/266 (46%), Gaps = 33/266 (12%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 160
KKLG G FG V+ G + ++AVK L K ++ E L LQH LV+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 161 IQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIH 220
+ E +I E+M SL F+ E +L K A G+ Y+ R IH
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 221 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYASDGQFSV 278
RDL+A+NVL+ + + KI+DFGLAR +E T R + + APE + G F++
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTI 183
Query: 279 KSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLA 338
KSDV+SFGILL EIV+ K+ GM + + S Q + +
Sbjct: 184 KSDVWSFGILLYEIVT-------------------YGKIPYPGMSNSDVMSALQRGYRMP 224
Query: 339 EVIRC----IHIGLLCVQQHPEDRPS 360
+ C I C ++ E+RP+
Sbjct: 225 RMENCPDELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 80/299 (26%), Positives = 136/299 (45%), Gaps = 50/299 (16%)
Query: 95 NNFSINKKLGQGGFGPVYKGK---LVDGQE---IAVKRLSK-ISEQGLKELKNEVILFSK 147
NN + +GQG FG V++ + L+ + +AVK L + S + + E L ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--------------------FDQER 187
H N+VKLLG C G+ L++E+M L+ F+
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 188 CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-A 246
L +++ I A G+ YL S + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 125 LP-LSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 247 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSD 305
+ D + + N + +M PE +++ +SDV+++G++L EI S G + Y+
Sbjct: 181 YSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP---YYGM 236
Query: 306 NNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSV 364
+ +I + +G D+C + +NL LC + P DRPS S+
Sbjct: 237 AHEEVIYYV----RDGNVLSCPDNCPLELYNLMR---------LCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 72/266 (27%), Positives = 126/266 (47%), Gaps = 26/266 (9%)
Query: 97 FSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 154
F++ + +G+G FG VYK Q +A+K + + +E +++++ E+ S+ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
K G ++G + +I E+ S D + LD + I+ GL YLH++
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
IHRD+KA+N+LL ++ + K++DFG++ T N VGT +MAPE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKRNTFVGTPFWMAPEVIKQS 173
Query: 275 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334
+ K+D++S GI +E+ G+ H L LI N P L + F
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-----NN--PPSLEGNKFSKP 226
Query: 335 FNLAEVIRCIHIGLLCVQQHPEDRPS 360
F + + C+ + P++RPS
Sbjct: 227 FK--DFVSL------CLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 81/276 (29%), Positives = 132/276 (47%), Gaps = 54/276 (19%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 158
+++G G FG V+ G ++ +++A+K R +SE+ E E + KL H LV+L G
Sbjct: 10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPKLVQLYG 66
Query: 159 CCIQGEEKLLIYEFMPNKSLDSFI------FDQERC--MILDWSKRFHIICGTARGLLYL 210
C + L++EFM + L ++ F QE M LD + G+ YL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCE----------GMAYL 116
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMA 267
+ +IHRDL A N L+ ++ K+SDFG+ R D+ +T GT + +
Sbjct: 117 ESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSS 169
Query: 268 PEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN---LNLIGHAWKLWNEGMPS 324
PE S ++S KSDV+SFG+L+ E+ S + + Y + +N + I ++L+ + S
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFS--EGKTPYENRSNSEVVETINAGFRLYKPRLAS 227
Query: 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
Q + Q C ++ PEDRPS
Sbjct: 228 QSVYELMQH----------------CWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 78/275 (28%), Positives = 128/275 (46%), Gaps = 51/275 (18%)
Query: 103 LGQGGFGPVYKG-KLVDGQEIAVKRLS-----KISEQGLKELKNEVILFSKLQHRNLVKL 156
LG G FG VY+G L DG AVK +S + ++ +K+L+ E+ L SKLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 157 LGCCIQGEEKLLIY-EFMPNKSLDSFI-----FDQERCMILDWSKRFHIICGTARGLLYL 210
LG + E+ L I+ E +P SL + F + +I ++++ GL YL
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP--VIRLYTRQI------LLGLEYL 118
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
H +HRD+K +N+L+D + K++DFG+A+ G+ +MAPE
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEV 172
Query: 271 -ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG----MPSQ 325
A G + + +D++S G +LE+ +GK + +K+ +P
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPPIPDH 226
Query: 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
L S + I C+Q+ P RP+
Sbjct: 227 L-------SDEAKDFIL------KCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 79/302 (26%), Positives = 133/302 (44%), Gaps = 60/302 (19%)
Query: 95 NNFSINKKLGQGGFGPVYKG---KLVDGQ---EIAVKRLSK---ISEQGLKELKNEVILF 145
++ ++LGQG FG VY+G +V G+ +A+K +++ + E+ E NE +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 146 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF----DQERC---MILDWSKRFH 198
+ ++V+LLG G+ L++ E M L S++ + E K
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
+ A G+ YL + +HRDL A N ++ +D+ KI DFG+ R D E + R
Sbjct: 124 MAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYR 176
Query: 259 VVGT----YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-------GKKNRGFYHSDNN 307
G +MAPE DG F+ KSDV+SFG++L E+ + G N +
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------EEV 230
Query: 308 LNLIGHAWKL-WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366
L + L E P +L++ + +C Q +P+ RP+ ++
Sbjct: 231 LKFVIDGGHLDLPENCPDKLLE-----------------LMRMCWQYNPKMRPTFLEIVS 273
Query: 367 ML 368
L
Sbjct: 274 SL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-26
Identities = 85/285 (29%), Positives = 133/285 (46%), Gaps = 47/285 (16%)
Query: 101 KKLGQGGFGPVYKGK---LVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 155
++LG+G FG V + L D G+ +AVK+L + + L++ + E+ + LQH N+VK
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 156 LLGCCIQ-GEEKL-LIYEFMPNKSL-DSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
G C G L L+ E++P SL D +ER D K +G+ YL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQICKGMEYL-- 124
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG---TYGYMAPE 269
R +HRDL N+L++ + KI DFGL + D+ E R G + Y APE
Sbjct: 125 -GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APE 181
Query: 270 YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329
++ +FSV SDV+SFG++L E+ F +SD + + ++ Q+I
Sbjct: 182 SLTESKFSVASDVWSFGVVLYEL--------FTYSDKSCSPPAEFMRMMGNDKQGQMI-- 231
Query: 330 CFQDSFNLAEVIR----------C---IH-IGLLCVQQHPEDRPS 360
++L E+++ C I+ I C P RPS
Sbjct: 232 ----VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 25/212 (11%)
Query: 97 FSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ 149
+ ++G+G +G VYK + G+ +A+K++ +E ++E+K L KL+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLR 56
Query: 150 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
H N+V+L + +++E+M + L + E + S+ + GL
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGL 113
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
YLH + I+HRD+K SN+L++ D K++DFGLAR + + TNRV+ T Y
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169
Query: 268 PEY---ASDGQFSVKSDVFSFGILLLEIVSGK 296
PE A+ ++ + D++S G +L E+ GK
Sbjct: 170 PELLLGAT--RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 96 NFSINKKLGQGGFGPVYKGKLV----DGQE--IAVKRLSKI-SEQGLKELKNEVILFSKL 148
+ ++ + LG G FG VY+G D E +AVK L + SEQ + E ++ SK
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD----QERCMILDWSKRFHIICGTA 204
H+N+V+L+G + + ++ E M L SF+ + ER L A
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLARAFGGDETEGNTNRVVG 261
+G YL ++ IHRD+ A N LL KI+DFG+AR R +
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-------GKKNR 299
+M PE DG F+ K+DV+SFG+LL EI S G+ N+
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-26
Identities = 68/206 (33%), Positives = 103/206 (50%), Gaps = 25/206 (12%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLG 158
K+LG G FG V+ GK ++A+K + + +SE E E + KL H NLV+L G
Sbjct: 10 KELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYG 66
Query: 159 CCIQGEEKLLIYEFMPNKSLDSFIFDQERC----MILDWSKRFHIICGTARGLLYLHQDS 214
C + ++ E+M N L +++ +++ +LD +C + YL +
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD---VC---EAMEYLESNG 120
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPEYA 271
IHRDL A N L+ +D K+SDFGLAR D+ + GT + PE
Sbjct: 121 ---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVF 173
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKK 297
+FS KSDV+SFG+L+ E+ S K
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRL-----SKISEQGLKELKNEVILFSKLQHRNLV 154
+LG G G V K G+ +AVK + I +Q L+EL IL K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD---ILH-KCNSPYIV 62
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
G + + E+M SLD + + + + + I +GL YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLH--E 118
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
+ +IIHRD+K SN+L++ K+ DFG++ G VGT YMAPE
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQGN 174
Query: 275 QFSVKSDVFSFGILLLEIVSGK 296
+SVKSD++S G+ L+E+ +G+
Sbjct: 175 DYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 67/212 (31%), Positives = 113/212 (53%), Gaps = 19/212 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKR-----LSKISEQGLKELKNEVILFSKL 148
N+ K LGQG FG VY VD G+E+AVK+ S +++ + L+ E+ L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 149 QHRNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQERCMILDWSKRF--HIICGTAR 205
QH +V+ GC ++ +E L I+ E+MP S+ + + ++++ I+
Sbjct: 62 QHERIVQYYGC-LRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQIL----E 115
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR-VVGTYG 264
G+ YLH + I+HRD+K +N+L D N K+ DFG ++ + G + V GT
Sbjct: 116 GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
+M+PE S + K+DV+S G ++E+++ K
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 66/204 (32%), Positives = 107/204 (52%), Gaps = 20/204 (9%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSK------ISEQGLKELKNEVILFSKLQHRNL 153
K+G+G +G VYK + + G+ +A+K++ I + L+E+K L +L H N+
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNI 60
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
+KLL + L++EFM + L I D++R L S + +GL + H
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQR--GLPESLIKSYLYQLLQGLAFCHSH 117
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YAS 272
I+HRDLK N+L++ + K++DFGLAR+FG T+ VV T Y APE
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLG 172
Query: 273 DGQFSVKSDVFSFGILLLEIVSGK 296
D +S D++S G + E++S +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 10/208 (4%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQE-IAVKR--LSKISEQGLKELKNEVILFSKLQHR 151
+++ + + +G G VY + E +A+KR L K + EL+ EV S+ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHP 59
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
N+VK + G+E L+ ++ SL + LD + ++ +GL YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTNRVVGTYGYMAPE 269
+ + IHRD+KA N+LL +D + KI+DFG++ + GGD T VGT +MAPE
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 270 YASDGQ-FSVKSDVFSFGILLLEIVSGK 296
+ K+D++SFGI +E+ +G
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 98 SINKKLGQGGFGPVYKGKLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSKL-Q 149
++ K LG+G FG V K + V +AVK L +E+ L +L +E+ + + +
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGT------ 203
H+N++ LLG C Q ++ E+ + +L F+ + T
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 204 -------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256
ARG+ +L + IHRDL A NVL+ +D KI+DFGLAR + T
Sbjct: 135 VSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 257 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 85/273 (31%), Positives = 131/273 (47%), Gaps = 38/273 (13%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 155
+ + KKLG G FG V+ ++AVK + K ++ E + LQH LVK
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 65
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQE-----RCMILDWSKRFHIICGTARGLLYL 210
L + E +I EFM SL F+ E ++D+S + A G+ ++
Sbjct: 66 L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFI 118
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTNRVVGTYGYMA 267
Q + IHRDL+A+N+L+ + KI+DFGLAR +E EG + T A
Sbjct: 119 EQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----A 171
Query: 268 PEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327
PE + G F++KSDV+SFGILL+EIV+ R Y +N +I + G
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVT--YGRIPYPGMSNPEVI----RALERGYRMPRP 225
Query: 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
++C ++ +N I + C + PE+RP+
Sbjct: 226 ENCPEELYN---------IMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 88/263 (33%), Positives = 131/263 (49%), Gaps = 28/263 (10%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 160
KKLG G FG V+ G ++AVK L K + E + KL+H LV+L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV- 69
Query: 161 IQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIH 220
+ E ++ E+M SL F+ D E L + A G+ Y+ R+ IH
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 221 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYASDGQFSV 278
RDL+++N+L+ + KI+DFGLAR +E T R + + APE A G+F++
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTI 182
Query: 279 KSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS-FNL 337
KSDV+SFGILL E+V+ K R Y NN ++ + + MP C QD +L
Sbjct: 183 KSDVWSFGILLTELVT--KGRVPYPGMNNREVLEQVERGYR--MP------CPQDCPISL 232
Query: 338 AEVIRCIHIGLLCVQQHPEDRPS 360
E++ L C ++ PE+RP+
Sbjct: 233 HELM------LQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 23/205 (11%)
Query: 103 LGQGGFGPVYKGKLVDGQ-EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 161
LG+G +G VY + + Q IA+K + + + ++ L E+ L S L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 162 QGEEKLLIYEFMPNKSLDSFI-------FDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+ + E +P SL + + D E+ +I ++K+ GL YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF-YTKQI------LEGLKYLHD-- 126
Query: 215 RLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 273
+I+HRD+K NVL++ KISDFG ++ G T GT YMAPE
Sbjct: 127 -NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDK 183
Query: 274 GQ--FSVKSDVFSFGILLLEIVSGK 296
G + +D++S G ++E+ +GK
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 67/205 (32%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 101 KKLGQGGFGPVYKG--KLVDGQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLVK 155
KKLG G FG V +G G+ I AVK L + + E + L H NL++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICG----TARGLLYLH 211
L G + + + E P SL D+ R L +C A G+ YL
Sbjct: 61 LYGVVLTHPLMM-VTELAPLGSL----LDRLRKDALG-HFLISTLCDYAVQIANGMRYLE 114
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTNRVVGTYGYMAPE 269
R IHRDL A N+LL D KI DFGL RA D + V + + APE
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPE 170
Query: 270 YASDGQFSVKSDVFSFGILLLEIVS 294
FS SDV+ FG+ L E+ +
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 102 KLGQGGFGPVYKGK---LVDGQE---IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 155
+LG+G FG V+ + L+ Q+ +AVK L + SE ++ + E L + LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSF---------IFDQER---CMILDWSKRFHIICGT 203
G C +G L+++E+M + L+ F I L + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
A G++YL + L +HRDL N L+ Q + KI DFG++R + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKK 297
+M PE +F+ +SD++SFG++L EI + GK+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 69/218 (31%), Positives = 124/218 (56%), Gaps = 15/218 (6%)
Query: 84 LFELATIVSATN---NFSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLSKISEQGLKELK 139
L +L TIVS + ++ +K+GQG G VY + GQE+A+K+++ + +Q KEL
Sbjct: 5 LEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELI 63
Query: 140 -NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFH 198
NE+++ + +H N+V L + G+E ++ E++ SL + E CM D +
Sbjct: 64 INEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCM--DEGQIAA 119
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
+ + L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T
Sbjct: 120 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-- 174
Query: 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
+VGT +MAPE + + K D++S GI+ +E+V G+
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (258), Expect = 6e-25
Identities = 73/215 (33%), Positives = 117/215 (54%), Gaps = 34/215 (15%)
Query: 97 FSINKKLGQGGFGPVYKGK-LVDGQEIAVK--RLSKISEQGLKE--LKNEVILFSKLQHR 151
+ +KLG+G +G VYK + G+ +A+K RL E+G+ L+ E+ L +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALR-EISLLKELKHP 58
Query: 152 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKR--FHIICGTARGLL 208
N+VKLL I E KL L++E+ + L ++ + + + K + ++ G L
Sbjct: 59 NIVKLL-DVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLRG----LA 112
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 268
Y H RI+HRDLK N+L+++D K++DFGLARAFG T+ VV T Y AP
Sbjct: 113 YCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYRAP 167
Query: 269 E-------YASDGQFSVKSDVFSFGILLLEIVSGK 296
E Y++ +V D++S G + E+++GK
Sbjct: 168 EILLGSKHYST----AV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 83/296 (28%), Positives = 132/296 (44%), Gaps = 52/296 (17%)
Query: 96 NFSINKKLGQGGFGPVYKGK------LVDGQEIAVKRLSKISEQG-LKELKNEVILFSKL 148
N + K LG+G FG V K +AVK L + + L++L +E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------------------FDQ 185
H +++KL G C Q LLI E+ SL SF+
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 186 ERCMILDWSKRFHI-ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244
ER + + F I RG+ YL + ++++HRDL A NVL+ + KISDFGL+
Sbjct: 121 ERALTMGDLISFAWQIS---RGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174
Query: 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS 304
R +++ ++ +MA E D ++ +SDV+SFG+LL EIV+ N +
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234
Query: 305 DNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
L + L G + ++C ++ +NL L C +Q P+ RP+
Sbjct: 235 PERL------FNLLKTGYRMERPENCSEEMYNLM---------LTCWKQEPDKRPT 275
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-25
Identities = 73/228 (32%), Positives = 115/228 (50%), Gaps = 28/228 (12%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRL-------SKISEQGLKELKNEVILF 145
NF I KK+G+G F VYK L+DG+ +A+K++ +K + LKE+ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 146 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQERCMILD---WSKRFHII 200
+L H N++K L I+ E ++ E L I F +++ +I + W K F +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW-KYFVQL 115
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
C L ++H RI+HRD+K +NV + K+ D GL R F T ++ +V
Sbjct: 116 C---SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LV 167
Query: 261 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNL 308
GT YM+PE + ++ KSD++S G LL E+ + + FY NL
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 66/199 (33%), Positives = 107/199 (53%), Gaps = 15/199 (7%)
Query: 97 FSINKKLGQGGFGPVYKGKLVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLVK 155
++ + +G+G FG V +G+ GQ++AVK + ++ Q E E + +KL H+NLV+
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVR 63
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSR 215
LLG I ++ E M +L +F+ + R ++ + A G+ YL
Sbjct: 64 LLGV-ILHNGLYIVMELMSKGNLVNFLRTRGRALV-SVIQLLQFSLDVAEGMEYLESK-- 119
Query: 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 275
+++HRDL A N+L+ +D K+SDFGLAR + G N + + APE +
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPV-KWTAPEALKHKK 173
Query: 276 FSVKSDVFSFGILLLEIVS 294
FS KSDV+S+G+LL E+ S
Sbjct: 174 FSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 103 LGQGGFGPVYKGKL------VDGQEIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVK 155
LG+G FG V+ K + VK L K ++ E + E+ +F KL H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSFI------FDQERCMILDWSKRFHIICGTARGLLY 209
LLG C + E +I E+ L F+ ++ + L ++ + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 269
L S R +HRDL A N L+ K+S L++ E N ++ ++APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 270 YASDGQFSVKSDVFSFGILLLEIVS 294
+ FS KSDV+SFG+L+ E+ +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 97 FSINKKLGQGGFGPVYKGKLV--DG--QEIAVK--RLSKISEQGLKELKNEVILFSKLQH 150
+ K LG+G FG V +G+L DG ++AVK +L + ++E +E H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 151 RNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIF-----DQERCMILDWSKRFHI 199
N++KL+G C + ++I FM + L SF+ + L +F +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGD-ETEGNTN 257
A G+ YL S IHRDL A N +L +DM ++DFGL++ + GD +G
Sbjct: 121 --DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 258 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
++ ++A E +D ++ KSDV++FG+ + EI +
Sbjct: 176 KM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 74/211 (35%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 95 NNFSINKKLGQGGFGPVYK------GKLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSK 147
NN S K LG G FG V + K ++AVK L + +E L +E+ + S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 148 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
L H N+V LLG C G L+I E+ L +F+ + L A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKG 153
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTNRVVGTY 263
+ +L + IHRDL A NVLL KI DFGLAR D +GN V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV--- 207
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+MAPE + ++ +SDV+S+GILL EI S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLVKLL 157
+ +G+G FG V K + DG+ + K + ++E+ ++L +EV + +L+H N+V+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 158 GCCIQGEEKLL--IYEFMPNKSLDSFI--FDQERCMILDWSKRFHIICGTARGLLYLH-- 211
I + L + E+ L I +ER I + + I+ L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI-EEEFIWRILTQLLLALYECHNR 124
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
D ++HRDLK +N+ LD + N K+ DFGLA+ G D + T VGT YM+PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQL 182
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGK 296
+ + KSD++S G L+ E+ +
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 75/278 (26%), Positives = 135/278 (48%), Gaps = 46/278 (16%)
Query: 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI----SEQG--LKELKNEVILFSKLQHRNL 153
++LG G F Y+ + V G +AVK+++ + SEQ ++ L+ E+ L ++L H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD----QERCMILDWSKRFHIICGTARGLLY 209
+++LG + L E+M S+ + +E +I + RGL Y
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII----NYTEQLL---RGLSY 118
Query: 210 LHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLA-----RAFGGDETEGNTNRVVG 261
LH++ +IIHRD+K +N+L+D Q + +I+DFG A + G E +G +++G
Sbjct: 119 LHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQG---QLLG 170
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG 321
T +MAPE Q+ DV+S G +++E+ + K N+L LI +K+ +
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASAT 227
Query: 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRP 359
+ + ++ L C++ PEDRP
Sbjct: 228 TAPSIPEHLSPGLRDVT---------LRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 68/223 (30%), Positives = 111/223 (49%), Gaps = 30/223 (13%)
Query: 93 ATNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QH 150
T F + + +G+G +G VYK + GQ +A+K + I ++ +E+K E + K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNH 62
Query: 151 RNLVKLLGCCIQ-----GEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRF------H 198
N+ G I+ +++L L+ E S + D + + KR +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVK-GLRKKGKRLKEEWIAY 117
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
I+ T RGL YLH++ ++IHRD+K N+LL ++ K+ DFG++ D T G N
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNT 172
Query: 259 VVGTYGYMAPE-----YASDGQFSVKSDVFSFGILLLEIVSGK 296
+GT +MAPE D + +SDV+S GI +E+ GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 7e-24
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 27/208 (12%)
Query: 98 SINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 156
++ KLG G +G VY+G +AVK L K ++E E + +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRL 216
LG C + +I EFM +L ++ + R ++ ++ + + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 217 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY----------GYM 266
IHRDL A N L+ ++ K++DFGL+R GD TY +
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----------TYTAHAGAKFPIKWT 172
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVS 294
APE + +FS+KSDV++FG+LL EI +
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 7e-24
Identities = 67/215 (31%), Positives = 113/215 (52%), Gaps = 25/215 (11%)
Query: 101 KKLGQGGFGPVYKGKLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 153
++LG+ FG VYKG L Q +A+K L +E L+E K+E ++ S+LQH N+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIF-----------DQERCM--ILDWSKRFHII 200
V LLG + + +I+ + + L F+ D ++ + L+ + HI+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTNRV 259
A G+ +L S ++H+DL NVL+ +N KISD GL R + D + N +
Sbjct: 131 TQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+ +M+PE G+FS+ SD++S+G++L E+ S
Sbjct: 188 LPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 7e-24
Identities = 78/294 (26%), Positives = 139/294 (47%), Gaps = 42/294 (14%)
Query: 95 NNFSINKKLGQGGFGPVYKGK---LVDGQE---IAVKRLSKISEQGLKELKNEVILFSKL 148
+N + ++LG+G FG V+ + L Q+ +AVK L S+ K+ E L + L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMI----------LDWSKRFH 198
QH ++VK G C++G+ ++++E+M + L+ F+ + L S+ H
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
I A G++YL + +HRDL N L+ +++ KI DFG++R D + R
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYR 177
Query: 259 VVG----TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHA 314
V G +M PE +F+ +SDV+S G++L EI + K + S+N +
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV------ 231
Query: 315 WKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+ +G Q +C ++ ++L L C Q+ P R ++ + +L
Sbjct: 232 IECITQGRVLQRPRTCPKEVYDLM---------LGCWQREPHMRLNIKEIHSLL 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 66/204 (32%), Positives = 113/204 (55%), Gaps = 20/204 (9%)
Query: 101 KKLGQGGFGPVYKGKLVDGQE-----IAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLV 154
K LG G FG VYKG V E +A+K L++ + + E +E ++ + + H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQE----RCMILDWSKRFHIICGTARGLLYL 210
+LLG C+ +L + + MP+ L ++ + + ++L+W + A+G++YL
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
+ R++HRDL A NVL+ + KI+DFGLAR GDE E N + +MA E
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 271 ASDGQFSVKSDVFSFGILLLEIVS 294
+F+ +SDV+S+G+ + E+++
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 1e-23
Identities = 71/277 (25%), Positives = 132/277 (47%), Gaps = 41/277 (14%)
Query: 103 LGQGGFGP--VYKGKLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNLVKLLG 158
LG+G FG +Y+ + D + K L+++SE+ ++ NE+++ S LQH N++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 159 CCIQGEEKLLIYEFMPNKSL-------DSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
+ L+ E+ +L +F++E M+L + F I+ + Y+H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEE--MVLWY--LFQIVSAVS----YIH 118
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
+ I+HRD+K N+ L + K+ DFG+++ G + + T VVGT YM+PE
Sbjct: 119 KAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELC 173
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331
+++ KSD+++ G +L E+++ K+ + + N LNL+ K+ +
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRT---FDATNPLNLV---VKI----VQGNYTPVVS 223
Query: 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
S L ++ +QQ PE RP+ V+
Sbjct: 224 VYSSELISLVHS------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-23
Identities = 77/261 (29%), Positives = 127/261 (48%), Gaps = 26/261 (9%)
Query: 102 KLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 161
KLGQG FG V+ G +A+K L K + E + KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 162 QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHR 221
E ++ E+M SL F+ + L + + A G+ Y+ R+ +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 222 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYASDGQFSVK 279
DL+A+N+L+ +++ K++DFGLAR +E T R + + APE A G+F++K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 280 SDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAE 339
SDV+SFGILL E+ + K R Y N ++ + + P + +S L +
Sbjct: 184 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPES-------LHD 234
Query: 340 VIRCIHIGLLCVQQHPEDRPS 360
++ C ++ PE+RP+
Sbjct: 235 LM------CQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 1e-23
Identities = 63/211 (29%), Positives = 109/211 (51%), Gaps = 26/211 (12%)
Query: 103 LGQGGFGPVYKG-KLVDGQEIAVKR--LSKISEQG-------LKELKNEVILFSKLQHRN 152
+G G FG VY G G+ +AVK+ L +S L L E+ L +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ---ERCMILDWSKRFHIICGTARGLLY 209
+V+ LG + + + E++P S+ + + + E ++ ++ ++ +GL Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGLNY 121
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR----VVGTYGY 265
LH IIHRD+K +N+L+D KISDFG+++ + TN + G+ +
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
MAPE ++ K+D++S G L++E+++GK
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-23
Identities = 75/263 (28%), Positives = 122/263 (46%), Gaps = 32/263 (12%)
Query: 103 LGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCCI 161
LG+G FG V+KG L D +AVK + Q LK + +E + + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 162 QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHR 221
Q + ++ E +P SF+ ++ + +F + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLESKN---CIHR 117
Query: 222 DLKASNVLLDQDMNPKISDFGLARAF-GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKS 280
DL A N L+ ++ KISDFG++R G + ++ + APE + G++S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 281 DVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEV 340
DV+S+GILL E S L + + GM +Q + + ++
Sbjct: 176 DVWSYGILLWETFS-------------LGVCPYP------GMTNQQAREQVEKGYRMSCP 216
Query: 341 IRC----IHIGLLCVQQHPEDRP 359
+C + C PE+RP
Sbjct: 217 QKCPDDVYKVMQRCWDYKPENRP 239
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 33/279 (11%)
Query: 91 VSATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 149
V+ + + I +LG G FG VYK + G A K + SE+ L++ E+ + S+ +
Sbjct: 1 VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK 60
Query: 150 HRNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLL 208
H N+V L E KL I EF +LDS + + ER L + ++ L
Sbjct: 61 HPNIVGLYEAYFY-ENKLWILIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALN 117
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 268
+LH ++IHRDLKA N+LL D + K++DFG++ A + + +GT +MAP
Sbjct: 118 FLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS-AKNKSTLQ-KRDTFIGTPYWMAP 172
Query: 269 EYA-----SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323
E D + K+D++S GI L+E+ + + LN + K+ P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEP------PHHELNPMRVLLKILKSEPP 226
Query: 324 SQLIDSCFQDSFN--LAEVIRCIHIGLLCVQQHPEDRPS 360
+ S + SFN L C+ + P+DRP+
Sbjct: 227 TLDQPSKWSSSFNDFLKS----------CLVKDPDDRPT 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 67/229 (29%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHR 151
+F + + +G+G FG V + D +++ A+K ++K + + ++ + NE + +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 152 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI-----FDQERCMILDWSKRFHIICGTAR 205
LV L Q EE + L+ + + L + F +E+ +F IC
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV-------KF-WICEIVL 111
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
L YLH IIHRD+K N+LLD+ + I+DF +A D T GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGY 165
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF-YHSDNNLNLIGH 313
MAPE +SV D +S G+ E + GK R + HS + I
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGK--RPYRGHSRTIRDQIRA 212
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 13/200 (6%)
Query: 103 LGQGGFGPVYKGKLVD--GQEI--AVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLL 157
+G+G FG VY G L+D GQ+I AVK L++I++ + +++ E I+ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 158 GCCIQGE-EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRL 216
G C+ E L++ +M + L +FI + + F + A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASK--- 117
Query: 217 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYASDG 274
+ +HRDL A N +LD+ K++DFGLAR E N +MA E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 275 QFSVKSDVFSFGILLLEIVS 294
+F+ KSDV+SFG+LL E+++
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 29/213 (13%)
Query: 103 LGQGGFGPVYKGKLVD-GQEIAVKRL---SKISEQG-------LKELKNEVILFSKLQHR 151
+G+G +G VY V G+ +AVK++ + I+ + +K L++E+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 152 NLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
N+V+ LG EE L I+ E++P S+ S + R + GL YL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYL 124
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR----AFGGDETEGNTNRVVGTYGYM 266
H I+HRDLKA N+L+D D KISDFG+++ + D+ + G+ +M
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ----NMSMQGSVFWM 177
Query: 267 APEY-ASDGQ-FSVKSDVFSFGILLLEIVSGKK 297
APE S Q +S K D++S G ++LE+ +G++
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 6e-23
Identities = 69/216 (31%), Positives = 125/216 (57%), Gaps = 15/216 (6%)
Query: 86 ELATIVSATN---NFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKEL-KN 140
+L TIVS + ++ +K+GQG G V+ V GQE+A+K+++ + +Q KEL N
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-LQKQPKKELIIN 65
Query: 141 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHII 200
E+++ +L++ N+V L + G+E ++ E++ SL + E CM D ++ +
Sbjct: 66 EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETCM--DEAQIAAVC 121
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
+ L +LH + ++IHRD+K+ NVLL D + K++DFG ++++ +T +V
Sbjct: 122 RECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MV 176
Query: 261 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
GT +MAPE + + K D++S GI+ +E+V G+
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 7e-23
Identities = 72/271 (26%), Positives = 134/271 (49%), Gaps = 44/271 (16%)
Query: 103 LGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQG-LKELKNEVILFSKLQH---RNLVKLL 157
+G+G +G VY+GK V G+ +A+K ++ + + +++ EV L S+L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSFIFDQ---ERCMILDWSKRFHIICGTARGLLYLHQDS 214
G ++G +I E+ S+ + + E+ + + II L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIHKVG 121
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
+IHRD+KA+N+L+ N K+ DFG+A ++ + VGT +MAPE ++G
Sbjct: 122 ---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 275 Q-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN----LNLIGHAWKLWNEGMPSQLIDS 329
+ + K+D++S GI + E+ +G +SD + + LI + P +L D+
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPP----YSDVDAFRAMMLIPKS-------KPPRLEDN 225
Query: 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
+ S L E + C+ + P++R S
Sbjct: 226 GY--SKLLREFV------AACLDEEPKERLS 248
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 7e-23
Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 103 LGQGGFGPVYKGKLVDGQEIAVKRLS------KISEQGLKELKNEVILFSKLQHRNLVKL 156
LG+G +G VY G GQ IAVK++ +E+ ++L+ EV L L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFH-----IICGTAR----GL 207
LG C+ + EF+P S+ S + RF + C + G+
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL------------NRFGPLPEPVFCKYTKQILDGV 115
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF---GGDETEGNTNRVV-GTY 263
YLH + ++HRD+K +NV+L + K+ DFG AR G T N + + GT
Sbjct: 116 AYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
+MAPE ++ + KSD++S G + E+ +GK
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-22
Identities = 77/288 (26%), Positives = 142/288 (49%), Gaps = 42/288 (14%)
Query: 95 NNFSINKKLGQGGFGPVYKGKL-VDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQ 149
++ + K +G G FG V++G L + G++ +A+K L +E+ ++ +E + +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWS--KRFHIICGTARGL 207
H N+++L G + + ++I E+M N +LD ++ D + ++S + ++ G A G+
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGM 120
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG--Y 265
YL S + +HRDL A N+L++ ++ K+SDFGL+R D+ EG G +
Sbjct: 121 KYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRW 176
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324
APE + +F+ SDV+SFGI++ E++S G++ W+ M +
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER------------------PYWD--MSN 216
Query: 325 QLIDSCFQDSFNLAEVIRC----IHIGLLCVQQHPEDRPSMPSVILML 368
+ D F L + C + L C QQ RP ++ +L
Sbjct: 217 HEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 152
+F + KKLG+G +G VYK K L D Q A+K L +S++ ++ NE+ + + + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERC-------MILDWSKRFHIICGTAR 205
++ + G + ++ E+ P L I +++ I W I R
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI--WR----IFIQLLR 114
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
GL LH+ +I+HRDLK++N+LL + KI D G+++ + +GT Y
Sbjct: 115 GLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHY 167
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
MAPE +S KSD++S G LL E+ +
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 75/234 (32%), Positives = 122/234 (52%), Gaps = 21/234 (8%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLL 157
+K+G+G +G VYKG+ GQ +A+K++ SE +G+ E+ L +LQH N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 158 GCCIQGEEKLLIYEFMP---NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+Q LI+EF+ K LDS Q L S + I+ +G+L+ H
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCH--- 118
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
R++HRDLK N+L+D K++DFGLARAF G T+ VV T Y APE
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGS 176
Query: 275 Q-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327
+S D++S G + E+ + + +H D+ ++ + +++ G P++ +
Sbjct: 177 PRYSTPVDIWSIGTIFAEMAT---KKPLFHGDSEIDQLFRIFRIL--GTPTEDV 225
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 2e-22
Identities = 73/219 (33%), Positives = 98/219 (44%), Gaps = 48/219 (21%)
Query: 101 KKLGQGGFGPV----YKGKLVD-GQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 154
+ LG+G FG V Y G+ +AVK L + Q K E+ + L H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 155 KLLGCCIQGEEK--LLIYEFMPNKSLDSF------------IFDQERCMILDWSKRFHII 200
K GCC + K LI E++P SL + +F Q+ C
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQIC------------ 117
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
G+ YLH IHRDL A NVLLD D KI DFGLA+A EG+ V
Sbjct: 118 ----EGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRV 166
Query: 261 GTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
G + A E + +FS SDV+SFG+ L E+++
Sbjct: 167 REDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 103 LGQGGFGPVY------KGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 156
LG+GGFG V GK+ +++ KRL K +G + NE + K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK--RKGEQMALNEKKILEKVSSRFIVSL 58
Query: 157 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFH---IICGTARGLLYLHQ 212
+ ++ L L+ M L I++ + F+ IICG L +LHQ
Sbjct: 59 -AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ 113
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 272
RI++RDLK NVLLD N +ISD GLA G + GT GYMAPE
Sbjct: 114 ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQ 167
Query: 273 DGQFSVKSDVFSFGILLLEIVSGK 296
+ D F+ G L E+++G+
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 35/272 (12%)
Query: 101 KKLGQGGFGPVYKG-KLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLL 157
K+G G FG VY L G+ +AVK R+ + +KE+ +E+ + L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSFI----FDQERCMILDWSKRFHIICGTARGLLYLHQD 213
G + E+ + E+ +L+ + E + + + + GL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI-----RVYTL--QLLEGLAYLHSH 118
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE--GNTNRVVGTYGYMAPEYA 271
I+HRD+K +N+ LD + K+ DFG A + T + GT YMAPE
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 272 SDGQFSVK---SDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328
+ G+ +D++S G ++LE+ +GK R + DN ++ H G + D
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGK--RPWSELDNEFQIMFHV----GAGHKPPIPD 229
Query: 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
S E + C++ P+ RP+
Sbjct: 230 SLQLSP----EGKDFLD---RCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 95.6 bits (237), Expect = 4e-22
Identities = 77/272 (28%), Positives = 145/272 (53%), Gaps = 30/272 (11%)
Query: 84 LFELATIVSATN---NFSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLSKISEQGLKELK 139
L +L +IVS + ++ +K+GQG G VY + GQE+A+K+++ + +Q KEL
Sbjct: 5 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN-LQQQPKKELI 63
Query: 140 -NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFH 198
NE+++ + ++ N+V L + G+E ++ E++ SL + E CM D +
Sbjct: 64 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCM--DEGQIAA 119
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
+ + L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T
Sbjct: 120 VCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-- 174
Query: 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318
+VGT +MAPE + + K D++S GI+ +E+V G+ Y ++N L + + +
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP---YLNENPLRAL---YLIA 228
Query: 319 NEGMPS----QLIDSCFQDSFNLAEVIRCIHI 346
G P + + + F+D N RC+ +
Sbjct: 229 TNGTPELQNPERLSAVFRDFLN-----RCLEM 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 4e-22
Identities = 82/261 (31%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 102 KLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 161
KLGQG FG V+ G ++A+K L K + E + KL+H LV L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV-V 70
Query: 162 QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHR 221
E ++ EFM SL F+ + + L + + A G+ Y+ R+ IHR
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 222 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYASDGQFSVK 279
DL+A+N+L+ ++ KI+DFGLAR +E T R + + APE A G+F++K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 280 SDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAE 339
SDV+SFGILL E+V+ K R Y N ++ + + P +S L E
Sbjct: 184 SDVWSFGILLTELVT--KGRVPYPGMVNREVLEQVERGYRMPCPQGCPES-------LHE 234
Query: 340 VIRCIHIGLLCVQQHPEDRPS 360
+++ LC ++ P++RP+
Sbjct: 235 LMK------LCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 5e-22
Identities = 64/210 (30%), Positives = 112/210 (53%), Gaps = 25/210 (11%)
Query: 99 INKKLGQGGFGPVYKGKL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQHRNL 153
I + +G G FG V +G+L + G+ +A+K L S +E+ ++ +E + + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIIC------GTARGL 207
+ L G + ++I EFM N +LDSF+ + +F +I G A G+
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQND--------GQFTVIQLVGMLRGIAAGM 119
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG---TYG 264
YL S + +HRDL A N+L++ ++ K+SDFGL+R D ++ +G
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+ APE + +F+ SDV+S+GI++ E++S
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 5e-22
Identities = 59/182 (32%), Positives = 95/182 (52%), Gaps = 20/182 (10%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLS------KISEQGLKELKNEVILFSKL 148
+ I ++G+G G V+K K G+ +A+K+++ I Q L+E+K
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQAC 56
Query: 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF-HIICGTARGL 207
QH +VKLL G +L+ E+MP+ L + D+ER + K + ++ +G+
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL---KGV 112
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
Y+H I+HRDLK +N+L+ D KI+DFGLAR F +E +++ V T Y A
Sbjct: 113 AYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRA 168
Query: 268 PE 269
PE
Sbjct: 169 PE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 6e-22
Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 29/210 (13%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLV 154
KKLG+G + VYK + G+ +A+K++ + K+ N E+ L +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF---HIIC---GTARGLL 208
LL L++EFM D E+ +I D S I T RGL
Sbjct: 66 GLLDVFGHKSNINLVFEFMET--------DLEK-VIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 268
YLH I+HRDLK +N+L+ D K++DFGLAR+FG + T++VV T Y AP
Sbjct: 117 YLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVV-TRWYRAP 171
Query: 269 E--YASDGQFSVKSDVFSFGILLLEIVSGK 296
E + + + V D++S G + E++
Sbjct: 172 ELLFGAR-HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 6e-22
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 103 LGQGGFGPVYKG-KLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 158
+ +G +G V+ K G A+K + K I + + ++ E + S+ Q +VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 159 CCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLR 217
QG++ L L+ E++P L S + + + D ++ I L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLAS-LLENVGSLDEDVAR--IYIAEIVLALEYLHS---NG 113
Query: 218 IIHRDLKASNVLLDQDMNPKISDFGLA------RAFGGDETEGNTNRVVGTYGYMAPEYA 271
IIHRDLK N+L+D + + K++DFGL+ R ++ E R+VGT Y+APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 272 SDGQFSVKSDVFSFGILLLEIVSG 295
S D +S G +L E + G
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 8e-22
Identities = 68/222 (30%), Positives = 111/222 (50%), Gaps = 20/222 (9%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 151
NF I KK+G+G F VY+ L+D + +A+K++ + + ++ E+ L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQERCMILD---WSKRFHIICGTARG 206
N++K L I+ E ++ E L I F +++ +I + W K F +C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYFVQLCSAVE- 120
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
H SR R++HRD+K +NV + K+ D GL R F T ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNL 308
+PE + ++ KSD++S G LL E+ + FY NL
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 8e-22
Identities = 78/278 (28%), Positives = 128/278 (46%), Gaps = 31/278 (11%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 151
NF I KK+G+G F VY+ L+DG +A+K++ + + + E+ L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQERCMILD---WSKRFHIICGTARG 206
N++K I+ E ++ E L I F +++ +I + W K F +C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSALE- 120
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
H SR R++HRD+K +NV + K+ D GL R F T ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326
+PE + ++ KSD++S G LL E+ + + FY + +NL K+ P
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FY--GDKMNLYSLCKKIEQCDYPPLP 229
Query: 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSV 364
D ++ L +C+ PE RP + V
Sbjct: 230 SDHYSEELRQLVN---------MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 30/226 (13%)
Query: 99 INKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 152
+ ++LG+G FG V+ + D +AVK L + K+ + E L + LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ-ERCMI------------LDWSKRFHI 199
+VK G C G+ ++++E+M + L+ F+ MI L S+ HI
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 259
A G++YL + +HRDL N L+ ++ KI DFG++R D + RV
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV 181
Query: 260 VG----TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 301
G +M PE +F+ +SDV+SFG++L EI + K F
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 64/223 (28%), Positives = 110/223 (49%), Gaps = 20/223 (8%)
Query: 86 ELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILF 145
+L+ + F + + +G G +G VYKG+ V ++A ++ ++E +E+K E+ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 146 SKL-QHRNLVKLLGCCI------QGEEKLLIYEFMPNKSLDSFIFDQE-RCMILDWSKRF 197
K HRN+ G I ++ L+ EF S+ + + + + DW
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA-- 124
Query: 198 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 257
+I RGL +LH ++IHRD+K NVLL ++ K+ DFG++ D T G N
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRN 179
Query: 258 RVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSG 295
+GT +MAPE + D + +SD++S GI +E+ G
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-21
Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 102 KLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 160
+LG G FG VYK K + G A K + SE+ L++ E+ + + H +VKLLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 161 IQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTA-RGLLYLHQDSRLRII 219
+ ++ EF P ++D+ + + +R + + +IC L YLH ++II
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS---MKII 132
Query: 220 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA-----SDG 274
HRDLKA NVLL D + K++DFG++ +T + +GT +MAPE D
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 275 QFSVKSDVFSFGILLLEI 292
+ K+D++S GI L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 101 KKLGQGGFGPVYKGKLV-----DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLV 154
++LG+ FG +YKG L Q +A+K L I+ Q E + E L ++L H N+V
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIF------------DQERCM--ILDWSKRFHII 200
LLG Q + +++E++ L F+ D++ + LD HI
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTNRV 259
A G+ YL S +H+DL A N+L+ + ++ KISD GL+R + D +
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+ +M PE G+FS SD++SFG++L EI S
Sbjct: 188 LPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 155
+ + +G+G FG V G G ++AVK + ++ + E + ++L+H NLV+
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQ 63
Query: 156 LLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
LLG ++ + L I E+M SL ++ + R +L + YL ++
Sbjct: 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN 122
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
+HRDL A NVL+ +D K+SDFGL + E + + APE +
Sbjct: 123 ---FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK 174
Query: 275 QFSVKSDVFSFGILLLEIVS 294
+FS KSDV+SFGILL EI S
Sbjct: 175 KFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 65/203 (32%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 102 KLGQGGFGPVYKGK-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 158
K+G+G +G VYK + + G+ +A+K RL E E+ L +L H N+V+LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 159 CCIQGEEKLLIYEFMP---NKSLDSFIFDQERCMILDWSKRF-HIICGTARGLLYLHQDS 214
+ L++EF+ K +DS ++ K + + + +G+ Y H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KSYLYQLL---QGIAYCHSH- 118
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
R++HRDLK N+L+D++ K++DFGLARAF G T+ VV T Y APE
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGS 174
Query: 275 -QFSVKSDVFSFGILLLEIVSGK 296
Q+S D++S G + E+V+ +
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 4e-21
Identities = 64/218 (29%), Positives = 123/218 (56%), Gaps = 15/218 (6%)
Query: 84 LFELATIVSATN---NFSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLSKISEQGLKELK 139
L +L +IVS + ++ +K+GQG G VY + GQE+A+++++ + +Q KEL
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELI 64
Query: 140 -NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFH 198
NE+++ + ++ N+V L + G+E ++ E++ SL + E CM D +
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCM--DEGQIAA 120
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
+ + L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RST 175
Query: 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
+VGT +MAPE + + K D++S GI+ +E++ G+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 6e-21
Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 48/273 (17%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLG 158
K+LG G FG V+ GK ++A+K +++ +SE+ E E + KL H LV+L G
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYG 66
Query: 159 CCIQGEEKLLIYEFMPNKSLDSFIFDQE----RCMILDWSKRFHIICGTARGLLYLHQDS 214
C Q + ++ EFM N L +++ ++ + M+L + +C G+ YL ++S
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD---VC---EGMEYLERNS 120
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG------YMAP 268
IHRDL A N L+ K+SDFG+ R DE + G + P
Sbjct: 121 ---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-------YTSSSGAKFPVKWSPP 170
Query: 269 EYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327
E + ++S KSDV+SFG+L+ E+ + GK + + +I ++L+ + S +
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTV 230
Query: 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
EV+ C + PE RP+
Sbjct: 231 ----------YEVM------YSCWHEKPEGRPT 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 7e-21
Identities = 64/217 (29%), Positives = 112/217 (51%), Gaps = 33/217 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQ 149
+ I K +G G FG V G+L + G+ +A+K L + +E+ ++ +E + +
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIIC------GT 203
H N++ L G + + +++ E+M N SLD+F+ + +F +I G
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD--------GQFTVIQLVGMLRGI 115
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
A G+ YL S + +HRDL A N+L++ ++ K+SDFGL+R D T R
Sbjct: 116 ASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR----- 167
Query: 264 G------YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
G + APE + +F+ SDV+S+GI++ E++S
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 8e-21
Identities = 72/210 (34%), Positives = 113/210 (53%), Gaps = 21/210 (10%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 152
NF +K+G+G +G VYK + + G+ +A+K RL +E E+ L +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 153 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFD----QERCMILDWSKRFHIICGTARGL 207
+VKLL I E KL L++EF+ ++ L F+ D + L S F ++ +GL
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLL----QGL 113
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
+ H R++HRDLK N+L++ + K++DFGLARAF G T+ VV T Y A
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRA 168
Query: 268 PEYASDGQF-SVKSDVFSFGILLLEIVSGK 296
PE ++ S D++S G + E+V+ +
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 8e-21
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 102 KLGQGGFGPVYKGKLVDGQEIAVKRL------SKISEQGLKELKNEVILFSKLQHRNLVK 155
+LG+G G V K +L + I + + +Q L+EL+ + + +VK
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSCKSPYIVK 63
Query: 156 LLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQ--ERCMILDWSKRFHIICGTARGLLYLH 211
G + + E+ SLDS I+ + +R + I +GL YLH
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
+IIHRD+K SN+LL + K+ DFG++ G+ GT YMAPE
Sbjct: 123 SR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAPERI 175
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGK 296
+S+ SDV+S G+ LLE+ +
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 9e-21
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 97 FSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVK 155
F + + +G G +G VYKG+ V ++A ++ ++ +E+K E+ + K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 156 LLGCCIQ------GEEKLLIYEFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLL 208
G I+ ++ L+ EF S+ I + + + +W +I RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLS 125
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 268
+LHQ ++IHRD+K NVLL ++ K+ DFG++ D T G N +GT +MAP
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAP 180
Query: 269 EYAS-----DGQFSVKSDVFSFGILLLEIVSG 295
E + D + KSD++S GI +E+ G
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 9e-21
Identities = 80/287 (27%), Positives = 136/287 (47%), Gaps = 32/287 (11%)
Query: 93 ATNNFSINKKLGQGGFGPVY----KGKLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 145
A +++++LGQG FG VY KG + D E +A+K +++ + + E NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 146 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF----DQERCMIL---DWSKRFH 198
+ ++V+LLG QG+ L+I E M L S++ + E + K
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
+ A G+ YL+ + + +HRDL A N ++ +D KI DFG+ R + +
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318
+ +M+PE DG F+ SDV+SFG++L EI + + Y +N ++ +
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGMSNEQVL----RFV 234
Query: 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365
EG D+C L E++R +C Q +P+ RPS +I
Sbjct: 235 MEGGLLDKPDNCPD---MLFELMR------MCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 63/215 (29%), Positives = 113/215 (52%), Gaps = 25/215 (11%)
Query: 98 SINKKLGQGGFGPVYKGKLVDGQEI---AVK--RLSKISEQGLKELKNEVILFSKLQHRN 152
++ K LG+G FG V +G+L I AVK +++ + +++ +E + + H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 153 LVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIF-----DQERCMILDWSKRFHIIC 201
+++L+G C+Q E ++I FM + L SF+ D + + +F +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF--MT 119
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGD-ETEGNTNRV 259
A G+ YL S IHRDL A N +L+++MN ++DFGL++ + GD +G ++
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
++A E +D ++ KSDV+SFG+ + EI +
Sbjct: 177 --PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 97 FSINKKLGQGGFGPVYKGKLVDGQEIAV-KRLSKISEQGLKELKNEVILFSKLQHRNLVK 155
+ I +LG G FG VYK + + +A K + SE+ L++ E+ + + H N+VK
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICG-TARGLLYLHQDS 214
LL ++ EF ++D+ + + ER + + ++C T L YLH++
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN- 122
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY---- 270
+IIHRDLKA N+L D + K++DFG++ T + +GT +MAPE
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 271 -ASDGQFSVKSDVFSFGILLLEI 292
+ D + K+DV+S GI L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 87 LATIVSATN---NFSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLSKISEQGLKELKNEV 142
L +V + K+G+G G V G+++AVK++ +Q + L NEV
Sbjct: 8 LQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV 67
Query: 143 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICG 202
++ QH N+V++ + G+E ++ EF+ +L I R ++ + +
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIATVCLA 123
Query: 203 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR--VV 260
+ L +LH +IHRD+K+ ++LL D K+SDFG F ++ R +V
Sbjct: 124 VLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLV 176
Query: 261 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
GT +MAPE S + + D++S GI+++E+V G+
Sbjct: 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 69/210 (32%), Positives = 114/210 (54%), Gaps = 21/210 (10%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELK-NEVILFSKLQHRNL 153
NF +KLG+G + VYKG+ G+ +A+K + +E+G E+ L +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 154 VKLLGCCIQGEEKL-LIYEFMPN---KSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209
V+L I E KL L++E+M K +D+ R LD + +G+ +
Sbjct: 61 VRLHDV-IHTENKLMLVFEYMDKDLKKYMDTH---GVRGA-LDPNTVKSFTYQLLKGIAF 115
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT--NRVVGTYGYMA 267
H++ R++HRDLK N+L+++ K++DFGLARAFG NT N VV T Y A
Sbjct: 116 CHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYRA 168
Query: 268 PEYASDGQ-FSVKSDVFSFGILLLEIVSGK 296
P+ + +S D++S G ++ E+++G+
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 4e-20
Identities = 66/202 (32%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLG 158
K+LG G FG V GK ++A+K + + +SE E E + KL H LV+L G
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYG 66
Query: 159 CCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRI 218
C + ++ E+M N L +++ + + S+ + G+ YL +
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QF 121
Query: 219 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPEYASDGQ 275
IHRDL A N L+D K+SDFGL+R DE + VG+ + PE +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSK 177
Query: 276 FSVKSDVFSFGILLLEIVS-GK 296
FS KSDV++FG+L+ E+ S GK
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-20
Identities = 83/275 (30%), Positives = 129/275 (46%), Gaps = 50/275 (18%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKL 156
+++G G FG VY + V E+ A+K++S K S + +++ EV +L+H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKR------FHIIC-GTARGLLY 209
GC ++ L+ E+ + D IL+ K+ IC G +GL Y
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASD----------ILEVHKKPLQEVEIAAICHGALQGLAY 130
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 269
LH R IHRD+KA N+LL + K++DFG A N VGT +MAPE
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPE 181
Query: 270 --YASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326
A D GQ+ K DV+S GI +E+ K + N ++ + H + N+ L
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQ--ND--SPTL 234
Query: 327 IDSCFQDSF-NLAEVIRCIHIGLLCVQQHPEDRPS 360
+ + D F N + C+Q+ P+DRPS
Sbjct: 235 SSNDWSDYFRNFVD---------SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 66/240 (27%), Positives = 111/240 (46%), Gaps = 53/240 (22%)
Query: 91 VSATNNFSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLSKISEQ------GLKELKNEVI 143
S ++ I KLG+G FG VYK ++ G+ +A+K++ +E+ L+E+K
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK---- 59
Query: 144 LFSKLQHRNLVKLLGCCI-----QGEEKLLIYEFMP-----------NKSLDSFIFDQER 187
+ KL+H N+V L+ + ++ +Y P N S+ Q +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV-KLTESQIK 118
Query: 188 CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247
C +L G+ YLH++ I+HRD+KA+N+L+D KI+DFGLAR +
Sbjct: 119 CYMLQ----------LLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY 165
Query: 248 ----------GGDETEGNTNRVVGTYGYMAPEY-ASDGQFSVKSDVFSFGILLLEIVSGK 296
GG T TN VV T Y PE + +++ D++ G + E+ + +
Sbjct: 166 DGPPPNPKGGGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 7e-20
Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 28/225 (12%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQE---------------IAVKRL-SKISEQGLKEL 138
+ +KLG+G FG V+ + E +AVK L + +++ +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 139 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQE---------RCM 189
E+ + S+L++ N+++LLG C+ + +I E+M N L+ F+ +E
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 190 ILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249
+ + ++ A G+ YL + L +HRDL N L+ KI+DFG++R
Sbjct: 125 SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181
Query: 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+ R V +MA E G+F+ SDV++FG+ L E+ +
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 7e-20
Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 97 FSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVK 155
+ + +++G G +G VYK + + E+ ++ K+ + ++ E+ + + +H N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 156 LLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
G +KL I E+ SL Q L + ++ T +GL YLH+
Sbjct: 65 YFGS-YLRRDKLWIVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHE-- 119
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA--- 271
IHRD+K +N+LL +D + K++DFG++ T +GT +MAPE A
Sbjct: 120 -TGKIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFIGTPYWMAPEVAAVE 176
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGK 296
G + K D+++ GI +E+ +
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 76/272 (27%), Positives = 131/272 (48%), Gaps = 36/272 (13%)
Query: 97 FSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 152
F+ +++G G FG VY + V E+ A+K++S K S + +++ EV +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
++ GC ++ L+ E+ + D ++ ++ + H G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH---GALQGLAYLHS 143
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY-- 270
+ +IHRD+KA N+LL + K++DFG A N VGT +MAPE
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194
Query: 271 -ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329
+GQ+ K DV+S GI +E+ +K F N+N + + + P+ L +
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAE-RKPPLF-----NMNAMSALYHIAQNESPT-LQSN 247
Query: 330 CFQDSF-NLAEVIRCIHIGLLCVQQHPEDRPS 360
+ D F N + C+Q+ P+DRP+
Sbjct: 248 EWSDYFRNFVDS---------CLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 1e-19
Identities = 76/272 (27%), Positives = 129/272 (47%), Gaps = 36/272 (13%)
Query: 97 FSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 152
FS +++G G FG VY + V E+ A+K++S K S + +++ EV KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
++ GC ++ L+ E+ + D ++ ++ + H G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH---GALQGLAYLHS 133
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY-- 270
+ +IHRD+KA N+LL + K+ DFG A N VGT +MAPE
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 271 -ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329
+GQ+ K DV+S GI +E+ ++ + N+N + + + P+ L
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLF----NMNAMSALYHIAQNESPA-LQSG 237
Query: 330 CFQDSF-NLAEVIRCIHIGLLCVQQHPEDRPS 360
+ + F N + C+Q+ P+DRP+
Sbjct: 238 HWSEYFRNFVDS---------CLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 79/291 (27%), Positives = 132/291 (45%), Gaps = 60/291 (20%)
Query: 105 QGGFGPVYKGKLVDG-----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLG 158
+G FG ++ G L+D +E+ VK + SE + L E L L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 159 CCIQGEEK-LLIYEFMPNKSLDSFIFDQERCMILDWSKR--------FHIICGTARGLLY 209
CI+ E ++Y +M +L F+ ++C + + + H+ A G+ Y
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFL---QQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGD-ETEG-NTNRVVGTYGYM 266
LH + +IH+D+ A N ++D+++ KI+D L+R F D G N NR V +M
Sbjct: 133 LH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WM 186
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326
A E + ++S SDV+SFG+LL E+++ +G P
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMT----------------LG--------QTPYVE 222
Query: 327 IDS-----CFQDSFNLAEVIRC----IHIGLLCVQQHPEDRPSMPSVILML 368
ID +D + LA+ I C + C PE+RPS ++ L
Sbjct: 223 IDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 63/208 (30%), Positives = 112/208 (53%), Gaps = 20/208 (9%)
Query: 97 FSINKKLGQGGFGPVYKGKLV-DGQEI----AVKRLSK-ISEQGLKELKNEVILFSKLQH 150
F K LG G FG VYKG + +G+++ A+K L + S + KE+ +E + + + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD-QERC---MILDWSKRFHIICGTARG 206
++ +LLG C+ +L I + MP L ++ + ++ +L+W + A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
+ YL + R++HRDL A NVL+ + KI+DFGLA+ G DE E + +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVS 294
A E ++ +SDV+S+G+ + E+++
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-19
Identities = 81/341 (23%), Positives = 152/341 (44%), Gaps = 31/341 (9%)
Query: 40 VIVISSAALLAVLLIAGYLIRKRRRNIAE--KTEND----QIQNIDLEL-PLFELATIVS 92
I + A L + L+A + R RN E + EN+ ++Q D ++ + I+S
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILS 690
Query: 93 ATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR 151
+ ++ + +G G YKGK + +G + VK ++ ++ +E+ KLQH
Sbjct: 691 SLKEENV---ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHP 743
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
N+VKL+G C + LI+E++ K+L + + L W +R I G A+ L +LH
Sbjct: 744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLH 797
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
++ +L +++D P + L D ++ Y+APE
Sbjct: 798 CRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETR 850
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331
+ KSD++ FG++L+E+++G K+ + +++ A +++ ID
Sbjct: 851 ETKDITEKSDIYGFGLILIELLTG-KSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI 909
Query: 332 --QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370
S N E++ +++ L C P RP V+ L S
Sbjct: 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 48/290 (16%)
Query: 101 KKLGQGGFGPVYKG---KLVDGQ---EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNL 153
++LGQG FG VY+G ++ G+ +AVK +++ S + E NE + ++
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILD-----------WSKRFHIICG 202
V+LLG +G+ L++ E M + L S++ R + + + +
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 203 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 262
A G+ YL+ + +HRDL A N ++ D KI DFG+ R D E + R G
Sbjct: 128 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGK 180
Query: 263 ----YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318
+MAPE DG F+ SD++SFG++L EI S + Y +N ++ K
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVL----KFV 234
Query: 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+G D+C + +L +C Q +P+ RP+ ++ +L
Sbjct: 235 MDGGYLDQPDNCPERVTDLMR---------MCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 61/197 (30%), Positives = 105/197 (53%), Gaps = 12/197 (6%)
Query: 102 KLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 160
K+G+G G V + G+++AVK + +Q + L NEV++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 161 IQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTA-RGLLYLHQDSRLRII 219
+ GEE ++ EF+ +L I Q R ++ +C + + L YLH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTD-IVSQTRLN----EEQIATVCESVLQALCYLHSQG---VI 139
Query: 220 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVK 279
HRD+K+ ++LL D K+SDFG D + + +VGT +MAPE S + +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTE 197
Query: 280 SDVFSFGILLLEIVSGK 296
D++S GI+++E+V G+
Sbjct: 198 VDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSKISEQGLKE---LKNEVILFSKLQH 150
+F I ++GQGG+G V+ K D EI A+KR+ K L E + E + + +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHI---ICGTARG 206
LVKLL Q +E L L E++P + + + ++ + RF++
Sbjct: 61 EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDA- 116
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
LH L IHRDLK N L+D + K++DFGL++ N VVG+ YM
Sbjct: 117 ---LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYM 165
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVSG 295
APE + D +S G +L E + G
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 73/223 (32%), Positives = 112/223 (50%), Gaps = 26/223 (11%)
Query: 95 NNFSINKKLGQGGFGPVYKGKL--VDGQE------IAVKRLS-KISEQGLKELKNEVILF 145
+ + K LG+G FG V + + +D +AVK L +++ L +L +E+ L
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 146 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQERCMILDW 193
+ +H+N++ LLG C Q +I E+ +L F+ FD +
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 194 SKRFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251
S + + C ARG+ YL +SR R IHRDL A NVL+ +D KI+DFGLAR +
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
T+ +MAPE D ++ +SDV+SFGIL+ EI +
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 4e-19
Identities = 62/217 (28%), Positives = 112/217 (51%), Gaps = 11/217 (5%)
Query: 97 FSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLV 154
F+ +++G+G FG VYKG +E+ ++ + +E +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+ G ++G + +I E++ S D + L+ + I+ +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
R IHRD+KA+NVLL + + K++DFG+A +T+ N VGT +MAPE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 275 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLI 311
+ K+D++S GI +E+ G+ H L LI
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 5e-19
Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 102 KLGQGGFGPVYKG--KLVDGQ-EIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLL 157
+LG G FG V KG K+ Q ++A+K L +E+ ++ E+ E + +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLR 217
G C + E +L+ E L+ F+ ++ + + S ++ + G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITV--SNVVELMHQVSMGMKYLEGKN--- 115
Query: 218 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY--GYMAPEYASDGQ 275
+HRDL A NVLL KISDFGL++A G D++ R G + + APE + +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPECINFRK 174
Query: 276 FSVKSDVFSFGILLLEIVS-GKK 297
FS +SDV+S+GI + E S G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-19
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 101 KKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 158
+++G+G FG V+ G+L D +AVK + LK + E + + H N+V+L+G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 159 CCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRI 218
C Q + ++ E + +F+ + L + ++ A G+ YL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 219 IHRDLKASNVLLDQDMNPKISDFGLAR--AFGGDETEGNTNRVVGTYGYMAPEYASDGQF 276
IHRDL A N L+ + KISDFG++R G + G ++ + APE + G++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRY 173
Query: 277 SVKSDVFSFGILLLEIVS 294
S +SDV+SFGILL E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 76/294 (25%), Positives = 127/294 (43%), Gaps = 46/294 (15%)
Query: 98 SINKKLGQGGFGPVYKGKLVDGQEI-----------------AVKRLSK-ISEQGLKELK 139
+ +KLG+G FG V+ + Q+ AVK L S+ ++
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 140 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-----IFDQERCM---IL 191
EV + S+L N+ +LLG C +I E+M N L+ F L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 192 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGD 250
+S ++ A G+ YL L +HRDL N L+ ++ KI+DFG++R + D
Sbjct: 128 SFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 251 --ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN- 307
+G R +MA E G+F+ KSDV++FG+ L EI++ + + + H +
Sbjct: 185 YYRVQG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
Query: 308 -LNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
+ GH ++ + +C +D + L L C ++ EDRP+
Sbjct: 242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELM---------LECWRRDEEDRPT 286
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 7e-19
Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 101 KKLGQGGFGPVY------KGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ +G+G FG V+ KLV ++I V++++K + NE + L H N++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERC-MILDWSKRFHIICGTARGLLYLHQD 213
+ ++ + +++ E+ P +L +I Q+RC +LD H L ++H
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 214 SRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 272
I+HRDLK N+LLD+ M KI DFG+++ ++ VVGT Y++PE
Sbjct: 121 L---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCE 174
Query: 273 DGQFSVKSDVFSFGILLLEIVSGKK 297
++ KSD+++ G +L E+ S K+
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 7e-19
Identities = 60/204 (29%), Positives = 110/204 (53%), Gaps = 15/204 (7%)
Query: 97 FSINKKLGQGGFGPVYKGKLVDG---QEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 152
F+ +++G+G FG V+KG +D Q +A+K + + +E +++++ E+ + S+
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
+ K G ++G + +I E++ S D R D + ++ +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 272
+ + IHRD+KA+NVLL + + K++DFG+A +T+ N VGT +MAPE
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQ 174
Query: 273 DGQFSVKSDVFSFGILLLEIVSGK 296
+ K+D++S GI +E+ G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 7e-19
Identities = 70/211 (33%), Positives = 107/211 (50%), Gaps = 17/211 (8%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 149
N+ K LGQG FG VY VD G+E+A K++ S + + + L+ E+ L LQ
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 150 HRNLVKLLGCCI-QGEEKLLIY-EFMPNKSLDSFIFDQERCM-ILDWSKRFHIICGTARG 206
H +V+ GC + E+ L I+ E+MP S+ DQ + L S G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEG 118
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR-VVGTYGY 265
+ YLH + I+HRD+K +N+L D N K+ DFG ++ G R V GT +
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
M+PE S + K+DV+S G ++E+++ K
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 8e-19
Identities = 70/209 (33%), Positives = 109/209 (52%), Gaps = 28/209 (13%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLL 157
+K+G+G +G VYK + V + IA+K RL + E E+ L ++QH N+V+L
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 158 GCCIQGEEKL-LIYEFMP---NKSLDSFIFDQERCMILDWSKRFHII----CGTARGLLY 209
+ E++L L++E++ K +DS D++K +I RG+ Y
Sbjct: 68 DV-VHSEKRLYLVFEYLDLDLKKHMDS---------SPDFAKNPRLIKTYLYQILRGIAY 117
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTNRVVGTYGYMAP 268
H R++HRDLK N+L+D+ N K++DFGLARAF G T+ VV T Y AP
Sbjct: 118 CHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAP 172
Query: 269 E-YASDGQFSVKSDVFSFGILLLEIVSGK 296
E +S D++S G + E+V+ K
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 64/204 (31%), Positives = 111/204 (54%), Gaps = 20/204 (9%)
Query: 101 KKLGQGGFGPVYKGKLV-DGQEI----AVKRLSK-ISEQGLKELKNEVILFSKLQHRNLV 154
K LG G FG VYKG + DG+ + A+K L + S + KE+ +E + + + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCM----ILDWSKRFHIICGTARGLLYL 210
+LLG C+ +L + + MP L ++ + + + +L+W + A+G+ YL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
+ +R++HRDL A NVL+ + KI+DFGLAR DETE + + +MA E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 271 ASDGQFSVKSDVFSFGILLLEIVS 294
+F+ +SDV+S+G+ + E+++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 97 FSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELK-NEVI-------LFSKL 148
+ + ++LG+G FG VY + D + +A +RL + E + EL NE + L SKL
Sbjct: 2 YILQQRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL 59
Query: 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERC-------MILDWSKRFHIIC 201
H +VK ++ + +I E+ + LD + + + + +W
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FI 113
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 261
G+ Y+HQ RI+HRDLKA N+ L ++ KI DFG++R G T G
Sbjct: 114 QLLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTG 167
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEI 292
T YM+PE + KSD++S G +L E+
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-18
Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 20/207 (9%)
Query: 101 KKLGQGGFGPVYKG--KLVDGQE-IAVKRLSKIS-EQGLK-ELKNEVILFSKLQHRNLVK 155
+LG G FG V KG K+ ++ +AVK L + + LK EL E + +L + +V+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSR 215
++G C + E +L+ E L+ F+ + + ++ H + + G+ YL + +
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV---SMGMKYLEETN- 115
Query: 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT----YGYMAPEYA 271
+HRDL A NVLL KISDFGL++A G DE N + + APE
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECM 170
Query: 272 SDGQFSVKSDVFSFGILLLEIVS-GKK 297
+ +FS KSDV+SFG+L+ E S G+K
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 75/291 (25%), Positives = 134/291 (46%), Gaps = 30/291 (10%)
Query: 97 FSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLV 154
F+ +K+G+G FG V+KG Q++ ++ + +E +++++ E+ + S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
K G ++ + +I E++ S D LD ++ I+ +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
+ IHRD+KA+NVLL + K++DFG+A +T+ N VGT +MAPE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 275 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334
+ K+D++S GI +E+ G+ H L LI EG S+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSK--------- 227
Query: 335 FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLPQPKQPGYLAD 385
L E + C+ + P RP+ +L + ++ K+ YL +
Sbjct: 228 -PLKEFVEA------CLNKEPSFRPTAKE---LLKHKFIVRFAKKTSYLTE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 95 NNFSINKKLGQGGFGPVY--------KGKLVDGQEIAVKRLS-KISEQGLKELKNEVILF 145
+ ++ K LG+G FG V K K + +AVK L +E+ L +L +E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 146 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQERCMILDW 193
+ +H+N++ LLG C Q +I E+ +L ++ +D R
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 194 SKRFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251
+ + + C ARG+ YL + + IHRDL A NVL+ ++ KI+DFGLAR +
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
T +MAPE D ++ +SDV+SFG+L+ EI +
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 69/219 (31%), Positives = 108/219 (49%), Gaps = 26/219 (11%)
Query: 99 INKKLGQGGFGPVY--------KGKLVDGQEIAVKRL-SKISEQGLKELKNEVILFSKL- 148
+ K LG+G FG V K K ++AVK L S +E+ L +L +E+ + +
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81
Query: 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQERCMILDWSKRF 197
+H+N++ LLG C Q +I E+ +L ++ ++ + S +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 198 HIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255
+ C ARG+ YL + + IHRDL A NVL+ +D KI+DFGLAR +
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
T +MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 26/221 (11%)
Query: 97 FSINKKLGQGGFGPVY--------KGKLVDGQEIAVKRLSK-ISEQGLKELKNEVILFSK 147
++ K LG+G FG V K K +AVK L +++ L +L +E+ +
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM 73
Query: 148 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI---------FDQERCMILDWSKRF 197
+ +H+N++ LLG C Q ++ E+ +L ++ + + C + + F
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 198 H--IICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253
+ C ARG+ YL + + IHRDL A NVL+ +D KI+DFGLAR +
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190
Query: 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
T +MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 67/231 (29%), Positives = 112/231 (48%), Gaps = 43/231 (18%)
Query: 101 KKLGQGGFGPVYKGKLVDGQE-----------------IAVKRL-SKISEQGLKELKNEV 142
+KLG+G FG V+ ++V+ Q+ +AVK L ++ + EV
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 143 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI---------------FDQER 187
+ S+L+ N+++LLG C+ + +I E+M N L+ F+
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 188 CM-ILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR- 245
C+ + +S H+ A G+ YL S L +HRDL N L+ +++ KI+DFG++R
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 246 AFGGD--ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+ GD +G R V +MA E G+F+ SDV++FG+ L EI+
Sbjct: 188 LYAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEIAVKRL------SKISEQGLKELKNEVILFSKLQHRNLV 154
LG G G V K K + + K++ S + +Q L+EL+ + + + +V
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----IMHECRSPYIV 66
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQERCMILDWSKRFHIICGTARGLLYLHQ 212
G + + EFM SLD IL I GL YL+
Sbjct: 67 SFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY- 120
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 272
+ RI+HRD+K SN+L++ K+ DFG++ G+ + VGT YM+PE
Sbjct: 121 -NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQ 175
Query: 273 DGQFSVKSDVFSFGILLLEIVSGK 296
G+++VKSDV+S GI ++E+ GK
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 71/208 (34%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 103 LGQGGFGPVY------KGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 156
LG+GGFG V GKL +++ KRL K +G + E + +K+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 157 LGCCIQGEEKL-LIYEFMPNKSLDSFIF--DQERCMILDWSKRFH---IICGTARGLLYL 210
Q + L L+ M L I+ D+E + F+ II G L +L
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHL 113
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTNRVVGTYGYMAP 268
HQ RII+RDLK NVLLD D N +ISD GLA G +T+G GT G+MAP
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG----YAGTPGFMAP 166
Query: 269 EYASDGQFSVKSDVFSFGILLLEIVSGK 296
E ++ D F+ G+ L E+++ +
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 75/268 (27%), Positives = 127/268 (47%), Gaps = 38/268 (14%)
Query: 102 KLGQGGFGPVYKGKLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKLL 157
++G G FG VY E+ AVK++S K + + +++ EV +L+H N ++
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLR 217
GC ++ L+ E+ + D ++ ++ + H G +GL YLH +
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH---GALQGLAYLHSHN--- 141
Query: 218 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY---ASDG 274
+IHRD+KA N+LL + K++DFG A N VGT +MAPE +G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 275 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334
Q+ K DV+S GI +E+ +K F N+N + + + P+ L + + DS
Sbjct: 196 QYDGKVDVWSLGITCIELAE-RKPPLF-----NMNAMSALYHIAQNDSPT-LQSNEWTDS 248
Query: 335 FNLAEVIRCIHIGLL--CVQQHPEDRPS 360
F G + C+Q+ P++RP+
Sbjct: 249 FR----------GFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 68/215 (31%), Positives = 112/215 (52%), Gaps = 25/215 (11%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 149
N+ + K LG+G FG VY D G+E+AVK++ S+ + + + L+ E+ L L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 150 HRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQERC---MILDWSKRF--HIICG 202
H +V+ GC EEK L E+MP S I DQ + + + ++R+ I+
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQIL-- 116
Query: 203 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TNRVVG 261
+G+ YLH + I+HRD+K +N+L D N K+ DFG ++ G V G
Sbjct: 117 --QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
T +M+PE S + K+DV+S ++E+++ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 68/223 (30%), Positives = 104/223 (46%), Gaps = 34/223 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKL-VDG--QEIAVKRLSK-ISEQGLKELKNEVILFSKL-Q 149
N+ +G+G FG V K ++ DG + A+KR+ + S+ ++ E+ + KL
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSL-------------DSFIFDQERCMILDWSKR 196
H N++ LLG C L E+ P+ +L +F L +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 197 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256
H ARG+ YL Q + IHRDL A N+L+ ++ KI+DFGL+R G
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 175
Query: 257 NRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
V T G +MA E + ++ SDV+S+G+LL EIVS
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 149
N+ + K LGQG FG VY D G+E+AVK++ S + + + L+ E+ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 150 HRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQER---CMILDWSKRF--HIICG 202
H +V+ GC E+ L E MP S I DQ + + + ++++ I+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQIL-- 116
Query: 203 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TNRVVG 261
G+ YLH + I+HRD+K +N+L D N K+ DFG ++ G V G
Sbjct: 117 --EGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
T +M+PE S + K+D++S G ++E+++ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 97 FSINKKLGQGGFGPVYKG--KLVDG--QEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 150
F++ + LG+G FG V + K DG Q++AVK L S ++E E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 151 RNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIFDQ---ERCMILDWSKRFHIIC 201
N++KL+G ++ K ++I FM + L +F+ E L +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGD-ETEGNTNRV 259
A G+ YL S IHRDL A N +L+++M ++DFGL++ + GD +G +++
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
++A E +D ++ SDV++FG+ + EI++
Sbjct: 178 --PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 96 NFSINKKLGQGGFGPVY--KGKLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHR 151
+ I KK+G+G FG +Y K K D + +K L+K+ + + K EVIL +K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 152 NLVKLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQERCM-----ILDWSKRFHIICGTAR 205
N+V Q +L I E+ L I Q + IL W +
Sbjct: 60 NIVTFFAS-FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISL 112
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
GL ++H +I+HRD+K+ N+ L ++ M K+ DFG+AR D E VGT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSME-LAYTCVGTPY 167
Query: 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
Y++PE + ++ K+D++S G +L E+ + K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 68/216 (31%), Positives = 112/216 (51%), Gaps = 49/216 (22%)
Query: 103 LGQGGFGPVYKGK-LVDGQEIAVKRLS-KISEQG--LKELKNEVILFSKLQ---HRNLVK 155
+G+G +G VYK + L G+ +A+K++ +SE+G L L+ E+ L +L+ H N+V+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVR 65
Query: 156 LLGCC--IQGEEKL---LIYEFMPNKSLDSFIFDQERC--------MILDWSKRFHIICG 202
LL C + + +L L++E + ++ L +++ +C I D ++
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-DQDLATYL---SKCPKPGLPPETIKDLMRQL----- 116
Query: 203 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 262
RG+ +LH RI+HRDLK N+L+ D KI+DFGLAR + T+ VV T
Sbjct: 117 -LRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVV-T 169
Query: 263 YGYMAPE------YASDGQFSVKSDVFSFGILLLEI 292
Y APE YA+ V D++S G + E+
Sbjct: 170 LWYRAPEVLLQSSYAT----PV--DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 4e-18
Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK--ISEQGLKE-LKNEVILFSKLQH 150
++F K LG G FG V + + A+K LSK I + E + NE + ++H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFH---IICGTARG 206
LV L G Q + L L+ E++P L S + + RF+ ++
Sbjct: 61 PFLVNLYGS-FQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVA-RFYAAQVVLA---- 113
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
L YLH L I++RDLK N+LLD D KI+DFG A+ +G T + GT Y+
Sbjct: 114 LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYL 165
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVSG 295
APE + D ++ GIL+ E+++G
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 8e-18
Identities = 75/279 (26%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 98 SINKKLGQGGFGPVYKG--KLVDGQE--IAVKRL-SKISEQGLKELKNEVILFSKLQHRN 152
I + LG G FG + +G KL +E +A+ L + S++ + E + + H N
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
+V+L G +G +++ E+M N +LDSF+ E ++ + ++ G A G+ YL
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVA--GQLMGMLPGLASGMKYL-- 123
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG--NTNRVVGTYGYMAPEY 270
S + +H+ L A VL++ D+ KIS F + D++E T + APE
Sbjct: 124 -SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLWAAPEA 179
Query: 271 ASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329
FS SDV+SFGI++ E++S G++ W+ M Q +
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGER------------------PYWD--MSGQDVIK 219
Query: 330 CFQDSFNLAEVIRC---IHIGLL-CVQQHPEDRPSMPSV 364
+D F L C +H +L C Q+ +RP +
Sbjct: 220 AVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 8e-18
Identities = 70/292 (23%), Positives = 132/292 (45%), Gaps = 42/292 (14%)
Query: 96 NFSINKKLGQGGFGPVYK-------GKLVDGQEIAVKRLS-----KISEQGLKELKNEV- 142
+++ + LG G FG VYK L+ +EI V + + ++ + ++ +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 143 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DSFIFDQERCMILDWSKRFHIIC 201
I+ +L+H N+V+ ++ + ++ + + L + F +E+ + ++I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 261
L YLH++ R I+HRDL +N++L +D I+DFGLA+ E VVG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ---PESKLTSVVG 175
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNL----IGHAWKL 317
T Y PE + + K+DV++FG +L ++ + + ++S N L+L + ++
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP---FYSTNMLSLATKIVEAVYEP 232
Query: 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369
EGM S+ + C+ E RP + V M+
Sbjct: 233 LPEGMYSEDVTDVITS----------------CLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 8e-18
Identities = 73/267 (27%), Positives = 114/267 (42%), Gaps = 38/267 (14%)
Query: 103 LGQGGFGPVYKG-KLVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLVKLLGCC 160
LG G G VYK L+ + +AVK + I+ + K++ +E+ + K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 161 IQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIH 220
+ EFM SLD + E + I +GL YL L+I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVL-------GRIAVAVVKGLTYLWS---LKILH 118
Query: 221 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKS 280
RD+K SN+L++ K+ DFG++ VGT YMAPE S Q+ + S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 281 DVFSFGILLLEIVSGK-------KNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333
DV+S GI +E+ G+ KN+G L I P L F +
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-------DPPVLPVGQFSE 227
Query: 334 SFNLAEVIRCIHIGLLCVQQHPEDRPS 360
F +H C+++ P++RP+
Sbjct: 228 KF--------VHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 41/222 (18%)
Query: 97 FSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQHRN 152
+ + K +G G +G V G+++A+K++S + L + K E+ L L+H N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHEN 60
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSF--------IFDQERCMILDWSKRF------- 197
++ LL + + S + F + + + ++ S +
Sbjct: 61 IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIK-SPQPLTDDHIQ 106
Query: 198 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-- 255
+ + RGL YLH +IHRDLK SN+L++ + + KI DFGLAR DE E
Sbjct: 107 YFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 256 TNRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 296
T VV T Y APE S +++ D++S G + E+++ K
Sbjct: 164 TEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 101 KKLGQGGFGPVYKGKLV-DGQEI----AVKRL-SKISEQGLKELKNEVILFSKLQHRNLV 154
K LG G FG V+KG + +G I A+K + + Q +E+ + ++ L H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCM----ILDWSKRFHIICGTARGLLYL 210
+LLG C G L+ + P SL + + +L+W + A+G+ YL
Sbjct: 73 RLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
+ R++HR+L A N+LL D +I+DFG+A D+ + + +MA E
Sbjct: 126 EEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 271 ASDGQFSVKSDVFSFGILLLEIVS 294
G+++ +SDV+S+G+ + E++S
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 103 LGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 158
LG GGFG V K+ + A+K + K I E G +E + +E + + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 159 CCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLR 217
+ ++ + ++ E+ L + + ++R + +++ RF+I C YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVV-LAFEYLH---NRG 113
Query: 218 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFS 277
II+RDLK N+LLD + K+ DFG A+ + T GT Y+APE + +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYD 170
Query: 278 VKSDVFSFGILLLEIVSGK 296
D +S GILL E+++G+
Sbjct: 171 FSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 22/207 (10%)
Query: 101 KKLGQGGFGPVYKGKL-----VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLV 154
+ LG+G FG V + G+++AVK L S + +LK E+ + L H N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 155 KLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHI-ICGTARGLLYLH 211
K G C + LI EF+P+ SL ++ + + L ++ + IC +G+ YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQIC---KGMDYL- 125
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE----TEGNTNRVVGTYGYMA 267
SR + +HRDL A NVL++ + KI DFGL +A D+ + + + V Y A
Sbjct: 126 -GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY---A 180
Query: 268 PEYASDGQFSVKSDVFSFGILLLEIVS 294
PE +F + SDV+SFG+ L E+++
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 54/196 (27%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 102 KLGQGGFGPV-YKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 160
K+G+G G V + G+++AVK++ +Q + L NEV++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 161 IQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIH 220
+ G+E ++ EF+ +L + ++ + + R L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 221 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKS 280
RD+K+ ++LL D K+SDFG + + + +VGT +MAPE S + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEV 199
Query: 281 DVFSFGILLLEIVSGK 296
D++S GI+++E++ G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 71/222 (31%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 87 LATIVSATNNFSINKKLGQGGFGPVYK-GKLVDGQEIAVKRLSKISEQGLKELKNEV-IL 144
L ++ T+ + I + +G+G +G VYK DG AVK L IS+ +E++ E IL
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 145 FSKLQHRNLVKLLGCCIQ-----GEEKLLIYEFMPNKSLDSFIFDQERC-MILDWSKRFH 198
S H N+VK G + G + L+ E S+ + C LD + +
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
I+ G GL +LH + RIIHRD+K +N+LL + K+ DFG++ NT+
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188
Query: 259 VVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSG 295
VGT +MAPE + D + + DV+S GI +E+ G
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 103 LGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLVKL 156
+G+G FG V K G +AVKR+ ++ KE K +V++ S +VK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSS-DCPYIVKF 68
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSF---IFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
G + + + E M + SLD F +++ + ++ I T + L YL ++
Sbjct: 69 YGALFREGDCWICMELM-DISLDKFYKYVYEVLK-SVIPEEILGKIAVATVKALNYLKEE 126
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE---- 269
L+IIHRD+K SN+LLD++ N K+ DFG++ G R G YMAPE
Sbjct: 127 --LKIIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPERIDP 181
Query: 270 YASDGQFSVKSDVFSFGILLLEIVSGK 296
A DG + V+SDV+S GI L E+ +GK
Sbjct: 182 SARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 5e-17
Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 102 KLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 160
K+G+G G V + G+ +AVK++ +Q + L NEV++ QH N+V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 161 IQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIH 220
+ G+E ++ EF+ +L + ++ + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 221 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKS 280
RD+K+ ++LL D K+SDFG + + +VGT +MAPE S + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEV 197
Query: 281 DVFSFGILLLEIVSGK 296
D++S GI+++E+V G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 6e-17
Identities = 78/238 (32%), Positives = 119/238 (50%), Gaps = 30/238 (12%)
Query: 101 KKLGQGGFGPVYKGKLV----DGQEIAVKRLSKISEQGLK-----ELKNEVILFSKLQHR 151
K LGQG FG V+ + + GQ A+K L K + LK K E + +++ H
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHP 58
Query: 152 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
+VKL Q E KL LI +F+ + D F + M + +F++ A L +L
Sbjct: 59 FIVKL-HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYL-AELALALDHL 114
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
H L II+RDLK N+LLD++ + K++DFGL++ + E GT YMAPE
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEV 169
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN--LNLIGHAWKLWNEGMPSQL 326
+ + +D +SFG+L+ E+++G + F D + +I A KL GMP L
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTG--SLPFQGKDRKETMTMILKA-KL---GMPQFL 221
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 6e-17
Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 16/222 (7%)
Query: 98 SINKKLGQGGFGPVYKGKLVDGQ----EIAVKRLSKISEQGLKEL-KNEVILFSKLQHRN 152
++ + +G+G FG VY+G + + +AVK + ++E E + + H +
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
+VKL+G + ++ E P L S++ Q LD + + L YL
Sbjct: 69 IVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 272
R +HRD+ A NVL+ K+ DFGL+R DE+ ++ +MAPE +
Sbjct: 126 ---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWMAPESIN 181
Query: 273 DGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGH 313
+F+ SDV+ FG+ + EI+ G K F NN ++IG
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKP--FQGVKNN-DVIGR 220
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 7e-17
Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 102 KLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVKL 156
+G+G +G V K K + GQ +A+K+ + + K +K E+ + +L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRL 216
+ + + L++EF+ + LD ++ LD S+ + RG+ + H +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN-- 120
Query: 217 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY-ASDGQ 275
IIHRD+K N+L+ Q K+ DFG AR E T+ V T Y APE D +
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTD-YVATRWYRAPELLVGDTK 177
Query: 276 FSVKSDVFSFGILLLEIVSG 295
+ D+++ G L+ E+++G
Sbjct: 178 YGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 71/215 (33%), Positives = 107/215 (49%), Gaps = 34/215 (15%)
Query: 103 LGQGGFGPVYKGKLV-DGQEI--AVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLL 157
+G+G FG V + + DG ++ A+K L + SE ++ E+ + KL H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTA-----RGLLYLHQ 212
G C + E+ P +L F+ + +L+ F GTA + LL
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 213 D--------SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
D S + IHRDL A NVL+ +++ KI+DFGL+R G+E V T G
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEV-----YVKKTMG 178
Query: 265 -----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+MA E + ++ KSDV+SFG+LL EIVS
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 76/224 (33%), Positives = 110/224 (49%), Gaps = 46/224 (20%)
Query: 97 FSINKKLGQGGFGPVYKGKLVD---GQEIAVKRLSKI-----SEQGLKELKNEVILFSKL 148
+ I +KLG+G +G V+K +D + +A+K KI + + E++ +L
Sbjct: 9 YEILQKLGKGAYGIVWKA--IDRRTKEVVALK---KIFDAFRNATDAQRTFREIMFLQEL 63
Query: 149 -QHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQERCMIL-DWSKRFHIICGT 203
H N+VKLL I+ E IY E+M L + I R IL D KR+ I+
Sbjct: 64 GDHPNIVKLLNV-IKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-IMYQL 116
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV---- 259
+ L Y+H S +IHRDLK SN+LL+ D K++DFGLAR+ + E N V
Sbjct: 117 LKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL-SELEENPENPVLTDY 172
Query: 260 VGTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 296
V T Y APE Y V D++S G +L E++ GK
Sbjct: 173 VATRWYRAPEILLGSTRYT----KGV--DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 30/210 (14%)
Query: 103 LGQGGFGPVYKGKLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHRNLVKLLGC 159
LG+G +G V K + V G +AVKR+ + ++ Q K L ++ I + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 160 CIQGEEKLLIYEFMPNKSLDSF---IFDQERCMILDWSKRFHIICGTARGLLYLHQDSRL 216
+ + + E M + SLD F ++D+ + D + I + L YLH S+L
Sbjct: 69 LFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLH--SKL 123
Query: 217 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TNRVV-----GTYGYMAPEY 270
+IHRD+K SNVL++++ K+ DFG++ G + V G YMAPE
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGIS---------GYLVDSVAKTIDAGCKPYMAPER 174
Query: 271 ----ASDGQFSVKSDVFSFGILLLEIVSGK 296
+ + VKSDV+S GI ++E+ +G+
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 103 LGQGGFGPVYKGKLV-DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 157
+G+G FG V K ++ DG + A+KR+ + S+ ++ E+ + KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTA-----RGLLYLHQ 212
G C L E+ P+ +L F+ + +L+ F I TA + LL+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 213 D--------SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
D S+ + IHRDL A N+L+ ++ KI+DFGL+R G E
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+MA E + ++ SDV+S+G+LL EIVS
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 101 KKLGQGGFGPVYKG-KLVDGQEIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVK 155
K + +G FG VY K G A+K L K ++ N I+ + + + K
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSR 215
L + L+ E++ S I + DW+K++ I G+ LHQ
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG- 117
Query: 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 275
IIHRD+K N+L+DQ + K++DFGL+R G E + + VGT Y+APE
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLENK----KFVGTPDYLAPETILGVG 169
Query: 276 FSVKSDVFSFGILLLEIVSG 295
SD +S G ++ E + G
Sbjct: 170 DDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 3e-16
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 30/209 (14%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEI-AVKR----LSKISE-QGLKELKNEVILFSKLQ-HRNL 153
K+LG G FG VY + + E+ A+K+ E L+E+K+ KL H N+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS----LRKLNEHPNI 60
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
VKL + +E ++E+M +L + D++ S II +GL ++H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIH-- 116
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR-----VVGTYGYMAP 268
+ HRDLK N+L+ KI+DFGLAR E +R V T Y AP
Sbjct: 117 -KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIR---SRPPYTDYVSTRWYRAP 167
Query: 269 E-YASDGQFSVKSDVFSFGILLLEIVSGK 296
E +S D+++ G ++ E+ + +
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 87 LATIVSATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK------ISEQGLKELK 139
T+ TN + + +G G FG V + + GQ +A+K++ K ++++ +ELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 140 NEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRF- 197
L L+H N++ L I E + + E + D R + + + F
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYFL 114
Query: 198 -HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256
I+ RGL Y+H ++HRDLK SN+L++++ + KI DFGLAR +
Sbjct: 115 YQIL----RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQM 162
Query: 257 NRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGK 296
V T Y APE Q + V+ D++S G + E++ GK
Sbjct: 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 158
++G G G VYK G+ A+K + E ++ ++ E+ + + H N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 159 CCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRI 218
E ++ EFM SL+ E+ + D +++ I+ G A YLH R I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQ-FLADVARQ--ILSGIA----YLH---RRHI 189
Query: 219 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA----SDG 274
+HRD+K SN+L++ N KI+DFG++R +T N VGT YM+PE + G
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYMSPERINTDLNHG 247
Query: 275 QFS-VKSDVFSFGILLLEIVSGK 296
+ D++S G+ +LE G+
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVK 155
K LG+G FG V +L E+ AVK L K + + ++ E + + +H L +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 156 LLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSK-RFHIICGTARGLLYLHQD 213
L C Q +++L + E++ L +F +R D + RF+ GL +LH+
Sbjct: 61 LH-SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAE-IVLGLQFLHER 115
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTNRVVGTYGYMAPEYAS 272
II+RDLK NVLLD + + KI+DFG+ + G T T+ GT Y+APE S
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEILS 169
Query: 273 DGQFSVKSDVFSFGILLLEIVSGK 296
+ D ++ G+LL E+++G+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 22/208 (10%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEIA---VKRL---SKISEQGLKELKNEVILFSKLQHRNLV 154
++G G FG V G+ G A VK L + EQ L EV + +L H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVL 58
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF--HIICGTARGLLYLHQ 212
+ LG CI+ LL+ EF P L +++ + K + C A GLL+LHQ
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTNRVVGTYGYMAPEYA 271
IH DL N L D++ KI D+GLA + D V ++APE
Sbjct: 119 ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELV 174
Query: 272 SDGQFSV-------KSDVFSFGILLLEI 292
+ KS+++S G+ + E+
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 61/186 (32%), Positives = 96/186 (51%), Gaps = 29/186 (15%)
Query: 102 KLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNLV 154
K+GQG FG V+K + Q +A+K++ +E+ L+E+K IL L+H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK---IL-QLLKHENVV 74
Query: 155 KLLGCC---IQGEEK-----LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
L+ C + L++EF + L + ++ L K+ ++ G
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKK--VMKMLLNG 131
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN---TNRVVGTY 263
L Y+H R +I+HRD+KA+N+L+ +D K++DFGLARAF + TNRVV T
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TL 187
Query: 264 GYMAPE 269
Y PE
Sbjct: 188 WYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 103 LGQGGFGPV------YKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 156
LG+GGFG V GK+ +++ KR+ K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGESMALNEKQILEKVNSRFVVSL 65
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFH---IICGTARGLLYLHQD 213
+ L+ M L I+ + F+ I CG L LHQ+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE 121
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 273
RI++RDLK N+LLD + +ISD GLA +T VGT GYMAPE +
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKN 175
Query: 274 GQFSVKSDVFSFGILLLEIVSGK 296
+++ D ++ G LL E+++G+
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 35/227 (15%)
Query: 97 FSINKKLGQGGFGPVY------------KGKLVDGQE-----IAVKRL-SKISEQGLKEL 138
+ +KLG+G FG V+ K +D +AVK L ++ +
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 139 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--------FDQERCMI 190
E+ + S+L+ N+++LL CI + +I E+M N L+ F+ ++ +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 191 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGG 249
+ +S + A G+ YL S L +HRDL N L+ ++ KI+DFG++R + G
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 250 D--ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
D +G R V +M+ E G+F+ SDV++FG+ L EI++
Sbjct: 184 DYYRIQG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 101 KKLGQGGFGPVYKG--KLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLL 157
+KLG+G + V+KG KL + +A+K + E+G EV L L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLR 217
+ L++E++ +K L ++ D M + K F + RGL Y H R +
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRK 124
Query: 218 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YASDGQF 276
++HRDLK N+L+++ K++DFGLARA T+ +N VV T Y P+ ++
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSSEY 182
Query: 277 SVKSDVFSFGILLLEIVSGK 296
S + D++ G + E+ SG+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 103 LGQGGFGPV------YKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 156
LG+GGFG V GK+ +++ KRL K S + + L+ E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFD-QERCMILDWSKRFHIICGTARGLLYLHQDSR 215
L+ M L I++ ER L+ + H G+L+LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG--LEMERVIHYSAQITCGILHLHS--- 113
Query: 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 275
+ I++RD+K NVLLD N ++SD GLA +T + GT GYMAPE +
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEP 170
Query: 276 FSVKSDVFSFGILLLEIVSGK 296
+S D F+ G + E+V+G+
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 72/221 (32%), Positives = 101/221 (45%), Gaps = 45/221 (20%)
Query: 97 FSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELK------NEVILFSKLQ 149
F + LG+GGFG V ++ G+ A K+L K + +K+ K NE + K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVN 58
Query: 150 HRNLVKLL-------GCCI------QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKR 196
R +V L C+ G+ K IY FD+ER +
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FDEERAVFY----A 108
Query: 197 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256
I CG L LH R RI++RDLK N+LLD + +ISD GLA EG T
Sbjct: 109 AEITCG----LEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEI----PEGET 157
Query: 257 NR-VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
R VGT GYMAPE + +++ D + G L+ E++ GK
Sbjct: 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKN----EVILFSKLQ 149
N + + +G+G +G V K + G+ +A+K+ K SE +++K EV + +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDD-EDVKKTALREVKVLRQLR 58
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209
H N+V L + L++E++ L+ + + D + I + + Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRS--YIWQLLQAIAY 115
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 269
H IIHRD+K N+L+ + K+ DFG ARA T+ V T Y APE
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPE 171
Query: 270 -YASDGQFSVKSDVFSFGILLLEIVSG 295
D + DV++ G ++ E++ G
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 69/219 (31%), Positives = 102/219 (46%), Gaps = 49/219 (22%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILF-----SKLQHRNLVK 155
K LG+G FG V +L E +K LK +V+L + R ++
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFF----------AIKALKKDVVLEDDDVECTMVERRVLA 50
Query: 156 L---------LGCCIQGEEKLL-IYEFMPNKSL-----DSFIFDQERCMILDWSKRFH-- 198
L L C Q +E L + E++ L S FD+ R RF+
Sbjct: 51 LAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARA-------RFYAA 103
Query: 199 -IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 257
IICG L +LH+ II+RDLK NVLLD+D + KI+DFG+ + E + +T
Sbjct: 104 EIICG----LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST- 155
Query: 258 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
GT Y+APE +++ D +SFG+LL E++ G+
Sbjct: 156 -FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 103 LGQGGFGPVYKGKL-VDGQEIAVKRLSK---ISEQGLK-ELKNEVILFSKLQHRNLVKLL 157
LG+G FG V +L G+ AVK L K + + ++ + + IL H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 158 GCCIQGEEKLL-IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRL 216
CC Q ++L + EF+ L +F ++ D ++ L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 217 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF 276
II+RDLK NVLLD + + K++DFG+ + G T+ GT Y+APE + +
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKE--GIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 277 SVKSDVFSFGILLLEIVSG 295
D ++ G+LL E++ G
Sbjct: 174 GPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 82 LPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNE 141
+P + A V A+ +++ K L G G V+ GQ V + KI ++G + E
Sbjct: 53 IPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPV--VLKIGQKGTTLI--E 107
Query: 142 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIIC 201
+L + H +++++ + G ++ +P+ S D + + +R L + I
Sbjct: 108 AMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 261
GL YLH RIIHRD+K N+ ++ I D G A+ + G
Sbjct: 165 QILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAG 218
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
T APE + +++ K+D++S GI+L E+++
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 97 FSINKKLGQGGFGPV------YKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 150
F + LG+GGFG V GK+ + + KR+ K +G NE + K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK--RKGESMALNEKQILEKVNS 59
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-------FDQERCMILDWSKRFHIICGT 203
+ +V L + L+ M L I F++ER + I+CG
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY----AAEILCG- 114
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA-RAFGGDETEGNTNRVVGT 262
L LH+++ ++RDLK N+LLD + +ISD GLA + G+ G VGT
Sbjct: 115 ---LEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGT 164
Query: 263 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
GYMAPE ++ ++++ D + G L+ E++ G+
Sbjct: 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-15
Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 41/215 (19%)
Query: 101 KKLGQGGFGPVYKGKLV----DGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLV 154
KK+G+G FG K LV DG++ +K + SK+S + +E + EV + S ++H N+V
Sbjct: 6 KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 155 KL------LGC-------CIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIIC 201
+ G C G+ +Y+ + + F DQ ILDW F IC
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGD----LYKKINAQRGVLFPEDQ----ILDW---FVQIC 111
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 261
L ++H +I+HRD+K+ N+ L +D K+ DFG+AR T +G
Sbjct: 112 ---LALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIG 163
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
T Y++PE + ++ KSD+++ G +L E+ + K
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 33/211 (15%)
Query: 101 KKLGQGGFGPVYKG-KLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLL 157
K +G G G V V GQ +A+K+LS+ + K E++L + H+N++ LL
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSF--------IFDQERC----MILDWSKRFHIICGTAR 205
F P KSL+ F + D C M LD + +++
Sbjct: 82 NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC 129
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
G+ +LH IIHRDLK SN+++ D KI DFGLAR G T VV Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 183
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
APE + D++S G ++ E++ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 53/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLV 154
+F + +++G G +G VYK + V+ E+A ++ K+ + ++ E+I+ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
G ++ ++ + EF SL L S+ ++ T +GL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIY---HVTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS-- 272
+ +HRD+K +N+LL + + K++DFG++ T +GT +MAPE A+
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVE 181
Query: 273 -DGQFSVKSDVFSFGILLLEI 292
G ++ D+++ GI +E+
Sbjct: 182 RKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 34/209 (16%)
Query: 103 LGQGGFGPV----YKGKLVDGQEIAVKRLSK---ISEQGLKELKNEVILF---SKLQHRN 152
LG+G FG V YK G+ A+K L K I+ ++ L E +F + +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 153 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI----FDQERCMILDWSKRFHIICGTARGL 207
LV L C Q E+ + + E+ L I F + R + F+ C GL
Sbjct: 64 LVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAV-------FYAAC-VVLGL 114
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTNRVVGTYGYM 266
YLH++ +I++RDLK N+LLD + KI+DFGL + G + T+ GT ++
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFL 168
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVSG 295
APE ++ ++ D + G+L+ E++ G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 25/191 (13%)
Query: 97 FSINKKLGQGGFGPVYKGKL---VDGQEIAVKRL--SKISEQGLKELK-NEVILFSKLQH 150
+ I +G+G +G VYK K DG+E A+K+ K G+ + E+ L +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 151 RNLVKLLGCCIQGEEKL--LIYEFMPNKSLD--SFIFDQERCMILDW---SKRFHIICGT 203
N+V L+ ++ +K L++++ + F +R I S + I+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN-- 119
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAFGGD-ETEGNTNR 258
G+ YLH + ++HRDLK +N+L+ + KI D GLAR F + + +
Sbjct: 120 --GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 259 VVGTYGYMAPE 269
VV T Y APE
Sbjct: 175 VVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 102 KLGQGGFGPVYKG--KLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 158
KLG+G + VYKG KL D +A+K + E+G EV L L+H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 159 CCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLR 217
I E+ L L++E++ +K L ++ D + + K F + RGL Y H R +
Sbjct: 72 I-IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRK 124
Query: 218 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YASDGQF 276
++HRDLK N+L+++ K++DFGLARA T+ +N VV T Y P+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV-TLWYRPPDILLGSTDY 182
Query: 277 SVKSDVFSFGILLLEIVSGK 296
S + D++ G + E+ +G+
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 40/214 (18%)
Query: 102 KLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG---LKELKNEVILFSKLQHRNLVKLL 157
++G+G +G VY+ + G+ +A+K++ +E+ + L+ E+ L L+H N+V+L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSFIF------DQERCMILDWSKR-FH------IICGTA 204
E + K LDS IF +Q+ +LD F ++
Sbjct: 73 -------------EVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
RGL YLH++ IIHRDLK SN+LL KI+DFGLAR + G + T +VV T
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLW 173
Query: 265 YMAPE--YASDGQFSVKSDVFSFGILLLEIVSGK 296
Y APE + D+++ G +L E+++ K
Sbjct: 174 YRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 67/239 (28%), Positives = 105/239 (43%), Gaps = 36/239 (15%)
Query: 96 NFSINKKLGQGGFGPVYKGKLV---DGQEIAVKRLSKI------SEQGLKELKNEVILFS 146
+ + K+LGQG +G V + + + +A+K+++ + +++ L+ELK +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELK---LLRH 57
Query: 147 KLQHRNLVKLLGCCI---QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHI---I 200
H+N+ L I +L +YE + L I + H I
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPL------TDAHFQSFI 111
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTNR 258
GL Y+H + ++HRDLK N+L++ D KI DFGLAR F E G
Sbjct: 112 YQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE 168
Query: 259 VVGTYGYMAPEYASDGQFSVKS-DVFSFGILLLEIVSGK---KNRGFYHSDNNLNLIGH 313
V T Y APE Q K+ DV+S G +L E++ K K + + LN I
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQ 224
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 74/273 (27%), Positives = 130/273 (47%), Gaps = 34/273 (12%)
Query: 101 KKLGQGGFGPVYKGKLV----DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLV 154
+ +G+G +G V LV DG++ +K+L+ S + K + E L S+L+H N+V
Sbjct: 6 RVVGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 155 KLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
+GE+ LL + F L + +Q+ ++ + ++ A L YLH+
Sbjct: 63 AYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLHE 120
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 272
I+HRDLK NV L + K+ D G+AR +T ++GT YM+PE S
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFS 175
Query: 273 DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332
+ ++ KSDV++ G + E+ + K H+ N ++ +++ +P D +
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLK------HAFNAKDMNSLVYRIIEGKLPPMPKDYSPE 229
Query: 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365
L E+I +L + PE RPS+ S++
Sbjct: 230 ----LGELIA----TMLS--KRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 90/341 (26%), Positives = 128/341 (37%), Gaps = 94/341 (27%)
Query: 101 KKLGQGGFGPVYK------GKLVDGQEIAVKRL---SKISEQG--LKELKNEVILFSKLQ 149
K LG+G FG V + K + +AVK L + SE + ELK IL
Sbjct: 13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK---ILIHIGH 69
Query: 150 HRNLVKLLGCCIQGEEKLLI------------------YEFMPNKS-------------- 177
H N+V LLG C + L++ F P ++
Sbjct: 70 HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGK 129
Query: 178 ---LDS-----------FIFD------QERCMILDWSKRF----HIICGT---ARGLLYL 210
LDS FI D +E + K +I + ARG+ +L
Sbjct: 130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL 189
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
SR + IHRDL A N+LL ++ KI DFGLAR D +MAPE
Sbjct: 190 --ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246
Query: 271 ASDGQFSVKSDVFSFGILLLEIVS--GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328
D ++ +SDV+SFG+LL EI S G + + ++ P
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM---RAPEYATP 303
Query: 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369
+ I L C +PEDRP+ ++ +LG
Sbjct: 304 EIYS-------------IMLDCWHNNPEDRPTFSELVEILG 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 31/208 (14%)
Query: 103 LGQGGFGPV------YKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 156
LG+GGFG V GK+ +++ KR+ K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKRILEKVNSRFVVSL 65
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFI-------FDQERCMILDWSKRFHIICGTARGLLY 209
+ L+ M L I FD++R + + CG
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY----AAELCCG------- 114
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR-VVGTYGYMAP 268
L R RI++RDLK N+LLD + +ISD GLA EG T R VGT GYMAP
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI----PEGETVRGRVGTVGYMAP 170
Query: 269 EYASDGQFSVKSDVFSFGILLLEIVSGK 296
E ++ +++ D + G L+ E++ G+
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 64/236 (27%), Positives = 108/236 (45%), Gaps = 39/236 (16%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQ-----GLKELKNEVILFSKLQ 149
+ +G+G +G V G ++A+K++S Q L+E+K + + +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFK 61
Query: 150 HRNLVKLLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTA 204
H N++ +L + ++ E M L I Q + D + F +
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH--LSNDHIQYF--LYQIL 116
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV---VG 261
RGL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR D +T + V
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVA 171
Query: 262 TYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK-----KNRGFYHSDNNLNLI 311
T Y APE + ++ D++S G +L E++S + K+ Y + LNLI
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD---YL--HQLNLI 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 52/206 (25%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQHRN 152
+++ + +++G G +G VYK + + E+A ++ K+ E G ++ E+ + + +H N
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECKHCN 67
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF---DQERCMILDWSKRFHIICGTARGLLY 209
+V G + E+ + E+ SL I ++ T +GL Y
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIA------YVCRETLQGLAY 121
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 269
LH ++ HRD+K +N+LL + + K++DFG+A T +GT +MAPE
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPE 176
Query: 270 YAS---DGQFSVKSDVFSFGILLLEI 292
A+ +G ++ D+++ GI +E+
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 34/92 (36%), Positives = 56/92 (60%), Gaps = 6/92 (6%)
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
RGL YL + + +I+HRD+K SN+L++ K+ DFG++ G + N VGT
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 163
Query: 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
YM+PE ++V+SD++S G+ L+E+ G+
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 63/239 (26%), Positives = 109/239 (45%), Gaps = 61/239 (25%)
Query: 99 INKKLGQGGFGPVYKGK-LVDGQEIAVKRL-------------SKISEQG-----LKELK 139
LG+G +G V K + G+ +A+K++ + G L+ELK
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 140 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN---KSLDSFIF---DQERCMILDW 193
+ ++++H N++ L+ ++G+ L+ + M + K +D I Q +C++L
Sbjct: 73 ----IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILL-- 126
Query: 194 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD--- 250
I+ GL LH+ +HRDL +N+ ++ KI+DFGLAR +G
Sbjct: 127 ----QIL----NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 251 ----------ETEGNTNRVVGTYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIVSGK 296
E T++VV T Y APE A F+V D++S G + E+++GK
Sbjct: 176 DTLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 50/154 (32%), Positives = 88/154 (57%), Gaps = 17/154 (11%)
Query: 102 KLGQGGFGPVYKGKLVDGQEI-AVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 158
K+G+G +G V+K K + EI A+KR+ + +G+ E+ L +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 159 CCIQGEEKL-LIYEFMPN---KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+ ++KL L++E+ K DS D + ++ S F ++ +GL + H
Sbjct: 67 V-LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK--SFMFQLL----KGLAFCHSH- 118
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248
++HRDLK N+L++++ K++DFGLARAFG
Sbjct: 119 --NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVK 155
K LG+G FG V+ +L Q A+K L K + + + + +L +H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 156 LLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQERCMILDWSK-RFH---IICGTARGLLYL 210
L C Q +E L + E++ L +F + C D + F+ IICG L +L
Sbjct: 61 LY-CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICG----LQFL 112
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTNRVVGTYGYMAPE 269
H I++RDLK N+LLD D + KI+DFG+ + GD T GT Y+APE
Sbjct: 113 HSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGTPDYIAPE 166
Query: 270 YASDGQFSVKSDVFSFGILLLEIVSGK 296
+++ D +SFG+LL E++ G+
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 68/200 (34%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 101 KKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVK 155
K +G+G FG V K DG AVK L K + KE + + +L L+H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSR 215
L Q EKL N F +ERC L+ RF+ A + YLH
Sbjct: 61 L-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCF-LEPRARFYA-AEVASAIGYLHS--- 114
Query: 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 275
L II+RDLK N+LLD + ++DFGL + G E E T+ GT Y+APE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 276 FSVKSDVFSFGILLLEIVSG 295
+ D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 96 NFSINKKLGQGGFGPVY----KGKLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSK 147
NF + + LG G +G V+ G G+ A+K L K + + + + E +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 148 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
++ + L Q + KL LI +++ L + ++ +E S+ I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLA 117
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
L +LHQ L II+RD+K N+LLD + + ++DFGL++ F +E E GT YM
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 267 APEY--ASDGQFSVKSDVFSFGILLLEIVSG 295
APE G D +S G+L E+++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 72/282 (25%), Positives = 133/282 (47%), Gaps = 44/282 (15%)
Query: 96 NFSINKKLGQGGFGPVYKGKLV----DGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 149
+++ + +G+G FG + LV Q+ A+K RL K S +++ + E +L +K++
Sbjct: 1 QYNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMK 56
Query: 150 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQE-----RCMILDWSKRFHIICGT 203
H N+V + + L ++ E+ L I Q IL W F +C
Sbjct: 57 HPNIVAFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---FVQMC-- 110
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
G+ ++H+ R++HRD+K+ N+ L Q+ K+ DFG AR T VGT
Sbjct: 111 -LGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTP 164
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323
Y+ PE + ++ KSD++S G +L E+ + K + +++ NLI + + +P
Sbjct: 165 YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP---FQANSWKNLILKVCQGSYKPLP 221
Query: 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365
S S+ L +I+ + +++P RPS +++
Sbjct: 222 SHY-------SYELRSLIKQM------FKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 65/244 (26%), Positives = 106/244 (43%), Gaps = 61/244 (25%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSKISEQGLKELKNEVILFSKLQHRN- 152
++F + K +G+G FG V+ + D ++ A+K L K +K +N++ R+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK--SDMIK--RNQIAHV--RAERDI 54
Query: 153 --------LVKLLGCCIQGEEKL-LIYEFMPNKSL-----DSFIFDQERCMILDWSKRFH 198
+VKL Q EE L L+ E+MP L +F +E + RF+
Sbjct: 55 LADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-------TARFY 106
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG-GDETEGNTN 257
I A +L L +L IHRD+K N+L+D D + K++DFGL + + E N
Sbjct: 107 I----AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 258 R--------------------------VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLE 291
VGT Y+APE + ++ D +S G++L E
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
Query: 292 IVSG 295
++ G
Sbjct: 223 MLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 53/210 (25%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 151
+ K +G G FG V+ + + A+K ++ I + + + NE + ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 152 NLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQERCMILDWSKRFH---IICGTARG 206
+++L + +++ L + E++P L S++ + R + + F+ I+C
Sbjct: 62 FIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCA---- 113
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
L YLH I++RDLK N+LLD++ + K++DFG A+ + T + GT Y+
Sbjct: 114 LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYL 165
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVSGK 296
APE + D ++ GIL+ E++ G
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 35/221 (15%)
Query: 97 FSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQ------GLKELKNEVILFSKLQ 149
F I ++G+G +G VYK + D G+ +A+K++ +E+ ++E+K + +L
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK----ILRQLN 64
Query: 150 HRNLVKLLGCCIQGEEKL----------LIYEFMPNK---SLDSFIFDQERCMILDWSKR 196
HRN+V L ++ L L++E+M + L+S + I + K+
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 197 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256
GL Y H+ + L HRD+K SN+LL+ K++DFGLAR + +E+ T
Sbjct: 125 L------LEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 257 NRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 296
N+V+ T Y PE + ++ DV+S G +L E+ + K
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 69/217 (31%), Positives = 107/217 (49%), Gaps = 28/217 (12%)
Query: 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVK 155
K LG+G FG V +L G+ AVK L K I + + + +L ++ L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 156 LLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQERCMILDWSKRFH---IICGTARGLLYLH 211
L C Q +E L + EF+ L I D+ R + + F+ I+CG L +LH
Sbjct: 61 LY-CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCG----LQFLH 113
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR--AFGGDETEGNTNRVVGTYGYMAPE 269
II+RDLK NV+LD+D + KI+DFG+ + FG + + GT Y+APE
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPE 166
Query: 270 YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306
+++ D +SFG+LL E++ G+ +H D+
Sbjct: 167 ILQGLKYTFSVDWWSFGVLLYEMLIGQSP---FHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 148
N+ ++G G G VYK + G +AVK++ + + +E K +V+L S
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKS-- 70
Query: 149 QHR--NLVKLLGCCIQGEEKLLIYEFMPN------KSLDSFIFDQERCMILDWSKRFHII 200
H +VK G I + + E M K + I + IL +
Sbjct: 71 -HDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPED----ILG-----KMT 120
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN-RV 259
+ L YL + +IHRD+K SN+LLD N K+ DFG++ G + R
Sbjct: 121 VAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKTRS 174
Query: 260 VGTYGYMAPEY----ASDGQFSVKSDVFSFGILLLEIVSGK 296
G YMAPE + ++ +++DV+S GI L+E+ +G+
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 43/214 (20%)
Query: 103 LGQGGFGPVYKGKLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 159
+G G +G V G+++A+K+LS+ S K E+ L + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 160 CIQGEEKLLIYEFMPNKSLDSF----------------IFDQERCMILDWSKRFHIICGT 203
F P SL+ F I ++ + D +F ++
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQF-LVYQI 127
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
RGL Y+H IIHRDLK SN+ +++D KI DFGLAR T+ V T
Sbjct: 128 LRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATR 179
Query: 264 GYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGK 296
Y APE + ++ D++S G ++ E+++GK
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 17/200 (8%)
Query: 102 KLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 159
KLG+G + VYKG+ + GQ +A+K + E+G E L L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70
Query: 160 CIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRI 218
I ++ L L++E++ + L ++ D + + + F + RGL Y HQ R+
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLF--LFQLLRGLAYCHQR---RV 124
Query: 219 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY---ASDGQ 275
+HRDLK N+L+ + K++DFGLARA ++ +N VV T Y P+ +++
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVV-TLWYRPPDVLLGSTE-- 180
Query: 276 FSVKSDVFSFGILLLEIVSG 295
+S D++ G + E+ +G
Sbjct: 181 YSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 25/206 (12%)
Query: 101 KKLGQGGFGPVYKG-KLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 158
+KLG+G + VYKG ++GQ +A+K +S +E+G+ E L L+H N+V LL
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLH 69
Query: 159 CCIQGEEKL-LIYEFMPNKSLDSFIFDQ----ERCMILDWSKRFHIICGTARGLLYLHQD 213
I +E L ++E+M + L ++ + + F ++ RGL Y+H
Sbjct: 70 DIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLF--MFQLL----RGLAYIH-- 120
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY--- 270
I+HRDLK N+L+ K++DFGLARA ++ ++ VV T Y P+
Sbjct: 121 -GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYRPPDVLLG 177
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSGK 296
A+D +S D++ G + +E++ G+
Sbjct: 178 ATD--YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 64/199 (32%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 101 KKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 158
+KLG+G + VYKGK V+G+ +A+K + E+G E L L+H N+V LL
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV-LLH 69
Query: 159 CCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLR 217
I +E L L++E++ + L ++ + + K F + RGL Y+HQ
Sbjct: 70 DIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYIHQRY--- 123
Query: 218 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YASDGQF 276
I+HRDLK N+L+ K++DFGLARA + +N VV T Y P+ ++
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 277 SVKSDVFSFGILLLEIVSG 295
S D++ G + +E++ G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 101 KKLGQGGFGPVYKG-KLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLL 157
K +G G G V V G +AVK+LS+ ++ K E++L + H+N++ LL
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSF--------IFDQERC----MILDWSKRFHIICGTAR 205
F P KSL+ F + D C M LD + +++
Sbjct: 87 NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC 134
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
G+ +LH IIHRDLK SN+++ D KI DFGLAR + T VV Y Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-Y 188
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSG 295
APE + D++S G ++ E+V G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 76/276 (27%), Positives = 112/276 (40%), Gaps = 82/276 (29%)
Query: 95 NNFSINKKLGQGGFGPVYKG------KLVDGQEIAVKRLSKISEQG-----LKELKNEVI 143
+ + K LG+G FG V + K + +AVK L + + + ELK I
Sbjct: 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 63
Query: 144 LFSKLQHRNLVKLLGCCIQGEEKLLIY------------------EFMPNKS-------- 177
L H N+V LLG C + L++ EF+P K+
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQG 123
Query: 178 --------------LDS-----------FIFDQERCMIL-------DWSKRF----HIIC 201
LDS F+ ++ + D K+ +IC
Sbjct: 124 KSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLIC 183
Query: 202 GT---ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
+ A+G+ +L SR + IHRDL A N+LL ++ KI DFGLAR D
Sbjct: 184 YSFQVAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+MAPE D ++++SDV+SFG+LL EI S
Sbjct: 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 41/244 (16%)
Query: 102 KLGQGGFGPVYKGKLVD--GQEIAVKRLS-KISEQG--LKELKNEVIL--FSKLQHRNLV 154
++G+G +G V+K + + G+ +A+KR+ + E+G L ++ +L +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 155 KLLGCCIQG----EEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTA----- 204
+L C E KL L++E + DQ+ LD + T
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 205 ---RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 261
RGL +LH R++HRDLK N+L+ K++DFGLAR + + VV
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 171
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG 321
T Y APE ++ D++S G + E+ + + + ++++ +G + G
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLGKILDVI--G 226
Query: 322 MPSQ 325
+P +
Sbjct: 227 LPGE 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVDGQE----IAVKRLSKIS----EQGLKELKNEVILFSK 147
NF + K LG G +G V+ + V G + A+K L K + + + + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 148 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
++ + L Q + KL LI +++ L + + +ER K + +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF------KEQEVQIYSGEI 114
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
+L L +L II+RD+K N+LLD + + ++DFGL++ F DE E GT YM
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 267 APEY--ASDGQFSVKSDVFSFGILLLEIVSG 295
AP+ DG D +S G+L+ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 102 KLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 159
KLG+G + V+KG+ + +A+K + E+G EV L L+H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 160 CIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRI 218
I E L L++E++ + L ++ + M + K F + RGL Y H + +I
Sbjct: 72 -IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIF--MFQLLRGLSYCH---KRKI 124
Query: 219 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YASDGQFS 277
+HRDLK N+L+++ K++DFGLARA T+ +N VV T Y P+ ++S
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSTEYS 182
Query: 278 VKSDVFSFGILLLEIVSGK 296
D++ G +L E+ +G+
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 101 KKLGQGGFGPVYKGKLVDG---QEIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKL 156
K++G G FG V G++ G ++ VK L S Q + E + LQH NL++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQERC--MILDWSKRFHIICGTARGLLYLHQDS 214
LG C + LL+ EF P L ++ + M D + + C A GLL+LH+++
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD- 273
IH DL N LL D+ KI D+GL+ ++ +++ ++APE +
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 274 -GQFSV-----KSDVFSFGILLLEI 292
G V +S+V+S G+ + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--- 151
++F +LG G G V K + I ++L + + ++N++I ++ H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 152 -NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
+V G E + E M SLD + + +R K + RGL YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VSIAVLRGLAYL 119
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
+ + +I+HRD+K SN+L++ K+ DFG++ G + N VGT YM+PE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSGK 296
+SV+SD++S G+ L+E+ G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 101 KKLGQGGFGPVYKG-KLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLL 157
K +G G G V + + +A+K+LS+ ++ K E++L + H+N++ LL
Sbjct: 30 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSF--------IFDQERC----MILDWSKRFHIICGTAR 205
F P KSL+ F + D C M LD + +++
Sbjct: 90 NV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC 137
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
G+ +LH IIHRDLK SN+++ D KI DFGLAR G T V T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
APE + D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 101 KKLGQGGFGPVYKG-KLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLL 157
K++G G +G V G+++A+K+LS+ SE K E+ L +QH N++ LL
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 158 G---CCIQGEEKLLIYEFMPNKSLDSFIF-DQERCMILDWS--KRFHIICGTARGLLYLH 211
+ G+E Y MP ++ D ++ M S K +++ GL Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMP------YMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH 134
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
IIHRDLK N+ +++D KI DFGLAR + T V T Y APE
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVTRWYRAPEVI 186
Query: 272 SDG-QFSVKSDVFSFGILLLEIVSGK 296
+ ++ D++S G ++ E+++GK
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLK-ELKNEVILFSKLQHRNLVK 155
K LG+G FG V +L E+ A+K L K + + + + + IL +H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 156 LLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQERCMILDWSK-RFHIICGTARGLLYLHQD 213
L CC Q +++L + E++ L +F +R D + RF+ T L++LH+
Sbjct: 61 LH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTL-ALMFLHRH 115
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 273
+I+RDLK N+LLD + + K++DFG+ + G T GT Y+APE +
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFGMCKE--GILNGVTTTTFCGTPDYIAPEILQE 170
Query: 274 GQFSVKSDVFSFGILLLEIVSGK 296
++ D ++ G+L+ E+++G+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 8e-13
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 103 LGQGGFGPVYKGKLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRN--LVKL 156
+G+GGFG VY + D G+ A+K L K +QG NE I+ S + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 157 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFH---IICGTARGLLYLHQ 212
+ +KL I + M L + + + + RF+ II G H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLE------HM 113
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 272
+R +++RDLK +N+LLD+ + +ISD GLA F + + VGT+GYMAPE
Sbjct: 114 HNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQ 168
Query: 273 DG-QFSVKSDVFSFGILLLEIVSG 295
G + +D FS G +L +++ G
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSKI------SEQGLKELKNEVILFSKLQHRNL 153
+ +G G FG V+ DG+ +A+K++ + ++ +ELK + +H N+
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK----MLCFFKHDNV 61
Query: 154 VKLLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF--HIICGTARG 206
+ L EE ++ E M L I + + D K F I+ RG
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQP-LSSDHVKVFLYQIL----RG 115
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
L YLH I+HRD+K N+L++ + KI DFGLAR DE++ T VV Y Y
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171
Query: 267 APEYASDGQ-FSVKSDVFSFGILLLEIVSGK 296
APE + ++ D++S G + E++ +
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 8e-13
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 102 KLGQGGFGPVYK------GKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 155
+LG+G +G VYK G + +EI RL + E ++ E+ + K +V
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE-LDESKFNQIIMELDILHKAVSPYIVD 63
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSR 215
G + E+M SLD + I +GL +L ++
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE-- 121
Query: 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG- 274
IIHRD+K +NVL++ + K+ DFG++ + N +G YMAPE G
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIKSGG 177
Query: 275 -----QFSVKSDVFSFGILLLEIVSGK 296
++V+SDV+S G+ +LE+ G+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 103 LGQGGFGPVYKG-KLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLGC 159
+G G +G V G +AVK+LS+ + + K E+ L ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 160 CIQGEEKLLIYEFMPNKSLDSF-------------IFDQERCMILDWSKRFHIICGTARG 206
F P +SL+ F + + +C L +I RG
Sbjct: 85 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
L Y+H IIHRDLK SN+ +++D KI DFGLAR DE G V T Y
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 184
Query: 267 APEYASDG-QFSVKSDVFSFGILLLEIVSGK 296
APE + ++ D++S G ++ E+++G+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 68/213 (31%), Positives = 98/213 (46%), Gaps = 17/213 (7%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVK 155
K +G+G FG V K DG+ AVK L K + KE K+ + +L ++H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 156 LLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
L Q +KL + +++ L F +ER + RF+ A L YLH
Sbjct: 61 L-HYSFQTADKLYFVLDYVNGGEL-FFHLQRERSF-PEPRARFYA-AEIASALGYLHS-- 114
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
L II+RDLK N+LLD + ++DFGL + G E T+ GT Y+APE
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 275 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN 307
+ D + G +L E++ G FY D
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP--FYSRDTA 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKR-LSKISEQGLKELK-NEVILFSKLQHRN-LVKL 156
+K+G+G +G VYK + G+ +A+K+ ++ E+G+ E+ L L +V+L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 157 LGCCIQGEEKL------LIYEFMPN---KSLDSFIFDQERCMILDWSKRF-HIICGTARG 206
L EEK L++E++ + K +DS R + K F + + +G
Sbjct: 67 L-DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL---KG 122
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTNRVVGTYGY 265
+ + H + ++HRDLK N+L+D+ KI+D GL RAF + T+ +V T Y
Sbjct: 123 VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWY 177
Query: 266 MAPEYASDG-QFSVKSDVFSFGILLLEIVSG 295
APE +S D++S G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 38/215 (17%)
Query: 101 KKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNL 153
K +G+G +G V K + +++A+K+++ + + L+E+K L L H N+
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK----LLRHLDHENV 66
Query: 154 VKLLGCCI-----QGEEKLLIYEFMPN------KSLDSFIFDQERCMILDWSKRFHIICG 202
+ + + ++YE M +S + D + + + ++
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFL------YQLL-- 118
Query: 203 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 262
RGL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR E V T
Sbjct: 119 --RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171
Query: 263 YGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 296
Y APE + +++ DV+S G + E++ K
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 101 KKLGQGGFGPVYKG-KLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLL 157
K +G G G V V + +A+K+LS+ ++ K E++L + H+N++ LL
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSF--------IFDQERC----MILDWSKRFHIICGTAR 205
F P KSL+ F + D C M LD + +++
Sbjct: 83 NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 130
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
G+ +LH IIHRDLK SN+++ D KI DFGLAR G T V T Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 184
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
APE + D++S G ++ E+V K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 48/123 (39%), Positives = 60/123 (48%), Gaps = 17/123 (13%)
Query: 191 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250
LD A+G+ +L + IHRD+ A NVLL KI DFGLAR D
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 251 ET---EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKK-------NR 299
+GN V +MAPE D ++V+SDV+S+GILL EI S GK N
Sbjct: 266 SNYVVKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322
Query: 300 GFY 302
FY
Sbjct: 323 KFY 325
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA--FGGDETEGNTNRVVG 261
A GL +LH II+RDLK NV+LD + + KI+DFG+ + FGG T G
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFCG 163
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
T Y+APE + + D ++FG+LL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 41/213 (19%)
Query: 103 LGQGGFGPV---YKGKLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLL 157
+G G +G V Y +L Q++AVK+LS+ + + + E+ L ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQERCMILDWSKRFHIICGTA 204
F P S+++F + + +C L +I
Sbjct: 81 DV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
RGL Y+H IIHRDLK SNV +++D +I DFGLAR DE G V T
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRW 180
Query: 265 YMAPEYASDG-QFSVKSDVFSFGILLLEIVSGK 296
Y APE + ++ D++S G ++ E++ GK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 57/168 (33%), Positives = 80/168 (47%), Gaps = 21/168 (12%)
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
ARG+ +L SR + IHRDL A N+LL ++ KI DFGLAR D
Sbjct: 184 ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323
+MAPE D ++ +SDV+SFG+LL EI S L + NE
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-------------LGASPYPGVQINEEFC 287
Query: 324 SQLIDSCFQDSFNLA--EVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369
+L D + A E+ R I L C Q P++RP+ +++ +LG
Sbjct: 288 QRLKDGTRMRAPENATPEIYR---IMLACWQGDPKERPTFSALVEILG 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 67/302 (22%), Positives = 109/302 (36%), Gaps = 59/302 (19%)
Query: 99 INKKLGQGGFGPVYKGKLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNLVKL 156
I K + K K +AVK+ L S++ LK L+ E+I +LQH N++
Sbjct: 6 IGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRL 216
+ I E ++ M S + + L I+ L Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLL-KTHFPEGLPELAIAFILKDVLNALDYIHS---K 120
Query: 217 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG--------YMAP 268
IHR +KAS++LL D +S + + G RVV + +++P
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSM---IKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 269 E--YASDGQFSVKSDVFSFGILLLEIVSG--------------KKNRG------------ 300
E + ++ KSD++S GI E+ +G +K RG
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237
Query: 301 FYHSD--NNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDR 358
Y + + H + P F + F+ LC+Q+ PE R
Sbjct: 238 LYEDSMSQSRSSNEHPNNRDSVDHPYT---RTFSEHFH--------QFVELCLQRDPESR 286
Query: 359 PS 360
PS
Sbjct: 287 PS 288
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVDGQE----IAVKRLSKIS----EQGLKELKNEVILFSK 147
NF + K LG G +G V+ + V G + A+K L K + + ++ + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 148 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
++ + L Q E KL LI +++ + + ++ +R + RF+ +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY--QRDNFSEDEVRFY----SGEI 114
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
+L L +L I++RD+K N+LLD + + ++DFGL++ F +E E T GT YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYM 173
Query: 267 APEYA-SDGQFSVKSDVFSFGILLLEIVSG 295
APE G D +S GIL+ E+++G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 103 LGQGGFGPVYKGK---LVDGQ-----EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
LGQG F ++KG + D E+ +K L K + + S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
G C+ G+E +++ E++ SLD+++ + + + W + + A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 215 RLRIIHRDLKASNVLL-----DQDMNP---KISDFGLARAFGGDETEGNTNRVVGTYGYM 266
+ H ++ A NVLL + NP K+SD G++ E R+ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWV 171
Query: 267 APEYASDGQ-FSVKSDVFSFGILLLEIVSG 295
PE + Q S+ +D +SFG L EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 103 LGQGGFGPVYKGKLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRN--LVKL 156
+G+GGFG VY + D G+ A+K L K +QG NE I+ S + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 157 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFH---IICGTARGLLYLHQ 212
+ +KL I + M L + + + + RF+ II G H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLE------HM 113
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 272
+R +++RDLK +N+LLD+ + +ISD GLA F + + VGT+GYMAPE
Sbjct: 114 HNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQ 168
Query: 273 DGQ-FSVKSDVFSFGILLLEIVSG 295
G + +D FS G +L +++ G
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 102 KLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLG 158
K+G+G +G V+K + + GQ +A+K+ + + + K E+ + +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 159 CCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRI 218
+ + L++E+ + L+ ++ + II T + + + H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNC 121
Query: 219 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY-ASDGQFS 277
IHRD+K N+L+ + K+ DFG AR G + V T Y APE D Q+
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTG--PGDDYTDYVATRWYRAPELLVGDTQYG 179
Query: 278 VKSDVFSFGILLLEIVSG 295
DV++ G + E+++G
Sbjct: 180 PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 33/213 (15%)
Query: 102 KLGQGGFGPVYKGKLVD-GQEIAVKRLS-KISEQGLK-ELKNEVILFSKLQ---HRNLVK 155
++G G +G VYK + G +A+K + + +E GL EV L +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 156 LLGCCIQG----EEKL-LIYEFMPNKSLDSFI-------FDQERCMILDWSKRFHIICGT 203
L+ C E K+ L++E + ++ L +++ E I D ++F
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAET--IKDLMRQF------ 117
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
RGL +LH + I+HRDLK N+L+ K++DFGLAR + + VV T
Sbjct: 118 LRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTL 171
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
Y APE ++ D++S G + E+ K
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (164), Expect = 6e-12
Identities = 74/252 (29%), Positives = 112/252 (44%), Gaps = 45/252 (17%)
Query: 92 SATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKE-----LKNEVILFS 146
S N + + KK+G G FG V+ K QE + IS +GLKE L EV +
Sbjct: 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMR 67
Query: 147 KLQHRNLVKLLGCCI-QGEEKLLI-YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTA 204
+L+H+N+V+ + + + +KL I EF L I ++C + H I
Sbjct: 68 ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI---QKCYKMFGKIEEHAIVDIT 124
Query: 205 RGLL----YLHQ----DSRLRIIHRDLKASNVLLD-------------QDMN----PKIS 239
R LL Y H + R++HRDLK N+ L ++N KI
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 240 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYA--SDGQFSVKSDVFSFGILLLEIVSGKK 297
DFGL++ G E + VGT Y +PE + KSD+++ G ++ E+ SGK
Sbjct: 185 DFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 298 NRGFYHSDNNLN 309
+H NN +
Sbjct: 242 P---FHKANNFS 250
|
Length = 1021 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 7e-12
Identities = 61/218 (27%), Positives = 111/218 (50%), Gaps = 36/218 (16%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSKISEQG----LKELKNEVILFSKLQH 150
+ ++ +G +G VY+ + EI A+K+L K+ ++ + L+ E+ + KLQH
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLR-EINILLKLQH 63
Query: 151 RNLVKL----LGCCIQGEEKLLIYEFMPN--KSL-----DSFIFDQERCMILDWSKRFHI 199
N+V + +G + ++ ++ E++ + KSL F+ + +C++L +
Sbjct: 64 PNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML------QL 115
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 259
+ G A +LH + I+HRDLK SN+LL+ KI DFGLAR +G ++
Sbjct: 116 LSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYTQL 166
Query: 260 VGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 296
V T Y APE ++S D++S G + E+++ K
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 34/92 (36%), Positives = 56/92 (60%), Gaps = 6/92 (6%)
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
+GL YL + + +I+HRD+K SN+L++ K+ DFG++ G + N VGT
Sbjct: 114 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 167
Query: 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
YM+PE +SV+SD++S G+ L+E+ G+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 47/234 (20%)
Query: 97 FSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLSK-ISEQGL--KELKNEVILFSKLQHRN 152
+ I + +G+GG G VY V + +A+K++ + +SE L K E + + L H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 153 LVKLLGCCIQGEEKLLIYEFMP---NKSLDSFIFDQERCMILDWSKR------------- 196
+V + C G+ +Y MP +L S + + L SK
Sbjct: 64 IVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSI 118
Query: 197 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE--- 253
FH IC T Y+H S+ ++HRDLK N+LL I D+G A +E +
Sbjct: 119 FHKICATIE---YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 254 ---GNTN----------RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
N ++VGT YMAPE S +D+++ G++L ++++
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 65/245 (26%), Positives = 109/245 (44%), Gaps = 48/245 (19%)
Query: 101 KKLGQGGFGPV-YKGKLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLL 157
K++G G +G V G ++A+K+L + SE K E+ L ++H N++ LL
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSF----------------IFDQERCMILDWSKRFHIIC 201
F P+ SLD F + E+ L + ++
Sbjct: 81 DV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDRIQFLVY 125
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 261
+GL Y+H IIHRDLK N+ +++D KI DFGLAR +T+ V
Sbjct: 126 QMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVV 177
Query: 262 TYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE 320
T Y APE + ++ D++S G ++ E+++GK + ++L+ + K+
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP---LFKGHDHLDQLMEIMKV--T 232
Query: 321 GMPSQ 325
G PS+
Sbjct: 233 GTPSK 237
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 94 TNNFSINKKLGQGGFGPVYK-GKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HR 151
++ + I + +G+G +G V+K +G + AVK L I + +E++ E + L H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHP 75
Query: 152 NLVKLLGC-----CIQGEEKLLIYEFMPNKSL----DSFIFDQERCMILDWSKRFHIICG 202
N+VK G G++ L+ E S+ F+ ER ++ +I+
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER---MEEPIIAYILHE 132
Query: 203 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 262
GL +LH + + IHRD+K +N+LL + K+ DFG++ NT+ VGT
Sbjct: 133 ALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGT 187
Query: 263 YGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSG 295
+MAPE + D + + DV+S GI +E+ G
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 96 NFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHR 151
+F + + LG G FG V K G+ A+K L K + + ++ + E + +L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 152 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLL-- 208
+V ++ C Q E ++ + EF+ L + + R D +K +H A +L
Sbjct: 79 FIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGR-FPNDVAKFYH-----AELVLAF 131
Query: 209 -YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
YLH II+RDLK N+LLD + K++DFG A+ + T + GT Y+A
Sbjct: 132 EYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLA 183
Query: 268 PEYASDGQFSVKSDVFSFGILLLEIVSG 295
PE D ++ G+LL E ++G
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 51/225 (22%)
Query: 96 NFSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLSKISE------QGLKELKNEVILFSKL 148
+ + +G G +G V G+++A+K++ + + L+ELK +
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHF 61
Query: 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDW--SKRFHIICGTA-- 204
+H N++ + P + ++ +++D S HII
Sbjct: 62 KHDNIIAIRDI------------LRPPGADFKDVY-----VVMDLMESDLHHIIHSDQPL 104
Query: 205 -------------RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251
RGL Y+H + +IHRDLK SN+L+++D +I DFG+AR
Sbjct: 105 TEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161
Query: 252 TEGNT--NRVVGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIV 293
TE V T Y APE S +++ D++S G + E++
Sbjct: 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 52/165 (31%), Positives = 69/165 (41%), Gaps = 33/165 (20%)
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
ARG+ +L + +HRDL A NVLL Q KI DFGLAR D +
Sbjct: 247 ARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323
+MAPE D ++ SDV+S+GILL EI S L P
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFS----------------------LGGTPYP 341
Query: 324 SQLIDSCF----QDSFNLAEVIRCIH----IGLLCVQQHPEDRPS 360
++DS F + + +A+ I + C PE RPS
Sbjct: 342 GMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSKI-----SEQGLKELKNEVILFSKLQ 149
++ + K +G+G FG V + Q++ A+K LSK S+ + +++ F+
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA--- 100
Query: 150 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLL 208
+ V L C Q ++ L ++ E+MP L + + + + + W+K + TA +L
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFY-----TAEVVL 153
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-NTNRVVGTYGYMA 267
L + +IHRD+K N+LLD+ + K++DFG DET + VGT Y++
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYIS 211
Query: 268 PEY----ASDGQFSVKSDVFSFGILLLEIVSG 295
PE DG + + D +S G+ L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVDGQ--EIAVKRLSK---ISEQGLKELKNEVILFSKLQH 150
+F+ + LG G FG V + +A+KR K I ++ + + +E + + + H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICG---TARGL 207
V L G L+ EF+ +F L +KRF G A+ +
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTF---------LRRNKRFPNDVGCFYAAQIV 141
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
L L I++RDLK N+LLD+D K++DFG A+ + T + GT Y+A
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIA 196
Query: 268 PEYASDGQFSVKSDVFSFGILLLEIVSG 295
PE + +D ++ GI + EI+ G
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 101 KKLGQGGFGPVYKGKLVDGQE----IAVKRLSKI----SEQGLKELKNEVILFSKLQHRN 152
K LG+GG+G V++ + V G + A+K L K +++ K E + ++H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
+V L+ G + LI E++ L F+ + + ++ + F++ + L +LHQ
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYL-SEISLALEHLHQ 118
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN--TNRVVGTYGYMAPEY 270
II+RDLK N+LLD + K++DFGL + + T+ GT YMAPE
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPEI 171
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSG 295
D +S G L+ ++++G
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 24/213 (11%)
Query: 101 KKLGQGGFGPVYKGKLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 157
+ LG G G V+ VD + +AVK++ Q +K E+ + +L H N+VK+
Sbjct: 11 RPLGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVY 68
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF--------HIICGT---ARG 206
L L+S QE M D + H RG
Sbjct: 69 EVLGPSGSDLTEDVGSLT-ELNSVYIVQE-YMETDLANVLEQGPLSEEHARLFMYQLLRG 126
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGD-ETEGNTNRVVGTYG 264
L Y+H + ++HRDLK +NV ++ D+ KI DFGLAR +G + + T
Sbjct: 127 LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 265 YMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 296
Y +P S ++ D+++ G + E+++GK
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 102 KLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKN--EVILFSKLQ-HRNLVKLL 157
K+G+G F V K + G+ A+K + K + L+++ N E+ +L H N+++L+
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 158 GCCIQGEEK--LLIYEFMPNKSLDSFIFDQERCMILDWSKRF-HIICGTARGLLYLHQDS 214
+ L++E M + +L I ++R + K + + + + L ++H++
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLL---KSLDHMHRNG 120
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTNRVVGTYGYMAPE-YA 271
I HRD+K N+L+ D K++DFG R TE + T Y APE
Sbjct: 121 ---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE-----YISTRWYRAPECLL 171
Query: 272 SDGQFSVKSDVFSFGILLLEIVS 294
+DG + K D+++ G + EI+S
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 36/79 (45%), Positives = 45/79 (56%), Gaps = 6/79 (7%)
Query: 219 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDET---EGNTNRVVGTYGYMAPEYASDGQ 275
IHRDL A N+LL KI DFGLAR D +GN V +MAPE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV---KWMAPESIFNCV 292
Query: 276 FSVKSDVFSFGILLLEIVS 294
++ +SDV+S+GILL EI S
Sbjct: 293 YTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 9/102 (8%)
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV-VGTYGY 265
L YLH +++RDLK N++LD+D + KI+DFGL + ++G T + GT Y
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCGTPEY 161
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN 307
+APE D + D + G+++ E++ G+ FY+ D+
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 103 LGQGGFGPVYKGKLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLG 158
+G+G + V +L +I ++ K ++ + ++ E +F + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 159 CCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMIL-DWSKRFHI--ICGTARGLLYLHQDS 214
C Q +L L+ E++ L +F +R L + RF+ IC L +LH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEIC---IALNFLHERG 116
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
II+RDLK NVLLD D + K++D+G+ + G T+ GT Y+APE
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGE 171
Query: 275 QFSVKSDVFSFGILLLEIVSGK 296
++ D ++ G+L+ E+++G+
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 103 LGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNE----------VILFSKLQHR 151
LGQG F +YKG L V V ++S LK L ++ L S+L H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVV-LKVLGSDHRDSLAFFETASLMSQLSHK 61
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
+LVKL G C++ +E +++ E++ LD F+ ++ + L W + + A L YL
Sbjct: 62 HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNP-------KISDFGLARAFGGDETEGNTNRVVGTYG 264
+++H ++ N+L+ + K+SD G+ E V
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VERIP 169
Query: 265 YMAPEYASDGQFSVKS--DVFSFGILLLEIVSGKK 297
++APE +GQ S+ D +SFG LLEI S +
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 101 KKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVK 155
K +G+G FG V K +DG+ AVK L K KE K+ + +L ++H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 156 LLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
L Q EKL + +F+ L F Q + RF+ A L YLH
Sbjct: 61 L-HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYA-AEIASALGYLHS-- 114
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
+ I++RDLK N+LLD + ++DFGL + G T GT Y+APE
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 275 QFSVKSDVFSFGILLLEIVSG 295
+ D + G +L E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVK 155
K +G+G FG V + + + AVK L K + KE K+ + +L ++H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 156 LLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
L Q +KL + +++ L + +ERC L+ RF+ A L YLH
Sbjct: 61 L-HFSFQTADKLYFVLDYINGGEL-FYHLQRERCF-LEPRARFYA-AEIASALGYLHS-- 114
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
L I++RDLK N+LLD + ++DFGL + E G T+ GT Y+APE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 275 QFSVKSDVFSFGILLLEIVSG 295
+ D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 66/232 (28%), Positives = 98/232 (42%), Gaps = 47/232 (20%)
Query: 101 KKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKN---EVILFSKLQHRNLVKL 156
K LG+G G V+ +L G+ A+K L K ++K E + + L H L L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 157 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFH---IICGTARGLLYLHQ 212
Q E L L+ ++ P L + Q + + RF+ ++ L YLH
Sbjct: 67 Y-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEYLHL 121
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGL-------------ARAFGG---------- 249
L I++RDLK N+LL + + +SDF L A G
Sbjct: 122 ---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 250 ----DETEGNTNRVVGTYGYMAPEYAS-DGQ-FSVKSDVFSFGILLLEIVSG 295
+E +N VGT Y+APE S DG +V D ++ GILL E++ G
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKL 156
K LG+G FG V + G+ A+K L K I++ + E + +H L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 157 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSR 215
Q +++L + E++ L F +ER D ++ + +A L YLH
Sbjct: 61 -KYSFQTKDRLCFVMEYVNGGEL-FFHLSRERVFSEDRTRFYGAEIVSA--LDYLHSG-- 114
Query: 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 275
+I++RDLK N++LD+D + KI+DFGL + G GT Y+APE D
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAPEVLEDND 171
Query: 276 FSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306
+ D + G+++ E++ G+ FY+ D+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 7/94 (7%)
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV-VGT 262
+ GL +LH+ II+RDLK NV+LD + + KI+DFG+ + +G T R GT
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE---HMVDGVTTRTFCGT 164
Query: 263 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
Y+APE + + D +++G+LL E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 103 LGQGGFGPVYKGKLVDGQEI-AVKRLSKISEQGLKEL-----KNEVILFSKLQHRNLVKL 156
+G+G FG VY+ + D + I A+K LSK KE+ + +++ + L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 157 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSR 215
L Q + L L+ ++M L F Q+ + +F+I A +L L +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYI----AELVLALEHLHK 114
Query: 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTNRVVGTYGYMAPEYASDG 274
I++RDLK N+LLD + + DFGL++A ++T TN GT Y+APE D
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAPEVLLDE 171
Query: 275 Q-FSVKSDVFSFGILLLEIVSG 295
+ ++ D +S G+L+ E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-10
Identities = 53/237 (22%), Positives = 105/237 (44%), Gaps = 35/237 (14%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEIA---VKRLSKISEQGLKELKNEVIL----FSKLQHRNL 153
+++G G FG V ++ +A VK L + KE +NE + + LQH N+
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELK--ANASSKE-QNEFLQQGDPYRILQHPNI 57
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQE------RCMILDWSKRFHIICGTARGL 207
++ LG C++ LL++E+ L S++ ++ + ++L + C A G+
Sbjct: 58 LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGV 112
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTNRVVGTYGYM 266
++H + +H DL N L D+ K+ D+G+ + + D E ++ V ++
Sbjct: 113 THMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWL 168
Query: 267 APEYASDGQFSV-------KSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWK 316
APE + + S+V++ G+ L E+ Y ++ ++ H K
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP--YSHLSDREVLNHVIK 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 31/91 (34%), Positives = 53/91 (58%)
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
LL +H +IHRD+K++N+LL + K+ DFG ++ + ++ GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVSGKK 297
APE +S K+D+FS G+LL E+++ K+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 75/305 (24%), Positives = 121/305 (39%), Gaps = 81/305 (26%)
Query: 119 GQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 176
G + V+ L +E+ LK L+NEV+L +H N++ G +I FM
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 177 SLDSFI---FDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 233
S +S + F + L + I+ G RGL YLHQ+ IHR++KAS++L+ D
Sbjct: 85 SANSLLKTYFPEGMSEALIGN----ILFGALRGLNYLHQNG---YIHRNIKASHILISGD 137
Query: 234 MNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ--------------FSVK 279
+S GL+ + G +VV Y P++++ ++VK
Sbjct: 138 GLVSLS--GLSHLYSLVR-NGQKAKVV----YDFPQFSTSVLPWLSPELLRQDLYGYNVK 190
Query: 280 SDVFSFGILLLEIVSG--------------KKNRGFYHSDNNLNLIGHA---WKLWNEGM 322
SD++S GI E+ +G +K +G +S ++ K G+
Sbjct: 191 SDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGV 250
Query: 323 PSQLIDSCFQDS----------------------FNLAEVIRCIHIGLLCVQQHPEDRPS 360
S + +S NL E LC+QQ PE RPS
Sbjct: 251 DSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE---------LCLQQDPEKRPS 301
Query: 361 MPSVI 365
S++
Sbjct: 302 ASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 18/190 (9%)
Query: 119 GQEIAVKRLSKISEQGLKE---LKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFMP 174
G E+A+K L + + + + E L ++L H N+V LL L ++E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---D 231
++L + L + ++ L H I+HRDLK N+++
Sbjct: 63 GRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 232 QDMNPKISDFGLARAFGGDE-----TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFG 286
+ K+ DFG+ G T T V+GT Y APE + SD++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 287 ILLLEIVSGK 296
++ LE ++G+
Sbjct: 177 LIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSKISEQGLKELKNEVILFSK----LQH 150
+F + K +G+G FG V + +++ A+K LSK + +K +++ F + + H
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF--EMIK--RSDSAFFWEERDIMAH 99
Query: 151 RN--LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
N + L Q ++ L ++ E+MP L + + + + + W+ RF+ TA +
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWA-RFY----TAEVV 152
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
L L + IHRD+K N+LLD+ + K++DFG + + VGT Y++
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYIS 211
Query: 268 PEY----ASDGQFSVKSDVFSFGILLLEIVSG 295
PE DG + + D +S G+ L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
A GL +LH II+RDLK NV+LD + + KI+DFG+ + D T GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTP 165
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
Y+APE + + D ++FG+LL E+++G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 40/220 (18%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRL------SKISEQGLKELKNEVILFSK 147
N F + +G+G +G V K + + +EI A+K+ ++ E L+ELK +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEF-----------MPNKSLDSFIFDQERCMILDWSKR 196
L+ N+V+L + + L++E+ MPN ++ R I K
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP----EKVRSYIYQLIKA 112
Query: 197 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256
H + H++ I+HRD+K N+L+ + K+ DFG AR + + N
Sbjct: 113 IH----------WCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANY 158
Query: 257 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
V T Y +PE + D++S G +L E+ G+
Sbjct: 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 7/100 (7%)
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
L YLH +++RD+K N++LD+D + KI+DFGL + G GT Y+
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYL 162
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306
APE D + D + G+++ E++ G+ FY+ D+
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 13/210 (6%)
Query: 103 LGQGGFGPVYKGKLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLG 158
+G+G + V +L + I ++ K ++ + ++ E +F + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 159 CCIQGEEKLL-IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLR 217
C Q E +L + E++ L +F +R L + L YLH+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 116
Query: 218 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFS 277
II+RDLK NVLLD + + K++D+G+ + G T+ GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 278 VKSDVFSFGILLLEIVSGKKNRGFYHSDNN 307
D ++ G+L+ E+++G+ S +N
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 6/101 (5%)
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
L YLH + +++RDLK N++LD+D + KI+DFGL + G + GT Y
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEY 162
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306
+APE D + D + G+++ E++ G+ FY+ D+
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 102 KLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 160
K+G+G +G VYK K DG++ L +I G+ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 161 IQGEEK--LLIYEFMPNKSLDSFIFDQ-----ERCMILDWSKRFHIICGTARGLLYLHQD 213
+ ++ L++++ + F + ++ M L S ++ G+ YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 214 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGD-ETEGNTNRVVGTYGYMAP 268
++HRDLK +N+L+ + KI+D G AR F + + + VV T+ Y AP
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 269 EYASDGQFSVKS-DVFSFGILLLEIVSGK 296
E + K+ D+++ G + E+++ +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 35/95 (36%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTNRVVGTY 263
R L Y+H + + HRDLK N+L + D KI DFGLAR AF T V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 264 GYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGK 296
Y APE +++ D++S G + E+++GK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 103 LGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 158
+G+G FG V + + D Q I A+K + K +S + E + +++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 159 CCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLR 217
Q EKL L+ F+ L F Q RF+ TA L L +
Sbjct: 60 FSFQSPEKLYLVLAFINGGEL--FHHLQREGRFDLSRARFY----TAELLCALENLHKFN 113
Query: 218 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFS 277
+I+RDLK N+LLD + + DFGL + D+ + TN GT Y+APE ++
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGYT 171
Query: 278 VKSDVFSFGILLLEIVSG 295
D ++ G+LL E+++G
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 64/253 (25%), Positives = 103/253 (40%), Gaps = 70/253 (27%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV----DGQEIAVKRLSKISEQGLKE----LKNEVILFS 146
++F K +G+G FG V +LV G A+K+L K SE KE ++ E + +
Sbjct: 1 DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILA 56
Query: 147 KLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSL-------DSFIFDQERCMILDWSKRFH 198
+ + +VKL Q E L LI E++P + D+F ++ RF+
Sbjct: 57 EADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE---------TRFY 106
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD-------- 250
I A +L + +L IHRD+K N+LLD + K+SDFGL
Sbjct: 107 I----AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI 162
Query: 251 --ETEGNTNR--------------------------VVGTYGYMAPEYASDGQFSVKSDV 282
+ VGT Y+APE ++ + D
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222
Query: 283 FSFGILLLEIVSG 295
+S G+++ E++ G
Sbjct: 223 WSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSK 147
+F + +G+G FG V ++V G A+K + K ++++ + + E + S
Sbjct: 1 KDFDVKSLVGRGHFGEV---QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWS-KRFHIICGTARG 206
+ +L + L+ E+ P L S + E D +F++ A
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDEDMAQFYL----AEL 111
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
+L +H ++ +HRD+K NVL+D+ + K++DFG A ++ N+ VGT Y+
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYI 170
Query: 267 APEY------ASDGQFSVKSDVFSFGILLLEIVSGK 296
APE G + V+ D +S G++ E++ G+
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 32/76 (42%), Positives = 42/76 (55%)
Query: 219 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSV 278
+HRDL A NVL+ + KI DFGLAR D + +MAPE + ++
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 279 KSDVFSFGILLLEIVS 294
SDV+SFGILL EI +
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 103 LGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 158
+G+G + V +L + I A+K + K ++ + ++ E +F + + L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 159 CCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMIL-DWSKRFHI--ICGTARGLLYLHQDS 214
C Q E +L + EF+ L +F +R L + RF+ I L +LH+
Sbjct: 63 SCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEIS---LALNFLHERG 116
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY--AS 272
II+RDLK NVLLD + + K++D+G+ + G T+ GT Y+APE
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GIRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 273 DGQFSVKSDVFSFGILLLEIVSGK 296
D FSV D ++ G+L+ E+++G+
Sbjct: 172 DYGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 29/171 (16%)
Query: 137 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE---FMPNKSLD----SFIFDQERCM 189
+L+NE++ +L H N++K+ E++L E +M + D SF++D+
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEA--- 257
Query: 190 ILDWSKR------FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243
DW R I+ + Y+H ++IHRD+K N+ L+ D + DFG
Sbjct: 258 -FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGT 313
Query: 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
A F E E VGT +PE + + +D++S G++LL+++S
Sbjct: 314 AMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 102 KLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 160
K+G+G +G VYK K DG++ L +I G+ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 161 IQGEEK--LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY-----LHQD 213
+ ++ L++++ + F + K + G + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 214 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGD-ETEGNTNRVVGTYGYMAP 268
++HRDLK +N+L+ + KI+D G AR F + + + VV T+ Y AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 269 EYASDGQFSVKS-DVFSFGILLLEIVSGK 296
E + K+ D+++ G + E+++ +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 53/221 (23%), Positives = 85/221 (38%), Gaps = 18/221 (8%)
Query: 91 VSATN-NFSINKKLGQGGFGPVY---KGKLVDGQEIAVKRLSKISEQGLKELKNEVILFS 146
S ++I L G G V+ K +++ VK ++ G K E+ +
Sbjct: 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILK 141
Query: 147 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
+ HR ++ L+ K + MP D F + +R L + I
Sbjct: 142 TISHRAIINLIHAY---RWKSTVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQRRLLEA 197
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
L YLH IIHRD+K N+ LD+ N + DFG A GT
Sbjct: 198 LAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN 307
+PE + + K+D++S G++L E+ KN +
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSV--KNVTLFGKQVK 293
|
Length = 392 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSKISEQGLKELKNEVILFSKLQHRNL 153
++F I K +G+G FG V K+ + I A+K L+K + LK + E F + RN+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--EMLK--RAETACFR--EERNV 54
Query: 154 --------VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTA 204
+ L Q E L L+ ++ L + + E + D + RF+I A
Sbjct: 55 LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYI----A 109
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
+L +H +L +HRD+K NVLLD + + +++DFG D T ++ VGT
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPD 168
Query: 265 YMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGK 296
Y++PE G++ + D +S G+ + E++ G+
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-08
Identities = 21/48 (43%), Positives = 27/48 (56%), Gaps = 3/48 (6%)
Query: 370 SET-VLPQPKQPGYLADRKSTRRDYSSIMP--ESCSTNTITVSGLEGR 414
SET +PQPKQPG+ R D SS ES + N +TVS ++ R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 60/256 (23%), Positives = 96/256 (37%), Gaps = 67/256 (26%)
Query: 95 NNFSINKKLGQGGFGPV-YKGKLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 150
+F K +G+G FG V K G+ A+K L K + L +K E + ++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWS------KRFHIICGTA 204
+V L + LI EF+P L + M++ + RF++ A
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMT--------MLIKYDTFSEDVTRFYM----A 108
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--------------GGD 250
+L + +L IHRD+K N+L+D+ + K+SDFGL+ F G
Sbjct: 109 ECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 251 ETEGNTNR-------------------------------VVGTYGYMAPEYASDGQFSVK 279
NR VGT Y+APE + +
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 280 SDVFSFGILLLEIVSG 295
D +S G ++ E + G
Sbjct: 229 CDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 41/158 (25%), Positives = 68/158 (43%), Gaps = 12/158 (7%)
Query: 141 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF--DQERCMILDWSKRFH 198
E + + H ++++L G + LI +P D + + + I D
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI---LA 186
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
I R + YLH++ RIIHRD+KA N+ ++ + + DFG A F D
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYG 242
Query: 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
GT APE + + D++S GI+L E+ +
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSKI-----SEQGLKELKNEVILFSKLQ 149
++ + K +G+G FG V + +++ A+K LSK S+ + +++ F+
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA--- 100
Query: 150 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLL 208
+ V L Q + L ++ E+MP L + + + + + W+ RF+ TA +L
Sbjct: 101 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWA-RFY----TAEVVL 153
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 268
L + IHRD+K N+LLD+ + K++DFG + + VGT Y++P
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISP 212
Query: 269 EY----ASDGQFSVKSDVFSFGILLLEIVSG 295
E DG + + D +S G+ L E++ G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 103 LGQGGFGPVYKGKLVD---------GQEIAVKRLSKISEQGLKELK----NEVILFSKLQ 149
LG+G +Y G L E +K + K+ + +++ + ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209
H+++V L G C++ E +++ EF+ LD F+ + + W +F + A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 210 LHQDSRLRIIHRDLKASNVLL-----DQDMNP--KISDFGLARAFGGDETEGNTNRVVGT 262
L +D L +H ++ N+LL D + P K+SD G+ T + V
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI------TVLSRQECVER 171
Query: 263 YGYMAPEYASDGQ-FSVKSDVFSFGILLLEI 292
++APE D + S+ +D +SFG L EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 44/170 (25%)
Query: 97 FSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLSK---ISEQGLKELKNE----------- 141
F I K + +G FG VY G K + + AVK + K I++ + +++ E
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 142 -VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----FDQERCMILDWSK 195
V L+ LQ N V L+ E++ + S + FD+E M + +
Sbjct: 66 IVHLYYSLQSANNV------------YLVMEYLIGGDVKSLLHIYGYFDEE--MAVKY-- 109
Query: 196 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245
I A L YLH+ IIHRDLK N+L+ + + K++DFGL++
Sbjct: 110 ----ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 24/78 (30%), Positives = 47/78 (60%)
Query: 217 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF 276
+++HRDLK++N+ L K+ DFG ++ + + + GT Y+APE ++
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 277 SVKSDVFSFGILLLEIVS 294
S K+D++S G++L E+++
Sbjct: 249 SKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 58/251 (23%), Positives = 101/251 (40%), Gaps = 63/251 (25%)
Query: 97 FSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRN 152
F K +G G FG V + VD + A+K L K + +K E + ++ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 153 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSF-----IFDQERCMILDWSKRFHIICGTARG 206
+VKL Q ++ L + +++P + S IF+++ RF+I A
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-------RFYI----AEL 110
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF-----------GG------ 249
+ ++ IHRD+K N+L+D+D + K++DFGL F G
Sbjct: 111 TCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 250 ----DETEGNTNR--------------------VVGTYGYMAPEYASDGQFSVKSDVFSF 285
+E +VGT Y+APE ++ D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 286 GILLLEIVSGK 296
G++L E++ G+
Sbjct: 231 GVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 43/237 (18%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHR 151
+F K +G+G FG V + D G A+K L K + ++ + ++ E + +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
+VK+ LI EF+P + + + ++ + + +F+I A +L +
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYI----AETVLAID 115
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA----------------RAFGGDETEGN 255
+L IHRD+K N+LLD + K+SDFGL + D T N
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 256 TN-----------------RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 295
N VGT Y+APE ++ D +S G+++ E++ G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 57/245 (23%), Positives = 98/245 (40%), Gaps = 55/245 (22%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKL 156
K LG G FG V VD + A+K L K ++ + +K E + ++ + +VKL
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRL 216
+ + +++P + S + E + + RF+I A L + ++
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYI----AELTLAIESVHKM 120
Query: 217 RIIHRDLKASNVLLDQDMNPKISDFGLARAFG---------------------------- 248
IHRD+K N+L+D D + K++DFGL F
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 249 -----GDETEGNTNR------------VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLE 291
GD + R +VGT Y+APE ++ D +S G++L E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 292 IVSGK 296
++ G+
Sbjct: 241 MLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 92 SATNNFSINKKLGQGGFGPVYKGKLVDGQE-IAVKRLSKISEQGLKELKNEVILFSKLQH 150
S ++ + +G G FG VY+ +D E +A+K++ + + +EL ++ L H
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNREL----LIMKNLNH 118
Query: 151 RNLVKLLGC----CIQGEEKLL----IYEFMP---NKSLDSFIFDQERCMILDWSKRFHI 199
N++ L C + EK + + EF+P +K + + + + +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ 178
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTNR 258
+C R L Y+H I HRDLK N+L+D + + K+ DFG A+ + +
Sbjct: 179 LC---RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVS 229
Query: 259 VVGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSG 295
+ + Y APE ++ D++S G ++ E++ G
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 19/157 (12%)
Query: 144 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGT 203
L S++ H +L + G C++G E +++ EF+ + LD + ++ + + W + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVL-----LDQDMNP--KISDFGLARAFGGDETEGNT 256
A L YL + ++H ++ A N+L L + +P K+SD G+ +F E
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV--SFTALSREERV 181
Query: 257 NRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEI 292
R+ ++APE G S +D +SFG LLEI
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 66/275 (24%), Positives = 126/275 (45%), Gaps = 39/275 (14%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSKI-----SEQGLKELKNEVILFSKLQ 149
+F I K +G+G FG V KL + ++ A+K L+K +E + +V++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-- 59
Query: 150 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLL 208
+ L Q E L L+ ++ L + + E + D + RF++ A ++
Sbjct: 60 -NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYL----AEMVI 113
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 268
+ +L +HRD+K N+L+D + + +++DFG D T ++ VGT Y++P
Sbjct: 114 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISP 172
Query: 269 EYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG-- 321
E G++ + D +S G+ + E++ G+ FY +L+ K+ N
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP--FYAE----SLVETYGKIMNHKER 226
Query: 322 --MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQH 354
P+Q+ D S + ++IR L+C ++H
Sbjct: 227 FQFPAQVTDV----SEDAKDLIR----RLICSREH 253
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 56/214 (26%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSKI-----SEQGLKELKNEVILFSKL 148
++F I K +G+G FG V K+ + ++ A+K L+K +E + +V++
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD- 59
Query: 149 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
R + L Q E L L+ ++ L + + E + D + RF++ A +
Sbjct: 60 --RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYL----AEMV 112
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
L + +L +HRD+K NVLLD++ + +++DFG D T +N VGT Y++
Sbjct: 113 LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYIS 171
Query: 268 PEY-----ASDGQFSVKSDVFSFGILLLEIVSGK 296
PE G++ + D +S G+ + E++ G+
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 50/245 (20%), Positives = 106/245 (43%), Gaps = 43/245 (17%)
Query: 66 IAEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVK 125
I ND I+ I+ + + ++ + SI YKG + +E+ ++
Sbjct: 4 ITRSYIND-IKCIESDDIDKYTSVLIKENDQNSI------------YKGIF-NNKEVIIR 49
Query: 126 RLSK-------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL----LIYEFMP 174
K + + E+KN ++ N++K+ G I + L LI E+
Sbjct: 50 TFKKFHKGHKVLIDITENEIKN----LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105
Query: 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQD 233
L + D+E+ L + + + +GL L++ ++ +++L + + L+ ++
Sbjct: 106 RGYLREVL-DKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVSFLVTEN 159
Query: 234 MNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLE 291
KI GL + + N N +V Y + + +D ++++K D++S G++L E
Sbjct: 160 YKLKIICHGLEKILSSPPFK-NVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVLWE 214
Query: 292 IVSGK 296
I +GK
Sbjct: 215 IFTGK 219
|
Length = 283 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 56/238 (23%), Positives = 100/238 (42%), Gaps = 43/238 (18%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 150
++F K +G+G FG V + D G A+K L K + ++ + ++ E + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
+VK+ LI EF+P + + + ++ + + + +F+I A +L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYI----AETVLAI 114
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG----------------GDETEG 254
+L IHRD+K N+LLD + K+SDFGL D +
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 255 NTN-----------------RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 295
N N VGT Y+APE ++ D +S G+++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 55/246 (22%), Positives = 99/246 (40%), Gaps = 57/246 (23%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKL 156
K LG G FG V + VD + + A+K L K + + +K E + ++ + +V+L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWS-KRFHIICGTARGLLYLHQDSR 215
+ + +++P + S + R I RF+I A + +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLI---RMGIFPEDLARFYI----AELTCAVESVHK 119
Query: 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAF----------GGDETEGNT--------- 256
+ IHRD+K N+L+D+D + K++DFGL F GD ++
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 257 --------------------------NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLL 290
+ +VGT Y+APE ++ D +S G++L
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 291 EIVSGK 296
E++ G+
Sbjct: 240 EMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 31/86 (36%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 95 NNFSINKKLGQGGFGPVYK------GKLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSK 147
+N K LG G FG V + GK + +AVK L + +E L +E+ + S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 148 L-QHRNLVKLLGCCIQGEEKLLIYEF 172
L QH+N+V LLG C G L+I E+
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 83 PLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNE 141
P E+A +V+ F+I++ L G G V++ D Q + VK S +E
Sbjct: 158 PPSEVAKVVAGLG-FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSV------HE 210
Query: 142 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIIC 201
L +L H ++ LL + G L+ +P D + + R L ++ +
Sbjct: 211 ARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ----VT 263
Query: 202 GTARGLL----YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 257
AR LL Y+H + IIHRD+K NVL++ + + DFG A G +
Sbjct: 264 AVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320
Query: 258 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLE 291
+ GT APE + ++ D++S G+++ E
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 16/106 (15%)
Query: 203 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR----AFGGDETEGNTNR 258
T L YLH I+HRDLK N+L+ + K++DFGL++ + + EG+ +
Sbjct: 110 TVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 259 ---------VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 295
V GT Y+APE + D ++ GI+L E + G
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.001
Identities = 9/22 (40%), Positives = 13/22 (59%)
Query: 1 MWFGDLIDIRYFQDGGQDLYIR 22
+W G L ++R GG LY+R
Sbjct: 61 LWNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.001
Identities = 33/149 (22%), Positives = 54/149 (36%), Gaps = 17/149 (11%)
Query: 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV--KLLG 158
K L G VY ++ +K S + + + EV + L + L K+L
Sbjct: 4 KLLKGGLTNRVYLLGT-KDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLA 60
Query: 159 CCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY-LHQDSRLR 217
L+ E++ ++LD +++ I LL LHQ L
Sbjct: 61 SGESDGWSYLLMEWIEGETLDEVSEEEKE-----------DIAEQLAELLAKLHQLPLLV 109
Query: 218 IIHRDLKASNVLLDQDMNPKISDFGLARA 246
+ H DL N+L+D I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 414 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.23 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.03 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.02 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.98 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.96 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.83 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.67 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.64 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.56 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.42 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.39 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.38 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.37 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.35 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.34 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.28 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.16 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.13 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.11 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.1 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.09 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.08 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.9 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.83 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.77 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.77 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.75 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.45 | |
| PLN02236 | 344 | choline kinase | 97.4 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.39 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.32 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.26 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.22 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.08 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.03 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.0 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.9 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.85 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.83 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.73 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.71 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.7 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.48 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.32 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.29 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.06 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.01 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.97 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.81 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.67 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.5 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.37 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=413.06 Aligned_cols=287 Identities=44% Similarity=0.766 Sum_probs=251.3
Q ss_pred CCCCcCHHHHHHhcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEE
Q 043285 81 ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 160 (414)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 160 (414)
....|.+.++..+|++|.....||+|+||.||+|.+.+|..||||++.....+...+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988764433145699999999999999999999999
Q ss_pred EeCC-eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEE
Q 043285 161 IQGE-EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 239 (414)
Q Consensus 161 ~~~~-~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~ 239 (414)
.+.+ +.+||+||+++|+|.++|+..... .++|..+++|+.++|+||+|||+...++|+||||||.|||+|+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999876544 68999999999999999999999988899999999999999999999999
Q ss_pred eecCccccCCCCCccccccc-cccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043285 240 DFGLARAFGGDETEGNTNRV-VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 240 Dfgl~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
|||+++..... ....... .||.+|+|||++..+..+.|+|||||||+|.||+||+.+...........+..|.+..+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999654321 1111122 79999999999999999999999999999999999998876554444555788888888
Q ss_pred hcCCCccccccccc-CcCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 319 NEGMPSQLIDSCFQ-DSFNL-AEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 319 ~~~~~~~~~~~~~~-~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
......+++|+.+. ..+.. .++.++..++.+|++.+|.+||+|.||+++|+.
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 88888999999886 55554 688889999999999999999999999999944
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-50 Score=362.05 Aligned_cols=252 Identities=29% Similarity=0.414 Sum_probs=208.3
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-eeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ey 172 (414)
+.+....||+|..|+||++++. +++-+|+|.+.. ..+...+++.+|+++++..+|||||.++|.|.+.. ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 5666789999999999999875 577899999953 45667789999999999999999999999999999 49999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|++|+|++++....+ +++..+..++.++++||.|||+ ++ |+||||||+||||+..|++||+|||.+..+.+.
T Consensus 160 MDgGSLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999976543 8999999999999999999996 55 999999999999999999999999999876433
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
..+..+||..|||||.+.+..|+.++||||||+.++|+++|+.|+.... ............+. .+.++.+.+.
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~Iv-~~ppP~lP~~-- 305 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCAIV-DEPPPRLPEG-- 305 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHHHh-cCCCCCCCcc--
Confidence 4567899999999999999999999999999999999999999976541 11122222222222 2223333322
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.++ .++.+++..||++||.+|||+.|+++.
T Consensus 306 --~fS----~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 --EFS----PEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --cCC----HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222 257789999999999999999999973
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=371.43 Aligned_cols=256 Identities=33% Similarity=0.514 Sum_probs=207.1
Q ss_pred CCCCCCeecccCCceEEEEEEcCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-eeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ey 172 (414)
++.+.+.||+|+||+||+|.+.+...||||++... .....+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34445679999999999999955445999999763 2223679999999999999999999999999888 79999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CeEEEeecCccccCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGGDE 251 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kL~Dfgl~~~~~~~~ 251 (414)
+++|+|..+++.. ....+++..++.++.|||+||.|||+++. ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999874 23459999999999999999999999873 99999999999999997 99999999998754221
Q ss_pred Ccccccccccccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYAS--DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.......||+.|||||++. ...|+.|+||||||++||||+||+.||..... .+...........+.+...
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~p~~ 270 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPPIPKE 270 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCCCCcc
Confidence 2233367999999999999 56999999999999999999999999865432 2222222223333333222
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
....+..++.+||..||+.||++.+++..|+..
T Consensus 271 ---------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 271 ---------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred ---------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 223566788899999999999999999999644
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=374.97 Aligned_cols=256 Identities=32% Similarity=0.507 Sum_probs=212.5
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
..+.+.+.||+|.||.||.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..+..++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 345667899999999999999987889999999763 3344678899999999999999999999999889999999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
.|+|.++|.... ...++..+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+++....+.. .
T Consensus 285 ~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~ 359 (468)
T KOG0197|consen 285 KGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-T 359 (468)
T ss_pred cCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce-e
Confidence 999999998733 345999999999999999999999998 99999999999999999999999999995543332 2
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......-...|.|||.+..+.|+.|||||||||+||||+| |+.|++ .....+++....+.++.+.+....+
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~---~msn~ev~~~le~GyRlp~P~~CP~----- 431 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP---GMSNEEVLELLERGYRLPRPEGCPD----- 431 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC---CCCHHHHHHHHhccCcCCCCCCCCH-----
Confidence 2333344678999999999999999999999999999999 556643 3344455555555555555444333
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 372 (414)
.+.++|..||+.+|++|||++.+...|+.-.
T Consensus 432 --------~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 432 --------EVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred --------HHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 4667889999999999999999999886543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=374.04 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=211.3
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.+|...+.||+|+|+.||.++. ..|..||+|++.+ ......+.+.+|+++.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999987 7799999999976 34556678899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
|+|.+++|..+++.. ..+++.++..++.||+.||.|||+++ |+|||||..|+|++++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999998743 34999999999999999999999998 999999999999999999999999999987533
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.....+.+|||.|.|||++....++..+||||+||+||.|++|++||+...-.+....+. ..+...+.
T Consensus 172 --~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik-----~~~Y~~P~----- 239 (592)
T KOG0575|consen 172 --GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK-----LNEYSMPS----- 239 (592)
T ss_pred --ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH-----hcCccccc-----
Confidence 234567899999999999999999999999999999999999999987432211111110 01111111
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
.......+|+.++|+.+|.+|||+.+|+..=.-...
T Consensus 240 -------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 240 -------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred -------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 111235578889999999999999999974433333
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=354.70 Aligned_cols=199 Identities=32% Similarity=0.556 Sum_probs=181.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
..+|.+.+.||.|+||+||+|++. ++..||||.+.+. .....+.+..|+.+|+.++|||||.+++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467999999999999999999864 5889999999764 6667788899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC------CCeEEEeecCc
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD------MNPKISDFGLA 244 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~------~~~kL~Dfgl~ 244 (414)
|||.||+|.++++.... +++.....++.|+|.||++||+++ |+||||||.|||++.. -.+||+|||++
T Consensus 89 EyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999987664 999999999999999999999998 9999999999999865 45899999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 301 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~ 301 (414)
+.+. ........+|++-|||||++..++|+.|+|+||+|+++|++++|+.||..
T Consensus 163 R~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 163 RFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9875 33345568999999999999999999999999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=357.85 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=202.9
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccCh-------hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISE-------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 164 (414)
..+.|.+.+.||+|+||.|-+|.. .+|+.||||++++... .......+|+++|++++|||||+++++|....
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346788899999999999999954 5799999999975211 12234579999999999999999999999999
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CCeEEEee
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDF 241 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kL~Df 241 (414)
..|+||||++||+|.+.+-.+.. +.+..-.-++.|++.|+.|||++| |+||||||+|||++.+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999976654 677777889999999999999999 9999999999999876 67999999
Q ss_pred cCccccCCCCCccccccccccccccccccccCCCC---CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043285 242 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF---SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 242 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
|+|+..+ ......+.|||+.|.|||++.++.+ ..+.|+||+||+||-+++|.+||.....+.. +...+.+
T Consensus 324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~eQI~~-- 396 (475)
T KOG0615|consen 324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKEQILK-- 396 (475)
T ss_pred chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHHHHhc--
Confidence 9999864 4456778999999999999977643 3488999999999999999999876554431 1111111
Q ss_pred hcCCCccccccccc--CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 319 NEGMPSQLIDSCFQ--DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 319 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..+. ......-..+.++++.+||..||++|||+.|+|+
T Consensus 397 ----------G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 ----------GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ----------CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111 0111122346678999999999999999999996
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=380.56 Aligned_cols=263 Identities=30% Similarity=0.482 Sum_probs=217.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc------CCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
..+.+..+.||+|+||+||+|+.. +...||||.++...+. ..++|.+|++++..++|||||+++|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 355666789999999999999753 2456999999875544 788999999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccc-----------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC
Q 043285 167 LLIYEFMPNKSLDSFIFDQER-----------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 235 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~ 235 (414)
++|+|||..|+|.+||..... ...++..+.+.||.|||.||.||-++. ++||||..+|+||+++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 999999999999999964211 234889999999999999999999987 999999999999999999
Q ss_pred eEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHH
Q 043285 236 PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHA 314 (414)
Q Consensus 236 ~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 314 (414)
|||+|||+++..+..++........-..+|||||.|..++||.+||||||||+|||+++ |+.|+..... .+++..+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~EVIe~i 718 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QEVIECI 718 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HHHHHHH
Confidence 99999999998877766655545556789999999999999999999999999999999 7777654332 3344333
Q ss_pred HHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 043285 315 WKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLP 375 (414)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 375 (414)
. .+......+.|+ .++..||..||+.+|++||+++||-..|+......
T Consensus 719 ~----~g~lL~~Pe~CP---------~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 719 R----AGQLLSCPENCP---------TEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred H----cCCcccCCCCCC---------HHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 2 233333333333 25677899999999999999999999997665543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=336.92 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=205.5
Q ss_pred CCCCCCCeecccCCceEEEEE-EcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEe-EEEeCCe-eeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLG-CCIQGEE-KLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~lv 169 (414)
.+|++.+.||.|.||+||++. ..+|..||.|.+.- .+....+.+..|+.+|++|+|||||++++ .+.+.+. +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 458888999999999999996 46799999998863 45666778999999999999999999999 4555554 8999
Q ss_pred EeecCCCChhHHhhc-ccccccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 170 YEFMPNKSLDSFIFD-QERCMILDWSKRFHIICGTARGLLYLHQDSR-LRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
||||..|+|...+.. ......+++..+++++.|++.||..+|++-+ ..++||||||.|||++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999864 2334569999999999999999999999532 23899999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.+. .......+|||.||+||.+.+..|+.||||||+||++|||+.-..||... .-..+...+. ....+.+.
T Consensus 179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~----qgd~~~~p 249 (375)
T KOG0591|consen 179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIE----QGDYPPLP 249 (375)
T ss_pred cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHH----cCCCCCCc
Confidence 543 34455679999999999999999999999999999999999999998643 2222222222 22221122
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
+ .....++..++..|+..||+.||+.-.+++.+
T Consensus 250 ~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 250 D--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred H--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 1 22334566788899999999999965555554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=337.32 Aligned_cols=242 Identities=27% Similarity=0.390 Sum_probs=200.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.++||+|+||+||.++.. .++-+|+|++++ ......+....|..+|..++||+||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 478999999999999999999765 488899999976 2334567789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
+||+.||.|..+|.++.. +++..+..++..|+.||.|||+.+ |+||||||+|||++.+|.++|+|||+++...
T Consensus 104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~- 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL- 176 (357)
T ss_pred EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc-
Confidence 999999999999987665 899999999999999999999999 9999999999999999999999999998542
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.....+...+||+.|||||++.+..|+..+|+||||+++|||++|.+||...... .....+...... ..
T Consensus 177 -~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~k~~--~~-- 245 (357)
T KOG0598|consen 177 -KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKGKLP--LP-- 245 (357)
T ss_pred -cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcCcCC--CC--
Confidence 2233455689999999999999999999999999999999999999998643221 222222222200 00
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCC
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRP 359 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP 359 (414)
..+ ...+..+++...|+.||++|.
T Consensus 246 ---p~~---ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 ---PGY---LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---Ccc---CCHHHHHHHHHHhccCHHHhc
Confidence 010 112456788899999999996
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=336.83 Aligned_cols=261 Identities=28% Similarity=0.414 Sum_probs=207.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC--eeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 170 (414)
..+|...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3557788999999999999998754 8999999987654444678999999999999999999999855554 588999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCeEEEeecCccccCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGG 249 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kL~Dfgl~~~~~~ 249 (414)
||+++|+|.+++..... .+++..+..+..|+++||.|||+++ ++|+||||+|||++. ++.+||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999987654 4999999999999999999999998 999999999999999 79999999999987653
Q ss_pred -CCCccccccccccccccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 250 -DETEGNTNRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 250 -~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
...........||+.|||||++.++. ...++|||||||++.||+||+.||... ................+.+.
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~ip 245 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEIP 245 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCCC
Confidence 12223344578999999999999643 345999999999999999999998654 12222333333333233333
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
+. . .....+++..|++.||++||||.++|........
T Consensus 246 ~~-----l----s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 246 DS-----L----SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred cc-----c----CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 22 1 1235578889999999999999999987644443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=326.78 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=202.0
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
+.|+...++|+|+||.||+++..+ |+-||||++... ++...+-.++|+.+|++++|+|+|.++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457888899999999999998754 899999999652 23344566899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
||+..-|.++=....+ ++...+.+++.|+++|+.|+|+++ ++||||||+||||+.+|.+||||||+|+.+..
T Consensus 82 ~~dhTvL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNG---VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred ecchHHHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 9998655554333333 889999999999999999999998 99999999999999999999999999998753
Q ss_pred CccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC--------
Q 043285 252 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM-------- 322 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 322 (414)
........+.|.+|.|||.+.+ .+|+...||||+||++.||++|.+-|..... .+....+...+..-.
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD---iDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD---IDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch---HHHHHHHHHHHcccCHHHHHHhc
Confidence 2333445678999999999887 6999999999999999999999987654333 333333322211111
Q ss_pred ----CcccccccccCcCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 323 ----PSQLIDSCFQDSFNLA-----EVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 323 ----~~~~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
-..+.-+.+.....++ -..-+++++..||+.||.+|++-+|++.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111111111111 1235678999999999999999999885
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=342.39 Aligned_cols=276 Identities=26% Similarity=0.372 Sum_probs=218.8
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc---cChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 167 (414)
..++|.+++.||.|+|++|++|+. ..++.||||++.+ ..+.-.+.+..|-..|.+| .||.|++++-.|.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 457899999999999999999975 4589999999965 2334445677888999999 8999999999999999999
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+|+||+++|+|.++|.+... +++.-...++.+|+.|++|||+.| ||||||||+|||+++|++++|+|||.++.+
T Consensus 151 FvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999987654 999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCc---------cc--cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH
Q 043285 248 GGDETE---------GN--TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWK 316 (414)
Q Consensus 248 ~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 316 (414)
...... .. ...++||..|.+||++.++..+..+|+|+|||+||+|+.|.+||... ......+.+..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~---NeyliFqkI~~ 301 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA---NEYLIFQKIQA 301 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc---cHHHHHHHHHH
Confidence 543221 11 14578999999999999999999999999999999999999997532 22222222221
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC-------CCCCCCCCcccCCCCC
Q 043285 317 LWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV-------LPQPKQPGYLADRKST 389 (414)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~-------~~~~~~~~~~~~~~~~ 389 (414)
.....+..+. ....+|+.+.|..||.+|+|.+|+-+...-+.+ ..+|+...|..-...+
T Consensus 302 -l~y~fp~~fp-------------~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p~~~~s 367 (604)
T KOG0592|consen 302 -LDYEFPEGFP-------------EDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPYKPATSIS 367 (604)
T ss_pred -hcccCCCCCC-------------HHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCCCCcccCC
Confidence 1222222221 245678889999999999999999887643322 4555555554433333
Q ss_pred CC
Q 043285 390 RR 391 (414)
Q Consensus 390 ~~ 391 (414)
..
T Consensus 368 ~e 369 (604)
T KOG0592|consen 368 PE 369 (604)
T ss_pred cc
Confidence 33
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=331.88 Aligned_cols=263 Identities=25% Similarity=0.376 Sum_probs=211.0
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
..++|++.+.||.|..++||+|+. ..+..||||++.- ......+.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 457899999999999999999976 4578999999964 23344789999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
+||.+|++.+++...-... +++..+..|+.++++||.|||.+| .||||||+.||||+++|.|||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999997654433 999999999999999999999999 999999999999999999999999998765432
Q ss_pred CCcc--ccccccccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 251 ETEG--NTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 251 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
.... ..+..+||++|||||++.. ..|+.|+||||||++..||.+|..||..+++.... ...+....+. .
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL------l~tLqn~pp~-~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL------LLTLQNDPPT-L 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH------HHHhcCCCCC-c
Confidence 2111 1156789999999999644 37899999999999999999999999877654321 1111111111 1
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
....+..+.....-..+.+++..||++||.+|||+.++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111122222222346778889999999999999999987
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=359.55 Aligned_cols=261 Identities=27% Similarity=0.437 Sum_probs=215.9
Q ss_pred CCCCCCCeecccCCceEEEEEEcC----CCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD----GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
....+.+.||.|.||.|++|+++- ...||||.++. ..+.+..+|..|+.+|.+++||||+++.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345677899999999999998742 34699999986 4566778999999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
+|||++|+|+.+|..+.+ .+.+.++..++.+||.||.||-+.+ ++||||.++||||+.+..+|++|||+++.+.+
T Consensus 709 TEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999987653 4899999999999999999999988 99999999999999999999999999998755
Q ss_pred CCC-ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 250 DET-EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 250 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
+.. ...+....-..+|.|||.+...+++.+|||||||++|||.++ |.+|+ -.....+++..+...++.+.+.+.
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY---WdmSNQdVIkaIe~gyRLPpPmDC- 859 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---WDMSNQDVIKAIEQGYRLPPPMDC- 859 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc---cccchHHHHHHHHhccCCCCCCCC-
Confidence 431 111112223579999999999999999999999999999877 88884 233345566666655555444333
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLPQ 376 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 376 (414)
...+.+||++||++|-.+||.+.|++..|......|.
T Consensus 860 ------------P~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 860 ------------PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred ------------cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 3357789999999999999999999999966554333
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=348.58 Aligned_cols=263 Identities=28% Similarity=0.433 Sum_probs=208.4
Q ss_pred HHhcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 91 VSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
....+.+.+...||+|.||+||+|++.+ .||||.++- ..++..+.|++|+..+++-+|-||+-|.|+|..... .+
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 3344567788999999999999999853 599999864 456688899999999999999999999999988877 99
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
|+.+|+|.+|+.+++-.+ ..++....+.|+.|+|+||.|||.++ |||||||..|||+.+++.|||+|||++..-.
T Consensus 465 iTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeee
Confidence 999999999999998655 34899999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCCccccccccccccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
.-..........|...|||||++.. .+|+..+||||||+++|||+||..|+..... ..++..+.+.+.......
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---dqIifmVGrG~l~pd~s~ 616 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---DQIIFMVGRGYLMPDLSK 616 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---hheEEEecccccCccchh
Confidence 3222233334567889999999864 4789999999999999999999999762221 222222222111111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
... ....++.+|+..||.+++++||.+.+|+.+|+....
T Consensus 617 ~~s---------~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 617 IRS---------NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hhc---------cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111 123356678889999999999999999998866654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=340.77 Aligned_cols=260 Identities=29% Similarity=0.443 Sum_probs=200.8
Q ss_pred hcCCCCCCCeecccCCceEEEEEE------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 164 (414)
..++|++.+.||+|+||.||+|.. .++..||+|++... .......+.+|+.++..+ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346899999999999999999964 23467999998753 233456788999999999 8999999999987654
Q ss_pred -eeeEEEeecCCCChhHHhhcccc--------------------------------------------------------
Q 043285 165 -EKLLIYEFMPNKSLDSFIFDQER-------------------------------------------------------- 187 (414)
Q Consensus 165 -~~~lv~ey~~~g~L~~~l~~~~~-------------------------------------------------------- 187 (414)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999865321
Q ss_pred ---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcccccccccccc
Q 043285 188 ---CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264 (414)
Q Consensus 188 ---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~ 264 (414)
...+++..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 123778889999999999999999988 99999999999999999999999999986533222222223345678
Q ss_pred ccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHH
Q 043285 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRC 343 (414)
Q Consensus 265 y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (414)
|+|||++.+..++.++|||||||++|||++ |..||...... .... ........... .... ...+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~----~~~~~~~~~~~-----~~~~----~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFC----QRLKDGTRMRA-----PENA----TPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHH----HHHhcCCCCCC-----CCCC----CHHH
Confidence 999999999999999999999999999997 98887543221 1111 11111111111 1111 2346
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 344 IHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 344 ~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.+++.+||+.||++|||+.|+++.|+.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=335.44 Aligned_cols=264 Identities=24% Similarity=0.333 Sum_probs=204.7
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 168 (414)
.+.|+.+++||+|.||.||+|+. .+|+.||+|++.-. .+.......+|+.+|++|+||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35688889999999999999975 56899999999753 355566778999999999999999999998876 68999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
|+|||++ +|..++.... ..+++.++..++.|++.||.|||+.+ |+|||||..|||||.+|.+||+|||+|+++.
T Consensus 196 VFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999987 8888775432 34999999999999999999999998 9999999999999999999999999999775
Q ss_pred CCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc--
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ-- 325 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 325 (414)
...... ....+-|.+|.|||++.+. .|+.+.|+||.||||.||++|++.+.....-+ .+..+.+....+....
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve---Ql~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE---QLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH---HHHHHHHHhCCCChhccc
Confidence 444333 3344679999999998876 89999999999999999999998865443322 2233322221111110
Q ss_pred ---cc---cccccCcC--CHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 326 ---LI---DSCFQDSF--NLAE-----VIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 326 ---~~---~~~~~~~~--~~~~-----~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
+. .......+ .+.+ ....++|+..+|..||.+|.|+.++|+-
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00 00011111 1111 2356788999999999999999999963
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=332.41 Aligned_cols=264 Identities=26% Similarity=0.412 Sum_probs=201.6
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-----------------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-----------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKL 156 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~ 156 (414)
++|.+.+.||+|+||.||++.+.+ +..||+|.+... .......+.+|+.++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999997532 336999998753 33445678999999999999999999
Q ss_pred EeEEEeCCeeeEEEeecCCCChhHHhhccc----------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 043285 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQE----------------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIH 220 (414)
Q Consensus 157 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH 220 (414)
++++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999986422 1124678889999999999999999998 999
Q ss_pred ccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCC--CC
Q 043285 221 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK--KN 298 (414)
Q Consensus 221 ~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~--~p 298 (414)
|||||+|||++.++.+||+|||++..+.............++..|+|||.+.++.++.++|||||||++|||+++. .|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999998654333222233345578899999999889999999999999999999754 45
Q ss_pred CCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 299 RGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
+.... ...................... . .. .....+.+++.+||+.||++|||+.||.+.|++
T Consensus 242 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~-~-~~----~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELT---DEQVIENAGEFFRDQGRQVYLF-R-PP----PCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCC---HHHHHHHHHHHhhhcccccccc-C-CC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 43322 1222222222221111100000 0 00 112356789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=340.63 Aligned_cols=265 Identities=26% Similarity=0.426 Sum_probs=216.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.+...+.++||+|-||.|.++....+..||||+++.. .....+.|.+|+++|.+++||||++++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 3556778899999999999999977899999999874 344458999999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++|+|..++.+..... +......+|+.||+.||+||.+.+ ++||||.++|+|++.++++||+|||+++.+...+.
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999998764322 566677889999999999999988 99999999999999999999999999998877777
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS--GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.......+-..+|||||.+..++++.+||||+||++|||+++ ...|++....+ +.+.........+.....+. .
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~l~-~ 768 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVVLS-R 768 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcceecc-C
Confidence 666666778899999999999999999999999999999865 56776543322 23333333333332222211 1
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
.......+.+++++||+.|.++|||++++...|.+.
T Consensus 769 -----P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 769 -----PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 112234567899999999999999999999988654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=337.35 Aligned_cols=265 Identities=24% Similarity=0.323 Sum_probs=208.4
Q ss_pred HhcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhH-HHHHHHHHHHHhcC-CCceeeeEeEEEeCC-eee
Q 043285 92 SATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQ-HRNLVKLLGCCIQGE-EKL 167 (414)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~ 167 (414)
...++|.+.++||.|+||.||+|+. .+|..||||++++.-.... .--.+|+..|++++ ||||+++.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3457899999999999999999975 4588999999976322211 12368999999998 999999999999988 999
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+|||||+. +|.+++.+. ...+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999975 999999776 346999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCccccccccccccccccccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
... ......+.|.+|+|||++ +++-|+.+.||||+|||++|+.+-++.|.. ....+.+.++...+..+....+
T Consensus 161 ~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG---~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 161 RSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG---ASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred ccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC---CcHHHHHHHHHHHhCCCccccc
Confidence 433 334456789999999976 667899999999999999999999887643 3333444444443332222211
Q ss_pred ccc---------ccc--CcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 327 IDS---------CFQ--DSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 327 ~~~---------~~~--~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
... .+. ....+ ....++++++.+|++.||.+|||+.|+++.-
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 110 000 01111 1335778899999999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=306.74 Aligned_cols=263 Identities=25% Similarity=0.401 Sum_probs=208.5
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++|...+.||+|.||.||+|+. ..|+.||||+++.. .+.......+|+..|+.++|+||+.++++|-..+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999975 56999999999742 23334567899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|++. +|...+.+.. ..++..++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+++.+....
T Consensus 82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9975 9999986644 46899999999999999999999998 9999999999999999999999999999886544
Q ss_pred CccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
..... .+-|..|.|||.+.|. .|+...||||.|||+.||+.|.+-| +++.+.+.+..+.+.+..+.+.+..+-.
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f---pG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF---PGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC---CCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 33322 2678999999988764 8999999999999999999987654 3444444445555544433333222110
Q ss_pred c--------------cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 331 F--------------QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 331 ~--------------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
- ....-.....+.++++..|+.+||.+|+|+.|++++=
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 0 0001111224568899999999999999999999754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=339.03 Aligned_cols=251 Identities=28% Similarity=0.471 Sum_probs=207.6
Q ss_pred cCCCCCCCeecccCCceEEEEE-EcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
...|....+||+|+.|.||.++ ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|..++.+|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3567777899999999999996 456889999999765555667789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++|+|.+++.... +++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||+|..+....
T Consensus 352 m~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~- 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ- 423 (550)
T ss_pred cCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc-
Confidence 99999999986543 899999999999999999999998 9999999999999999999999999998774332
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
......+|||.|||||+.....|+++.||||||++++||+-|.+||-. +.....+ +.+...+.+ .+.. .
T Consensus 424 -~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln---E~PlrAl---yLIa~ng~P-~lk~---~ 492 (550)
T KOG0578|consen 424 -SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN---ENPLRAL---YLIATNGTP-KLKN---P 492 (550)
T ss_pred -CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC---CChHHHH---HHHhhcCCC-CcCC---c
Confidence 355677999999999999999999999999999999999999999643 2222222 222222222 1111 0
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
+.. ...+.+++.+||+.|+.+||+++|+|+.
T Consensus 493 ~kl----S~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 493 EKL----SPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccc----CHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 111 1246678889999999999999999974
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=333.30 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=203.8
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc----Ch-hhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI----SE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE 165 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 165 (414)
..+.|.+.+.||+|+||+|+.|.. .++..||+|++.+. .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 347899999999999999999965 46899999977542 11 23456778999999999 9999999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCeEEEeecCc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLA 244 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kL~Dfgl~ 244 (414)
.++||||+.+|+|.+++.+..+ +.+.....++.|++.|++|||+++ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999987443 888999999999999999999998 9999999999999999 99999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQ-FS-VKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.... .......+.....
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRKIRKGEF 240 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHHHhcCCc
Confidence 8763 2233455679999999999999987 85 78999999999999999999987521 1111111111111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 323 PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. + ..... ..++..++.+||..||.+|+|+.+++.
T Consensus 241 ~--~-----p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 241 K--I-----PSYLL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred c--C-----CCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 0 1 11110 235677899999999999999999994
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=360.31 Aligned_cols=259 Identities=34% Similarity=0.531 Sum_probs=210.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC--CC----EEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD--GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
..+.++.+.||+|.||.||.|...+ |. .||+|.+++ .+.+...+|.+|+.+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4566777899999999999997643 43 389999977 4567788999999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeec
Q 043285 167 LLIYEFMPNKSLDSFIFDQER----CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 242 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfg 242 (414)
++++|||++|+|..+|.+... ...+...+++.++.|+|+|+.||++++ +|||||..+|+|++....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999986521 245889999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcC
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEG 321 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
+|+.+...+.........-..+|||||.+.++.|+.|+|||||||+|||++| |..||+ .....++........+.+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~---~~~n~~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP---SRSNFEVLLDVLEGGRLD 924 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC---CcchHHHHHHHHhCCccC
Confidence 9997766555554444445679999999999999999999999999999999 556643 333333333222222222
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
.+..+. ..+.++|.+||+.+|++||++..+++.+..-
T Consensus 925 ~P~~CP-------------~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 925 PPSYCP-------------EKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred CCCCCC-------------hHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 222222 2456799999999999999999999977444
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=338.20 Aligned_cols=238 Identities=29% Similarity=0.471 Sum_probs=194.4
Q ss_pred CCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCChh
Q 043285 100 NKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 179 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~ 179 (414)
++-||+|+.|-||+|++ .+..||||+++... ..+++-|++|+||||+.|.|+|.....+|||||||..|.|.
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 36899999999999998 67899999886533 35788899999999999999999999999999999999999
Q ss_pred HHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccc
Q 043285 180 SFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 259 (414)
Q Consensus 180 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~ 259 (414)
++|..... +.......|..+||.||.|||.+. |||||||.-||||+.+..|||+|||-++.+... ...-.+
T Consensus 201 ~VLka~~~---itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 201 EVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred HHHhccCc---cCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 99987654 788889999999999999999997 999999999999999999999999999876422 233457
Q ss_pred cccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHH
Q 043285 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAE 339 (414)
Q Consensus 260 ~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (414)
+||..|||||++.+.+.++|+||||||||||||+||..|+..-... ..+.......+....+ ..|
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss--AIIwGVGsNsL~LpvP----stc--------- 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS--AIIWGVGSNSLHLPVP----STC--------- 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh--eeEEeccCCcccccCc----ccC---------
Confidence 8999999999999999999999999999999999999996432211 1111000011111111 111
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 340 VIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 340 ~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
...+.-|+.+||+..|..||++.+++..|.
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 224555788999999999999999999984
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=330.73 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=201.3
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
..++|++++.||+|+||.||+++.. .|..+|+|++++. ...+.+.++.|-.+|...++|+||+++..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4588999999999999999999764 5889999999873 34456678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||++||++..+|.... .+++.....++.+++.|+..+|+.| +|||||||+|+|||..|++||+||||+..+.
T Consensus 219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999997654 4999999999999999999999999 9999999999999999999999999986442
Q ss_pred CC----------------------CCcc-----c------------------cccccccccccccccccCCCCCcchhHH
Q 043285 249 GD----------------------ETEG-----N------------------TNRVVGTYGYMAPEYASDGQFSVKSDVF 283 (414)
Q Consensus 249 ~~----------------------~~~~-----~------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvw 283 (414)
.. .... . ....+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 0000 0 0124699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCC---
Q 043285 284 SFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS--- 360 (414)
Q Consensus 284 slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs--- 360 (414)
||||||||||.|.+||....+......+ ..|+..... .. ......+..+||.+||. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI----~nwr~~l~f--P~-------~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKI----VNWRETLKF--PE-------EVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHH----HHHhhhccC--CC-------cCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 9999999999999998654333221111 112211110 00 00111356678889999 9999986
Q ss_pred HHHHHH
Q 043285 361 MPSVIL 366 (414)
Q Consensus 361 ~~evl~ 366 (414)
++||-+
T Consensus 439 ~~EIK~ 444 (550)
T KOG0605|consen 439 AEEIKK 444 (550)
T ss_pred HHHHhc
Confidence 555544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=339.01 Aligned_cols=260 Identities=31% Similarity=0.473 Sum_probs=206.1
Q ss_pred CCCCCCCeecccCCceEEEEEEcC--C--CE-EEEEEecc---cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD--G--QE-IAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
++..+.++||+|+||.||+|++.. + .. ||||..+. .......++++|+++|++++|||||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 455666899999999999997643 2 23 89999874 4567788999999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++|||+|+||+|.++|.+..+ .++..+...++.+.|.||+|||+++ ++||||.++|+|++.++.+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999987654 4899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
.. ..........-..+|+|||.+..+.|+.++|||||||++||+++ |..|+.. ....++..++ ...+....
T Consensus 312 ~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g---~~~~~v~~kI---~~~~~r~~ 383 (474)
T KOG0194|consen 312 GS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG---MKNYEVKAKI---VKNGYRMP 383 (474)
T ss_pred Cc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC---CCHHHHHHHH---HhcCccCC
Confidence 42 11111111235679999999999999999999999999999999 6666432 2222333333 12222222
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLPQ 376 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 376 (414)
... .....+..++.+||..+|++||||.++.+.|+.......
T Consensus 384 ~~~---------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 384 IPS---------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CCC---------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 111 122245567779999999999999999999976665433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=336.70 Aligned_cols=248 Identities=26% Similarity=0.359 Sum_probs=206.5
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
+-|++++.||.|+.|.|-+|+. ..|+.+|||++.+. .......+.+|+.+|+.+.|||++++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5688999999999999999965 57999999999763 3334567899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|.|.+++..... +.+.+..+++.||+.|+.|+|..+ |+||||||+|+|++..+++||+|||+|..-.
T Consensus 92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 99999999999987665 899999999999999999999998 9999999999999999999999999998632
Q ss_pred CCccccccccccccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
....-.+.||+|.|.|||++.|.+| +.++||||.|||||.|+||+.||+. ++...++.++.+. .-.++..+ .
T Consensus 164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G-~f~MPs~I-s- 236 (786)
T KOG0588|consen 164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRG-VFEMPSNI-S- 236 (786)
T ss_pred -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcC-cccCCCcC-C-
Confidence 2223446799999999999999998 6899999999999999999999862 2222222222211 11122111 1
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
.++.+|+.+|+..||++|.|++||++.-
T Consensus 237 -----------~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 237 -----------SEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -----------HHHHHHHHHHhccCccccccHHHHhhCc
Confidence 2456788899999999999999999854
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=333.19 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=207.8
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+ ..+...+.+.+|+++++.++||||+.++++|+...++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999754 578899999976 455567889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+.| +|..++....+ +++..+..++.++..||.|||+++ |.|||+||.|||+..++.+|++|||+++....
T Consensus 82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-- 152 (808)
T ss_pred hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--
Confidence 9977 99999987765 999999999999999999999998 99999999999999999999999999997643
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.......+.|||-|||||...++.|+..+|+||+||++||+++|++||.. ..+.+.+..+..++.....
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~v~~p~----- 221 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDPVKPPS----- 221 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCCCCCcc-----
Confidence 22334457899999999999999999999999999999999999999742 1222333333332221111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.....+..++...|.+||..|.|..+++..
T Consensus 222 ------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 222 ------TASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ------cccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 222356778889999999999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=304.75 Aligned_cols=199 Identities=30% Similarity=0.428 Sum_probs=180.3
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|+..+.||.|+||+|.+++.+ +|..+|+|++++. .-.+.+...+|..+|+.+.||+++++++.|.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 67889999999999999999864 5888999999763 2334556788999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||.+||.|..++.+..+ +++.....++.||+.|++|||+.+ |++|||||+|||+|.+|.+||+|||+++.+.
T Consensus 124 eyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred eccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 99999999999987655 999999999999999999999998 9999999999999999999999999999763
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS 304 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~ 304 (414)
..+-+.||||.|+|||++....|+.++|.|||||++|||+.|.+||.....
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 335678999999999999999999999999999999999999999865433
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=323.83 Aligned_cols=244 Identities=18% Similarity=0.301 Sum_probs=195.1
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChh---hHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCeeeEEEeec
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFM 173 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ey~ 173 (414)
..||+|++|.||+|.+ +|+.||||.++..... ..+.+.+|+.++++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999988 7899999999764322 25678899999999999999999999977 34678999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
++|+|.+++.... .+++.....++.+++.|+.|||+. + ++||||||+||++++++.+||+|||++..+....
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999997644 388999999999999999999985 5 7899999999999999999999999988653221
Q ss_pred ccccccccccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+..... ........+.
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~~i---~~~~~~~~~~--- 244 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYDLI---INKNNSLKLP--- 244 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---HhcCCCCCCC---
Confidence 22357889999999976 6899999999999999999999999864321 1111111 1111111111
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
. .....+.+++.+||+.||++|||++|+++.|+..
T Consensus 245 --~----~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 245 --L----DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred --C----cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0 1122467789999999999999999999998653
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=321.60 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=197.3
Q ss_pred CCCCCeecccCCceEEEEEE-cCCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 97 FSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
|+..+.||+|+||.||++.. .+|+.||+|.+.+.. ......+.+|+.+++.++|+|++++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67789999999999999976 468999999986422 22334577899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999999988764332 24889999999999999999999998 9999999999999999999999999998653221
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........... ........ ... +.
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~~-~~~-----~~ 225 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVKED-QEE-----YS 225 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhhcc-ccc-----CC
Confidence 12234689999999999999999999999999999999999999864332211111 11111110 001 11
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPS-----MPSVIL 366 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 366 (414)
...+ ..+.+|+.+||+.||.+||+ ++++++
T Consensus 226 ~~~s----~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 226 EKFS----EDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCC----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1111 24667889999999999997 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=334.32 Aligned_cols=259 Identities=30% Similarity=0.424 Sum_probs=201.2
Q ss_pred cCCCCCCCeecccCCceEEEEEE------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 165 (414)
.++|++.+.||+|+||.||+|+. .++..||||+++.. .....+.+.+|+.+++.+ +||||++++++|.++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999963 23568999998643 233456788999999999 89999999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccc----------------------------------------------------------
Q 043285 166 KLLIYEFMPNKSLDSFIFDQER---------------------------------------------------------- 187 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~---------------------------------------------------------- 187 (414)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864321
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 188 --------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 188 --------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788899999999999999999988 999999999999999999999999999865432221
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .... ............
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~----~~~~~~~~~~~~----- 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFY----KMIKEGYRMLSP----- 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHH----HHHHhCccCCCC-----
Confidence 11222335667999999999999999999999999999998 77776433211 1111 111111111100
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. ...++.+++.+||+.||++|||+.|+++.|+.
T Consensus 340 ~~----~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 EC----APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 00 12356789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=333.46 Aligned_cols=260 Identities=31% Similarity=0.453 Sum_probs=201.4
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 164 (414)
..++|++.+.||+|+||.||+++.. ++..||+|+++.. .......+.+|+.+++.+ +|+||++++++|....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3467999999999999999998742 2357999999753 333456788999999999 8999999999999999
Q ss_pred eeeEEEeecCCCChhHHhhcccc---------------------------------------------------------
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQER--------------------------------------------------------- 187 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~--------------------------------------------------------- 187 (414)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999999854211
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccc
Q 043285 188 ----------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 257 (414)
Q Consensus 188 ----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~ 257 (414)
...+++..+..++.|+++||+|||+++ ++||||||+|||+++++.+||+|||++.............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 123678889999999999999999988 9999999999999999999999999997653322211122
Q ss_pred cccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCC
Q 043285 258 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFN 336 (414)
Q Consensus 258 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
...++..|+|||++.+..++.++|||||||++|||++ |+.||....... .. ............. ...
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~----~~~~~~~~~~~~~-----~~~- 340 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF----YKMVKRGYQMSRP-----DFA- 340 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH----HHHHHcccCccCC-----CCC-
Confidence 2335678999999999999999999999999999997 999875432211 11 1111111111110 011
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 337 LAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 337 ~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
...+.+++.+||+.||++|||+.+++++|+.
T Consensus 341 ---~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 341 ---PPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1356778899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=318.63 Aligned_cols=250 Identities=36% Similarity=0.605 Sum_probs=192.4
Q ss_pred CCCeecccCCceEEEEEEc-----CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 99 INKKLGQGGFGPVYKGKLV-----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 99 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+.+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999876 2567999999653 344578899999999999999999999999988889999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++|+|.+++..... ..+++..+..++.|+++||.|||+.+ ++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999987622 34899999999999999999999987 99999999999999999999999999987633322
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
............|+|||.+.+..++.++||||||+++|||++ |+.|+... ...+..... .........+.+
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~----~~~~~~~~~~~~- 230 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKL----KQGQRLPIPDNC- 230 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHH----HTTEETTSBTTS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc----cccccceeccch-
Confidence 223333456788999999999999999999999999999999 67775433 112222222 111111111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
...+.+++.+||+.+|++|||+.++++.|
T Consensus 231 --------~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 231 --------PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --------BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --------hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 22466789999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=324.21 Aligned_cols=248 Identities=27% Similarity=0.434 Sum_probs=206.4
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
..|...+.||+|.||.||+|... .++.||+|++.- ........+..|+.++...+++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777789999999999999764 478899999964 3445667889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
|.+|++.+.+.... .+++..+..++.+++.|+.|||+++ .+|||||+.|||+..+|.+||+|||.+..+....
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~- 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV- 165 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh-
Confidence 99999999986544 2588888889999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
....+.+||+.|||||++.+..|+.|+||||||++.+||++|.+|+...++..-..++ .+-..+.+.
T Consensus 166 -~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------pk~~PP~L~ 232 (467)
T KOG0201|consen 166 -KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------PKSAPPRLD 232 (467)
T ss_pred -hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------cCCCCCccc
Confidence 3346789999999999999889999999999999999999999998766553322222 111112222
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..++ ..+.+++..||.+||+.|||+.++++
T Consensus 233 ~~~S----~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 GDFS----PPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccC----HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2222 24667888999999999999999987
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=321.56 Aligned_cols=199 Identities=27% Similarity=0.376 Sum_probs=174.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||.||+++.. ++..||+|.+... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999875 5788999988653 33445678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999987644 3889999999999999999999853 3999999999999999999999999998765321
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 301 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~ 301 (414)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22345689999999999999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=316.92 Aligned_cols=269 Identities=29% Similarity=0.424 Sum_probs=207.0
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc--CCCceeeeEeEEEeCC----eeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL--QHRNLVKLLGCCIQGE----EKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~~l 168 (414)
...++.++||+|+||.||+|.+ +++.||||++. .+..+.+.+|-++++.. +|+||++|+++-..+. .++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 4556678999999999999998 56999999995 45566788888887764 7999999999987666 7899
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC------CCCCeeeccCCCCCEEEcCCCCeEEEeec
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDFG 242 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~iiH~dlk~~Nill~~~~~~kL~Dfg 242 (414)
|++|.++|+|.++|..+. ++|....+++..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999997654 89999999999999999999965 45789999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccccccccCC-CCC-----cchhHHHHHHHHHHHHhCCCCCC------CCCCC-----
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFS-----VKSDVFSFGILLLEIVSGKKNRG------FYHSD----- 305 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~sDvwslGvil~elltg~~p~~------~~~~~----- 305 (414)
++..+...........-+||.+|||||++.+. .+. .+.||||+|.|||||++.-.-.. |..+-
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99988766666666667899999999999875 233 36899999999999998543221 11000
Q ss_pred CCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 043285 306 NNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLP 375 (414)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 375 (414)
....+-.......+....+.+.+.-.. . ..+..+.+.+..||..||+.|.|+.-|-+++.+..-+.
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~-h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRK-H---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhc-C---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 000111111111222233333332221 1 33556778899999999999999999999987766543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.69 Aligned_cols=245 Identities=23% Similarity=0.315 Sum_probs=198.6
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 67899999999999999999875 5889999998652 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999987654 3788889999999999999999998 999999999999999999999999999865321
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ....... . ..... .+
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~---i-~~~~~-~~---- 234 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIYEK---I-LAGRL-KF---- 234 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHHHH---H-hcCCc-CC----
Confidence 223578999999999999999999999999999999999999975321 1111111 1 11110 01
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPS-----MPSVILM 367 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 367 (414)
....+ ..+.+++.+||+.||.+||+ +++++..
T Consensus 235 -p~~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 -PNWFD----GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -CCCCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111 24567899999999999997 6777754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=333.28 Aligned_cols=243 Identities=26% Similarity=0.387 Sum_probs=200.5
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc---cChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 167 (414)
..++|.+.++||+|.||+|+++..+ +++.+|||++++ ..+...+..+.|..++.... ||.++.++.+|+..+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4478999999999999999999875 477899999987 34567788899999988885 999999999999999999
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
.||||+.||++..+.+. ..+++..+..++..++.||+|||+++ ||+||||.+|||+|.+|.+||+|||+++..
T Consensus 446 fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999995444332 34999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
. .....+.+.+|||.|||||++.+..|+.+.|.|||||+||||+.|..||... +..++...+. .++
T Consensus 519 m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd---dEee~FdsI~---~d~------ 584 (694)
T KOG0694|consen 519 M--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD---DEEEVFDSIV---NDE------ 584 (694)
T ss_pred C--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHh---cCC------
Confidence 2 2344677899999999999999999999999999999999999999997532 2222222221 111
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 361 (414)
.. +......+.+.++.++|..+|++|.-+
T Consensus 585 -~~----yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 -VR----YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CC----CCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 111223356778889999999999977
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=329.00 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=201.7
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||+|+.. +++.||+|++++. .......+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999875 4889999999753 2234457888999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999996543 3889999999999999999999998 99999999999999999999999999976432
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC-cccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP-SQLIDS 329 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 329 (414)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +...... .+..... ....++
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i~-~~~~~~~~~~~~~~ 225 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---ETWENLK-YWKETLQRPVYDDP 225 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH---HHHHHHH-hccccccCCCCCcc
Confidence 233457899999999999999999999999999999999999997543221 1111111 1111000 000000
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. ......+.+++.+||+.+|.+||++.++++.
T Consensus 226 ~------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 R------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred c------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0 1112356778889999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=315.94 Aligned_cols=257 Identities=30% Similarity=0.477 Sum_probs=204.2
Q ss_pred CCCCCCCeecccCCceEEEEEEcCC------CEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
++|++.+.||+|+||.||+|..... ..|++|.+... .......+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 4688899999999999999976432 57999998653 3344567899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 043285 168 LIYEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 234 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~ 234 (414)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 134788999999999999999999998 99999999999999999
Q ss_pred CeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHH
Q 043285 235 NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGH 313 (414)
Q Consensus 235 ~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~ 313 (414)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .+....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999986543332223334456788999999998999999999999999999998 9888753221 112111
Q ss_pred HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 314 AWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
........... .....+.+++.+||+.||.+||++.|+++.|+.
T Consensus 239 ----i~~~~~~~~~~---------~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ----IRSRQLLPCPE---------DCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcCCcCCCcc---------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111111 112357788999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=324.91 Aligned_cols=245 Identities=20% Similarity=0.264 Sum_probs=198.6
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999875 5889999998642 2234456889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~- 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD- 153 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC-
Confidence 9999999999987544 3889999999999999999999998 99999999999999999999999999886532
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ....... .... . .+
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~~i---~~~~-~-~~---- 217 (291)
T cd05612 154 ----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FGIYEKI---LAGK-L-EF---- 217 (291)
T ss_pred ----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH---HhCC-c-CC----
Confidence 12235689999999999999999999999999999999999999754221 1111111 1111 0 01
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPS-----MPSVILM 367 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 367 (414)
.... ...+.+++.+||+.||.+||+ +.++++.
T Consensus 218 -~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 -PRHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1111 124667899999999999995 8888864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=319.37 Aligned_cols=265 Identities=21% Similarity=0.272 Sum_probs=198.6
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999875 4788999998652 23345677899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|++++++..+.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99988776554322 24889999999999999999999988 9999999999999999999999999998753222
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH--------HHHh-hcCC
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHA--------WKLW-NEGM 322 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~-~~~~ 322 (414)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+... ...+ ....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 1223356899999999999989999999999999999999999998643221110000000 0000 0000
Q ss_pred CcccccccccCcCCH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 323 PSQLIDSCFQDSFNL------AEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 323 ~~~~~~~~~~~~~~~------~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
......+........ .....+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000000 11235788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=362.82 Aligned_cols=260 Identities=25% Similarity=0.472 Sum_probs=204.9
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
...|...+.||+|+||.||+|+. .++..||||++...... ...|+..+++++||||++++|+|.+....++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 35577778999999999999986 47899999998653322 23468889999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++|+|.+++.. ++|..+..++.|+++|++|||....++++||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 999999999852 7899999999999999999996655569999999999999999888875 665543211
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.....+++.|+|||++.+..++.++|||||||++|||+||+.|+..... .......+..............++...
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence 1123578999999999999999999999999999999999999743222 223344444333333333333444332
Q ss_pred C--cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 333 D--SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 333 ~--~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
. .....+..++.+++.+||+.+|++||||.|+++.|+..
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 2 33456677888999999999999999999999999654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=321.23 Aligned_cols=242 Identities=21% Similarity=0.280 Sum_probs=193.8
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 176 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g 176 (414)
+.||+|+||.||+++.. +|+.||+|++++. .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 6889999999752 2334456788999999999999999999999999999999999999
Q ss_pred ChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcccc
Q 043285 177 SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256 (414)
Q Consensus 177 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~ 256 (414)
+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~ 152 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATM 152 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcc
Confidence 9999887544 3889999999999999999999998 99999999999999999999999999875321 11223
Q ss_pred ccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCC
Q 043285 257 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFN 336 (414)
Q Consensus 257 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... ..... ..+ ....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~---~~~~~--~~~-----p~~~- 218 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFEL---ILMEE--IRF-----PRTL- 218 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHH---HHcCC--CCC-----CCCC-
Confidence 345799999999999999999999999999999999999999753211 111111 11111 011 1111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043285 337 LAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILM 367 (414)
Q Consensus 337 ~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 367 (414)
...+.+++.+||+.||++|| ++.++++.
T Consensus 219 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 219 ---SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ---CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 23466788999999999999 79998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.22 Aligned_cols=260 Identities=26% Similarity=0.313 Sum_probs=210.6
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCC-CEEEEEEecccChhhHHHHHHHHHHHHhcC-CCceeeeEeE-EEe------C
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGC-CIQ------G 163 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~------~ 163 (414)
...++++.+.|.+|||+.||++....+ ..||+|++-..++...+.+.+|+.+|+.|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 346778889999999999999998776 999999998778889999999999999997 9999999993 221 1
Q ss_pred CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecC
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl 243 (414)
-+.+|.||||.+|.|-+++....... |++.++++|+.++++|+++||... ++|||||||-+||||+.+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 35689999999999999998654433 999999999999999999999986 7899999999999999999999999999
Q ss_pred ccccCCCCCccc-------cccccccccccccccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHH
Q 043285 244 ARAFGGDETEGN-------TNRVVGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGH 313 (414)
Q Consensus 244 ~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 313 (414)
+.-......... .-...-|+.|+|||.+ .+...++|+|||||||+||-|+....||+...
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------- 262 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------- 262 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------
Confidence 874322211100 0012358999999976 67789999999999999999999999986421
Q ss_pred HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 314 AWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
...++...+.-.........+.+||..||+.||.+||++-||+..+.....
T Consensus 263 ---------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 263 ---------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ---------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 122333333333334556678889999999999999999999998855544
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=314.68 Aligned_cols=256 Identities=27% Similarity=0.462 Sum_probs=203.8
Q ss_pred CCCCCCCeecccCCceEEEEEEcC------CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD------GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
++|.+.+.||+|+||.||+|...+ +..|++|.++..... ..+.+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 568888999999999999997633 478999999764333 5578999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhccc-----------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCe
Q 043285 168 LIYEFMPNKSLDSFIFDQE-----------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 236 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~ 236 (414)
+||||+++++|.+++.... ....+++..+..++.|++.|++|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996532 1234788999999999999999999998 9999999999999999999
Q ss_pred EEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043285 237 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 237 kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 315 (414)
+|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ........
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH
Confidence 9999999976533322222233345788999999999999999999999999999998 9988643221 11211111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 316 KLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
........ .. ....+.+++.+||+.||++||++.|+++.|+
T Consensus 239 ----~~~~~~~~-----~~----~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ----QGRLLQRP-----RT----CPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----cCCcCCCC-----CC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111111 11 1235678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=310.45 Aligned_cols=255 Identities=31% Similarity=0.452 Sum_probs=204.1
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.++|++.+.||+|+||.||+|...++..|++|.+.... ...+.+.+|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 36789999999999999999998888899999886532 34568899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++..... ..+++..+..++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 99999999875432 34788899999999999999999987 999999999999999999999999999875432211
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.... ......... ........
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~----~~~~~~~~----- 226 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSALQ----RGYRMPRM----- 226 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC---HHHHHHHHH----cCCCCCCC-----
Confidence 1122345678999999998999999999999999999998 888875322 111222211 11111000
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. ....+.+++.+||+.+|++||+++++.+.|++
T Consensus 227 ~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 EN----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11 12346788999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=311.35 Aligned_cols=255 Identities=33% Similarity=0.506 Sum_probs=207.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
..+|++.+.||.|+||.||+|...++..+++|.+..........+..|+.+++.++|+||+++++++.+....++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688999999999999999998889999999998765555678899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++..... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 99999999976443 34899999999999999999999988 999999999999999999999999999765332111
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ......... ........
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~----~~~~~~~~----- 226 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQIT----AGYRMPCP----- 226 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHH----hCCcCCCC-----
Confidence 113345678999999998899999999999999999998 788875332 111222221 11111110
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
......+.+++.+||+.+|.+|||+.++++.|++
T Consensus 227 ----~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 ----AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112356789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=318.61 Aligned_cols=261 Identities=21% Similarity=0.292 Sum_probs=196.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|++.+.||.|+||.||+|+.. ++..||+|.++... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999764 58899999986432 22345677899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++ +|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 975 8988886443 23788899999999999999999998 9999999999999999999999999987643221
Q ss_pred ccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC---c----
Q 043285 253 EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP---S---- 324 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~---- 324 (414)
.......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... +...........+.. .
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK---EELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHHhhcccc
Confidence 12233467899999998865 56899999999999999999999997543221 111111111110000 0
Q ss_pred --c---cccccccCcCC----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 325 --Q---LIDSCFQDSFN----LAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 325 --~---~~~~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ...+....... .....++.+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 00000000000 001235678999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=327.32 Aligned_cols=262 Identities=29% Similarity=0.395 Sum_probs=203.6
Q ss_pred HhcCCCCCCCeecccCCceEEEEEEcC------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeC
Q 043285 92 SATNNFSINKKLGQGGFGPVYKGKLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG 163 (414)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 163 (414)
...++|++.+.||+|+||.||+|.... +..||||++... .....+.+.+|+.+++.+. ||||++++++|.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 346789999999999999999997521 346999999753 3334567899999999996 99999999999999
Q ss_pred CeeeEEEeecCCCChhHHhhcccc--------------------------------------------------------
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQER-------------------------------------------------------- 187 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~-------------------------------------------------------- 187 (414)
...++|||||++|+|.+++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999998864311
Q ss_pred -------------------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 043285 188 -------------------------------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 230 (414)
Q Consensus 188 -------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill 230 (414)
...+++..+..++.|+++||+|||+.+ ++||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 123778888999999999999999988 9999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 043285 231 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLN 309 (414)
Q Consensus 231 ~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~ 309 (414)
+.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--- 347 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--- 347 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---
Confidence 9999999999999986543222222233456788999999999999999999999999999997 888865322111
Q ss_pred hHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 310 LIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
............... . .....+.+++.+||+.+|++|||+.+|.++|+..
T Consensus 348 ---~~~~~~~~~~~~~~~-----~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 348 ---TFYNKIKSGYRMAKP-----D----HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ---HHHHHHhcCCCCCCC-----c----cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 111111111111110 1 1123567899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=335.89 Aligned_cols=253 Identities=17% Similarity=0.231 Sum_probs=201.8
Q ss_pred CCCCCCCeecccCCceEEEEEEc-C-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-D-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
..|.+.+.||+|+||.||++... + +..|++|.+..........+..|+.+++.++||||+++++++...+..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34888999999999999999653 3 567888877655555556778899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcc-cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 173 MPNKSLDSFIFDQ-ERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 173 ~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988643 22345889999999999999999999988 9999999999999999999999999998764333
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........ ..... ....
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~~~~---~~~~~-~~~~---- 292 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQV---LYGKY-DPFP---- 292 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH---HhCCC-CCCC----
Confidence 2223445679999999999999999999999999999999999999975321 11111111 11111 1110
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
... ...+.+++.+||+.+|++||++.+++.
T Consensus 293 -~~~----s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 -CPV----SSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -ccC----CHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111 124677889999999999999999875
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=318.00 Aligned_cols=199 Identities=26% Similarity=0.378 Sum_probs=173.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||.||++... ++..+++|.+... .......+.+|+.+++.++||||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999875 5778899988653 33445678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ +++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999987543 3788999999999999999999753 3999999999999999999999999998754221
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 301 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~ 301 (414)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12334688999999999999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=324.46 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=209.3
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe-eeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-KLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 170 (414)
++|..++++|+|+||.++..+. .++..+++|.+.- ..+...+....|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 6789999999999999999965 4578899999853 344455578899999999999999999999999888 99999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
+||+||++.+.+.+.+ ...+++..++.|+.|++.|+.|||+.. |+|||||+.|||++.++.|+|+|||+++.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998766 356999999999999999999999876 999999999999999999999999999987544
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
. .......||+.||.||++.+.+|+.|+|||||||++|||++-+++|... +...++..+.+....+.
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~---~m~~Li~ki~~~~~~Pl-------- 226 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS---NMSELILKINRGLYSPL-------- 226 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc---chHHHHHHHhhccCCCC--------
Confidence 3 2455678999999999999999999999999999999999999887532 22333333332221111
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
......++..++..|++.+|..||++.++|..-
T Consensus 227 -----p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 227 -----PSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred -----CccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 112233566788899999999999999999863
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=311.13 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=199.6
Q ss_pred CCCCCCCeecccCCceEEEEEEc----CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
++|++.+.||+|+||.||+|.+. .+..||+|.++.. .......+.+|+..++.++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999753 3568999998764 333456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++|+|.+++.... ..+++..++.++.|++.|++|||+++ ++||||||+||+++.++.++++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999987543 24889999999999999999999988 99999999999999999999999998765322
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
... .......++..|+|||.+.+..++.++|||||||++||+++ |..||..... ....... .........
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~~----~~~~~~~~~- 230 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKAV----EDGFRLPAP- 230 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHH----HCCCCCCCC-
Confidence 111 11112335678999999999999999999999999999875 9988753221 1111111 111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. ....+.+++.+||+.+|.+||++.++++.|+.
T Consensus 231 ----~~----~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 231 ----RN----CPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ----CC----CCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 11 12346778899999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=324.94 Aligned_cols=248 Identities=26% Similarity=0.370 Sum_probs=192.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|+..+.||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 46778899999999999999864 5899999998653 334456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++|+|.+.. ..++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||++..+....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986532 2566778899999999999999998 9999999999999999999999999998653221
Q ss_pred ccccccccccccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.......||..|+|||.+.. ...+.++|||||||++|||++|+.||............ .... ........
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~-~~~~~~~~ 297 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM---CAIC-MSQPPEAP 297 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---HHHh-ccCCCCCC
Confidence 12234568999999998743 23456899999999999999999998732222111111 1110 11111110
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.. ....+.+++.+||+.||++|||+.|+++.
T Consensus 298 -----~~----~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 298 -----AT----ASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -----Cc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 12356788999999999999999999974
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=307.85 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=200.3
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
++|++.+.||+|+||.||+++..++..+++|.+... ......+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 458888999999999999999888889999988643 2234678889999999999999999999999999999999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+|+|.+++..... .+++..+..++.|++.||.|||+++ ++||||+|+||++++++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 9999999865332 4889999999999999999999988 999999999999999999999999998765322211
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......... ..... .+ .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~~~~~~~i~~----~~~~~--~~---~ 224 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMISR----GFRLY--RP---K 224 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHC----CCCCC--CC---C
Confidence 1122235568999999998899999999999999999999 888864321 1112222111 11100 00 0
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
. ....+.+++.+||+.+|++||++.++++.|.
T Consensus 225 ~----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 L----ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred C----CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1 1235678999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=311.80 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=200.7
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 165 (414)
..++|++.+.||+|+||.||+|... .+..||+|.+... .......+.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999999753 2467999988643 22345578899999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEE
Q 043285 166 KLLIYEFMPNKSLDSFIFDQER-------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 238 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL 238 (414)
.++||||+++++|.+++..... ...+++..+..++.|+++|++|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 123678889999999999999999987 999999999999999999999
Q ss_pred EeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHH
Q 043285 239 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKL 317 (414)
Q Consensus 239 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 317 (414)
+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~~--- 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRFV--- 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---
Confidence 99999876543222222222345778999999999999999999999999999999 67776432211 111111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
.......... . ....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 235 -~~~~~~~~~~-----~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 -MEGGLLDKPD-----N----CPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -HcCCcCCCCC-----C----CCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111111111 1 1235678999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=314.97 Aligned_cols=241 Identities=26% Similarity=0.345 Sum_probs=187.9
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHh-cCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||+|+.. +++.||+|+++.. .....+.+..|..++.. .+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 4778999998752 22334455666666665 4899999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|..++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 99999886544 3889999999999999999999988 9999999999999999999999999997643221 22
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ....... .... .. +....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i----~~~~-~~-----~~~~~ 219 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSI----LNDR-PH-----FPRWI 219 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HcCC-CC-----CCCCC
Confidence 3345789999999999999999999999999999999999999754221 1111111 1111 00 11111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSMP-SVIL 366 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~ 366 (414)
...+.+++.+||+.+|++||++. ++++
T Consensus 220 ----~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 220 ----SKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ----CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 12456788899999999999876 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=312.03 Aligned_cols=259 Identities=28% Similarity=0.470 Sum_probs=205.1
Q ss_pred CCCCCCCeecccCCceEEEEEEc------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
++|.+.+.||+|+||.||++... ++..+++|.+..........+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888999999999999999742 245689999877666667789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhccc----------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEE
Q 043285 169 IYEFMPNKSLDSFIFDQE----------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 238 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL 238 (414)
||||+++++|.+++.... ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1234899999999999999999999988 999999999999999999999
Q ss_pred EeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHH
Q 043285 239 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKL 317 (414)
Q Consensus 239 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 317 (414)
+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||..... .......
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~~i--- 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECI--- 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---
Confidence 99999986543322222223345778999999999999999999999999999998 8888643221 1111111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 372 (414)
......... ... ...+.+++.+||+.+|.+|||+.++++.|++..
T Consensus 236 -~~~~~~~~~-----~~~----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 236 -TQGRVLQRP-----RTC----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred -HcCCcCCCC-----CCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111111111 111 124778999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=311.07 Aligned_cols=257 Identities=29% Similarity=0.444 Sum_probs=201.9
Q ss_pred CCCCCCCeecccCCceEEEEEE-----cCCCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-----VDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
++|++.+.||+|+||.||+|.. .++..|++|.+.. ........+.+|+.+++.++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 2457899999975 334445678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcccc--------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 043285 169 IYEFMPNKSLDSFIFDQER--------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 234 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~ 234 (414)
||||+++++|.+++..... ...+++..+..++.|++.||.|||+++ ++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853221 234788899999999999999999998 99999999999999999
Q ss_pred CeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHH
Q 043285 235 NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGH 313 (414)
Q Consensus 235 ~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~ 313 (414)
.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.... .......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Confidence 999999999986543322222333445678999999998899999999999999999998 887864321 1111111
Q ss_pred HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 314 AWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. ......... ... ...+.+++.+||+.+|++||++.++++.|..
T Consensus 239 ~----~~~~~~~~~-----~~~----~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 V----RKRQLLPCS-----EDC----PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----HcCCcCCCC-----CCC----CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 111111111 111 1346678899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=315.81 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=196.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999875 68899999987532 2233467789999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|++ ++|.+++.... ..++...+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 57777775432 23788899999999999999999998 9999999999999999999999999987542211
Q ss_pred CccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc------
Q 043285 252 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS------ 324 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 324 (414)
.......+++.|+|||++.+ ..++.++|||||||++|||++|..||..... ..................
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence 12233467899999998865 4688999999999999999999999864321 111111111111110000
Q ss_pred ---cccccccc--CcCCHH-------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 325 ---QLIDSCFQ--DSFNLA-------EVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 325 ---~~~~~~~~--~~~~~~-------~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
........ ...... ....+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000 000000 1134668899999999999999999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=317.93 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=199.7
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCC----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
.+|++.+.||+|+||.||+|++. ++. .||+|.++.. .....+.+.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56899999999999999999763 333 3899998753 344556888999999999999999999999764 5779
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999987643 23788999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
............++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... .. .............
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~~~~ 233 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI----SSILEKGERLPQP 233 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHhCCCCCCCC
Confidence 3322222222334678999999999999999999999999999998 88887532211 11 1111111111000
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 372 (414)
... ...+.+++.+||+.+|.+||++.+++..|....
T Consensus 234 -----~~~----~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 234 -----PIC----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred -----CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 124677899999999999999999999886553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=306.66 Aligned_cols=255 Identities=31% Similarity=0.448 Sum_probs=203.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.++|++.+.||+|++|.||+|...+++.|++|.++... ...+.+.+|+.++++++|||++++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46788899999999999999988778889999987532 33567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986644 234899999999999999999999988 999999999999999999999999999876422111
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......+..|+|||.+.+..++.++||||||+++|||++ |+.||.... ........ .........
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~----~~~~~~~~~----- 226 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQQV----DQGYRMPCP----- 226 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH----HcCCCCCCC-----
Confidence 1111223457999999999999999999999999999999 888864321 11111111 111110000
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
......+.+++.+||+.+|.+||++.++++.|++
T Consensus 227 ----~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 ----PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0112357789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=321.15 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=196.4
Q ss_pred CCCCCCeecccCCceEEEEEE----cCCCEEEEEEeccc----ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCee
Q 043285 96 NFSINKKLGQGGFGPVYKGKL----VDGQEIAVKRLSKI----SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 166 (414)
+|++.+.||+|+||.||+++. .++..||+|++.+. .....+.+..|+.+++.+ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999975 35789999998642 223345678899999999 599999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++||||+++|+|.+++..... +++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999875443 889999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.............. ..... ...
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~--~~~~~--~~~ 229 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR--RILKC--DPP 229 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH--HHhcC--CCC
Confidence 432211 122345789999999999875 478999999999999999999999864333222111111 11111 001
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILM 367 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 367 (414)
+.... ...+.+++.+||+.||++|| +++++++.
T Consensus 230 -----~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 230 -----FPSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -----CCCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11111 12456788899999999999 67788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=307.47 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=202.6
Q ss_pred CCCCCCCeecccCCceEEEEEEcC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
++|++.+.||+|+||.||+|.+.. ...|++|.++.. .......+.+|+.+++.++||||+++++++......+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578899999999999999998742 357999988753 344456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++..... .+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999865432 4899999999999999999999987 99999999999999999999999999987642
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
...........++..|+|||.+.+..++.++||||||+++|||++ |..||..... ........ ........
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~----~~~~~~~~- 230 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVE----DGYRLPPP- 230 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHH----cCCCCCCC-
Confidence 222222222345678999999999999999999999999999998 8888643221 11111111 11111000
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. .....+.+++.+||+.+|++||++.|+++.|..
T Consensus 231 ----~----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 231 ----M----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred ----C----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=321.53 Aligned_cols=242 Identities=22% Similarity=0.306 Sum_probs=193.9
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 176 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g 176 (414)
+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 5889999999752 2334567788999999999999999999999999999999999999
Q ss_pred ChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcccc
Q 043285 177 SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256 (414)
Q Consensus 177 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~ 256 (414)
+|..++.... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 152 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM 152 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence 9998886543 3889999999999999999999998 999999999999999999999999998753211 1122
Q ss_pred ccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCC
Q 043285 257 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFN 336 (414)
Q Consensus 257 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...... ...... . +....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~---~~~~~~--~-----~p~~~- 218 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFEL---ILMEDI--K-----FPRTL- 218 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHH---hccCCc--c-----CCCCC-
Confidence 345789999999999999999999999999999999999999853211 111111 111110 0 11111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043285 337 LAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILM 367 (414)
Q Consensus 337 ~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 367 (414)
...+.+++.+||+.||++|| ++.|+++.
T Consensus 219 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 ---SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 12466788899999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=317.75 Aligned_cols=239 Identities=23% Similarity=0.291 Sum_probs=190.7
Q ss_pred ecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCCh
Q 043285 103 LGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 178 (414)
Q Consensus 103 lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L 178 (414)
||+|+||.||+++.. ++..||+|++.+. .......+..|+.+++.++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 4788999998642 234456778899999999999999999999999999999999999999
Q ss_pred hHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcccccc
Q 043285 179 DSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258 (414)
Q Consensus 179 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~ 258 (414)
.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 152 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNT 152 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCcccc
Confidence 99987643 3889999999999999999999998 999999999999999999999999998753221 122334
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHH
Q 043285 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLA 338 (414)
Q Consensus 259 ~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (414)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ........... ..+ ....+
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~--~~~-----~~~~~-- 217 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEP--LRF-----PDGFD-- 217 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCC--CCC-----CCcCC--
Confidence 5789999999999999999999999999999999999999753211 11111111111 111 11111
Q ss_pred HHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 043285 339 EVIRCIHIGLLCVQQHPEDRPS---MPSVIL 366 (414)
Q Consensus 339 ~~~~~~~l~~~cl~~dP~~RPs---~~evl~ 366 (414)
..+.+++.+||+.||++||+ +.|++.
T Consensus 218 --~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 218 --RDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred --HHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 24667889999999999986 455554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=322.30 Aligned_cols=245 Identities=23% Similarity=0.305 Sum_probs=198.6
Q ss_pred CCCCCCCeecccCCceEEEEEEcC--CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD--GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
++|++.+.||+|+||.||+|...+ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 579999999999999999997543 368999998642 233456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++|+|.+++..... +++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKR---FPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999976543 889999999999999999999998 99999999999999999999999999986532
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... .... . .+
T Consensus 184 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~~i---~~~~-~-~~--- 247 (340)
T PTZ00426 184 -----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIYQKI---LEGI-I-YF--- 247 (340)
T ss_pred -----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---HHHHHHH---hcCC-C-CC---
Confidence 12345789999999999998999999999999999999999999753211 1111111 1111 0 00
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILM 367 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 367 (414)
....+ ..+.+++.+||+.||++|+ +++++++.
T Consensus 248 --p~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 --PKFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CCCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11111 2356788999999999995 89999875
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=320.58 Aligned_cols=245 Identities=25% Similarity=0.375 Sum_probs=191.6
Q ss_pred CCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHH---HhcCCCceeeeEeEEEeCCeeeEE
Q 043285 97 FSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILF---SKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
|++.+.||+|+||.||++... +++.||||++++. .....+.+..|..++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999764 5889999999752 223345566666655 566899999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|..++... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999887542 3899999999999999999999998 99999999999999999999999999875321
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.........|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ....... ..... ..
T Consensus 154 --~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~~~i---~~~~~--~~--- 220 (324)
T cd05589 154 --FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVFDSI---VNDEV--RY--- 220 (324)
T ss_pred --CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHHHHH---HhCCC--CC---
Confidence 11223345789999999999999999999999999999999999999753321 1111111 11110 00
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILM 367 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 367 (414)
.... ...+.+++.+||+.||.+|| ++.++++.
T Consensus 221 --p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 221 --PRFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --CCCC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1111 12456789999999999999 56677663
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.99 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=206.4
Q ss_pred CCCCCCCeecccCCceEEEEEEc------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+.+++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999742 345689999876655556788999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC
Q 043285 169 IYEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 235 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~ 235 (414)
||||+++++|.+++..... ...+++..++.++.|++.|++|||+++ ++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999965321 234789999999999999999999998 999999999999999999
Q ss_pred eEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHH
Q 043285 236 PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHA 314 (414)
Q Consensus 236 ~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 314 (414)
++|+|||++................++..|+|||.+.+..++.++|||||||++|||+| |+.||...... .....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH-
Confidence 99999999976543322222233456788999999999999999999999999999999 88886433211 11111
Q ss_pred HHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 315 WKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
........... .....+.+++.+||+.+|++|||+.+|+++|.+...
T Consensus 238 ---~~~~~~~~~~~---------~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ---ITQGRVLERPR---------VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---HhCCCCCCCCc---------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111111111 112356789999999999999999999999976643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=294.39 Aligned_cols=249 Identities=26% Similarity=0.359 Sum_probs=206.6
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
+.++|++++.||+|.||.||.|+.. ++--||+|++.+. ..+..+++.+|+++-..|+||||++++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3478999999999999999999764 5677999998652 33345688999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
++||.++|++...|..+.. ..+++.....+..|+|.|+.|+|..+ ++||||||+|+|++.++.+|++|||.+-.-
T Consensus 100 ilEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~- 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA- 174 (281)
T ss_pred EEEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec-
Confidence 9999999999999985543 34889999999999999999999987 999999999999999999999999998642
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
..+.....+||..|.+||...+..++...|+|++|++.||++.|.+||+....++ ....+.+ .+...+..+
T Consensus 175 ---p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tYkrI~k-~~~~~p~~i-- 245 (281)
T KOG0580|consen 175 ---PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TYKRIRK-VDLKFPSTI-- 245 (281)
T ss_pred ---CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HHHHHHH-ccccCCccc--
Confidence 2455667899999999999999999999999999999999999999987544222 2222211 111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...+.+++++|+..+|.+|.+..|++.
T Consensus 246 -----------s~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 246 -----------SGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -----------ChhHHHHHHHHhccCccccccHHHHhh
Confidence 124667899999999999999999985
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=319.76 Aligned_cols=242 Identities=22% Similarity=0.313 Sum_probs=193.0
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 176 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g 176 (414)
+.||+|+||.||+++.. +|..||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999764 5889999999752 2334456778999999999999999999999999999999999999
Q ss_pred ChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcccc
Q 043285 177 SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256 (414)
Q Consensus 177 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~ 256 (414)
+|..++.... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 9998886544 3889999999999999999999998 9999999999999999999999999987532211 122
Q ss_pred ccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCC
Q 043285 257 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFN 336 (414)
Q Consensus 257 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..... ...... . +....+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~---~~~~~~--~-----~p~~~~ 219 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFEL---ILMEEI--R-----FPRTLS 219 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH---HhcCCC--C-----CCCCCC
Confidence 3456899999999999999999999999999999999999997532211 11111 111110 0 111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043285 337 LAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILM 367 (414)
Q Consensus 337 ~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 367 (414)
..+.+++.+||+.||++|| ++.++++.
T Consensus 220 ----~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 220 ----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ----HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 2456788899999999998 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=305.34 Aligned_cols=260 Identities=23% Similarity=0.371 Sum_probs=205.0
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||+|+.. +++.|++|.+.. ........+.+|+.+++.++|||++++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999764 688999998754 23344557889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 171 EFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
||+++++|.+++.... ....++...+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886432 2234788999999999999999999988 99999999999999999999999999886532
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.. .......+++.|+|||.+.+..++.++||||||+++|||++|+.|+...... ....... ..........
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~----~~~~~~~~~~-- 229 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQK----IEQCDYPPLP-- 229 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHH----HhcCCCCCCC--
Confidence 22 1122346788999999999888999999999999999999999997432111 1111111 1111111110
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 372 (414)
.......+.+++.+||+.+|++||++.++++.|++..
T Consensus 230 ------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 230 ------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0112235778899999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.75 Aligned_cols=252 Identities=26% Similarity=0.331 Sum_probs=198.0
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.|++.+.||+|+||+||++... +++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999864 58899999986522 2223456789999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++|+|.+++..... ..+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999988865332 34899999999999999999999998 9999999999999999999999999987653221
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
......|++.|+|||.+.+..++.++||||+||++|||++|+.||....... ............ ....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~-~~~~----- 224 (285)
T cd05605 157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKED-QEEY----- 224 (285)
T ss_pred ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhc-cccc-----
Confidence 1223468999999999999999999999999999999999999986432211 111111111110 0000
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILM 367 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 367 (414)
... ....+.+++.+||+.||++|| ++.++++.
T Consensus 225 ~~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 SEK----FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred Ccc----cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011 123466789999999999999 88898764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=312.52 Aligned_cols=265 Identities=26% Similarity=0.397 Sum_probs=203.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-----------------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-----------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 155 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 155 (414)
.++|++.+.||+|+||.||++...+ +..|++|.+... .....+.+.+|+.+++.++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999987543 245899998753 3345678899999999999999999
Q ss_pred eEeEEEeCCeeeEEEeecCCCChhHHhhcccc--------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 043285 156 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQER--------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 227 (414)
Q Consensus 156 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~N 227 (414)
+++++......++++||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999865431 124899999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 043285 228 VLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS--GKKNRGFYHSD 305 (414)
Q Consensus 228 ill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt--g~~p~~~~~~~ 305 (414)
|++++++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999886543332222334456778999999998899999999999999999998 555553221
Q ss_pred CCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 306 NNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
...........+.......... . ......++.+++.+||+.||++|||+.|+++.|++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 -DQQVIENAGHFFRDDGRQIYLP-R-----PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -hHHHHHHHHhccccccccccCC-C-----ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1122222222111111111110 0 00112357789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.24 Aligned_cols=253 Identities=22% Similarity=0.293 Sum_probs=194.3
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.|++.+.||+|+||+||+|+.. +++.||+|++.+. .......+..|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999764 5789999999652 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987644 3888889999999999999999988 9999999999999999999999999976431100
Q ss_pred C---------------------------------------------ccccccccccccccccccccCCCCCcchhHHHHH
Q 043285 252 T---------------------------------------------EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFG 286 (414)
Q Consensus 252 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG 286 (414)
. ........||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001234699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHh--ccCCCCCCCCCHHHH
Q 043285 287 ILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLL--CVQQHPEDRPSMPSV 364 (414)
Q Consensus 287 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--cl~~dP~~RPs~~ev 364 (414)
|++|||++|+.||...... .... ..........+.. ....+ .++.+++.+ |+..+|..||++.|+
T Consensus 236 ~il~elltG~~Pf~~~~~~---~~~~---~i~~~~~~~~~~~---~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPT---ETQL---KVINWENTLHIPP---QVKLS----PEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHH---HHHH---HHHccccccCCCC---CCCCC----HHHHHHHHHHccCcccccCCCCHHHH
Confidence 9999999999998643211 1111 1111010001100 00111 234556655 556677779999999
Q ss_pred HHH
Q 043285 365 ILM 367 (414)
Q Consensus 365 l~~ 367 (414)
+..
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=312.32 Aligned_cols=263 Identities=24% Similarity=0.387 Sum_probs=199.5
Q ss_pred CCCCCCCeecccCCceEEEEEEcC---------------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD---------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLG 158 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~ 158 (414)
++|++.+.||+|+||.||+++..+ ...||+|.++.. .......+.+|+++++.++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999986532 224899998753 3344567899999999999999999999
Q ss_pred EEEeCCeeeEEEeecCCCChhHHhhccc---------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 043285 159 CCIQGEEKLLIYEFMPNKSLDSFIFDQE---------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 229 (414)
Q Consensus 159 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nil 229 (414)
++......++||||+++++|.+++.... ....+++..++.++.|++.|++|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999986432 1123688899999999999999999998 999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhC--CCCCCCCCCCCC
Q 043285 230 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG--KKNRGFYHSDNN 307 (414)
Q Consensus 230 l~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg--~~p~~~~~~~~~ 307 (414)
+++++.+||+|||++................++..|+|||.+.++.++.++|||||||++|+|+++ ..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 999999999999999765332222222233456789999999988999999999999999999984 445432211
Q ss_pred cchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 308 LNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
...+......+.......... .... ....+.+++.+||+.+|++|||+.+|++.|.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~--~~~~----~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLS--QTPL----CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhccccccCC--CCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 122222222111111100000 0001 1235778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.62 Aligned_cols=256 Identities=23% Similarity=0.300 Sum_probs=202.8
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 164 (414)
..++|.+.+.||+|+||+||+++. .+|+.||||++.. ........+.+|+..+..++|+|+++++..+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 457899999999999999999975 4689999999864 34455667889999999999999999988775432
Q ss_pred ---eeeEEEeecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEe
Q 043285 165 ---EKLLIYEFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 240 (414)
Q Consensus 165 ---~~~lv~ey~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~D 240 (414)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence 3679999999999999986532 2345889999999999999999999988 99999999999999999999999
Q ss_pred ecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhc
Q 043285 241 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE 320 (414)
Q Consensus 241 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....... ...
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~~~~~~---~~~- 259 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---MEEVMHK---TLA- 259 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHH---Hhc-
Confidence 999987644333333445679999999999999999999999999999999999999975321 1111111 111
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 321 GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.....+. ... ...+.+++.+||+.||.+||++.+++..
T Consensus 260 ~~~~~~~-----~~~----~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRYDPLP-----PSI----SPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCC-----CCC----CHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111111 111 2346778999999999999999999864
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=317.21 Aligned_cols=259 Identities=30% Similarity=0.450 Sum_probs=200.1
Q ss_pred cCCCCCCCeecccCCceEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC-C
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG-E 164 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~ 164 (414)
.++|++.+.||+|+||.||+|... .++.||+|++... .....+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 467999999999999999999642 2468999998753 233456778899999999 899999999988654 5
Q ss_pred eeeEEEeecCCCChhHHhhcccc---------------------------------------------------------
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQER--------------------------------------------------------- 187 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~--------------------------------------------------------- 187 (414)
..++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999864321
Q ss_pred -cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcccccccccccccc
Q 043285 188 -CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266 (414)
Q Consensus 188 -~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~ 266 (414)
...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++..+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125789999999999999999999988 9999999999999999999999999998764332222223345567899
Q ss_pred ccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHH
Q 043285 267 APEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIH 345 (414)
Q Consensus 267 aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (414)
|||.+.+..++.++|||||||++|||++ |..||...... +.. ............ .. ....++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~~~---~~~~~~~~~~~~-----~~----~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---EEF---CRRLKEGTRMRA-----PE----YATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---HHH---HHHHhccCCCCC-----Cc----cCCHHHHH
Confidence 9999999999999999999999999998 98887532211 111 111111111110 01 11235778
Q ss_pred HHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 346 IGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 346 l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
++.+||+.+|++||++.|+++.|+.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHH
Confidence 8999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=304.94 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=194.1
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCCh
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 178 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L 178 (414)
+.||+|+||.||+|+.. +++.|++|.+... .......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999864 6889999988653 344556789999999999999999999999999999999999999999
Q ss_pred hHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcccccc
Q 043285 179 DSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258 (414)
Q Consensus 179 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~ 258 (414)
.+++.... ..+++..++.++.|++.||.|||+.+ ++||||+|.||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99986432 24789999999999999999999988 99999999999999999999999999876432211111111
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCH
Q 043285 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNL 337 (414)
Q Consensus 259 ~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (414)
...+..|+|||.+.++.++.++|||||||++|||++ |..|+...... . .............. ..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~----~~~~~~~~~~~~~~-----~~--- 220 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---Q----TREAIEQGVRLPCP-----EL--- 220 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---H----HHHHHHcCCCCCCc-----cc---
Confidence 223457999999999999999999999999999998 77776432111 1 11111111111111 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 338 AEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 338 ~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
....+.+++.+||+.+|++|||+.+++++|+
T Consensus 221 -~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 -CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1235677999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=311.17 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=192.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc--CCCEEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCceeeeEeEEEe-----
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV--DGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQ----- 162 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~----- 162 (414)
++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46889999999999999999763 46789999886422 22234556677777665 69999999999852
Q ss_pred CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeec
Q 043285 163 GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 242 (414)
Q Consensus 163 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfg 242 (414)
....++||||++ ++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999996 589888865433 23889999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
++...... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.............
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~---~~~~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHHhCCCC
Confidence 99765322 223345689999999999989999999999999999999999999764322 122222211111000
Q ss_pred Cccc------cccccc--CcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 323 PSQL------IDSCFQ--DSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 323 ~~~~------~~~~~~--~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.... ....+. ..... .....+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 000000 00000 01134567999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=310.47 Aligned_cols=256 Identities=28% Similarity=0.435 Sum_probs=199.8
Q ss_pred CCCCCCeecccCCceEEEEEEcC------CCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVD------GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
+|.+.+.||+|+||.||+|+..+ +..||+|+++.... .....+..|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46777899999999999997632 46899999975432 334678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhccc-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC
Q 043285 169 IYEFMPNKSLDSFIFDQE-------------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 235 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~ 235 (414)
++||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||.||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1234788889999999999999999988 999999999999999999
Q ss_pred eEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHH
Q 043285 236 PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHA 314 (414)
Q Consensus 236 ~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 314 (414)
+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..|+..... ......
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~- 238 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIEM- 238 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH-
Confidence 99999999886543322222233445788999999988899999999999999999998 7777643211 111111
Q ss_pred HHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 315 WKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
..........+ . ....+.+++.+||+.+|.+||++++++..|+.
T Consensus 239 ---i~~~~~~~~~~-----~----~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 ---IRNRQVLPCPD-----D----CPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---HHcCCcCCCCC-----C----CCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111111 1 12246678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=293.16 Aligned_cols=265 Identities=22% Similarity=0.263 Sum_probs=207.6
Q ss_pred hcCCCCCCCeecccCCceEEEEE-EcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe-----e
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-----K 166 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~ 166 (414)
..++|.+.+.||+|||+-||+++ ..++..+|+|++.....++.+..++|++..++++|||+++++++...+.. .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999997 45688999999988777788899999999999999999999998765443 8
Q ss_pred eEEEeecCCCChhHHhhcccc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 167 LLIYEFMPNKSLDSFIFDQER-CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
|++++|...|+|.+.+..... ...+++.+++.|+.++++||.+||+.. +++.||||||.|||+++.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999976433 336999999999999999999999986 579999999999999999999999999987
Q ss_pred ccCCCCCcc-------ccccccccccccccccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH
Q 043285 246 AFGGDETEG-------NTNRVVGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 246 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 315 (414)
...-..... ....-..|..|.|||.+.-+ ..++++|||||||+||+|+.|..||+..-........
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL---- 253 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL---- 253 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE----
Confidence 642111100 01112468889999988654 5689999999999999999999998643221111000
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 316 KLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
....+.+.-..+......+.+++.+|++.||.+||++.+++..+.+.
T Consensus 254 ---------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 ---------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 00010111111111334678899999999999999999999988654
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=322.91 Aligned_cols=262 Identities=22% Similarity=0.345 Sum_probs=193.3
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----eee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 167 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 167 (414)
+|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999864 5889999998642 2234456889999999999999999999886433 479
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+||||++ ++|.+++.... .+++..+..++.|+++||.|||+++ ++||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888886544 3899999999999999999999998 999999999999999999999999999764
Q ss_pred CCCCC-ccccccccccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC---
Q 043285 248 GGDET-EGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG--- 321 (414)
Q Consensus 248 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 321 (414)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPE 230 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHH
Confidence 32211 112234568999999999876 678999999999999999999999985432111 000000000000
Q ss_pred --------CCccccccccc-CcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 322 --------MPSQLIDSCFQ-DSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 322 --------~~~~~~~~~~~-~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
........... ..... .....+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 00000 011245688999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=323.80 Aligned_cols=253 Identities=22% Similarity=0.294 Sum_probs=197.4
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||+||+++.. +++.||||++... .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999874 5889999999752 2334456788999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999987644 3899999999999999999999998 999999999999999999999999998754321
Q ss_pred CCcc------------------------------------ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh
Q 043285 251 ETEG------------------------------------NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294 (414)
Q Consensus 251 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt 294 (414)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 043285 295 GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS---MPSVILM 367 (414)
Q Consensus 295 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs---~~evl~~ 367 (414)
|..||..... ...... .........+.... .. ...+.+++.+|+. +|.+|++ +.|+++.
T Consensus 235 G~~Pf~~~~~---~~~~~~---i~~~~~~~~~~~~~---~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNP---QETYRK---IINWKETLQFPDEV---PL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCH---HHHHHH---HHcCCCccCCCCCC---CC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999853321 111111 11111111111100 11 1245567778886 9999998 8888874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=326.63 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=201.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|.+.+.||+|+||+||+|+.. +++.||+|++... .......+..|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999875 5889999999752 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999997653 4889999999999999999999988 999999999999999999999999999865432
Q ss_pred C---------------------------CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 043285 251 E---------------------------TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 303 (414)
Q Consensus 251 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~ 303 (414)
. .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012234568999999999999999999999999999999999999976432
Q ss_pred CCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHh
Q 043285 304 SDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS-MPSVILML 368 (414)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~~L 368 (414)
. ......... +.... .+.. .. . ....+.+++.+|++ +|.+||+ +.++++..
T Consensus 235 ~---~~~~~~i~~-~~~~~--~~p~--~~-~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 235 L---QETYNKIIN-WKESL--RFPP--DP-P----VSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred H---HHHHHHHhc-cCCcc--cCCC--CC-C----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 1 111111110 00110 0000 00 0 12346678889998 9999999 99999853
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=318.82 Aligned_cols=241 Identities=25% Similarity=0.336 Sum_probs=190.9
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 170 (414)
+|.+.+.||+|+||.||+|+.. ++..||+|++.+. .......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999865 4678999998752 223344567788888777 5899999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++..... +++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999998865443 889999999999999999999998 999999999999999999999999998753211
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .... .+
T Consensus 155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~---~~~~--~~---- 220 (323)
T cd05616 155 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIM---EHNV--AY---- 220 (323)
T ss_pred --CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHH---hCCC--CC----
Confidence 1122345689999999999999999999999999999999999999854321 11221111 1110 00
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 361 (414)
.... ...+.+++.+||+.+|++|++.
T Consensus 221 -p~~~----s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 -PKSM----SKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCcC----CHHHHHHHHHHcccCHHhcCCC
Confidence 1111 2346778999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=305.22 Aligned_cols=254 Identities=28% Similarity=0.445 Sum_probs=201.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.+|.+.+.||+|+||.||+|... .++.|++|.+... ......+.+|+.+++.++|+||+++++++......+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778899999999999999764 4788999998753 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++..... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99999999865432 34889999999999999999999987 999999999999999999999999999875432211
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
......++..|+|||.+.+..++.++|||||||++|||++ |..|+.... ..... ............
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~---~~~~~----~~~~~~~~~~~~----- 227 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVY----ELLEKGYRMERP----- 227 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHH----HHHHCCCCCCCC-----
Confidence 1112234568999999999999999999999999999998 888864321 11111 111111111111
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... ...+.+++.+||+.+|++|||+.++++.|++
T Consensus 228 ~~~----~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 228 EGC----PPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCC----CHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 111 2356778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=321.46 Aligned_cols=192 Identities=21% Similarity=0.306 Sum_probs=166.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
..+|++.+.||+|+||.||++... .++.||+|.... ..+.+|+.+++.++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999764 578899996532 3467899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+. ++|..++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 165 ~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~ 236 (391)
T PHA03212 165 YK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N 236 (391)
T ss_pred CC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence 95 68888876543 3889999999999999999999998 999999999999999999999999998753221 1
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNR 299 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~ 299 (414)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 12223457999999999999999999999999999999999999775
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=308.98 Aligned_cols=256 Identities=30% Similarity=0.453 Sum_probs=200.0
Q ss_pred CCCCCCeecccCCceEEEEEEc------CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
+|++.+.||+|+||.||+|... ....+++|.+.... ......+..|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999753 23468888886533 3345678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhccc---------------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 043285 169 IYEFMPNKSLDSFIFDQE---------------------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 227 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~N 227 (414)
++||+++++|.+++.... ....+++..++.++.|++.|+.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 1134788999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 043285 228 VLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDN 306 (414)
Q Consensus 228 ill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~ 306 (414)
|++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999986533222222223345678999999988899999999999999999998 8888743221
Q ss_pred CcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 307 NLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
..+. ........... .... ...+.+++.+||+.+|++||++.|+++.|++
T Consensus 236 -~~~~----~~~~~~~~~~~-----~~~~----~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 236 -ERLF----NLLKTGYRMER-----PENC----SEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred -HHHH----HHHhCCCCCCC-----CCCC----CHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1111 11111111111 0111 2357788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=307.63 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=202.2
Q ss_pred CCCCCCCeecccCCceEEEEEEc------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
++|.+.+.||+|+||.||++... ++..+++|.+..........+.+|+.+++.++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56788899999999999999642 355789999887666667789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcccc------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCe
Q 043285 169 IYEFMPNKSLDSFIFDQER------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 236 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~ 236 (414)
+|||+++++|.+++..... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 124788999999999999999999988 9999999999999999999
Q ss_pred EEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043285 237 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 237 kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 315 (414)
||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ........
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~ 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIECIT 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHHHHH
Confidence 9999999876533222222223345678999999999999999999999999999998 8888643211 11111111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 316 KLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
......... .. ...+.+++.+||+.||.+||++.+|++.|+
T Consensus 239 ----~~~~~~~~~-----~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 ----QGRELERPR-----TC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----cCccCCCCC-----CC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111111 11 124668899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=304.55 Aligned_cols=255 Identities=26% Similarity=0.439 Sum_probs=195.4
Q ss_pred CCCCCeecccCCceEEEEEEcCCC---EEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------Ce
Q 043285 97 FSINKKLGQGGFGPVYKGKLVDGQ---EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EE 165 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 165 (414)
|.+.+.||+|+||.||+|+..++. .||+|.++.. .....+.+..|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356789999999999999875432 5899988652 344567788999999999999999999987532 24
Q ss_pred eeEEEeecCCCChhHHhhccc---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeec
Q 043285 166 KLLIYEFMPNKSLDSFIFDQE---RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 242 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfg 242 (414)
.++++||+++|+|.+++.... ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874321 2234889999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcC
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEG 321 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
++................+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... ...... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~----~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NSEIYD----YLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH----HHHcC
Confidence 9987543222112223346778999999999999999999999999999999 777764321 111111 11111
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
....... . ....+.+++.+||+.+|++|||+.++++.|+.
T Consensus 231 ~~~~~~~-----~----~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLKQPP-----D----CLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCCCCC-----C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1111111 1 12246789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=303.54 Aligned_cols=252 Identities=27% Similarity=0.429 Sum_probs=200.3
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
++|++.+.||+|+||.||+|+..++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688889999999999999988777789999886532 234678899999999999999999999999989999999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+|+|.+++..... .+++..++.++.|++.|++|||+.+ ++|+||+|.||+++.++.+||+|||++........ .
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 9999999865432 4899999999999999999999988 99999999999999999999999999876533221 1
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....... ........ .
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~-----~ 224 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKVS----QGLRLYRP-----H 224 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHh----cCCCCCCC-----C
Confidence 1112235678999999998899999999999999999998 88887533211 1111111 11111000 0
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
. ....+.+++.+||+.+|.+||++.++++.|+
T Consensus 225 ~----~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 L----ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred C----CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1 1245678999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=304.18 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=198.3
Q ss_pred CCCCCeecccCCceEEEEEEcC----CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe-----
Q 043285 97 FSINKKLGQGGFGPVYKGKLVD----GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 165 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 165 (414)
|.+.+.||+|+||.||+|.... +..||+|.++.. .......+..|+..++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999997643 367999998742 33445678999999999999999999999876554
Q ss_pred -eeEEEeecCCCChhHHhhccc---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEee
Q 043285 166 -KLLIYEFMPNKSLDSFIFDQE---RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 241 (414)
Q Consensus 166 -~~lv~ey~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Df 241 (414)
.++++||+++|+|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999985432 2235889999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhc
Q 043285 242 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNE 320 (414)
Q Consensus 242 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.... ......... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~~~~~----~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIYDYLR----H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----c
Confidence 99987643332222222345678999999998899999999999999999999 777764322 111111111 1
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 321 GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
........ . ....+.+++.+||+.||++|||+.|+++.|++
T Consensus 231 ~~~~~~~~-----~----~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 GNRLKQPE-----D----CLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCCCCCCc-----C----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11111111 1 12357788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=306.03 Aligned_cols=246 Identities=23% Similarity=0.414 Sum_probs=206.4
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.+|++.+.||+|.||+|-+++. ..|+.||||.+++ .++++.-.+.+|+++|..|+||||+.++.+|++.+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 5788899999999999999964 6799999999976 35566678899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||..+|.|++++.+... +++.+..+++.||..|+.|+|.++ ++|||||.+|||+|.++++||+|||++-++.
T Consensus 133 EYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~-- 204 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA-- 204 (668)
T ss_pred EecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc--
Confidence 99999999999987665 999999999999999999999987 9999999999999999999999999998753
Q ss_pred CCccccccccccccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
......++||++-|.+||++.+.+| ++..|-|||||+||.|+.|..||.... ...++ .++.+..
T Consensus 205 -~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lv---rQIs~Ga-------- 269 (668)
T KOG0611|consen 205 -DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLV---RQISRGA-------- 269 (668)
T ss_pred -cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHH---HHhhccc--------
Confidence 2334567899999999999999998 689999999999999999999985431 11222 2221111
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
+.+.. ...+..-|+.|||..+|++|.|+.++...
T Consensus 270 -YrEP~---~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 270 -YREPE---TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -ccCCC---CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 11111 11123447889999999999999999874
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=321.95 Aligned_cols=201 Identities=26% Similarity=0.375 Sum_probs=173.7
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||+||+++.. +++.||+|++.+. .......+..|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999764 5889999999752 2234456788999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997644 3899999999999999999999998 999999999999999999999999998754321
Q ss_pred CCc---------------------------------cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 043285 251 ETE---------------------------------GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 297 (414)
Q Consensus 251 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~ 297 (414)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123479999999999999999999999999999999999999
Q ss_pred CCCC
Q 043285 298 NRGF 301 (414)
Q Consensus 298 p~~~ 301 (414)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=317.17 Aligned_cols=242 Identities=25% Similarity=0.330 Sum_probs=192.2
Q ss_pred CeecccCCceEEEEEE----cCCCEEEEEEeccc----ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 101 KKLGQGGFGPVYKGKL----VDGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+.||+|+||.||+++. ..++.||+|++++. .......+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 35788999998752 222345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++.... .+.+..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 153 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-- 153 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC--
Confidence 99999999986543 3788888899999999999999998 999999999999999999999999998753221
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
........|++.|+|||++.+..++.++|||||||++|||++|+.||..... . ........... .+ .
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~---~---~~~~~~~~~~~--~~-----~ 220 (323)
T cd05584 154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR---K---KTIDKILKGKL--NL-----P 220 (323)
T ss_pred CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH---H---HHHHHHHcCCC--CC-----C
Confidence 1222345789999999999998999999999999999999999999754221 1 11111111110 11 1
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILM 367 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 367 (414)
... ...+.+++.+||+.+|++|| ++.++++.
T Consensus 221 ~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 221 PYL----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCC----CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111 12466789999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=308.86 Aligned_cols=265 Identities=24% Similarity=0.392 Sum_probs=200.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-----------------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-----------------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 155 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 155 (414)
.++|++.+.||+|+||.||+++.. ++..||+|.+... .......+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998532 2346899998753 3344568899999999999999999
Q ss_pred eEeEEEeCCeeeEEEeecCCCChhHHhhcccc--------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 043285 156 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQER--------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 227 (414)
Q Consensus 156 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~N 227 (414)
+++++......++||||+++++|.+++..... ...+++..+..++.|++.|++|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999865321 124778889999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 043285 228 VLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS--GKKNRGFYHSD 305 (414)
Q Consensus 228 ill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt--g~~p~~~~~~~ 305 (414)
|+++.++.++|+|||++..+.............++..|+|||...++.++.++|||||||++|||++ |..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 9999999999999999886533222222222344678999999888899999999999999999998 5566543221
Q ss_pred CCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 306 NNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.................... +.. .. ....+.+++.+||+.||.+||++.+|++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~-~~~-~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 --EQVIENTGEFFRDQGRQVYL-PKP-AL----CPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHHHHHHHhhccccccC-CCC-CC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11121111111111110000 000 01 11356789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=310.13 Aligned_cols=267 Identities=28% Similarity=0.366 Sum_probs=197.3
Q ss_pred CCCCCeecccCCceEEEEEE-----cCCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeeE
Q 043285 97 FSINKKLGQGGFGPVYKGKL-----VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 168 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 168 (414)
|++.+.||+|+||+||++.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988643 357789999987533 33456788999999999999999999998764 35789
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
+|||+++++|.+++... .+++..++.++.|++.|+.|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999998653 2899999999999999999999998 9999999999999999999999999988654
Q ss_pred CCCCcc-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 249 GDETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 249 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+........ ...................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhh
Confidence 322111 11223456679999999988999999999999999999999988754322110 0000000000000000000
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
+..............+.+++.+||+.+|++|||+++++++|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 00000000111224677899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=320.78 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=198.1
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|.+.+.||+|+||.||+++.. +|+.||+|+++.. .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999764 5889999999752 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999997642 24889999999999999999999998 999999999999999999999999999875432
Q ss_pred CCcccccccccccccccccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYAS------DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ... ..........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~---~~i~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---KTY---NNIMNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH---HHH---HHHHcCCCcc
Confidence 211 222346899999999986 456789999999999999999999997532211 111 1111111111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.+.. . ......+.+++..||+ +|.+|||+++++..
T Consensus 229 ~~~~-----~--~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 KFPE-----D--PKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCC-----C--CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1111 0 0112346678888998 99999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=304.94 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=197.3
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCC----EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
++|++.+.||+|+||.||+|.+. ++. .+++|.+.... .....++..|+..++.++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 56888899999999999999864 344 47777775432 234467788888999999999999999885 456789
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999997543 24899999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
............++..|+|||.+.++.++.++|||||||++|||++ |..||...... .. .............
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~~~~ 233 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EV----PDLLEKGERLAQP 233 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHHCCCcCCCC
Confidence 3322222333456778999999999999999999999999999998 88887532211 11 1111111111110
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 372 (414)
. .. ...+.+++.+||..+|++|||+.|+++.|....
T Consensus 234 ~-----~~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 234 Q-----IC----TIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred C-----CC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 0 11 124567888999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=307.04 Aligned_cols=259 Identities=26% Similarity=0.409 Sum_probs=203.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe-CCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 166 (414)
.++|++.+.||+|+||.||+|...+ +..|++|.+... .......+.+|+.+++.++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678999999999999999998755 678999988753 34456778899999999999999999998876 4678
Q ss_pred eEEEeecCCCChhHHhhccccc-----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEee
Q 043285 167 LLIYEFMPNKSLDSFIFDQERC-----MILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 241 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Df 241 (414)
++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654322 45899999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhc
Q 043285 242 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNE 320 (414)
Q Consensus 242 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
|+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |+.||.... ....... ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~----~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID---PFEMAAY----LKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC---HHHHHHH----HHc
Confidence 99986533222212222345678999999998899999999999999999999 998875321 1111111 111
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 321 GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
........ . ....+.+++.+||+.+|++|||+.++++.|++.
T Consensus 235 ~~~~~~~~-----~----~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 GYRLAQPI-----N----CPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCCCCCCC-----c----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11110000 1 123567899999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.00 Aligned_cols=254 Identities=22% Similarity=0.278 Sum_probs=195.1
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|.+.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999764 6889999998652 2334567888999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999987543 3788899999999999999999998 999999999999999999999999998633110
Q ss_pred CC------------cc---------------------------------ccccccccccccccccccCCCCCcchhHHHH
Q 043285 251 ET------------EG---------------------------------NTNRVVGTYGYMAPEYASDGQFSVKSDVFSF 285 (414)
Q Consensus 251 ~~------------~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwsl 285 (414)
.. .. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 00 0012468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCC---CCHH
Q 043285 286 GILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDR---PSMP 362 (414)
Q Consensus 286 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R---Ps~~ 362 (414)
||++|||++|..||..... ....... ........+.+. ... ...+.+++.+|++ +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~---~~~~~~i---~~~~~~~~~p~~---~~~----s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS---HETYRKI---INWRETLYFPDD---IHL----SVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCH---HHHHHHH---HccCCccCCCCC---CCC----CHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999854221 1111111 110100011110 011 1245678889997 66665 5999
Q ss_pred HHHHHh
Q 043285 363 SVILML 368 (414)
Q Consensus 363 evl~~L 368 (414)
|++..-
T Consensus 301 ~~l~hp 306 (377)
T cd05629 301 EIKSHP 306 (377)
T ss_pred HHhcCC
Confidence 998853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=305.36 Aligned_cols=257 Identities=29% Similarity=0.451 Sum_probs=199.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC------CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
.++|.+.+.||+|+||.||+|...+ +..|++|.+.... ......+..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678899999999999999998743 5678999886533 33445788999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---CeEEE
Q 043285 167 LLIYEFMPNKSLDSFIFDQER----CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS 239 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kL~ 239 (414)
++||||+++++|.+++..... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865432 124889999999999999999999998 99999999999998654 59999
Q ss_pred eecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHh
Q 043285 240 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 240 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||...... ..... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~----~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEF----V 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----H
Confidence 9999987633222222222234568999999999999999999999999999997 88887532211 11111 1
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
........ .... ...+.+++.+||+.+|++|||+.+|++.|.
T Consensus 235 ~~~~~~~~-----~~~~----~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGRLDP-----PKGC----PGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCcCCC-----CCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111111 0111 235677899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=305.63 Aligned_cols=247 Identities=26% Similarity=0.344 Sum_probs=191.7
Q ss_pred ecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCCh
Q 043285 103 LGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 178 (414)
Q Consensus 103 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L 178 (414)
||+|+||.||+++.. +|+.||+|.+.... ......+..|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999764 58999999986421 12234556799999999999999999999999999999999999999
Q ss_pred hHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcccccc
Q 043285 179 DSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258 (414)
Q Consensus 179 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~ 258 (414)
.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 988865432 23889999999999999999999988 9999999999999999999999999987653221 1223
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHH
Q 043285 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLA 338 (414)
Q Consensus 259 ~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (414)
..|+..|+|||++.+..++.++|||||||++|||++|+.||......... ............. ... ..+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~--~~~----~~~--- 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLEDEVK--FEH----QNF--- 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhccccc--ccc----ccC---
Confidence 46889999999999989999999999999999999999997643221111 1111111111100 000 111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 339 EVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 339 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
...+.+++.+||+.||++||+++|+++.+
T Consensus 223 -~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 -TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred -CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 22467899999999999999998776544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=310.41 Aligned_cols=259 Identities=30% Similarity=0.434 Sum_probs=202.6
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcC------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 164 (414)
..++|++.+.||+|+||.||++...+ ...+++|.+... .......+.+|+.+++.+ +|+||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34678889999999999999997642 357899988753 334456788999999999 7999999999999999
Q ss_pred eeeEEEeecCCCChhHHhhcc-------------cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQ-------------ERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 231 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~ 231 (414)
..+++|||+++|+|.+++... .....+++..++.++.|++.|++|||+.+ ++||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998642 12245889999999999999999999988 99999999999999
Q ss_pred CCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcch
Q 043285 232 QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNL 310 (414)
Q Consensus 232 ~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~ 310 (414)
.++.+||+|||++..+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ...
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~ 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EEL 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---HHH
Confidence 999999999999987643322222222334678999999999999999999999999999998 8887643211 111
Q ss_pred HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 311 IGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. ........... ......+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 244 ~~----~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 244 FK----LLKEGYRMEKP---------QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred HH----HHHcCCcCCCC---------CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 11 11111111110 0112357789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=301.98 Aligned_cols=252 Identities=28% Similarity=0.443 Sum_probs=199.2
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
.+|++.+.||+|+||.||++...++..+++|.+.+.. .....+.+|+.+++.++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4578889999999999999988777789999886422 233567889999999999999999999999999999999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+++|.+++..... .+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 83 NGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 9999999865432 4899999999999999999999998 999999999999999999999999998765322111
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... ......... .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~~~~~-----~ 224 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVESV----SAGYRLYRP-----K 224 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHH----HcCCcCCCC-----C
Confidence 1111223457999999999999999999999999999999 78887533211 111111 111111110 0
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
. ....+.+++.+||+.+|++|||+.|+++.|.
T Consensus 225 ~----~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 225 L----APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred C----CCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1 1235778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=314.62 Aligned_cols=248 Identities=21% Similarity=0.336 Sum_probs=193.6
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||+++.. +++.||+|++++. .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 5889999999752 233445678899999888 799999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..... ....
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~ 152 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDT 152 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc--CCCc
Confidence 99998886543 3899999999999999999999998 99999999999999999999999999874211 1122
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC--CcchHHHHHHHhhcCCCcccccccccC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN--NLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ................. .+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-RI-----PR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-CC-----CC
Confidence 334578999999999999999999999999999999999999986432221 11111111111111111 11 11
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPS------MPSVIL 366 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs------~~evl~ 366 (414)
..+ ..+.+++.+||+.||.+||+ +.++++
T Consensus 227 ~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 SLS----VKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCC----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111 24667889999999999997 677765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=324.42 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=194.2
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.+|++.+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999864 5889999998652 1233456789999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++.... .++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999996543 3788888999999999999999998 999999999999999999999999997532100
Q ss_pred C-----------------------------------------CccccccccccccccccccccCCCCCcchhHHHHHHHH
Q 043285 251 E-----------------------------------------TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 289 (414)
Q Consensus 251 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil 289 (414)
. .........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00001134699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCC---CHHHHHH
Q 043285 290 LEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRP---SMPSVIL 366 (414)
Q Consensus 290 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP---s~~evl~ 366 (414)
|||++|+.||...... ...... ........+.. ....+ ..+.+++.+|+ .+|.+|+ |+.|+++
T Consensus 235 yell~G~~Pf~~~~~~---~~~~~i---~~~~~~~~~~~---~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPA---ETQLKV---INWETTLHIPS---QAKLS----REASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHH---HHHHHH---hccCccccCCC---CCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999998643221 111111 11000000000 01111 23455666766 4999999 8899987
Q ss_pred H
Q 043285 367 M 367 (414)
Q Consensus 367 ~ 367 (414)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=310.17 Aligned_cols=263 Identities=26% Similarity=0.421 Sum_probs=199.9
Q ss_pred cCCCCCCCeecccCCceEEEEEE-----cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Cee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 166 (414)
..+|++.+.||+|+||.||++.. .++..|++|.+........+.+.+|+.+++.++||||+++++++... ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 35788899999999999999974 24788999999876666677899999999999999999999987543 467
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 89999999999999986532 24889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcc-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC---------cchHHHHHH
Q 043285 247 FGGDETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN---------LNLIGHAWK 316 (414)
Q Consensus 247 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~---------~~~~~~~~~ 316 (414)
........ ......++..|+|||.+.+..++.++|||||||++|||++|..++........ .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 64322111 11112234569999999999999999999999999999998766432211100 000000001
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 317 LWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.......... ... ....+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 238 ~~~~~~~~~~-----~~~----~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 238 LLKNNGRLPA-----PPG----CPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HHhcCCcCCC-----CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 1111100000 011 12357789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=306.26 Aligned_cols=246 Identities=26% Similarity=0.349 Sum_probs=191.6
Q ss_pred ecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCCh
Q 043285 103 LGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 178 (414)
Q Consensus 103 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L 178 (414)
||+|+||+||++... +++.||+|.+.... ....+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999764 58899999986522 22345677899999999999999999999999999999999999999
Q ss_pred hHHhhcc-cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccc
Q 043285 179 DSFIFDQ-ERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 257 (414)
Q Consensus 179 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~ 257 (414)
..++... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..+.... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 9887542 22345899999999999999999999998 9999999999999999999999999987653222 1223
Q ss_pred cccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCH
Q 043285 258 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNL 337 (414)
Q Consensus 258 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (414)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ........... ...+ ...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~--~~~~-----~~~--- 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILND--SVTY-----PDK--- 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhccc--CCCC-----ccc---
Confidence 45689999999999999999999999999999999999999754322111 00111111100 0000 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 043285 338 AEVIRCIHIGLLCVQQHPEDRP-----SMPSVIL 366 (414)
Q Consensus 338 ~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~ 366 (414)
....+.+++.+||+.||++|| ++.++++
T Consensus 224 -~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 -FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred -CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 123466788999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=301.47 Aligned_cols=254 Identities=30% Similarity=0.461 Sum_probs=200.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.++|++.+.||+|+||.||++...++..+++|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 357889999999999999999888888999999875322 3457889999999999999999999885 45689999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++..... ..+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999999875432 34789999999999999999999988 999999999999999999999999999865332211
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
......++..|+|||.+.+..++.++||||||+++|||++ |..||.... ......... ........
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~----~~~~~~~~----- 225 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQVE----RGYRMPCP----- 225 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHH----cCCCCCCC-----
Confidence 1112234567999999988899999999999999999999 888875321 111111111 11111110
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. .....+.+++.+||+.+|++|||+.++++.|++
T Consensus 226 ~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 Q----DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred C----cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1 112357789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=305.26 Aligned_cols=257 Identities=26% Similarity=0.442 Sum_probs=203.1
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
.++|.+.+.||+|+||.||+|...+ +..|++|.+... .......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3678889999999999999997642 367999998653 334456788999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEE
Q 043285 167 LLIYEFMPNKSLDSFIFDQER-------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 239 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~ 239 (414)
++||||+++|+|.+++..... ...+++..++.++.|++.|+.|||+.+ ++||||+|+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999865321 224788899999999999999999988 9999999999999999999999
Q ss_pred eecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHh
Q 043285 240 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 240 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||..... .......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~---- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFV---- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHH----
Confidence 9999886543332222233456788999999998899999999999999999998 8888643211 1111111
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
.......... .. ...+.+++.+||+.+|++|||+.+++..|+
T Consensus 235 ~~~~~~~~~~-----~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGGHLDLPE-----NC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCCCCCCCC-----CC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111111111 11 235778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=314.06 Aligned_cols=248 Identities=22% Similarity=0.343 Sum_probs=191.9
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||+++.. +++.||+|++++. .......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999864 5788999999752 233445677888888776 799999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|..++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~ 152 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDT 152 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCc
Confidence 99998886544 3899999999999999999999998 999999999999999999999999998753211 122
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC--cchHHHHHHHhhcCCCcccccccccC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN--LNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ................ .+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~-----p~ 226 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RI-----PR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-CC-----CC
Confidence 2345789999999999999999999999999999999999999853222111 1111111111111111 11 11
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSM------PSVIL 366 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~evl~ 366 (414)
.. ...+.+++.+||+.||++||++ .++++
T Consensus 227 ~~----~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 227 SL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CC----CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 11 1246678899999999999984 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=315.72 Aligned_cols=242 Identities=22% Similarity=0.333 Sum_probs=192.1
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||+|+.. +++.||+|++.+. .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 4789999998752 233445677888888866 799999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|..++..... +++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQRSRK---FDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 999998865443 889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ...... .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~~~i---~~~~~~-------~p~~~ 219 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFESI---LHDDVL-------YPVWL 219 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHHHHH---HcCCCC-------CCCCC
Confidence 2345689999999999999999999999999999999999999854321 1111111 111110 00111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRP-------SMPSVILM 367 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RP-------s~~evl~~ 367 (414)
...+.+++.+||+.||++|| ++.++++.
T Consensus 220 ----~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 220 ----SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ----CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 12466788999999999999 88888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=305.05 Aligned_cols=255 Identities=22% Similarity=0.372 Sum_probs=199.6
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|++.+.||+|+||.||+|+. .++..|++|++..........+.+|+.+++.++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 36799999999999999999986 46788999998754444556788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++.... .+++..+..++.|+++|+.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 99999999886543 3889999999999999999999987 9999999999999999999999999998653211
Q ss_pred cccccccccccccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.......++..|+|||.+. ...++.++|||||||++|||++|+.|+.......... ........ .+
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~----~~ 229 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMSKSNFQ----PP 229 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eeecCCCC----CC
Confidence 1223346788999999874 3457889999999999999999999864322111000 00000000 00
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
..... ......+.+++.+||+.+|++|||++++++.|
T Consensus 230 ~~~~~--~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKDK--TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCccc--cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000 01123567899999999999999999999765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=302.28 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=197.7
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|++.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999975 46889999998653 334456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|..+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999987542 2678888999999999999999998 999999999999999999999999999765322
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||............................ .
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 222 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP----V 222 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCC----C
Confidence 2233568899999999999999999999999999999999999986433222111111111111111111111 1
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
... ..++.+++.+||+.+|++||++.|+++.
T Consensus 223 ~~~----~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQF----SEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcC----CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111 1246788999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=310.22 Aligned_cols=260 Identities=29% Similarity=0.419 Sum_probs=201.4
Q ss_pred CCCCCCCeecccCCceEEEEEEcC--------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 164 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 164 (414)
.+|++.+.||+|+||.||+++... +..|++|.+... .....+.+.+|+.+++++ +||||++++++|....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 568999999999999999996421 236899988753 344567889999999999 7999999999999999
Q ss_pred eeeEEEeecCCCChhHHhhccc-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQE-------------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 231 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~ 231 (414)
..++++||+++|+|.+++.... ....+++..+..++.|++.||+|||+++ ++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 1224788899999999999999999988 99999999999999
Q ss_pred CCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcch
Q 043285 232 QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNL 310 (414)
Q Consensus 232 ~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~ 310 (414)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.... ....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~ 245 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---VEEL 245 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHH
Confidence 999999999999986543222222222334567999999999999999999999999999998 777764321 1111
Q ss_pred HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 311 IGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
.............. . ....+.+++.+||+.+|.+|||+.|+++.|.....
T Consensus 246 ----~~~~~~~~~~~~~~-----~----~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 246 ----FKLLKEGHRMDKPA-----N----CTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ----HHHHHcCCCCCCCC-----C----CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11111111111111 1 12356678999999999999999999999965543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=306.33 Aligned_cols=257 Identities=27% Similarity=0.410 Sum_probs=196.7
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccC---------h-----hhHHHHHHHHHHHHhcCCCceeeeEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKIS---------E-----QGLKELKNEVILFSKLQHRNLVKLLG 158 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~-----~~~~~~~~E~~~l~~l~h~niv~~~~ 158 (414)
.++|++.+.||+|.||.|-+|+. .+++.||||++.+.. . ...+...+|+.+|+++.|||||+++.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 47899999999999999999986 468999999996521 0 12357889999999999999999999
Q ss_pred EEEeC--CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCe
Q 043285 159 CCIQG--EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 236 (414)
Q Consensus 159 ~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~ 236 (414)
+..+. +.+|||+|||..|.+... ......++..+.++++.++..||+|||.++ |+||||||.|+||+++|++
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcE
Confidence 98765 478999999998876542 222233899999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccCCCCC---ccccccccccccccccccccCCC---C-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 043285 237 KISDFGLARAFGGDET---EGNTNRVVGTYGYMAPEYASDGQ---F-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLN 309 (414)
Q Consensus 237 kL~Dfgl~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~---~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~ 309 (414)
||+|||.+........ ........|||.|+|||...++. + +.+.||||+||+||.|+.|+.||-. +....
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~~~~~ 326 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---DFELE 326 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---chHHH
Confidence 9999999986632211 11223468999999999887642 2 5688999999999999999999742 11122
Q ss_pred hHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 310 LIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
+. .++.+.... +.. . .+.-..+.+|++++|++||+.|.+..+|....--.
T Consensus 327 l~---~KIvn~pL~--fP~-----~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 327 LF---DKIVNDPLE--FPE-----N--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred HH---HHHhcCccc--CCC-----c--ccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 22 222222211 111 0 11223456789999999999999999998766333
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=300.56 Aligned_cols=256 Identities=31% Similarity=0.474 Sum_probs=204.1
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
..++|.+.+.||+|+||.||++...++..|++|.+.... ...+.+.+|+.+++.++|+|++++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346899999999999999999998788899999987532 3446789999999999999999999999988899999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++..... ..+++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 83 ~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999976432 34899999999999999999999998 99999999999999999999999999886543211
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ......... ........
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~~----~~~~~~~~---- 226 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQVE----RGYRMPRP---- 226 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----cCCCCCCC----
Confidence 11112234568999999998899999999999999999999 888874321 111111111 11110000
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... ...+.+++.+||+.+|++||+++++.+.|++
T Consensus 227 -~~~----~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 -PNC----PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCC----CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011 2356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=308.56 Aligned_cols=248 Identities=22% Similarity=0.358 Sum_probs=193.7
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||+++.. +++.||+|++++. .....+.+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999864 5788999999752 233456678899998888 699999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|..++.... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~ 152 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDT 152 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCc
Confidence 99998886543 3899999999999999999999998 99999999999999999999999999875321 1122
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....................... ..+ ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~-----p~~~ 226 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-IRI-----PRFL 226 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-CCC-----CCCC
Confidence 3345789999999999999999999999999999999999999864333222222222222211111 111 1111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSM------PSVIL 366 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~------~evl~ 366 (414)
+ ..+.+++.+||+.||++||++ .+++.
T Consensus 227 ~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 227 S----VKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred C----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 1 245678899999999999985 46654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=311.86 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=193.9
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCC-ceeeeEeEEEeCCeeeEEE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~ 170 (414)
+|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+..|..++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999865 4678999998752 234456778899999999765 5888999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++..... +++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF- 153 (324)
T ss_pred cCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC-
Confidence 99999999998865443 789999999999999999999988 99999999999999999999999999874321
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ ... ..+
T Consensus 154 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~---~~~--~~~---- 220 (324)
T cd05587 154 -GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQSIM---EHN--VSY---- 220 (324)
T ss_pred -CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH---cCC--CCC----
Confidence 11223345689999999999999999999999999999999999999753221 11111111 111 011
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM-----PSVIL 366 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~ 366 (414)
....+ ..+.+++.+||+.||.+||+. .++++
T Consensus 221 -~~~~~----~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 221 -PKSLS----KEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred -CCCCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11111 246678899999999999986 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=321.92 Aligned_cols=260 Identities=29% Similarity=0.462 Sum_probs=208.4
Q ss_pred eecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCChhH
Q 043285 102 KLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 180 (414)
Q Consensus 102 ~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~ 180 (414)
+||+|.||+||.|+..+ ...+|||.+........+.+.+|+.+-+.++|.|||+++|.|.++...-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999998765 45689999988777788899999999999999999999999999998999999999999999
Q ss_pred HhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCeEEEeecCccccCCCCCccccccc
Q 043285 181 FIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGDETEGNTNRV 259 (414)
Q Consensus 181 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kL~Dfgl~~~~~~~~~~~~~~~~ 259 (414)
++...=+...-++..+-.+..||++||.|||++. |+|||||-+||||+. .|.+||+|||-++.+.+ ....+.++
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 9976544333488899999999999999999998 999999999999974 68899999999988743 33455678
Q ss_pred cccccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCH
Q 043285 260 VGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNL 337 (414)
Q Consensus 260 ~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (414)
.||..|||||++..+ .|+.++|||||||++.||.||++||-....... ..+..++.. .-.....
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmyK------vHP~iPe 802 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMYK------VHPPIPE 802 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhccee------cCCCCcH
Confidence 899999999999776 588999999999999999999999853322211 111111110 0011222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH--HhcCCCCCCCCCCC
Q 043285 338 AEVIRCIHIGLLCVQQHPEDRPSMPSVIL--MLGSETVLPQPKQP 380 (414)
Q Consensus 338 ~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~~~~~~~~~~ 380 (414)
+...++..++++|+.+||.+||+++++|+ +|......++|+.+
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls 847 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLS 847 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCCC
Confidence 33456778999999999999999999997 45444444555544
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=317.82 Aligned_cols=238 Identities=25% Similarity=0.319 Sum_probs=189.6
Q ss_pred CeecccCCceEEEEEE----cCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 101 KKLGQGGFGPVYKGKL----VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
+.||+|+||.||+++. .+|+.||+|++.+.. ......+..|+.++++++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999865 357899999997532 2234567789999999999999999999999999999999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+|+|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 999999986543 3899999999999999999999998 9999999999999999999999999987643221 2
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCc
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (414)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ...... ...... .+ ...
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~---i~~~~~--~~-----p~~ 220 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTM---ILKAKL--GM-----PQF 220 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHH---HHcCCC--CC-----CCC
Confidence 22345789999999999998999999999999999999999999753221 111111 111110 01 111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 043285 335 FNLAEVIRCIHIGLLCVQQHPEDRPSMPS 363 (414)
Q Consensus 335 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 363 (414)
. ...+.+++.+||+.||++||++.+
T Consensus 221 ~----~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 L----SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C----CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 124567889999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.02 Aligned_cols=261 Identities=28% Similarity=0.413 Sum_probs=202.9
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 162 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 162 (414)
..++|.+.+.||+|+||.||+++.. ++..|++|.+... .......+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3467889999999999999999641 2447999988653 344567889999999999 89999999999999
Q ss_pred CCeeeEEEeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 043285 163 GEEKLLIYEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 229 (414)
Q Consensus 163 ~~~~~lv~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nil 229 (414)
....++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+++ ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999975321 124788889999999999999999998 999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 043285 230 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNL 308 (414)
Q Consensus 230 l~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~ 308 (414)
++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~ 246 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VE 246 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---HH
Confidence 99999999999999987643322222223345678999999999899999999999999999998 677754321 11
Q ss_pred chHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 043285 309 NLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372 (414)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 372 (414)
... ............. .....+.+++.+||+.+|++|||+.|+++.|....
T Consensus 247 ~~~----~~~~~~~~~~~~~---------~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 247 ELF----KLLKEGHRMDKPA---------NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHH----HHHHcCCcCCCCC---------CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 111 1111111111110 11235667899999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=301.07 Aligned_cols=259 Identities=26% Similarity=0.387 Sum_probs=205.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||+|... +|+.|++|.++. ......+.+.+|+.++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999876 789999998863 22334567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 171 EFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
||+++++|.+++.... ....++...+..++.+++.|++|||+.+ ++||||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886432 2345889999999999999999999988 99999999999999999999999999876532
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.. .......++..|+|||.+.+..++.++|||||||++|+|++|+.|+..... ........ ..........
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~~~~~-- 229 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK-IEKCDYPPLP-- 229 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhh-hhcCCCCCCC--
Confidence 21 112234578899999999988999999999999999999999998743221 11111111 1111111111
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
. ......+.+++.+||+.+|++|||+.+++++|.+.
T Consensus 230 --~----~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 --A----DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --h----hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0 01223567889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=297.38 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=201.9
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+|.+.+.||+|++|.||++... ++..|++|.+.. ........+.+|+.+++.++|||++++++++.+....++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999864 588999999864 3445567888999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++..... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~- 155 (256)
T cd08529 81 AENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT- 155 (256)
T ss_pred CCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc-
Confidence 999999999976432 34889999999999999999999987 9999999999999999999999999988654322
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.... ........ .......+..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~----~~~~~~~~~~---- 223 (256)
T cd08529 156 -NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKI----IRGVFPPVSQ---- 223 (256)
T ss_pred -chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH----HcCCCCCCcc----
Confidence 12233467889999999999999999999999999999999999975432 11111111 1111111111
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 -----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 -----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 122357789999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=301.32 Aligned_cols=254 Identities=27% Similarity=0.430 Sum_probs=200.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.++|++.+.||+|+||.||+|+..++..|++|.++... ...+.+.+|+.+++.++||||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35689999999999999999988777789999987522 23457889999999999999999999874 45679999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++|+|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99999999975432 34789999999999999999999988 999999999999999999999999999765432211
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
......++..|+|||...+..++.++|||||||++|||+| |..||..... ....... .......
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~~~~----~~~~~~~------- 223 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQV----ERGYRMP------- 223 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHH----hcCCCCC-------
Confidence 1122345678999999998899999999999999999999 7777643221 1111111 1111100
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
........+.+++.+||+.+|++||++++++++|++
T Consensus 224 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 224 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred --CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 011223457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=319.95 Aligned_cols=242 Identities=22% Similarity=0.302 Sum_probs=192.5
Q ss_pred CeecccCCceEEEEEE-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCC
Q 043285 101 KKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 176 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g 176 (414)
+.||+|+||.||+++. .+|..||+|++.+. .......+..|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999976 46889999999752 2234456778999999999999999999999999999999999999
Q ss_pred ChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 177 SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 177 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
+|..++.... .+++..+..++.|++.||+|||+ .+ ++||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GAT 152 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Ccc
Confidence 9998886543 38999999999999999999997 56 999999999999999999999999998753211 112
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... ..... .+ ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i---~~~~~--~~-----p~~~ 219 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELI---LMEEI--RF-----PRTL 219 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHH---hcCCC--CC-----CCCC
Confidence 23456899999999999999999999999999999999999997532211 111111 11110 01 1111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILM 367 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 367 (414)
+ ..+.+++.+||+.||++|+ ++.++++.
T Consensus 220 ~----~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 220 S----PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C----HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1 2466788999999999997 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.45 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=201.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
.++|++.+.||+|+||.||++... ++..|++|.+... .......+.+|+.+++.++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999753 4678999998753 334456788999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccc-------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 043285 167 LLIYEFMPNKSLDSFIFDQER-------------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 227 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~N 227 (414)
++|+||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||+|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999964321 124778889999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 043285 228 VLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDN 306 (414)
Q Consensus 228 ill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~ 306 (414)
|+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999876533222222222334667999999998999999999999999999998 7777532111
Q ss_pred CcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 307 NLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
.+.... .......... .. ....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 239 -~~~~~~----~~~~~~~~~~-----~~----~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 -EEVIYY----VRDGNVLSCP-----DN----CPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred -HHHHHH----HhcCCCCCCC-----CC----CCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 111111 1111111110 01 1235778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=303.68 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=200.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCC----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
.++|++.+.||+|+||+||+|+.. +|. .||+|.+... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 367888999999999999999753 444 4899998653 34445678899999999999999999999975 4578
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 9999999999999986543 24889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
.............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~----~~~~~~~~~ 232 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDL----LEKGERLPQ 232 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCCCcCCC
Confidence 43222111222334678999999999999999999999999999998 8888653221 111111 111111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLP 375 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 375 (414)
.. . ....+.+++.+||+.||++||++.++++.|......+
T Consensus 233 ~~-----~----~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 233 PP-----I----CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred Cc-----c----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 00 1 1235677899999999999999999999886554433
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.76 Aligned_cols=200 Identities=25% Similarity=0.372 Sum_probs=171.3
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.|++.+.||+|+||+||+|+.. +++.||+|++.+. .......+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888899999999999999764 5788999998752 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999986543 3788889999999999999999998 9999999999999999999999999975331000
Q ss_pred ---------------------------------------------CccccccccccccccccccccCCCCCcchhHHHHH
Q 043285 252 ---------------------------------------------TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFG 286 (414)
Q Consensus 252 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG 286 (414)
.........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00001234689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 043285 287 ILLLEIVSGKKNRGF 301 (414)
Q Consensus 287 vil~elltg~~p~~~ 301 (414)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=298.70 Aligned_cols=250 Identities=34% Similarity=0.505 Sum_probs=200.9
Q ss_pred CeecccCCceEEEEEEcC----CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLVD----GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||++.... +..|++|.+...... ..+.+.+|+..++.++|+|++++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998754 788999999764333 367889999999999999999999999999999999999999
Q ss_pred CChhHHhhcccc------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 176 KSLDSFIFDQER------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 176 g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
++|.+++..... ...+++..++.++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999976521 245899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
...........++..|+|||.+....++.++||||||+++|||++ |..||.... ......... .........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~----~~~~~~~~~ 230 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---NEEVLEYLR----KGYRLPKPE 230 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHH----cCCCCCCCc
Confidence 332223334567889999999988899999999999999999999 588875431 111111111 111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
.. ...+.+++.+||+.+|++|||+.|+++.|+
T Consensus 231 -----~~----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 231 -----YC----PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----cC----ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11 235778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=305.12 Aligned_cols=260 Identities=26% Similarity=0.438 Sum_probs=200.5
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc------CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 165 (414)
..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999653 24579999886532 2334467889999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEE
Q 043285 166 KLLIYEFMPNKSLDSFIFDQER-------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 238 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL 238 (414)
.++||||+++|+|.+++..... ....++..+..++.|++.||.|||+++ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999965321 234567788999999999999999988 999999999999999999999
Q ss_pred EeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHH
Q 043285 239 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKL 317 (414)
Q Consensus 239 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 317 (414)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||..... .......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~~~--- 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLKFV--- 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---
Confidence 99999886533222222222345678999999999999999999999999999998 6777643211 1111111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
...... ... .. ....+.+++.+||+.+|++|||+.++++.|...
T Consensus 235 ~~~~~~-~~~-----~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 MDGGYL-DQP-----DN----CPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HcCCCC-CCC-----CC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111 110 01 123577889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.67 Aligned_cols=258 Identities=29% Similarity=0.413 Sum_probs=200.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEc--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 163 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 163 (414)
.++|.+.+.||+|+||.||+++.. ++..+|+|.+... .......+..|+.+++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 367999999999999999999752 2346999998753 334456788899999999 799999999999999
Q ss_pred CeeeEEEeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 230 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill 230 (414)
...++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999975421 124788999999999999999999987 9999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 043285 231 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLN 309 (414)
Q Consensus 231 ~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~ 309 (414)
+.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~ 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HH
Confidence 9999999999999876532221111222234568999999999999999999999999999998 7777643211 11
Q ss_pred hHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 310 LIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... ............ .....+.+++.+||+.+|++|||+.++++.|..
T Consensus 251 ~~~----~~~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 251 LFK----LLKEGHRMDKPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred HHH----HHHcCCCCCCCC---------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 111 111111111111 112356678999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=307.48 Aligned_cols=259 Identities=31% Similarity=0.450 Sum_probs=202.3
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 164 (414)
..++|.+.+.||+|+||.||++... .+..||+|.++.. .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3467999999999999999999642 2447999998753 234456788999999999 7999999999999999
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
..++||||+++|+|.+++..... ..+++..+..++.|++.|++|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999875432 23799999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCC
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
................++..|+|||.+.+..++.++|||||||++|||++ |..||...... .. ..........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~---~~---~~~~~~~~~~ 262 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD---SK---FYKLIKEGYR 262 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch---HH---HHHHHHcCCc
Confidence 86543222112222345778999999999999999999999999999998 88886432211 11 1111111111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... .... ...+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 263 ~~~-----~~~~----~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 263 MAQ-----PEHA----PAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCC-----CCCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 100 0111 2357789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=307.27 Aligned_cols=240 Identities=26% Similarity=0.340 Sum_probs=188.4
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||+|+.. +|..||+|.++.. ..........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999875 5789999999752 123345566777777654 899999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|..++.... .+++..+..++.|+++||+|||+++ ++||||||+||+++.++.++|+|||++..... ....
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 152 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNR 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCc
Confidence 99999886543 3889999999999999999999998 99999999999999999999999999874311 1122
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... .... .. +....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~----~~~~-~~-----~~~~~ 219 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESI----RVDT-PH-----YPRWI 219 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhCC-CC-----CCCCC
Confidence 3345789999999999999999999999999999999999999853221 1111111 1111 00 11111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSMP-SVI 365 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl 365 (414)
...+.+++.+||+.||++||++. +++
T Consensus 220 ----~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 ----TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ----CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12456788999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=299.68 Aligned_cols=254 Identities=32% Similarity=0.474 Sum_probs=201.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.++|++.+.||+|+||.||+|...+++.|++|.+.... .....+.+|+.+++.++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 46789999999999999999998889999999987533 23467889999999999999999999874 45789999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 99999999865443 34889999999999999999999988 999999999999999999999999999765422211
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
......++..|+|||.+....++.++||||||+++|||++ |+.||.... ........ .........
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~----~~~~~~~~~----- 225 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQNL----ERGYRMPRP----- 225 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHH----HcCCCCCCC-----
Confidence 1122345678999999998899999999999999999999 998875322 11111111 111111111
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. ....+.+++.+||+.+|++|||+++++..|++
T Consensus 226 ~~----~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DN----CPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CC----CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11 12357789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=297.06 Aligned_cols=252 Identities=28% Similarity=0.418 Sum_probs=199.3
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
++|.+.+.||+|++|.||.+... ++..|++|.+.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999764 58899999886421 1234568889999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
|+||+++++|.+++.... .++......++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999886543 3788899999999999999999998 9999999999999999999999999987653
Q ss_pred CCCCcc-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 249 GDETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 249 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.... ..... ...........+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~---~~~~~~~~~~~~- 228 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE---AMAAI---FKIATQPTNPQL- 228 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc---hHHHH---HHHhccCCCCCC-
Confidence 221111 1123457889999999999999999999999999999999999974321 11111 111111111111
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.... ...+.+++.+||+.+|.+|||+.|+++.
T Consensus 229 ----~~~~----~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 229 ----PSHV----SPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CccC----CHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111 1246678899999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.16 Aligned_cols=261 Identities=27% Similarity=0.399 Sum_probs=201.5
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 164 (414)
..++|.+.+.||+|+||.||+|++. .+..||+|+++.. .....+.+..|+.++..+. ||||++++++|....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3457888899999999999999753 2457999999753 2333457889999999997 999999999999999
Q ss_pred eeeEEEeecCCCChhHHhhcccc---------------------------------------------------------
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQER--------------------------------------------------------- 187 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~--------------------------------------------------------- 187 (414)
..++|+||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999865321
Q ss_pred --------------------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 043285 188 --------------------------------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 229 (414)
Q Consensus 188 --------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nil 229 (414)
...+++..+..++.|++.||+|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 123677788999999999999999987 999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 043285 230 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNL 308 (414)
Q Consensus 230 l~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~ 308 (414)
+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--- 348 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--- 348 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch---
Confidence 99999999999999986532221111223356788999999998899999999999999999998 88886533211
Q ss_pred chHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 309 NLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
... ............. ... ...+.+++.+||+.+|.+||++.|+++.|+..
T Consensus 349 ~~~---~~~~~~~~~~~~p-----~~~----~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 EQF---YNAIKRGYRMAKP-----AHA----SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHH---HHHHHcCCCCCCC-----CCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 1111111111110 111 23567788999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.30 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=197.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.+.||+|+||.||+++.. ++..||+|++.+. .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 467999999999999999999864 5889999998642 223345578899999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++|+|.+++... .++...+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999988643 2788888899999999999999998 99999999999999999999999999986532
Q ss_pred CCCccccccccccccccccccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDG----QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ...............
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~~ 267 (370)
T cd05596 195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNSLT 267 (370)
T ss_pred CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCcCC
Confidence 211 122345789999999988653 478999999999999999999999754221 111111111111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPED--RPSMPSVILM 367 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~ 367 (414)
+.+ . ......+.+++.+||+.+|.+ |||+.|++..
T Consensus 268 ~~~-----~--~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 FPD-----D--IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC-----c--CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111 0 011235667888999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=309.55 Aligned_cols=237 Identities=24% Similarity=0.296 Sum_probs=184.4
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHH-HHHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||+++.. ++..||+|++.+.. ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 57899999986521 22233455554 467889999999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|...+.... .++...+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++...... ...
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET 152 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence 99998886543 3788889999999999999999988 999999999999999999999999998753211 122
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....||+.|+|||.+.+..++.++|||||||++|||++|..||.... ............ ..+. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~--~~~~-----~~- 218 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILHKP--LQLP-----GG- 218 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhcCC--CCCC-----CC-
Confidence 334578999999999999999999999999999999999999975321 111111111111 1111 11
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSMP 362 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~~ 362 (414)
....+.+++.+||+.+|.+||++.
T Consensus 219 ---~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 ---KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---CCHHHHHHHHHHccCCHhhcCCCC
Confidence 122467789999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=307.41 Aligned_cols=261 Identities=24% Similarity=0.298 Sum_probs=198.6
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|++.+.||+|+||.||++... ++..+++|.+... .......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999764 4778888888653 334456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
+++++|.+++.... .+++..+..++.|+++||.|||+. + ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999997553 388999999999999999999984 5 999999999999999999999999998754221
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc-------
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS------- 324 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 324 (414)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||....... ...............
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCccccc
Confidence 1233568899999999988889999999999999999999999974322111 110000000000000
Q ss_pred -------------ccccccc----cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 325 -------------QLIDSCF----QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 325 -------------~~~~~~~----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
...+... ...........+.+++.+||+.+|++|||+.|+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000 0000000123477899999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=316.25 Aligned_cols=241 Identities=25% Similarity=0.366 Sum_probs=190.6
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||+++.. +++.||+|++.+. .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 5789999998752 233455677888888776 699999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|.+++..... +++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++...... ...
T Consensus 81 g~L~~~i~~~~~---l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~ 152 (320)
T cd05590 81 GDLMFHIQKSRR---FDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKT 152 (320)
T ss_pred chHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCc
Confidence 999998865543 889999999999999999999998 999999999999999999999999998753211 122
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ....... ..... .. ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i---~~~~~--~~-----~~~~ 219 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAI---LNDEV--VY-----PTWL 219 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHH---hcCCC--CC-----CCCC
Confidence 3345789999999999999999999999999999999999999854321 1111111 11110 00 0111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSM------PSVIL 366 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~------~evl~ 366 (414)
...+.+++.+||+.||++||++ +++++
T Consensus 220 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 220 ----SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred ----CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 1246778899999999999998 55554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=307.10 Aligned_cols=242 Identities=25% Similarity=0.323 Sum_probs=192.4
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||+||+++.. ++..||+|++++. .......+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 4788999999752 233455677888888887 699999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|..++.... .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++...... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVT 152 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCc
Confidence 99999886554 3899999999999999999999998 999999999999999999999999998653211 112
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ........ .... . . +....
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i---~~~~-~-~-----~~~~~ 219 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSI---LEDE-V-R-----YPRWL 219 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHH---HcCC-C-C-----CCCcC
Confidence 234568999999999999999999999999999999999999975322 11111111 1111 0 0 11111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSM-----PSVILM 367 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~~ 367 (414)
...+.+++.+||+.||.+|||+ .++++.
T Consensus 220 ----~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 220 ----SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 2346788999999999999999 888763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=304.09 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=196.2
Q ss_pred CCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 97 FSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
|+..+.||+|+||.||++... +++.||+|.+.... ......+..|+.+++.++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999764 58899999986421 22334577899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999998865332 34889999999999999999999988 9999999999999999999999999987643221
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.||..................... . ..
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~-----~~ 225 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE----E-----YS 225 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh----h-----cC
Confidence 112346899999999999999999999999999999999999998643221111111111110000 0 11
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPS-----MPSVIL 366 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 366 (414)
... ...+.+++.+||+.||++||| +.|+++
T Consensus 226 ~~~----~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 EKF----SPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ccC----CHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 111 124667889999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=292.95 Aligned_cols=263 Identities=23% Similarity=0.300 Sum_probs=199.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 168 (414)
.++|+.+..|++|+||.||+|+.. ++.-||+|+++-..+ ..--.-.+|+.+|.+.+|||||.+-.+..- -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356888999999999999999864 477899999975322 122345789999999999999999887754 346999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
|||||+. +|..++..-. ..+...++..+..|+++|++|||.+. |+|||||++|+|++..|.+||+|||+|+.++
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999987 8999887644 35889999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC---c
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP---S 324 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ 324 (414)
... ......+-|..|.|||.+.+. .|+...|+||+|||+.||+++++.|..... .+.+..+.+.+..+.. +
T Consensus 229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE---~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE---IDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch---HHHHHHHHHHhCCCccccCC
Confidence 442 234456779999999988775 799999999999999999999988654332 2333333332222111 1
Q ss_pred cccc--------------ccccCcCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 325 QLID--------------SCFQDSFNLA-EVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 325 ~~~~--------------~~~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.+.. ..+...+... ....-.+|+..+|.+||.+|.|+.|.|+.
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1100 0000000000 11234578889999999999999999863
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=299.64 Aligned_cols=263 Identities=27% Similarity=0.381 Sum_probs=202.2
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe-----CC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-----GE 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~ 164 (414)
....|...+.||+|+||.|+.+.. .+|..||||++.. ......++..+|+.+++.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345666679999999999999975 4689999999974 344566788899999999999999999998865 34
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
..|+|+|+| ..+|...++.+.. ++......++.|++.||.|+|+.+ ++||||||.|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 689999999 5589999876553 889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHH----------
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGH---------- 313 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~---------- 313 (414)
+..............+.|..|.|||++. ...|+...||||.|||+.||++|++-|.....-....++-.
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 9875443344445677899999999764 56899999999999999999999988765433222111111
Q ss_pred --H-----HHHhh-cCC-CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 314 --A-----WKLWN-EGM-PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 314 --~-----~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
+ ..... .+. +..-....+. ..+ ...++|+.+||..||.+|+|++|+|+.
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~----p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFP-NAN----PLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcC-CCC----HHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1 11000 000 0100011111 111 245678889999999999999999974
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=305.62 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=198.7
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-CC--EEEEEEecc-cChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-GQ--EIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 169 (414)
++|++.+.||+|+||.||+|...+ +. .+++|.++. ......+.+..|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998644 32 478888875 3344556789999999999 799999999999999999999
Q ss_pred EeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCe
Q 043285 170 YEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 236 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~ 236 (414)
+||+++++|.+++..... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999965321 124788999999999999999999988 9999999999999999999
Q ss_pred EEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043285 237 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 237 kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 315 (414)
||+|||++..... .........+..|+|||.+.+..++.++|||||||++|||++ |..||...... ......
T Consensus 159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~~~~- 231 (297)
T cd05089 159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELYEKL- 231 (297)
T ss_pred EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH-
Confidence 9999999864211 111111223457999999998899999999999999999997 98887533211 111111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 316 KLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
........ .... ...+.+++.+||+.+|.+|||+.++++.|++...
T Consensus 232 ---~~~~~~~~-----~~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 232 ---PQGYRMEK-----PRNC----DDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred ---hcCCCCCC-----CCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111100 1111 1346789999999999999999999999865544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=305.60 Aligned_cols=258 Identities=25% Similarity=0.321 Sum_probs=193.2
Q ss_pred CCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----eeeEE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKLLI 169 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 169 (414)
.|...+++|.|+||.||.|.... +..||||++-.... .-.+|+.+|+.++|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 35666899999999999998754 68999999865332 2346999999999999999998886533 34589
Q ss_pred EeecCCCChhHHhhcc-cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCeEEEeecCcccc
Q 043285 170 YEFMPNKSLDSFIFDQ-ERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAF 247 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kL~Dfgl~~~~ 247 (414)
|||+|. +|..++..- .....++...+.-+..||++||+|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 888888641 11234778888889999999999999988 9999999999999976 89999999999987
Q ss_pred CCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
...... .....|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|......+....+ .+.+..+...++
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eI---ik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEI---IKVLGTPTREDI 250 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHH---HHHhCCCCHHHH
Confidence 543322 334568889999988775 8999999999999999999999887654433332222 222221111111
Q ss_pred ----------ccccccC-----cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 327 ----------IDSCFQD-----SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 327 ----------~~~~~~~-----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
..+.+.. ........+.++++.++|+++|.+|.++.|++..
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111111 1122233567889999999999999999999874
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=317.63 Aligned_cols=254 Identities=19% Similarity=0.248 Sum_probs=195.9
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
..++|++.+.||+|+||.||+++.. +++.||+|.+.+. .......+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3478999999999999999999875 4788999998642 22334567889999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||+++|+|.+++... .++...+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999998643 2788899999999999999999998 9999999999999999999999999998653
Q ss_pred CCCCccccccccccccccccccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDG----QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..............
T Consensus 194 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~ 266 (370)
T cd05621 194 ETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSL 266 (370)
T ss_pred cCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCccc
Confidence 221 1122345799999999998754 378899999999999999999999853221 11111111111111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPED--RPSMPSVILM 367 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~ 367 (414)
.+.. . ......+.+++.+|++.++.+ |||+.|+++.
T Consensus 267 ~~p~-----~--~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFPE-----D--VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCC-----c--ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111 0 011223556777888755543 8999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=298.06 Aligned_cols=253 Identities=29% Similarity=0.443 Sum_probs=198.9
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
++|.+.+.||+|++|.||++...++..+++|.+.... ...+.+.+|+.+++.++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999988777789999886532 23467888999999999999999999875 456889999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+++|.+++..... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++........ .
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05069 84 KGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-c
Confidence 9999999975432 34789999999999999999999988 99999999999999999999999999976532221 1
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... .........
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~~~~~------ 225 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQV----ERGYRMPCP------ 225 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCCCCCC------
Confidence 1122345678999999998899999999999999999999 8888653211 1111111 111111110
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
......+.+++.+||+.+|++||++++++++|++
T Consensus 226 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 ---QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0112356788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=297.03 Aligned_cols=250 Identities=30% Similarity=0.487 Sum_probs=202.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.++|++.+.||.|+||.||+|.. .|+.|++|.+..... ..+.+.+|+.+++.++|+|++++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 36788899999999999999987 588999999976543 5678899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++..... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999875542 24899999999999999999999998 99999999999999999999999999986532111
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
....+..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+.... .........
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~~~~----- 221 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHV----EKGYRMEAP----- 221 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----hcCCCCCCc-----
Confidence 2234567999999998899999999999999999997 8888753321 1111111 111111111
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. ....+.+++.+||+.+|++|||+.|++++|..
T Consensus 222 ~~----~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EG----CPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cC----CCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11 12356788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=297.26 Aligned_cols=246 Identities=29% Similarity=0.412 Sum_probs=192.5
Q ss_pred eecccCCceEEEEEE---cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCC
Q 043285 102 KLGQGGFGPVYKGKL---VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 176 (414)
Q Consensus 102 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g 176 (414)
.||+|+||.||+|.+ .++..+|+|+++.. .....+.+..|+.+++.++||||+++++++. ....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 34778999998643 2334567899999999999999999999885 45678999999999
Q ss_pred ChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc-c
Q 043285 177 SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-N 255 (414)
Q Consensus 177 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~-~ 255 (414)
+|.+++.... .+++..+..++.|++.|++|||+++ ++||||||.||+++.++.+||+|||++.......... .
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999986543 3889999999999999999999988 9999999999999999999999999998764332211 1
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCc
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (414)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ....... ......... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i----~~~~~~~~~-----~~ 222 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMI----ESGERMECP-----QR 222 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HCCCCCCCC-----CC
Confidence 112234578999999988889999999999999999998 8888754321 1222221 111111111 11
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 335 FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 335 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. ...+.+++.+||+.||++||++.+|.+.|.+
T Consensus 223 ~----~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 223 C----PPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred C----CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1 1346679999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=312.95 Aligned_cols=241 Identities=27% Similarity=0.369 Sum_probs=189.0
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHh-cCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||+|+.. ++..||+|+++.. ..........|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 4788999998752 12334456677777775 4899999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...... ...
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAK 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCc
Confidence 99999986543 3889999999999999999999988 999999999999999999999999998753211 112
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ....+ .+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i----~~~~~------~~~~~~ 219 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSI----RMDNP------CYPRWL 219 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhCCC------CCCccC
Confidence 3345689999999999999999999999999999999999999754221 1111111 11110 011111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSMP-SVIL 366 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~ 366 (414)
...+.+++.+||+.||++||++. ++.+
T Consensus 220 ----~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 220 ----TREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ----CHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 12466788999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=301.13 Aligned_cols=258 Identities=25% Similarity=0.388 Sum_probs=203.1
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||+++. .++..++||.+... .......+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999985 47889999988642 2334467889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 171 EFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
||+++++|.+++.... ....+++..++.++.|+++|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 2345899999999999999999999988 99999999999999999999999999876532
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ........ .........
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~~~~~~-- 229 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-EQCDYPPLP-- 229 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhh-hcCCCCCCC--
Confidence 221 122346888999999999989999999999999999999999997432111 11111111 111111000
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. ......+.+++.+||+.+|++|||+.+|++.++.
T Consensus 230 --~----~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 230 --S----DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred --c----ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 0 1122356778899999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=306.58 Aligned_cols=259 Identities=29% Similarity=0.412 Sum_probs=200.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEc--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 163 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 163 (414)
.++|.+.+.||+|+||.||+++.. .+..+++|.++.. .......+..|+.+++.+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 367889999999999999999642 2456899988753 344566788999999999 699999999999999
Q ss_pred CeeeEEEeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 230 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill 230 (414)
...+++|||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999965321 234888999999999999999999988 9999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 043285 231 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLN 309 (414)
Q Consensus 231 ~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~ 309 (414)
+.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~ 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EE 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence 9999999999999986543222111222234567999999999999999999999999999999 7777643221 11
Q ss_pred hHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 310 LIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
..... .......... . ....+.+++.+||+.+|++|||+.|+++.|...
T Consensus 245 ~~~~~----~~~~~~~~~~-----~----~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 245 LFKLL----REGHRMDKPS-----N----CTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHHHH----HcCCCCCCCC-----C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111 1111111111 1 122466788999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=297.46 Aligned_cols=254 Identities=27% Similarity=0.423 Sum_probs=190.1
Q ss_pred CeecccCCceEEEEEEcC---CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCC
Q 043285 101 KKLGQGGFGPVYKGKLVD---GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 176 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g 176 (414)
+.||+|+||.||+|...+ +..+++|.++... ......+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999997643 3568999886533 334457888999999999999999999999999999999999999
Q ss_pred ChhHHhhcccc--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 177 SLDSFIFDQER--CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 177 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+|.+++..... ....++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975332 234667788889999999999999988 9999999999999999999999999987543322222
Q ss_pred ccccccccccccccccccCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 255 NTNRVVGTYGYMAPEYASDG-------QFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||...... ...... .. ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~~---~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTYT---VR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHHH---hh-cccCCC
Confidence 22334567889999988643 35789999999999999996 99887543221 111111 11 111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
..+....... ..+.+++..|| .+|++|||+.||++.|+
T Consensus 231 ~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLPLS----DRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCCCC----hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222211111 23556778898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=316.51 Aligned_cols=253 Identities=28% Similarity=0.467 Sum_probs=204.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
..+..+..+||.|.||.||.|.++. ...||||.++. +....++|..|+.+|+.++|||+|+++|+|......|||+||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3455666889999999999998865 67899999976 445678999999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
|..|+|.++|.+..+. .++...++.++.||+.||.||...+ +|||||..+|+||.++..+|++|||+++++..+.+
T Consensus 345 M~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred ccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 9999999999876653 4777888999999999999999988 99999999999999999999999999998765433
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.. .....-...|.|||.+....|+.|+|||+|||+|||+.| |.-|+. .-+. ..+...+..+...+-...|.
T Consensus 421 TA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP---Gidl----SqVY~LLEkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 421 TA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP---GIDL----SQVYGLLEKGYRMDGPEGCP 492 (1157)
T ss_pred ec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC---CccH----HHHHHHHhccccccCCCCCC
Confidence 22 222334678999999999999999999999999999999 555532 2222 22223333333333333333
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
. .+.+||.+||+.+|.+||++.|+-+.+
T Consensus 493 p---------kVYeLMraCW~WsPsDRPsFaeiHqaf 520 (1157)
T KOG4278|consen 493 P---------KVYELMRACWNWSPSDRPSFAEIHQAF 520 (1157)
T ss_pred H---------HHHHHHHHHhcCCcccCccHHHHHHHH
Confidence 2 466788999999999999998887655
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=302.19 Aligned_cols=252 Identities=32% Similarity=0.513 Sum_probs=197.7
Q ss_pred CCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHH--HHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 97 FSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLK--ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
|++.+.||+|+||+||+++... ++.||+|.+......... ....|+.+++.++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6678999999999999998765 568999999875433322 3456999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++.... .+++..+..++.|+++||.+||+.+ ++|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred ccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 9999999997333 3899999999999999999999998 9999999999999999999999999997641 222
Q ss_pred ccccccccccccccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......++..|+|||.+. +..++.++||||+|+++|+|++|..|+................ ..... .....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~---~~~~~----~~~~~ 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL---KRPLP----SSSQQ 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH---HTHHH----HHTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc---ccccc----ccccc
Confidence 3344556889999999998 8889999999999999999999999976441111111111111 00000 00000
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
... ....+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~---~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SRE---KSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTT---SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cch---hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0146778999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=323.24 Aligned_cols=261 Identities=20% Similarity=0.299 Sum_probs=189.8
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--------
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-------- 163 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------- 163 (414)
..++|++.+.||+|+||.||+|... .+..||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999864 57899999885432 2345799999999999999999887532
Q ss_pred CeeeEEEeecCCCChhHHhhcc-cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CeEEEee
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQ-ERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDF 241 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kL~Df 241 (414)
...++||||+++ +|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 236689999985 676666432 22345889999999999999999999998 99999999999999665 7999999
Q ss_pred cCccccCCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhc
Q 043285 242 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE 320 (414)
Q Consensus 242 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
|+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||...... +...........
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~ 289 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV---DQLVRIIQVLGT 289 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Confidence 9998653221 22234679999999988764 6899999999999999999999997543221 111111111110
Q ss_pred CCC-------ccccccccc--------CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 321 GMP-------SQLIDSCFQ--------DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 321 ~~~-------~~~~~~~~~--------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
... ..+.+..+. ..+......++.+++.+||++||.+|||+.|+++.
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000 000000000 00000112357789999999999999999999964
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.70 Aligned_cols=259 Identities=22% Similarity=0.335 Sum_probs=195.6
Q ss_pred CCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----eee
Q 043285 96 NFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 167 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 167 (414)
+|++.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999986 46899999998652 2334567889999999999999999999998776 789
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+|+||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57877775443 3899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh--------
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW-------- 318 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 318 (414)
..... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||....... .........
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---QLDLITDLLGTPSLEAM 229 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence 32211 112234578899999998774 57999999999999999999999986433211 111111100
Q ss_pred ------------hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 319 ------------NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 319 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.............. ........+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYT--LSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcc--cCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000000 000112356789999999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=313.87 Aligned_cols=250 Identities=26% Similarity=0.455 Sum_probs=200.9
Q ss_pred CCCCCeecccCCceEEEEEEcC---CC--EEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 97 FSINKKLGQGGFGPVYKGKLVD---GQ--EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~~---~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
..+.+.||.|-||.||+|...+ |. .||||..+. ......+.|..|+.+|++++||||++++|+|. ....++||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEE
Confidence 3445689999999999997532 32 589999886 34455788999999999999999999999996 45789999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
|.++.|.|..++..++. .++......++.||+.||+|||+.. ++||||..+||||.+..-+||+|||+++.+..+
T Consensus 470 EL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred ecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999976553 4888899999999999999999987 999999999999999999999999999998665
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
...... ...-...|||||.+.-..|+.+||||.|||+|||++. |..||..-...+ ++.... .+......+.
T Consensus 545 ~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD---VI~~iE----nGeRlP~P~n 616 (974)
T KOG4257|consen 545 AYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD---VIGHIE----NGERLPCPPN 616 (974)
T ss_pred chhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---eEEEec----CCCCCCCCCC
Confidence 544333 4445778999999999999999999999999999876 889986543322 222221 1222222233
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
|.. .+..++.+||.++|.+||.+.|+...|+
T Consensus 617 CPp---------~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 617 CPP---------ALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred CCh---------HHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 322 4556888999999999999999887763
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.60 Aligned_cols=259 Identities=18% Similarity=0.232 Sum_probs=197.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEc---CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
..+|.+.+.||+|+||.||++... .+..|++|.+... ....+|+.+++.++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999653 3567999988643 23467999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+. ++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++..+...
T Consensus 166 e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 5888887433 34899999999999999999999998 999999999999999999999999999866443
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC---------
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG--------- 321 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 321 (414)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33233334679999999999999999999999999999999999999975443322211121111111000
Q ss_pred -------------CCcccc-cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 322 -------------MPSQLI-DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 322 -------------~~~~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
...... ...+.. .....++.+++.+||+.||++|||+.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRK---YGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhc---cCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 000000 0012346678899999999999999999965
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=314.45 Aligned_cols=237 Identities=24% Similarity=0.303 Sum_probs=185.5
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHH-HHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||+||+|+.. +|+.||+|++.+. .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999874 5889999998642 1222334445544 56789999999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|..++.... .+++..+..++.|+++||.|||+++ ++||||||+|||++.++.+||+|||++..... ....
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~ 152 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKT 152 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCc
Confidence 99999887544 3888999999999999999999998 99999999999999999999999999875321 1122
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ....... ..+ ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~---~~i~~~~--~~~-----~~~~ 219 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AEMY---DNILNKP--LRL-----KPNI 219 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HHHH---HHHHcCC--CCC-----CCCC
Confidence 3345689999999999999999999999999999999999999753211 1111 1111111 011 0111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSMP 362 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~~ 362 (414)
...+.+++.+||+.||.+||++.
T Consensus 220 ----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 ----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 23467788999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=293.32 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=200.4
Q ss_pred hcCCCCCCCeecccCCceEEEEE-EcCCCEEEEEEec--ccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.+++|++-+.||+|.|+.|+++. ...|+.+++|++. +......+.+.+|+.+.+.++||||+++.+...+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 35778888999999999999984 4568889988874 34455778999999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CCeEEEeecCccc
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARA 246 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kL~Dfgl~~~ 246 (414)
+|++.|++|..-+-.. ..+++..+-+...||+++|.|+|.++ |+|||+||+|+++.+. .-+||+|||++..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999998766544 34788889999999999999999998 9999999999999643 3599999999998
Q ss_pred cCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
+.. ........|||.|||||++...+|+..+|||+.||+||-|+.|.+||...... .+...+... ....+...
T Consensus 163 l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~~g-~yd~~~~~ 235 (355)
T KOG0033|consen 163 VND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIKAG-AYDYPSPE 235 (355)
T ss_pred eCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHhcc-ccCCCCcc
Confidence 752 22333567999999999999999999999999999999999999997542222 222222111 11111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.+.. ..+..+|+.+||..||.+|.|+.|.|+
T Consensus 236 w~~i---------s~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 236 WDTV---------TPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cCcC---------CHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1111 123456888999999999999999885
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=293.01 Aligned_cols=247 Identities=28% Similarity=0.402 Sum_probs=195.4
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCChh
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 179 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~ 179 (414)
+.||+|+||.||+|...++..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888999999987643 333456889999999999999999999999999999999999999999
Q ss_pred HHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccc
Q 043285 180 SFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 259 (414)
Q Consensus 180 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~ 259 (414)
+++.... ..+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.+||+|||++........ ......
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 154 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLK 154 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCC
Confidence 9886543 24789999999999999999999988 99999999999999999999999999875432211 111122
Q ss_pred cccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHH
Q 043285 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLA 338 (414)
Q Consensus 260 ~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (414)
.++..|+|||.+.+..++.++||||||+++|++++ |..||..... ....... .......... .
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---~~~~~~~----~~~~~~~~~~-----~---- 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---QQAREQV----EKGYRMSCPQ-----K---- 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHH----HcCCCCCCCC-----C----
Confidence 34567999999998899999999999999999998 8888743211 1111111 1111111111 1
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 339 EVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 339 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
....+.+++.+||+.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1235778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=309.55 Aligned_cols=261 Identities=22% Similarity=0.337 Sum_probs=195.1
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|.+.+.||+|+||.||+|+.. ++..||+|.++... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67899999999999999999864 57889999986432 22334677899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++ +|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 975 7888775543 24788899999999999999999998 9999999999999999999999999987643221
Q ss_pred ccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc-------
Q 043285 253 EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS------- 324 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 324 (414)
.......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||......+. ..............
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE---LHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhhcc
Confidence 11223457889999998865 4689999999999999999999999864332211 11111111000000
Q ss_pred --cccc---ccccCc----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 325 --QLID---SCFQDS----FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 325 --~~~~---~~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...+ +..... ........+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000 000000 00001234568999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=317.77 Aligned_cols=194 Identities=23% Similarity=0.309 Sum_probs=166.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
...|.+.+.||+|+||.||++.... ++.|+||.... ..+.+|+.++++++|+||+++++++..+...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3469999999999999999998754 78899996432 2456899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+. ++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 68888876432 24899999999999999999999998 99999999999999999999999999986543322
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNR 299 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~ 299 (414)
........||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22233456999999999999999999999999999999999988653
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=304.56 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=201.0
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
..+|++.+.||+|+||.||+|.. .+++.|++|.+..........+.+|+.+++.++|+|++++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 46899999999999999999975 46889999998765545567788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++... .+++.++..++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~- 170 (296)
T cd06654 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (296)
T ss_pred cCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence 9999999998543 3788999999999999999999998 9999999999999999999999999987643221
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... . ........... .... .
T Consensus 171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~---~---~~~~~~~~~~~-~~~~---~ 239 (296)
T cd06654 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---R---ALYLIATNGTP-ELQN---P 239 (296)
T ss_pred -cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH---H---hHHHHhcCCCC-CCCC---c
Confidence 1122346788999999999888999999999999999999999997532211 1 11111111111 0000 0
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. .....+.+++.+||..+|++|||+.++++.
T Consensus 240 ~----~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 E----KLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred c----ccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1 111346678899999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=310.23 Aligned_cols=260 Identities=28% Similarity=0.432 Sum_probs=198.2
Q ss_pred hcCCCCCCCeecccCCceEEEEEE------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC-
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG- 163 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~- 163 (414)
..++|++.+.||+|+||.||+|.. .+++.||||.++.. .......+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346899999999999999999963 34678999999753 233456788999999999 689999999988654
Q ss_pred CeeeEEEeecCCCChhHHhhcccc--------------------------------------------------------
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQER-------------------------------------------------------- 187 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~-------------------------------------------------------- 187 (414)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999999864211
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccc
Q 043285 188 --------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 259 (414)
Q Consensus 188 --------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~ 259 (414)
...+++..+..++.|+++||+|||+++ ++||||||+||+++.++.+||+|||++...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 123678888999999999999999988 999999999999999999999999998865322221222223
Q ss_pred cccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHH
Q 043285 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLA 338 (414)
Q Consensus 260 ~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (414)
.++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .... ............ ...+
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~----~~~~~~~~~~~~-----~~~~-- 308 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFC----RRLKEGTRMRAP-----DYTT-- 308 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHH----HHHhccCCCCCC-----CCCC--
Confidence 45678999999999999999999999999999997 88886432211 1111 111111111110 1111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 339 EVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 339 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 309 --~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 309 --PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred --HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 246788899999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=297.08 Aligned_cols=249 Identities=29% Similarity=0.421 Sum_probs=196.8
Q ss_pred CeecccCCceEEEEEEcC--C--CEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLVD--G--QEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|++|.||+|.+.+ + ..|++|.+..... ...+.+..|+.++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 2689999977544 566789999999999999999999999988 889999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc-c
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE-G 254 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~-~ 254 (414)
++|.+++..... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999976543 35899999999999999999999988 999999999999999999999999999876432211 1
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......++..|+|||.+.+..++.++|||||||++|||++ |+.|+..... .+....... ........ .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~---~~~~~~~~-----~ 224 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKIDK---EGERLERP-----E 224 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHh---cCCcCCCC-----c
Confidence 1223456788999999999999999999999999999999 9988743211 111111111 11100000 0
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
.....+.+++.+||+.+|++|||+.++++.|.
T Consensus 225 ----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ----ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11235678899999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=313.02 Aligned_cols=240 Identities=24% Similarity=0.297 Sum_probs=186.6
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHH-HHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||+||+++.. +|+.||+|++.+. .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999764 5889999998652 2223344555554 56778999999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|..++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~ 152 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDT 152 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCC
Confidence 99998886543 3889999999999999999999998 99999999999999999999999999875321 1122
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....||+.|+|||.+.+..++.++|||||||++|||++|..||.... ...... ....... .+ ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~---~~~~~~~--~~-----~~~~ 219 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMYD---NILHKPL--VL-----RPGA 219 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHHHH---HHHcCCc--cC-----CCCC
Confidence 334578999999999999999999999999999999999999975321 111111 1111110 00 1111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl 365 (414)
...+.+++.+||+.+|.+||++.+.+
T Consensus 220 ----~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 220 ----SLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ----CHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 12456788899999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=294.34 Aligned_cols=264 Identities=25% Similarity=0.329 Sum_probs=201.1
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCc-eeeeEeEEEeCC------
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRN-LVKLLGCCIQGE------ 164 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------ 164 (414)
..|...+.||+|+||+||+|+. .+|+.||+|++.-..+ .......+|+.+++.++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3466668899999999999975 4688999999975322 23346689999999999999 999999999877
Q ss_pred eeeEEEeecCCCChhHHhhccccc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecC
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERC-MILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl 243 (414)
.+++||||++. +|..++...... ..++...+..++.||+.|++|||+++ |+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78999999965 999999765432 33677889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
++...-. ......-.+|..|.|||++.+. .|+...||||+|||+.||++++.-|..... .+.+..+.+....+.
T Consensus 167 Ara~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPN 241 (323)
T ss_pred HHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCC
Confidence 9965321 1223345689999999999876 799999999999999999998877654333 333334433332222
Q ss_pred Ccccc------c--ccccCc---CCHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 323 PSQLI------D--SCFQDS---FNLAE-----VIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 323 ~~~~~------~--~~~~~~---~~~~~-----~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
..... + ..+... ..+.. ..+..+++.+||+++|.+|.|++.++.+
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11110 0 001111 11111 0256789999999999999999999975
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=305.07 Aligned_cols=254 Identities=29% Similarity=0.457 Sum_probs=196.7
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCC--EEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 169 (414)
++|++.+.||+|+||.||+|... ++. .+++|.++.. .......+.+|+.++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888899999999999999864 344 4577777642 334556788999999999 899999999999999999999
Q ss_pred EeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCe
Q 043285 170 YEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 236 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~ 236 (414)
|||+++++|.+++..... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999965321 235789999999999999999999988 9999999999999999999
Q ss_pred EEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043285 237 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 237 kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 315 (414)
||+|||++..... ........++..|+|||.+.+..++.++|||||||++|||+| |..||...... +....
T Consensus 164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~-- 235 (303)
T cd05088 164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK-- 235 (303)
T ss_pred EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHH--
Confidence 9999999864211 111111234567999999988889999999999999999998 88887432211 11111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 316 KLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.......... ... ...+.+++.+||+.+|++||++.++++.|+.
T Consensus 236 --~~~~~~~~~~-----~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 236 --LPQGYRLEKP-----LNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred --HhcCCcCCCC-----CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111110000 011 2246788999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=302.02 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=198.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|++.+.||+|+||.||++... ++..||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999875 6889999988653 344557888999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
+++++|..++........+++..+..++.|++.|+.|||+. + ++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999887643333589999999999999999999974 5 999999999999999999999999998765322
Q ss_pred CccccccccccccccccccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...... ......... .......
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~-~~~~~~~ 229 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLSAI-VDGDPPT 229 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHHHH-hhcCCCC
Confidence 12234578899999998654 3588999999999999999999997532211 111111111 1111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+.. .....+.+++.+||+.+|++||++.+++.
T Consensus 230 ~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 230 LPS---------GYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCc---------ccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111 12234667899999999999999999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=299.39 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=199.6
Q ss_pred CCCCCCCeecccCCceEEEEEE-----cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Cee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-----VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 166 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 166 (414)
+-|++.+.||+|+||.||.++. .++..|++|.++.. .......+.+|+.+++.++|||++++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478889999999999999974 34778999998753 344456789999999999999999999999875 568
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 89999999999999986543 24799999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC--------CCcchHHHHHHH
Q 043285 247 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSD--------NNLNLIGHAWKL 317 (414)
Q Consensus 247 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~--------~~~~~~~~~~~~ 317 (414)
+...... .......++..|+|||.+.+..++.++|||||||++|||++++.|....... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 5432211 1122345677899999999889999999999999999999987653221100 000001111111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.......... .. ....+.+++.+||+.+|++|||+.++++.|+.
T Consensus 239 ~~~~~~~~~~-----~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 239 LEEGKRLPRP-----PN----CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHcCccCCCC-----CC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 1111111100 11 12357789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=295.38 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=196.6
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEE-eCCeeeEEEeec
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI-QGEEKLLIYEFM 173 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~ey~ 173 (414)
++|++.+.||+|+||.||++.. .|..|++|.++... ..+.+.+|+.+++.++|+|++++++++. .++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 5788899999999999999976 57889999886532 3467889999999999999999999764 456789999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++..... ..+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999875433 34789999999999999999999988 9999999999999999999999999987643211
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
....++..|+|||++.+..++.++|||||||++|||++ |+.|+.... ........ .........+
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~----~~~~~~~~~~---- 222 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRV----EKGYKMDAPD---- 222 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----hcCCCCCCCC----
Confidence 12234568999999999899999999999999999998 888864321 11111111 1111111111
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. ....+.+++.+||+.+|++|||+.++++.|..
T Consensus 223 -~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 -G----CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -C----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1 12356678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=301.43 Aligned_cols=250 Identities=25% Similarity=0.344 Sum_probs=194.9
Q ss_pred CCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 97 FSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
|+..+.||+|+||+||++... +++.||+|.+.... ......+.+|+.+++.++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666789999999999999764 58899999986522 22334577899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999988865432 34899999999999999999999988 9999999999999999999999999987643211
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
......|+..|+|||.+.+..++.++|+|||||++|||++|..||....... ............ ... ..
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~-~~~-----~~ 225 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLET-EEV-----YS 225 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhcc-ccc-----cC
Confidence 1223468999999999999999999999999999999999999975432111 111111111110 001 11
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPS-----MPSVIL 366 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 366 (414)
... ...+.+++..||+.||++||+ +.+++.
T Consensus 226 ~~~----~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 226 AKF----SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccC----CHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 111 124567888999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=298.48 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=198.7
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-C---CEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.+|++.+.||+|+||.||+|.... + ..|++|.+... .......+..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998643 3 35999998753 444567899999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++.... ..+++..+..++.|++.|++|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999986543 24889999999999999999999988 99999999999999999999999999876533
Q ss_pred CCCccccc-cc--cccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 250 DETEGNTN-RV--VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 250 ~~~~~~~~-~~--~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
........ .. ..+..|+|||.+.+..++.++|||||||++||+++ |..||..... ........ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~----~~~~~~ 231 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIE----QDYRLP 231 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHH----cCCcCC
Confidence 22111111 11 12457999999999999999999999999999886 8888643221 11111111 111100
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. .. ....+.+++.+||+.+|.+||++.+++..|+.
T Consensus 232 ~~-----~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 232 PP-----MD----CPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred Cc-----cc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 00 11 12346678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=295.95 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=201.3
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|++.+.||+|+||.||+|...+ +..+++|.+..... .+.+.+|+.+++.++|||++++++++.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4679999999999999999998765 78999999875432 67899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++.... ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (256)
T cd06612 80 CGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM- 153 (256)
T ss_pred CCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence 99999999986433 34899999999999999999999988 9999999999999999999999999988754322
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......++..|+|||.+.+..++.++||||||+++|+|++|+.|+......... .. ......... .
T Consensus 154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---~~----~~~~~~~~~-----~ 220 (256)
T cd06612 154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---FM----IPNKPPPTL-----S 220 (256)
T ss_pred -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---hh----hccCCCCCC-----C
Confidence 1223345788999999999999999999999999999999999997643221110 00 000000000 0
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
........+.+++.+||+.+|++|||+.|+++
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 --DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00111235677899999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=312.98 Aligned_cols=242 Identities=23% Similarity=0.304 Sum_probs=186.4
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHH-HHHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||+++.. +++.||+|++.+.. ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 46789999986521 12223444444 456788999999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|.+++..... +....+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~~L~~~~~~~~~---~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~ 152 (325)
T cd05602 81 GELFYHLQRERC---FLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGT 152 (325)
T ss_pred CcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCC
Confidence 999999875443 778888899999999999999998 99999999999999999999999999875321 1222
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ..... .. . ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i---~~~~~--~~-~----~~~ 219 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNI---LNKPL--QL-K----PNI 219 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHHHH---HhCCc--CC-C----CCC
Confidence 3345789999999999999999999999999999999999999753221 1111111 11110 00 0 111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
...+.+++.+||+.+|.+||++.+.+..
T Consensus 220 ----~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 220 ----TNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred ----CHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1246678889999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=296.65 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=199.8
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-CC---EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-GQ---EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
++|+..+.||+|+||.||+|.... +. .+++|.+... .....+.+..|+.+++.++|||++++.+++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 567888999999999999998642 33 6899988653 344556788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++.... ..+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999986533 24889999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCccc-cccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 250 DETEGN-TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 250 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
...... ......+..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....... .........
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i----~~~~~~~~~ 232 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAI----NDGFRLPAP 232 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHH----hcCCCCCCC
Confidence 221111 111223457999999998899999999999999999997 9988743221 1111111 111111000
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. .....+.+++.+||+.+|++||++.+|++.|..
T Consensus 233 ~---------~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 233 M---------DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred C---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=295.61 Aligned_cols=254 Identities=31% Similarity=0.456 Sum_probs=201.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.++|++.+.||+|+||.||++...++..+++|.+... ......+.+|+.+++.++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678999999999999999998877888999988653 3345678899999999999999999999887 7789999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 83 AKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred CCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 99999999976432 34788899999999999999999987 99999999999999999999999999876533221
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......++..|+|||.+....++.++|+|||||++|++++ |+.||.... ........ .........
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~----~~~~~~~~~----- 225 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRAL----ERGYRMPRP----- 225 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH----hCCCCCCCc-----
Confidence 11122335677999999998899999999999999999999 888865321 11111111 111111110
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. ....+.+++.+||+.+|++||++.++++.|++
T Consensus 226 ~~----~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 EN----CPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cc----CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11 12357788999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=296.23 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=186.7
Q ss_pred CeecccCCceEEEEEEcC---CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCC
Q 043285 101 KKLGQGGFGPVYKGKLVD---GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 176 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g 176 (414)
+.||+|+||.||+|...+ ...+++|.+... .......+.+|+..++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997543 346888877543 3334567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcccc--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 177 SLDSFIFDQER--CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 177 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+|.+++..... ....++.....++.|++.|++|||+++ ++||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 223567788899999999999999998 9999999999999999999999999986543222111
Q ss_pred ccccccccccccccccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 255 NTNRVVGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
......++..|+|||++.. ..++.++|||||||++|||++ |..||.... ..+...... . ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~~~~~~~~---~-~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS---DEQVLKQVV---R-EQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC---HHHHHHHHh---h-ccCccC
Confidence 1223345678999998643 456889999999999999999 667764321 111111111 1 111112
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
..+....... ..+.+++..|| .||++|||+++|++.|.
T Consensus 231 ~~~~~~~~~~----~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLKYS----DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccccCC----HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222221222 23445667788 59999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=295.68 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=199.7
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
+|++.+.||+|+||.||++... ++..+++|.+.. ......+.+..|+.+++.++|+|++++++.+.+.+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999764 588999999864 23445567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++..... ..++...+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 154 (255)
T cd08219 81 DGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-- 154 (255)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence 99999998865332 34788999999999999999999998 9999999999999999999999999987653221
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..... ... ......... .
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~~~~---~~~-~~~~~~~~~-----~ 222 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLI---LKV-CQGSYKPLP-----S 222 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HHHHH---HHH-hcCCCCCCC-----c
Confidence 12233568889999999999899999999999999999999999975321 11111 111 111111111 1
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.. ...+.+++.+||+.||++|||+.+++..
T Consensus 223 ~~----~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HY----SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cc----CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11 1246678899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=299.39 Aligned_cols=262 Identities=28% Similarity=0.437 Sum_probs=202.3
Q ss_pred CCCCCCCeecccCCceEEEEEEc-----CCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-----DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 166 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 166 (414)
+.|++.+.||+|+||.||++... .+..+|+|.+...... ....+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999753 3678999999764332 56789999999999999999999999987 5578
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
+++|||+++++|.+++..... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999976442 4899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc--------chHHHHHHH
Q 043285 247 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNL--------NLIGHAWKL 317 (414)
Q Consensus 247 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~ 317 (414)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6422211 1111234456799999998889999999999999999999999886433221100 011111111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.......... . .....+.+++.+||+.+|++|||+.||+++|+.
T Consensus 239 ~~~~~~~~~~-----~----~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 239 LKEGERLPRP-----P----SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred HHcCCcCCCC-----c----cCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 1111110000 0 112457789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=314.00 Aligned_cols=256 Identities=20% Similarity=0.247 Sum_probs=196.7
Q ss_pred HhcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 92 SATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
...++|++.+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34578999999999999999999875 5788999998642 2233456788999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+||||+++|+|.+++... .++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 999999999999998643 2788888999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCccccccccccccccccccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDG----QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
.... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .............
T Consensus 193 ~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~ 265 (371)
T cd05622 193 NKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNS 265 (371)
T ss_pred CcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCc
Confidence 3221 1122345799999999998754 378999999999999999999999853211 1111111111111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHh
Q 043285 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPED--RPSMPSVILML 368 (414)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~L 368 (414)
..+.+. .. ....+.+++.+||+.++.+ ||++.|+++..
T Consensus 266 ~~~~~~---~~----~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 LTFPDD---ND----ISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ccCCCc---CC----CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111110 01 1224566888999844433 78999999865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=317.78 Aligned_cols=201 Identities=26% Similarity=0.383 Sum_probs=173.3
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||+++.. +++.||+|++... .......+..|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999764 5889999998652 2334567788999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++..... +++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT---LSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999876443 889999999999999999999998 999999999999999999999999998754221
Q ss_pred CCc---------------------------------cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 043285 251 ETE---------------------------------GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 297 (414)
Q Consensus 251 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~ 297 (414)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113468999999999999999999999999999999999999
Q ss_pred CCCC
Q 043285 298 NRGF 301 (414)
Q Consensus 298 p~~~ 301 (414)
||..
T Consensus 235 Pf~~ 238 (360)
T cd05627 235 PFCS 238 (360)
T ss_pred CCCC
Confidence 9854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=297.66 Aligned_cols=253 Identities=29% Similarity=0.416 Sum_probs=200.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.+.|++.+.||+|+||.||+|+... +..|++|.+........+.+..|+.+++.++|||++++++.+......++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 4679999999999999999998754 789999999876666677889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|..++.+.. ..+++..+..++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 91 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 91 CPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 99999998875433 23899999999999999999999987 999999999999999999999999998754221
Q ss_pred cccccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 253 EGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
........++..|+|||.+. ...++.++|||||||++|||++|+.|+..... ........... .....
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~-~~~~~ 236 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE-PPTLS 236 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCC-CccCC
Confidence 12223456788999999884 34578899999999999999999999754321 11111111111 11110
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. ... ...++.+++.+||+.+|++||++.++++.
T Consensus 237 ~---~~~----~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 Q---PSK----WSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred C---Ccc----cCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 011 12246778999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=300.38 Aligned_cols=267 Identities=22% Similarity=0.324 Sum_probs=204.4
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHh--cCCCceeeeEeEEEeCC----ee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE----EK 166 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~ 166 (414)
..++..+.+.||+|.||.||+|++ .|..||||++....+ +.+.+|.++++. ++|+||+.|++.-..++ ++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 346788889999999999999999 789999999987544 356677777765 59999999998865443 68
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeeeccCCCCCEEEcCCCCeEEEee
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ-----DSRLRIIHRDLKASNVLLDQDMNPKISDF 241 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~iiH~dlk~~Nill~~~~~~kL~Df 241 (414)
+||++|.+.|||.|+|... +++....++++..+|.||++||. +|++.|.|||||+.||||.+++.+.|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 9999999999999999764 38999999999999999999994 57888999999999999999999999999
Q ss_pred cCccccCCC--CCccccccccccccccccccccCC----CCC--cchhHHHHHHHHHHHHhCC----------CCCCCCC
Q 043285 242 GLARAFGGD--ETEGNTNRVVGTYGYMAPEYASDG----QFS--VKSDVFSFGILLLEIVSGK----------KNRGFYH 303 (414)
Q Consensus 242 gl~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~----~~~--~~sDvwslGvil~elltg~----------~p~~~~~ 303 (414)
|+|-..... ......+..+||.+|||||++... .|. ..+||||||.++||++..- .||...-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999765433 223345667899999999998654 222 3689999999999997522 4443222
Q ss_pred CCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 043285 304 SDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372 (414)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 372 (414)
+.+... ... ...-..+.+-....+...+.+.+..+.++|..||..+|..|.|+--+-+.|....
T Consensus 441 p~DPs~--eeM---rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 441 PSDPSF--EEM---RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCCH--HHH---hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 222110 000 1111222222233334556677888999999999999999999988888775544
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=293.98 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=198.5
Q ss_pred CCCCCCeecccCCceEEEEEEcCCCEEEEEEecccC------hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999988789999999886421 22345688999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
+||+++++|.+++.+.. .+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999996543 3788999999999999999999988 99999999999999999999999999876532
Q ss_pred CC----CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhc-CCCc
Q 043285 250 DE----TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE-GMPS 324 (414)
Q Consensus 250 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 324 (414)
.. .........++..|+|||.+.+..++.++|||||||++|+|++|..||...... ......... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~ 228 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL------AAMFYIGAHRGLMP 228 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH------HHHHHhhhccCCCC
Confidence 11 111222346888999999999999999999999999999999999997532111 111111111 1111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ....+ ...+.+++.+||+.+|.+||++.|+++
T Consensus 229 ~-----~~~~~----~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 R-----LPDSF----SAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C-----CCCCC----CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 11111 234677889999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=308.40 Aligned_cols=241 Identities=24% Similarity=0.337 Sum_probs=190.4
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 170 (414)
+|+..+.||+|+||+||+++.. +|+.||+|++.+. .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999764 5889999998752 2334456778888888886 567888999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999886544 3899999999999999999999988 999999999999999999999999998753221
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .... ..
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~---~~~~--~~---- 220 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIM---EHNV--SY---- 220 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH---hCCC--CC----
Confidence 1 122345689999999999999999999999999999999999999754321 11111111 1110 01
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 361 (414)
.... ...+.+++.+||+.+|.+|++.
T Consensus 221 -p~~~----~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 -PKSL----SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CccC----CHHHHHHHHHHcccCHhhCCCC
Confidence 1111 1246678899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=296.33 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=199.6
Q ss_pred CCCCCCCeecccCCceEEEEEEc-C---CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-D---GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.+|++.+.||+|+||.||+|+.. + +..+++|.++.. .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888999999999999999763 2 336899988653 334456889999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999996543 24789999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCcc-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 250 DETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 250 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
..... ......++..|+|||.+.+..++.++|+||||+++||+++ |..||...... ....... ........
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~ 231 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIE----EGYRLPAP 231 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHh----CCCcCCCC
Confidence 22111 1111223568999999999899999999999999999886 99887533221 1111111 11110000
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. .....+.+++.+||+.+|.+||++.++++.|..
T Consensus 232 -----~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 232 -----M----DCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -----C----CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 112346788999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=300.97 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=195.0
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+|++.+.||+|++|.||+|+.. ++..|++|.++.. .......+.+|+.+++.++|||++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999874 5889999998642 223346788899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
++ ++|.+++........+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 688888865444345899999999999999999999988 9999999999999999999999999987653221
Q ss_pred ccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC---------
Q 043285 253 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM--------- 322 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 322 (414)
.......+++.|+|||.+.+. .++.++|||||||++|+|+||+.||...... .........+....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI---DQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCCCChhhhhcchh
Confidence 111223568899999988654 5789999999999999999999987532211 01100000000000
Q ss_pred -------CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 323 -------PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 323 -------~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
............ ......++.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSA-VKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHh-cCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 0001234568999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=293.65 Aligned_cols=248 Identities=30% Similarity=0.447 Sum_probs=195.8
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCChh
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 179 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~ 179 (414)
+.||+|+||.||++...+++.|++|.+..... .....+.+|+.+++.++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999887799999999876333 35568899999999999999999999999999999999999999999
Q ss_pred HHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccc
Q 043285 180 SFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 259 (414)
Q Consensus 180 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~ 259 (414)
+++..... .+++..+..++.+++.|+.|||+++ ++||||+|+||+++.++.++|+|||++...............
T Consensus 81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99865332 4788999999999999999999988 999999999999999999999999998765322211111222
Q ss_pred cccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHH
Q 043285 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLA 338 (414)
Q Consensus 260 ~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (414)
..+..|+|||.+.++.++.++|||||||++|||+| |..||...... ..... ......... .. .
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~~----~~~~~~~~~-----~~----~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRER----IESGYRMPA-----PQ----L 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHHH----HhcCCCCCC-----Cc----c
Confidence 34567999999998899999999999999999999 77776433211 11111 111110000 01 1
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 339 EVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 339 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
....+.+++.+||+.+|.+|||+.|+++.|.
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1235778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=297.04 Aligned_cols=240 Identities=21% Similarity=0.359 Sum_probs=186.3
Q ss_pred CeecccCCceEEEEEEcC-------------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 101 KKLGQGGFGPVYKGKLVD-------------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
+.||+|+||.||+|...+ ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2258889887655555567888999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC-------eEEEe
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-------PKISD 240 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~-------~kL~D 240 (414)
+||||+++|+|..++.... ..+++..++.++.|+++||+|||+.+ ++||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999998886533 24889999999999999999999988 999999999999987664 89999
Q ss_pred ecCccccCCCCCcccccccccccccccccccc-CCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCCcchHHHHHHHh
Q 043285 241 FGLARAFGGDETEGNTNRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIV-SGKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 241 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
||++..... .....++..|+|||.+. +..++.++|||||||++|||+ +|..|+...... ......
T Consensus 156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~ 222 (262)
T cd05077 156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-------EKERFY 222 (262)
T ss_pred CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------HHHHHH
Confidence 999875422 12235678899999887 467899999999999999998 477665422110 011111
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
..... ... .....+.+++.+||+.||.+||++.++++.|+
T Consensus 223 ~~~~~--~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQCM--LVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCcc--CCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 11110 001 01235678899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=308.68 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=207.6
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccCh---hhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 167 (414)
....|++.+.||.|.||.||+++... |+.+|+|.+.+... .....+.+|+.+|+++. ||||+.+.+.|.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45679999999999999999998755 99999999976332 34568999999999998 999999999999999999
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC----CCeEEEeecC
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFGL 243 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~----~~~kL~Dfgl 243 (414)
+|||+|.||.|.+.+... .+++.....++.|+++++.|||+.+ ++||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999776 2899999999999999999999988 9999999999999643 4799999999
Q ss_pred ccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... .......
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF- 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC-
Confidence 998643 345667899999999999999999999999999999999999999986443222111 1111111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.+ ............-+++..|+..||.+|+|+.++++.
T Consensus 256 -~f-----~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -DF-----TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CC-----CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11 111111222345578889999999999999999984
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=307.28 Aligned_cols=255 Identities=20% Similarity=0.231 Sum_probs=194.1
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||+++.. +++.||+|.+.+. .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999865 5788999998652 2233456788999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997532 23788899999999999999999988 999999999999999999999999998765332
Q ss_pred CCccccccccccccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
.. .......||+.|+|||++.+ +.++.++|||||||++|||++|+.||..... ...............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~ 228 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERFQ 228 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCccc
Confidence 21 11223568999999999875 5678999999999999999999999753211 111111111111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPED--RPSMPSVILM 367 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~ 367 (414)
+.. ... . ....+.+++.+|++.++.+ |++++++++.
T Consensus 229 ~p~-~~~-~----~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPS-HIT-D----VSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCC-ccc-c----CCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111 000 1 1234667788888865544 5688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=299.12 Aligned_cols=253 Identities=23% Similarity=0.411 Sum_probs=198.6
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
++|.+.+.||+|+||.||+|+.. ++..|++|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57888899999999999999764 58899999987655455567888999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...... .
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~ 160 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--I 160 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--c
Confidence 9999999986544 3899999999999999999999998 999999999999999999999999998765322 1
Q ss_pred ccccccccccccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.......|+..|+|||.+. ...++.++|||||||++|+|++|..|+....... .. ................
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~---~~~~~~~~~~~~~~~~ 234 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---AL---FLMTKSNFQPPKLKDK 234 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hH---HhhhccCCCCCccccc
Confidence 2223456889999999874 4568899999999999999999999864322111 11 0000011110000000
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. .. ...+.+++.+||+.+|++||++.++++.
T Consensus 235 ~--~~----~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 235 M--KW----SNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred C--CC----CHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 11 1246678999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=293.03 Aligned_cols=247 Identities=27% Similarity=0.405 Sum_probs=190.7
Q ss_pred eecccCCceEEEEEEc---CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCC
Q 043285 102 KLGQGGFGPVYKGKLV---DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 177 (414)
Q Consensus 102 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~ 177 (414)
.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 34569999987543 334467889999999999999999999885 457899999999999
Q ss_pred hhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc-c
Q 043285 178 LDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-T 256 (414)
Q Consensus 178 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~-~ 256 (414)
|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........... .
T Consensus 81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999986432 24899999999999999999999988 99999999999999999999999999976533222111 1
Q ss_pred ccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 257 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 257 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..... ............
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~----~~~~~~~~~~~~------- 221 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEVMS----FIEQGKRLDCPA------- 221 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHHHH----HHHCCCCCCCCC-------
Confidence 11223578999999988889999999999999999996 8888753321 11111 111111111111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.....+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 222 --~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 222 --ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred --CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 112356678999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=301.53 Aligned_cols=250 Identities=24% Similarity=0.418 Sum_probs=200.3
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|++.+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++|+|++++++++..+...++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46899999999999999999986 46899999999764444556788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~- 169 (297)
T cd06656 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (297)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc-
Confidence 9999999998543 3788899999999999999999988 9999999999999999999999999987653222
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......... . ......+ .... .
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---~---~~~~~~~-~~~~---~ 238 (297)
T cd06656 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---L---IATNGTP-ELQN---P 238 (297)
T ss_pred -cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---e---eccCCCC-CCCC---c
Confidence 11223467889999999999999999999999999999999999975322211100 0 0000100 0000 0
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. .....+.+++.+||+.+|++||++.++++
T Consensus 239 ~----~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 E----RLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred c----ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 11123567889999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=293.47 Aligned_cols=252 Identities=27% Similarity=0.460 Sum_probs=199.4
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
.+|++.+.||+|+||.||++...++..+++|.+.... .....+..|+.+++.++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4678889999999999999988778899999886532 234578899999999999999999999999999999999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+++|.+++..... .+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 9999999865432 3788999999999999999999988 999999999999999999999999998765322111
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......++..|+|||.+.++.++.++||||||+++|||++ |..||..... ....... ...... ..+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~~~~~--~~~~--- 224 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETI----NAGFRL--YKPR--- 224 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHH----hCCCCC--CCCC---
Confidence 1112234578999999998899999999999999999998 8888653221 1111111 111000 0010
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
. ....+.+++.+||+.+|++|||+.++++.|.
T Consensus 225 ~----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 L----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred C----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 0 1235778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=301.21 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=198.4
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++|++.+.||+|+||.||+|+.. +|+.|++|++.... ....+.+.+|+.+++.++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999875 58899999886422 2234567899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++++|..++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998888765433 3899999999999999999999988 9999999999999999999999999998764322
Q ss_pred CccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH--------Hhhc-C
Q 043285 252 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWK--------LWNE-G 321 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~-~ 321 (414)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+..... .+.. .
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457789999999876 5678999999999999999999999864332211111110000 0000 0
Q ss_pred CCcccccccccCcCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 322 MPSQLIDSCFQDSFNLA-----EVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 322 ~~~~~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.......+......... ....+.+++.+||+.+|++|||+.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000000000111 12456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=292.66 Aligned_cols=248 Identities=33% Similarity=0.480 Sum_probs=193.1
Q ss_pred CeecccCCceEEEEEEcC----CCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLVD----GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||+|.... +..+++|.+..... ...+.+..|+.+++.++|+|++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999996532 26899999875332 34567889999999999999999999875 5568999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc-
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG- 254 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~- 254 (414)
|+|.+++.... .+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999997654 4899999999999999999999988 9999999999999999999999999998664322211
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ........ ........ .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~~~~~~-----~ 221 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGERLPRP-----E 221 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCcCCCC-----C
Confidence 1111223467999999998999999999999999999998 8888754321 11222211 11111111 1
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
.. ...+.+++.+||+.+|++||++.++++.|...
T Consensus 222 ~~----~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 222 EC----PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11 13567899999999999999999999999653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=310.00 Aligned_cols=260 Identities=25% Similarity=0.301 Sum_probs=194.3
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 164 (414)
..++|++.+.||+|+||.||++... +|..||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999764 5889999998642 3334567789999999999999999999986543
Q ss_pred -eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecC
Q 043285 165 -EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 165 -~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl 243 (414)
..++||||+++ +|...+.. .++...+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999976 56555532 2788889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH------
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL------ 317 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~------ 317 (414)
+...... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...... .........
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~~ 243 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI---DQWNKVIEQLGTPSA 243 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCcH
Confidence 8754221 1223356899999999999999999999999999999999999998643211 111100000
Q ss_pred ------------hhcCCC--cc-ccccccc-------CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 318 ------------WNEGMP--SQ-LIDSCFQ-------DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 318 ------------~~~~~~--~~-~~~~~~~-------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
+..... .. ....... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 00 0000000 00001112356789999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=303.20 Aligned_cols=260 Identities=24% Similarity=0.335 Sum_probs=190.5
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCceeeeEeEEEeC-----C
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQG-----E 164 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~-----~ 164 (414)
+|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999765 58899999986422 22223455677766655 799999999988642 4
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
..+++|||+++ +|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999975 88888865432 34899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
...... .......++..|+|||.+.+..++.++|||||||++|||++|++||...... ................
T Consensus 156 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLIGLPPED 229 (288)
T ss_pred ccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH---HHHHHHHHHhCCCChh
Confidence 865322 1222346789999999999999999999999999999999999987543221 1111111111100000
Q ss_pred cc------cccccc--C-----cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 325 QL------IDSCFQ--D-----SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 325 ~~------~~~~~~--~-----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. ....+. . .........+.+++.+||+.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000 0 000011234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=299.63 Aligned_cols=255 Identities=26% Similarity=0.375 Sum_probs=201.7
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|++.+.||+|+||+||++... +++.|++|++... .....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999764 5888999987653 334456889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
+++++|.+++.... .+++..+..++.+++.|+.|||+. + ++||||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 99999999886543 388999999999999999999974 5 999999999999999999999999998654221
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC-----cchHHHHHHHhhcCCCccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN-----LNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 326 (414)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.||........ ............. ....+
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 233 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRL 233 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCC
Confidence 12345689999999999888999999999999999999999999864433211 1111111111111 11111
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
.. ......+.+++.+||+.||++|||+.|++++.
T Consensus 234 ~~--------~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 234 PS--------SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred Cc--------hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 10 01223567889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=294.71 Aligned_cols=254 Identities=22% Similarity=0.382 Sum_probs=202.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|++.+.||.|+||.||++... ++..+++|.+........+.+.+|+.+++.++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 467899999999999999999864 4788999999765555678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++.... ..++...+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 99999999886542 23889999999999999999999988 9999999999999999999999999987653211
Q ss_pred ccccccccccccccccccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.|+...... ..............
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~------~~~~~~~~~~~~~~---- 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM------RALFLISKSNFPPP---- 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCCCc----
Confidence 122334678899999998776 8899999999999999999999997532211 11111111111100
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
... ........+.+++.+||+.+|.+|||+.+++.
T Consensus 225 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 11112345778999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=304.01 Aligned_cols=197 Identities=25% Similarity=0.415 Sum_probs=159.8
Q ss_pred CCeecccCCceEEEEEEc---CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCeeeEEEeecC
Q 043285 100 NKKLGQGGFGPVYKGKLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMP 174 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ey~~ 174 (414)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++.. ....+++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 45789999986532 22457789999999999999999999865 446789999996
Q ss_pred CCChhHHhhccc------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCCeEEEeecCc
Q 043285 175 NKSLDSFIFDQE------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLA 244 (414)
Q Consensus 175 ~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~~kL~Dfgl~ 244 (414)
+ +|.+++.... ....++...+..++.|++.||+|||+++ ++||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 7887765321 1234888999999999999999999998 9999999999999 45678999999999
Q ss_pred cccCCCCC-ccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 043285 245 RAFGGDET-EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFY 302 (414)
Q Consensus 245 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~ 302 (414)
........ ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87543221 1223345789999999998774 6899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=295.27 Aligned_cols=248 Identities=29% Similarity=0.448 Sum_probs=191.4
Q ss_pred CeecccCCceEEEEEEcC-CC--EEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||+|+..+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 33 4688888753 344556788999999999 799999999999999999999999999
Q ss_pred CChhHHhhccc-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeec
Q 043285 176 KSLDSFIFDQE-------------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 242 (414)
Q Consensus 176 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfg 242 (414)
|+|.+++.... ....+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1124789999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcC
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEG 321 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
++..... .........+..|+|||++.+..++.++|||||||++|||++ |..||..... ....... ...
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~----~~~ 227 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKL----PQG 227 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHHH----hCC
Confidence 9863211 111111233567999999988899999999999999999997 8888743211 1111111 111
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
...... .. ....+.+++.+||+.+|.+|||+.+++..|..
T Consensus 228 ~~~~~~-----~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 228 YRLEKP-----LN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CCCCCC-----Cc----CCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 111110 01 12246789999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=331.04 Aligned_cols=258 Identities=20% Similarity=0.266 Sum_probs=197.4
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999865 4889999998652 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccc--------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeec
Q 043285 171 EFMPNKSLDSFIFDQER--------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 242 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfg 242 (414)
||+++|+|.+++..... ....++..++.++.|+++||+|||+++ ++||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 123567788899999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCC----------------ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 043285 243 LARAFGGDET----------------EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306 (414)
Q Consensus 243 l~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~ 306 (414)
++........ ........||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 011123468999999999999999999999999999999999999975422111
Q ss_pred CcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhc
Q 043285 307 NLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRP-SMPSVILMLG 369 (414)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~ 369 (414)
.... .. ...+..... .. .....+.+++.+||+.||++|| +++++++.|+
T Consensus 239 ---i~~~--~~--i~~P~~~~p---~~----~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le 288 (932)
T PRK13184 239 ---ISYR--DV--ILSPIEVAP---YR----EIPPFLSQIAMKALAVDPAERYSSVQELKQDLE 288 (932)
T ss_pred ---hhhh--hh--ccChhhccc---cc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1000 00 000000000 00 1112466788999999999997 4566666553
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=322.14 Aligned_cols=257 Identities=20% Similarity=0.249 Sum_probs=188.7
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCC------CceeeeEeEEEeC-C
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH------RNLVKLLGCCIQG-E 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~-~ 164 (414)
..++|++.+.||+|+||+||+|... .++.||||+++... ........|+.+++.++| .+++++++++... .
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 4578999999999999999999764 47889999996532 223455667777777654 4588899988765 4
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCC---------
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDM--------- 234 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~~~~--------- 234 (414)
..++|||++ +++|.+++.... .+++..+..++.|++.||+|||++ + |+||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccc
Confidence 688999988 678888886543 389999999999999999999984 6 99999999999998765
Q ss_pred -------CeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 043285 235 -------NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN 307 (414)
Q Consensus 235 -------~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~ 307 (414)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-- 351 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL-- 351 (467)
T ss_pred ccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--
Confidence 49999999876421 2233467899999999999999999999999999999999999998643321
Q ss_pred cchHHHHHHHhhcCCCcc------------cc------ccccc-----------CcCCHHHHHHHHHHHHhccCCCCCCC
Q 043285 308 LNLIGHAWKLWNEGMPSQ------------LI------DSCFQ-----------DSFNLAEVIRCIHIGLLCVQQHPEDR 358 (414)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~------------~~------~~~~~-----------~~~~~~~~~~~~~l~~~cl~~dP~~R 358 (414)
+.......... ..+.. +. .++.. ..........+++|+.+||++||++|
T Consensus 352 -~~~~~i~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 352 -EHLHLMEKTLG-RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred -HHHHHHHHHcC-CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 11111111000 00000 00 00000 00001112356789999999999999
Q ss_pred CCHHHHHH
Q 043285 359 PSMPSVIL 366 (414)
Q Consensus 359 Ps~~evl~ 366 (414)
||++|+++
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999997
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=293.63 Aligned_cols=249 Identities=28% Similarity=0.439 Sum_probs=188.7
Q ss_pred CeecccCCceEEEEEEcC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe-CCeeeEEEeecC
Q 043285 101 KKLGQGGFGPVYKGKLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFMP 174 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ey~~ 174 (414)
+.||+|+||.||+|...+ +..||+|.+... .....+.+..|+.+++.++|||++++++++.. +...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999997532 357999988643 34456788899999999999999999998764 556789999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc-
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE- 253 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~- 253 (414)
+|+|.+++..... ..++..+..++.|+++|++|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999865432 3677888899999999999999987 999999999999999999999999998765322111
Q ss_pred -cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 254 -GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK-NRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 254 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.......++..|+|||.+.+..++.++|||||||++|||++|.. |+... ........ ....... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~---~~~~~~~-~~----- 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITVY---LLQGRRL-LQ----- 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHH---HhcCCCC-CC-----
Confidence 11122345678999999988899999999999999999999654 44321 11111111 1111110 00
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.... ...+.+++.+||+.+|++||++.|+++.|+.
T Consensus 224 ~~~~----~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 224 PEYC----PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred CCcC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0011 1246789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=298.18 Aligned_cols=239 Identities=23% Similarity=0.335 Sum_probs=184.3
Q ss_pred eecccCCceEEEEEEcC-------------------------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeee
Q 043285 102 KLGQGGFGPVYKGKLVD-------------------------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 156 (414)
Q Consensus 102 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 156 (414)
.||+|+||.||+|.... ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13488898865444445678889999999999999999
Q ss_pred EeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC--
Q 043285 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-- 234 (414)
Q Consensus 157 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-- 234 (414)
+++|.+....++||||+++|+|..++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999886532 24788999999999999999999987 99999999999997643
Q ss_pred -----CeEEEeecCccccCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCC
Q 043285 235 -----NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIV-SGKKNRGFYHSDNN 307 (414)
Q Consensus 235 -----~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~ell-tg~~p~~~~~~~~~ 307 (414)
.++++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..|+.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 3899999987643211 12346788999998865 56899999999999999995 6888865332211
Q ss_pred cchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 308 LNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
.... ..... ... ... ...+.+++.+||+.+|++|||+.++++.|+
T Consensus 230 --~~~~----~~~~~--~~~-----~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 --KERF----YEKKH--RLP-----EPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHH----HHhcc--CCC-----CCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111 11000 000 011 124677899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=295.60 Aligned_cols=254 Identities=25% Similarity=0.303 Sum_probs=204.3
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
+.|++.+.||.|.-|+||+++..+ +...|+|++.+. ......+...|-+||+.++||.++.+|..|......|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 567888999999999999999865 478999999763 3445567788999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC-
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG- 249 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~- 249 (414)
|||+||+|..+++++... .+++..+..++..++-||+|||-.| ||.|||||+||||.++|.+-|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999999877654 4899999999999999999999998 99999999999999999999999999754310
Q ss_pred --------------------------------CCC---------------------ccccccccccccccccccccCCCC
Q 043285 250 --------------------------------DET---------------------EGNTNRVVGTYGYMAPEYASDGQF 276 (414)
Q Consensus 250 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 276 (414)
... ....+..+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 011223579999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCC
Q 043285 277 SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPE 356 (414)
Q Consensus 277 ~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~ 356 (414)
+.++|+|+|||++|||+.|..||.......... ..... +..+.. . ..-...+.+||.+.|.+||+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~------NIv~~--~l~Fp~-----~--~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR------NIVGQ--PLKFPE-----E--PEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH------HHhcC--CCcCCC-----C--CcchhHHHHHHHHHhccChh
Confidence 999999999999999999999986554433211 11111 111111 1 12234567899999999999
Q ss_pred CCCC----HHHHHHH
Q 043285 357 DRPS----MPSVILM 367 (414)
Q Consensus 357 ~RPs----~~evl~~ 367 (414)
+|.. ++||-+.
T Consensus 378 kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhccccchHHhhcC
Confidence 9998 7777653
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=295.49 Aligned_cols=249 Identities=26% Similarity=0.433 Sum_probs=201.3
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|++.+.||.|++|.||+|+.. +++.|++|.+.... ......+.+|+.+++.++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999865 58899999986532 34456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++... .+++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999998654 4899999999999999999999988 9999999999999999999999999998764321
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......++..|+|||.+.+..++.++|||||||++|+|++|..||..... ....... ...........
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~----~~~~~~~~~~~--- 221 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLI----PKNNPPSLEGN--- 221 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHh----hhcCCCCCccc---
Confidence 222344678899999999998899999999999999999999999754321 1111111 11111111111
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. ....+.+++.+||+.+|++|||++++++.
T Consensus 222 -~----~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 -K----FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -c----cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 12246678899999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=296.55 Aligned_cols=257 Identities=27% Similarity=0.423 Sum_probs=200.5
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-CC----EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-GQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
++|++.+.||+|+||.||+|...+ |. .+++|.+.... ......+.+|+.+++.++|||++++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 578888999999999999997643 32 58999886543 3455678899999999999999999999987 78899
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
|+||+++|+|.+++..... .+++..+..++.|++.|++|||+.+ ++||||+|+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999876432 3899999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
............++..|+|||.+.+..++.++|+||||+++||+++ |+.||..... .+..... ........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~~~~~~~- 232 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPDLL----EKGERLPQ- 232 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHH----hCCCCCCC-
Confidence 3222111122234568999999988899999999999999999998 9988754321 1111111 11111000
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
... ....+.+++.+||..+|.+||++.++++.|+....
T Consensus 233 ----~~~----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 233 ----PPI----CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ----CCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 001 11246678889999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=303.73 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=195.2
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 67899999999999999999764 57889999986432 23344677899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 97 58888876543 24788999999999999999999988 9999999999999999999999999987643221
Q ss_pred ccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC---cccc-
Q 043285 253 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP---SQLI- 327 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~- 327 (414)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ............... ..+.
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhhchhhhc
Confidence 112233568899999988654 5789999999999999999999998643221 111111111100000 0000
Q ss_pred -----c---ccccCc----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 328 -----D---SCFQDS----FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 328 -----~---~~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. +..... ........+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 000000 00001224568999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=310.43 Aligned_cols=196 Identities=24% Similarity=0.336 Sum_probs=169.3
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-C-----CceeeeEeEEEeCCeee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-H-----RNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~ 167 (414)
.+|.+.+.||+|+||+|.+|... .++.||||++++. .....+...|+.+|..++ | -|+|+++++|...++.|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 37899999999999999999754 5889999999873 345567788999999997 4 38999999999999999
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC--CCeEEEeecCcc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLAR 245 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~--~~~kL~Dfgl~~ 245 (414)
||+|.+. .+|.+++..+.-. .++...+..++.||+.||.+||+.+ |||.||||+||||.+. ..+||+|||+++
T Consensus 265 iVfELL~-~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeehhhh-hhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999995 5999999876543 3999999999999999999999988 9999999999999754 469999999998
Q ss_pred ccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 301 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~ 301 (414)
...... .....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|..
T Consensus 340 ~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 340 FESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 753221 145678889999999999999999999999999999999766543
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=293.33 Aligned_cols=249 Identities=26% Similarity=0.459 Sum_probs=196.8
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccCh---------hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISE---------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 165 (414)
+|.+...||+|++|.||+|... ++..|++|.+..... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999764 578999998864221 123567889999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.++|+||+++++|.+++.... .++...+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999996543 3788899999999999999999988 9999999999999999999999999988
Q ss_pred ccCCCCCc----cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC
Q 043285 246 AFGGDETE----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG 321 (414)
Q Consensus 246 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
........ .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||..... ........ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAIFKIG-EN 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHHHHHh-cc
Confidence 76422111 111234578899999999998999999999999999999999999754211 11111111 11
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
....+ ... ....+.+++.+||+.||.+||++.|+++
T Consensus 228 ~~~~~-----~~~----~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ASPEI-----PSN----ISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCcC-----Ccc----cCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111 111 1235667888999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=296.57 Aligned_cols=250 Identities=34% Similarity=0.510 Sum_probs=194.5
Q ss_pred CeecccCCceEEEEEEcC-------CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 101 KKLGQGGFGPVYKGKLVD-------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+.||+|+||.||+|+..+ +..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997643 2578999886532 34556788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccc----ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-----CeEEEeecC
Q 043285 173 MPNKSLDSFIFDQE----RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-----NPKISDFGL 243 (414)
Q Consensus 173 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-----~~kL~Dfgl 243 (414)
+++++|.+++.... ....+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996532 2234788999999999999999999987 99999999999999877 899999999
Q ss_pred ccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
+................++..|+|||.+.++.++.++|||||||++|||++ |+.||.... ........ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~---~~~~~~~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN---NQEVLQHV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC---HHHHHHHH----hcCC
Confidence 876533222222223345678999999999999999999999999999998 888875321 11111111 1111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 323 PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
..... . .....+.+++.+||+.+|.+||++.++++.|.
T Consensus 231 ~~~~~-----~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 RLQKP-----E----NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ccCCc-----c----cchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 10100 0 11235678999999999999999999999985
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=294.24 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=197.5
Q ss_pred CCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 97 FSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
|++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 6777899999999999998754 677899988766666677889999999999999999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
++|..++.... ..+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||++...... ...
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~ 159 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR 159 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--ccc
Confidence 99999876432 24899999999999999999999988 999999999999999999999999998764321 122
Q ss_pred ccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 256 TNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.....++..|+|||.+. +..++.++|||||||++|||++|+.||..... .... ....... ......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~---~~~~~~~-~~~~~~-- 230 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVL---LKIAKSE-PPTLAQ-- 230 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHH---HHHhhcC-CCCCCC--
Confidence 23456889999999874 34678899999999999999999998753221 1111 1111111 101100
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
...+ ...+.+++.+||+.+|.+||++.++++.-
T Consensus 231 -~~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 231 -PSRW----SSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -cccc----CHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 0111 13567889999999999999999998644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=308.13 Aligned_cols=193 Identities=22% Similarity=0.321 Sum_probs=163.9
Q ss_pred HhcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 92 SATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
....+|++.+.||+|+||.||+|+.. ++..||+|..... ....|+.+++.++||||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999875 4678999975432 2346899999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 58888875433 34899999999999999999999998 999999999999999999999999998753211
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNR 299 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~ 299 (414)
.......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1222356899999999999999999999999999999999866553
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=294.21 Aligned_cols=252 Identities=28% Similarity=0.431 Sum_probs=195.5
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC------C
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG------E 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~ 164 (414)
+++.|++.+.||+|+||.||+|... ++..||+|.+.... .....+..|+.+++.+ +|+|++++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888899999999999999864 47889999986532 3345788899999998 699999999998753 3
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
..+++|||+++++|.+++..... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 57899999999999999875432 34889999999999999999999988 999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN 319 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 319 (414)
...... ........|+..|+|||++. +..++.++|||||||++|||++|+.||...... ........
T Consensus 159 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------~~~~~~~~ 230 (272)
T cd06637 159 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIPR 230 (272)
T ss_pred eecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------HHHHHHhc
Confidence 765321 12233456889999999886 346788999999999999999999997532211 11111111
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 320 EGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. ...... .. ....+.+++.+||+.+|.+|||+.|+++
T Consensus 231 ~~-~~~~~~----~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NP-APRLKS----KK----WSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CC-CCCCCC----CC----cCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11 111111 11 1234678899999999999999999985
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=301.13 Aligned_cols=249 Identities=25% Similarity=0.442 Sum_probs=200.0
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.+|++.+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++|||++++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999975 468899999987654455677889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++... .+++..+..++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 999999988543 3899999999999999999999998 99999999999999999999999999876532221
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ............ .... ..
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~------~~~~~~~~~~~~-~~~~---~~ 239 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNGTP-ELQN---PE 239 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCc-ccCC---cc
Confidence 122346788999999999989999999999999999999999997542211 111111111110 0000 01
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. ...+.+++.+||+.+|++|||+.+++.
T Consensus 240 ~~----~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 KL----SPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cC----CHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11 124667889999999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=294.21 Aligned_cols=238 Identities=25% Similarity=0.412 Sum_probs=186.8
Q ss_pred CeecccCCceEEEEEEcCCC-----------EEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 101 KKLGQGGFGPVYKGKLVDGQ-----------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999875433 4777877653332 5788899999999999999999999988 778999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-------CeEEEeec
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-------NPKISDFG 242 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-------~~kL~Dfg 242 (414)
|||+++|+|.+++..... .+++..+..++.|++.||+|||+++ ++||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999876442 4889999999999999999999988 99999999999999887 79999999
Q ss_pred CccccCCCCCccccccccccccccccccccCC--CCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCcchHHHHHHHhh
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSG-KKNRGFYHSDNNLNLIGHAWKLWN 319 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 319 (414)
++..... .....++..|+|||++.+. .++.++|||||||++|||++| ..|+...... .... .+.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~~----~~~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKER----FYQ 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHHH----HHh
Confidence 9886532 1223466789999999876 789999999999999999995 5555432211 1111 111
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 320 EGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
.... ...+ ....+.+++.+||..+|.+|||+.++++.|+
T Consensus 221 ~~~~--~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHR--LPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCC--CCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1110 0000 0146778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.00 Aligned_cols=260 Identities=23% Similarity=0.289 Sum_probs=194.8
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 163 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 163 (414)
..++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999764 5888999998752 233456778899999999999999999987543
Q ss_pred CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecC
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl 243 (414)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 67666632 2788889999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhc---
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE--- 320 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 320 (414)
++..... .......+|..|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 246 (364)
T cd07875 173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCP 246 (364)
T ss_pred ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCH
Confidence 9765322 1223456899999999999999999999999999999999999998543211 111111110000
Q ss_pred ---------------CCC--cc-----ccccc-cc--CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 321 ---------------GMP--SQ-----LIDSC-FQ--DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 321 ---------------~~~--~~-----~~~~~-~~--~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
..+ .. ..... .. ..........+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 00 00000 00 00000112356789999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=294.46 Aligned_cols=255 Identities=26% Similarity=0.394 Sum_probs=196.4
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
+++++.....||+|+||.||+|+.. ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 3455555679999999999999854 577899999877666667789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCeEEEeecCccccCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGD 250 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kL~Dfgl~~~~~~~ 250 (414)
|+++++|.+++.........+...+..++.|++.|++|||+.+ ++||||||+||+++. ++.++|+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999999999975432212378888899999999999999988 999999999999986 678999999998765322
Q ss_pred CCccccccccccccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
.. ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.|+....... ... ...........
T Consensus 163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~---~~~~~~~~~~~--- 232 (268)
T cd06624 163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAM---FKVGMFKIHPE--- 232 (268)
T ss_pred CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhH---hhhhhhccCCC---
Confidence 11 12233578899999998664 37899999999999999999999975322111 000 00000000011
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+... ....+.+++.+||+.+|++|||+.|++.
T Consensus 233 --~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 233 --IPES----LSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --CCcc----cCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1111 1234667889999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=289.87 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=201.6
Q ss_pred CCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+|+..+.||.|+||.||.++. .++..+++|.+.. ........+.+|+.++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999875 4588899998764 2345567788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999987653 234899999999999999999999988 99999999999999999999999999886533221
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
......+++.|+|||.+.+..++.++||||||+++|||++|..||.... ..... ..... .......
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~~~~---~~~~~-~~~~~~~----- 222 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLV---VKIVQ-GNYTPVV----- 222 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC---HHHHH---HHHHc-CCCCCCc-----
Confidence 2234568899999999998889999999999999999999999875321 11111 11111 1111110
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
.. ....+.+++.+||+.+|.+||++.++++.+
T Consensus 223 ~~----~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 SV----YSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cc----cCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11 123467788999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=289.83 Aligned_cols=251 Identities=34% Similarity=0.545 Sum_probs=198.2
Q ss_pred CCCCCeecccCCceEEEEEEcC-----CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 97 FSINKKLGQGGFGPVYKGKLVD-----GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
+++.+.||.|+||.||+++..+ +..|++|.+...... ..+.+..|+..++.++|+|++++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998754 378999999764332 5678899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++++|.+++...... .+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999998754331 2899999999999999999999998 999999999999999999999999999876433
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
...... ...+++.|+|||.+.+..++.++||||||+++++|++ |..|+... .......... ........
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---~~~~~~~~~~----~~~~~~~~-- 226 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---SNEEVLEYLK----KGYRLPKP-- 226 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHh----cCCCCCCC--
Confidence 221111 2236789999999988889999999999999999998 67775432 1111111111 11111111
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
.. ....+.+++.+||+.+|++|||+.|+++.|
T Consensus 227 ---~~----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 ---EN----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---Cc----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11 223567789999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=289.45 Aligned_cols=247 Identities=28% Similarity=0.445 Sum_probs=198.1
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
+|+..+.||+|+||.||+|... ++..|++|.+.... ....+.+..|+.+++.++|+|++++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999875 68899999986432 23556789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
+||+++++|.+++.... .+++..+..++.|+++|++|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999986543 3789999999999999999999998 99999999999999999999999999876533
Q ss_pred CCCccccccccccccccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
.. ......++..|+|||.+.... ++.++|+|||||++|+|++|+.||..... .. .............+
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~---~~~~~~~~~~~~~~-- 223 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VA---AVFKIGRSKELPPI-- 223 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HH---HHHHHHhcccCCCc--
Confidence 22 223456788999999987776 89999999999999999999999754321 11 11111111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.... ...+.+++.+||+.+|.+||++.++++
T Consensus 224 ---~~~~----~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 ---PDHL----SDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CCCc----CHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1111 134567888999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=303.89 Aligned_cols=199 Identities=21% Similarity=0.276 Sum_probs=164.9
Q ss_pred CCCeeccc--CCceEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 99 INKKLGQG--GFGPVYKGKL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 99 ~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
+.++||+| +|++||+++. .+|..||+|++... .......+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 6889999976 46889999998653 2344567788999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC-
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET- 252 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~- 252 (414)
++|+|.+++..... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999865332 23889999999999999999999988 99999999999999999999999987654321110
Q ss_pred ----ccccccccccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 043285 253 ----EGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGF 301 (414)
Q Consensus 253 ----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~ 301 (414)
........++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 011122346778999999876 4689999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=292.68 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=203.2
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|++.+.||.|+||+||+|... ++..+++|++... .....+.+.+|+..++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999864 5788999998642 233567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++........+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976443345899999999999999999999988 99999999999999999999999999887643322
Q ss_pred c--cccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 253 E--GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 253 ~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
. .......++..|+|||.+... .++.++|+|||||++|||++|+.||....... ..... ... ....+...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~---~~~-~~~~~~~~ 230 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLT---LQN-DPPSLETG 230 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHH---hcC-CCCCcCCc
Confidence 2 122344688999999998877 78999999999999999999999975432211 11111 111 11111110
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ........+.+++.+||+.||++|||++++++
T Consensus 231 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 A----DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred c----ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00111235678899999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=289.42 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=197.7
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe-CCeeeEEEe
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYE 171 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 171 (414)
+|++.+.||+|++|.||++... +++.|++|.+... .....+.+..|+.+++.++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999764 4788999998642 33445678899999999999999999998764 446789999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++++|.+++..... ..+++.++..++.+++.|++|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999999875432 34899999999999999999999998 9999999999999999999999999998653321
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.......+++.|+|||.+.+..++.++||||||+++++|++|+.||.... .......... ......
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~-~~~~~~----- 222 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIE-GKLPPM----- 222 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHh-cCCCCC-----
Confidence 22334567899999999999999999999999999999999999875321 1111111111 111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.. .....+.+++.+||+.+|++|||+.++++.
T Consensus 223 ~~----~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 PK----DYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cc----ccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11 122357789999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=291.71 Aligned_cols=254 Identities=20% Similarity=0.379 Sum_probs=186.1
Q ss_pred CeecccCCceEEEEEEcCCC---EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCC
Q 043285 101 KKLGQGGFGPVYKGKLVDGQ---EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 176 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g 176 (414)
+.||+|+||.||+|...++. .+++|.+... .....+.+.+|+.+++.++||||+++++.|.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999754433 4566766543 2344568899999999999999999999999999999999999999
Q ss_pred ChhHHhhcccc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 177 SLDSFIFDQER-CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 177 ~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
+|.+++..... ....+...+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999975432 234667778899999999999999987 99999999999999999999999999864322221122
Q ss_pred cccccccccccccccccC-------CCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 256 TNRVVGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIVSG-KKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.....++..|+|||++.. ..++.++|||||||++|||+++ ..|+... ......... .... .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~---~~~~~~~~~---~~~~-~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL---SDREVLNHV---IKDQ-QVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHH---Hhhc-ccccC
Confidence 234467889999998753 2457899999999999999975 4554321 111111111 1111 11222
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
++.....++ ..+.+++..|| .+|++||++.+|++.|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222222222 23555777899 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=299.13 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=196.9
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCC----EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
++|+..+.||+|+||.||+|... +|. .|++|.+.... ......+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56788899999999999999763 343 47888886532 33345788999999999999999999998754 4679
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 999999999999986543 24788999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...... .........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~----~~~~~~~~~- 232 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDL----LEKGERLPQ- 232 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHCCCCCCC-
Confidence 3322222223345678999999999999999999999999999997 8888643221 111111 111111000
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
... ....+.+++.+||..+|++||++.++++.|...
T Consensus 233 ----~~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 233 ----PPI----CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ----CCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011 123567789999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=292.20 Aligned_cols=256 Identities=27% Similarity=0.410 Sum_probs=200.1
Q ss_pred CCCCCCCeecccCCceEEEEEEc------CCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
++|++.+.||+|+||.||+|+.. +.+.|++|.+...... ..+.+..|+.++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999853 2457899988654333 4567899999999999999999999999989999
Q ss_pred EEEeecCCCChhHHhhccccc------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEee
Q 043285 168 LIYEFMPNKSLDSFIFDQERC------MILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 241 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Df 241 (414)
+||||+++|+|.+++...... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754421 14899999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhc
Q 043285 242 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNE 320 (414)
Q Consensus 242 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ....... ...
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~---~~~ 234 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRL---QAG 234 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHH---HcC
Confidence 99875432211 12223356778999999988889999999999999999999 6777642211 1111111 101
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 321 GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
...... .... ...+.+++.+||+.+|++|||+.|++..|+
T Consensus 235 ~~~~~~-----~~~~----~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELPV-----PEGC----PSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCCC-----CCCC----CHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 110000 0111 125677999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=305.43 Aligned_cols=240 Identities=23% Similarity=0.284 Sum_probs=183.5
Q ss_pred ecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc---CCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 103 LGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 103 lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
||+|+||+||+|+.. +++.||+|++.+. ..........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 5889999998642 122233445566666555 699999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|..++.... .+++..+..++.|+++||+|||+++ ++||||||+|||++.++.++|+|||++...... ...
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~ 152 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKT 152 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCC
Confidence 99999886544 3889999999999999999999998 999999999999999999999999998753221 122
Q ss_pred cccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCc
Q 043285 256 TNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (414)
.....||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ..... .. ..... .+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~~~~~---~i-~~~~~-~~~~----~~ 220 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---QQMYR---NI-AFGKV-RFPK----NV 220 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---HHHHH---HH-HcCCC-CCCC----cc
Confidence 3345789999999998765 479999999999999999999999753211 11111 11 11110 1111 11
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCC----CHHHHHH
Q 043285 335 FNLAEVIRCIHIGLLCVQQHPEDRP----SMPSVIL 366 (414)
Q Consensus 335 ~~~~~~~~~~~l~~~cl~~dP~~RP----s~~evl~ 366 (414)
. ...+.+++.+||+.||.+|| ++.++++
T Consensus 221 ~----~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 221 L----SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred C----CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1 12456788999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=292.08 Aligned_cols=253 Identities=26% Similarity=0.459 Sum_probs=198.8
Q ss_pred CCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccC------hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 96 NFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
+|+..+.||+|++|.||++.. .+++.|++|.+.... ....+.+..|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999975 568899999986422 1235678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CeEEEeecCcccc
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAF 247 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kL~Dfgl~~~~ 247 (414)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999986543 3789999999999999999999998 99999999999998776 5999999998766
Q ss_pred CCCCC--ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 248 GGDET--EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 248 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
..... ........++..|+|||.+.+..++.++||||+|+++|+|++|+.||........... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~- 230 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASATTAP- 230 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhccCCCC-
Confidence 43211 1112234678899999999888999999999999999999999999754332211111 11111111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.........+.+++.+||+.+|.+||++.++++
T Consensus 231 --------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 --------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111112245677899999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=294.22 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=200.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|++.+.||.|+||.||++... ++..+++|.+........+.+..|+.+++.++|||++++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999874 5889999998766666667889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++.... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 156 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-- 156 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence 99999999986543 24899999999999999999999998 999999999999999999999999998764322
Q ss_pred cccccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 253 EGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
........+++.|+|||.+. ...++.++||||||+++|||++|+.||...... ......... ....+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~~~~ 229 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKS-EPPTLD 229 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcC-CCCCcC
Confidence 11223456889999999874 345778999999999999999999997543211 111111111 111110
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. .... ...+.+++.+||+.+|.+||++.++++.
T Consensus 230 ~---~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 Q---PSKW----SSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred C---cccC----CHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 0111 1246678889999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=297.72 Aligned_cols=247 Identities=25% Similarity=0.424 Sum_probs=197.3
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.|+..+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666788999999999999764 4778999988643 2345567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++... .+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 999999988542 3789999999999999999999987 9999999999999999999999999987653221
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
.......++..|+|||.+.+..++.++|||||||++|||++|+.|+....... .... ........ +..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~----~~~~~~~~-----~~~ 223 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFL----IPKNSPPT-----LEG 223 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhh----hhcCCCCC-----CCc
Confidence 12223457889999999999999999999999999999999999875322111 1100 11111111 111
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 ----QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 122356788999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=290.48 Aligned_cols=253 Identities=28% Similarity=0.381 Sum_probs=203.8
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|++.+.||+|++|.||+++..+ ++.|++|++..... .....+.+|+..+..++|+|++++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468888999999999999998764 89999999876433 4567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
+++++|.+++.... .++...+..++.|+++|++|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999997643 48999999999999999999999 87 9999999999999999999999999988764322
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+............... . .........
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~-~~~~~~~~~--- 225 (264)
T cd06623 155 D--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---C-DGPPPSLPA--- 225 (264)
T ss_pred C--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH---h-cCCCCCCCc---
Confidence 2 122446788999999999999999999999999999999999997544321111111111 1 111111110
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.. ....+.+++.+||+.+|++|||+.|+++.
T Consensus 226 -~~----~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 -EE----FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -cc----CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 12357778899999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=292.92 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=200.1
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
..|+..+.||.|+||.||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777889999999999999864 5788999998643 344567888999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++... .++...+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 9999999988643 3788899999999999999999987 9999999999999999999999999997653322
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......++..|+|||.+.+..++.++|+|||||++|||++|..|+....... .... ......
T Consensus 156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~----~~~~~~--------- 218 (277)
T cd06640 156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLFL----IPKNNP--------- 218 (277)
T ss_pred -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hhhh----hhcCCC---------
Confidence 12223457888999999998899999999999999999999999875432211 0000 001111
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11112234567789999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=290.74 Aligned_cols=247 Identities=28% Similarity=0.461 Sum_probs=195.4
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
++|++.+.||+|+||.||++.. .++.|++|.+.... ....+.+|+.+++.++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688899999999999999975 67889999986532 335788999999999999999999998654 5799999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+++|.+++..... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 9999999875432 34789999999999999999999987 999999999999999999999999998754211
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......+..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....... ........ ..
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~~~~~~~-----~~ 220 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVKECV----EKGYRMEP-----PE 220 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHH----hCCCCCCC-----CC
Confidence 112234567999999998899999999999999999998 8888753221 1111111 11111111 11
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. ...+.+++.+||+.+|.+||++.++++.|+.
T Consensus 221 ~~----~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GC----PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11 2356688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=292.97 Aligned_cols=254 Identities=24% Similarity=0.426 Sum_probs=197.9
Q ss_pred CCCCCCeecccCCceEEEEEEcC--CCEEEEEEecc----------cChhhHHHHHHHHHHHHh-cCCCceeeeEeEEEe
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVD--GQEIAVKRLSK----------ISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ 162 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~----------~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 162 (414)
+|++.+.||+|+||.||+|.... ++.+++|.+.. ........+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998755 67899998753 122344567788888765 799999999999999
Q ss_pred CCeeeEEEeecCCCChhHHhhcc-cccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCeEEEe
Q 043285 163 GEEKLLIYEFMPNKSLDSFIFDQ-ERCMILDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISD 240 (414)
Q Consensus 163 ~~~~~lv~ey~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dlk~~Nill~~~~~~kL~D 240 (414)
.+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988542 222358899999999999999999996 44 99999999999999999999999
Q ss_pred ecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhc
Q 043285 241 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE 320 (414)
Q Consensus 241 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.... ......... .
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~------~~~~~~~~~-~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLSLATKIV-E 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC------HHHHHHHHh-h
Confidence 99998653322 2334567889999999999889999999999999999999999864321 111111111 1
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 321 GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
...... ..... ...+.+++.+||+.||++||++.|+..++++
T Consensus 228 ~~~~~~----~~~~~----~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVYEPL----PEGMY----SEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccCCcC----CcccC----CHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111111 01111 1346778889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=301.77 Aligned_cols=255 Identities=22% Similarity=0.250 Sum_probs=192.9
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999864 5889999998642 2334456888999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999986532 23888999999999999999999998 999999999999999999999999998765322
Q ss_pred CCccccccccccccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ...............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~ 228 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQ 228 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCccc
Confidence 21 11223468999999999863 4578899999999999999999999753211 111111111111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQ--HPEDRPSMPSVILM 367 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~--dP~~RPs~~evl~~ 367 (414)
+.... ... ...+.+++.+|+.. ++..||++.++++.
T Consensus 229 ~~~~~--~~~----~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPPDV--TDV----SEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCcc--CCC----CHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11100 011 12345566676654 33448899999986
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=299.73 Aligned_cols=195 Identities=27% Similarity=0.430 Sum_probs=158.5
Q ss_pred CeecccCCceEEEEEEcC---CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ey~~~ 175 (414)
..||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.+++.++||||+++++++.. ....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 689999999999998643 4689999886532 22457789999999999999999999854 4567899999975
Q ss_pred CChhHHhhcc------cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCCeEEEeecCcc
Q 043285 176 KSLDSFIFDQ------ERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLAR 245 (414)
Q Consensus 176 g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~~kL~Dfgl~~ 245 (414)
+|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777776422 12234788999999999999999999998 9999999999999 456789999999998
Q ss_pred ccCCCCC-ccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 043285 246 AFGGDET-EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGF 301 (414)
Q Consensus 246 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~ 301 (414)
....... ........+|+.|+|||.+.+. .++.++|||||||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 7643221 1222345689999999998764 589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=292.00 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=195.8
Q ss_pred CCCCCeecccCCceEEEEEEc----CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------
Q 043285 97 FSINKKLGQGGFGPVYKGKLV----DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 164 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 164 (414)
|.+.+.||+|+||.||+|... .+..||+|.+... .....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 3678999998652 3445667889999999999999999999886543
Q ss_pred eeeEEEeecCCCChhHHhhccc---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEee
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQE---RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 241 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Df 241 (414)
..++++||+++|+|.+++.... ....+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875321 2234788999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhc
Q 043285 242 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNE 320 (414)
Q Consensus 242 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
|+++...............+++.|++||.+.+..++.++|||||||++|||++ |+.|+.... ......... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~---~~~~~~~~~----~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE---NSEIYNYLI----K 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC---HHHHHHHHH----c
Confidence 99986543322222223345678999999999999999999999999999999 777764321 111111111 1
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 321 GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
....... ......+.+++.+||+.+|++|||+.++++.|++
T Consensus 231 ~~~~~~~---------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 231 GNRLKQP---------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CCcCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1100000 0112357789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=289.18 Aligned_cols=250 Identities=28% Similarity=0.414 Sum_probs=192.4
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Cee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 166 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 166 (414)
.+|+..+.||+|+||.||++... ++..|++|.+... .......+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999764 5889999988642 123345688899999999999999999998763 567
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++++||+++++|.+++..... +++.....++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999875433 788999999999999999999987 99999999999999999999999999876
Q ss_pred cCCCCC-ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 247 FGGDET-EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 247 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
+..... ........++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~ 229 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPTNPQ 229 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCCCCC
Confidence 532111 1112234578899999999998999999999999999999999999753211 111111111111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+ .... ...+.+++ +||..+|++||+++|+++
T Consensus 230 ~-----~~~~----~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 230 L-----PSHI----SEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred C-----chhc----CHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1 1111 11233344 788899999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=292.22 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=198.0
Q ss_pred CCCCCCCeecccCCceEEEEEEcC----CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD----GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
++|.+.+.||+|+||.||+|...+ ...|++|...... ....+.+.+|+.+++.++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 568888999999999999997643 2468999887543 4556788999999999999999999999875 557899
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++|+|.+++.... ..+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999996543 24899999999999999999999988 99999999999999999999999999886543
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
.... ......++..|+|||.+....++.++||||||+++|||++ |..||...... ....... ........
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~----~~~~~~~~- 230 (270)
T cd05056 160 ESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIE----NGERLPMP- 230 (270)
T ss_pred ccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH----cCCcCCCC-
Confidence 3211 1112234568999999988889999999999999999986 99887533211 1111111 11111111
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
... ...+.+++.+||..+|.+|||+.+++..|.+.
T Consensus 231 ----~~~----~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 231 ----PNC----PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred ----CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 23567788999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.25 Aligned_cols=260 Identities=25% Similarity=0.293 Sum_probs=194.6
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 164 (414)
..++|++.+.||+|+||.||++... .++.||+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999764 5889999998753 3334567788999999999999999999886543
Q ss_pred -eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecC
Q 043285 165 -EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 165 -~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl 243 (414)
..++||||+++ +|.+.+.. .++...+..++.|+++||+|||+++ ++||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46999999975 56665532 2788889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh-----
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW----- 318 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 318 (414)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 239 (355)
T cd07874 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCP 239 (355)
T ss_pred cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence 9764322 1223456899999999999999999999999999999999999998533211 1111000000
Q ss_pred -------------hcCCC--------ccccccccc--CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 319 -------------NEGMP--------SQLIDSCFQ--DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 319 -------------~~~~~--------~~~~~~~~~--~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
....+ ....+.... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 000000000 00001112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=309.34 Aligned_cols=259 Identities=25% Similarity=0.330 Sum_probs=192.7
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 163 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 163 (414)
..++|++.+.||+|+||.||+|.. .++..||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457899999999999999999976 457899999987532 23345677899999999999999999987543
Q ss_pred CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecC
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl 243 (414)
...+++++++ +++|.+++... .+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 77898877532 3899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...............
T Consensus 165 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~ 236 (343)
T cd07878 165 ARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY---IDQLKRIMEVVGTPS 236 (343)
T ss_pred ceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHhCCCC
Confidence 986532 2233468999999999877 5789999999999999999999999753221 111111111000000
Q ss_pred C-----------ccccccccc-CcCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 323 P-----------SQLIDSCFQ-DSFNLA-----EVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 323 ~-----------~~~~~~~~~-~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. ......... ...+.. ....+.+++.+||+.||.+|||+.|++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000000 000000 01235688999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=324.72 Aligned_cols=255 Identities=25% Similarity=0.322 Sum_probs=195.5
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Ceee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 167 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 167 (414)
..++|++.+.||+|+||+||+++.. .+..|++|.+.. ........+..|+.+++.++||||++++++|.+. ...|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4578999999999999999999865 467789998864 2344556788999999999999999999998654 4689
Q ss_pred EEEeecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeeccCCCCCEEEcCC---------
Q 043285 168 LIYEFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDSR----LRIIHRDLKASNVLLDQD--------- 233 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~iiH~dlk~~Nill~~~--------- 233 (414)
+||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999986532 22358999999999999999999998541 349999999999999642
Q ss_pred --------CCeEEEeecCccccCCCCCccccccccccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 043285 234 --------MNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYH 303 (414)
Q Consensus 234 --------~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~ 303 (414)
+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||+||..||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 348999999998653221 2234568999999999854 458999999999999999999999975321
Q ss_pred CCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 304 SDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ...+. ....... .+.. ... ...+.+|+..||+.+|.+||++.|++.
T Consensus 248 ~--~~qli----~~lk~~p--~lpi----~~~----S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 N--FSQLI----SELKRGP--DLPI----KGK----SKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred c--HHHHH----HHHhcCC--CCCc----CCC----CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1 11111 1111111 0000 011 234677899999999999999999984
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=296.92 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=198.6
Q ss_pred HHHHHhcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEE----
Q 043285 88 ATIVSATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCI---- 161 (414)
Q Consensus 88 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~---- 161 (414)
..+....++|++.+.||+|+||.||++... +++.+++|.+.... .....+.+|+.+++.+ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 444556789999999999999999999764 57889999886532 2235678899999999 6999999999884
Q ss_pred -eCCeeeEEEeecCCCChhHHhhcc-cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEE
Q 043285 162 -QGEEKLLIYEFMPNKSLDSFIFDQ-ERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 239 (414)
Q Consensus 162 -~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~ 239 (414)
.+...++||||+++++|.+++... .....+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 345689999999999999987642 12235788999999999999999999987 9999999999999999999999
Q ss_pred eecCccccCCCCCccccccccccccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH
Q 043285 240 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHA 314 (414)
Q Consensus 240 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 314 (414)
|||++....... .......|++.|+|||.+.+ ..++.++|||||||++|||++|+.|+...... ...
T Consensus 167 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~--- 238 (286)
T cd06638 167 DFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RAL--- 238 (286)
T ss_pred cCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHH---
Confidence 999987653221 12233468899999998853 45788999999999999999999997543211 110
Q ss_pred HHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 315 WKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
... ..........+ ... ...+.+++.+||+.+|++|||+.|+++.+
T Consensus 239 ~~~-~~~~~~~~~~~---~~~----~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 FKI-PRNPPPTLHQP---ELW----SNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hhc-cccCCCcccCC---CCc----CHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 01111111110 111 12467789999999999999999999753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=292.06 Aligned_cols=240 Identities=25% Similarity=0.415 Sum_probs=187.0
Q ss_pred CeecccCCceEEEEEEcC--------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 101 KKLGQGGFGPVYKGKLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+.||+|+||.||+|.... ...|++|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997532 234888887665555566788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC--------eEEEeecCc
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--------PKISDFGLA 244 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~--------~kL~Dfgl~ 244 (414)
+++|+|.+++..... .+++..+..++.|++.|++|||+.+ ++||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999875432 4789999999999999999999988 999999999999987765 699999988
Q ss_pred cccCCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGK-KNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
..... .....++..|+|||.+.+. .++.++|||||||++|||++|. .|+..... .... .....
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~---~~~~----~~~~~-- 220 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---QKKL----QFYED-- 220 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---HHHH----HHHHc--
Confidence 65422 2234578889999999874 5799999999999999999995 44322111 1100 01111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 323 PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
...+.. .. ..++.+++.+||+.+|++|||++++++.|+
T Consensus 221 ~~~~~~-----~~----~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 RHQLPA-----PK----WTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cccCCC-----CC----cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011111 11 134678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=290.13 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=196.7
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC----------hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS----------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 164 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 164 (414)
+|.+.+.||+|+||.||+|... +|+.|++|.+.... ....+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4777899999999999999754 58899999875311 112346788999999999999999999999999
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
..++|+||+++++|.+++.... .+++..+..++.|++.|+.|||+++ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999987653 4888999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
................++..|+|||.+.+.. ++.++|+||||+++||+++|..|+.... . ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---~---~~~~~~~~~~~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE---A---IAAMFKLGNKRS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc---h---HHHHHHhhcccc
Confidence 7653322222233456788999999987654 7899999999999999999999974211 1 111111111111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 323 PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
...+.. .........+.+++.+||+.+|.+|||+.++++.
T Consensus 230 ~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPP-----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCc-----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111 1111123457778899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=300.45 Aligned_cols=255 Identities=20% Similarity=0.244 Sum_probs=192.8
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||+++... ++.+|+|++.+. .......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468899999999999999998754 678999998642 2223445788999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++..... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999975322 3788899999999999999999988 999999999999999999999999998764322
Q ss_pred CCcccccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ................
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~ 228 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERFQ 228 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCcccc
Confidence 11 1222356899999999886 3468899999999999999999999975321 1111111111111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCC--CCCCHHHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPE--DRPSMPSVILM 367 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~--~RPs~~evl~~ 367 (414)
+... .... ...+.+++.+|+..++. .||++.|+++.
T Consensus 229 ~p~~--~~~~----s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FPAQ--VTDV----SEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCc--cccC----CHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1110 0111 12455677777755444 47899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=313.68 Aligned_cols=245 Identities=25% Similarity=0.424 Sum_probs=193.5
Q ss_pred CCCCeecccCCceEEEEEEc-CCCEEEEEEe--cc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe--eeEEE
Q 043285 98 SINKKLGQGGFGPVYKGKLV-DGQEIAVKRL--SK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--KLLIY 170 (414)
Q Consensus 98 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~--~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~ 170 (414)
++...||+|+|-+||+|.+. +|-.||=-.+ .+ ..+...+.|..|+.+|+.|+||||++++.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 55689999999999999763 3666653222 11 345566899999999999999999999999988765 77899
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCeEEEeecCccccCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFGG 249 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kL~Dfgl~~~~~~ 249 (414)
|.+..|+|..|+.+..+ .+...+..|+.||++||.|||++. +||+|||||-+||||+.+ |.|||+|+|+|.....
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999987765 889999999999999999999986 789999999999999855 8999999999997632
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
. ......|||.|||||... ..|++..||||||++|+||+|+.+|+. .......+..++ ..+..+.-+.
T Consensus 199 s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs--EC~n~AQIYKKV----~SGiKP~sl~- 266 (632)
T KOG0584|consen 199 S----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS--ECTNPAQIYKKV----TSGIKPAALS- 266 (632)
T ss_pred c----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh--hhCCHHHHHHHH----HcCCCHHHhh-
Confidence 2 233468999999999887 899999999999999999999999953 222222222222 2222221111
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...+ .++.++|.+|+.. .++|||+.|+|.
T Consensus 267 ---kV~d----Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 ---KVKD----PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---ccCC----HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1111 2456789999999 999999999997
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=299.72 Aligned_cols=261 Identities=24% Similarity=0.345 Sum_probs=196.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999875 48899999886422 2234567889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++++|..+..... .+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999988765433 3899999999999999999999988 9999999999999999999999999988653322
Q ss_pred CccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC---------
Q 043285 252 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG--------- 321 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 321 (414)
.......++..|+|||.+.+ ..++.++||||||+++|||++|++||..... .+...........-
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD---IDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHHHhCCCchhhHHHhc
Confidence 12223457889999998875 4578899999999999999999988753221 11111111100000
Q ss_pred ---CCcccccccccCcCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 322 ---MPSQLIDSCFQDSFN-----LAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 322 ---~~~~~~~~~~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.......+....... ......+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000000000 011245778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=288.31 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=199.3
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+|++.+.||+|+||.+|++... +|+.|++|.+.. ........+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999764 588999999864 2344556889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++..... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 999999998865432 23788999999999999999999988 9999999999999999999999999997653321
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......|++.|+|||.+.+..++.++|+|||||++++|++|+.|+.... ..+ ......... .... .
T Consensus 156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~~---~~~~~~~~~-~~~~-----~ 222 (256)
T cd08218 156 -ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN---MKN---LVLKIIRGS-YPPV-----S 222 (256)
T ss_pred -hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC---HHH---HHHHHhcCC-CCCC-----c
Confidence 11223457889999999999999999999999999999999999875321 111 111111111 1111 1
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.. ....+.+++.+||+.+|.+||++.+|++.
T Consensus 223 ~~----~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 223 SH----YSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cc----CCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11 12346778999999999999999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=296.90 Aligned_cols=262 Identities=21% Similarity=0.306 Sum_probs=198.4
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++|++.+.||+|+||.||+|... +++.|++|.++.. .....+.+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999875 4789999988642 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|++++.+..+..... .+++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877776554432 3889999999999999999999988 9999999999999999999999999988764332
Q ss_pred CccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC--------
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM-------- 322 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 322 (414)
. .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... +........+....
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHhhhcc
Confidence 2 122234678899999999888 8899999999999999999999887533211 11111111000000
Q ss_pred ----Cc--cccccc----ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 323 ----PS--QLIDSC----FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 323 ----~~--~~~~~~----~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. ...... ....+.......+.+++.+||+.+|++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 000000 000000111356788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=290.82 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=200.7
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|+..+.||.|+||.||++... +++.+++|.+... .......+.+|+.+++.++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999875 5889999998764 334556788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
+++++|.+++.... ..++...+..++.|+++|++|||+ .+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999987543 348899999999999999999999 77 9999999999999999999999999987653211
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ........... ......+...
T Consensus 156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~-- 227 (265)
T cd06605 156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIV-NEPPPRLPSG-- 227 (265)
T ss_pred ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHh-cCCCCCCChh--
Confidence 112567889999999999999999999999999999999999975432211 11111111111 1111111110
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ....+.+++.+||..+|++|||+.+++.
T Consensus 228 --~----~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 --K----FSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --h----cCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0 2234678889999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=289.84 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=194.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Cee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 166 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 166 (414)
++|++.+.||+|+||.||+|... ++..|++|.+... .....+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999864 4889999987531 123456788899999999999999999998764 467
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
+++|||+++++|.+++.... .+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999986543 3788889999999999999999998 99999999999999999999999999876
Q ss_pred cCCCCC-ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 247 FGGDET-EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 247 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||..... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~- 228 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPTNP- 228 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHHHHHhcCCCCC-
Confidence 532211 1122334588899999999888899999999999999999999999753211 11111111111110
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. ........+.+++.+|+. +|++||+++|+++.
T Consensus 229 ----~----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 ----V----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ----C----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0 111222346677888885 99999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=296.10 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=196.8
Q ss_pred CCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 97 FSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
|.....||+|+||.||++... ++..|+||.+........+.+.+|+..++.++|+|++++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 444578999999999999764 5889999998765555567788999999999999999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
++|.+++... .+++..+..++.|++.||+|||+++ ++||||+|+||++++++.++|+|||++....... ..
T Consensus 104 ~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~ 174 (292)
T cd06658 104 GALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PK 174 (292)
T ss_pred CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--cc
Confidence 9999988543 3789999999999999999999998 9999999999999999999999999987653221 12
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....... .......... ..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~----~~~~~~~~~~-----~~ 242 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRI----RDNLPPRVKD-----SH 242 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhcCCCcccc-----cc
Confidence 2335688999999999988999999999999999999999999753211 1111111 1111111111 00
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.....+.+++.+||+.||++|||++|+++.
T Consensus 243 --~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 --KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011245678889999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=297.77 Aligned_cols=253 Identities=24% Similarity=0.280 Sum_probs=198.9
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||++...+ +..|++|.+..... ...+.+..|+++++.++|+||+++++.+.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468888999999999999998754 88999999975321 24567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+.+++|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999999865432 34899999999999999999999988 999999999999999999999999998754321
Q ss_pred CCc---------------------------cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 043285 251 ETE---------------------------GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 303 (414)
Q Consensus 251 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~ 303 (414)
... ...+...|+..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01123467889999999998889999999999999999999999975332
Q ss_pred CCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 043285 304 SDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS----MPSVIL 366 (414)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs----~~evl~ 366 (414)
.. .. ......... .. ... ......+.+++.+||+.+|++||| ++|++.
T Consensus 237 ~~---~~---~~~~~~~~~--~~-----~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD---ET---FSNILKKEV--TF-----PGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH---HH---HHHHhcCCc--cC-----CCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 11 111111110 00 000 002345778999999999999999 777776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=289.67 Aligned_cols=261 Identities=25% Similarity=0.287 Sum_probs=199.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 170 (414)
++|+..+.||.|++|.||++... +++.+++|.+... .......+.+|+++++.++||||++++++|.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999874 5788999998753 334556789999999999999999999998654 3689999
Q ss_pred eecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 171 EFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
||+++++|.+++.... ....++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999875422 2344788999999999999999999988 99999999999999999999999999875432
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..|+........ ......... .......+.+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~ 231 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELLSYI-VNMPNPELKDE 231 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHHHHH-hcCCchhhccC
Confidence 11 1234578899999999999999999999999999999999999865432111 111111111 11111111111
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
... ...-...+.+++.+||+.+|++|||+.|+++.
T Consensus 232 -~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 -PGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -CCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 110 01123457789999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=294.37 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=200.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|.+.+.||+|+||.||++... ++..|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368999999999999999999753 5788999998654444556788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++.+. .+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~- 169 (293)
T cd06647 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (293)
T ss_pred CCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc-
Confidence 9999999998643 2788899999999999999999998 9999999999999999999999999987653222
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......+++.|+|||.+.+..++.++|||||||++|++++|+.||.......... .. .....+ .. .
T Consensus 170 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~---~~---~~~~~~-~~-----~ 236 (293)
T cd06647 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LI---ATNGTP-EL-----Q 236 (293)
T ss_pred -cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee---eh---hcCCCC-CC-----C
Confidence 12233467889999999988889999999999999999999999985432211100 00 001100 00 0
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
........+.+++.+||+.+|++||++.+++..
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 --NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000112346678899999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=308.02 Aligned_cols=244 Identities=29% Similarity=0.442 Sum_probs=195.7
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
-|.-.+.||.|+||-||-++.. +...||||+++- .....++.+.+|+.+|++++|||++.+-|||......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4666689999999999999864 567899999864 344456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
||- |+-.|++.-.. .++.+.++..|+.+.+.||+|||+++ .||||||+.|||+++.|.|||+|||.+...
T Consensus 107 YCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~---- 176 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIM---- 176 (948)
T ss_pred HHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhc----
Confidence 994 57777775433 24889999999999999999999998 999999999999999999999999999764
Q ss_pred Ccccccccccccccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
...+.++|||.|||||++. .++|+-++||||||++..||...++|.= ..+....+ ..+. .+..+.+..
T Consensus 177 --~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF---nMNAMSAL---YHIA-QNesPtLqs 247 (948)
T KOG0577|consen 177 --APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSAL---YHIA-QNESPTLQS 247 (948)
T ss_pred --CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc---CchHHHHH---HHHH-hcCCCCCCC
Confidence 3445678999999999874 5799999999999999999999988832 22222222 2221 222222211
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.+=...+++++..||++=|.+|||.+++++
T Consensus 248 --------~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 248 --------NEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --------chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 111235678888999999999999988776
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=293.68 Aligned_cols=261 Identities=25% Similarity=0.356 Sum_probs=196.4
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
+|++.+.||+|+||.||+|... +++.|++|.+.... ......+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999864 58899999997532 22345667899999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+ +++|.+++.... ..+++..+..++.|+++||+|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999986543 24899999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc----
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS---- 324 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 324 (414)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|.++|.... ..................
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS---DIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc---cHHHHHHHHHHcCCCchhhhhh
Confidence 211 1222345778999998865 467899999999999999999977654322 112222211111000000
Q ss_pred -----ccccccccCcCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 325 -----QLIDSCFQDSFN-----LAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 325 -----~~~~~~~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
............ ......+.+++.+||+.+|++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 1113467789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=296.57 Aligned_cols=256 Identities=20% Similarity=0.245 Sum_probs=197.4
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||++... .++.|++|.+.... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999764 47889999986532 233457789999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999996543 3889999999999999999999987 999999999999999999999999998642100
Q ss_pred CC-------------ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043285 251 ET-------------EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL 317 (414)
Q Consensus 251 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 317 (414)
.. ........++..|+|||.+.+..++.++|+|||||++|||++|..||.... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---~~~~~~~~--- 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PEELFGQV--- 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH---
Confidence 00 001112457889999999998899999999999999999999999974321 11111111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
....... +..... ....+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~~~~~~----~~~~~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDDIEW----PEGDEA----LPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HhcccCC----CCcccc----CCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111100 000001 12246678999999999999997767666644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=288.03 Aligned_cols=252 Identities=27% Similarity=0.467 Sum_probs=199.1
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+|.+.+.||+|+||.||+|... +++.|++|.++.... ...+.+..|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999864 688999999875433 3677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999987543 3788899999999999999999988 99999999999999999999999999887643322
Q ss_pred ccc--cccccccccccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 253 EGN--TNRVVGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 253 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
... .....++..|+|||.+.+.. ++.++||||||+++||+++|+.||...... . ...... .......+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~---~~~~~~-~~~~~~~~~ 228 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--F---QIMFHV-GAGHKPPIP 228 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--H---HHHHHH-hcCCCCCCC
Confidence 111 12346788999999998766 889999999999999999999998533211 1 111111 111111111
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. .. .....+.+++.+||+.+|.+|||+.|++.
T Consensus 229 ~-----~~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 D-----SL--QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred c-----cc--ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1 10 01224567889999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=293.14 Aligned_cols=258 Identities=28% Similarity=0.441 Sum_probs=197.4
Q ss_pred HHHHHHhcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEe--
Q 043285 87 LATIVSATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ-- 162 (414)
Q Consensus 87 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-- 162 (414)
+.++..+.+.|++.+.||.|+||.||+|+.. +++.+++|.+.... .....+..|+.+++.+ +|+|++++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3344445678999999999999999999864 57889999886532 3345678899999988 69999999999853
Q ss_pred ----CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEE
Q 043285 163 ----GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 238 (414)
Q Consensus 163 ----~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL 238 (414)
....+++|||+++|+|.+++..... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 4578999999999999999865432 34788888999999999999999988 999999999999999999999
Q ss_pred EeecCccccCCCCCcccccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHH
Q 043285 239 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGH 313 (414)
Q Consensus 239 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 313 (414)
+|||++...... ........|+..|+|||.+. +..++.++|||||||++|||++|+.||....... ....
T Consensus 163 ~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~---~~~~ 237 (282)
T cd06636 163 VDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR---ALFL 237 (282)
T ss_pred eeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh---hhhh
Confidence 999998754321 11223456889999999875 3467889999999999999999999975332111 1100
Q ss_pred HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 314 AWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ......... ...+ ...+.+++.+||+.||.+||++.|+++
T Consensus 238 ---~-~~~~~~~~~----~~~~----~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ---I-PRNPPPKLK----SKKW----SKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---H-hhCCCCCCc----cccc----CHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 001111110 1111 235778899999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=291.58 Aligned_cols=244 Identities=27% Similarity=0.351 Sum_probs=197.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||++... +++.|++|.+... .......+.+|+++++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999865 5889999998652 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++++|.+++.... .++...+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999987653 3889999999999999999999988 999999999999999999999999998875332
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ........ . ... ..+
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~---~-~~~-~~~---- 217 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKI---L-EGK-VRF---- 217 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH---h-cCC-ccC----
Confidence 234468899999999988889999999999999999999999975322 11111111 1 111 011
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVIL 366 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~ 366 (414)
.... ...+.+++.+||+.+|.+|| +++|+++
T Consensus 218 -~~~~----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 -PSFF----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -CccC----CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111 23566788999999999999 7777774
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=300.05 Aligned_cols=254 Identities=28% Similarity=0.371 Sum_probs=200.8
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 170 (414)
...|++.++||+||.+.||++...+.+.+|+|++.- .+.+...-+.+|+.+|.+++ |.+|+++++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 457999999999999999999988888899887753 56777889999999999995 999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||-+ .+|..+|...... ...| .+..+..||+.|+.++|.++ |||.||||.|+|+- .|.+||+|||+|..+..+
T Consensus 440 E~Gd-~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred eccc-ccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 9874 4899998765432 2334 77889999999999999998 99999999999984 578999999999987666
Q ss_pred CCccccccccccccccccccccCCC-----------CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQ-----------FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN 319 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 319 (414)
...-....-+||+.||+||.+.... .+.++||||||||||+|+.|+.||+.+.. .+.....+..
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~aKl~aI~~ 587 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QIAKLHAITD 587 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HHHHHHhhcC
Confidence 5555555678999999999885432 45789999999999999999999874321 1222222222
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 320 EGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.+..-++.+ .... ..+++++..||+.||.+|||..|||+.
T Consensus 588 P~~~Iefp~-----~~~~---~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 588 PNHEIEFPD-----IPEN---DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CCccccccC-----CCCc---hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 212111111 1111 127778899999999999999999964
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=285.10 Aligned_cols=248 Identities=24% Similarity=0.414 Sum_probs=197.7
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+|+..+.||+|+||.||++... +++.+++|.+... .......+..|+.+++.++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999764 5788999998642 344567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCeEEEeecCccccCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDE 251 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kL~Dfgl~~~~~~~~ 251 (414)
+++++|.+++..... ..+++..+..++.++++|+.|||+++ ++|+||+|+||+++++ +.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999976432 34789999999999999999999988 9999999999999865 458999999998754321
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...... . ......+.+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~---~-~~~~~~~~~--- 223 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKI---M-SGTFAPISD--- 223 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHH---H-hcCCCCCCC---
Confidence 222346788999999999888999999999999999999999987543211 111111 1 111111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. ...+.+++.+||+.+|.+|||+.|+++
T Consensus 224 --~~----~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 --RY----SPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --Cc----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 224667889999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=282.10 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=195.5
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc-----Ch---hhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI-----SE---QGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 164 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 164 (414)
+.|...+.||.|..++|-++.. ..|...|+|++... .+ .-.+.-..|+.+|+++ .||+|+.+.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 5677788999999999988854 46888999988431 11 1223446799999998 5999999999999999
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
-.++|+|.|+.|.|.+++...- ++++++..+|+.|+.+|+.|||..+ |+||||||+|||++++.++||+|||++
T Consensus 97 F~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 9999999999999999997654 4999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASD------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
+.+.. ...-...+|||+|+|||.+.+ ..|+...|+||+|||||.|+.|.+||- +.. .... .+..
T Consensus 171 ~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--HRk-QmlM----LR~I 240 (411)
T KOG0599|consen 171 CQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--HRK-QMLM----LRMI 240 (411)
T ss_pred eccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--HHH-HHHH----HHHH
Confidence 98743 334456799999999999865 357889999999999999999999962 111 0000 1111
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.++.- ++.. .-..+-....-+|+.+||+.||.+|.|++|+|+
T Consensus 241 meGky-qF~s-----peWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 241 MEGKY-QFRS-----PEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred Hhccc-ccCC-----cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11110 1111 111112234567899999999999999999986
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=294.24 Aligned_cols=261 Identities=21% Similarity=0.303 Sum_probs=192.6
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+|++.+.||+|+||.||+|+.. +|..|++|.+... .......+.+|+.+++.++|||++++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999874 5889999998642 222335677899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
++ ++|.+++.... ..+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 97 47877775432 24899999999999999999999998 9999999999999999999999999988653221
Q ss_pred ccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC----------
Q 043285 253 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG---------- 321 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 321 (414)
.......++..|+|||.+.+. .++.++|||||||++|||+||+.|+... .................
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG--NDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC--CCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 112233568899999988765 4789999999999999999999885321 11111111111100000
Q ss_pred CCcccccccccCcCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 322 MPSQLIDSCFQDSFN-----LAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 322 ~~~~~~~~~~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.+............. ......+.+++.+||+.||.+|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000000000000 011235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=290.46 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=198.4
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+|++.+.||+|+||.||+|... +|+.|++|++.... ......+.+|+.+++.++|||++++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999864 68899999987533 33456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+ +++|.+++.... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999986543 34899999999999999999999988 99999999999999999999999999987643221
Q ss_pred ccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC--------
Q 043285 253 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP-------- 323 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 323 (414)
.......++..|+|||.+.+. .++.++||||+||++|||++|.++|.... .................
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN---DIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC---HHHHHHHHHHHcCCCChHHHhhccC
Confidence 112234678899999988654 46899999999999999999977654321 11111111111110000
Q ss_pred -ccccccccc--CcCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 324 -SQLIDSCFQ--DSFN-----LAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 324 -~~~~~~~~~--~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.....-... .... ......+.+++.+||+.+|++|||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0000 0112567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=286.25 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=198.3
Q ss_pred CCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCeeeEEE
Q 043285 96 NFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIY 170 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 170 (414)
+|++.+.||.|+||.||++.. .++..+++|.+.. ......+.+..|+.+++.++|||++++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999975 4578899998864 334455678899999999999999999998864 44678999
Q ss_pred eecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 171 EFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
||+++++|.+++.... ....+++..++.++.|+++|+.|||..+ ..+++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999986532 2245899999999999999999999322 233999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+.... ........ .......+
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~----~~~~~~~~- 230 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKI----KEGKFRRI- 230 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHH----hcCCCCCC-
Confidence 43221 1233468899999999999899999999999999999999999976432 11111111 11111111
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.. .....+.+++.+||+.+|++||++.+|++.
T Consensus 231 ----~~----~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 231 ----PY----RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----cc----ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11 122356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=297.30 Aligned_cols=204 Identities=26% Similarity=0.399 Sum_probs=168.8
Q ss_pred CCCCCCeecccCCceEEEEEEc---CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Ceee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV---DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 167 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 167 (414)
+|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999874 47899999997632 33446778899999999999999999999988 7899
Q ss_pred EEEeecCCCChhHHhhccc--ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC----CCCeEEEee
Q 043285 168 LIYEFMPNKSLDSFIFDQE--RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ----DMNPKISDF 241 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~----~~~~kL~Df 241 (414)
+||||+++ +|.+++.... ....++...+..++.|++.|+.|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6766664322 1235889999999999999999999998 999999999999999 899999999
Q ss_pred cCccccCCCCC-ccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 043285 242 GLARAFGGDET-EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYH 303 (414)
Q Consensus 242 gl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~ 303 (414)
|++........ ........++..|+|||.+.+. .++.++|||||||++|+|++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99987543222 1122344678899999987664 57999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=292.14 Aligned_cols=262 Identities=23% Similarity=0.336 Sum_probs=194.6
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|++.+.||+|++|.||+|... +++.|++|.+.... ......+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999865 57899999986532 22234567899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++ +|.+++..... .+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.+||+|||++.......
T Consensus 85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 157 (291)
T cd07844 85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS- 157 (291)
T ss_pred CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC-
Confidence 985 89988865432 4789999999999999999999988 9999999999999999999999999987542211
Q ss_pred ccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccc-----
Q 043285 253 EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL----- 326 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 326 (414)
.......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||..... ....................
T Consensus 158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhh
Confidence 11122346788999998875 4589999999999999999999999753321 11111111111111000000
Q ss_pred -----------c-cccc-cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 327 -----------I-DSCF-QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 327 -----------~-~~~~-~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ...+ ...........+.+++.+||+.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0000 00000111245678899999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=282.80 Aligned_cols=251 Identities=28% Similarity=0.450 Sum_probs=203.2
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeeEEE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 170 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 170 (414)
+|...+.||+|++|.||+|... ++..|++|++.... ....+.+.+|+..+++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999875 68899999987543 24567889999999999999999999999988 8899999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++++|.+++.... .+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999987654 4899999999999999999999987 999999999999999999999999999876443
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
..........++..|+|||.+.+..++.++||||||+++++|++|..||.... .................+..
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~-- 227 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPEIPE-- 227 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcCCCc--
Confidence 32112334568889999999998889999999999999999999999976443 11111111111111111111
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.....+.+++.+|++.+|++||++.|++.
T Consensus 228 -------~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 228 -------HLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -------ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11245778889999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=309.32 Aligned_cols=253 Identities=27% Similarity=0.399 Sum_probs=200.9
Q ss_pred CCCCCCCeecccCCceEEEEEEc--CCC--EEEEEEecccChh-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV--DGQ--EIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
++..+.++||+|.||.|+.|.+. +|+ .||||.++..... ....|.+|+.+|.+|+|+|++++||+..+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 34556689999999999999774 344 5899999864433 67899999999999999999999999987 788999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
||.++.|+|.+.|++ .....+-...+..++.|||.||.||.+++ +|||||..+|+|+..-..|||+|||+.+.++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999988 33456888999999999999999999988 99999999999999999999999999998865
Q ss_pred CCCcc-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 250 DETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG-KKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 250 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.+... ......-...|+|||.+....|+.+||||+|||++|||+|+ ..||. .....++++.+.. ... +
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~---G~~g~qIL~~iD~----~er--L- 334 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV---GCRGIQILKNIDA----GER--L- 334 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC---CCCHHHHHHhccc----ccc--C-
Confidence 43322 22223346789999999999999999999999999999994 45543 2233333332221 111 0
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
.....+..++.+++..||..+|.+|||+..+.+.+
T Consensus 335 ------pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 335 ------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 01112334677899999999999999999997433
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=297.34 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=196.1
Q ss_pred CCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 97 FSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
|.....||+|+||.||++... +++.|++|.+........+.+.+|+.+++.++|||++++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334468999999999999764 6889999998654444556788999999999999999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
++|..++... .+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... ..
T Consensus 103 ~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~ 173 (297)
T cd06659 103 GALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PK 173 (297)
T ss_pred CCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cc
Confidence 9999977542 3789999999999999999999988 9999999999999999999999999987543221 12
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...... ........... ....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~----~~~~~~~~~~~---~~~~ 243 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKR----LRDSPPPKLKN---AHKI 243 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HhccCCCCccc---cCCC
Confidence 2335688999999999988999999999999999999999999753221 111111 11111100000 0011
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
...+.+++.+||+.+|++||++.++++.
T Consensus 244 ----~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 ----SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ----CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1245678889999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=290.22 Aligned_cols=249 Identities=26% Similarity=0.421 Sum_probs=206.7
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
+-|.++.+||+|+||.||++.+ ..|+.+|+|.+.- +.+.+++.+|+.+|++.+.|++|++||.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3477788999999999999965 4699999999864 446689999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
..|+..+++.... .++.+.++..++..-++||+|||... -+|||||+.|||++.+|.+||+|||.+..+. +..
T Consensus 111 GAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTM 183 (502)
T KOG0574|consen 111 GAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTM 183 (502)
T ss_pred CCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh--hhH
Confidence 9999999996544 46999999999999999999999986 7999999999999999999999999997653 334
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
...+...|||.|||||++..-.|+.++||||||++..||..|++|+..-++....-. .+.-..+.++.
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM------------IPT~PPPTF~K 251 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM------------IPTKPPPTFKK 251 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe------------ccCCCCCCCCC
Confidence 456678899999999999999999999999999999999999999765443322111 11111111111
Q ss_pred cCCHHH-HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 334 SFNLAE-VIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 334 ~~~~~~-~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.++ ..++-+++.+||-++|++|-|+.++++.
T Consensus 252 ---PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 ---PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ---hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 111 2356789999999999999999999874
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=289.92 Aligned_cols=247 Identities=24% Similarity=0.321 Sum_probs=199.1
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
+|++.+.||.|+||.||+++.. ++..|++|.+.+. .....+.+.+|+.+++.++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999875 5889999999752 22456788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++++|.+++... ..++...+..++.|+++||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998665 24889999999999999999999988 9999999999999999999999999988654321
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
......++..|+|||.+.+..++.++|+||||+++|+|++|..|+......... ........ ......
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~-~~~~~~---- 222 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QIRAKQET-ADVLYP---- 222 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH----HHHHHhcc-ccccCc----
Confidence 223345788999999999888999999999999999999999997644332111 11111110 111110
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSM--PSVI 365 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~--~evl 365 (414)
.. ....+.+++.+||+.||.+||++ +|++
T Consensus 223 -~~----~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 -AT----WSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -cc----CcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11 12467789999999999999999 6665
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=291.93 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=194.7
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++++|.+.+.||+|+||.||+|... ++..|++|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999764 58899999986532 223346678999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||++ +++.+++.... ..+.+..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 67777665432 23678888899999999999999988 999999999999999999999999998754321
Q ss_pred CCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC--------
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG-------- 321 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 321 (414)
. .......+++.|+|||.+.+. .++.++|||||||++|||++|..||..... ........+.....+
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhh
Confidence 1 112233568899999998764 578999999999999999999999864322 111111111111000
Q ss_pred -----CCcccccccccCc-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 322 -----MPSQLIDSCFQDS-----FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 322 -----~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
........+.... ........+.+++.+|++.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000 00011235667889999999999999999984
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=293.34 Aligned_cols=263 Identities=28% Similarity=0.395 Sum_probs=199.9
Q ss_pred cCHHHHHHhcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEe
Q 043285 85 FELATIVSATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 162 (414)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 162 (414)
+.+.++..+.++|.+.+.||+|+||.||++... +++.+++|.+.... .....+..|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 334445556789999999999999999999864 58899999986532 2235677899999998 89999999999875
Q ss_pred C-----CeeeEEEeecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCe
Q 043285 163 G-----EEKLLIYEFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 236 (414)
Q Consensus 163 ~-----~~~~lv~ey~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~ 236 (414)
. ...++|+||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 35799999999999999886421 2234889999999999999999999987 9999999999999999999
Q ss_pred EEEeecCccccCCCCCccccccccccccccccccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchH
Q 043285 237 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLI 311 (414)
Q Consensus 237 kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~ 311 (414)
||+|||++....... .......++..|+|||.+... .++.++|||||||++|||++|+.|+..... .
T Consensus 168 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~------~ 239 (291)
T cd06639 168 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------V 239 (291)
T ss_pred EEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH------H
Confidence 999999988653221 112234678899999987654 368899999999999999999999753211 1
Q ss_pred HHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 312 GHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
....... ......+.++ .. ....+.+++.+||+.+|++||++.|+++.
T Consensus 240 ~~~~~~~-~~~~~~~~~~---~~----~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 KTLFKIP-RNPPPTLLHP---EK----WCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHHh-cCCCCCCCcc---cc----cCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111 1111111110 11 12347789999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=287.83 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=197.4
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
-|+..+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3677789999999999999764 5789999988642 2344567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 999999988543 3789999999999999999999988 9999999999999999999999999987653221
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..|+...... ..... ........ +..
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~----~~~~~~~~-----~~~ 223 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KVLFL----IPKNNPPT-----LEG 223 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HHHHH----HhcCCCCC-----CCc
Confidence 1122345788999999999888999999999999999999999987532211 11111 11111111 111
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. ....+.+++.+||+.+|.+||++.++++.
T Consensus 224 ~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 N----YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred c----cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1 12346678999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=290.38 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=197.2
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC------
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE------ 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------ 164 (414)
..++|++.+.||+|++|.||+|... +++.+++|.+..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4688999999999999999999874 577899998875433 346788999999999 7999999999997654
Q ss_pred eeeEEEeecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecC
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl 243 (414)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999886532 1235899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
+...... ........++..|+|||.+.. ..++.++|||||||++|+|++|+.||...... ... ....
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~ 231 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RAL---FKIP 231 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHH---HHhh
Confidence 8765322 122233468889999998753 35678999999999999999999997532111 111 1111
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ........ .......+.+++.+||..||++|||+.|+++
T Consensus 232 ~-~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 R-NPPPTLKS-------PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred c-cCCCCCCc-------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11111110 0112235678999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=287.89 Aligned_cols=248 Identities=25% Similarity=0.428 Sum_probs=196.8
Q ss_pred CCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcC---CCceeeeEeEEEeCCeeeEEE
Q 043285 96 NFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 170 (414)
.|+..+.||+|+||.||+|.. .++..|++|.+... .......+.+|+.+++.++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477789999999999999986 46889999998653 3345567888999999986 999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999988543 4889999999999999999999998 999999999999999999999999999876433
Q ss_pred CCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
. .......|+..|+|||.+.++ .++.++|||||||++|+|++|..||...... ..... ........+..
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~~-~~~~~~~~~~~- 224 (277)
T cd06917 155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMML-IPKSKPPRLED- 224 (277)
T ss_pred c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhhc-cccCCCCCCCc-
Confidence 2 222334688899999988754 5689999999999999999999997532211 11100 00111111111
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.. ....+.+++.+||+.||++||++.|+++.
T Consensus 225 ---~~----~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 ---NG----YSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---cc----CCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11 12356778899999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=287.10 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=191.0
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHH-HHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++|++.+.||+|+||.||++... +|..||+|+++... ......+..|+.. ++.++|||++++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999875 58999999987532 2233455556665 666789999999999999999999999
Q ss_pred ecCCCChhHHhhcc-cccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 172 FMPNKSLDSFIFDQ-ERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 172 y~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|++ |+|.+++... .....+++..+..++.|++.||+|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888877542 2234589999999999999999999987 6 99999999999999999999999999876532
Q ss_pred CCCccccccccccccccccccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASD----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
. .......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||..... ..... .... ......
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~---~~~~-~~~~~~ 227 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQL---KQVV-EEPSPQ 227 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHH---HHHH-hcCCCC
Confidence 1 11222457889999998865 4568899999999999999999999753221 11111 1111 111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+... .+ ...+.+++.+||+.+|.+||++.++++
T Consensus 228 ~~~~----~~----~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LPAE----KF----SPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCcc----cc----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 11 134677899999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=291.77 Aligned_cols=261 Identities=23% Similarity=0.308 Sum_probs=195.2
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 169 (414)
++|++.+.||.|+||.||+|... +++.+++|.++... ......+.+|+.+++.++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999875 47889999986422 22234567899999999999999999999877 789999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
+||+++ +|.+++..... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 89888865432 4899999999999999999999998 99999999999999999999999999887643
Q ss_pred CCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC-------
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG------- 321 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 321 (414)
.. .......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...... .............
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI---DQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchHHHHH
Confidence 22 122234568899999988764 4689999999999999999999997643321 1111111100000
Q ss_pred ----------CCcccccccccCcCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 322 ----------MPSQLIDSCFQDSFNLA-EVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 322 ----------~~~~~~~~~~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.........+...+... ....+.+++.+||+.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000111100 1234667889999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=289.47 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=193.4
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+|+..+.||.|++|.||+|+.. +++.|++|.+... .......+.+|+.++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 5889999988642 222345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
++ ++|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 588888865433 34899999999999999999999988 99999999999999999999999999876532211
Q ss_pred ccccccccccccccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC--------
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP-------- 323 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 323 (414)
......++..|+|||.+.+.. ++.++|||||||++|||+||+.||..... ................
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHhCCCChhhhhhhhH
Confidence 122234678899999887654 68899999999999999999998753221 1111111110000000
Q ss_pred --------cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 324 --------SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 324 --------~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.......+... .......+.+++.+||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 0001134567899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=281.20 Aligned_cols=250 Identities=30% Similarity=0.474 Sum_probs=202.0
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
+|.+.+.||+|++|.||++... ++..+++|++..........+.+|+..++.++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999875 688999999977554566789999999999999999999999999999999999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+++|.+++.... ..+++..+..++.|+++|+.|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999986643 34899999999999999999999987 99999999999999999999999999887543221
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCc
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (414)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... ...... .. .........
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~---~~-~~~~~~~~~----- 220 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKI---AT-NGPPGLRNP----- 220 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHH---Hh-cCCCCcCcc-----
Confidence 33456788999999999888999999999999999999999987532211 111111 11 111111111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 335 FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 335 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. .....+.+++.+||+.||++|||+.|+++.
T Consensus 221 ~--~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 E--KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred c--ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 012356778899999999999999999853
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=285.99 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=210.2
Q ss_pred HHHHHhcCCCCCCCeecccCCceEEEEEEc------CCCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEE
Q 043285 88 ATIVSATNNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCC 160 (414)
Q Consensus 88 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 160 (414)
.++.....+++....+-+|.||.||.|.+. +.+.|.+|.++. .+.-+...+..|.-.+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 344445567888889999999999999553 345678888876 3445667788999999999999999999998
Q ss_pred EeC-CeeeEEEeecCCCChhHHhh-----cccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 043285 161 IQG-EEKLLIYEFMPNKSLDSFIF-----DQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 234 (414)
Q Consensus 161 ~~~-~~~~lv~ey~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~ 234 (414)
.+. ...++++.++.-|+|..++. +......+...+...++.|++.|++|||.++ ++|.||..+|++|++..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 764 46789999999999999998 4444566888999999999999999999998 99999999999999999
Q ss_pred CeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHH
Q 043285 235 NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGH 313 (414)
Q Consensus 235 ~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~ 313 (414)
++||+|=.+++.+...+...-...-.....||+||.+.+..|+.++|||||||+||||+| |+.|+..- +..+....
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI---DPfEm~~y 510 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI---DPFEMEHY 510 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc---CHHHHHHH
Confidence 999999999998766666555555556789999999999999999999999999999998 77775432 22233333
Q ss_pred HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 314 AWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
....++...+....| ++..++.-||+..|++||+++|++.-|.
T Consensus 511 lkdGyRlaQP~NCPD-------------eLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 511 LKDGYRLAQPFNCPD-------------ELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred HhccceecCCCCCcH-------------HHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 333333333333222 4556788899999999999999999884
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=287.37 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=196.8
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
+|++.+.||.|++|.||+|+.. +|..|++|++.... ......+.+|+.+++.++|+|++++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999875 58899999987532 223456778999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++ +|.+++........+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 85 88888865543345899999999999999999999988 9999999999999999999999999997653221
Q ss_pred cccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC---------C
Q 043285 254 GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM---------P 323 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~ 323 (414)
.......++..|++||.+.+. .++.++|||||||++|+|++|+.||...... .............. .
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE---DQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCChhhHHHHhcC
Confidence 112233568889999988654 5789999999999999999999987543221 11111111110000 0
Q ss_pred ccccccccc------CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 324 SQLIDSCFQ------DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 324 ~~~~~~~~~------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..+...... ..........+.+++.+||+.||.+||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 0000011235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=283.83 Aligned_cols=242 Identities=24% Similarity=0.342 Sum_probs=193.3
Q ss_pred ecccCCceEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCCh
Q 043285 103 LGQGGFGPVYKGKLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 178 (414)
Q Consensus 103 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L 178 (414)
||.|++|.||+++... ++.|++|.+.+.. ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999998754 8899999986522 23456789999999999999999999999999999999999999999
Q ss_pred hHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcccccc
Q 043285 179 DSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258 (414)
Q Consensus 179 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~ 258 (414)
.+++..... ++...+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDRGL---FDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999976433 889999999999999999999988 9999999999999999999999999998764321 2223
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHH
Q 043285 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLA 338 (414)
Q Consensus 259 ~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (414)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||.....+ ....... ........... ...
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~---~~~~~~~~~~~-----~~~--- 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIYND---ILKGNGKLEFP-----NYI--- 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHHHH---HhccCCCCCCC-----ccc---
Confidence 46788999999998888999999999999999999999998654321 1111111 11111111111 111
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 043285 339 EVIRCIHIGLLCVQQHPEDRPS-----MPSVIL 366 (414)
Q Consensus 339 ~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 366 (414)
...+.+++.+||+.+|++||+ ++|+++
T Consensus 220 -~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 -DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 235778999999999999999 777775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=287.90 Aligned_cols=247 Identities=24% Similarity=0.397 Sum_probs=196.6
Q ss_pred CCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 97 FSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
|...+.||+|++|.||++.. .++..+++|.+........+.+.+|+.+++.++|||++++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999975 46889999998655445556788999999999999999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
++|.+++... .+++..+..++.|++.|++|||+++ ++||||+|+||+++.++.++|+|||.+........ .
T Consensus 101 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 101 GALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 9999998652 3889999999999999999999998 99999999999999999999999998875532211 1
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||.... ........ ........... ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~---~~~~~~~~----~~~~~~~~~~~---~~- 240 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP---PLQAMKRI----RDNLPPKLKNL---HK- 240 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHH----HhcCCCCCccc---cc-
Confidence 223458899999999998889999999999999999999999874311 11111111 11111111000 00
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
....+.+++.+||+.+|++|||+.++++
T Consensus 241 ---~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 ---VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ---CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1135778999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=285.37 Aligned_cols=244 Identities=28% Similarity=0.372 Sum_probs=189.7
Q ss_pred ecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCCh
Q 043285 103 LGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 178 (414)
Q Consensus 103 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L 178 (414)
||+|+||+||++... +|+.|++|.+.... ......+..|+.+++.++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999754 58899999986421 22344567899999999999999999999999999999999999999
Q ss_pred hHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcccccc
Q 043285 179 DSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258 (414)
Q Consensus 179 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~ 258 (414)
.+++..... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||.+..... ......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCcccc
Confidence 999876543 34899999999999999999999998 99999999999999999999999999876532 112223
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHH
Q 043285 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLA 338 (414)
Q Consensus 259 ~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (414)
..++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+... . ....... ....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~--~~~~~~~-----~~~~--- 221 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR--T--LEMAVEY-----PDKF--- 221 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--c--ccccccC-----CccC---
Confidence 45778999999998888999999999999999999999998543322111111000 0 0000011 1111
Q ss_pred HHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 043285 339 EVIRCIHIGLLCVQQHPEDRP-----SMPSVIL 366 (414)
Q Consensus 339 ~~~~~~~l~~~cl~~dP~~RP-----s~~evl~ 366 (414)
...+.+++.+||+.+|++|| ++.+++.
T Consensus 222 -~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 -SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 23467889999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=287.48 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=202.3
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
..+.|+..+.||+|++|.||+|... ++..|++|++..... ....+.+|+..++.++|+|++++++++......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999875 588999999976443 55678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999997654 24899999999999999999999987 9999999999999999999999999987543221
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.......++..|+|||.+.+..++.++|||||||++|+|++|+.|+...... ... ...... ........
T Consensus 171 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~---~~~~~~-~~~~~~~~-- 239 (286)
T cd06614 171 --SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RAL---FLITTK-GIPPLKNP-- 239 (286)
T ss_pred --hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhc-CCCCCcch--
Confidence 1222345778999999999888999999999999999999999997532211 111 111111 11111110
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.. ....+.+++.+||+.+|.+|||+.++++.
T Consensus 240 -~~----~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 240 -EK----WSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -hh----CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00 12346678999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=313.49 Aligned_cols=250 Identities=28% Similarity=0.446 Sum_probs=201.9
Q ss_pred CCCCCeecccCCceEEEEEE-cCCC----EEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 97 FSINKKLGQGGFGPVYKGKL-VDGQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.+..++||+|+||+||+|.+ .+|. +||+|++.. ...+...++.+|+..|..++|||+++++|+|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45568999999999999975 3343 588998865 45556789999999999999999999999998776 88999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
+|++.|+|.++++.++. .+..+..+.|+.|||+||.|||.+. ++||||.++||||.+-..+|+.|||+++.+..+
T Consensus 777 q~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999977543 4888999999999999999999987 999999999999999999999999999998766
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
..........-.+.|||-|.+....|+.++|||||||++||++| |..|+...+.++..+++ ..+......
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-------e~geRLsqP-- 922 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-------EKGERLSQP-- 922 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-------hccccCCCC--
Confidence 65555555556788999999999999999999999999999998 66775543333222211 111111111
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
.....++..++.+||..|+..||+++++...+
T Consensus 923 -------piCtiDVy~~mvkCwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 923 -------PICTIDVYMVMVKCWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred -------CCccHHHHHHHHHHhccCcccCccHHHHHHHH
Confidence 11233566688899999999999999988765
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=291.70 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=206.0
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.-|.+.+.||+|.|+.|-++++ -.|..||||++.+. +......+..|+..|+.++|||||++|.+......+|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4588889999999999999964 47999999999763 44455678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCeEEEeecCccccCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kL~Dfgl~~~~~~~ 250 (414)
.-++|+|.+||.+... .+++....+++.||+.|+.|+|+.. ++||||||+||.+- .-|-+||.|||++-.+..
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P- 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP- 171 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC-
Confidence 9999999999987654 3889999999999999999999998 99999999999775 568999999999876532
Q ss_pred CCccccccccccccccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
...-...+|+..|-|||++.+..|+ ++.||||||||||-|++|..||+.....+.... ++|-
T Consensus 172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImDC 234 (864)
T KOG4717|consen 172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMDC 234 (864)
T ss_pred --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhcc
Confidence 2344567899999999999999996 678999999999999999999876544433221 1221
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.+ .....-..+|.+||..||..||++|.|.+|++.
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 11 112233457899999999999999999999985
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=282.42 Aligned_cols=250 Identities=25% Similarity=0.400 Sum_probs=197.6
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+|.+.+.||+|+||.||++... +|..+++|.+... .....+.+.+|+.+++.++|+|++++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999875 4788999998642 223446778999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CeEEEeecCccccCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGGDE 251 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kL~Dfgl~~~~~~~~ 251 (414)
+++++|.+++..... ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++ .++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999875433 34789999999999999999999988 99999999999999886 46999999988654321
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.......|++.|+|||.+.+..++.++|+||||+++|||++|..|+.... .......... .......
T Consensus 157 --~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~~~~---- 223 (257)
T cd08225 157 --ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ-GYFAPIS---- 223 (257)
T ss_pred --ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc-ccCCCCC----
Confidence 11223457889999999988889999999999999999999999974321 1111111111 1111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.. ....+.+++.+||+.+|++|||+.|+++.
T Consensus 224 -~~----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 -PN----FSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CC----CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11 11357788899999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=305.01 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=202.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.+.|.++..||.|+||.||++...+ +-..|.|++........+.+.-|+++|...+||+||++++.|...+.++++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3557778899999999999997654 334566777766777888999999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
|+||-.+.++.+..+ .+.+.++.-++.|++.||.|||++. |||||||+.|||++-+|.++|+|||.+.... ..
T Consensus 111 C~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--ST 183 (1187)
T ss_pred cCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hH
Confidence 999999999877553 4899999999999999999999998 9999999999999999999999999986532 22
Q ss_pred cccccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 253 EGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
......+.|||.|||||+.. +.+|+.++||||||++|.||..+.+|..... . .....++.. ..++.+.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln---p---MRVllKiaK-SePPTLl 256 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN---P---MRVLLKIAK-SEPPTLL 256 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc---h---HHHHHHHhh-cCCCccc
Confidence 33455678999999999764 5689999999999999999999998843211 1 111111111 2222222
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
. .... ...+.+++.+||.+||..||++.++++.-
T Consensus 257 q----PS~W---s~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 257 Q----PSHW---SRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred C----cchh---hhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 2 1111 23466788899999999999999999753
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=287.79 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=195.6
Q ss_pred CCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeeEEEe
Q 043285 97 FSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIYE 171 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 171 (414)
|++.+.||.|+||.||+|... +++.+++|.+... .......+.+|+.+++.++|+|++++++++.+. ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999875 4789999999764 233446788999999999999999999999988 78999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++ +|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8888886542 34899999999999999999999988 9999999999999999999999999998764332
Q ss_pred CccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccc----
Q 043285 252 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL---- 326 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 326 (414)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..................
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL---EQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchhhccccc
Confidence 1 11222346788999998765 46789999999999999999999987543321 111111111110000000
Q ss_pred -------------ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 327 -------------IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 327 -------------~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
....+.+.........+.+++.+||+.+|.+||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000001346788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=286.06 Aligned_cols=259 Identities=18% Similarity=0.210 Sum_probs=182.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCC----CEEEEEEecccChhhH-----------HHHHHHHHHHHhcCCCceeeeEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDG----QEIAVKRLSKISEQGL-----------KELKNEVILFSKLQHRNLVKLLG 158 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 158 (414)
.++|++.+.||+|+||.||+|...++ ..+++|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999987543 4556665332111110 11223334456678999999999
Q ss_pred EEEeCC----eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 043285 159 CCIQGE----EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 234 (414)
Q Consensus 159 ~~~~~~----~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~ 234 (414)
++.... ..++++|++.. ++.+.+.... ..++..+..++.|+++||+|||+.+ ++||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876544 34677887743 5666554332 2567888999999999999999988 99999999999999999
Q ss_pred CeEEEeecCccccCCCCC-----ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 043285 235 NPKISDFGLARAFGGDET-----EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLN 309 (414)
Q Consensus 235 ~~kL~Dfgl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~ 309 (414)
.++|+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....... .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~ 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--N 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--H
Confidence 999999999986532211 112223469999999999999999999999999999999999999986542221 1
Q ss_pred hHHHHHH-HhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 310 LIGHAWK-LWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 310 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
....... ....-...... .. .. ...+.+++..|++.+|++||+++++++.|.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~---~~-~~----~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKIK---IK-NA----NKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhhhhhhc---cC-CC----CHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111110 00000000000 00 01 234667888999999999999999998763
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=286.34 Aligned_cols=248 Identities=28% Similarity=0.418 Sum_probs=193.8
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.+.|+..+.||+|+||.||+|... +++.|++|.+... .....+.+.+|+.+++.++|||+++++++|.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999864 5889999988642 233446788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
+||++ |++.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 57777665332 24899999999999999999999988 99999999999999999999999999875422
Q ss_pred CCCcccccccccccccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
.....++..|+|||.+. ...++.++||||||+++|||++|..|+..... .......... .....
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~~~~-~~~~~ 234 (307)
T cd06607 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN-DSPTL 234 (307)
T ss_pred ------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHHhcC-CCCCC
Confidence 12345788999999874 45688999999999999999999998643211 1111111111 11111
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
. .......+.+++.+||+.+|++||++.+++...
T Consensus 235 ~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 235 S--------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred C--------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 001223577889999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=277.48 Aligned_cols=247 Identities=28% Similarity=0.451 Sum_probs=199.6
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+|++.+.||+|++|.||++... +++.|++|.+..... .....+.+|+++++.++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999765 578999999976433 4567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999987653 4899999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
. .....++..|+|||...+..++.++||||+|+++|+|++|..|+.... .... .+.... .....+ .
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~---~~~~---~~~~~~-~~~~~~-----~ 220 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN---PMAA---LFRIVQ-DDHPPL-----P 220 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc---HHHH---HHHHhc-cCCCCC-----C
Confidence 1 233467889999999988888999999999999999999999875322 1111 111111 111111 1
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
... ...+.+++.+||+.+|++|||+.+++.
T Consensus 221 ~~~----~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGI----SPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCC----CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111 234667889999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=293.39 Aligned_cols=260 Identities=26% Similarity=0.340 Sum_probs=195.1
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 163 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 163 (414)
..++|++.+.||+|+||.||+++.. +++.||+|.+.+. .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999764 6889999998642 333445677899999999999999999998644
Q ss_pred CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecC
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl 243 (414)
...++||||+++ +|.+.+... ++...+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 346999999964 787777432 788889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH------
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL------ 317 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~------ 317 (414)
+....... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ..........
T Consensus 165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 238 (353)
T cd07850 165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH---IDQWNKIIEQLGTPSD 238 (353)
T ss_pred ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence 98653221 12234578899999999999999999999999999999999999753321 1111111000
Q ss_pred ------------hhcCCC-------cccccccc----cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 318 ------------WNEGMP-------SQLIDSCF----QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 318 ------------~~~~~~-------~~~~~~~~----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
+..... ........ ...........+.+++.+||+.||++|||+.|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 00000000 000011123456789999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=291.19 Aligned_cols=267 Identities=22% Similarity=0.325 Sum_probs=191.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 164 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 164 (414)
.++|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 367999999999999999999864 58899999886422 222345678999999999999999999987654
Q ss_pred --eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeec
Q 043285 165 --EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 242 (414)
Q Consensus 165 --~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfg 242 (414)
..++||||+.+ +|.+++.... ..+++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 34999999965 7877775432 24899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCc--cccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043285 243 LARAFGGDETE--GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN 319 (414)
Q Consensus 243 l~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 319 (414)
++......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99865332211 112234567889999988665 478899999999999999999988754322111111111110000
Q ss_pred cCCCccc-----ccc-cccCcC---------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 320 EGMPSQL-----IDS-CFQDSF---------NLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 320 ~~~~~~~-----~~~-~~~~~~---------~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
....+.. .+. ...... .......+.+++.+||+.||.+|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000 000 000000 0001234568999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=297.88 Aligned_cols=263 Identities=22% Similarity=0.324 Sum_probs=193.8
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----ee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 166 (414)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+... .......+..|+.+++.++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 47899999999999999999975 46889999998642 2334566788999999999999999999876543 57
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++|+||+++ +|..++... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 787777432 3899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCCCc-cccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 247 FGGDETE-GNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 247 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
....... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .............+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~---~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY---LHQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCCHH
Confidence 5332211 11223467899999998654 5689999999999999999999999753221 11111111111100000
Q ss_pred c-----------cccccc-cCcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 325 Q-----------LIDSCF-QDSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 325 ~-----------~~~~~~-~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. ...... ...... .....+.+++.+||+.+|++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 000000 000000 012357789999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=285.07 Aligned_cols=255 Identities=23% Similarity=0.329 Sum_probs=196.2
Q ss_pred CCCCCCeecccCCceEEEEEE----cCCCEEEEEEecccC----hhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCee
Q 043285 96 NFSINKKLGQGGFGPVYKGKL----VDGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 166 (414)
+|++.+.||+|++|.||+++. .++..|++|.+++.. ....+.+..|+.++..+ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999974 256789999986421 22345678899999999 599999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++||||+++|+|.+++.... .+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999986543 3889999999999999999999987 99999999999999999999999999876
Q ss_pred cCCCCCccccccccccccccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
+..... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..||........... ......... .
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~--~ 229 (288)
T cd05583 155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE--ISRRILKSK--P 229 (288)
T ss_pred cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHH--HHHHHHccC--C
Confidence 533221 1122345788999999987765 78899999999999999999999753322111111 111111110 0
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. .....+ ..+.+++.+||+.+|++|||+.++...|+.
T Consensus 230 ~-----~~~~~~----~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 230 P-----FPKTMS----AEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred C-----CCcccC----HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 011111 245678889999999999999888877744
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=281.88 Aligned_cols=243 Identities=23% Similarity=0.252 Sum_probs=185.7
Q ss_pred CeecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHH-HHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||+|... +++.||+|.+.+.. ......+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999764 58899999986532 1222334445444 3455899999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999986543 3889999999999999999999988 99999999999999999999999999875422
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
.....++..|+|||.+.+..++.++||||||+++|||++|..||..... ....... ...... ... ....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~~~~~-~~~-~~~~-- 218 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNI----LSRRIN-WPE-EVKE-- 218 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH----HhcccC-CCC-cccc--
Confidence 2234578899999999888899999999999999999999999753221 1111111 111000 000 0000
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
.....+.+++.+||+.+|++||++.++.+.|
T Consensus 219 --~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 219 --FCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred --cCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 1123567899999999999999887666555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=282.68 Aligned_cols=243 Identities=26% Similarity=0.338 Sum_probs=184.3
Q ss_pred eecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHH---hcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 102 KLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFS---KLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 102 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
.||+|+||.||++... +++.+|+|.+.+.. ......+.+|..+++ ..+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 58899999886421 111223344444333 3479999999999999999999999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---- 150 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc----
Confidence 999999886544 3899999999999999999999998 999999999999999999999999998754321
Q ss_pred ccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 255 NTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ..... ......+ ..
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~----~~~~~~~-----~~ 220 (279)
T cd05633 151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMT----LTVNVEL-----PD 220 (279)
T ss_pred CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHh----hcCCcCC-----cc
Confidence 1223468999999998864 568999999999999999999999986433222111 11110 0111111 11
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILML 368 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L 368 (414)
.. ...+.+++.+||+.||++|| |++|+++..
T Consensus 221 ~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 221 SF----SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cc----CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 11 23567788999999999999 599998853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=286.84 Aligned_cols=255 Identities=27% Similarity=0.385 Sum_probs=191.9
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 171 (414)
++|...+.||+|+||.||++... +++.||+|.+... .......+.+|+.++.++. |+||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35666789999999999999764 5889999998653 2344567889999999996 9999999999999999999999
Q ss_pred ecCCCChhHHhhc--ccccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 172 FMPNKSLDSFIFD--QERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 172 y~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
|++. ++.++... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++..+.
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 55544321 11123489999999999999999999975 5 9999999999999999999999999987653
Q ss_pred CCCCccccccccccccccccccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
... ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ........... .....
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~~~~ 230 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GDPPI 230 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CCCCc
Confidence 221 11233578899999998776 68999999999999999999999975432 11111111111 11111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
+. ..........+.+++.+||+.+|++|||+.++++.
T Consensus 231 ~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LS-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CC-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 11101122357789999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=290.70 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=193.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 168 (414)
.++|++.+.||+|+||.||+|... +|..||+|.++... ......+.+|+.+++.++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999874 58899999986422 22233566899999999999999999998765 46899
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||+++ +|.+++.... ..+++..+..++.|+++|++|||+.+ ++||||+|+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 8888876532 34899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc--
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ-- 325 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 325 (414)
... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .............+....
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE---IEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChhhch
Confidence 322 11122345778999998865 4679999999999999999999998753321 112211111111000000
Q ss_pred -c------cccccc-Cc-CCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 326 -L------IDSCFQ-DS-FNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 326 -~------~~~~~~-~~-~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
+ ...... .. ... .....+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 000000 00 000 012345679999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=285.04 Aligned_cols=259 Identities=24% Similarity=0.324 Sum_probs=193.3
Q ss_pred CCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 97 FSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
|++.+.||.|++|.||+|... +|..|++|++.... ......+.+|+.+++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999764 68999999986432 223456788999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
+ ++|.+++..... ..+++..+..++.|+++||+|||+++ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-- 153 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-- 153 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence 5 689998865442 34899999999999999999999987 9999999999999999999999999987643221
Q ss_pred cccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC---------C
Q 043285 254 GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM---------P 323 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~ 323 (414)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .............. .
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI---DQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHHhhhhhhc
Confidence 111223467899999988664 5789999999999999999999987543211 11111111000000 0
Q ss_pred cccc-------cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 324 SQLI-------DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 324 ~~~~-------~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.... ..... .........+.+++.+||+.+|++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 00000 000011135778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=308.94 Aligned_cols=266 Identities=20% Similarity=0.275 Sum_probs=185.7
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcC--CCEEEEEE--------------ecc---cChhhHHHHHHHHHHHHhcCCCce
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVD--GQEIAVKR--------------LSK---ISEQGLKELKNEVILFSKLQHRNL 153 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~--------------~~~---~~~~~~~~~~~E~~~l~~l~h~ni 153 (414)
..++|++.+.||+|+||+||++.... +...+.|. +.+ ........+.+|+.+++.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34689999999999999999986532 21122221 111 122234567899999999999999
Q ss_pred eeeEeEEEeCCeeeEEEeecCCCChhHHhhcccc--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 043285 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQER--CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 231 (414)
Q Consensus 154 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~ 231 (414)
+++++++.+.+..++|++++. ++|.+++..... ........+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999995 477776654221 112345667789999999999999998 99999999999999
Q ss_pred CCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCCCCCCcch
Q 043285 232 QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNR-GFYHSDNNLNL 310 (414)
Q Consensus 232 ~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~-~~~~~~~~~~~ 310 (414)
.++.+||+|||++..+..... .......||..|+|||++.+..++.++|||||||++|||++|..++ ..........+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999987643221 1223457899999999999999999999999999999999988543 22211111111
Q ss_pred HHHHHHHhh---cCCCc------------------ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 311 IGHAWKLWN---EGMPS------------------QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 311 ~~~~~~~~~---~~~~~------------------~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.... .... .+.+. ......+... ....++.+++.+||+.||++|||+.|++..
T Consensus 381 ~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL---GLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc---CCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111 1000 00000 0000000000 011245567889999999999999999974
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=287.05 Aligned_cols=262 Identities=23% Similarity=0.279 Sum_probs=191.7
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCe-----
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE----- 165 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~----- 165 (414)
++|++.+.||+|+||.||+|... +++.|++|.+.... ......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999864 58899999876422 223456788999999995 6999999999987665
Q ss_pred eeEEEeecCCCChhHHhhcccc--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCeEEEeec
Q 043285 166 KLLIYEFMPNKSLDSFIFDQER--CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFG 242 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kL~Dfg 242 (414)
.++||||+++ +|.+++..... ...+++..+..++.|+++||.|||+.+ ++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78888765332 235899999999999999999999988 999999999999998 8899999999
Q ss_pred CccccCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG 321 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
++..+.... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..... ..............
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE---LQQLLHIFKLLGTP 231 (295)
T ss_pred cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHhCCC
Confidence 987653221 11122346788999998865 4679999999999999999999998754221 11111111111000
Q ss_pred CCccc---------------ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 322 MPSQL---------------IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 322 ~~~~~---------------~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..... ....+. .........+.+++.+||+.+|.+||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 000000 000011235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=275.52 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=202.0
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+|.+.+.||.|+||.||++... ++..+++|++... .......+..|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999875 5889999998753 235566788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 173 MPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 173 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
+++++|.+++.... ....+++..+..++.+++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987642 1245899999999999999999999998 9999999999999999999999999998754332
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.|+.... ....... . .......+..
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~---~-~~~~~~~~~~--- 225 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALK---I-LKGQYPPIPS--- 225 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHH---H-hcCCCCCCCC---
Confidence 12233468889999999998899999999999999999999999875332 1111111 1 1111111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.. ...+.+++.+||..+|++|||+.++++.
T Consensus 226 --~~----~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 --QY----SSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --CC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 2356778999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=285.06 Aligned_cols=257 Identities=21% Similarity=0.291 Sum_probs=189.5
Q ss_pred CCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeC--CeeeEEEe
Q 043285 97 FSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIYE 171 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 171 (414)
|++.+.||+|+||.||+|... +++.|++|+++.. ..........|+..+.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999764 5889999998753 2222234457888888885 99999999999987 88999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 57877775533 24899999999999999999999988 999999999999999 999999999998653322
Q ss_pred Ccccccccccccccccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC-------
Q 043285 252 TEGNTNRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP------- 323 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 323 (414)
. .....++..|+|||.+. ++.++.++|||||||++|||++|..||..... .+..............
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHHhhc
Confidence 1 12345788999999764 45678999999999999999999998754322 1111111111000000
Q ss_pred -cccccccccCcC-------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 324 -SQLIDSCFQDSF-------NLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 324 -~~~~~~~~~~~~-------~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
............ .......+.+++.+||+++|++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000 0112356788999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=287.94 Aligned_cols=263 Identities=22% Similarity=0.247 Sum_probs=191.3
Q ss_pred CCCCeecccCCceEEEEEEcCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 98 SINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 98 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
.+.+.+|.|+++.|+++.. +++.||+|++... .......+..|+.+++.++|+||+++++++.+.+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3444555556655565544 6899999998753 445667899999999999999999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC---
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET--- 252 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~--- 252 (414)
|+|.+++..... ..+++..+..++.|+++||+|||+++ ++||||||+||+++.++.++|+|||.+........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999999875433 23788899999999999999999998 99999999999999999999999999875532211
Q ss_pred --ccccccccccccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh---------
Q 043285 253 --EGNTNRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN--------- 319 (414)
Q Consensus 253 --~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 319 (414)
........++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ............
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchh
Confidence 1112234567789999998763 5889999999999999999999997642211 111111100000
Q ss_pred ---cCCCc---cccccc----ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 320 ---EGMPS---QLIDSC----FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 320 ---~~~~~---~~~~~~----~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
..... ...+.. ............+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 000000 0011111122457789999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=276.35 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=194.7
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Cee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 166 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 166 (414)
.+|.+.+.||+|+||.||+|+.. ++..|++|.+... .......+.+|+.+++.++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999864 5889999987431 233456788999999999999999999998764 457
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++++||+++++|.+++.... .+++.....++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999986543 2788899999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCC-ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 247 FGGDET-EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 247 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
...... ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||..... ..........+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~ 229 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQPTKPM 229 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCCCCCC
Confidence 532111 1112234588899999999988899999999999999999999999753211 111111111111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+. .. ....+.+++.+||+ +|..||++.+++.
T Consensus 230 ~p-----~~----~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 230 LP-----DG----VSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CC-----cc----cCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11 11 11346678889999 5799999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=283.11 Aligned_cols=246 Identities=26% Similarity=0.334 Sum_probs=193.6
Q ss_pred ecccCCceEEEEEEcC-CCEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCCh
Q 043285 103 LGQGGFGPVYKGKLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 178 (414)
Q Consensus 103 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L 178 (414)
||.|+||.||++...+ |+.+++|.+..... .....+.+|+.+++.++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998764 89999999865322 4556788999999999999999999999999999999999999999
Q ss_pred hHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC------
Q 043285 179 DSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET------ 252 (414)
Q Consensus 179 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~------ 252 (414)
.+++.... .+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99987644 4899999999999999999999988 99999999999999999999999999876432211
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
........++..|+|||...+..++.++||||||+++|+|++|..||..... ....... ..... ....
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~~---~~~~~--~~~~---- 222 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---EEIFQNI---LNGKI--EWPE---- 222 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH---hcCCc--CCCc----
Confidence 1122344678899999999888899999999999999999999999753321 1111111 11010 0000
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
.. .....+.+++.+||+.+|++|||+.++.+.|+
T Consensus 223 -~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 -DV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -cc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 01235678899999999999999966665553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=283.18 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=195.6
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
+.|...+.||+|+||.||+++.. ++..|++|.+... .......+.+|+.+++.++|||++++++++.+....++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34777789999999999999864 5789999998642 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++ +|.+++.... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 105 EYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred eCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 99974 7777765432 24899999999999999999999988 99999999999999999999999999875422
Q ss_pred CCcccccccccccccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.....++..|+|||.+. .+.++.++|||||||++|||++|+.||.... ...... ......... ..
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~~---~~~~~~~~~-~~ 245 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALY---HIAQNESPT-LQ 245 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHHHH---HHHhccCCC-CC
Confidence 22345788999999873 4578999999999999999999999864321 111111 111111110 00
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCCC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVL 374 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 374 (414)
. . .....+.+++.+||+.+|.+||++.++++.+-.....
T Consensus 246 ~----~----~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 246 S----N----EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred C----c----cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 0 0 1112466788999999999999999999876444433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=286.24 Aligned_cols=243 Identities=24% Similarity=0.397 Sum_probs=193.5
Q ss_pred CeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCChh
Q 043285 101 KKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 179 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~ 179 (414)
..||+|+||.||++.. .++..|++|.+..........+.+|+.+++.++|+|++++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 6799999999999976 468899999986544455567889999999999999999999999999999999999999999
Q ss_pred HHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccc
Q 043285 180 SFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 259 (414)
Q Consensus 180 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~ 259 (414)
+++... .+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++....... ......
T Consensus 106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 176 (292)
T cd06657 106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 176 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence 987543 3788999999999999999999988 9999999999999999999999999987653221 122334
Q ss_pred cccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHH
Q 043285 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAE 339 (414)
Q Consensus 260 ~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (414)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....... .......+.. . .. .
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~----~~~~~~~~~~--~-~~----~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMI----RDNLPPKLKN--L-HK----V 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhhCCcccCC--c-cc----C
Confidence 678899999999888899999999999999999999999753211 1111111 1111111100 0 01 1
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 340 VIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 340 ~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 124567888999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=276.65 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=200.4
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+|++.+.||.|+||.||++... ++..+++|.+... .......+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999754 5788999998652 334456778899999999999999999999999999999999
Q ss_pred cCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 173 MPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 173 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
+++++|.+++.... ....+++..+..++.|++.|++|||+.+ ++|+||+|.||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999986532 1245889999999999999999999988 999999999999999999999999999876433
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ...... ..........
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~----~~~~~~~~~~---- 222 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYK----VQRGKYPPIP---- 222 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HhcCCCCCCc----
Confidence 22234578899999999999999999999999999999999999754321 111111 1111111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.....++.+++.+||+.+|.+|||+.++++.
T Consensus 223 -----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 -----PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1223457789999999999999999999853
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=288.40 Aligned_cols=261 Identities=25% Similarity=0.333 Sum_probs=190.6
Q ss_pred Ceeccc--CCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQG--GFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
..||+| +||+||+++.. +|+.||+|++.. ......+.+.+|+.+++.++||||++++++|..+...++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 89999999864 689999999864 2334457888999999999999999999999999999999999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc--
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE-- 253 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~-- 253 (414)
++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999998875432 23888999999999999999999988 999999999999999999999999865433211110
Q ss_pred ---cccccccccccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH-----------
Q 043285 254 ---GNTNRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL----------- 317 (414)
Q Consensus 254 ---~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----------- 317 (414)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||....... .........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence 011112345679999998764 47899999999999999999999986432110 000000000
Q ss_pred ------------hhc---------CCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 318 ------------WNE---------GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 318 ------------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
... ......................+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 00000000001111112234567889999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=283.18 Aligned_cols=262 Identities=22% Similarity=0.319 Sum_probs=192.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++|++.+.||+|++|.||+|... +|+.|++|.+.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888999999999999999875 58899999986422 2334578889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCeEEEeecCccccCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGD 250 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kL~Dfgl~~~~~~~ 250 (414)
|++ ++|.+++..... ..+++..+..++.|++.||+|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 578777754332 23678888899999999999999987 999999999999985 567999999999764322
Q ss_pred CCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc----
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ---- 325 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 325 (414)
. .......+++.|+|||.+.+. .++.++|||||||++|+|+||+.||..... .+...........+....
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE---IDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChhhcccc
Confidence 1 111223567899999988664 578999999999999999999999754221 111111111111110000
Q ss_pred -----ccc--ccccCc----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 326 -----LID--SCFQDS----FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 326 -----~~~--~~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
... +..... ........+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000000 00011234678999999999999999999996
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=289.56 Aligned_cols=264 Identities=25% Similarity=0.364 Sum_probs=195.1
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC--Cee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG--EEK 166 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~ 166 (414)
..++|++.+.||+|+||.||+|... ++..+++|++.. ........+..|+.+++.+ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467899999999999999999875 578899998854 2233445677899999999 999999999998653 368
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++||||++ ++|.+++... .+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5898888653 3788899999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCCc---cccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh----
Q 043285 247 FGGDETE---GNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW---- 318 (414)
Q Consensus 247 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---- 318 (414)
....... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~ 233 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN---QLEKIIEVIGPPS 233 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCC
Confidence 5432221 12233468899999998765 467899999999999999999999975432211 111110000
Q ss_pred -------hcCCCccccccccc-CcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 319 -------NEGMPSQLIDSCFQ-DSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 319 -------~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.......+.+.... ..... .....+.+++.+||+.+|++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000 00000 012357789999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=282.10 Aligned_cols=249 Identities=27% Similarity=0.380 Sum_probs=199.7
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 169 (414)
++|.+.+.||+|+||.||++... +++.|++|++... .......+..|+.+++.++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999864 6899999998652 2334567889999999998 99999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997654 4899999999999999999999988 99999999999999999999999999887643
Q ss_pred CCCc------------------cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchH
Q 043285 250 DETE------------------GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLI 311 (414)
Q Consensus 250 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~ 311 (414)
.... .......++..|+|||.+.+..++.++||||||++++++++|+.|+.... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~ 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLTF 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHHH
Confidence 3221 22233457889999999988889999999999999999999999976432 11111
Q ss_pred HHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 043285 312 GHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM----PSVIL 366 (414)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~----~evl~ 366 (414)
... .... ..+ .... ...+.+++.+||+.+|++|||+ .++++
T Consensus 232 ~~~---~~~~--~~~-----~~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QKI---LKLE--YSF-----PPNF----PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHH---HhcC--CCC-----CCcc----CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111 1100 000 0111 2346789999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=283.83 Aligned_cols=259 Identities=25% Similarity=0.348 Sum_probs=196.4
Q ss_pred CCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 97 FSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
|++.+.||+|++|.||++... +++.+++|.+.... ......+..|+.+++.++|+||+++++++.++...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999874 58889999986532 234567888999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++ +|.+++.... ..+++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 8888776533 34899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC---ccc---
Q 043285 254 GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP---SQL--- 326 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 326 (414)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... .+.............. ...
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE---IDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCchHhcccchhh
Confidence 112224577889999998776 789999999999999999999988753321 1111111111111000 000
Q ss_pred --------cccccc--CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 327 --------IDSCFQ--DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 327 --------~~~~~~--~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...... ..........+.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 0001112346788999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=276.90 Aligned_cols=247 Identities=22% Similarity=0.267 Sum_probs=187.6
Q ss_pred HHHhcCCCCCCCee--cccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCe
Q 043285 90 IVSATNNFSINKKL--GQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 90 ~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 165 (414)
.....++|++.+.+ |+|+||.||+++.. ++..+++|.+....... .|+.....+ +|||++++++++...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 33445677777776 99999999999764 57889999886422111 122222222 79999999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CeEEEeecCc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLA 244 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kL~Dfgl~ 244 (414)
.++||||+++++|.+++.... .+++..+..++.|+++|+.|||+.+ ++||||+|+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 999999999999999997654 4899999999999999999999998 99999999999999998 9999999998
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ......... . ....
T Consensus 158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-~--~~~~ 227 (267)
T PHA03390 158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKR-Q--QKKL 227 (267)
T ss_pred eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHh-h--cccC
Confidence 765322 22357889999999999999999999999999999999999986332211 111111111 1 1110
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS-MPSVIL 366 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~ 366 (414)
.... .....+.+++.+||+.+|.+||+ ++|+++
T Consensus 228 ~~~~---------~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 PFIK---------NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred Cccc---------ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1110 12234677889999999999996 598884
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=294.35 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=194.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-----Ce
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 165 (414)
.++|.+.+.||+|+||+||+++.. ++..|++|.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999764 5889999998652 233345677899999999999999999988654 34
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.++|+||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 68888886543 3899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC-
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP- 323 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 323 (414)
...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ...............
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSEE 231 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCChH
Confidence 653221 22233457889999998765 46899999999999999999999998543211 111111100000000
Q ss_pred -----------------cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 324 -----------------SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 324 -----------------~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.......... ........+.+++.+||+.+|++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000 000112456789999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=286.57 Aligned_cols=263 Identities=23% Similarity=0.332 Sum_probs=193.6
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 164 (414)
..++|++.+.||+|+||.||+|... +|+.|++|.++... ......+.+|+.+++.++|||++++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999875 48899999986432 233456778999999999999999999987655
Q ss_pred -----eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEE
Q 043285 165 -----EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 239 (414)
Q Consensus 165 -----~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~ 239 (414)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 666666543 234899999999999999999999998 9999999999999999999999
Q ss_pred eecCccccCCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043285 240 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 240 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
|||++........ .......++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ..........
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~ 234 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLC 234 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence 9999986533221 111123457789999987654 5789999999999999999999887532211 1111111111
Q ss_pred hcCCCcccc---c--------c------cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 319 NEGMPSQLI---D--------S------CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 319 ~~~~~~~~~---~--------~------~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
......... . . ....... .....+.+++.+||+.+|.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111110000 0 0 0000000 01245778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=294.54 Aligned_cols=265 Identities=20% Similarity=0.310 Sum_probs=196.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 166 (414)
.++|++.+.||+|+||.||+|... +|..|++|++... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999764 5889999998753 22345677889999999999999999998763 3468
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++|+||+. ++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 58988886543 3899999999999999999999988 99999999999999999999999999876
Q ss_pred cCCCCCc--cccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC-
Q 043285 247 FGGDETE--GNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM- 322 (414)
Q Consensus 247 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 322 (414)
....... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~---~~~~~~~~~~g~~~~ 233 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV---HQLKLILSVLGSPSE 233 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH---HHHHHHHHHhCCChh
Confidence 5332211 11123468889999998865 46899999999999999999999998533211 11111110000000
Q ss_pred ----------Cccccccc-ccCcCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 323 ----------PSQLIDSC-FQDSFN-----LAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 323 ----------~~~~~~~~-~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
........ ...... ......+.+++.+||+.+|.+|||+.+++..-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 00000000 000000 01134678899999999999999999999744
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=293.47 Aligned_cols=262 Identities=25% Similarity=0.345 Sum_probs=198.4
Q ss_pred CCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----eee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 167 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 167 (414)
+|++.+.||.|++|.||+|+..+ +..|++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 57888999999999999998754 8899999987633 345567889999999999999999999998775 789
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
++|||++ ++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||.||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 48888886543 4899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCc-cccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC--
Q 043285 248 GGDETE-GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP-- 323 (414)
Q Consensus 248 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 323 (414)
...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... ...............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI---DQLNLIVEVLGTPSEED 230 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHhcCCCChhH
Confidence 433210 112334578899999999887 8899999999999999999999997543321 111111111000000
Q ss_pred ---------cccccc-cccCcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 324 ---------SQLIDS-CFQDSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 324 ---------~~~~~~-~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
...... ........ .....+.+++.+||+.+|.+|||+.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000 00000000 012356789999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.15 Aligned_cols=260 Identities=31% Similarity=0.439 Sum_probs=203.8
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc--------CCCEEEEEEecc-cChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV--------DGQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 162 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 162 (414)
..++..+.+.||+|.||.|++|... ....||||.++. ......+.+..|+++|+.+ +|+||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 4455567789999999999999642 145699999986 3445677899999999999 69999999999999
Q ss_pred CCeeeEEEeecCCCChhHHhhccc------c-----c--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 043285 163 GEEKLLIYEFMPNKSLDSFIFDQE------R-----C--MILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 229 (414)
Q Consensus 163 ~~~~~lv~ey~~~g~L~~~l~~~~------~-----~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nil 229 (414)
....++|+||+..|+|.+++.... . . ..+.....+.++.|||.||+||++.. ++||||.++|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999997655 0 0 23888999999999999999999987 999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCCcccc-ccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 043285 230 LDQDMNPKISDFGLARAFGGDETEGNT-NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNN 307 (414)
Q Consensus 230 l~~~~~~kL~Dfgl~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~ 307 (414)
++.+..+||+|||+++........... ....-...|||||.+.+..|+.++||||||++|||++| |..|+... ...
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~--~~~ 528 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI--PPT 528 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC--CcH
Confidence 999999999999999975544333211 11113567999999999999999999999999999999 55564321 112
Q ss_pred cchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 308 LNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.++.. ..+.+...+....| ..++.++|..||+.+|++||++.++.+.++.
T Consensus 529 ~~l~~----~l~~G~r~~~P~~c---------~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 529 EELLE----FLKEGNRMEQPEHC---------SDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHHH----HHhcCCCCCCCCCC---------CHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 22222 22333332222222 2246678899999999999999999999977
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=294.02 Aligned_cols=245 Identities=24% Similarity=0.402 Sum_probs=203.7
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
...|.+.+.||+|.|+.|.+++. ..+..||+|.+.+. +....+.+.+|+++|..++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 36789999999999999999975 45899999999763 3334456889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+.+|.+.+++.+..+ ........++.|+..|++|||+++ |+|||||++|+|++.+.++||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec--
Confidence 99999999999987765 556888889999999999999998 9999999999999999999999999998874
Q ss_pred CCccccccccccccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
........+|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||....-. .+-+.
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------~Lr~r 266 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------ELRPR 266 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------cccch
Confidence 3344567899999999999999877 68999999999999999999998642211 11111
Q ss_pred cccCcCCHH--HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 CFQDSFNLA--EVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 ~~~~~~~~~--~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
++...+... ...+|-+++.++|-.+|.+|++..++.+
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 111111111 1124667888999999999999999876
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=284.56 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=191.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 170 (414)
.++|++.+.||+|+||.||+|...+ ++.||||.++.. .......+..|+.++.... ||||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3678889999999999999998865 889999999753 2334455666777666664 999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
||++ +++.+++..... .+++..+..++.|++.|++|||+. + ++||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 477777654322 488999999999999999999974 5 99999999999999999999999999876532
Q ss_pred CCCccccccccccccccccccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+.. ....... ...
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~---~~~~~~~-~~~ 238 (296)
T cd06618 168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVL---TKILQEE-PPS 238 (296)
T ss_pred CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHH---HHHhcCC-CCC
Confidence 211 12234678899999987553 788999999999999999999997532111 1111 1111111 111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
..... .....+.+++.+||+.||.+||++.++++.-
T Consensus 239 ~~~~~-------~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 239 LPPNE-------GFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCCCC-------CCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 11100 1123567889999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=280.38 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=192.9
Q ss_pred CCCCCCeecccCCceEEEEEE----cCCCEEEEEEecccC----hhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCee
Q 043285 96 NFSINKKLGQGGFGPVYKGKL----VDGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 166 (414)
+|++.+.||+|+||.||+++. .+|..||+|++.... ....+.+.+|+.+++.+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999975 368899999986522 12345678899999999 599999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++|+||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999987543 3788899999999999999999988 99999999999999999999999999876
Q ss_pred cCCCCCccccccccccccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
...... .......|+..|+|||.+.+. .++.++||||||+++|+|++|..|+........ ............ .
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~--~ 229 (290)
T cd05613 155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE--P 229 (290)
T ss_pred cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccC--C
Confidence 532221 122234688899999998753 467899999999999999999999753221111 111111111111 0
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILM 367 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 367 (414)
.. .... ...+.+++.+||+.+|++|| ++.+++..
T Consensus 230 ~~-----~~~~----~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 230 PY-----PQEM----SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CC-----CccC----CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 01 1111 12456788899999999997 66777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=287.95 Aligned_cols=264 Identities=22% Similarity=0.291 Sum_probs=194.4
Q ss_pred cCCCC-CCCeecccCCceEEEEEEc-CCCEEEEEEecccChhh--------------HHHHHHHHHHHHhcCCCceeeeE
Q 043285 94 TNNFS-INKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQG--------------LKELKNEVILFSKLQHRNLVKLL 157 (414)
Q Consensus 94 ~~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~ 157 (414)
.++|. +.+.||.|+||.||+|... +++.||+|.+....... ...+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 45665 4577999999999999864 58899999986422111 12467899999999999999999
Q ss_pred eEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeE
Q 043285 158 GCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 237 (414)
Q Consensus 158 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k 237 (414)
+++...+..++||||++ |+|.+++.... .+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 58998886543 3889999999999999999999988 99999999999999999999
Q ss_pred EEeecCccccCCCCC------------ccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 043285 238 ISDFGLARAFGGDET------------EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHS 304 (414)
Q Consensus 238 L~Dfgl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~ 304 (414)
|+|||++........ ........++..|+|||.+.+. .++.++|||||||++|||++|..||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999976541110 1111123467889999998765 468999999999999999999998754332
Q ss_pred CCCcchHHHHHHHhhcCCCcccc---------------cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 305 DNNLNLIGHAWKLWNEGMPSQLI---------------DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
. .................+. ....... .......+.+++.+||+.+|++|||+.|++..-
T Consensus 240 ~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 240 I---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred H---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 1 1122221111111100000 0000000 001124567899999999999999999999643
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=278.84 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=191.5
Q ss_pred CCCCCeecccCCceEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCceeeeEeEEEeCCe-----
Q 043285 97 FSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEE----- 165 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~----- 165 (414)
|++.+.||+|+||.||+|+... ++.|++|.+.... ......+.+|+.+++++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999998764 8899999997422 22234556777777665 59999999999988776
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.+++|||+++ +|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 88888865432 24899999999999999999999988 9999999999999999999999999987
Q ss_pred ccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC---
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM--- 322 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 322 (414)
...... ......++..|+|||.+.+..++.++|||||||++|||++|..||...... +.............
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH---HHHHHHHHHcCCCChHh
Confidence 753221 112334788999999999999999999999999999999998887532221 11111111110000
Q ss_pred -Cc------ccccccccC---cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 323 -PS------QLIDSCFQD---SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 323 -~~------~~~~~~~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+. ......... .........+.+++.+||+.||++||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 000000000 000112345678999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=321.55 Aligned_cols=254 Identities=26% Similarity=0.352 Sum_probs=202.0
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
+-++.....||.|.||.||.|.. .+|.-.|+|.++- ........+.+|..++..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 34677778999999999999965 4577889998864 22345567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
|||++|+|.+++..... .++.....+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|..+.+.
T Consensus 1314 EyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999865543 566666778899999999999999 999999999999999999999999999987654
Q ss_pred C--CccccccccccccccccccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 251 E--TEGNTNRVVGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 251 ~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
. ....-+...||+.|||||++.+. ....++||||+|||+.||+||+.||..+..+.. +......+..++
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a------IMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA------IMYHVAAGHKPQ 1461 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH------HHhHHhccCCCC
Confidence 2 12233456899999999999764 356789999999999999999999876544322 122222222223
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
+... ....-.+++.+||+.||++|.++.|+++.=
T Consensus 1462 ~P~~---------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1462 IPER---------LSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred Cchh---------hhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 2221 112345788899999999999999998754
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=284.41 Aligned_cols=248 Identities=27% Similarity=0.369 Sum_probs=197.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.+.|..-+.||+|+||.||.++.. +|+.+|.|++.+. ......-..+|..++.+++.+.||.+-..|...+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 466788899999999999999754 5889999988542 223334567899999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
+..|.||+|.-+|.+..+ +.+++.++..++.+|+.||++||... |+.||+||+|||+|+.|+++|+|+|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999987665 45999999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.. .....+||.+|||||++.++.|+...|.|||||++|||+.|+.||..+......+.+.... .+...++.
T Consensus 340 g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~----~~~~~ey~-- 410 (591)
T KOG0986|consen 340 GK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT----LEDPEEYS-- 410 (591)
T ss_pred CC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH----hcchhhcc--
Confidence 22 2223489999999999999999999999999999999999999987554433321111111 11111111
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 361 (414)
+.++ .++.+++...|+.||++|..-
T Consensus 411 ---~kFS----~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 411 ---DKFS----EEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred ---cccC----HHHHHHHHHHHccCHHHhccC
Confidence 1222 234456667899999999754
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=279.86 Aligned_cols=260 Identities=23% Similarity=0.292 Sum_probs=193.3
Q ss_pred CCCCCeecccCCceEEEEEEc-CCCEEEEEEecccCh-hhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEEeec
Q 043285 97 FSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
|++.+.||.|++|.||+|+.. ++..|++|++..... .......+|+..++.++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999875 478899999865322 22234457899999999 999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
+|+|.+++..... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 7899988866542 34899999999999999999999988 9999999999999999999999999998653221
Q ss_pred cccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC-----------
Q 043285 254 GNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG----------- 321 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 321 (414)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||......+ ............
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID---QLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH---HHHHHHHhcCCCChhhhhhHhhh
Confidence 1223457889999998754 567999999999999999999998875432211 111111000000
Q ss_pred --CCcccccccccC---cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 322 --MPSQLIDSCFQD---SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 322 --~~~~~~~~~~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
............ .........+.+++.+||+.+|++|||++|++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000 0000112467889999999999999999999853
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=276.13 Aligned_cols=242 Identities=26% Similarity=0.338 Sum_probs=184.3
Q ss_pred eecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHH---HHHHhcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 102 KLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEV---ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 102 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
.||+|+||.||++... +++.||+|.+.+.. ......+..|. ..++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 58899999986521 11112233343 34445679999999999999999999999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+++|.+++.... .+++..+..++.|+++|+.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---- 150 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence 999999886543 4899999999999999999999988 999999999999999999999999998754322
Q ss_pred ccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 255 NTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......|+..|+|||.+.++ .++.++||||+||++|||++|+.||............ .... .....+ ..
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~----~~~~~~-----~~ 220 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTL----TMAVEL-----PD 220 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhh----ccCCCC-----CC
Confidence 12234689999999998754 6899999999999999999999998654322211111 1100 001111 11
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILM 367 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 367 (414)
.. ...+.+++.+||..+|.+|| ++.++++.
T Consensus 221 ~~----s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 221 SF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred cC----CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11 23567788899999999999 99999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.38 Aligned_cols=253 Identities=28% Similarity=0.445 Sum_probs=190.4
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe---------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--------- 162 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------- 162 (414)
..+|+..+.||+|+||.||+++. .||+.||||++.- ........+.+|+.++.+++|||+|+++..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 35788889999999999999975 4899999999964 345566788999999999999999999864210
Q ss_pred --------------------------------------------------------------------------------
Q 043285 163 -------------------------------------------------------------------------------- 162 (414)
Q Consensus 163 -------------------------------------------------------------------------------- 162 (414)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHh
Q 043285 163 ----------------------G--------EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212 (414)
Q Consensus 163 ----------------------~--------~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 212 (414)
. ..+||-||||+..++.+++.++.-. -.....++++.+|++||.|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHh
Confidence 0 1246789999998888888765421 1477889999999999999999
Q ss_pred CCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC----C------------CCCccccccccccccccccccccCC--
Q 043285 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG----G------------DETEGNTNRVVGTYGYMAPEYASDG-- 274 (414)
Q Consensus 213 ~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~-- 274 (414)
+| +|||||||.|||++++..|||+|||++.... . ...........||.-|+|||++.+.
T Consensus 716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 98 9999999999999999999999999998721 0 0111133456799999999999765
Q ss_pred -CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCC
Q 043285 275 -QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQ 353 (414)
Q Consensus 275 -~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 353 (414)
.|+.|+|+||||+|++||+. ||+. .++....... ++.+..+.- ..+...+...-..++.+|++.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~T-----sMERa~iL~~-LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGT-----SMERASILTN-LRKGSIPEP------ADFFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCc-----hHHHHHHHHh-cccCCCCCC------cccccccchHHHHHHHHHhcC
Confidence 49999999999999999985 3321 2222222222 222222111 112222333345688899999
Q ss_pred CCCCCCCHHHHHH
Q 043285 354 HPEDRPSMPSVIL 366 (414)
Q Consensus 354 dP~~RPs~~evl~ 366 (414)
||.+|||+.|+|.
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999984
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=276.29 Aligned_cols=242 Identities=24% Similarity=0.310 Sum_probs=196.2
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|...++||+|.||+|.+++- ..++.+|+|++++. .......-..|-.+|+.-+||.+..+-..|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46899999999999999999964 46899999999873 233344556789999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||..||.|.-+|.+.. .+++.....+-..|..||.|||+++ |+.||||.+|.|++.+|.+||+|||+|+.-
T Consensus 247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~-- 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE-- 318 (516)
T ss_pred EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--
Confidence 99999999999887654 3888888999999999999999988 999999999999999999999999999752
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
-.........+|||.|+|||++.+..|+.+.|.|.+||+||||++|+.||.....+...+++-... ...+..+
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed----~kFPr~l--- 391 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED----LKFPRTL--- 391 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh----ccCCccC---
Confidence 123445667899999999999999999999999999999999999999986544443333321110 1111111
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCC
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs 360 (414)
+. +...|+...|.+||.+|..
T Consensus 392 ------s~----eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 392 ------SP----EAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred ------CH----HHHHHHHHHhhcChHhhcC
Confidence 11 2334566789999999973
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=269.69 Aligned_cols=271 Identities=21% Similarity=0.302 Sum_probs=201.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-----CCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCceeeeEeEEEe-CCe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-----GQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 165 (414)
-..|+....||+|.||.||++.-.+ ...+|+|+++...+ .......+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4568889999999999999994322 23689999975322 233567899999999999999999999987 778
Q ss_pred eeEEEeecCCCChhHHhhcc--cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC----CCeEEE
Q 043285 166 KLLIYEFMPNKSLDSFIFDQ--ERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKIS 239 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~----~~~kL~ 239 (414)
.++++||.+. +|..+++-. .+...++...+..|+.||+.|+.|||++. ++||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 888888542 23346888999999999999999999998 9999999999999887 899999
Q ss_pred eecCccccCCCCCc-cccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC------CCCcchH
Q 043285 240 DFGLARAFGGDETE-GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHS------DNNLNLI 311 (414)
Q Consensus 240 Dfgl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~------~~~~~~~ 311 (414)
|||+++.+.+.-.. ...+..+-|..|.|||.+.+. .|+.+.||||.|||+.||+|-.+-|..... .-..+..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999987544322 245567789999999998875 789999999999999999998876643221 1112222
Q ss_pred HHHHHHhhcCCCcccccc---------------cccCcCCHHHH--------HHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 312 GHAWKLWNEGMPSQLIDS---------------CFQDSFNLAEV--------IRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~--------~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
..+...+..+......+- ...+..++... ....+|+..+|++||-+|.|++++++..
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 333333222222111110 00011111111 1256788899999999999999999765
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=284.24 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=193.4
Q ss_pred HhcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe-CCeee
Q 043285 92 SATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKL 167 (414)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 167 (414)
..+++|++.+.||.|+||.||++... ++..|++|++.+. .....+.+..|+.+++.++|||++++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46788999999999999999999754 6889999988542 22344677889999999999999999999876 55789
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+++||+ +++|..++... .++......++.|+++||.|||+.+ ++||||+|.||++++++.++|+|||++...
T Consensus 87 lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999999 56888887532 3778888899999999999999998 999999999999999999999999998754
Q ss_pred CCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH--------HHHh
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHA--------WKLW 318 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~ 318 (414)
.. ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+... ....
T Consensus 159 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 21 1123456788999998766 57899999999999999999999987543221100000000 0000
Q ss_pred hcCCCcccccccc-cCcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 319 NEGMPSQLIDSCF-QDSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 319 ~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.......+..... ...... .....+.+++.+||+.+|++|||+.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 000000 012457788999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=283.00 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=191.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 164 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 164 (414)
.++|++.+.||+|+||.||+|... +++.+++|++.... ......+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999864 58899999885422 222345678999999999999999999875543
Q ss_pred --eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeec
Q 043285 165 --EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 242 (414)
Q Consensus 165 --~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfg 242 (414)
..++|+||+++ +|...+.... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 6766665432 34899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCcc---------ccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHH
Q 043285 243 LARAFGGDETEG---------NTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIG 312 (414)
Q Consensus 243 l~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~ 312 (414)
++.......... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~---~~~~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI---DQLH 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH---HHHH
Confidence 997653322111 11223567889999987654 5799999999999999999999887533221 1111
Q ss_pred HHHHHhhcCCC---------ccccc--ccccCcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 313 HAWKLWNEGMP---------SQLID--SCFQDSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 313 ~~~~~~~~~~~---------~~~~~--~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
........... ....+ ......... .....+.+++.+||+.+|++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111110000 00000 000000000 01145778999999999999999999985
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=288.80 Aligned_cols=263 Identities=25% Similarity=0.347 Sum_probs=195.2
Q ss_pred HHHHHhcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-
Q 043285 88 ATIVSATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG- 163 (414)
Q Consensus 88 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 163 (414)
.++....++|.+.+.||+|+||.||++.. .++..||+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 44555779999999999999999999975 46889999998753 223345678899999999999999999988643
Q ss_pred -----CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEE
Q 043285 164 -----EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 238 (414)
Q Consensus 164 -----~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL 238 (414)
...+++++++ +++|.+++... .+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3467888877 77998877543 3889999999999999999999998 999999999999999999999
Q ss_pred EeecCccccCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043285 239 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL 317 (414)
Q Consensus 239 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 317 (414)
+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .........
T Consensus 162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~ 233 (345)
T cd07877 162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRL 233 (345)
T ss_pred ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHH
Confidence 99999876422 2223467889999998866 56889999999999999999999987532211 111111110
Q ss_pred hhcC-------CC-----------cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 318 WNEG-------MP-----------SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 318 ~~~~-------~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.... .. .......+.... ......+.+++.+||+.||.+||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhc-CCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 00 000000000000 0012346789999999999999999999965
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=277.02 Aligned_cols=244 Identities=28% Similarity=0.446 Sum_probs=189.7
Q ss_pred CCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 97 FSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
|...+.||+|+||.||+|+.. ++..|++|.+... .......+.+|+.+++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566678999999999999864 5788999998642 223445788899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+. |++.+++.... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 96 57777765432 24889999999999999999999998 9999999999999999999999999986432
Q ss_pred cccccccccccccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
......|+..|+|||.+. ...++.++|||||||++|||++|..|+.... ...... .......+ ....
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~---~~~~~~---~~~~~~~~-~~~~- 242 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALY---HIAQNDSP-TLQS- 242 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHH---HHHhcCCC-CCCc-
Confidence 122346788999999874 4568899999999999999999999864321 111111 11111111 1111
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
... ...+.+++.+||+.+|.+||++.+++..
T Consensus 243 ---~~~----~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 ---NEW----TDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---ccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 1236678889999999999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=281.40 Aligned_cols=250 Identities=28% Similarity=0.414 Sum_probs=193.2
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
+.|...+.||+|+||.||+|+.. ++..+++|.+.. ........+.+|+.+++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44777789999999999999864 578899998863 23334567888999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+. |++.+++.... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence 9996 57877765432 23789999999999999999999988 99999999999999999999999999876432
Q ss_pred CCcccccccccccccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.....++..|+|||.+. ...++.++|||||||++|+|++|..|+...... ... ........ ....
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~---~~~~~~~~-~~~~ 235 (308)
T cd06634 168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SAL---YHIAQNES-PALQ 235 (308)
T ss_pred -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---HHH---HHHhhcCC-CCcC
Confidence 12345788999999874 356788999999999999999999986432111 111 11111111 1100
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
.. .....+.+++.+||+.+|++||++.++++.....
T Consensus 236 ----~~----~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 236 ----SG----HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred ----cc----cccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 01 1123466788999999999999999999765333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=286.13 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=191.1
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC---------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--------- 163 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------- 163 (414)
..+|.+.+.||.|+||.||+|... +|..|++|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999764 5889999998765555667788999999999999999999776543
Q ss_pred -----CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCeE
Q 043285 164 -----EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPK 237 (414)
Q Consensus 164 -----~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~k 237 (414)
...++|+||++ ++|.+++... .+++..+..++.|+++||.|||+.+ ++||||||+||+++ .++.++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 5888877532 3889999999999999999999988 99999999999997 456789
Q ss_pred EEeecCccccCCCCC-ccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH
Q 043285 238 ISDFGLARAFGGDET-EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 238 L~Dfgl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 315 (414)
|+|||++..+..... ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~~~~~~ 232 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL---EQMQLIL 232 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence 999999876532211 111122357889999997654 56788999999999999999999998533211 1111100
Q ss_pred HHhhc-----------CCCcccccccccCcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 316 KLWNE-----------GMPSQLIDSCFQDSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 316 ~~~~~-----------~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..... ................. ....++.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 00000000000000000 11235678999999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=276.68 Aligned_cols=259 Identities=27% Similarity=0.371 Sum_probs=195.5
Q ss_pred CCCCCeecccCCceEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 97 FSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
|+..+.||+|++|.||+|+..+ ++.+++|.+... .....+.+..|+.+++.++|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5567889999999999998754 899999998764 2334567788999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
+ ++|.+++.... ..+++..+..++.|++.|++|||+++ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58999997653 24899999999999999999999998 99999999999999999999999999886533221
Q ss_pred cccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc------cc
Q 043285 254 GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS------QL 326 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 326 (414)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||..... ................. .+
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE---IDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHHHhCCCcHHHHHhhccc
Confidence 12223456789999998776 889999999999999999999888754221 11111111110000000 00
Q ss_pred --ccccccC-------cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 327 --IDSCFQD-------SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 327 --~~~~~~~-------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.+..+.. .........+.+++.+||+.+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 000011346788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=288.53 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=190.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 164 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 164 (414)
.++|.+.+.||+|+||.||+|... +|..||+|++.+. .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999864 6899999998652 2233456789999999999999999999987543
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
..++|+||+.. +|..++. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 6766542 23788999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC--
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG-- 321 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 321 (414)
..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ..............
T Consensus 165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGP 236 (342)
T ss_pred cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence 75421 1223457889999999876 4689999999999999999999999864221 11111111100000
Q ss_pred ---------CCccccc---ccccCcCC---HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 322 ---------MPSQLID---SCFQDSFN---LAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 322 ---------~~~~~~~---~~~~~~~~---~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
....... ........ ......+.+++.+||+.||++||++.|++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 00000000 0012346789999999999999999999954
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=288.25 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=193.1
Q ss_pred HHhcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC---
Q 043285 91 VSATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--- 164 (414)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 164 (414)
....++|++.+.||+|+||.||++.. .++..||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999975 46889999998642 2333456789999999999999999999987654
Q ss_pred ---eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEee
Q 043285 165 ---EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 241 (414)
Q Consensus 165 ---~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Df 241 (414)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 67898887542 3889999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh--
Q 043285 242 GLARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW-- 318 (414)
Q Consensus 242 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-- 318 (414)
|++..... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... ...........
T Consensus 163 g~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~~~~~~~~ 234 (343)
T cd07880 163 GLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH---LDQLMEIMKVTGT 234 (343)
T ss_pred cccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCC
Confidence 99876432 1223456889999998876 4688999999999999999999999753221 11111110000
Q ss_pred ---------hcCCCcccccc--cccC----cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 319 ---------NEGMPSQLIDS--CFQD----SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 319 ---------~~~~~~~~~~~--~~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
........... .+.. .........+.+++.+|++.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 0000 000011224678999999999999999999994
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=271.49 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=191.5
Q ss_pred CCCCCCeecccCCceEEEEEEcC-CCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
+|.+.+.||+|+||.||+++... +..+++|.++.. .......+..|+.+++.++|||++++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999997643 444556655431 222334567789999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcc-cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 170 YEFMPNKSLDSFIFDQ-ERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
+||+++++|.+++... .....+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988642 22345899999999999999999999988 999999999999975 569999999987653
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
... .......++..|+|||.+.+..++.++|+||||+++|+|++|..|+.... .......... ......
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~-~~~~~~-- 225 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE-GPTPSL-- 225 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc-CCCCCC--
Confidence 321 12233457889999999988889999999999999999999999874221 1111111111 111111
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ......+.+++.+||+.+|++||++.|+++
T Consensus 226 ---~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 226 ---P----ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---c----chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 112235677899999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=293.19 Aligned_cols=205 Identities=29% Similarity=0.466 Sum_probs=177.1
Q ss_pred CCCCCCeecccCCceEEEEE-EcCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------eee
Q 043285 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------EKL 167 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~ 167 (414)
.|...+.||+|+||.||+|+ ...|..||||.+++. .....+...+|+++|++++|+|||++++.-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 45666899999999999998 456999999999763 2334567889999999999999999998865543 568
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc--CCCC--eEEEeecC
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMN--PKISDFGL 243 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~--~~~~--~kL~Dfgl 243 (414)
+|||||.+|+|...+.+.++...+++.+.+.++.+++.||.|||+++ |+||||||.||++- .+|+ .||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999998888778999999999999999999999988 99999999999984 3343 79999999
Q ss_pred ccccCCCCCcccccccccccccccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~ 306 (414)
|+.+..+. .....+||..|++||... .+.|+..+|.|||||++|+++||..||.......
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk 231 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK 231 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc
Confidence 99875433 556788999999999998 4889999999999999999999999987655543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.47 Aligned_cols=282 Identities=21% Similarity=0.238 Sum_probs=214.8
Q ss_pred HHHHHhcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC
Q 043285 88 ATIVSATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 163 (414)
Q Consensus 88 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 163 (414)
.++....++|.+++.||+|+||.|..++.. .++.||+|++++ ........|..|-.+|..-+.+.|+.++..|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 344445689999999999999999999874 478899999987 3445567899999999999999999999999999
Q ss_pred CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecC
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl 243 (414)
.++|+||||++||+|-.++.+.. .+++.-+..++..|..||.-||+.| +|||||||+|||++..|++||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999997655 3888888999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccc----C-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYAS----D-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
|-.+..+. .-.....+|||.|.+||++. + +.|+..+|+||+||++|||+.|..||... .+...-.++.
T Consensus 222 Clkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KIm 294 (1317)
T KOG0612|consen 222 CLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKIM 294 (1317)
T ss_pred HHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHHh
Confidence 98775332 23345678999999999984 3 57899999999999999999999997531 2333333333
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHhcCC-------CCCCCCCCCCcccCCCC
Q 043285 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS---MPSVILMLGSE-------TVLPQPKQPGYLADRKS 388 (414)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs---~~evl~~L~~~-------~~~~~~~~~~~~~~~~~ 388 (414)
+......+++ ..+ -.....+||.+.+. +|+.|.. .+++-....-. +...+|=-|....+.+-
T Consensus 295 ~hk~~l~FP~-----~~~--VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DT 366 (1317)
T KOG0612|consen 295 NHKESLSFPD-----ETD--VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDT 366 (1317)
T ss_pred chhhhcCCCc-----ccc--cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCcc
Confidence 3322222221 111 11233456655555 7888888 88887654222 23455555554444433
Q ss_pred CC
Q 043285 389 TR 390 (414)
Q Consensus 389 ~~ 390 (414)
++
T Consensus 367 sn 368 (1317)
T KOG0612|consen 367 SN 368 (1317)
T ss_pred cc
Confidence 33
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=283.83 Aligned_cols=260 Identities=25% Similarity=0.336 Sum_probs=188.6
Q ss_pred CCCCCCeecccCCceEEEEEEc-C--CCEEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC----Ce
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-D--GQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG----EE 165 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~ 165 (414)
+|++.+.||+|+||.||+++.. . +..||+|.+... .....+.+.+|+.+++.+ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999864 3 678999998652 222345678899999999 599999999876432 35
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.++++||++ ++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688899986 58888886543 3889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCc--cccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC-
Q 043285 246 AFGGDETE--GNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG- 321 (414)
Q Consensus 246 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 321 (414)
.+...... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ..............
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY---VDQLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH---HHHHHHHHHHhCCCC
Confidence 65432211 11233468899999998765 4689999999999999999999988754221 11111110000000
Q ss_pred ----------CC-------cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 322 ----------MP-------SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 322 ----------~~-------~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. .......+... .......+.+++.+||+.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESI-FPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhh-CCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 00000000000 0001235678999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=288.82 Aligned_cols=258 Identities=25% Similarity=0.359 Sum_probs=194.1
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe----
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE---- 165 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 165 (414)
..++|++.+.||+|++|.||+|+.. ++..|++|++... .......+.+|+.+++.++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999875 5788999998652 23344567789999999999999999998866554
Q ss_pred --eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecC
Q 043285 166 --KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 166 --~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl 243 (414)
.++|+||+ +++|.+++... .+++..+..++.|+++|++|||+.+ ++||||+|+||++++++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 56999988642 3899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
+...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ............ ..
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~-~~ 235 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVG-TP 235 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcC-CC
Confidence 9865322 223457888999998865 3678999999999999999999999753221 111111111100 00
Q ss_pred Ccccc------------ccccc-CcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 323 PSQLI------------DSCFQ-DSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 323 ~~~~~------------~~~~~-~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
...+. ..... ..... .....+.+++.+||+.+|++|||+.||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000 00000 00000 013467789999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=265.76 Aligned_cols=236 Identities=27% Similarity=0.350 Sum_probs=189.1
Q ss_pred ecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCCh
Q 043285 103 LGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 178 (414)
Q Consensus 103 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L 178 (414)
||.|+||.||++... +++.+++|.+.... ......+..|+.+++.++|+|++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 48899999986532 22456788999999999999999999999999999999999999999
Q ss_pred hHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcccccc
Q 043285 179 DSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258 (414)
Q Consensus 179 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~ 258 (414)
.+++.... .+++..+..++.|+++|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 99987654 3899999999999999999999987 9999999999999999999999999998753321 12334
Q ss_pred ccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHH
Q 043285 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLA 338 (414)
Q Consensus 259 ~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (414)
..++..|+|||.+.+...+.++|+||||+++|+|++|..||..... ....... .. .. ..+ ....
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~---~~-~~-~~~-----~~~~--- 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI---LK-DP-LRF-----PEFL--- 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---hc-CC-CCC-----CCCC---
Confidence 5678899999999888899999999999999999999999743221 1111111 11 00 001 1111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHH
Q 043285 339 EVIRCIHIGLLCVQQHPEDRPSMPS 363 (414)
Q Consensus 339 ~~~~~~~l~~~cl~~dP~~RPs~~e 363 (414)
...+.+++.+||..||++||++.+
T Consensus 217 -~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 -SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CHHHHHHHHHHhcCCHhhCCCccc
Confidence 235677899999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.35 Aligned_cols=145 Identities=28% Similarity=0.428 Sum_probs=130.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|.+.+.||+|+||.||+|... +++.||+|+++.. .......+..|+.+++.++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999875 5889999998652 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999986543 3788899999999999999999987 9999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=256.79 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=193.1
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecc-cChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 171 (414)
++.+.+..||.|+.|+|++.+... |.-.|||.+.+ .+.+..+++...+.++..-+ +|+||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 445556789999999999998754 78899999976 45556678888888877664 8999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
.|. ..++.++..-. .++++..+-++...+.+||.||.++. +|+|||+||+|||+|+.|++||+|||++-.+-...
T Consensus 172 lMs-~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 984 35555554433 23788888899999999999999876 69999999999999999999999999998764332
Q ss_pred CccccccccccccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
......|-+.|||||.+.- ..|+..+||||||+.++||.||..||..-.. ..+....+. + +.++.+ +
T Consensus 247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~ltkvl---n-~ePP~L-~ 316 (391)
T KOG0983|consen 247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEVLTKVL---N-EEPPLL-P 316 (391)
T ss_pred ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHHHHHHH---h-cCCCCC-C
Confidence 2234467789999998853 4788999999999999999999999754222 222332222 2 222211 1
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.. ..++ ..+.+++..||++|+.+||...++++.
T Consensus 317 ~~--~gFS----p~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 GH--MGFS----PDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cc--cCcC----HHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11 1122 246778889999999999999999964
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=272.84 Aligned_cols=260 Identities=20% Similarity=0.275 Sum_probs=200.4
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCC--C----ceeeeEeEEEeCCe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH--R----NLVKLLGCCIQGEE 165 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~~~~~~~~~~~ 165 (414)
.+++|.+...+|+|.||.|-.+.... +..||||+++... ...+..+-|+++++++.+ | -++.+.++|...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 36889999999999999999996543 6889999987643 334566779999999942 2 37888899999999
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-------------
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ------------- 232 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~------------- 232 (414)
.|+|+|.+ |-|+.+++.++.- .+++...+..++.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999999 5599999976543 45899999999999999999999998 999999999999921
Q ss_pred -------CCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 043285 233 -------DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 305 (414)
Q Consensus 233 -------~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~ 305 (414)
+..++++|||.+..-. ......+.|..|.|||++.+-.++..+||||+||||.||.||...|+.....
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 3358999999998632 2235678899999999999999999999999999999999999887655433
Q ss_pred CCcchHHHHHHHhhcCCCccccc-----------------------------cccc----CcCCHHHHHHHHHHHHhccC
Q 043285 306 NNLNLIGHAWKLWNEGMPSQLID-----------------------------SCFQ----DSFNLAEVIRCIHIGLLCVQ 352 (414)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~----~~~~~~~~~~~~~l~~~cl~ 352 (414)
+.....+.+.. +.+..++. ++.. ......+...+.+|+.+||.
T Consensus 316 EHLaMMerIlG----p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 316 EHLAMMERILG----PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred HHHHHHHHhhC----CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 32222222111 11111110 0000 01122456788999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 043285 353 QHPEDRPSMPSVILM 367 (414)
Q Consensus 353 ~dP~~RPs~~evl~~ 367 (414)
+||.+|+|+.|++..
T Consensus 392 fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 392 FDPARRITLREALSH 406 (415)
T ss_pred cCccccccHHHHhcC
Confidence 999999999999863
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=260.83 Aligned_cols=219 Identities=20% Similarity=0.155 Sum_probs=172.5
Q ss_pred cCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCChhHHhhc
Q 043285 106 GGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD 184 (414)
Q Consensus 106 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~ 184 (414)
|.+|.||+++.. +++.||+|.+.... ....|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999764 58899999997642 223344555556799999999999999999999999999999999865
Q ss_pred ccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcccccccccccc
Q 043285 185 QERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264 (414)
Q Consensus 185 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~ 264 (414)
.. .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 43 3889999999999999999999988 999999999999999999999999987654321 122345677
Q ss_pred ccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHH
Q 043285 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCI 344 (414)
Q Consensus 265 y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (414)
|+|||.+.+..++.++||||+|+++|||++|+.|+........ ..... .+.... ...+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~~~~-----~~~~~~----~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------THTTL-----NIPEWV----SEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------ccccc-----CCcccC----CHHHH
Confidence 9999999888899999999999999999999977543211100 00000 011111 13466
Q ss_pred HHHHhccCCCCCCCCCH
Q 043285 345 HIGLLCVQQHPEDRPSM 361 (414)
Q Consensus 345 ~l~~~cl~~dP~~RPs~ 361 (414)
+++.+||+.||++||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 78999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=256.71 Aligned_cols=254 Identities=23% Similarity=0.299 Sum_probs=194.9
Q ss_pred CeecccCCceEEEEE-EcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEEeecCCCCh
Q 043285 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 178 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ey~~~g~L 178 (414)
+.||+|+|+.|-.+. ..+|.++|||++.+.......++.+|++++..-+ |+||+.++++|++++..|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999885 5679999999998877777789999999999985 99999999999999999999999999999
Q ss_pred hHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---CeEEEeecCccccCCCC----
Q 043285 179 DSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLARAFGGDE---- 251 (414)
Q Consensus 179 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kL~Dfgl~~~~~~~~---- 251 (414)
..+|++... +++.+...+..+|+.||.|||.+| |.|||+||+|||...-. -+||+||.+........
T Consensus 164 LshI~~~~~---F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKRKH---FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999987654 899999999999999999999998 99999999999997554 38999999976542211
Q ss_pred -Ccccccccccccccccccccc---C--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-------CcchHH-HHHHH
Q 043285 252 -TEGNTNRVVGTYGYMAPEYAS---D--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN-------NLNLIG-HAWKL 317 (414)
Q Consensus 252 -~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~-------~~~~~~-~~~~~ 317 (414)
....-...+|+..|||||+.. + ..|+.++|.||||||||-|++|.+||......+ .-...+ .....
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 112223467899999999652 2 368899999999999999999999997655422 111111 11111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..++. -++.+. ....-....-+++...+..|+..|.++.+++.
T Consensus 318 IQEGk-YeFPdk-----dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGK-YEFPDK-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccC-CcCChh-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11111 111111 11111123345777888899999999999987
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=255.25 Aligned_cols=254 Identities=22% Similarity=0.252 Sum_probs=192.5
Q ss_pred hcCCCCCC-CeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEe----CCe
Q 043285 93 ATNNFSIN-KKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ----GEE 165 (414)
Q Consensus 93 ~~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~ 165 (414)
.+++|.+. ++||-|-.|.|-.+.. ..++.+|+|++... ....+|+++--.. .|||||.+++++.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45677765 6799999999998864 46888999988542 3456777775444 69999999998864 346
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCeEEEeec
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFG 242 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kL~Dfg 242 (414)
+++|||.++||.|...+.++.. ..+++.++..|..||+.|+.|||+.+ |.||||||+|+|... |..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999999976544 56999999999999999999999998 999999999999974 4569999999
Q ss_pred CccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
+++... ........+-||.|.|||++....|+..+|+||+||++|-|++|.+||...+...... ....++.....
T Consensus 210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp--gMk~rI~~gqy 284 (400)
T KOG0604|consen 210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKRRIRTGQY 284 (400)
T ss_pred cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh--hHHhHhhccCc
Confidence 998642 2334455678999999999999999999999999999999999999986544321110 01111111110
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 323 PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
++.+ .-...-....-+++..+|+.+|++|.|+.|++..
T Consensus 285 --~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 --EFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred --cCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1111 1111112334568888999999999999999863
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=253.76 Aligned_cols=282 Identities=23% Similarity=0.342 Sum_probs=217.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc---cChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 168 (414)
.++|.+.++||.|+|++|..+++. ..+-+|+|++++ ..++...-...|..++... +||.+|.+..+|.....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 368999999999999999999875 467799999976 3455566677788887776 79999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
|.||++||+|--++..+.+ +++.....+...|+.||.|||+.| |+.||||.+|+|++..|.+||.|||+++.-
T Consensus 329 vieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~- 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG- 401 (593)
T ss_pred EEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC-
Confidence 9999999999888877665 899999999999999999999998 999999999999999999999999999853
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch-HHHHHHHhhcCCCcccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNL-IGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 327 (414)
......+.+.+|||.|.|||++.+..|+...|.|+|||+|+||+.|+.||..-..++.... -....+...+...+
T Consensus 402 -l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--- 477 (593)
T KOG0695|consen 402 -LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--- 477 (593)
T ss_pred -CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---
Confidence 2234456678999999999999999999999999999999999999999974433222111 11112211111110
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCC------HHHH----------HHHhcCCCCCCCCCCCCcccCCCCCCC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS------MPSV----------ILMLGSETVLPQPKQPGYLADRKSTRR 391 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs------~~ev----------l~~L~~~~~~~~~~~~~~~~~~~~~~~ 391 (414)
+....+ .+...++..-|.+||.+|.. +.++ ..+|++.++.| |-+|+...+.+.++.
T Consensus 478 ---iprsls----vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~p-pf~p~i~~d~~l~~f 549 (593)
T KOG0695|consen 478 ---IPRSLS----VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLP-PFQPQITDDYGLDNF 549 (593)
T ss_pred ---ccceee----hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCC-CCCCccccccCcccc
Confidence 111111 12334666789999999863 2333 23556665554 477888888887777
Q ss_pred CCC
Q 043285 392 DYS 394 (414)
Q Consensus 392 ~~~ 394 (414)
|.+
T Consensus 550 d~q 552 (593)
T KOG0695|consen 550 DTQ 552 (593)
T ss_pred ccc
Confidence 776
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=277.64 Aligned_cols=239 Identities=23% Similarity=0.299 Sum_probs=189.0
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++.|.+...+|.|+|+.|-.+.. .+++..++|++.+... +..+|+.++... +||||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 67888889999999999988865 4688899999976422 233566554444 79999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE-cCCCCeEEEeecCccccCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill-~~~~~~kL~Dfgl~~~~~~~ 250 (414)
.+.++-+.+.+..... ....+..|+.+|+.|+.|||++| ++||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~----~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE----FCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcch----hHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999988887765542 33777889999999999999998 9999999999999 68999999999999876433
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
....+-|..|.|||++....|++++|+||||++||+|++|+.||...+.+ .++...+ ..+...
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i----~~~~~s------ 532 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRI----QMPKFS------ 532 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhh----cCCccc------
Confidence 22345688999999999999999999999999999999999998754443 1111111 111111
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
... .....+|+.+||+.||.+||++.++..
T Consensus 533 --~~v----S~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 --ECV----SDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred --ccc----CHHHHHHHHHhccCChhhCcChhhhcc
Confidence 111 123456888999999999999999985
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=281.56 Aligned_cols=262 Identities=28% Similarity=0.434 Sum_probs=209.8
Q ss_pred cCHHHHHHhcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEe
Q 043285 85 FELATIVSATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 162 (414)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 162 (414)
..+..+...++.|++.+.||.|.+|.||+++. .+++.+|+|+.....+ .-+++..|.++++.. .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 34555666778899999999999999999964 4688899998865333 335788899999888 69999999999864
Q ss_pred -----CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeE
Q 043285 163 -----GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 237 (414)
Q Consensus 163 -----~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k 237 (414)
++.+|||||||.+|+.-|+++... ...+.|..+..|+..++.|+.+||.+. ++|||||-.|||++.++.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 567999999999999999997655 455999999999999999999999987 99999999999999999999
Q ss_pred EEeecCccccCCCCCccccccccccccccccccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHH
Q 043285 238 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIG 312 (414)
Q Consensus 238 L~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~ 312 (414)
|+|||.+..+. ......++..|||.|||||++.+. .|+..+|+||||++..||.-|.+|+...++...+-.+
T Consensus 164 LvDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I- 240 (953)
T KOG0587|consen 164 LVDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI- 240 (953)
T ss_pred Eeeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-
Confidence 99999998763 344556678899999999999654 5778999999999999999999997655443221111
Q ss_pred HHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 313 HAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
....++.+.. ...=..++.++|..||.+|-+.||++.++++.
T Consensus 241 ------pRNPPPkLkr-------p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 ------PRNPPPKLKR-------PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ------CCCCCccccc-------hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111111111 11123467789999999999999999998864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=282.64 Aligned_cols=259 Identities=19% Similarity=0.256 Sum_probs=166.5
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcC-----CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeE------EE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVD-----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC------CI 161 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~ 161 (414)
..++|++.+.||+|+||.||+|...+ +..||+|++...... +....+ .++...+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999998754 688999988653221 111111 1122222222222211 24
Q ss_pred eCCeeeEEEeecCCCChhHHhhccccc-----------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 043285 162 QGEEKLLIYEFMPNKSLDSFIFDQERC-----------------MILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 224 (414)
Q Consensus 162 ~~~~~~lv~ey~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk 224 (414)
.....++|+||+++++|.+++...... .......+..++.|++.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999998653210 01123345678999999999999988 9999999
Q ss_pred CCCEEEcC-CCCeEEEeecCccccCCCCCccccccccccccccccccccCC----------------------CCCcchh
Q 043285 225 ASNVLLDQ-DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG----------------------QFSVKSD 281 (414)
Q Consensus 225 ~~Nill~~-~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 281 (414)
|+|||++. ++.+||+|||++..+.... ........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5799999999998653221 1223345789999999965322 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH---------HhhcCCCcccccccccCcCCH--HHHHHHHHHHHhc
Q 043285 282 VFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWK---------LWNEGMPSQLIDSCFQDSFNL--AEVIRCIHIGLLC 350 (414)
Q Consensus 282 vwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~c 350 (414)
||||||+||||+++..++.. ........ .|....... ........++. .......+|+.+|
T Consensus 362 VwSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRKLVEPR-ASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHHhhccc-cchhhhhhhhhccccchHHHHHHHHH
Confidence 99999999999997654321 11110000 010000000 00000000000 0011344789999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 043285 351 VQQHPEDRPSMPSVILM 367 (414)
Q Consensus 351 l~~dP~~RPs~~evl~~ 367 (414)
|++||++|||+.|+++.
T Consensus 434 L~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 434 MRFKGRQRISAKAALAH 450 (566)
T ss_pred ccCCcccCCCHHHHhCC
Confidence 99999999999999974
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=265.03 Aligned_cols=257 Identities=26% Similarity=0.349 Sum_probs=192.4
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEec--cc-C----hhhHHHHHHHHHHHHhcCCCceeeeEeEEE-eCC
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLS--KI-S----EQGLKELKNEVILFSKLQHRNLVKLLGCCI-QGE 164 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~--~~-~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~ 164 (414)
.++|-++.+||+|+|+.||++.. ...+.||||+-. +. . ....+...+|..+-+.|+||.||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 35688889999999999999965 457788998753 21 1 122345678999999999999999999986 455
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCeEEEee
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDF 241 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kL~Df 241 (414)
..|-|+|||+|.+|+-+|....- +++.+...|+.||..||.||.+.. ++|||-||||.|||+-+ .|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 78899999999999999976553 899999999999999999999875 78999999999999954 478999999
Q ss_pred cCccccCCCCCcc-----ccccccccccccccccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHH
Q 043285 242 GLARAFGGDETEG-----NTNRVVGTYGYMAPEYASD----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIG 312 (414)
Q Consensus 242 gl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~ 312 (414)
|+++.+..+.... -+....||.+|++||.+.- ...+.|.||||.|||+|.++.|+.||+..... .++++
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHh
Confidence 9999876543321 2334679999999998743 35789999999999999999999999753322 11111
Q ss_pred HHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 043285 313 HAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365 (414)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl 365 (414)
.. .++.... ..+.. . ... ..+.-.++.+||++.-++|....++.
T Consensus 696 eN-TIlkAtE-VqFP~-K--PvV----sseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 EN-TILKATE-VQFPP-K--PVV----SSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hh-chhccee-ccCCC-C--Ccc----CHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11 0000000 00100 0 011 12344588899999999998877776
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=251.08 Aligned_cols=238 Identities=28% Similarity=0.392 Sum_probs=190.3
Q ss_pred CCceEEEEEEcC-CCEEEEEEecccChhh-HHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCChhHHhhc
Q 043285 107 GFGPVYKGKLVD-GQEIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD 184 (414)
Q Consensus 107 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~ 184 (414)
+||.||+|...+ +..+++|++....... .+.+.+|+..++.++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998764 8899999997644433 67899999999999999999999999999999999999999999999876
Q ss_pred ccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcccccccccccc
Q 043285 185 QERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264 (414)
Q Consensus 185 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~ 264 (414)
... +++..+..++.+++.++.|||+.+ ++|+||+|.||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 443 789999999999999999999987 9999999999999999999999999998764322 2334567889
Q ss_pred ccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHH
Q 043285 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCI 344 (414)
Q Consensus 265 y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (414)
|++||.+.+..++.++||||||+++++|++|..|+... ....... ........... .. .. .....+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~~~~~----~~~~~~~~~~~-~~---~~---~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQLLELF----KKIGKPKPPFP-PP---EW---KISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHH----HHHhccCCCCc-cc---cc---cCCHHHH
Confidence 99999999888999999999999999999999887432 1111111 11111111100 00 00 0123577
Q ss_pred HHHHhccCCCCCCCCCHHHHHH
Q 043285 345 HIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 345 ~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+++.+||..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 8999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=256.17 Aligned_cols=257 Identities=27% Similarity=0.357 Sum_probs=192.6
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccCh-hhHHHHHHHHHHHHh-cCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISE-QGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++.+-...||.|+||+|++-.+ ..|+..|||+++.... ...+++..|.+...+ -++||||+++|.+..+...|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3444457899999999999865 4689999999987443 566778888876544 479999999999999999999999
Q ss_pred ecCCCChhHHhhc--ccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 172 FMPNKSLDSFIFD--QERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 172 y~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
.|+ .+|+.+... ......+++.-+-+|......||.||...- .|+|||+||+|||++..|.+||+|||++-.+.+
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 995 477665432 111234888888899999999999998765 599999999999999999999999999987643
Q ss_pred CCCccccccccccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
+.. ...-.|-..|||||.+.. ..|+-+|||||||++|+|+.||+.|+..+.. +........ .+.++.+.
T Consensus 221 SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-~gdpp~l~ 291 (361)
T KOG1006|consen 221 SIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-IGDPPILL 291 (361)
T ss_pred HHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-cCCCCeec
Confidence 221 122345667999998854 3589999999999999999999988653322 222222222 22222222
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. +....+....+..++.-|+.+|-++||+..++.++
T Consensus 292 ~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 F----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred C----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2 12223334567888999999999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=268.64 Aligned_cols=276 Identities=22% Similarity=0.282 Sum_probs=214.6
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCC-EEEEEEecc---cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQ-EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.+++.+..||-|+||.|=+++.+... .+|+|++++ ....+.+.+..|-.+|...+.|.||++|-.|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999999875433 378888876 34445567788999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
|-|-||.|+..+.+... ++......++..+.+|++|||+++ ||.|||||+|.+++.+|-+||.|||+++.+.
T Consensus 500 EaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~-- 571 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG-- 571 (732)
T ss_pred HhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc--
Confidence 99999999999976554 888888899999999999999998 9999999999999999999999999999874
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
....+-+++|||.|.|||++.+...+.++|.||||+++|||++|.+||....+.....++-.....+ ..+..+.
T Consensus 572 -~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--~~Pr~I~--- 645 (732)
T KOG0614|consen 572 -SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--EFPRRIT--- 645 (732)
T ss_pred -cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--hcccccc---
Confidence 3345667899999999999999999999999999999999999999987665554444332221111 1111111
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHh----cCCCC-----CCCCCCCCcccCCCCCCCCCC
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPS-----MPSVILML----GSETV-----LPQPKQPGYLADRKSTRRDYS 394 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~L----~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 394 (414)
....+++.+.++.+|.+|.. ..++-+.- .+... +++|-.|......+....|..
T Consensus 646 ----------k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~ 713 (732)
T KOG0614|consen 646 ----------KTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNF 713 (732)
T ss_pred ----------hhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCC
Confidence 23456788889999999987 55555432 12222 455666665555544444443
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=269.40 Aligned_cols=244 Identities=27% Similarity=0.381 Sum_probs=192.5
Q ss_pred CCeecccCCceEEEEEE-cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCC
Q 043285 100 NKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 176 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g 176 (414)
.+.||+|.||+||-|+. .+|+.||||++.+ .......++.+|+.+|+++.||.||.+...|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 37899999999999965 5799999999976 33445578999999999999999999999999999999999999 56
Q ss_pred ChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CCeEEEeecCccccCCCCCc
Q 043285 177 SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 177 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kL~Dfgl~~~~~~~~~~ 253 (414)
+..+.+...++ ..+++..-..++.||+.||.|||.++ |+|.||||+|||+.+. -++||+|||+++.++..
T Consensus 648 DMLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--- 720 (888)
T KOG4236|consen 648 DMLEMILSSEK-GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--- 720 (888)
T ss_pred hHHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh---
Confidence 77776655444 33888888889999999999999998 9999999999999754 46999999999987543
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......+|||.|+|||++.++.|+..-|+||.|||+|-=++|.-||. .+++..+.++.+.-.+......+
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFMyPp~PW~e-------- 790 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFMYPPNPWSE-------- 790 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhccccccCCCchhh--------
Confidence 34556789999999999999999999999999999999999998864 22333333333222221111111
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
-....++++...|+..-.+|.|..+-+.
T Consensus 791 -----is~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 791 -----ISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -----cCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1123566777888888888888766543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=259.58 Aligned_cols=243 Identities=24% Similarity=0.324 Sum_probs=193.1
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 168 (414)
..+|..+.+||+|+||.|.++.... ...+|||++++. .+.+.+.-+.|-++|... +-|.++++..+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3568889999999999999996544 456999999872 334445556777888776 46789999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||+.||+|--+++.-.+ +.+.....++..||-||-+||+++ |+.||||.+||+++.+|.+||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999888876554 778888999999999999999998 9999999999999999999999999997421
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
-....+.+.+|||.|+|||++..++|+.++|.|||||+||||+.|.+||+... ..++.+.+..
T Consensus 502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD---E~elF~aI~e------------ 564 (683)
T KOG0696|consen 502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQAIME------------ 564 (683)
T ss_pred --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHH------------
Confidence 12234567899999999999999999999999999999999999999986432 2233333321
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 361 (414)
... .+......+.+.++...|.+.|.+|...
T Consensus 565 hnv--syPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 565 HNV--SYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred ccC--cCcccccHHHHHHHHHHhhcCCccccCC
Confidence 111 1111222345667778899999999643
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=253.26 Aligned_cols=268 Identities=23% Similarity=0.351 Sum_probs=191.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe--------C
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--------G 163 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 163 (414)
..|+-..+||+|.||.||+++.. .|+.|++|++-- .....-....+|+.+|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 44666678999999999999764 477888887532 222233456789999999999999999988753 2
Q ss_pred CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecC
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl 243 (414)
...|+||.+|+. +|..++.+.. ..++..++.+++.++.+||.|+|... |+|||+|+.|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347999999987 8888886542 34899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCc--cccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhc
Q 043285 244 ARAFGGDETE--GNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE 320 (414)
Q Consensus 244 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
++.+...... ......+-|..|.+||.+.+ ..|+++.|||+-||||.||+||.+-+..........++.........
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9876433322 22233456999999998876 58999999999999999999998765443322222222211111000
Q ss_pred CCCcc-----cc-----cccccCcCC--HHHH------HHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 321 GMPSQ-----LI-----DSCFQDSFN--LAEV------IRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 321 ~~~~~-----~~-----~~~~~~~~~--~~~~------~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
+..+. +. .+.....+. .+.+ ...++|+..++..||.+||.+.+++..-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 00000 00 000000000 0111 1567788899999999999999998644
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=267.79 Aligned_cols=207 Identities=24% Similarity=0.371 Sum_probs=174.4
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.-|..++.||-|+||.|.+++..| ...+|+|.+.+. ...+....+.|-.||...+.+.||+++..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457778899999999999997655 456899999763 3345556789999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC--
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG-- 248 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~-- 248 (414)
+|++||++-.+|-+.. .+.+.....++..+..|+++.|..| +|||||||+|||||.+|.+||.|||||.-+.
T Consensus 709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999998886543 4888888899999999999999988 9999999999999999999999999987541
Q ss_pred -CCCCc-------------------------------------cccccccccccccccccccCCCCCcchhHHHHHHHHH
Q 043285 249 -GDETE-------------------------------------GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLL 290 (414)
Q Consensus 249 -~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ 290 (414)
+..+. ......+||+.|+|||++....|+..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00000 0001247999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCC
Q 043285 291 EIVSGKKNRGFYHSDNN 307 (414)
Q Consensus 291 elltg~~p~~~~~~~~~ 307 (414)
||+.|+.||-.....+.
T Consensus 863 em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHhhCCCCccCCCCCcc
Confidence 99999999865554443
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=228.14 Aligned_cols=260 Identities=23% Similarity=0.337 Sum_probs=190.4
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+|...++||+|.||+||+|+.. .+.-||+|.++-. ++.-.....+|+-+++.++|.|||++++....+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4555689999999999999754 4778999998642 233345678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
|.. +|..+..... ..++......++.|+++|+.++|+++ +.|||+||.|.+|+.+|++||+|||+++.++-..
T Consensus 83 cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred hhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 954 7887775543 24888999999999999999999998 9999999999999999999999999999764322
Q ss_pred ccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCC-CCCCCCCCCcchHHHHHHHhhcCCC------c
Q 043285 253 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKN-RGFYHSDNNLNLIGHAWKLWNEGMP------S 324 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~------~ 324 (414)
.....-+-|..|.+|.++.+. -|+...|+||-||++.|+.....| |. ..+-.+....+.+....... .
T Consensus 156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp---g~dvddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP---GNDVDDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC---CCcHHHHHHHHHHHhCCCccccCCccc
Confidence 122233568999999998876 579999999999999999874444 43 22222333333333222221 1
Q ss_pred ccccccccCcC----CHHHH-----HHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 325 QLIDSCFQDSF----NLAEV-----IRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 325 ~~~~~~~~~~~----~~~~~-----~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.+.|-..-..+ +..+. ..-.+++...+.-+|..|.++++.++
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 12221111111 11111 12245666777779999999998874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=267.13 Aligned_cols=263 Identities=19% Similarity=0.246 Sum_probs=177.1
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-----------------cCCCEEEEEEecccChhhHHH--------------HHHH
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-----------------VDGQEIAVKRLSKISEQGLKE--------------LKNE 141 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 141 (414)
..++|++.++||+|+||.||+|.. .+++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 457899999999999999999963 235679999986533222222 3346
Q ss_pred HHHHHhcCCCce-----eeeEeEEEe--------CCeeeEEEeecCCCChhHHhhcccc---------------------
Q 043285 142 VILFSKLQHRNL-----VKLLGCCIQ--------GEEKLLIYEFMPNKSLDSFIFDQER--------------------- 187 (414)
Q Consensus 142 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~ey~~~g~L~~~l~~~~~--------------------- 187 (414)
+.++.+++|.++ ++++++|.. ....++||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766654 677777753 3468999999999999999864211
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccc
Q 043285 188 CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267 (414)
Q Consensus 188 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~a 267 (414)
...+++..+..++.|++++|.|||+.+ ++||||||+||+++.++.+||+|||++........ .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 112467788899999999999999988 99999999999999999999999999975432211 11112335789999
Q ss_pred cccccCCC--------------------C--CcchhHHHHHHHHHHHHhCCC-CCCCCCCCCC----cchHHHHHHHhhc
Q 043285 268 PEYASDGQ--------------------F--SVKSDVFSFGILLLEIVSGKK-NRGFYHSDNN----LNLIGHAWKLWNE 320 (414)
Q Consensus 268 PE~~~~~~--------------------~--~~~sDvwslGvil~elltg~~-p~~~~~~~~~----~~~~~~~~~~~~~ 320 (414)
||.+.... + ..+.||||+||++++|++|.. |+........ .......|+....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875432 1 134799999999999999875 4432111000 0000011111111
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHhccCCCC---CCCCCHHHHHHH
Q 043285 321 GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHP---EDRPSMPSVILM 367 (414)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP---~~RPs~~evl~~ 367 (414)
... +-..-+. ......+++.+||..+| .+|+|++|+++.
T Consensus 459 ~~~----~~~~~d~----~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKY----DFSLLDR----NKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCC----Ccccccc----cChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 110 0000011 11245678888998765 689999999964
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-33 Score=274.03 Aligned_cols=246 Identities=25% Similarity=0.375 Sum_probs=187.6
Q ss_pred CCCCCeecccCCce-EEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 97 FSINKKLGQGGFGP-VYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 97 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
|...+.+|.|+.|+ ||+|.+ +|+.||||++-. .......+|+..++.- +|||||++++.-.+....|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 34446789998876 699988 789999998843 3445678999999988 59999999999999999999999996
Q ss_pred CCChhHHhhcc-cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---C--CCeEEEeecCccccC
Q 043285 175 NKSLDSFIFDQ-ERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---D--MNPKISDFGLARAFG 248 (414)
Q Consensus 175 ~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~--~~~kL~Dfgl~~~~~ 248 (414)
. +|.+++... ...........+.++.|+++||++||+.+ |+||||||.||||+. + ..++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 999999763 11111122445778899999999999987 999999999999976 3 469999999999886
Q ss_pred CCCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 249 GDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG-KKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 249 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
..... .......||-+|+|||++....-+.++||||+||++|+.++| ..||+.....+ ..+.........
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccceee
Confidence 54332 234556799999999999999888899999999999999997 78987532221 111111111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+. ... +. ...+||.+|+.++|..||++.+|+.
T Consensus 735 L~----~~~--d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 LE----PLP--DC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ec----cCc--hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11 111 11 4567899999999999999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=228.00 Aligned_cols=205 Identities=27% Similarity=0.388 Sum_probs=167.1
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc-cChhhHHHHHHHHHHHHh-cCCCceeeeEeEEEeCCeeeEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK-ISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv 169 (414)
..++......||+|++|.|-+-++ .+|.-.|+|.+.. .+.+..++..+|+.+..+ ..+|.+|.|+|...+....++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 345566678899999999988865 5689999999975 455666778888887544 5799999999999999999999
Q ss_pred EeecCCCChhHHhhc-ccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 170 YEFMPNKSLDSFIFD-QERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||.|.. +|+.+..+ -.....+++..+-+|+..+.+||.|||++- .++|||+||.|||++.+|++|+||||.+-.+.
T Consensus 124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 999964 78776644 223456889999999999999999999975 69999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASD----GQFSVKSDVFSFGILLLEIVSGKKNRGFYH 303 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslGvil~elltg~~p~~~~~ 303 (414)
++-.. ....|-..|||||.+.. ..|+-+|||||||+.+.||.+++.|+..+.
T Consensus 201 dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 201 DSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 33211 11245567999998753 478999999999999999999999976443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=227.75 Aligned_cols=211 Identities=36% Similarity=0.579 Sum_probs=182.2
Q ss_pred ecccCCceEEEEEEcC-CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCChhH
Q 043285 103 LGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 180 (414)
Q Consensus 103 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~ 180 (414)
||+|.+|.||++...+ +..+++|++...... ....+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998854 889999999764332 35678999999999999999999999999999999999999999999
Q ss_pred HhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCeEEEeecCccccCCCCCccccccc
Q 043285 181 FIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGDETEGNTNRV 259 (414)
Q Consensus 181 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kL~Dfgl~~~~~~~~~~~~~~~~ 259 (414)
++.... ..++...+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 986542 23889999999999999999999998 999999999999999 89999999999986533221 12334
Q ss_pred cccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHH
Q 043285 260 VGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLA 338 (414)
Q Consensus 260 ~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (414)
.+...|++||.+... .++.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 567889999999887 888999999999999999
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 339 EVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 339 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
..+.+++.+|++.+|++||++.++++.+
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3466788899999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=227.52 Aligned_cols=257 Identities=21% Similarity=0.342 Sum_probs=193.4
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCe--eeE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE--KLL 168 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~--~~l 168 (414)
..++|++.+++|.|.++.||.|.. .++..++||+++.. ..+.+++|+.+|+.+. ||||+++++...+... ..+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 457899999999999999999964 56788999999753 3468899999999997 9999999999987654 579
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCeEEEeecCcccc
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAF 247 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kL~Dfgl~~~~ 247 (414)
|+||+.+.+...+.. .++...+..++.++++||.|+|+.| |.|||+||.|++|+. ...++|+|+|++.+.
T Consensus 113 iFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 999999988877653 3777788899999999999999999 999999999999985 457999999999886
Q ss_pred CCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh--------
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW-------- 318 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 318 (414)
.... ..+..+.+..|-.||.+-+ ..|+.+-|+|||||++..|+..+.|| ..+.+..+.+..+.+.+
T Consensus 184 Hp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF--FhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 184 HPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred CCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc--cCCCCCHHHHHHHHHHhChHHHHHH
Confidence 4322 2233445667889998866 56899999999999999999999996 34444433333332211
Q ss_pred ----hcCCCccccc-----------ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 319 ----NEGMPSQLID-----------SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 319 ----~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.....+++-+ ..+..+...-...+.++++...|.+|-.+|||++|...
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111111111 01111110001135677888999999999999999875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-33 Score=240.66 Aligned_cols=267 Identities=23% Similarity=0.338 Sum_probs=192.0
Q ss_pred CCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----eeeE
Q 043285 97 FSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKLL 168 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l 168 (414)
.+..+.||.|+||.||.... .+|+.|++|++... +-...+.+.+|+.++.-.+|.|++..++...-.. ++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34458999999999999976 46999999998652 3335578889999999999999999888765443 4678
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
++|.+. .+|..++-... .++...+.-++.||++||.|||+.+ |.||||||.|.|++++..+||+|||+++.-.
T Consensus 135 ~TELmQ-SDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHH-hhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 889885 47777775433 4788888889999999999999998 9999999999999999999999999998754
Q ss_pred CCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHH------------HH
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGH------------AW 315 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~------------~~ 315 (414)
.++....+ .-+-|..|.|||++.+. .|+.+.||||.|||+.||+..+..|....+-...+++-. ..
T Consensus 208 ~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 QRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 33333222 33458899999999875 789999999999999999998877754433222222211 11
Q ss_pred -----HHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 316 -----KLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 316 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
..++......-..-.+.-......-.+.+.+.+.++.+||.+|.+-++.+..+-..
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 11111111111111111000011112344566688999999999999999876443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=253.79 Aligned_cols=202 Identities=22% Similarity=0.250 Sum_probs=172.1
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCC------CceeeeEeEEEeCCe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH------RNLVKLLGCCIQGEE 165 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~~~ 165 (414)
..++|.+....|+|-|++|..|... .|+.||||++.+ ++...+.=..|+++|++|+. -|.++++-.|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 4577888889999999999999764 488999999976 33444556789999999963 489999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCeEEEeecCc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLA 244 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kL~Dfgl~ 244 (414)
+|||||-+ ..+|.++|..-.....+....+..++.|++-||..|...+ |+|.||||+||||++. ..+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999998 4699999988766667999999999999999999999988 9999999999999976 45899999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 303 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~ 303 (414)
....... -..+.-+-.|.|||++.+.+|+...|+||.||+||||.||+..|....
T Consensus 585 ~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 585 SFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred ccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 8764332 223344667999999999999999999999999999999998876543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=235.91 Aligned_cols=132 Identities=27% Similarity=0.379 Sum_probs=110.1
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-----C---CceeeeEeEEEe--
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----H---RNLVKLLGCCIQ-- 162 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~-- 162 (414)
..+|.+.++||-|.|++||++.. .+.+.||+|+.+.. ....+....|+.+|++++ | .+||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36899999999999999999975 45778999999763 233456788999999983 3 369999999974
Q ss_pred --CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 043285 163 --GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 230 (414)
Q Consensus 163 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill 230 (414)
+.++|||+|++ |-+|..+|....-. .++...+..|+.|++.||.|||... +|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56899999999 55788887654432 3899999999999999999999986 59999999999999
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=250.07 Aligned_cols=196 Identities=28% Similarity=0.413 Sum_probs=169.5
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccC--------hhhHHHHHHHHHHHHhcC---CCceeeeEeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQ 162 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 162 (414)
.+|...+.+|+|+||.|+.+.++. ...|+||.+.+.. +...-.+..|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468889999999999999997754 5578999886521 112224567999999997 9999999999999
Q ss_pred CCeeeEEEeec-CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEee
Q 043285 163 GEEKLLIYEFM-PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 241 (414)
Q Consensus 163 ~~~~~lv~ey~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Df 241 (414)
.+..|++||-. ++.+|.+++....+ +++.+..-|+.|++.|+++||+++ |+|||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999985 56689999976655 899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 043285 242 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRG 300 (414)
Q Consensus 242 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~ 300 (414)
|.+.+..+ ......+||..|.|||++.+..| +..-|||++|++||.++....||.
T Consensus 715 gsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99987643 34556789999999999999988 667899999999999999888853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=223.27 Aligned_cols=198 Identities=33% Similarity=0.484 Sum_probs=171.4
Q ss_pred CCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 97 FSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
|.+.+.||.|++|.||++...+ +..+++|.+...... ..+.+.+|+..++.++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999998865 889999999765444 56788999999999999999999999999999999999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+++|.+++...... +++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 99999998754321 788999999999999999999987 99999999999999999999999999887643321 1
Q ss_pred ccccccccccccccccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 043285 255 NTNRVVGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGKKNRG 300 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslGvil~elltg~~p~~ 300 (414)
......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22344677889999998 66778889999999999999999999973
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=251.84 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=198.4
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
..++|++...+|+|.||.||+++. ..+...|+|.++-.....+.-+..|+-+++.-+||||+.++|.+.....+++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 457899999999999999999986 4588899999987666777788899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
||.+|+|.+..+-. ..+++.++..++...++|+.|||+++ -+|||||-.||++++.|.+|++|||.+..+..
T Consensus 93 ycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred ecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--
Confidence 99999999977543 34899999999999999999999998 79999999999999999999999999876532
Q ss_pred Cccccccccccccccccccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh---cCCCcc
Q 043285 252 TEGNTNRVVGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN---EGMPSQ 325 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 325 (414)
.-.......||+.|||||+. ..+.|..++|||++|+...|+-.-.+|.- ++.....-.+. ...+..
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf--------dlhpmr~l~LmTkS~~qpp~ 236 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF--------DLHPMRALFLMTKSGFQPPT 236 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc--------ccchHHHHHHhhccCCCCCc
Confidence 22344557899999999975 45689999999999999999977665521 11111111111 111112
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+.| .... ..-+.+++..|+.++|++|||++.++.
T Consensus 237 lkD-----k~kw--s~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LKD-----KTKW--SEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccC-----Cccc--hHHHHHHHHHHhcCCCccCCChhhhee
Confidence 211 1111 123567888999999999999987765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=226.53 Aligned_cols=262 Identities=25% Similarity=0.289 Sum_probs=191.6
Q ss_pred cCCCCCCCeecccCCceEEEEE-EcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 164 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 164 (414)
..+|.-.+.+|.|.- .|..+. ...++.|++|++.. ......+...+|..++..++|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 467777888999988 555553 23588999998864 33445677889999999999999999999986433
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
..|+|||||. .+|...+.. .++-..+..++.|++.|++|||+.+ |+||||||+||++..+..+||.|||++
T Consensus 95 e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 5689999995 588888862 2677888999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC---------------cc
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN---------------LN 309 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~---------------~~ 309 (414)
+.-.. .-.....+.|..|.|||++.+..|.+.+||||+||++.||++|+.-|.....-+. ..
T Consensus 166 r~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 86321 1234456778899999999998899999999999999999999976642111000 00
Q ss_pred hHHHHHHHhhcCC--------CcccccccccCcC--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 310 LIGHAWKLWNEGM--------PSQLIDSCFQDSF--NLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 310 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
......+.+-... ...+.|..+.... +.-......+++.+||-.+|++|.|+.++|+.=
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 0000111111111 1112222222111 111223456788999999999999999999853
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=218.02 Aligned_cols=252 Identities=21% Similarity=0.340 Sum_probs=182.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEe-EEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLG-CCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~-~~~~~~~~~lv~ 170 (414)
.+.|.+.+.+|+|.||.+-++++.. .+.+++|.+.... ...++|.+|...--.| .|.||+.-++ .|+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3679999999999999999998754 6779999887632 3446788887765555 4899987665 466677788999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc--CCCCeEEEeecCccccC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLARAFG 248 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~--~~~~~kL~Dfgl~~~~~ 248 (414)
||+|.|+|.+-+.... +.+.....++.|++.|+.|+|+.+ ++|||||.+||||- +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999998775432 778888899999999999999998 99999999999994 34579999999988653
Q ss_pred CCCCccccccccccccccccccccC---C--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASD---G--QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
... ....-+..|.+||.... + ...+.+|||.||++++.++||..||+-.... +.-.+.+..|.....
T Consensus 175 ~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~---d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 175 TTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM---DKPYWEWEQWLKRKN 246 (378)
T ss_pred cee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc---CchHHHHHHHhcccC
Confidence 221 12223567899996532 2 3467899999999999999999998732222 223344444444443
Q ss_pred cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
....+. ++ .++ ..++++-.+-+..+|++|=...++-++
T Consensus 247 ~~~P~~-F~-~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 247 PALPKK-FN-PFS----EKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred ccCchh-hc-ccC----HHHHHHHHHhcCCcccccchhHHHHHH
Confidence 332221 11 111 234455667889999999544444443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=225.05 Aligned_cols=267 Identities=24% Similarity=0.389 Sum_probs=196.4
Q ss_pred HHHhcCCCCCCCeecccCCceEEEEEEc----CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCC
Q 043285 90 IVSATNNFSINKKLGQGGFGPVYKGKLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 164 (414)
Q Consensus 90 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 164 (414)
.....+.|..+.+||+|.|++||++.+. ....||+|.+...... ..+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445678999999999999999999653 3678999998764433 56889999999994 899999999999999
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCeEEEeecC
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL 243 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kL~Dfgl 243 (414)
+..+|+||++.....+++.. ++..++..++..++.||.++|.+| |+||||||.|+|.+.. +.-.|+|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999998754 778899999999999999999999 9999999999999855 6689999999
Q ss_pred ccccCCCC-------------Cc-----------------------------ccccccccccccccccccc-CCCCCcch
Q 043285 244 ARAFGGDE-------------TE-----------------------------GNTNRVVGTYGYMAPEYAS-DGQFSVKS 280 (414)
Q Consensus 244 ~~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~s 280 (414)
+....... .. .......||++|.|||++. ....++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 87210000 00 0001235999999999875 56789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH--------HH---------HhhcCC---C-------ccc-cccccc
Q 043285 281 DVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHA--------WK---------LWNEGM---P-------SQL-IDSCFQ 332 (414)
Q Consensus 281 DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~---------~~~~~~---~-------~~~-~~~~~~ 332 (414)
||||.|||++-+++++.||-....+.. .+...+ .+ .|.... . ..+ ...+..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred ceeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 999999999999999999754333221 111110 00 000000 0 000 011111
Q ss_pred Cc--------CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 333 DS--------FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 333 ~~--------~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
.. ........+.+++.+|+..||.+|.|++++|+.-
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 00 0001123678899999999999999999999865
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=257.03 Aligned_cols=197 Identities=19% Similarity=0.239 Sum_probs=136.6
Q ss_pred hcCC-CceeeeEeEE-------EeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 043285 147 KLQH-RNLVKLLGCC-------IQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRI 218 (414)
Q Consensus 147 ~l~h-~niv~~~~~~-------~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 218 (414)
.++| +||+.++++| ......+.++||+ +++|.+++.... ..+++.++..++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 5888888887 2334567888987 569999996532 34899999999999999999999998 9
Q ss_pred eeccCCCCCEEEcCCCC-------------------eEEEeecCccccCCCCC--------------ccccccccccccc
Q 043285 219 IHRDLKASNVLLDQDMN-------------------PKISDFGLARAFGGDET--------------EGNTNRVVGTYGY 265 (414)
Q Consensus 219 iH~dlk~~Nill~~~~~-------------------~kL~Dfgl~~~~~~~~~--------------~~~~~~~~gt~~y 265 (414)
+||||||+||||+..+. +|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965444 45555555543210000 0001123578899
Q ss_pred cccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHH
Q 043285 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIH 345 (414)
Q Consensus 266 ~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (414)
||||++.+..++.++|||||||+||||++|..|+... ......... ...+... .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~~~~~---~~~~~~~----------~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-----SRTMSSLRH---RVLPPQI----------LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-----HHHHHHHHH---hhcChhh----------hhcCHHHHH
Confidence 9999999999999999999999999999988764311 011111100 0001000 011223456
Q ss_pred HHHhccCCCCCCCCCHHHHHHH
Q 043285 346 IGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 346 l~~~cl~~dP~~RPs~~evl~~ 367 (414)
++.+||+++|.+||++.|+++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 7889999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=200.20 Aligned_cols=167 Identities=17% Similarity=0.154 Sum_probs=122.1
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
|+|.+++.... ..+++..++.++.|++.||.|||+++ ||+||+++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 68999987532 24899999999999999999999875 999999999999999 9998765321
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
...||+.|+|||++.+..++.++|||||||++|||+||+.||...... ................ ... ....
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~----~~~-~~~~ 133 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDP----RDR-SNLE 133 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCc----ccc-ccHH
Confidence 125789999999999999999999999999999999999997532211 1111111111111100 000 0000
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
.......+.+++.+||+.+|.+||++.|+++.+.
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 0111125788999999999999999999998774
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-25 Score=208.81 Aligned_cols=176 Identities=20% Similarity=0.196 Sum_probs=133.8
Q ss_pred HhcCCCCCCCeecccCCceEEEEEEc--CCCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 043285 92 SATNNFSINKKLGQGGFGPVYKGKLV--DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 164 (414)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 164 (414)
...++|.+.+.||+|+||+||+|+.. +++.||||++... .......+.+|+.+++.++|+|+++.+.. ..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34578999999999999999999764 4777899987532 22335678999999999999999863322 24
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC-CCCCEEEcCCCCeEEEeecC
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dl-k~~Nill~~~~~~kL~Dfgl 243 (414)
..++||||+++++|... . . .. ...++.+++++|.|||+++ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~-~-~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R-P-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHh-C-c-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 68999999999999632 1 1 11 1467889999999999998 999999 99999999999999999999
Q ss_pred ccccCCCCCccc------cccccccccccccccccCC------CCCcchhHH
Q 043285 244 ARAFGGDETEGN------TNRVVGTYGYMAPEYASDG------QFSVKSDVF 283 (414)
Q Consensus 244 ~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~------~~~~~sDvw 283 (414)
++.+........ -....+++.|+|||.+... ..+..+|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 997654321111 1245688899999988543 233445655
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-26 Score=197.01 Aligned_cols=247 Identities=21% Similarity=0.356 Sum_probs=185.4
Q ss_pred CCCCCCeecccCCceEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
+..+..+|.+...|..|+|++ .|..+++|++.- ......+.|..|.-.++.+.||||++++|.|....++.++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 344556789999999999999 566777787753 33344567888999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEE--eecCccccCCCC
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS--DFGLARAFGGDE 251 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~--Dfgl~~~~~~~~ 251 (414)
+.|+|..+++++.. ...+..+..+++.++++|++|||+.. +-|.---|.+..++++++.+.+|. |--++..
T Consensus 270 p~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq----- 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----- 342 (448)
T ss_pred cchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence 99999999988765 44788889999999999999999987 224445699999999999887775 3222111
Q ss_pred CccccccccccccccccccccCCCC---CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQF---SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
.....-.|.||+||.++..+- -.++|+|||.+++|||.|...||....+.+-... .. .++....+..
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk--ia----leglrv~ipp 412 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK--IA----LEGLRVHIPP 412 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh--hh----hccccccCCC
Confidence 011123678999999977643 3579999999999999999999876554321111 11 1222211111
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
..+ ..+.+++.-|+..||.+||.+..++-.|+
T Consensus 413 -----gis----~hm~klm~icmnedpgkrpkfdmivpile 444 (448)
T KOG0195|consen 413 -----GIS----RHMNKLMNICMNEDPGKRPKFDMIVPILE 444 (448)
T ss_pred -----Ccc----HHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence 111 24567888899999999999999988775
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-24 Score=201.63 Aligned_cols=259 Identities=22% Similarity=0.255 Sum_probs=189.2
Q ss_pred CCCCCCeecccCCceEEEEEEcCC--CEEEEEEecccChhhHHHHHHHHHHHHhcCC----CceeeeEeEE-EeCCeeeE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVDG--QEIAVKRLSKISEQGLKELKNEVILFSKLQH----RNLVKLLGCC-IQGEEKLL 168 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~l 168 (414)
+|.+.+.||+|+||.||++...+. ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999986553 4788888765433322267888888888863 5888888888 46778899
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-----CCeEEEeecC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGL 243 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-----~~~kL~Dfgl 243 (414)
||+.+ |.+|.++..... ...++....+.++.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99998 679999875554 345999999999999999999999998 9999999999999855 4699999999
Q ss_pred cc--ccCCCCCc----cc--cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH
Q 043285 244 AR--AFGGDETE----GN--TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 244 ~~--~~~~~~~~----~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 315 (414)
++ ........ .. .....||.+|+++....+...+.+.|+||++.++.||+.|..||................
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 32211111 11 223559999999999999999999999999999999999999985443322211111111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 316 KLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
....... .......+ +.++..-+-..+..++|....+...|.+.
T Consensus 254 ---~~~~~~~------~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 254 ---RKLLTDR------FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred ---hhhcccc------ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1111000 01111222 33344344557899999999998887444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-22 Score=190.35 Aligned_cols=262 Identities=29% Similarity=0.379 Sum_probs=195.3
Q ss_pred CCCCCeecccCCceEEEEEEcCCCEEEEEEecccChh---hHHHHHHHHHHHHhcCCC-ceeeeEeEEEeCCeeeEEEee
Q 043285 97 FSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~ey 172 (414)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999876 88899998753222 467889999999999988 799999999777778999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CeEEEeecCccccCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGGDE 251 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kL~Dfgl~~~~~~~~ 251 (414)
+.++++.+++........+.......+..|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976654331124888999999999999999999998 99999999999999988 79999999998654332
Q ss_pred Ccc----ccccccccccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 252 TEG----NTNRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 252 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
... ......|+..|+|||.+.+ ..++...|+|++|++++++++|..|+...... ................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 221 3456789999999999987 57899999999999999999999995443321 0011111111111111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
..... ............+.+++..|+..+|..|.+..+....
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASP-LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccc-cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000 0000001122345678889999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=217.38 Aligned_cols=254 Identities=23% Similarity=0.289 Sum_probs=185.3
Q ss_pred CCCCeecccCCceEEEEEEc-CCCEEEEEEec----c-cChhhH-HHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 98 SINKKLGQGGFGPVYKGKLV-DGQEIAVKRLS----K-ISEQGL-KELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 98 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~-~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.....+|.|++|.|+..... .......|.+. . ...... ..+..|+.+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34578999999977777532 23333333332 1 111111 22667777888899999988877777766666669
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
|||++ +|..++.... .+...++..++.|++.|++|+|+.| +.|||+|++|+++..+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999987653 3788889999999999999999999 999999999999999999999999998876443
Q ss_pred CCc--cccccccccccccccccccCCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 251 ETE--GNTNRVVGTYGYMAPEYASDGQFSV-KSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 251 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
... ......+|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||......+.... ...........
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------~~~~~~~~~~~ 547 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------TNNYSDQRNIF 547 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------hhccccccccc
Confidence 333 4455678999999999999999965 67999999999999999999876655544320 00000000000
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. ..............++.+||+.+|.+|.|+++|++
T Consensus 548 ~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 EG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00 00111122345667899999999999999999985
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-24 Score=215.18 Aligned_cols=247 Identities=17% Similarity=0.185 Sum_probs=179.2
Q ss_pred CCCCCCeecccCCceEEEEEEcCCCEEEEEEecccC-hhhHHHH---HHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKIS-EQGLKEL---KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
+|...+.||++.|=+|.+|+..+|. |+||++-+.. .-....+ ..|++ ...++|||.+++..+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6777899999999999999987777 9999986533 2233333 34444 556689999999888777778899999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC--
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG-- 249 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~-- 249 (414)
|..+ +|.|.+... +.+...+...|+.|++.|+..+|..| |+|||||.+||||+.-+.+.|+||...+...-
T Consensus 102 yvkh-nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9965 888887543 45888899999999999999999998 99999999999999999999999998765421
Q ss_pred CCCc---cccccccccccccccccccCC----------C-CCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHH
Q 043285 250 DETE---GNTNRVVGTYGYMAPEYASDG----------Q-FSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHA 314 (414)
Q Consensus 250 ~~~~---~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 314 (414)
++.. ....+...-.+|+|||.+... . .+++.||||+||++.||++ |+++|.. -+..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---------SQL~ 245 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---------SQLL 245 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---------HHHH
Confidence 1111 112223344579999977431 2 5788999999999999988 5666642 1111
Q ss_pred HHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 315 WKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
..........+..-..+++ ..+..++..|++.||++|.++++.|+.
T Consensus 246 aYr~~~~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHhccCccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1110101111111111111 145678889999999999999999986
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-22 Score=178.69 Aligned_cols=212 Identities=22% Similarity=0.350 Sum_probs=175.8
Q ss_pred CCCCCCCeecccCCceEEEEE-EcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ey 172 (414)
-.|.++++||+|.||.++.|. +-++..||||.-...++ .-++..|....+.|. .++|..++.+...+.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 469999999999999999996 45799999997654332 246778888888885 78999999888888889999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-----CCeEEEeecCcccc
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGLARAF 247 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-----~~~kL~Dfgl~~~~ 247 (414)
+ |-+|.|+..-..+ .++.+.+..+|.|++.-++|+|++. +|.|||||+|+||..- ..+.++|||+++..
T Consensus 106 L-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 9 6688887754433 3899999999999999999999998 9999999999999643 35899999999977
Q ss_pred CCCCCc-----cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH
Q 043285 248 GGDETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHA 314 (414)
Q Consensus 248 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 314 (414)
...... .......||.+||+-....+.+.+...|+-|||-++.+++.|..||.....+...+..+.+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 544332 2344567999999999999999999999999999999999999999877766655444444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=173.80 Aligned_cols=207 Identities=21% Similarity=0.321 Sum_probs=171.5
Q ss_pred cCCCCCCCeecccCCceEEEEE-EcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC-CceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 171 (414)
.+.|.++++||+|+||.+|.|. ..+|..||||.-++.... .++..|..+.+.+++ ..|..+.-+..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4679999999999999999996 457999999987653322 367789999999975 577777888888888999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CCeEEEeecCccccC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARAFG 248 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kL~Dfgl~~~~~ 248 (414)
.+ |-+|.++..-..+ .++...++-++-|++.-++|+|.++ ++||||||+|+|..-+ ..+.|+|||+++.+.
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 99 6699998865543 3888999999999999999999998 9999999999999754 468999999999765
Q ss_pred CCCC-----ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 043285 249 GDET-----EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNL 308 (414)
Q Consensus 249 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~ 308 (414)
+... ........||.+|.+-....+...+...|+-|+|.+|.++-.|..||+........
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~ 230 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK 230 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence 4322 22344568999999998888888999999999999999999999999866554433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.2e-23 Score=180.83 Aligned_cols=171 Identities=14% Similarity=0.180 Sum_probs=132.7
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChh---hHHH------HHHHHHHHHhcCCCceeeeEeEEEeC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQ---GLKE------LKNEVILFSKLQHRNLVKLLGCCIQG 163 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~ 163 (414)
..++|...+.+|.|+||.||+... ++..+|+|.+...... .... +.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999766 6778999999752222 1122 67899999999999999998886643
Q ss_pred --------CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC
Q 043285 164 --------EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 235 (414)
Q Consensus 164 --------~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~ 235 (414)
...+++|||++|.+|.++.. ++. ....+++.++..+|..+ ++|||++|.||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999988631 222 24558999999999998 99999999999999988
Q ss_pred eEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHH
Q 043285 236 PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIV 293 (414)
Q Consensus 236 ~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ell 293 (414)
++|+|||........... ..+.....|..++|+|+||+++.-+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988654211110 11344456778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-22 Score=173.63 Aligned_cols=139 Identities=18% Similarity=0.168 Sum_probs=107.8
Q ss_pred CCeecccCCceEEEEEEcCCCEEEEEEecccChh--h------------------------HHHHHHHHHHHHhcCCCce
Q 043285 100 NKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQ--G------------------------LKELKNEVILFSKLQHRNL 153 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 153 (414)
...||+|+||.||+|...+|+.||||+++..... . ......|+..+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999998878999999999653110 0 0122459999999988776
Q ss_pred eeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeccCCCCCEEEcC
Q 043285 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL-HQDSRLRIIHRDLKASNVLLDQ 232 (414)
Q Consensus 154 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiH~dlk~~Nill~~ 232 (414)
.....+.. ...++||||++++++....... ..++......++.|++.+|.|+ |+.+ ++||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 2348999999998776553332 2388899999999999999999 6877 99999999999998
Q ss_pred CCCeEEEeecCcccc
Q 043285 233 DMNPKISDFGLARAF 247 (414)
Q Consensus 233 ~~~~kL~Dfgl~~~~ 247 (414)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=168.09 Aligned_cols=140 Identities=20% Similarity=0.233 Sum_probs=110.1
Q ss_pred CCeecccCCceEEEEEEcCCCEEEEEEecccChh--------------------------hHHHHHHHHHHHHhcCCCce
Q 043285 100 NKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQ--------------------------GLKELKNEVILFSKLQHRNL 153 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 153 (414)
...||+|+||+||+|...+|+.||||+++..... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4789999999999998778999999998753210 01223578999999999987
Q ss_pred eeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcC
Q 043285 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQ 232 (414)
Q Consensus 154 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dlk~~Nill~~ 232 (414)
.....+... ..++||||++++++....... ..++......++.|++.++.++|+ .+ ++||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 348999999988654432222 236788889999999999999999 87 99999999999999
Q ss_pred CCCeEEEeecCccccC
Q 043285 233 DMNPKISDFGLARAFG 248 (414)
Q Consensus 233 ~~~~kL~Dfgl~~~~~ 248 (414)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=189.03 Aligned_cols=218 Identities=24% Similarity=0.343 Sum_probs=162.3
Q ss_pred HHhcCCCceeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 043285 145 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 224 (414)
Q Consensus 145 l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk 224 (414)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.... ..+++.....+..++++||+|||+.. -.+|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 457899999999999999999999999999999999997632 35899999999999999999999875 23999999
Q ss_pred CCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCC-------CCCcchhHHHHHHHHHHHHhCCC
Q 043285 225 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-------QFSVKSDVFSFGILLLEIVSGKK 297 (414)
Q Consensus 225 ~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslGvil~elltg~~ 297 (414)
+.|++++..+.+||+|||+.................-..-|.|||.+.+. ..+.+.||||||++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998876421111111122234569999998764 24678999999999999999999
Q ss_pred CCCCCCCCCC-cchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 298 NRGFYHSDNN-LNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 298 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
||........ .+++............+.+.. .. +....+..++.+||..+|.+||++.++-..++....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~-----~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL-----LN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhh-----hh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9875433322 233333322111111111111 10 112257778899999999999999999988855443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=189.19 Aligned_cols=266 Identities=26% Similarity=0.323 Sum_probs=190.6
Q ss_pred eecccCCceEEEEEE----cCCCEEEEEEecccChh--hHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEEeecC
Q 043285 102 KLGQGGFGPVYKGKL----VDGQEIAVKRLSKISEQ--GLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 102 ~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
.+|+|.||.|++++. ..|.-+++|.+++.... .......|..++...+ ||.++++...+......+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998743 34667888888653211 1114456778888886 9999999999999999999999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+|.|...+..... ++......+...++-+++++|+.+ ++|||+|++||+++.+|.+++.|||+++..-....
T Consensus 81 gg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 9999887765443 667777778888999999999998 99999999999999999999999999986532221
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCc
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (414)
.+||..|||||++. .....+|.||||++++||+||..||.. +.... +..... .
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~---Il~~~~-----------~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKR---ILKAEL-----------E 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHH---Hhhhcc-----------C
Confidence 28999999999998 667899999999999999999999764 11111 111110 1
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHhcCC------------CCCCCCCCCCcccCCCCCCCCC--CCCCC
Q 043285 335 FNLAEVIRCIHIGLLCVQQHPEDRPSMP--SVILMLGSE------------TVLPQPKQPGYLADRKSTRRDY--SSIMP 398 (414)
Q Consensus 335 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~--evl~~L~~~------------~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 398 (414)
..........+++..++..+|..|.-.. .+.+.+... ...++|-+|....+.+....|. ++.+|
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P 285 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVP 285 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCc
Confidence 1111222344566678888999998663 444433222 2245566666655555444443 34444
Q ss_pred CCcC
Q 043285 399 ESCS 402 (414)
Q Consensus 399 ~~~~ 402 (414)
..++
T Consensus 286 ~dsp 289 (612)
T KOG0603|consen 286 ADSP 289 (612)
T ss_pred ccCC
Confidence 4433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.8e-20 Score=168.38 Aligned_cols=232 Identities=22% Similarity=0.317 Sum_probs=145.9
Q ss_pred CCCCCeecccCCceEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhcCC----------CceeeeEeEEE-
Q 043285 97 FSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH----------RNLVKLLGCCI- 161 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~- 161 (414)
+...+.||.|+++.||.++..+ |+++++|++.. ......+++++|......+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4556789999999999998865 88999999853 223356677777665555332 12222222221
Q ss_pred --------eCC--------eeeEEEeecCCCChhHHhhc---ccc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 043285 162 --------QGE--------EKLLIYEFMPNKSLDSFIFD---QER-CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHR 221 (414)
Q Consensus 162 --------~~~--------~~~lv~ey~~~g~L~~~l~~---~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~ 221 (414)
... +.+++|+-+ .++|.+++.. ... ...+....+..+..|+++.+++||++| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 111 235677777 4588877642 111 122445556677799999999999999 9999
Q ss_pred cCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccC--------CCCCcchhHHHHHHHHHHHH
Q 043285 222 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD--------GQFSVKSDVFSFGILLLEIV 293 (414)
Q Consensus 222 dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslGvil~ell 293 (414)
||+|+|++++.+|.++|+||+.....+.... ....+..|.+||.... -.++.+.|.|+||+++|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999998775432111 1234577999997643 25788999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCC
Q 043285 294 SGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDR 358 (414)
Q Consensus 294 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 358 (414)
+|+.||+........+. ....| . +-...+..|+..+|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~~---------------~f~~C----~--~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW---------------DFSRC----R--DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG---------------GGTTS----S-----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc---------------cchhc----C--CcCHHHHHHHHHHccCCcccC
Confidence 99999875433222111 11222 1 333455678889999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.2e-20 Score=158.71 Aligned_cols=184 Identities=17% Similarity=0.176 Sum_probs=136.4
Q ss_pred CCCCeecccCCceEEEEEEcCCCEEEEEEecccCh----hhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEEee
Q 043285 98 SINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISE----QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 98 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.+...|++|+||+||.+.. ++.+++.+.+..... -....+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4568999999999998765 778888777754221 11225789999999995 5788888886 456999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC-CCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dl-k~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
+.|.+|...+.. ....++.|++.++.++|++| ++|||| ||.|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999988654311 11357789999999999998 999999 7999999999999999999998643322
Q ss_pred Cc----cc-------cccccccccccccccccCC-CCC-cchhHHHHHHHHHHHHhCCCCC
Q 043285 252 TE----GN-------TNRVVGTYGYMAPEYASDG-QFS-VKSDVFSFGILLLEIVSGKKNR 299 (414)
Q Consensus 252 ~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwslGvil~elltg~~p~ 299 (414)
.. .. ......++.|++|+...-. ..+ ...+.++-|+-+|.++|++.+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 10 00 0011256777777754322 333 5678999999999999999773
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.8e-21 Score=195.64 Aligned_cols=197 Identities=21% Similarity=0.282 Sum_probs=158.7
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC---CCceeeeEeEEEeCCeeeEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 169 (414)
....|.+.+.||+|+||+||+|...+|+.||+|+-+..+.- +|.--.+++.+|+ -+-|..+..++.-.+.-++|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 34678889999999999999999888999999987653321 1211223334444 24455566666677888999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-------CCCCeEEEeec
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-------QDMNPKISDFG 242 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-------~~~~~kL~Dfg 242 (414)
+||.+.|+|.+++... ..+++..+..++.|++.-+++||..+ ||||||||+|++|. +...++|+|||
T Consensus 773 ~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999999733 34899999999999999999999998 99999999999994 23459999999
Q ss_pred CccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 298 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p 298 (414)
.+..+.-..........++|-.+-.+|...|..++...|.|.|..+++-|+.|+..
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 98866443334455566788899999999999999999999999999999999865
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=159.19 Aligned_cols=135 Identities=21% Similarity=0.306 Sum_probs=104.8
Q ss_pred CCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc-----CCCceeeeEeEEEeCC---eee-EE
Q 043285 99 INKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-----QHRNLVKLLGCCIQGE---EKL-LI 169 (414)
Q Consensus 99 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~-lv 169 (414)
-.+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+ +||||++++|++.++. ..+ +|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 347899999999996 3333444 68888654444557889999999999 5799999999998874 333 78
Q ss_pred Eee--cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeeccCCCCCEEEcC----CCCeEEEeec
Q 043285 170 YEF--MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL-LYLHQDSRLRIIHRDLKASNVLLDQ----DMNPKISDFG 242 (414)
Q Consensus 170 ~ey--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~iiH~dlk~~Nill~~----~~~~kL~Dfg 242 (414)
+|| +++++|.+++.+.. +++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 55899999996532 4444 35677888777 9999998 999999999999974 3479999944
Q ss_pred Cc
Q 043285 243 LA 244 (414)
Q Consensus 243 l~ 244 (414)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=163.61 Aligned_cols=197 Identities=21% Similarity=0.278 Sum_probs=138.2
Q ss_pred CCCceeeeEeEEEe---------------------------CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHH
Q 043285 149 QHRNLVKLLGCCIQ---------------------------GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIIC 201 (414)
Q Consensus 149 ~h~niv~~~~~~~~---------------------------~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 201 (414)
+|||||++.++|.+ +..+|+||...+. +|.+++-.+. .+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 59999999998753 2356899988865 8999886654 45556677889
Q ss_pred HHHHHHHHHHhCCCCCeeeccCCCCCEEEc--CCC--CeEEEeecCccccCCC----CCccccccccccccccccccccC
Q 043285 202 GTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDM--NPKISDFGLARAFGGD----ETEGNTNRVVGTYGYMAPEYASD 273 (414)
Q Consensus 202 ~i~~~l~~LH~~~~~~iiH~dlk~~Nill~--~~~--~~kL~Dfgl~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 273 (414)
|+++|+.|||.++ +.|||+|++|||+. +|+ .+.++|||++-.-... ......-...|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999994 333 4789999997532210 11122223457778899998754
Q ss_pred CC------CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHH
Q 043285 274 GQ------FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIG 347 (414)
Q Consensus 274 ~~------~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 347 (414)
.+ .-.|+|.|+.|.+.||+++...||... .+...+. +.+.+...+.+.+.+.. .+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-Gem~L~~-----r~Yqe~qLPalp~~vpp---------~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-GEMLLDT-----RTYQESQLPALPSRVPP---------VARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCccccc-chheech-----hhhhhhhCCCCcccCCh---------HHHHHH
Confidence 32 135899999999999999999997531 1111111 11334444444443332 355788
Q ss_pred HhccCCCCCCCCCHHHHHHHh
Q 043285 348 LLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 348 ~~cl~~dP~~RPs~~evl~~L 368 (414)
...|+.||++|+++.=....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 889999999999986555444
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.8e-20 Score=175.08 Aligned_cols=124 Identities=29% Similarity=0.467 Sum_probs=109.5
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
.+++.|++|...+|.++|.........++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999876666668899999999999999999 55 899999999999999999999999998
Q ss_pred cccCCCC----CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh
Q 043285 245 RAFGGDE----TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294 (414)
Q Consensus 245 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt 294 (414)
....... .........||..||+||.+.+..|+.++||||||++|+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8764433 2234455689999999999999999999999999999999998
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=156.96 Aligned_cols=144 Identities=18% Similarity=0.171 Sum_probs=111.5
Q ss_pred cCCCCCCCeecccCCceEEEEE--EcCCCEEEEEEecccChh------------------------hHHHHHHHHHHHHh
Q 043285 94 TNNFSINKKLGQGGFGPVYKGK--LVDGQEIAVKRLSKISEQ------------------------GLKELKNEVILFSK 147 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~ 147 (414)
..-|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|+..+..
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458889999999999999998 567999999998642210 11235689999999
Q ss_pred cCCCc--eeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC
Q 043285 148 LQHRN--LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKA 225 (414)
Q Consensus 148 l~h~n--iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~ 225 (414)
+.+.+ +.+++++ ...++||||+++++|........ .........++.|++.++.+||+++ .++||||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp 177 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE 177 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence 97533 3444432 23589999999988876543222 2556667889999999999999986 499999999
Q ss_pred CCEEEcCCCCeEEEeecCcccc
Q 043285 226 SNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 226 ~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-18 Score=153.43 Aligned_cols=134 Identities=21% Similarity=0.291 Sum_probs=113.4
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccCh--h------hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISE--Q------GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
+.||+|++|.||+|.. .|..+++|+...... . ....+.+|+.++..+.|+++.....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999987 778899998653211 1 123577899999999999998877787788889999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++|++|.+++.... . .+..++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999885422 2 77889999999999999998 99999999999999 78899999999864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.1e-18 Score=171.66 Aligned_cols=137 Identities=20% Similarity=0.311 Sum_probs=111.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEE-eccc-C------hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKR-LSKI-S------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~-~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 165 (414)
...|...+.||+|+||.||+|.+.+. .+++|+ +.+. . ....+.+.+|+.+++.++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456678999999999999987544 344443 2221 1 1123567899999999999999988888888788
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.++||||+++++|.+++. ....++.++++++.|||+.+ ++||||||+||++ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999999874 24578999999999999998 9999999999999 67899999999987
Q ss_pred c
Q 043285 246 A 246 (414)
Q Consensus 246 ~ 246 (414)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.4e-18 Score=149.99 Aligned_cols=130 Identities=22% Similarity=0.352 Sum_probs=107.3
Q ss_pred eecccCCceEEEEEEcCCCEEEEEEecccC--h------hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 102 KLGQGGFGPVYKGKLVDGQEIAVKRLSKIS--E------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 102 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.||+|+||.||+|.. ++..|++|...... . .....+.+|+.++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 67889999864321 1 12356778999999999888766666666777789999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++++|.+++..... .++.+++.+|.+||+.+ ++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988744211 78899999999999998 99999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-17 Score=147.58 Aligned_cols=143 Identities=19% Similarity=0.179 Sum_probs=110.8
Q ss_pred HHHHhcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccCh----------------------hhHHHHHHHHHHHH
Q 043285 89 TIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISE----------------------QGLKELKNEVILFS 146 (414)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~ 146 (414)
++......|.+.+.||+|+||.||++...+|+.|+||++..... ........|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444445888899999999999999887899999998753210 01123567888898
Q ss_pred hcCCCc--eeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 043285 147 KLQHRN--LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 224 (414)
Q Consensus 147 ~l~h~n--iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk 224 (414)
.+.|++ +...++ ....++||||+++++|...... .....++.+++.++.++|+.+ ++||||+
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 888774 444443 2456899999999998765421 234578889999999999988 9999999
Q ss_pred CCCEEEcCCCCeEEEeecCcccc
Q 043285 225 ASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 225 ~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
|.||++++++.++|+|||++..+
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred cccEEEcCCCcEEEEECCccccC
Confidence 99999999999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-17 Score=167.59 Aligned_cols=216 Identities=23% Similarity=0.283 Sum_probs=140.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
..+|..++.|..|+||.||..++.. .+..|+| +++.+ .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee------------------
Confidence 4689999999999999999997754 5667774 32211 11110 22222333333
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
|+=...+..-. .++. +++.+++|||+.+ |+|||+||+|.+|+.-|.+|+.|||+.+.......
T Consensus 136 ---gDc~tllk~~g---~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG---PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcccCC---CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 33333332211 1222 2367899999998 99999999999999999999999999875321110
Q ss_pred -------------ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043285 253 -------------EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN 319 (414)
Q Consensus 253 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 319 (414)
+-.....+||+.|.|||++.-..|+..+|+|++|+|+||++-|..||....++ ++....... .
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe---elfg~visd-~ 274 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISD-D 274 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH---HHHhhhhhh-h
Confidence 11123468999999999999999999999999999999999999997543332 222222110 0
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 320 EGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...+.. +.....+..+++.+.|+.+|..|--....++
T Consensus 275 i~wpE~----------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 275 IEWPEE----------DEALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred cccccc----------CcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 011111 1111224556777889999999985554443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=6e-16 Score=129.88 Aligned_cols=135 Identities=23% Similarity=0.190 Sum_probs=113.5
Q ss_pred CCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC--CceeeeEeEEEeCCeeeEEEeecCCC
Q 043285 99 INKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMPNK 176 (414)
Q Consensus 99 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~ey~~~g 176 (414)
+.+.||+|.++.||++... +..+++|....... ...+..|+..++.++| .++.++++++...+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 3578999999999999874 47899999865433 4578899999999976 58899998888888899999999988
Q ss_pred ChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 177 SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 177 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
.+..+ +......++.+++++++++|.....+++|+|++|.||++++.+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77653 4455667889999999999987545699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.5e-16 Score=135.70 Aligned_cols=136 Identities=21% Similarity=0.226 Sum_probs=97.3
Q ss_pred CCeecccCCceEEEEEEcCCCEEEEEEecccChh--hHHH----------------------HHHHHHHHHhcCCCc--e
Q 043285 100 NKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQ--GLKE----------------------LKNEVILFSKLQHRN--L 153 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 153 (414)
.+.||+|+||+||+|...+|+.||||++...... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4789999999999998878999999998642211 1111 134556666664432 4
Q ss_pred eeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcC
Q 043285 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQ 232 (414)
Q Consensus 154 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dlk~~Nill~~ 232 (414)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ ++|+||+|+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444433 246899999999554321111110 11 5567889999999999999 77 99999999999999
Q ss_pred CCCeEEEeecCcccc
Q 043285 233 DMNPKISDFGLARAF 247 (414)
Q Consensus 233 ~~~~kL~Dfgl~~~~ 247 (414)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.5e-15 Score=136.31 Aligned_cols=134 Identities=17% Similarity=0.214 Sum_probs=103.9
Q ss_pred Ceec-ccCCceEEEEEEcCCCEEEEEEecccC-------------hhhHHHHHHHHHHHHhcCCCce--eeeEeEEEeCC
Q 043285 101 KKLG-QGGFGPVYKGKLVDGQEIAVKRLSKIS-------------EQGLKELKNEVILFSKLQHRNL--VKLLGCCIQGE 164 (414)
Q Consensus 101 ~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~ 164 (414)
..|| .|+.|+||.+.. ++..++||.+.... ......+.+|+.++..++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 899999999987 47789998874311 1223467889999999998875 66776654332
Q ss_pred e----eeEEEeecCC-CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEE
Q 043285 165 E----KLLIYEFMPN-KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 239 (414)
Q Consensus 165 ~----~~lv~ey~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~ 239 (414)
. .++||||+++ .+|.+++... .++.. .+.+++.++.+||+.| |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 3599999997 6898887542 24433 3568999999999998 9999999999999999999999
Q ss_pred eecCccc
Q 043285 240 DFGLARA 246 (414)
Q Consensus 240 Dfgl~~~ 246 (414)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.9e-17 Score=166.53 Aligned_cols=256 Identities=24% Similarity=0.307 Sum_probs=186.3
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC--CCEEEEEEecccC--hhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD--GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 168 (414)
...|.+.+.||+|.|+.|-...... ...+++|.+.... .........|..+-..+. |.|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4568888999999999998886533 3446666665432 233345556777777776 9999999999999999999
Q ss_pred EEeecCCCChhHHhh-cccccccCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeccCCCCCEEEcCCC-CeEEEeecCcc
Q 043285 169 IYEFMPNKSLDSFIF-DQERCMILDWSKRFHIICGTARGLLYLH-QDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLAR 245 (414)
Q Consensus 169 v~ey~~~g~L~~~l~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiH~dlk~~Nill~~~~-~~kL~Dfgl~~ 245 (414)
+++|..++++.+.+. ... ...+....-.++.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..+++|||++.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 999999999998883 322 12455556678999999999999 776 99999999999999999 99999999999
Q ss_pred ccCC-CCCccccccccc-cccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 246 AFGG-DETEGNTNRVVG-TYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 246 ~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
.+.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........... .+. ...
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-~~~-----~~~ 247 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-SWK-----SNK 247 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-eec-----ccc
Confidence 8765 444445556678 9999999999885 447789999999999999999999876544332110 010 000
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 323 PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. .. ....-.... ...+++..+++..+|+.|.+.+++-.
T Consensus 248 ~-~~-~~~~~~~~~----~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 G-RF-TQLPWNSIS----DQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c-cc-ccCccccCC----hhhhhcccccccCCchhccccccccc
Confidence 0 00 000000111 12344566788899999999888753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=8.1e-15 Score=132.18 Aligned_cols=203 Identities=20% Similarity=0.227 Sum_probs=137.6
Q ss_pred HHHhcCCCceeeeEeEEEeCC-----eeeEEEeecCCCChhHHhhcccc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 043285 144 LFSKLQHRNLVKLLGCCIQGE-----EKLLIYEFMPNKSLDSFIFDQER-CMILDWSKRFHIICGTARGLLYLHQDSRLR 217 (414)
Q Consensus 144 ~l~~l~h~niv~~~~~~~~~~-----~~~lv~ey~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 217 (414)
-+-.+.|.||++++.|+.+.. ...+++||+..|++..+|++-.+ ...+......+|+.||..||.|||+.. ++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 344567999999999986543 46789999999999999976433 345777888899999999999999975 78
Q ss_pred eeeccCCCCCEEEcCCCCeEEEeecC--ccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhC
Q 043285 218 IIHRDLKASNVLLDQDMNPKISDFGL--ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 295 (414)
Q Consensus 218 iiH~dlk~~Nill~~~~~~kL~Dfgl--~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg 295 (414)
++|+++..+.|++..+|-+|++---- ....-............+.++|.+||.=.-.+.+..+|||+||+...||.-+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999998888753111 1110000111112233567899999977666778899999999999999888
Q ss_pred CCCCCCCCCC-CCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 296 KKNRGFYHSD-NNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 296 ~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
..-....... .....+...-.... ++.- ..++..|++..|..||+|.+++..
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~le--------n~lq------------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGLE--------NGLQ------------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcceeehhhhhhhheeecc--------Cccc------------cCcCcccccCCCCCCcchhhhhcC
Confidence 7432211111 00111111100000 1111 123447999999999999988753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.7e-14 Score=139.60 Aligned_cols=140 Identities=27% Similarity=0.319 Sum_probs=98.2
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChhhHH----------------------------------------HHHH
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLK----------------------------------------ELKN 140 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~ 140 (414)
+.||.|++|+||+|++.+|+.||||+.+........ ++..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 689999999999999999999999998642211100 1334
Q ss_pred HHHHHHhcC----CCceeeeEeEE-EeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHH-HHHHHHhCC
Q 043285 141 EVILFSKLQ----HRNLVKLLGCC-IQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTAR-GLLYLHQDS 214 (414)
Q Consensus 141 E~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~~ 214 (414)
|+..+.++. |.+-+.+-..+ ...+..++||||++|++|.++...... ..+ ...++..++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhCC
Confidence 555554442 22223322222 234567999999999999887643211 122 3345666665 467889887
Q ss_pred CCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 215 ~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
++|+|++|.||++++++.++++|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.6e-12 Score=128.09 Aligned_cols=168 Identities=16% Similarity=0.232 Sum_probs=128.1
Q ss_pred EEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHH
Q 043285 115 KLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWS 194 (414)
Q Consensus 115 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~ 194 (414)
+..++.+|.|...+..+........+-+..|+.++||||++++..+......|+|+|-+. .|..++.+. ...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHH
Confidence 345788899888876555445667888999999999999999999999999999999973 566666543 345
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCC
Q 043285 195 KRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274 (414)
Q Consensus 195 ~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 274 (414)
.+..-+.||+.||.|||+.+ .++|++|.-..|+|+..|..||++|.++........ .......-..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 56667899999999999765 499999999999999999999999999875432221 11111222345666644322
Q ss_pred CCCcchhHHHHHHHHHHHHhCC
Q 043285 275 QFSVKSDVFSFGILLLEIVSGK 296 (414)
Q Consensus 275 ~~~~~sDvwslGvil~elltg~ 296 (414)
. ...|.|.|||++||++.|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcc
Confidence 2 4569999999999999994
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.1e-13 Score=113.25 Aligned_cols=130 Identities=23% Similarity=0.162 Sum_probs=97.1
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceee-eEeEEEeCCeeeEEEeecCCCChh
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK-LLGCCIQGEEKLLIYEFMPNKSLD 179 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~ey~~~g~L~ 179 (414)
+.|+.|.++.||+++. ++..|++|....... ....+..|+..++.+.+.++++ ++.+ .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 6789999999999987 478899998765322 1234678999999887655544 4443 234468999999998876
Q ss_pred HHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 180 SFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 180 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
..- .. ...++.+++++++.||+.+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~--------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 430 11 1235678999999999986 23369999999999999 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.1e-13 Score=132.88 Aligned_cols=248 Identities=22% Similarity=0.317 Sum_probs=177.0
Q ss_pred CCCCCCCeecc--cCCceEEEEEE---cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCee
Q 043285 95 NNFSINKKLGQ--GGFGPVYKGKL---VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 95 ~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 166 (414)
..|.+.+.+|. |.+|.||.+.. .++..+|+|.-+. ........-.+|+.....+ .|+|.++.+..+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677789999 99999999976 3577888887443 1222223334566666666 499999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeeccCCCCCEEEcCC-CCeEEEee
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTAR----GLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDF 241 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kL~Df 241 (414)
++-+|+|. .+|..+.+.... .++...++....+... |+.++|+.+ ++|-|+||.||+...+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999996 678777755332 3667777888888888 999999988 9999999999999999 88999999
Q ss_pred cCccccCCCCCccc---cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043285 242 GLARAFGGDETEGN---TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 242 gl~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
|+...++....... .....|...|++||.++ +.++..+|+|++|.+..+-.+|......-.... |...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~~ 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQL 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC--------cccc
Confidence 99998765543221 12335788999999764 567889999999999999988875532110000 0000
Q ss_pred hcC-CCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 319 NEG-MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 319 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+.. ...++.+ ... .++...+..|++.+|-.|++.+.+..
T Consensus 339 r~~~ip~e~~~-----~~s----~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGYIPLEFCE-----GGS----SSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccCchhhhc-----Ccc----hhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 110 1111111 111 12223667899999999999988774
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.2e-13 Score=133.78 Aligned_cols=143 Identities=20% Similarity=0.242 Sum_probs=92.6
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChh----------------------------------hHHH--
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQ----------------------------------GLKE-- 137 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~-- 137 (414)
.+|+. +.||+|++|+||+|++.+ |+.||||+.+..... ..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 799999999999999987 999999999743111 0111
Q ss_pred ----HHHHHHHHHhcC----CCceeeeEeEEEe-CCeeeEEEeecCCCChhHHh--hccc-ccccCCHHHHHHHHHHHHH
Q 043285 138 ----LKNEVILFSKLQ----HRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLDSFI--FDQE-RCMILDWSKRFHIICGTAR 205 (414)
Q Consensus 138 ----~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~ey~~~g~L~~~l--~~~~-~~~~l~~~~~~~i~~~i~~ 205 (414)
+.+|+..+.++. +.+.+.+-.++.+ .+..++||||++|+.+.++- .... ....+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 233443333332 3333333333332 45678999999999998752 2111 00112222233333333
Q ss_pred HHHHHHhCCCCCeeeccCCCCCEEEcCCC----CeEEEeecCccccC
Q 043285 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGLARAFG 248 (414)
Q Consensus 206 ~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kL~Dfgl~~~~~ 248 (414)
...| ++|+|++|.||+++.++ .++++|||++..+.
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3455 99999999999999888 99999999998764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.6e-11 Score=102.24 Aligned_cols=137 Identities=15% Similarity=0.138 Sum_probs=97.3
Q ss_pred CCeecccCCceEEEEEEcC-------CCEEEEEEeccc------------Ch----------hhHHHH----HHHHHHHH
Q 043285 100 NKKLGQGGFGPVYKGKLVD-------GQEIAVKRLSKI------------SE----------QGLKEL----KNEVILFS 146 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~------------~~----------~~~~~~----~~E~~~l~ 146 (414)
...||.|--+.||.|...+ +..+|||+.+-. .+ ...+.+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997543 478999987420 00 011222 37999999
Q ss_pred hcCC--CceeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeccC
Q 043285 147 KLQH--RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL-HQDSRLRIIHRDL 223 (414)
Q Consensus 147 ~l~h--~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiH~dl 223 (414)
++.. -++.+++++ ..-++||||+.+..+..-.... ..++......+..+++.+|..| |..+ ++||||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9854 355566654 5678999999765442211111 1244555667788999999998 7877 999999
Q ss_pred CCCCEEEcCCCCeEEEeecCcccc
Q 043285 224 KASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 224 k~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
++.||+++ ++.++|+|||.+-..
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeC
Confidence 99999997 468999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.2e-11 Score=105.94 Aligned_cols=142 Identities=19% Similarity=0.235 Sum_probs=108.2
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCC--ceeeeEeEEEeCC---eeeEEEeecC
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHR--NLVKLLGCCIQGE---EKLLIYEFMP 174 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~---~~~lv~ey~~ 174 (414)
+.|+.|.++.||++...+|..+++|....... .....+..|+.+++.+.+. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999886678999998765322 2345788999999999763 4566777765532 5689999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS---------------------------------------- 214 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 214 (414)
+.++.+.+.. ..++......++.++++++..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988775532 12566677777888888888887531
Q ss_pred -------------CCCeeeccCCCCCEEEcC--CCCeEEEeecCccc
Q 043285 215 -------------RLRIIHRDLKASNVLLDQ--DMNPKISDFGLARA 246 (414)
Q Consensus 215 -------------~~~iiH~dlk~~Nill~~--~~~~kL~Dfgl~~~ 246 (414)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.5e-10 Score=97.48 Aligned_cols=131 Identities=21% Similarity=0.306 Sum_probs=101.5
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEe-ccc-Chh------hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRL-SKI-SEQ------GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~-~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
..+++|+-+.+|.+.+. |.++++|.- ++. ... ....-.+|+.++.+++--.|...+-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999774 444666653 221 111 223457899999999877776666677788899999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++|-.|.+.+... ...++..+-.-+.-||..+ |+|+||.++||.+..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888654 1456667777788999998 99999999999998765 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-10 Score=96.74 Aligned_cols=143 Identities=24% Similarity=0.281 Sum_probs=108.4
Q ss_pred CCCeecccCCceEEEEEEcCCCEEEEEEe-cc-cC------hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 99 INKKLGQGGFGPVYKGKLVDGQEIAVKRL-SK-IS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 99 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~-~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
....+-+|+-+.|+++.+ .|+..+||.- .+ .. .-..++.++|+..+.+..--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999988 6777666653 32 11 112346678999999887666666666777888889999
Q ss_pred eecCC-CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---CeEEEeecCccc
Q 043285 171 EFMPN-KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLARA 246 (414)
Q Consensus 171 ey~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kL~Dfgl~~~ 246 (414)
||+++ .++.+++...-... ........++..+-+.+.-||..+ ++||||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 57888887654433 222333678888999999999998 99999999999997654 358999999865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.5e-11 Score=120.07 Aligned_cols=246 Identities=20% Similarity=0.168 Sum_probs=170.2
Q ss_pred hcCCCCCCCeecccCCceEEEEEE--cCCCEEEEEEecccChhhHHH--HHHHHHHHHhc-CCCceeeeEeEEEeCCeee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL--VDGQEIAVKRLSKISEQGLKE--LKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 167 (414)
...+|..+..||.|.|+.|+.... .++..|++|.+.+.......+ -..|+.+...+ .|.+.+.....+....+.+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 356788899999999999998854 357889999887633322222 24556555555 5888888887777777888
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCeEEEeecCccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARA 246 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kL~Dfgl~~~ 246 (414)
+=-|||+++++...+.- ...++...++.+..|++.++.++|+.. ++|+|++|.||++..+ +..++.|||++..
T Consensus 343 ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 99999999988776622 223788888999999999999999887 9999999999999886 8899999999864
Q ss_pred cCCCCCcccccccccccccc--ccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 247 FGGDETEGNTNRVVGTYGYM--APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
+.-.... ....-+++ +|+......+..+.|+++||.-+.+.+++..-... ... . .....+.
T Consensus 417 ~~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~~~---~----~~i~~~~-- 479 (524)
T KOG0601|consen 417 LAFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---GVQ---S----LTIRSGD-- 479 (524)
T ss_pred cceeccc-----ccccccccccchhhccccccccccccccccccccccccCcccCcc---ccc---c----eeeeccc--
Confidence 3111111 11222344 56666777889999999999999999998743110 000 0 0000010
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
+....... ..+..+...+...++..||.+.++..+..
T Consensus 480 -----~p~~~~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 480 -----TPNLPGLK---LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -----ccCCCchH---HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00001111 22334555688899999999998876543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.1e-09 Score=101.34 Aligned_cols=170 Identities=23% Similarity=0.348 Sum_probs=128.9
Q ss_pred CCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCeeeEEEeecCC-CChhH
Q 043285 107 GFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFMPN-KSLDS 180 (414)
Q Consensus 107 ~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ey~~~-g~L~~ 180 (414)
...+.|++.. .||..|++|+++....+.......-++.++++.|+|+|++..+|.. ...+++|++|.|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3456788854 5899999999965444444445566788999999999999998872 4468999999876 57777
Q ss_pred Hhhccc------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 181 FIFDQE------------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 181 ~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
+..... .....++..+|.++.|+..||.++|+.| +.-+-|.+.+|+++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 654321 1224678899999999999999999998 8889999999999999999998877765543
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 298 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p 298 (414)
.+.. |-+.+ -.+-|.=.||.++..|.||...
T Consensus 445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 2220 11111 2367999999999999999643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.5e-11 Score=122.92 Aligned_cols=206 Identities=21% Similarity=0.266 Sum_probs=142.4
Q ss_pred HhcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEe---cccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 92 SATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~---~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
...+.+.+.+.+-+|.++.++.+.-. .|...+.|.. .+......+....+-.+.-...+|.++...-.+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567888888999999999877432 2322222222 2222222233333333332334566666555555567889
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
|+++|..+++|...++.... .+..-.......+..+++|||+.. +.|+|++|.|.+...++..++.|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999998876542 344444455666788999999876 899999999999999999999999843321
Q ss_pred CC------C---------------CC----c----cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 043285 248 GG------D---------------ET----E----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 298 (414)
Q Consensus 248 ~~------~---------------~~----~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p 298 (414)
+- . .. . .......+|+.|.+||.+.+......+|+|+.|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0 00 0 012235689999999999999999999999999999999999999
Q ss_pred CCCCC
Q 043285 299 RGFYH 303 (414)
Q Consensus 299 ~~~~~ 303 (414)
|....
T Consensus 1035 ~na~t 1039 (1205)
T KOG0606|consen 1035 FNAET 1039 (1205)
T ss_pred CCCcc
Confidence 76443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=8.2e-09 Score=94.85 Aligned_cols=141 Identities=17% Similarity=0.107 Sum_probs=100.6
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChh-hHH----------HHHHHHHHHHhcCCCce--eeeEeEEEe-----
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQ-GLK----------ELKNEVILFSKLQHRNL--VKLLGCCIQ----- 162 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~h~ni--v~~~~~~~~----- 162 (414)
+.+-......|++..+ +|+.+.||......-. ..+ .+.+|...+..+...+| .+.+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455777766 7788999977542211 111 36788888888854443 444555543
Q ss_pred CCeeeEEEeecCCC-ChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-------CC
Q 043285 163 GEEKLLIYEFMPNK-SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-------DM 234 (414)
Q Consensus 163 ~~~~~lv~ey~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-------~~ 234 (414)
....++|+|++++. +|.+++..... ...+......++.+++..+.-||..| ++|+|+++.|||++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23468999999886 89988753221 22456677789999999999999998 999999999999975 46
Q ss_pred CeEEEeecCccc
Q 043285 235 NPKISDFGLARA 246 (414)
Q Consensus 235 ~~kL~Dfgl~~~ 246 (414)
.+.|+||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 799999998854
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.3e-08 Score=92.99 Aligned_cols=193 Identities=13% Similarity=0.146 Sum_probs=127.9
Q ss_pred CCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEE------EeCCe-eeEE
Q 043285 98 SINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCC------IQGEE-KLLI 169 (414)
Q Consensus 98 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~------~~~~~-~~lv 169 (414)
...+.||+|+-+.+|..- .-...+.|+..........+. +..|... .||-+-.-+.+- -++.. .-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 345789999999999642 222335577766443322222 2223333 455432211111 11222 4567
Q ss_pred EeecCCC-ChhHHhh---cccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 170 YEFMPNK-SLDSFIF---DQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 170 ~ey~~~g-~L~~~l~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
|+.+++. ....++. +.......+|...++.+..++.+.+-||.+| ..-+|+.++|+|+++++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 7777654 2333332 2333456889999999999999999999999 8899999999999999999999855443
Q ss_pred ccCCCCCcccccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSG-KKNRGF 301 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg-~~p~~~ 301 (414)
.. .........+|...|.+||.-. +-.-+..+|-|.|||++++|+.| +.||..
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 32 1222333457889999999654 34556789999999999999887 888753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=9.2e-09 Score=89.22 Aligned_cols=125 Identities=23% Similarity=0.258 Sum_probs=81.1
Q ss_pred eEEEEEEcCCCEEEEEEecccC--------------h------------hhHHHHHHHHHHHHhcCCC--ceeeeEeEEE
Q 043285 110 PVYKGKLVDGQEIAVKRLSKIS--------------E------------QGLKELKNEVILFSKLQHR--NLVKLLGCCI 161 (414)
Q Consensus 110 ~V~~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 161 (414)
.||.|...+|..+|+|..+... . .......+|+..|.++... ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998899999999874210 0 0123457899999999766 455565442
Q ss_pred eCCeeeEEEeecC--CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHH-HHhCCCCCeeeccCCCCCEEEcCCCCeEE
Q 043285 162 QGEEKLLIYEFMP--NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY-LHQDSRLRIIHRDLKASNVLLDQDMNPKI 238 (414)
Q Consensus 162 ~~~~~~lv~ey~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~iiH~dlk~~Nill~~~~~~kL 238 (414)
.-.+||||++ |..+..+.... ++......++.+++..+.. +|..| ++|+||.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4579999998 55554433221 1123345567777775555 56777 9999999999999988 9999
Q ss_pred EeecCcccc
Q 043285 239 SDFGLARAF 247 (414)
Q Consensus 239 ~Dfgl~~~~ 247 (414)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.4e-08 Score=98.23 Aligned_cols=141 Identities=16% Similarity=0.213 Sum_probs=92.7
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChhhH----------------------------------H------HHHH
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGL----------------------------------K------ELKN 140 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------~------~~~~ 140 (414)
+.|+.++-|+||+|++.+|+.||||+.+..-.... + ++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999999999999999864221111 0 1233
Q ss_pred HHHHHHhcC-----CCceeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCC
Q 043285 141 EVILFSKLQ-----HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSR 215 (414)
Q Consensus 141 E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 215 (414)
|+..+.+++ .+++.-..-+..-.+...|+|||++|..+.++..... ...+...+.....++.- ..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f~--~q~~~dg- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAFL--RQLLRDG- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHHH--HHHHhcC-
Confidence 444444432 2333222222334567889999999999888743222 12554444433333322 2222234
Q ss_pred CCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 216 ~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
++|.|..|.||+++.+|.+.+.|||+...+.
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.3e-08 Score=87.16 Aligned_cols=135 Identities=19% Similarity=0.197 Sum_probs=96.6
Q ss_pred CCCCCeecccCCceEEEEEEcCCCEEEEEEeccc----------C------------hhhHHHHHHHHHHHHhcCCC--c
Q 043285 97 FSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKI----------S------------EQGLKELKNEVILFSKLQHR--N 152 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----------~------------~~~~~~~~~E~~~l~~l~h~--n 152 (414)
..++..||-|--+.||.|...+|.+++||.-+-. . ........+|.+.|..+... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4566899999999999999989999999964210 0 01123457899999998644 6
Q ss_pred eeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC
Q 043285 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 232 (414)
Q Consensus 153 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~ 232 (414)
+.+.+++ +.-.+||||+++-.|...-. +....-.++..|++-+.-+-..| ++|+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6666543 45679999999876655321 12222334444555555444556 999999999999999
Q ss_pred CCCeEEEeecCccc
Q 043285 233 DMNPKISDFGLARA 246 (414)
Q Consensus 233 ~~~~kL~Dfgl~~~ 246 (414)
+|.+.++||.-+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999987654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.2e-09 Score=106.57 Aligned_cols=153 Identities=17% Similarity=0.205 Sum_probs=98.5
Q ss_pred HHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc-------ccccccccccccccccccC
Q 043285 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-------NTNRVVGTYGYMAPEYASD 273 (414)
Q Consensus 201 ~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 273 (414)
.+++.|+.|+|... .++|++|.|++|.++.++..||+.|+++....+..... ..........|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999865 69999999999999999999999999987543311110 0111234568999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCC-CCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccC
Q 043285 274 GQFSVKSDVFSFGILLLEIVSGKKN-RGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQ 352 (414)
Q Consensus 274 ~~~~~~sDvwslGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 352 (414)
...+.++|+||+||++|.+..|+.+ +...... +...... ...+. ....+...-..++.+=+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~----~~~~~~~-~~~~~--------~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL----LSYSFSR-NLLNA--------GAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc----chhhhhh-ccccc--------ccccccccCcHHHHHHHHHHhc
Confidence 8899999999999999999955544 2111111 1111100 00010 0111111112234444557899
Q ss_pred CCCCCCCCHHHHHHHh
Q 043285 353 QHPEDRPSMPSVILML 368 (414)
Q Consensus 353 ~dP~~RPs~~evl~~L 368 (414)
.++.-||++.++....
T Consensus 251 ~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLSIP 266 (700)
T ss_pred CCcccCcchhhhhccc
Confidence 9999999887776543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.2e-07 Score=84.06 Aligned_cols=105 Identities=27% Similarity=0.309 Sum_probs=83.0
Q ss_pred HHHHHHHHHHHhcCCC--ceeeeEeEEEeCC----eeeEEEeecCCC-ChhHHhhcccccccCCHHHHHHHHHHHHHHHH
Q 043285 136 KELKNEVILFSKLQHR--NLVKLLGCCIQGE----EKLLIYEFMPNK-SLDSFIFDQERCMILDWSKRFHIICGTARGLL 208 (414)
Q Consensus 136 ~~~~~E~~~l~~l~h~--niv~~~~~~~~~~----~~~lv~ey~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~ 208 (414)
....+|...+..+... ...+.+++..... ..++|+|++++. +|.+++..... .+......++.+++..++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 3567788888777543 3455666665532 358999999874 79998865333 556677889999999999
Q ss_pred HHHhCCCCCeeeccCCCCCEEEcCCC---CeEEEeecCccc
Q 043285 209 YLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLARA 246 (414)
Q Consensus 209 ~LH~~~~~~iiH~dlk~~Nill~~~~---~~kL~Dfgl~~~ 246 (414)
-||..| ++|+|+++.|||++.++ .+.++||+-++.
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 99999999999999887 899999998775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=7.1e-07 Score=78.05 Aligned_cols=138 Identities=16% Similarity=0.155 Sum_probs=102.2
Q ss_pred ecccCCceEEEEEEcCCCEEEEEEeccc-----C-hhhHHHHHHHHHHHHhcCCC--ceeeeEeEEE-eC----CeeeEE
Q 043285 103 LGQGGFGPVYKGKLVDGQEIAVKRLSKI-----S-EQGLKELKNEVILFSKLQHR--NLVKLLGCCI-QG----EEKLLI 169 (414)
Q Consensus 103 lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~-~~----~~~~lv 169 (414)
-|.||-+.|+...+ +|+.+-+|+-.+. . +.....|.+|...+..+..- .+.++. ++. .. ..-+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 35688888998877 5557889987521 1 33456889999999998543 344444 332 11 235799
Q ss_pred EeecCC-CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC--eEEEeecCccc
Q 043285 170 YEFMPN-KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLARA 246 (414)
Q Consensus 170 ~ey~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~--~kL~Dfgl~~~ 246 (414)
+|-+++ .+|.+++.+... ...+......++.+++.+++-||+.+ +.|+|+.+.||+++.++. +.++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997753 588888755322 23677778899999999999999998 999999999999986666 99999998764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.64 E-value=7.9e-07 Score=80.01 Aligned_cols=139 Identities=16% Similarity=0.145 Sum_probs=86.7
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCc--eeeeEeEEEeCCeeeEEEeecCCCC-
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYEFMPNKS- 177 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~ey~~~g~- 177 (414)
.+||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 58999999999984 35567888876532 3345788999999986544 4667778777777889999999863
Q ss_pred hhHHh---------------------hcccccccCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCeeeccC
Q 043285 178 LDSFI---------------------FDQERCMILDWSKRFH-IIC----------GTAR-GLLYLHQD-SRLRIIHRDL 223 (414)
Q Consensus 178 L~~~l---------------------~~~~~~~~l~~~~~~~-i~~----------~i~~-~l~~LH~~-~~~~iiH~dl 223 (414)
+...+ +.... .......... +.. .+.+ ...+|... ....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 11000 0011111000 000 0111 12222211 2345799999
Q ss_pred CCCCEEEcCCCCeEEEeecCccc
Q 043285 224 KASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 224 k~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
.|.||++++++ +.++||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.3e-06 Score=76.80 Aligned_cols=138 Identities=16% Similarity=0.156 Sum_probs=92.4
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHH---------HHHHHHHHhcC---CCceeeeEeEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKEL---------KNEVILFSKLQ---HRNLVKLLGCC 160 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---h~niv~~~~~~ 160 (414)
..++|...+.+.......|.+-.. +|..+++|..+.......+.+ .+.+..+..++ -.....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 357788888888888888887766 788999998865332222222 23333333332 22333333333
Q ss_pred E-----eCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC
Q 043285 161 I-----QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 235 (414)
Q Consensus 161 ~-----~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~ 235 (414)
. -....+++|||++|..|.++.. ++. .++..+.+++.-||+.| ++|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 2 2234568999999988876531 222 24456778899999998 99999999999998654
Q ss_pred eEEEeecCccc
Q 043285 236 PKISDFGLARA 246 (414)
Q Consensus 236 ~kL~Dfgl~~~ 246 (414)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.5e-06 Score=74.91 Aligned_cols=149 Identities=19% Similarity=0.199 Sum_probs=95.3
Q ss_pred HHHHHHhcCCCCCC---CeecccCCceEEEEEEcCCCEEEEEEecccChhh------------------------HHHHH
Q 043285 87 LATIVSATNNFSIN---KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQG------------------------LKELK 139 (414)
Q Consensus 87 ~~~~~~~~~~~~~~---~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~ 139 (414)
...+....++..+. ..|++|--+.||+|...++..+|+|+++...... .....
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 33343333444333 3566788888999988789999999985421110 01134
Q ss_pred HHHHHHHhcC--CCceeeeEeEEEeCCeeeEEEeecCCCC-hhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHh-CCC
Q 043285 140 NEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKS-LDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ-DSR 215 (414)
Q Consensus 140 ~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ey~~~g~-L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~ 215 (414)
+|+.-|.++. +-.+.+.+++. .-.|||||+.... -.-.|.+. .+...+...+..++++.+.-|-. .+
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~a~- 187 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKEAG- 187 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHhcC-
Confidence 6777777764 33444444443 4579999986541 11112111 12222456677778888887776 44
Q ss_pred CCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 216 ~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
++|+||+.-|||+. ++.+.++|||-+-..
T Consensus 188 --LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 188 --LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred --cccccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999999 889999999987653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.2e-06 Score=84.07 Aligned_cols=140 Identities=16% Similarity=0.217 Sum_probs=88.8
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChhh-------------------------------HHH------HHHHHH
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQG-------------------------------LKE------LKNEVI 143 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~------~~~E~~ 143 (414)
+.||..+.|+||+|++.+|+.||||+-+..-... .+. |..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999976422111 011 223333
Q ss_pred HHHh----cCCCce---eeeEeEEE-eCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCC
Q 043285 144 LFSK----LQHRNL---VKLLGCCI-QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSR 215 (414)
Q Consensus 144 ~l~~----l~h~ni---v~~~~~~~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 215 (414)
-..+ +.|-+. |.+=.++. ......|+||||+|..+.+.-.-... .++...+..-+.+...-+-+- .|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qIf~--~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQIFK--TG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHHHh--cC-
Confidence 3222 234441 11222222 24578999999999887775321111 155555444444333222222 23
Q ss_pred CCeeeccCCCCCEEEcC----CCCeEEEeecCcccc
Q 043285 216 LRIIHRDLKASNVLLDQ----DMNPKISDFGLARAF 247 (414)
Q Consensus 216 ~~iiH~dlk~~Nill~~----~~~~kL~Dfgl~~~~ 247 (414)
++|.|-.|.||++.. ++.+.+.|||+...+
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 999999999999984 678999999998765
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.38 E-value=6.9e-06 Score=74.90 Aligned_cols=141 Identities=14% Similarity=0.123 Sum_probs=85.9
Q ss_pred eecccCC-ceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEEeecCCCChh
Q 043285 102 KLGQGGF-GPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 179 (414)
Q Consensus 102 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ey~~~g~L~ 179 (414)
.|..|.+ ..||+... ++..+++|...... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 78899876 34788888876533 345678898888884 444567777777666789999999998776
Q ss_pred HHhh-------------------cccc-cccCC--HHHHHHHHH--------------------HHHHHHHHHHh----C
Q 043285 180 SFIF-------------------DQER-CMILD--WSKRFHIIC--------------------GTARGLLYLHQ----D 213 (414)
Q Consensus 180 ~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~i~~~l~~LH~----~ 213 (414)
.... .... ...+. ......... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 1000 00011 000000000 01111222211 1
Q ss_pred CCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 214 ~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
..+.++|+|+.|.||++++++.+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999987789999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.37 E-value=7.9e-06 Score=73.58 Aligned_cols=143 Identities=20% Similarity=0.188 Sum_probs=84.5
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC--ceeeeEeEEEeC---CeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGCCIQG---EEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~ey~~~ 175 (414)
+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.+.... ...+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 678999999999998866 69999987654 4556778899998888533 345666644332 346899999999
Q ss_pred CChhH----------------Hhh---ccc-ccccCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 043285 176 KSLDS----------------FIF---DQE-RCMILDWSK---------RFHI------------ICGTAR-GLLYLHQ- 212 (414)
Q Consensus 176 g~L~~----------------~l~---~~~-~~~~l~~~~---------~~~i------------~~~i~~-~l~~LH~- 212 (414)
..+.. .+. ... ......... .... ...+.+ .++.+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 111 110 000001000 0000 011222 2333332
Q ss_pred ---CCCCCeeeccCCCCCEEEc-CCCCeEEEeecCccc
Q 043285 213 ---DSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARA 246 (414)
Q Consensus 213 ---~~~~~iiH~dlk~~Nill~-~~~~~kL~Dfgl~~~ 246 (414)
.....++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 666668999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.3e-06 Score=74.46 Aligned_cols=105 Identities=22% Similarity=0.236 Sum_probs=83.8
Q ss_pred HHHHHHHHhcCC-CceeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 043285 139 KNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLR 217 (414)
Q Consensus 139 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 217 (414)
..|..+++.+++ +++.+++|+| ..++|+||.+.+++......-......+|..+.+++.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888889976 6999999999 56889999987766432111011123689999999999999999999865556
Q ss_pred eeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 218 IIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 218 iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+.-.|++++|+-+++++++|++|.+.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.8e-08 Score=96.37 Aligned_cols=187 Identities=17% Similarity=0.144 Sum_probs=134.4
Q ss_pred CCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCc-eeeeEeEEEeCCeeeEEEeecC
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ey~~ 174 (414)
-+..-+-++++++++++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..+...+++++++.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 34444568899999999987544444555655432 34566889999999999 6677777777778899999998
Q ss_pred CC-ChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 175 NK-SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 175 ~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++ +-...... ....+...+...++..-.++++++|+.. -+|+| ||+.++ +..+..||+....+....
T Consensus 318 ~~rs~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 318 TGRSSALEMTV--SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred CCccccccCCh--hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--
Confidence 87 22211110 0011334444556666778999999864 48898 777665 679999999987764322
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 300 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~ 300 (414)
..+...+++.|+|||......+..+.|+|++|+-..++.-|-+|..
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 4456678999999999999999999999999998788877776643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=7.9e-06 Score=68.78 Aligned_cols=129 Identities=21% Similarity=0.275 Sum_probs=90.1
Q ss_pred CCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceee-eEeEEEeCCeeeEEEeecCCC
Q 043285 98 SINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK-LLGCCIQGEEKLLIYEFMPNK 176 (414)
Q Consensus 98 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~ey~~~g 176 (414)
...+.|++|++|.||+|.+ .|..+|+|+-... .....+..|++++..++--++-+ ++.|- ..++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 4457899999999999988 5668999887643 33468899999999998777654 44433 234559999988
Q ss_pred ChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC-CCCEEEcCCCCeEEEeecCccc
Q 043285 177 SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK-ASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 177 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk-~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
.|.+.-... +..+ ...+++..--|...| |-|+.|. |...++-+++.+.|+||..+..
T Consensus 98 ~L~~~~~~~------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887754321 2222 334455544555555 8899887 5555555566999999999874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.16 E-value=4.3e-05 Score=81.92 Aligned_cols=79 Identities=15% Similarity=0.336 Sum_probs=57.6
Q ss_pred CCeecccCCceEEEEEEcCC---CEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCce--eeeEeEEEeC---CeeeEE
Q 043285 100 NKKLGQGGFGPVYKGKLVDG---QEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNL--VKLLGCCIQG---EEKLLI 169 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 169 (414)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+.+++.+. |+++ .+++.+|.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999877554 367777764321 123356889999999995 6665 7778887764 357899
Q ss_pred EeecCCCCh
Q 043285 170 YEFMPNKSL 178 (414)
Q Consensus 170 ~ey~~~g~L 178 (414)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.7e-05 Score=70.65 Aligned_cols=73 Identities=16% Similarity=0.292 Sum_probs=46.1
Q ss_pred CeecccCCc-eEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC---ceeeeEeEEEeCC---eeeEEEeec
Q 043285 101 KKLGQGGFG-PVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCIQGE---EKLLIYEFM 173 (414)
Q Consensus 101 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~---~~~lv~ey~ 173 (414)
+.|+.|+.. .||+. +..+++|..+.. .....+..|+..++.+... .+.++++.....+ ..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777666 48875 345777865542 2335788899999888532 3344444333222 347899999
Q ss_pred CCCChh
Q 043285 174 PNKSLD 179 (414)
Q Consensus 174 ~~g~L~ 179 (414)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.11 E-value=9.6e-05 Score=64.73 Aligned_cols=132 Identities=17% Similarity=0.276 Sum_probs=91.6
Q ss_pred CCeecccCCceEEEEEEcCCCEEEEEEecccC----------------hhhHHHHHHHHHHHHhcC------CCceeeeE
Q 043285 100 NKKLGQGGFGPVYKGKLVDGQEIAVKRLSKIS----------------EQGLKELKNEVILFSKLQ------HRNLVKLL 157 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~~~ 157 (414)
...||+|+.-.||. +.+.....||+..... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 36899999999886 4566778888886544 122455666666665555 78999999
Q ss_pred eEEEeCCeeeEEEeecCC------CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 043285 158 GCCIQGEEKLLIYEFMPN------KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 231 (414)
Q Consensus 158 ~~~~~~~~~~lv~ey~~~------g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~ 231 (414)
|+..++...-+|+|.+.+ -+|.+++.+.. ++. ..... +-+-..||-+++ |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998632 25777774332 444 33333 334456777766 99999999999996
Q ss_pred CC--C--CeEEEe-ecCc
Q 043285 232 QD--M--NPKISD-FGLA 244 (414)
Q Consensus 232 ~~--~--~~kL~D-fgl~ 244 (414)
.. + .+.|+| ||..
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 43 2 477777 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.4e-05 Score=69.10 Aligned_cols=141 Identities=20% Similarity=0.259 Sum_probs=82.0
Q ss_pred CeecccCCceEEEEEEcC--CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeeEEEeecCCCC
Q 043285 101 KKLGQGGFGPVYKGKLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMPNKS 177 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ey~~~g~ 177 (414)
+.|..|-...+|+....+ +..|++|........ ......|+.+++.+...++ .++++.+. ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567888899999997654 678999977542221 1233578888888854444 34444332 247999999876
Q ss_pred hhHH--------------h---hccccc--------ccCC-HHHHHHHHH----------------------HHHHHHHH
Q 043285 178 LDSF--------------I---FDQERC--------MILD-WSKRFHIIC----------------------GTARGLLY 209 (414)
Q Consensus 178 L~~~--------------l---~~~~~~--------~~l~-~~~~~~i~~----------------------~i~~~l~~ 209 (414)
+... + +..... .... +..+..+.. .+...+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5321 1 111100 0111 111111111 11111111
Q ss_pred ----HHhC-CCCCeeeccCCCCCEEEcC-CCCeEEEeecCccc
Q 043285 210 ----LHQD-SRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARA 246 (414)
Q Consensus 210 ----LH~~-~~~~iiH~dlk~~Nill~~-~~~~kL~Dfgl~~~ 246 (414)
+... ....++|+|+.+.||++++ ++.+.++||..+..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2211 2345999999999999998 57899999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.09 E-value=7.6e-05 Score=70.10 Aligned_cols=76 Identities=12% Similarity=0.094 Sum_probs=56.4
Q ss_pred CCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC---CceeeeEeEEEeC---CeeeEEEeec
Q 043285 100 NKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH---RNLVKLLGCCIQG---EEKLLIYEFM 173 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~---~~~~lv~ey~ 173 (414)
.+.||.|..+.||.....++ .+++|..+... ....+..|+..++.+.. -.+.+++++|..+ +..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 46899999999999876555 46667654311 22478889999998853 3677888887653 5689999999
Q ss_pred CCCCh
Q 043285 174 PNKSL 178 (414)
Q Consensus 174 ~~g~L 178 (414)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.5e-05 Score=70.82 Aligned_cols=139 Identities=17% Similarity=0.154 Sum_probs=79.7
Q ss_pred eecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCcee-eeEeEEEeCCeeeEEEeecCCCChhH
Q 043285 102 KLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMPNKSLDS 180 (414)
Q Consensus 102 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~ey~~~g~L~~ 180 (414)
.+..|-.+.+|+... ++..+++|..........-....|..+++.+....+. +++..+ . .++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 456788889998874 6778888876543222112356788888888644343 344333 1 368999999876542
Q ss_pred H-----------------hhcccc-cccCCHHHH-HHHHHHH---------HHHHHHHHhC-----CCCCeeeccCCCCC
Q 043285 181 F-----------------IFDQER-CMILDWSKR-FHIICGT---------ARGLLYLHQD-----SRLRIIHRDLKASN 227 (414)
Q Consensus 181 ~-----------------l~~~~~-~~~l~~~~~-~~i~~~i---------~~~l~~LH~~-----~~~~iiH~dlk~~N 227 (414)
. ++.... ...++.... ..+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 111110 011222211 1111111 1112222211 12358999999999
Q ss_pred EEEcCCCCeEEEeecCccc
Q 043285 228 VLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 228 ill~~~~~~kL~Dfgl~~~ 246 (414)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00014 Score=77.17 Aligned_cols=198 Identities=20% Similarity=0.189 Sum_probs=134.2
Q ss_pred HHHHHHHHHHHhcCCCceeeeEeEEEeCCe----eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHH
Q 043285 136 KELKNEVILFSKLQHRNLVKLLGCCIQGEE----KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211 (414)
Q Consensus 136 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 211 (414)
.....|...+.++.|+|++.++.|...... ..+..++|..-++...+..... .+......+..++.+|++|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---IPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---cCHHHHHHHHHHHhhhHHHHH
Confidence 344567778888999999999998765443 2355688888888887765443 788888889999999999999
Q ss_pred hCCCCCeeeccCCCC---CEEEcCCCCeEEE--eecCccccCCCCCccccccccccccccccccccCCCCCc--chhHHH
Q 043285 212 QDSRLRIIHRDLKAS---NVLLDQDMNPKIS--DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSV--KSDVFS 284 (414)
Q Consensus 212 ~~~~~~iiH~dlk~~---Nill~~~~~~kL~--Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDvws 284 (414)
+.. ..|.-+... +.-.+..+.+..+ ||+....+....... ....+..|.+||......+.. ..|+|+
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHH
Confidence 985 555555544 4444556666666 888887654332211 122345678888777665554 479999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 043285 285 FGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSV 364 (414)
Q Consensus 285 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev 364 (414)
+|..+..+..|..+...... +..+.+..... ...+....|+..++++|+++.++
T Consensus 378 lgll~~~~~~~~~i~~~~~~------------------~~~~l~~~~~~--------~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSAV------------------PVSLLDVLSTS--------ELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHHhhhhhcCcccccccc------------------hhhhhccccch--------hhhhhhhhhcchhhhhccchhhh
Confidence 99999999998765322110 11111111100 23344557999999999999999
Q ss_pred HHHh
Q 043285 365 ILML 368 (414)
Q Consensus 365 l~~L 368 (414)
+...
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 9865
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00055 Score=66.50 Aligned_cols=75 Identities=15% Similarity=0.218 Sum_probs=53.6
Q ss_pred CeecccCCceEEEEEEcCC-CEEEEEEeccc----C---hhhHHHHHHHHHHHHhcC---CCceeeeEeEEEeCCeeeEE
Q 043285 101 KKLGQGGFGPVYKGKLVDG-QEIAVKRLSKI----S---EQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 169 (414)
+.||.|.+..||++...+| +.|+||.-... . +...+....|.+.|+.+. -.++.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6799999999999998776 48999985421 1 224456777888887763 2345666655 45667899
Q ss_pred EeecCCCC
Q 043285 170 YEFMPNKS 177 (414)
Q Consensus 170 ~ey~~~g~ 177 (414)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00022 Score=67.24 Aligned_cols=141 Identities=26% Similarity=0.364 Sum_probs=84.0
Q ss_pred CeecccCCceEEEEEEcC-------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeeEEEee
Q 043285 101 KKLGQGGFGPVYKGKLVD-------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ey 172 (414)
+.+..|-...+|+....+ +..+++|...... ........|..++..+....+ .++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 466778888999987654 4789999876532 223456778888888854334 34555543 2358999
Q ss_pred cCCCChhHH-----------------hhcccccc------cCC--HHHHHH--------------------------HHH
Q 043285 173 MPNKSLDSF-----------------IFDQERCM------ILD--WSKRFH--------------------------IIC 201 (414)
Q Consensus 173 ~~~g~L~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~ 201 (414)
++|..+... ++...... ..+ +..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766431 11111000 000 001000 111
Q ss_pred HHHHHHHHHHh------CCCCCeeeccCCCCCEEEcCC----CCeEEEeecCccc
Q 043285 202 GTARGLLYLHQ------DSRLRIIHRDLKASNVLLDQD----MNPKISDFGLARA 246 (414)
Q Consensus 202 ~i~~~l~~LH~------~~~~~iiH~dlk~~Nill~~~----~~~kL~Dfgl~~~ 246 (414)
.+...+..+.. .....++|+|+.+.||+++++ +.+.++||+.+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 134568999999999999985 8899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00035 Score=60.82 Aligned_cols=125 Identities=27% Similarity=0.395 Sum_probs=88.7
Q ss_pred CCCCCCCeecccCC-ceEEEEEEcCCCEEEEEEecc---cCh------------------hhHHHHHHHHHHHHhcC---
Q 043285 95 NNFSINKKLGQGGF-GPVYKGKLVDGQEIAVKRLSK---ISE------------------QGLKELKNEVILFSKLQ--- 149 (414)
Q Consensus 95 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 149 (414)
.+++..+.||.|.- |.||+++. +|+.+|+|.+.. ... .....|..|.+.+.+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78888999999999 99999988 788999999422 000 11234667777777764
Q ss_pred CCce--eeeEeEEEeCC------------------eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHH
Q 043285 150 HRNL--VKLLGCCIQGE------------------EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209 (414)
Q Consensus 150 h~ni--v~~~~~~~~~~------------------~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~ 209 (414)
+.++ ++++||..-.. ...||.||.+... .+.. .-+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4566 89999984321 1247788776533 0222 234566777888
Q ss_pred HHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 210 LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
+|..+ |+-+|+++.|.. .-+|+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99988 999999999976 3489999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00027 Score=66.32 Aligned_cols=143 Identities=20% Similarity=0.201 Sum_probs=85.3
Q ss_pred CCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCc--eeeeEeE------EEeCCeeeEEEe
Q 043285 100 NKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYE 171 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e 171 (414)
.+.|..|....+|+... ++..+++|+... .....+..|+.++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~-~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTT-DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEe-CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45778888889999876 445788898764 22345677888888875333 3444331 123445689999
Q ss_pred ecCCCChhH----H----------hhccccc--------ccCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 043285 172 FMPNKSLDS----F----------IFDQERC--------MILDWSKRF----------HIICGTARGLLYLHQ----DSR 215 (414)
Q Consensus 172 y~~~g~L~~----~----------l~~~~~~--------~~l~~~~~~----------~i~~~i~~~l~~LH~----~~~ 215 (414)
|++|..+.. . ++..... ....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 1 1110000 001111110 011123334445443 122
Q ss_pred CCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 216 ~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
..++|+|+.|.||++++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999987788999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0063 Score=57.78 Aligned_cols=142 Identities=20% Similarity=0.211 Sum_probs=77.2
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCc--eeeeEe------EEEeCCeeeEEEee
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLG------CCIQGEEKLLIYEF 172 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~------~~~~~~~~~lv~ey 172 (414)
+.|+.|....+|.....+| .+++|++.... ...+..|..++..+...+ +.+++. +....+..+++++|
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 5577788889999877555 68888875222 234444556665553222 233332 12234567899999
Q ss_pred cCCCChhH-----------Hh---hccccc--------ccCCH-HHHHH------------HH-HHHHHHHHHHHhC---
Q 043285 173 MPNKSLDS-----------FI---FDQERC--------MILDW-SKRFH------------II-CGTARGLLYLHQD--- 213 (414)
Q Consensus 173 ~~~g~L~~-----------~l---~~~~~~--------~~l~~-~~~~~------------i~-~~i~~~l~~LH~~--- 213 (414)
++|..+.. .+ +..... ..+.+ ..... .. ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 11 111000 00111 11111 11 1111122333211
Q ss_pred -CCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 214 -SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 214 -~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
-..++||+|+.+.||+++.+...-++||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234599999999999999765568999998753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.002 Score=61.91 Aligned_cols=141 Identities=19% Similarity=0.273 Sum_probs=82.3
Q ss_pred CeecccCCceEEEEEEcC-----CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCcee-eeEeEEEeCCeeeEEEeecC
Q 043285 101 KKLGQGGFGPVYKGKLVD-----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~ey~~ 174 (414)
+.|..|-...+|+....+ ++.|++|.......... .-..|..+++.+...++. ++++.+..+ .|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456668888999987533 36789998765433322 236788888888655553 456655332 5899998
Q ss_pred CCChhHH-----------------hhccc--ccc-cCCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 043285 175 NKSLDSF-----------------IFDQE--RCM-ILDWSKRFHIICG-----------------TARGLLYL----HQ- 212 (414)
Q Consensus 175 ~g~L~~~-----------------l~~~~--~~~-~l~~~~~~~i~~~-----------------i~~~l~~L----H~- 212 (414)
+.++... ++... ... ...+.++..+..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7666421 11111 000 1112222222211 11112222 21
Q ss_pred CCCCCeeeccCCCCCEEEcC-CCCeEEEeecCccc
Q 043285 213 DSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARA 246 (414)
Q Consensus 213 ~~~~~iiH~dlk~~Nill~~-~~~~kL~Dfgl~~~ 246 (414)
.....++|+|+++.||++++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22335899999999999986 46899999998864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0043 Score=58.61 Aligned_cols=144 Identities=22% Similarity=0.197 Sum_probs=81.8
Q ss_pred CCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCc--eeeeEeEE------EeCCeeeEEEe
Q 043285 100 NKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCC------IQGEEKLLIYE 171 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~------~~~~~~~lv~e 171 (414)
.+.++.|....+|+....+| .+++|...... ....+..|..++..+.... +.+++... ...+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 35677787789999876444 67788775422 1234556677777764322 33443321 12345689999
Q ss_pred ecCCCChhH-----------H---hhccccc-----c----cCCHHHHHH------------HHHHHHHHHHHHHh----
Q 043285 172 FMPNKSLDS-----------F---IFDQERC-----M----ILDWSKRFH------------IICGTARGLLYLHQ---- 212 (414)
Q Consensus 172 y~~~g~L~~-----------~---l~~~~~~-----~----~l~~~~~~~------------i~~~i~~~l~~LH~---- 212 (414)
|++|..+.. . ++..... . ...|..... ....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998855321 0 1111000 0 011111000 01122334555532
Q ss_pred CCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 213 ~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
.....++|+|+.+.||++++++...|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1234699999999999999887778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00041 Score=64.20 Aligned_cols=136 Identities=15% Similarity=0.170 Sum_probs=93.0
Q ss_pred CCCCCCeecccCCceEEEEEEcCCCEEEEEEecc--c-------Ch--------h-----hHHHHHHHHHHHHhcC-CC-
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSK--I-------SE--------Q-----GLKELKNEVILFSKLQ-HR- 151 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~-------~~--------~-----~~~~~~~E~~~l~~l~-h~- 151 (414)
-+.++.+||-|--+.||.+-..+|++.++|.-.- . .. . +.-...+|+..|+.+. |.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4677899999999999999988899999885311 0 00 0 0112457888888885 33
Q ss_pred ceeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 043285 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 231 (414)
Q Consensus 152 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~ 231 (414)
-+.+.+++ +.-++|||++.+-.|...-+- .+...+.. .+..-+--|..+| +||+|..--||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~---~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYD---DLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHH---HHHHHHHHHHHcC---ceecccchheeEEe
Confidence 34444433 456799999988877654321 23333332 3333344566666 99999999999999
Q ss_pred CCCCeEEEeecCcccc
Q 043285 232 QDMNPKISDFGLARAF 247 (414)
Q Consensus 232 ~~~~~kL~Dfgl~~~~ 247 (414)
+++.++++||.-+...
T Consensus 237 dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVST 252 (465)
T ss_pred cCCCEEEeechHhhcc
Confidence 9999999999866543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0033 Score=58.53 Aligned_cols=73 Identities=19% Similarity=0.256 Sum_probs=47.9
Q ss_pred CCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC---CCceeeeEeEEEeCCeeeEEEeecCCC
Q 043285 100 NKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMPNK 176 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ey~~~g 176 (414)
.+.++.|....+|+.. .+++.+.||.-.. .....+..|+.-|+.|. --.+.+++++....+..++|+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 3678989999999987 5788999998763 22246778888888873 346778898888888889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.005 Score=57.16 Aligned_cols=31 Identities=26% Similarity=0.528 Sum_probs=26.0
Q ss_pred CCeeeccCCCCCEEEcCCCC-eEEEeecCccc
Q 043285 216 LRIIHRDLKASNVLLDQDMN-PKISDFGLARA 246 (414)
Q Consensus 216 ~~iiH~dlk~~Nill~~~~~-~kL~Dfgl~~~ 246 (414)
..++|+|+++.||++++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0089 Score=56.17 Aligned_cols=147 Identities=15% Similarity=0.243 Sum_probs=84.2
Q ss_pred CCCCeecccCCceEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCC--CceeeeEeEEEeCC--eeeEEEe
Q 043285 98 SINKKLGQGGFGPVYKGKLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE--EKLLIYE 171 (414)
Q Consensus 98 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e 171 (414)
.+.+.+..|..-.+|.... +++.+++. ... ..........+|+.+++.+.- --....+++|.++. ..+.||+
T Consensus 28 ~~v~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred ceeeeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3344554454444555443 37778887 331 233445567788888888753 23455677777766 6799999
Q ss_pred ecCCCChhHHhhcccc-----------------------------------cccCCHHHHHHHH--------HHHHHHHH
Q 043285 172 FMPNKSLDSFIFDQER-----------------------------------CMILDWSKRFHII--------CGTARGLL 208 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~-----------------------------------~~~l~~~~~~~i~--------~~i~~~l~ 208 (414)
|++|..+.+.+..... .+...+......+ -....-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 9988432222111000 0000011111000 01122234
Q ss_pred HHHhC-----CCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 209 YLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 209 ~LH~~-----~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
+|+.+ +.+.++|+|+.+.|+++++++-+=+.||+++..
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 44433 234599999999999999998899999999875
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.00065 Score=44.31 Aligned_cols=45 Identities=47% Similarity=0.770 Sum_probs=41.2
Q ss_pred CCCCCCCCCCCCcccCCCCCCCCCCCCCC--CCcCcccccccccccC
Q 043285 370 SETVLPQPKQPGYLADRKSTRRDYSSIMP--ESCSTNTITVSGLEGR 414 (414)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 414 (414)
+...+|+|++|.+...+.....++|+... ..++.|.+++|-+|+|
T Consensus 2 e~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 2 ETATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred CcccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 45679999999999999999999998887 8999999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0093 Score=56.92 Aligned_cols=73 Identities=16% Similarity=0.170 Sum_probs=48.1
Q ss_pred eecccCCceEEEEEEcCC-CEEEEEEecc-------cChhhHHHHHHHHHHHHhcC--CCceeeeEeEEEeCCeeeEEEe
Q 043285 102 KLGQGGFGPVYKGKLVDG-QEIAVKRLSK-------ISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 102 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e 171 (414)
.||.|....||++...+| +.|+||.-.. ..+-...+..-|...|+... .|..++-+ ++.+.....+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~v-y~~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRI-FHFDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeE-EEEccccceehHh
Confidence 579999999999987654 5899998532 11233455667777776653 45444432 2335666679999
Q ss_pred ecCC
Q 043285 172 FMPN 175 (414)
Q Consensus 172 y~~~ 175 (414)
+++.
T Consensus 81 dL~~ 84 (370)
T TIGR01767 81 DLSH 84 (370)
T ss_pred hCcc
Confidence 9854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0089 Score=57.08 Aligned_cols=141 Identities=16% Similarity=0.219 Sum_probs=80.1
Q ss_pred CeecccCCceEEEEEEcC----CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCcee-eeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLVD----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.|..|-...+|+....+ +..|++|+....... .-.-.+|..+++.+..-++- ++++++. +. +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC--Cc--EeehhhcC
Confidence 456668888899886543 237889987653332 22336788888888665553 5565552 22 58999977
Q ss_pred CChhHH-------h----------hcccc--cccC-CHHHHHHHHHHH----------------------HHHHH----H
Q 043285 176 KSLDSF-------I----------FDQER--CMIL-DWSKRFHIICGT----------------------ARGLL----Y 209 (414)
Q Consensus 176 g~L~~~-------l----------~~~~~--~~~l-~~~~~~~i~~~i----------------------~~~l~----~ 209 (414)
.++..- + +...- .... -+..+..+..++ .+-+. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 655321 1 11110 0001 122222222111 11111 1
Q ss_pred HHhC-CCCCeeeccCCCCCEEEcC-CCCeEEEeecCccc
Q 043285 210 LHQD-SRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARA 246 (414)
Q Consensus 210 LH~~-~~~~iiH~dlk~~Nill~~-~~~~kL~Dfgl~~~ 246 (414)
+.+. ....++|+|+.+.||++++ ++.++++||..+..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 2111 1234799999999999975 57899999998864
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0031 Score=56.07 Aligned_cols=30 Identities=33% Similarity=0.516 Sum_probs=21.5
Q ss_pred CeeeccCCCCCEEE-cCCCCeEEEeecCccc
Q 043285 217 RIIHRDLKASNVLL-DQDMNPKISDFGLARA 246 (414)
Q Consensus 217 ~iiH~dlk~~Nill-~~~~~~kL~Dfgl~~~ 246 (414)
.++|+|+.+.||++ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.014 Score=55.31 Aligned_cols=140 Identities=21% Similarity=0.220 Sum_probs=92.5
Q ss_pred CCCCeecccCCceEEEEEEcCCCEEEEEEeccc------Ch-------------------hh-HHHHHHHHHHHHhcCCC
Q 043285 98 SINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKI------SE-------------------QG-LKELKNEVILFSKLQHR 151 (414)
Q Consensus 98 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------~~-------------------~~-~~~~~~E~~~l~~l~h~ 151 (414)
.+...|..|--+.||.+.-.+|..+|||+++.. .+ .- .-....|+.-|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 455788999999999999889999999987420 00 00 01235677778777655
Q ss_pred ceeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 043285 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 231 (414)
Q Consensus 152 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~ 231 (414)
.|.-.--... ..-.|||+|+.......=.. +...++...+..+-.+++.-|.-|.... ++||.||+--|+|+.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 5322111111 12368999996432211111 1123666677777788888888887776 499999999999996
Q ss_pred CCCCeEEEeecCcc
Q 043285 232 QDMNPKISDFGLAR 245 (414)
Q Consensus 232 ~~~~~kL~Dfgl~~ 245 (414)
+|.+.++|.+-+-
T Consensus 300 -dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSV 312 (520)
T ss_pred -CCEEEEEEccccc
Confidence 5689999987654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.022 Score=53.89 Aligned_cols=32 Identities=25% Similarity=0.314 Sum_probs=28.4
Q ss_pred CCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 215 ~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
+..+||+|+.++|+++++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34599999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0098 Score=57.76 Aligned_cols=73 Identities=14% Similarity=0.121 Sum_probs=50.2
Q ss_pred CCeecccCCceEEEEEEcCCCEEEEEEecc----cCh---hhHHHHHHHHHHHHhcC---CCceeeeEeEEEeCCeeeEE
Q 043285 100 NKKLGQGGFGPVYKGKLVDGQEIAVKRLSK----ISE---QGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~----~~~---~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 169 (414)
.+.||.|....||+... ++..++||+-.. ... ....+-..|+..|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46889999999999876 456799998652 111 13344455666666653 246777887775 556788
Q ss_pred EeecCC
Q 043285 170 YEFMPN 175 (414)
Q Consensus 170 ~ey~~~ 175 (414)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.00035 Score=76.14 Aligned_cols=160 Identities=14% Similarity=-0.019 Sum_probs=112.2
Q ss_pred HHHHHHHHHhcCCCceeeeEeEEEe--CCeeeEEEeecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhC-
Q 043285 138 LKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQD- 213 (414)
Q Consensus 138 ~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~- 213 (414)
...|....+...|+++.....-... ....+.+++|+.+|.+.+.+.+.. +.+.++..-+...-.+...+..-+|+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445555666789988766544332 335689999999999999986543 233344333333333324444554443
Q ss_pred -CCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHH
Q 043285 214 -SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEI 292 (414)
Q Consensus 214 -~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~el 292 (414)
+....+|+++|+-|.+|..+.++|++++|+.+... ..........+++-|+.|++...-.++.++|+|..|+-+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 23347899999999999999999999999998321 122233345678889999998888999999999999999999
Q ss_pred HhCCCCC
Q 043285 293 VSGKKNR 299 (414)
Q Consensus 293 ltg~~p~ 299 (414)
..|..++
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8888664
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.046 Score=51.60 Aligned_cols=29 Identities=24% Similarity=0.353 Sum_probs=25.4
Q ss_pred CCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 216 LRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 216 ~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.021 Score=55.26 Aligned_cols=74 Identities=14% Similarity=0.153 Sum_probs=50.3
Q ss_pred CCeecccCCceEEEEEEcC-CCEEEEEEecc------cChhhHHHHHHHHHHHHhcC--CCceee-eEeEEEeCCeeeEE
Q 043285 100 NKKLGQGGFGPVYKGKLVD-GQEIAVKRLSK------ISEQGLKELKNEVILFSKLQ--HRNLVK-LLGCCIQGEEKLLI 169 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~niv~-~~~~~~~~~~~~lv 169 (414)
.+.||.|.-..||++...+ ++.|+||.-.. ..+-..++..-|.+.|+... .|..++ ++ +.+.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhHH
Confidence 3689999999999998743 67899997532 12334566677888887763 454444 43 3356667788
Q ss_pred EeecCC
Q 043285 170 YEFMPN 175 (414)
Q Consensus 170 ~ey~~~ 175 (414)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.12 Score=45.97 Aligned_cols=75 Identities=16% Similarity=0.265 Sum_probs=50.3
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC---CCceeeeEeEEEeCCeeeEEEeecCCCC
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMPNKS 177 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ey~~~g~ 177 (414)
+.+..|.--..|.... +..++.||+-.. ....-|..|+.-|..+. .-++.+++.+-.+..+.|+|+||++.+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3444444444444433 567788886432 33356677777766664 4567788888888999999999999876
Q ss_pred hh
Q 043285 178 LD 179 (414)
Q Consensus 178 L~ 179 (414)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 66
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.0044 Score=60.89 Aligned_cols=49 Identities=18% Similarity=0.274 Sum_probs=37.9
Q ss_pred HHHHHHHHHHHhcCCCceeeeEeEEEeCC-eeeEEEeecCCCChhHHhhcc
Q 043285 136 KELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEFMPNKSLDSFIFDQ 185 (414)
Q Consensus 136 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ey~~~g~L~~~l~~~ 185 (414)
.++......++.+.|+|+..++.+..... ...+|+|++ +.+|.+.+...
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 45667788899999999999988876433 467889999 56888887554
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.21 Score=47.61 Aligned_cols=71 Identities=14% Similarity=0.088 Sum_probs=44.3
Q ss_pred cCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCc--eeeeE---e--EEEeCCeeeEEEeecCCCC
Q 043285 106 GGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLL---G--CCIQGEEKLLIYEFMPNKS 177 (414)
Q Consensus 106 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~---~--~~~~~~~~~lv~ey~~~g~ 177 (414)
+.-..||.....++..+++|+.+.. ......+..|...+..+.... ++... | ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 4456799988877888999987532 223456677888777764221 22211 1 1223456778999998764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.07 Score=51.89 Aligned_cols=74 Identities=23% Similarity=0.349 Sum_probs=45.8
Q ss_pred CeecccCCceEEEEEEcCC--CE-----EEEEEecccChhhHHHHHHHHHHHHhcCCCcee-eeEeEEEeCCeeeEEEee
Q 043285 101 KKLGQGGFGPVYKGKLVDG--QE-----IAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~ey 172 (414)
+.|..|-...+|++...++ .. |.++...... ...-.-..|+.+++.+...++- ++++.+. -.++.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 5666688899999976443 22 4444332211 1112235688999999766654 4555553 2599999
Q ss_pred cCCCChh
Q 043285 173 MPNKSLD 179 (414)
Q Consensus 173 ~~~g~L~ 179 (414)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987664
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.14 Score=48.71 Aligned_cols=141 Identities=24% Similarity=0.299 Sum_probs=82.1
Q ss_pred eecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCce------eeeEe----EEEeCCeeeEEEe
Q 043285 102 KLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL------VKLLG----CCIQGEEKLLIYE 171 (414)
Q Consensus 102 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni------v~~~~----~~~~~~~~~lv~e 171 (414)
.|.+ .-..+|+....+|+. ++|+.... ....++..|...+..+.-.++ ...-| ....+...+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556789998877766 88887664 344577778888888742221 11111 1111236778999
Q ss_pred ecCCCChhH-H--------------hhccc------c---cccCCHHH---H----------HHHHHHHHHHHHHHHhC-
Q 043285 172 FMPNKSLDS-F--------------IFDQE------R---CMILDWSK---R----------FHIICGTARGLLYLHQD- 213 (414)
Q Consensus 172 y~~~g~L~~-~--------------l~~~~------~---~~~l~~~~---~----------~~i~~~i~~~l~~LH~~- 213 (414)
|++|..+.. . ++... . .....|.. . .....++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988772 1 11100 0 00122220 0 01122333344444432
Q ss_pred ------CCCCeeeccCCCCCEEEcCCCC-eEEEeecCccc
Q 043285 214 ------SRLRIIHRDLKASNVLLDQDMN-PKISDFGLARA 246 (414)
Q Consensus 214 ------~~~~iiH~dlk~~Nill~~~~~-~kL~Dfgl~~~ 246 (414)
+...+||+|+.|.||+++.+.. +-++||+-+..
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1123899999999999999885 89999998753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.056 Score=47.73 Aligned_cols=136 Identities=14% Similarity=0.160 Sum_probs=80.4
Q ss_pred EEEEEecccChh-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHH
Q 043285 122 IAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHII 200 (414)
Q Consensus 122 vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~ 200 (414)
..+|++....-. ....+..+..+++++. .|+++..- ++...-++.|+|..-.. . .. .++
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~--~~-N~i 147 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------N--FS-NFI 147 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------c--hh-HHH
Confidence 445555443222 3345677888887764 45666522 33345688999843211 0 11 111
Q ss_pred HHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcch
Q 043285 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKS 280 (414)
Q Consensus 201 ~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s 280 (414)
..=+++|.-.|+.. ...+|||-.|+||+-+..|.+||.|=+..-. .+..|.- ......+.++
T Consensus 148 ~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN---~~Y~~lT~~a 209 (308)
T PF07387_consen 148 TAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVN---IEYESLTQEA 209 (308)
T ss_pred HHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEe---eeccccChHH
Confidence 11146777888543 3599999999999999999999999554311 0111222 1123346677
Q ss_pred hHHHHHHHHHHHHhC
Q 043285 281 DVFSFGILLLEIVSG 295 (414)
Q Consensus 281 DvwslGvil~elltg 295 (414)
.+-+|=.-++++...
T Consensus 210 E~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 210 EVKVFVKSCLKLVEK 224 (308)
T ss_pred HHHHHHHHHHHHHHH
Confidence 777777777777653
|
The function of this family is unknown. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.18 Score=50.04 Aligned_cols=75 Identities=12% Similarity=0.151 Sum_probs=48.1
Q ss_pred CCeecccCCceEEEEEEcC---------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCcee-eeEeEEEeCCeeeEE
Q 043285 100 NKKLGQGGFGPVYKGKLVD---------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLI 169 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv 169 (414)
.+.|..|-.-.+|+....+ ++.|++++.......-. .-..|..+++.+...+|- ++++.+. -..|
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 3567778888889887542 45788888765333322 345688888887655554 4555442 3467
Q ss_pred EeecCCCChh
Q 043285 170 YEFMPNKSLD 179 (414)
Q Consensus 170 ~ey~~~g~L~ 179 (414)
.||++|.+|.
T Consensus 185 ~efi~g~~l~ 194 (442)
T PTZ00296 185 EEWLYGDPLR 194 (442)
T ss_pred EEeeCCccCC
Confidence 9999886443
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.26 Score=54.24 Aligned_cols=142 Identities=20% Similarity=0.240 Sum_probs=77.4
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-------CCceeeeE-e----EEEe-CC--e
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-------HRNLVKLL-G----CCIQ-GE--E 165 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-------h~niv~~~-~----~~~~-~~--~ 165 (414)
+.|+ |..-.+|+....+|..+++|+.+.... ......|...+..+. -|.+++-. | .... .. .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 456788998887888999999875322 223344555555442 23333321 1 1111 12 4
Q ss_pred eeEEEeecCCCChhHH-----------------hhc------cc-ccccCCHH-----------------HHHHHHHHHH
Q 043285 166 KLLIYEFMPNKSLDSF-----------------IFD------QE-RCMILDWS-----------------KRFHIICGTA 204 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~-----------------l~~------~~-~~~~l~~~-----------------~~~~i~~~i~ 204 (414)
.+-+++|++|..+.+. ++. .. ....+.|. ....++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999999877651 010 00 00011121 1112222222
Q ss_pred HHHH-----HHHhCCCCCeeeccCCCCCEEEcCCC--CeE-EEeecCccc
Q 043285 205 RGLL-----YLHQDSRLRIIHRDLKASNVLLDQDM--NPK-ISDFGLARA 246 (414)
Q Consensus 205 ~~l~-----~LH~~~~~~iiH~dlk~~Nill~~~~--~~k-L~Dfgl~~~ 246 (414)
+.+. .+.+ -+..+||+|+.+.||+++.++ ++. |+|||.+..
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 1222 234599999999999999875 555 999998764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 414 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-36 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-23 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-22 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-21 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-21 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-21 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-21 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-21 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-21 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-20 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-20 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-20 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-20 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-19 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-18 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-18 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-17 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-17 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-17 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-17 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-17 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-17 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-17 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-17 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-17 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-17 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-17 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-17 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-17 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-17 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-17 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-17 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-17 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-17 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-17 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-15 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 421 bits (1086), Expect = e-148
Identities = 103/314 (32%), Positives = 159/314 (50%), Gaps = 19/314 (6%)
Query: 71 ENDQIQNIDLELPLFELATIVSATNNFS------INKKLGQGGFGPVYKGKLVDGQEIAV 124
EN ++ D F + + TNNF K+G+GGFG VYKG + + +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 125 KRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 180
K+L+ + +E+ ++ E+ + +K QH NLV+LLG G++ L+Y +MPN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 181 FIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 240
+ + L W R I G A G+ +LH++ IHRD+K++N+LLD+ KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 241 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 300
FGLARA T+R+VGT YMAPE G+ + KSD++SFG++LLEI++G
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 301 FYHSDNNLNLIGHAWKLWNEGMP-SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRP 359
+ L+ ++ +E ID D + V + C+ + RP
Sbjct: 236 EHREPQ--LLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 360 SMPSVILMLGSETV 373
+ V +L T
Sbjct: 293 DIKKVQQLLQEMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 405 bits (1044), Expect = e-141
Identities = 117/294 (39%), Positives = 174/294 (59%), Gaps = 5/294 (1%)
Query: 85 FELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLK-ELKNEVI 143
F L + A++NFS LG+GGFG VYKG+L DG +AVKRL + QG + + + EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 144 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQER-CMILDWSKRFHIICG 202
+ S HRNL++L G C+ E+LL+Y +M N S+ S + ++ LDW KR I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 203 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 262
+ARGL YLH +IIHRD+KA+N+LLD++ + DFGLA+ +T T V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 263 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN--RGFYHSDNNLNLIGHAWKLWNE 320
G++APEY S G+ S K+DVF +G++LLE+++G++ +D+++ L+ L E
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 321 GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVL 374
L+D Q ++ EV + I + LLC Q P +RP M V+ ML + +
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 366 bits (942), Expect = e-126
Identities = 105/286 (36%), Positives = 158/286 (55%), Gaps = 6/286 (2%)
Query: 85 FELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVIL 144
L + ATNNF +G G FG VYKG L DG ++A+KR + S QG++E + E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 145 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQER-CMILDWSKRFHIICGT 203
S +H +LV L+G C + E +LIY++M N +L ++ + M + W +R I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF-GGDETEGNTNRVVGT 262
ARGL YLH + IIHRD+K+ N+LLD++ PKI+DFG+++ D+T +T V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204
Query: 263 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322
GY+ PEY G+ + KSDV+SFG++L E++ + +NL A + N G
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 323 PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
Q++D D + + + C+ EDRPSM V+ L
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 2e-97
Identities = 72/306 (23%), Positives = 126/306 (41%), Gaps = 28/306 (9%)
Query: 85 FELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVIL 144
+ + + + +G FG V+K + + + +AVK +Q + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 145 FSKLQHRNLVKLLGCCIQGE----EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHII 200
++H N+++ +G +G + LI F SL F+ ++ W++ HI
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIA 127
Query: 201 CGTARGLLYLHQD-------SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253
ARGL YLH+D + I HRD+K+ NVLL ++ I+DFGLA F ++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 254 GNTNRVVGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNL 308
G+T+ VGT YMAPE ++ D+++ G++L E+ S + L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 309 NLIGHAWKLWN-EGMPS----QLIDSCFQDSFNLAEVIRCI-HIGLLCVQQHPEDRPSMP 362
+ + E M + +D + + + C E R S
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 363 SVILML 368
V +
Sbjct: 308 CVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 2e-81
Identities = 70/323 (21%), Positives = 118/323 (36%), Gaps = 42/323 (13%)
Query: 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 152
+N + + +G+G +G VYKG L D + +AVK S + Q K + ++H N
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68
Query: 153 LVKLLGCCIQGE-----EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
+ + + + E LL+ E+ PN SL ++ DW + RGL
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124
Query: 208 LYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG------DETEGN 255
YLH + + I HRDL + NVL+ D ISDFGL+ G E +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 256 TNRVVGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNL 308
VGT YMAPE + D+++ G++ EI + S
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 309 NLIGHAWKLWNEGMPSQLIDS-CFQ-------DSFNLAEVIRCIHIGLL--CVQQHPEDR 358
+ ++ N + + +++ + + C Q E R
Sbjct: 245 QMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303
Query: 359 PSMPSVILMLGS-ETVLPQPKQP 380
+ + + + K
Sbjct: 304 LTAQXAEERMAELMMIWERNKSV 326
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 3e-71
Identities = 76/287 (26%), Positives = 135/287 (47%), Gaps = 23/287 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 152
+ +I +K+G G FG V++ + G ++AVK L + + E EV + +L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
+V +G Q ++ E++ SL + LD +R + A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 272
I+HR+LK+ N+L+D+ K+ DFGL+R T ++ GT +MAPE
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAPEVLR 212
Query: 273 DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332
D + KSDV+SFG++L E+ + ++ + NLN + + ++ +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQ---PWG---NLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS--ETVLPQP 377
+A +I C P RPS +++ +L ++ +P P
Sbjct: 267 Q---VAAIIE------GCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 8e-68
Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 26/288 (9%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ + +G+G FG V K K +++A+K++ SE K E+ S++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
KL G C+ L+ E+ SL + + E + ++G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 215 RLRIIHRDLKASNVLLDQDMN-PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 273
+IHRDLK N+LL KI DFG A + + + G+ +MAPE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 274 GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333
+S K DVFS+GI+L E+++ +K + + W + N P LI + +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PF-DEIGGPAFRIMWAVHNGTRPP-LIKNLPKP 232
Query: 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS-ETVLPQPKQP 380
+ ++ C + P RPSM ++ ++ P +P
Sbjct: 233 ---IESLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 1e-66
Identities = 76/282 (26%), Positives = 133/282 (47%), Gaps = 36/282 (12%)
Query: 99 INKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQ----GLKELKNEVILFSKLQHRNLV 154
+ + +G GGFG VY+ G E+AVK ++ ++ ++ E LF+ L+H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
L G C++ L+ EF L+ + + + + ARG+ YLH ++
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEA 125
Query: 215 RLRIIHRDLKASNVLLDQDMNP--------KISDFGLARAFGGDETEGNTNRVVGTYGYM 266
+ IIHRDLK+SN+L+ Q + KI+DFGLAR + G Y +M
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWM 181
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326
APE FS SDV+S+G+LL E+++G+ + ++ + A+ + + +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV---PFR---GIDGLAVAYGVAMNKLALPI 235
Query: 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+C + A+++ C P RPS +++ L
Sbjct: 236 PSTCPEP---FAKLME------DCWNPDPHSRPSFTNILDQL 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 4e-66
Identities = 76/289 (26%), Positives = 136/289 (47%), Gaps = 38/289 (13%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQG-------LKELKNEVILFS 146
N K++G+GGFG V+KG+LV D +A+K L +G +E + EV + S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 147 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
L H N+VKL G ++ EF+P L + D+ + WS + ++ A G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALG 134
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLARAFGGDETEGNTNRVVG 261
+ Y+ I+HRDL++ N+ L + K++DFGL++ ++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 262 TYGYMAPE--YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN 319
+ +MAPE A + ++ K+D +SF ++L I++G+ + + + I +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PF-DEYSYGKIKFINMIRE 244
Query: 320 EGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
EG+ + + C L VI LC P+ RP ++ L
Sbjct: 245 EGLRPTIPEDCPPR---LRNVIE------LCWSGDPKKRPHFSYIVKEL 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 1e-65
Identities = 73/283 (25%), Positives = 117/283 (41%), Gaps = 32/283 (11%)
Query: 99 INKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 157
+ LG+G FG K G+ + +K L + E+ + EV + L+H N++K +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLR 217
G + + I E++ +L I + WS+R A G+ YLH +
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 218 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR------------VVGTYGY 265
IIHRDL + N L+ ++ N ++DFGLAR ++T+ R VVG +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325
MAPE + + K DVFSFGI+L EI+ + ++ +
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-DYLPRTMDFG----LNVRGFLDRY 243
Query: 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+C F + + C PE RPS + L
Sbjct: 244 CPPNCPPSFFPIT---------VRCCDLDPEKRPSFVKLEHWL 277
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-64
Identities = 59/281 (20%), Positives = 120/281 (42%), Gaps = 32/281 (11%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 152
+ KL + G ++KG+ G +I VK L S + ++ E H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 153 LVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
++ +LG C I +MP SL + + + ++D S+ ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFL 127
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE- 269
H L I L + +V++D+DM +IS + +F + + ++APE
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEA 179
Query: 270 --YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327
+ +D++SF +LL E+V+ + + +L+ + K+ EG+ +
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREV---PFA---DLSNMEIGMKVALEGLRPTIP 233
Query: 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
S +++++++ +C+ + P RP ++ +L
Sbjct: 234 PGI---SPHVSKLMK------ICMNEDPAKRPKFDMIVPIL 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 4e-64
Identities = 78/282 (27%), Positives = 137/282 (48%), Gaps = 30/282 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 152
++ +++G G FG VYKGK ++AVK L + + Q L+ KNEV + K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
++ +G + ++ ++ SL + E + K I TARG+ YLH
Sbjct: 82 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHA 138
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE--- 269
IIHRDLK++N+ L +D KI DFGLA ++ G+ +MAPE
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 270 YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP---SQL 326
+S +SDV++FGI+L E+++G+ Y + NN + I + + S++
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQI--IEMVGRGSLSPDLSKV 250
Query: 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+C + + ++ C+++ ++RPS P ++ +
Sbjct: 251 RSNCPKR---MKRLMA------ECLKKKRDERPSFPRILAEI 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-60
Identities = 73/325 (22%), Positives = 134/325 (41%), Gaps = 47/325 (14%)
Query: 58 LIRKRRRNIAEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLV 117
L R+ K I + ++P +L I + +G+G FG VY G+
Sbjct: 6 LSLLSARSFPRKASQTSIFLQEWDIPFEQL----------EIGELIGKGRFGQVYHGRW- 54
Query: 118 DGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175
E+A++ + + +E LK K EV+ + + +H N+V +G C+ +I
Sbjct: 55 -HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113
Query: 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 235
++L S + D + +LD +K I +G+ YLH I+H+DLK+ NV D +
Sbjct: 114 RTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGK 167
Query: 236 PKISDFGLARAFGGDETEGNTNR---VVGTYGYMAPE---------YASDGQFSVKSDVF 283
I+DFGL G + ++ G ++APE FS SDVF
Sbjct: 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227
Query: 284 SFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRC 343
+ G + E+ + + + W++ P+ ++ +++++
Sbjct: 228 ALGTIWYELHAREWP---FK---TQPAEAIIWQMGTGMKPNLSQIGMGKE---ISDILL- 277
Query: 344 IHIGLLCVQQHPEDRPSMPSVILML 368
C E+RP+ ++ ML
Sbjct: 278 -----FCWAFEQEERPTFTKLMDML 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-56
Identities = 73/318 (22%), Positives = 127/318 (39%), Gaps = 49/318 (15%)
Query: 82 LPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNE 141
LPL TI + K++G+G +G V+ GK G+++AVK E + E
Sbjct: 27 LPLLVQRTIAK---QIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA-SWFRETE 81
Query: 142 VILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQERCMILDWSKRF 197
+ ++H N++ + I+G LI ++ N SL ++ + LD
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSML 137
Query: 198 HIICGTARGLLYLHQDSRLR-----IIHRDLKASNVLLDQDMNPKISDFGLARAF--GGD 250
+ + GL +LH + I HRDLK+ N+L+ ++ I+D GLA F +
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 251 ETEGNTNRVVGTYGYMAPE------YASDGQFSVKSDVFSFGILLLEIVSGKKNRGF--- 301
E + N VGT YM PE + Q + +D++SFG++L E+ + G
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257
Query: 302 ----YHSDNNLNLIGHAWKLW--NEGM-----PSQLIDSCFQDSFNLAEVIRCIHIGLLC 350
YH + + + + D C + + +++ C
Sbjct: 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQ---MGKLMT------EC 308
Query: 351 VQQHPEDRPSMPSVILML 368
+P R + V L
Sbjct: 309 WAHNPASRLTALRVKKTL 326
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-55
Identities = 64/303 (21%), Positives = 117/303 (38%), Gaps = 50/303 (16%)
Query: 99 INKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILF--SKLQHRNLVKL 156
+ + +G+G +G V++G G+ +AVK S + K E L+ L+H N++
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 157 LGCCIQGEEK----LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
+ + LI + SL ++ + LD I+ A GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 213 DSRLR-----IIHRDLKASNVLLDQDMNPKISDFGLAR--AFGGDETEGNTNRVVGTYGY 265
+ I HRDLK+ N+L+ ++ I+D GLA + ++ + N VGT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 266 MAPE------YASDGQFSVKSDVFSFGILLLEIVSGKKNRGF-------YHSDNNLNLIG 312
MAPE + D+++FG++L E+ + G ++ +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 313 HAWKLW--NEGM-----PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365
+ + D LA++++ C Q+P R + +
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTS---LAKLMK------ECWYQNPSARLTALRIK 294
Query: 366 LML 368
L
Sbjct: 295 KTL 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-53
Identities = 70/317 (22%), Positives = 125/317 (39%), Gaps = 47/317 (14%)
Query: 82 LPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQG-LKELKN 140
LPL TI + + +G+G FG V++GK G+E+AVK S E+ +E
Sbjct: 32 LPLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA-- 85
Query: 141 EVILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQERCMILDWSKR 196
E+ L+H N++ + + L+ ++ + SL ++ +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGM 141
Query: 197 FHIICGTARGLLYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GG 249
+ TA GL +LH + + I HRDLK+ N+L+ ++ I+D GLA
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 250 DETEGNTNRVVGTYGYMAPE------YASDGQFSVKSDVFSFGILLLEIVSGKKNRGF-- 301
D + N VGT YMAPE + ++D+++ G++ EI G
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 302 -----YHSDNNLNLIGHAWKLW--NEGM-PS--QLIDSCFQDSFNLAEVIRCIHIGLLCV 351
Y+ + + + + P+ SC +A+++R C
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR-VMAKIMR------ECW 314
Query: 352 QQHPEDRPSMPSVILML 368
+ R + + L
Sbjct: 315 YANGAARLTALRIKKTL 331
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-50
Identities = 69/308 (22%), Positives = 117/308 (37%), Gaps = 68/308 (22%)
Query: 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRL-SKISEQGLKELKNEVILFSKLQHRN 152
+ + +++G+G FG V+ G+L D +AVK + + E + + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
+V+L+G C Q + ++ E + +F+ + L ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY----MAP 268
IHRDL A N L+ + KISDFG++R +E +G G AP
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAP 284
Query: 269 EYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327
E + G++S +SDV+SFGILL E S G Y +
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASP---Y-----------------PNL----- 319
Query: 328 DSCFQDSFNLAEVIRCIHIG-----------------LLCVQQHPEDRPSMPSVILMLGS 370
+ + + G C P RPS ++ L
Sbjct: 320 --------SNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL-- 369
Query: 371 ETVLPQPK 378
+++ + +
Sbjct: 370 QSIRKRHR 377
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 9e-48
Identities = 75/290 (25%), Positives = 127/290 (43%), Gaps = 29/290 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 149
+ ++LG+G FG V + G+ +AVK+L +E+ L++ + E+ + LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 150 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
H N+VK G C + LI E++P SL ++ Q+ +D K +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG--- 264
YL R IHRDL N+L++ + KI DFGL + D+ V G
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY----YKVKEPGESP 211
Query: 265 --YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322
+ APE ++ +FSV SDV+SFG++L E+ + + ++ + M
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ----GQM 267
Query: 323 PSQLIDSCFQDSFNLAEVIRC---IH-IGLLCVQQHPEDRPSMPSVILML 368
+ +++ L C I+ I C + RPS + L +
Sbjct: 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-47
Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 31/223 (13%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQE------IAVKRLSKISEQGLKELKNEVILFSKL 148
+ + +LG+G FG V+ + + +AVK L + SE ++ + E L + L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF------------IFDQERCMILDWSKR 196
QH+++V+ G C +G L+++E+M + L+ F + L +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 197 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256
+ A G++YL + L +HRDL N L+ Q + KI DFG++R D +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDY 213
Query: 257 NRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
R VG +M PE +F+ +SDV+SFG++L EI +
Sbjct: 214 YR-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-47
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 32/224 (14%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDG------QEIAVKRLSKISEQGLKELKNEVILFSKL 148
+ + ++LG+G FG V+ + + +AVK L + K+ + E L + L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQERCMILDWSK 195
QH ++VK G C G+ ++++E+M + L+ F ++ L S+
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 196 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255
HI A G++YL + +HRDL N L+ ++ KI DFG++R D +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTD 187
Query: 256 TNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
R VG + +M PE +F+ +SDV+SFG++L EI +
Sbjct: 188 YYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-47
Identities = 75/290 (25%), Positives = 127/290 (43%), Gaps = 29/290 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 149
+ ++LG+G FG V + G+ +AVK+L +E+ L++ + E+ + LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 150 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
H N+VK G C + LI E++P SL ++ Q+ +D K +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG--- 264
YL R IHRDL N+L++ + KI DFGL + D+ V G
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF----FKVKEPGESP 180
Query: 265 --YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322
+ APE ++ +FSV SDV+SFG++L E+ + + ++ + M
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ----GQM 236
Query: 323 PSQLIDSCFQDSFNLAEVIRC---IH-IGLLCVQQHPEDRPSMPSVILML 368
+ +++ L C I+ I C + RPS + L +
Sbjct: 237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-47
Identities = 75/304 (24%), Positives = 123/304 (40%), Gaps = 58/304 (19%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 149
+ +LG+G FG V + G +AVK+L ++ + E+ + L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 150 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
+VK G + L+ E++P+ L F+ Q LD S+ +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG--- 264
YL R +HRDL A N+L++ + + KI+DFGLA+ D+ VV G
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----YVVREPGQSP 193
Query: 265 --YMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEG 321
+ APE SD FS +SDV+SFG++L E+ + K+ +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS-------------------CSPS 234
Query: 322 MPSQLIDSCFQDSFNLAEVIRCIHIG-----------------LLCVQQHPEDRPSMPSV 364
+ C +D L+ ++ + G LC P+DRPS ++
Sbjct: 235 AEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294
Query: 365 ILML 368
L
Sbjct: 295 GPQL 298
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-46
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 13/203 (6%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
++ K+LG G FG V GK ++AVK + K E E KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
K G C + ++ E++ N L +++ + L+ S+ + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPEYA 271
+ IHRDL A N L+D+D+ K+SDFG+ R D+ VGT + APE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV----SSVGTKFPVKWSAPEVF 177
Query: 272 SDGQFSVKSDVFSFGILLLEIVS 294
++S KSDV++FGIL+ E+ S
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFS 200
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-46
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 98 SINKKLGQGGFGPVYKGKLVDG----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 152
N+ +G+G FG VY G L+D AVK L++I + + E I+ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 153 LVKLLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
++ LLG C++ E L + +M + L +FI + A+G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 144
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG------Y 265
+ + +HRDL A N +LD+ K++DFGLAR D + V G +
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKW 198
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVS 294
MA E +F+ KSDV+SFG+LL E+++
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-46
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ + K+LG G FG V GK ++A+K + K E E + L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+L G C + +I E+M N L +++ +E + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPEYA 271
+ +HRDL A N L++ K+SDFGL+R DE VG+ + PE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPPEVL 193
Query: 272 SDGQFSVKSDVFSFGILLLEIVS 294
+FS KSD+++FG+L+ EI S
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-46
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ + +++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+L G C++ L+ EFM + L ++ + + + + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPEYA 271
+IHRDL A N L+ ++ K+SDFG+ R D+ GT + +PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT----SSTGTKFPVKWASPEVF 177
Query: 272 SDGQFSVKSDVFSFGILLLEIVS 294
S ++S KSDV+SFG+L+ E+ S
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-46
Identities = 73/305 (23%), Positives = 110/305 (36%), Gaps = 61/305 (20%)
Query: 95 NNFSINKKLGQGGFGPVYKGKL---VDGQEI--AVKRL-SKISEQGLKELKNEVILFSKL 148
+ LG+G FG V DG AVK L + Q K E+ + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 149 QHRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
H +++K GCC L+ E++P SL ++ + ++ G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEG 146
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG-- 264
+ YLH IHRDL A NVLLD D KI DFGLA+A V G
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY----YRVREDGDS 199
Query: 265 ---YMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNE 320
+ APE + +F SDV+SFG+ L E+++ ++ L
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-----------I 248
Query: 321 GMPSQLIDSCFQDSFNLAEVIRCIHIG-----------------LLCVQQHPEDRPSMPS 363
G+ Q + + + G C + RP+ +
Sbjct: 249 GIA--------QGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFEN 300
Query: 364 VILML 368
+I +L
Sbjct: 301 LIPIL 305
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-46
Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 27/219 (12%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQE------IAVKRLSKI-SEQGLKELKNEVILFSK 147
+++++LGQG FG VY+G + +A+K +++ S + E NE + +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------IFDQERCMILDWSKRFHII 200
++V+LLG QG+ L+I E M L S+ + + SK +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
A G+ YL + + +HRDL A N ++ +D KI DFG+ R D E + R
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-K 196
Query: 261 GTYGY-----MAPEYASDGQFSVKSDVFSFGILLLEIVS 294
G G M+PE DG F+ SDV+SFG++L EI +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-46
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ + +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 155 KLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
+LLG ++ + L I E+M SL ++ + R +L + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG------YMA 267
+HRDL A NVL+ +D K+SDFGL + + + + A
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTA 182
Query: 268 PEYASDGQFSVKSDVFSFGILLLEIVS 294
PE + +FS KSDV+SFGILL EI S
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 7e-46
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 153
+ ++ KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
V+LLG C + +I EFM +L ++ + R + ++ + + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYL--- 127
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN-----RVVGTYGYMAP 268
+ IHRDL A N L+ ++ K++DFGL+R GD + + + AP
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAP 181
Query: 269 EYASDGQFSVKSDVFSFGILLLEIVS 294
E + +FS+KSDV++FG+LL EI +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-46
Identities = 70/202 (34%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ ++LG G FG V+ G ++AVK L K E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+L Q E +I E+M N SL F+ + L +K + A G+ ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI---E 126
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY--MAPEYAS 272
IHRDL+A+N+L+ ++ KI+DFGLAR +E T R + APE +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 183
Query: 273 DGQFSVKSDVFSFGILLLEIVS 294
G F++KSDV+SFGILL EIV+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 9e-46
Identities = 68/305 (22%), Positives = 118/305 (38%), Gaps = 59/305 (19%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV-----DGQEIAVKRL-SKISEQGLKELKNEVILFSKL 148
+ LG+G FG V + G+++AVK L + + +LK E+ + L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 149 QHRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
H N+VK G C + LI EF+P+ SL ++ + ++ ++ +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG-- 264
+ YL + +HRDL A NVL++ + KI DFGL +A D+ V
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY----YTVKDDRDS 191
Query: 265 ---YMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNE 320
+ APE +F + SDV+SFG+ L E+++ + + + L +
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS------SPMALFLKMIGPTHG 245
Query: 321 GMPSQLIDSCFQDSFNLAEVIRCIHIG-----------------LLCVQQHPEDRPSMPS 363
M ++ + G C + P +R S +
Sbjct: 246 QMTVT-------------RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQN 292
Query: 364 VILML 368
+I
Sbjct: 293 LIEGF 297
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-45
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 148
F K LG G FG VYKG + E +A+K L + S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLL 208
+ ++ +LLG C+ LI + MP L ++ +E + + A+G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG---- 264
YL R++HRDL A NVL+ + KI+DFGLA+ G +E E + G
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPI 183
Query: 265 -YMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKK 297
+MA E ++ +SDV+S+G+ + E+++ G K
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-45
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 99 INKKLGQGGFGPVYKGKLVDGQE----IAVKRLSKI-SEQGLKELKNEVILFSKLQHRNL 153
++ +G+G FG VY G+ +D + A+K LS+I Q ++ E +L L H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 154 VKLLGCCIQGEE-KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
+ L+G + E ++ +M + L FI +R ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL-- 140
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG------YM 266
+ + +HRDL A N +LD+ K++DFGLAR D + V +
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLAR----DILDREYYSVQQHRHARLPVKWT 195
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVS 294
A E +F+ KSDV+SFG+LL E+++
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ + +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 155 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
+LLG ++ + L ++ E+M SL ++ + R + L + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL--- 305
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY--MAPEYA 271
+HRDL A NVL+ +D K+SDFGL + E ++ + G APE
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEAL 358
Query: 272 SDGQFSVKSDVFSFGILLLEIVS 294
+ +FS KSDV+SFGILL EI S
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYS 381
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-45
Identities = 69/202 (34%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ + KKLG G FG V+ ++AVK + K ++ E + LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
KL + E +I EFM SL F+ E K A G+ ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY--MAPEYAS 272
+ IHRDL+A+N+L+ + KI+DFGLAR +E T R + APE +
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAIN 358
Query: 273 DGQFSVKSDVFSFGILLLEIVS 294
G F++KSDV+SFGILL+EIV+
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 78/334 (23%), Positives = 129/334 (38%), Gaps = 87/334 (26%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILF 145
+ ++ K LG+G FG V + V +AVK L +E+ L +L +E+ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 146 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQERCMIL 191
+ +H+N++ LLG C Q +I E+ +L + ++ +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 192 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251
+ ARG+ YL + + IHRDL A NVL+ ++ KI+DFGLAR D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207
Query: 252 TEGNTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306
+ + T G +MAPE D ++ +SDV+SFG+L+ EI + G
Sbjct: 208 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LG------ 256
Query: 307 NLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIG-----------------LL 349
G P + E+ + + G
Sbjct: 257 --------------GSPYP--------GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 294
Query: 350 CVQQHPEDRPSMPSVILMLGSETVLPQPKQPGYL 383
C P RP+ ++ L + +L YL
Sbjct: 295 CWHAVPSQRPTFKQLVEDL--DRILTLTTNEEYL 326
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-45
Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 147
N ++ + LG G FG VY+G++ ++AVK L ++ SEQ + E ++ SK
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI----FDQERCMILDWSKRFHIICGT 203
H+N+V+ +G +Q + ++ E M L SF+ + L H+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTNRVV 260
A G YL IHRD+ A N LL KI DFG+AR D + R
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-K 201
Query: 261 GTYGY-----MAPEYASDGQFSVKSDVFSFGILLLEIVS 294
G M PE +G F+ K+D +SFG+LL EI S
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-45
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 98 SINKKLGQGGFGPVYKGKLVDG----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 152
N+ +G+G FG VY G L+D AVK L++I + + E I+ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 153 LVKLLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
++ LLG C++ E L + +M + L +FI + A+G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG------Y 265
+ + +HRDL A N +LD+ K++DFGLAR D + + V G +
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKW 262
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVS 294
MA E +F+ KSDV+SFG+LL E+++
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-45
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 149
+ I K +G G G V G+L +++ A+K L + +E+ ++ +E + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209
H N+++L G +G +++ E+M N SLD+F+ + + ++ G G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY---- 265
L S L +HRDL A NVL+D ++ K+SDFGL+R D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTT 212
Query: 266 --------MAPEYASDGQFSVKSDVFSFGILLLEIVS 294
APE + FS SDV+SFG+++ E+++
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-45
Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQE---IAVKRL-SKISEQGLKELKNEVILFSKL-Q 149
N+ +G+G FG V K ++ A+KR+ S+ ++ E+ + KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQERCMILDWSKR 196
H N++ LLG C L E+ P+ +L F L +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 197 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256
H ARG+ YL S+ + IHRDL A N+L+ ++ KI+DFGL+R G + T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 199
Query: 257 N-----RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
R +MA E + ++ SDV+S+G+LL EIVS
Sbjct: 200 MGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-45
Identities = 69/233 (29%), Positives = 106/233 (45%), Gaps = 41/233 (17%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 147
N + K LG+G FG V K +AVK L + S L++L +E + +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQERCMILDWS 194
+ H +++KL G C Q LLI E+ SL F LD
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 195 KRFHIICGT--------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246
+ G ++G+ YL + ++++HRDL A N+L+ + KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 247 FGGDETEGNTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
D E ++ + G +MA E D ++ +SDV+SFG+LL EIV+
Sbjct: 199 ---DVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-45
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQE----IAVKRLSK--ISEQGLKELKNEVILFSKL 148
N + K LG+G FG V +G L +AVK + S++ ++E +E
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 149 QHRNLVKLLGCCIQGE-----EKLLIYEFMPNKSLDSFI---FDQERCMILDWSKRFHII 200
H N+++LLG CI+ + ++I FM L +++ + + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
A G+ YL S +HRDL A N +L DM ++DFGL++ G+ R
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYR-Q 205
Query: 261 GTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
G ++A E +D ++ KSDV++FG+ + EI +
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-45
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDG----QEIAVKRLSK--ISEQGLKELKNEVILFSKL 148
F++ + LG+G FG V + +L ++AVK L I+ ++E E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 149 QHRNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIFD---QERCMILDWSKRFHI 199
H ++ KL+G ++ K ++I FM + L +F+ E L
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 259
+ A G+ YL S IHRDL A N +L +DM ++DFGL+R G+ R
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYR- 194
Query: 260 VGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
G ++A E +D ++V SDV++FG+ + EI++
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 6e-45
Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 7/201 (3%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 153
+ ++ KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
V+LLG C + +I EFM +L ++ + R + ++ + + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYL--- 334
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 273
+ IHR+L A N L+ ++ K++DFGL+R GD + + APE +
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 274 GQFSVKSDVFSFGILLLEIVS 294
+FS+KSDV++FG+LL EI +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-45
Identities = 68/219 (31%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 147
N ++ + LG G FG VY+G++ ++AVK L ++ SEQ + E ++ SK
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI----FDQERCMILDWSKRFHIICGT 203
H+N+V+ +G +Q + ++ E M L SF+ + L H+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTNRVV 260
A G YL IHRD+ A N LL KI DFG+AR D R
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-K 242
Query: 261 GTYGY-----MAPEYASDGQFSVKSDVFSFGILLLEIVS 294
G M PE +G F+ K+D +SFG+LL EI S
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-45
Identities = 69/288 (23%), Positives = 121/288 (42%), Gaps = 49/288 (17%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 153
+F + +G GGFG V+K K +DG+ +KR+ +E + + EV +KL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 154 VKLLGC---------------CIQGEEKLLIY-EFMPNKSLDSFIFDQERCMILDWSKRF 197
V GC + L I EF +L+ +I ++ R LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 198 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 257
+ +G+ Y+H ++I+RDLK SN+ L KI DFGL + + +G
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179
Query: 258 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL 317
R GT YM+PE S + + D+++ G++L E++ + + +
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSKFFTDL------ 231
Query: 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365
+I F +++ + + PEDRP+ ++
Sbjct: 232 -----RDGIISDIF--DKKEKTLLQ------KLLSKKPEDRPNTSEIL 266
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-45
Identities = 66/281 (23%), Positives = 134/281 (47%), Gaps = 39/281 (13%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 151
+ +K+G+G FG K DG++ +K +S++S + +E + EV + + ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-------FDQERCMILDWSKRFHIICGTA 204
N+V+ + ++ ++ L I F +++ ILDW F IC
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQ--ILDW---FVQIC--- 135
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
L ++H +I+HRD+K+ N+ L +D ++ DFG+AR +GT
Sbjct: 136 LALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPY 190
Query: 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324
Y++PE + ++ KSD+++ G +L E+ + K + + + NL+ K+ + P
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHA---FEAGSMKNLV---LKIISGSFPP 244
Query: 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365
+ + S++L ++ +++P DRPS+ S++
Sbjct: 245 --VSLHY--SYDLRSLVS------QLFKRNPRDRPSVNSIL 275
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-44
Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 33/225 (14%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 147
+ ++LG+ FG VYKG L Q +A+K L +E ++E +L ++
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQERCMILDWS 194
LQH N+V LLG + + +I+ + + L F D+ L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 195 KRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254
H++ A G+ YL S ++H+DL NVL+ +N KISD GL R +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAA 181
Query: 255 NTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+ + + +MAPE G+FS+ SD++S+G++L E+ S
Sbjct: 182 DYYK-LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 83 PLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQE-----IAVKRL-SKISEQGLK 136
+ LA I T K LG G FG V+KG + E + +K + K Q +
Sbjct: 2 AMKVLARIFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 60
Query: 137 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCM----ILD 192
+ + ++ L H ++V+LLG C L+ +++P SL + + +L+
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 193 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252
W A+G+ YL ++HR+L A NVLL +++DFG+A D+
Sbjct: 120 WG------VQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170
Query: 253 EGNTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+ ++ + +MA E G+++ +SDV+S+G+ + E+++
Sbjct: 171 Q-----LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-44
Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 41/233 (17%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 147
NN + +G+G FG V++ + +AVK L + S + + E L ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF---------------------IFDQE 186
+ N+VKLLG C G+ L++E+M L+ F
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 187 RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246
L +++ I A G+ YL S + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR- 222
Query: 247 FGGDETEGNTNRVVGTYGY-----MAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+ + + M PE +++ +SDV+++G++L EI S
Sbjct: 223 ---NIYSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 36/228 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVD--------GQEIAVKRL-SKISEQGLKELKNEVILF 145
+ ++ K LG+G FG V + V +AVK L +E+ L +L +E+ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 146 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQERCMIL 191
+ +H+N++ LLG C Q +I E+ +L + ++ +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 192 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251
+ ARG+ YL + + IHRDL A NVL+ ++ KI+DFGLAR D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 253
Query: 252 TEGNTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+ + T G +MAPE D ++ +SDV+SFG+L+ EI +
Sbjct: 254 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-44
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 148
+ + K +G G FG VYKG L +A+K L +E+ + E + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLL 208
H N+++L G + + ++I E+M N +LD F+ +E+ + ++ G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY--M 266
YL + + +HRDL A N+L++ ++ K+SDFGL+R D+ E G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWT 217
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVS 294
APE S +F+ SDV+SFGI++ E+++
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-44
Identities = 66/211 (31%), Positives = 110/211 (52%), Gaps = 21/211 (9%)
Query: 95 NNFSINKKLGQGGFGPVYKG--KLVDGQEI--AVKRLSK-ISEQGLKELKNEVILFSKLQ 149
N SI+K +G G FG V G KL +EI A+K L +E+ ++ E + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209
H N+++L G + + +++ E+M N SLDSF+ ++ + ++ G A G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG----- 264
L S + +HRDL A N+L++ ++ K+SDFGL R D T G
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA-----AYTTRGGKIPI 214
Query: 265 -YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+ +PE + +F+ SDV+S+GI+L E++S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-44
Identities = 74/224 (33%), Positives = 101/224 (45%), Gaps = 32/224 (14%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 147
NN K LG G FG V + + +AVK L S + L +E+ + S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 148 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKR---------- 196
L QH N+V LLG C G L+I E+ L +F+ + R + D +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 197 -FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255
H A+G+ +L + IHRD+ A NVLL KI DFGLAR D +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDS 218
Query: 256 TNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
V +MAPE D ++V+SDV+S+GILL EI S
Sbjct: 219 NYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 7e-44
Identities = 65/229 (28%), Positives = 92/229 (40%), Gaps = 38/229 (16%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQE------IAVKRLSKI-SEQGLKELKNEVILFSK 147
N S K LG G FG V + + +AVK L + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 148 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF------IFDQERCMILDWSKRFHII 200
L H N+V LLG C G L+I E+ L +F F + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 201 CGT---------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGD 250
A+G+ +L + IHRDL A N+LL KI DFGLAR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 251 ETEGNTN-----RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
N + +MAPE + ++ +SDV+S+GI L E+ S
Sbjct: 200 NYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-43
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 35/227 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 147
+ + K LG+G FG V + + +AVK L + + L +E+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 148 L-QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGT-- 203
+ H N+V LLG C + L +I EF +L +++ + + +
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 204 -----------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252
A+G+ +L + + IHRDL A N+LL + KI DFGLAR D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIY 199
Query: 253 EGNTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+ +MAPE D ++++SDV+SFG+LL EI S
Sbjct: 200 KDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-43
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQE-----IAVKRL-SKISEQGLKELKNEVILFSKL 148
F K LG G FG VYKG + E +A+K L S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLL 208
+ ++ +LLG C+ LI + MP L ++ +E + + A+G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG---- 264
YL R++HRDL A NVL+ + KI+DFGLA+ G +E E + G
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPI 183
Query: 265 -YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+MA E ++ +SDV+S+G+ + E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-43
Identities = 61/270 (22%), Positives = 118/270 (43%), Gaps = 31/270 (11%)
Query: 99 INKKLGQGGFGPVYKGK-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVK 155
+ ++G+G F VYKG E+A + K+++ + K E + LQH N+V+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 156 LLGCCI---QGEEKLLIY-EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
+G++ +++ E M + +L +++ +R ++ +GL +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 212 QDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
+ IIHRDLK N+ + + KI D GLA + V+GT +MAPE
Sbjct: 147 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM 201
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330
+ + DV++FG+ +LE+ + + + + ++ G+ D
Sbjct: 202 YEEK-YDESVDVYAFGMCMLEMATSE------YPYSECQNAAQIYRRVTSGVKPASFDKV 254
Query: 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
+ E+I C++Q+ ++R S
Sbjct: 255 A--IPEVKEIIE------GCIRQNKDERYS 276
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 26/276 (9%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ + KLGQG FG V+ G +A+K L K + E + KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+L + E ++ E+M SL F+ + L + + A G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV---E 380
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
R+ +HRDL+A+N+L+ +++ K++DFGLAR +E + APE A G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 275 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG--MPSQLIDSCFQ 332
+F++KSDV+SFGILL E+ + K R Y N ++ G MP C +
Sbjct: 440 RFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQV----ERGYRMPCP--PECPE 491
Query: 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+L C ++ PE+RP+ + L
Sbjct: 492 SLHDLM---------CQCWRKEPEERPTFEYLQAFL 518
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 38/229 (16%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILF 145
+ + K LG+G FG V + + ++AVK L +E+ L +L +E+ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 146 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGT- 203
+ +H+N++ LLG C Q +I E+ +L ++ R L++S
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQ 187
Query: 204 -------------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250
ARG+ YL + + IHRDL A NVL+ +D KI+DFGLAR D
Sbjct: 188 LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----D 240
Query: 251 ETEGNTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+ + T G +MAPE D ++ +SDV+SFG+LL EI +
Sbjct: 241 IHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-43
Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 38/222 (17%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVD--------GQEIAVKRLSKISEQGLKELKNEVILFS 146
+ N+ LGQG F ++KG + E+ +K L K + + S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 147 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
KL H++LV G C+ G+E +L+ EF+ SLD+++ ++ ++ + + A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNP--------KISDFGLARAFGGDETEGNTNR 258
+ +L +IH ++ A N+LL ++ + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 259 VVGTYGY-----MAPEYASDG-QFSVKSDVFSFGILLLEIVS 294
+ PE + ++ +D +SFG L EI S
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-43
Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 41/233 (17%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 147
N K LG G FG V + +AVK L K + L +E+ + ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 148 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-----------IFDQERCMILDWSK 195
L H N+V LLG C LI+E+ L ++ + E L+ +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 196 RFHIICGT---------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246
+++ A+G+ +L +HRDL A NVL+ KI DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR- 220
Query: 247 FGGDETEGNTNRVVGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
D + V +MAPE +G +++KSDV+S+GILL EI S
Sbjct: 221 ---DIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-43
Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 26/276 (9%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ + KLGQG FG V+ G +A+K L K + E + KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+L + E ++ E+M SL F+ + L + + A G+ Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV---E 297
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
R+ +HRDL+A+N+L+ +++ K++DFGLAR +E + APE A G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 275 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG--MPSQLIDSCFQ 332
+F++KSDV+SFGILL E+ + K R Y N ++ G MP C +
Sbjct: 357 RFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQV----ERGYRMPCP--PECPE 408
Query: 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+L C ++ PE+RP+ + L
Sbjct: 409 SLHDLM---------CQCWRKEPEERPTFEYLQAFL 435
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-43
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 45/295 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 152
+F + LG+GGFG V++ K VD A+KR+ E +++ EV +KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 153 LVKLLGCCI---------QGEEKLLIY---EFMPNKSLDSFIFDQERCMILDWSKRFHII 200
+V+ + K+ +Y + ++L ++ + + S HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV- 259
A + +LH ++HRDLK SN+ D K+ DFGL A DE E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 260 ---------VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNL 310
VGT YM+PE +S K D+FS G++L E++ F +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFSTQMERVRT 236
Query: 311 IGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365
L + +++ + P +RP ++I
Sbjct: 237 ----LTDVRNLKFPPLFTQKYPC---EYVMVQ------DMLSPSPMERPEAINII 278
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-43
Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 39/279 (13%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQH 150
NF I KK+G+G F VY+ L+DG +A+K++ + + + E+ L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 151 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQERC-------MILDWSKRFHIICG 202
N++K I+ + +L I E L I ++ + + F +C
Sbjct: 92 PNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY---FVQLC- 146
Query: 203 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 262
L ++H R++HRD+K +NV + K+ D GL R F T ++ +VGT
Sbjct: 147 --SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
Query: 263 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNL-NLIGHAWKLWNEG 321
YM+PE + ++ KSD++S G LL E+ + + FY NL +L K +
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNLYSLC----KKIEQC 253
Query: 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
L + S L +++ +C+ PE RP
Sbjct: 254 DYPPLPSDHY--SEELRQLVN------MCINPDPEKRPD 284
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-42
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV--DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKLQ 149
+ + +G+G FG V++G + + + A+K S+ ++ E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209
H ++VKL+G + +I E L SF+ Q R LD + + L Y
Sbjct: 75 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG----- 264
L R +HRD+ A NVL+ + K+ DFGL+R + G
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIK 182
Query: 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+MAPE + +F+ SDV+ FG+ + EI+
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-42
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV--DGQEI--AVKRLSKI-SEQGLKELKNEVILFSKLQ 149
+ +N+ LG+G FG VY+G G++I AVK K + ++ +E ++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209
H ++VKL+G + E +I E P L ++ + L + + Y
Sbjct: 72 HPHIVKLIGII-EEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYM 266
L + +HRD+ N+L+ K+ DFGL+R ++ + T +M
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY----KASVTRLPIKWM 181
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVS 294
+PE + +F+ SDV+ F + + EI+S
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 99 INKKLGQGGFGPVYKGKLVDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLV 154
+ +LG G FG V +G ++ +A+K L + + +E+ E + +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+L+G C Q E +L+ E L F+ + + S ++ + G+ YL
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY--------- 265
+HRDL A NVLL KISDFGL++A G D++ Y
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-----------YTARSAGKWP 176
Query: 266 ---MAPEYASDGQFSVKSDVFSFGILLLEIVS 294
APE + +FS +SDV+S+G+ + E +S
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-42
Identities = 59/214 (27%), Positives = 88/214 (41%), Gaps = 26/214 (12%)
Query: 95 NNFSINKKLGQGGFGPVYKG--KLVDGQEI--AVKRL---SKISEQGLKELKNEVILFSK 147
+ + +KLG G FG V +G G+ + AVK L + + + EV
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQER----CMILDWSKRFHIICGT 203
L HRNL++L G + ++ E P SL + + + ++
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA------VQV 130
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT- 262
A G+ YL R IHRDL A N+LL KI DFGL RA ++
Sbjct: 131 AEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRK 185
Query: 263 --YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+ + APE FS SD + FG+ L E+ +
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-42
Identities = 73/288 (25%), Positives = 117/288 (40%), Gaps = 38/288 (13%)
Query: 92 SATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKL 148
S ++ + +G G +G K + DG+ + K ++E + L +EV L +L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 149 QHRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQERC-------MILDWSKRFHI 199
+H N+V+ I L + E+ L S I + +L
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV---MTQ 119
Query: 200 ICGTARGLLYLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 257
+ L H+ D ++HRDLK +NV LD N K+ DFGLAR D + T
Sbjct: 120 LT---LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT- 175
Query: 258 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL 317
VGT YM+PE + ++ KSD++S G LL E+ + F + + L G K+
Sbjct: 176 -FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM--PPFT-AFSQKELAG---KI 228
Query: 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365
I + S L E+I + RPS+ ++
Sbjct: 229 REGKFRR--IPYRY--SDELNEIIT------RMLNLKDYHRPSVEEIL 266
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-42
Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 100 NKKLGQGGFGPVYKGKL-VDGQEI--AVKRLSK--ISEQGLKELKNEVILFSKLQHRNLV 154
+K+LG G FG V KG + AVK L EL E + +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+++G C + E +L+ E L+ ++ + ++ + G+ YL
Sbjct: 82 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL---E 134
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG------YMAP 268
+HRDL A NVLL KISDFGL++A DE + AP
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAP 189
Query: 269 EYASDGQFSVKSDVFSFGILLLEIVS 294
E + +FS KSDV+SFG+L+ E S
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-41
Identities = 72/283 (25%), Positives = 121/283 (42%), Gaps = 37/283 (13%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 152
+SI K++G GG V++ Q A+K L + Q L +NE+ +KLQ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 153 L--VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
++L ++ + + N L+S++ ++ +D +R + +
Sbjct: 116 DKIIRLYDY-EITDQYIYMVMECGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTI 171
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE- 269
HQ I+H DLK +N L+ D K+ DFG+A D T + VG YM PE
Sbjct: 172 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 270 ----------YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN 319
S + S KSDV+S G +L + GK F N ++ KL
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQIS------KLHA 279
Query: 320 EGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMP 362
P+ I+ +L +V++C C+++ P+ R S+P
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIP 316
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-41
Identities = 75/283 (26%), Positives = 123/283 (43%), Gaps = 37/283 (13%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 152
+SI K++G GG V++ Q A+K L + Q L +NE+ +KLQ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 153 L--VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
++L I + ++ E N L+S++ ++ +D +R + +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTI 143
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE- 269
HQ I+H DLK +N L+ D K+ DFG+A D T + VGT YM PE
Sbjct: 144 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 270 ----------YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN 319
S + S KSDV+S G +L + GK F N ++ KL
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS------KLHA 251
Query: 320 EGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMP 362
P+ I+ +L +V++C C+++ P+ R S+P
Sbjct: 252 IIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIP 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 72/301 (23%), Positives = 119/301 (39%), Gaps = 62/301 (20%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 152
++F LGQG FG V K + +D + A+K++ +E+ L + +EV+L + L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 153 LVKLLGC----------CIQGEEKLLIY---EFMPNKSLDSFIFDQ----ERCMILDWSK 195
+V+ ++K ++ E+ N +L I + +R
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL-- 121
Query: 196 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF-------- 247
F I L Y+H IIHRDLK N+ +D+ N KI DFGLA+
Sbjct: 122 -FRQIL---EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 248 ----GGDETEGNTNRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 302
+ N +GT Y+A E G ++ K D++S GI+ E++ F
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-----PFS 229
Query: 303 HSDNNLNLIGHAWKLWNEG---MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRP 359
+N+ K P D+ + ++IR L + P RP
Sbjct: 230 TGMERVNI----LKKLRSVSIEFPPDFDDNKMKV---EKKIIR------LLIDHDPNKRP 276
Query: 360 S 360
Sbjct: 277 G 277
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 66/318 (20%), Positives = 118/318 (37%), Gaps = 54/318 (16%)
Query: 89 TIVSATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSK 147
++ ++ +KLG+GGF V + L DG A+KR+ +Q +E + E +
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82
Query: 148 LQHRNLVKLLGCCIQ----GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF------ 197
H N+++L+ C++ E L+ F +L + I + D
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI--ERL---KDKGNFLTEDQIL 137
Query: 198 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 257
++ G RGL +H HRDLK +N+LL + P + D G
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 258 RVV-------GTYGYMAPE------YASDGQFSVKSDVFSFGILLLEIVSGKK--NRGFY 302
+ T Y APE + + ++DV+S G +L ++ G+ + F
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQ 251
Query: 303 HSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMP 362
D+ + + + P S L +++ + P RP +P
Sbjct: 252 KGDSVALAVQNQLSI-----P---QSPRH--SSALWQLLNS------MMTVDPHQRPHIP 295
Query: 363 SVILMLGSETVLPQPKQP 380
++ L P P Q
Sbjct: 296 LLLSQL-EALQPPAPGQH 312
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-40
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 99 INKKLGQGGFGPVYKGKL-VDGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQHRNLV 154
+ +LG G FG V +G + ++I A+K L + +E+ E + +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+L+G C Q E +L+ E L F+ + + S ++ + G+ YL
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT---YGYMAPEYA 271
+HR+L A NVLL KISDFGL++A G D++ + APE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECI 511
Query: 272 SDGQFSVKSDVFSFGILLLEIVS 294
+ +FS +SDV+S+G+ + E +S
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 37/283 (13%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRN 152
+SI K++G GG V++ Q A+K ++ Q L +NE+ +KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 153 L--VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
++L ++ + + N L+S++ ++ +D +R + +
Sbjct: 69 DKIIRLYDY-EITDQYIYMVMECGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTI 124
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE- 269
HQ I+H DLK +N L+ D K+ DFG+A D T + VGT YM PE
Sbjct: 125 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 270 ----------YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN 319
S + S KSDV+S G +L + GK F N ++ KL
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS------KLHA 232
Query: 320 EGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMP 362
P+ I+ +L +V++C C+++ P+ R S+P
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIP 269
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-40
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 95 NNFSINKKLGQGGFGPVYKG--KLVDGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 149
+ + +G+G FG V++G + + A+K + S+ ++ E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209
H ++VKL+G + +I E L SF+ Q R LD + + L Y
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 269
L R +HRD+ A NVL+ + K+ DFGL+R + + +MAPE
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 562
Query: 270 YASDGQFSVKSDVFSFGILLLEIVS 294
+ +F+ SDV+ FG+ + EI+
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILM 587
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-39
Identities = 64/270 (23%), Positives = 101/270 (37%), Gaps = 34/270 (12%)
Query: 96 NFSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QHR 151
+F +LG G +G V+K DG+ AVKR + EV K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 152 NLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
V+L + L + E SL + L ++ + + T L +L
Sbjct: 118 CCVRLEQA-WEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
H ++H D+K +N+ L K+ DFGL G T G G YMAPE
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPE- 226
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330
G + +DVFS G+ +LE+ + H +L +P +
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNME---LPHGGEGWQ------QLRQGYLPPEFTAGL 277
Query: 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
S L V+ + ++ P+ R +
Sbjct: 278 ---SSELRSVLV------MMLEPDPKLRAT 298
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 159
LG+G +G VY G+ L + IA+K + + + + L E+ L L+H+N+V+ LG
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 160 CIQGEEKLLIY-EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRI 218
+ I+ E +P SL + + + + + GL YLH + +I
Sbjct: 88 F-SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 219 IHRDLKASNVLLDQDM-NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE--YASDGQ 275
+HRD+K NVL++ KISDFG ++ G T GT YMAPE
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRG 201
Query: 276 FSVKSDVFSFGILLLEIVSGK 296
+ +D++S G ++E+ +GK
Sbjct: 202 YGKAADIWSLGCTIIEMATGK 222
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-38
Identities = 62/220 (28%), Positives = 121/220 (55%), Gaps = 19/220 (8%)
Query: 84 LFELATIVSATN---NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELK 139
L +L +IVS + ++ +K+GQG G VY + GQE+A+++++ + + +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 140 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHI 199
NE+++ + ++ N+V L + G+E ++ E++ SL + E CM I
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCM-----DEGQI 118
Query: 200 --IC-GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256
+C + L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 257 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
+VGT +MAPE + + K D++S GI+ +E++ G+
Sbjct: 176 --MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 19/218 (8%)
Query: 86 ELATIVSATN---NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNE 141
+L F + +KLG+G +G VYK GQ +A+K++ E L+E+ E
Sbjct: 17 KLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKE 74
Query: 142 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHI-- 199
+ + + ++VK G + + ++ E+ S+ I + + + I
Sbjct: 75 ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL-----TEDEIAT 129
Query: 200 IC-GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
I T +GL YLH R IHRD+KA N+LL+ + + K++DFG+A +T N
Sbjct: 130 ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNT 184
Query: 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
V+GT +MAPE + ++ +D++S GI +E+ GK
Sbjct: 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-37
Identities = 72/284 (25%), Positives = 122/284 (42%), Gaps = 48/284 (16%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 151
++ +LG+G +G V K + V GQ +AVKR+ + ++ Q K L ++ I +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF------HIICGTAR 205
V G + + + E M + SLD F ++D + I +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQ-----VIDKGQTIPEDILGKIAVSIVK 120
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
L +LH S+L +IHRD+K SNVL++ K+ DFG++ G + + G Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGCKPY 175
Query: 266 MAPE----YASDGQFSVKSDVFSFGILLLEIVSGKKNRGF-YHSDNN----LNLIGHAWK 316
MAPE + +SVKSD++S GI ++E+ + F Y S L +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR----FPYDSWGTPFQQLKQVVE--- 228
Query: 317 LWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
QL F F + C++++ ++RP+
Sbjct: 229 ----EPSPQLPADKFSAEFV--DFTSQ------CLKKNSKERPT 260
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 19/218 (8%)
Query: 86 ELATIVSATN---NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNE 141
L +V + K+G+G G V + G+++AVK + +Q + L NE
Sbjct: 33 ALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNE 92
Query: 142 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHI-- 199
V++ QH N+V++ + GEE ++ EF+ +L + + + I
Sbjct: 93 VVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRL-----NEEQIAT 145
Query: 200 IC-GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
+C + L YLH +IHRD+K+ ++LL D K+SDFG D + +
Sbjct: 146 VCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-- 200
Query: 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
+VGT +MAPE S ++ + D++S GI+++E+V G+
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-36
Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 86 ELATIVSATN---NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNE 141
E + + + I +LG G FG VYK K G A K + SE+ L++ E
Sbjct: 7 EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVE 66
Query: 142 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHI-- 199
+ + + H +VKLLG + ++ EF P ++D+ + + +R + I
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL-----TEPQIQV 121
Query: 200 IC-GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
+C L +LH RIIHRDLKA NVL+ + + +++DFG++ +T +
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDS 176
Query: 259 VVGTYGYMAPE-----YASDGQFSVKSDVFSFGILLLEIVSGK 296
+GT +MAPE D + K+D++S GI L+E+ +
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLL 157
++G+G FG V++ K G + AVK RL + E++ + L +V L
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLY 116
Query: 158 GCCIQGEEKLLIY-EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRL 216
G +G + I+ E + SL I ++ L + + + GL YLH
Sbjct: 117 GAVREG-PWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR--- 169
Query: 217 RIIHRDLKASNVLLDQDMNP-KISDFGLAR---AFGGDETEGNTNRVVGTYGYMAPEYAS 272
RI+H D+KA NVLL D + + DFG A G ++ + + GT +MAPE
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 273 DGQFSVKSDVFSFGILLLEIVSGK 296
K D++S ++L +++G
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-36
Identities = 62/238 (26%), Positives = 106/238 (44%), Gaps = 24/238 (10%)
Query: 68 EKTENDQIQNIDLELPLFELATIVSATNN-FSINKKLGQGGFGPVYKGKLV-DGQEIAVK 125
E+ E D+ Q LE L + + ++ F +LG G G V+K G +A K
Sbjct: 5 EELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64
Query: 126 RLS-KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD 184
+ +I ++ E+ + + +V G E + E M SLD
Sbjct: 65 LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ---- 120
Query: 185 QERCMILDWSKRF------HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 238
+L + R + +GL YL + +I+HRD+K SN+L++ K+
Sbjct: 121 -----VLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKL 173
Query: 239 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
DFG++ ++ N+ VGT YM+PE +SV+SD++S G+ L+E+ G+
Sbjct: 174 CDFGVSGQL--IDSMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 50/222 (22%), Positives = 91/222 (40%), Gaps = 24/222 (10%)
Query: 92 SATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 149
++ + + ++ LGQG V++G+ G A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 150 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
H+N+VKL + EF P SL + + + L S+ ++ G
Sbjct: 66 HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 207 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTNRVVGT 262
+ +L + I+HR++K N++ D K++DFG AR DE + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGT 178
Query: 263 YGYMAPE--------YASDGQFSVKSDVFSFGILLLEIVSGK 296
Y+ P+ ++ D++S G+ +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 62/293 (21%), Positives = 107/293 (36%), Gaps = 55/293 (18%)
Query: 94 TNNFSINKKLGQGGFGPVYKG-KLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKL-Q 149
T F +K+G G FG V+K K +DG A+KR + EV + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 150 HRNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQERCM-ILDWSKRFHIICGTARGL 207
H ++V+ + + +LI E+ SL I + R M ++ ++ RGL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNP-------------------KISDFGLARAFG 248
Y+H ++H D+K SN+ + + P KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 249 GDETEGNTNRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN 307
+ E G ++A E + K+D+F+ + ++ + N
Sbjct: 186 SPQVE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE------PLPRN 233
Query: 308 LNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
G W +G ++ S E+++ + + PE RPS
Sbjct: 234 ----GDQWHEIRQGRLPRIPQVL---SQEFTELLK------VMIHPDPERRPS 273
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-34
Identities = 50/222 (22%), Positives = 91/222 (40%), Gaps = 24/222 (10%)
Query: 92 SATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 149
++ + + ++ LGQG V++G+ G A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 150 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
H+N+VKL + EF P SL + + + L S+ ++ G
Sbjct: 66 HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 207 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTNRVVGT 262
+ +L + I+HR++K N++ D K++DFG AR DE + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGT 178
Query: 263 YGYMAPE--------YASDGQFSVKSDVFSFGILLLEIVSGK 296
Y+ P+ ++ D++S G+ +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLV 154
+F LG G G + + D +++AVKR+ + EV L + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 155 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
+ C + + + E +L ++ +++ + ++ T GL +LH
Sbjct: 82 RYF-CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 214 SRLRIIHRDLKASNVLL-----DQDMNPKISDFGLARAFGGDETE-GNTNRVVGTYGYMA 267
L I+HRDLK N+L+ + ISDFGL + + V GT G++A
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 268 PEY---ASDGQFSVKSDVFSFGILLLEIVSG 295
PE + D+FS G + ++S
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 151
+ ++G+G +G V K GQ +AVKR+ S + E+ K+L ++ ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF------HIICGTAR 205
+V+ G + + + E M + S D F + + I T +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
L +L L+IIHRD+K SN+LLD+ N K+ DFG++ ++ T G Y
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTR-DAGCRPY 191
Query: 266 MAPE----YASDGQFSVKSDVFSFGILLLEIVSGK 296
MAPE AS + V+SDV+S GI L E+ +G+
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-34
Identities = 61/209 (29%), Positives = 114/209 (54%), Gaps = 17/209 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 150
+F + LG+G F VY+ + + G E+A+K + K + + G+ + ++NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRF--HIICGTARGL 207
++++L + + L+ E N ++ ++ ++ + + ++ F II G +
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG----M 125
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
LYLH I+HRDL SN+LL ++MN KI+DFGLA + T + GT Y++
Sbjct: 126 LYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYIS 180
Query: 268 PEYASDGQFSVKSDVFSFGILLLEIVSGK 296
PE A+ ++SDV+S G + ++ G+
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 59/202 (29%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 97 FSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 154
F+ +K+G+G FG V+KG + +A+K + + +E +++++ E+ + S+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
K G ++ + +I E++ S D LD ++ I+ +GL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE- 138
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
+ IHRD+KA+NVLL + K++DFG+A +T+ N VGT +MAPE
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 194
Query: 275 QFSVKSDVFSFGILLLEIVSGK 296
+ K+D++S GI +E+ G+
Sbjct: 195 AYDSKADIWSLGITAIELARGE 216
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-34
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHR 151
+ + LG+GGF ++ D + A K + K + + +E + E+ + L H+
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 152 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRF--HIICGTARGLL 208
++V G + + + ++ E +SL + + + ++ + I+ G
Sbjct: 102 HVVGFHGF-FEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLG----CQ 155
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 268
YLH+ R+IHRDLK N+ L++D+ KI DFGLA D + GT Y+AP
Sbjct: 156 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAP 210
Query: 269 EYASDGQFSVKSDVFSFGILLLEIVSGK 296
E S S + DV+S G ++ ++ GK
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHR 151
+ + LG+GGF ++ D + A K + K + + +E + E+ + L H+
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 152 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRF--HIICGTARGLL 208
++V G + + + ++ E +SL + + + ++ + I+ G
Sbjct: 76 HVVGFHGF-FEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLG----CQ 129
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 268
YLH R R+IHRDLK N+ L++D+ KI DFGLA D + GT Y+AP
Sbjct: 130 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAP 184
Query: 269 EYASDGQFSVKSDVFSFGILLLEIVSGK 296
E S S + DV+S G ++ ++ GK
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 72/336 (21%), Positives = 118/336 (35%), Gaps = 46/336 (13%)
Query: 89 TIVSATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSK 147
T+ + + L +GGF VY+ + + G+E A+KRL E+ + + EV K
Sbjct: 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKK 81
Query: 148 LQ-HRNLVKLLGCCI-------QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHI 199
L H N+V+ G+ + L+ + L F+ E L I
Sbjct: 82 LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR- 258
T R + ++H+ + IIHRDLK N+LL K+ DFG A + +
Sbjct: 142 FYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 259 ---------VVGTYGYMAPE---YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306
T Y PE S+ K D+++ G +L + + F D
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--FE--DG 256
Query: 307 NLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI- 365
I + +P +IR +Q +PE+R S+ V+
Sbjct: 257 AKLRIVNG----KYSIPPHD-----TQYTVFHSLIRA------MLQVNPEERLSIAEVVH 301
Query: 366 ---LMLGSETVLPQPKQPGYLADRKSTRRDYSSIMP 398
+ + V P+ L S P
Sbjct: 302 QLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 34/227 (14%)
Query: 86 ELATIVSATN---NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLS---KISEQGLKEL 138
++A + + FS +++G G FG VY + + + + +A+K++S K S + +++
Sbjct: 42 DVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 101
Query: 139 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFH 198
EV KL+H N ++ GC ++ L+ E+ + D ++ K
Sbjct: 102 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD---------LLEVHKKPLQ 152
Query: 199 -----IIC-GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252
+ G +GL YLH +IHRD+KA N+LL + K+ DFG A
Sbjct: 153 EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMA 205
Query: 253 EGNTNRVVGTYGYMAPE---YASDGQFSVKSDVFSFGILLLEIVSGK 296
N+ VGT +MAPE +GQ+ K DV+S GI +E+ K
Sbjct: 206 PANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 153
+ + ++LG GGFG V + G+++A+K+ + +E E+ + KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 154 VKLLGCCIQGEEKL-------LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
V G +KL L E+ L ++ E C L ++ +
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
L YLH+ RIIHRDLK N++L Q + KI D G A+ E VGT
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTL 187
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
Y+APE +++V D +SFG L E ++G
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 60/279 (21%), Positives = 110/279 (39%), Gaps = 39/279 (13%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 151
N+ ++G G G V+K + G IAVK++ +++ K + ++ ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
+V+ G I + + E M + + + + + L YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILG--KMTVAIVKALYYLK 141
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-- 269
+ +IHRD+K SN+LLD+ K+ DFG++ G + +R G YMAPE
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERI 196
Query: 270 ---YASDGQFSVKSDVFSFGILLLEIVSGKKNRGF-YHSDNN----LNLIGHAWKLWNEG 321
+ + +++DV+S GI L+E+ +G+ F Y + L + E
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQ----FPYKNCKTDFEVLTKVLQ------EE 246
Query: 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
P F F ++ C+ + RP
Sbjct: 247 PPLLPGHMGFSGDFQ--SFVKD------CLTKDHRKRPK 277
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 150
+F I + LG+G FG VY + +A+K L K + + G++ L+ EV + S L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209
N+++L G ++ LI E+ P ++ + + D + I A L Y
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSY 124
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV-GTYGYMAP 268
H R+IHRD+K N+LL KI+DFG + + + GT Y+ P
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRTDLCGTLDYLPP 176
Query: 269 EYASDGQFSVKSDVFSFGILLLEIVSGK 296
E K D++S G+L E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 20/213 (9%)
Query: 97 FSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLV 154
F + + +G G +G VYKG+ + GQ A+K + ++ +E+K E+ + K HRN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 155 KLLGCCIQG-----EEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLL 208
G I+ +++L L+ EF S+ + + L +I RGL
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLS 143
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 268
+LHQ ++IHRD+K NVLL ++ K+ DFG++ D T G N +GT +MAP
Sbjct: 144 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAP 198
Query: 269 E-----YASDGQFSVKSDVFSFGILLLEIVSGK 296
E D + KSD++S GI +E+ G
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-32
Identities = 76/302 (25%), Positives = 136/302 (45%), Gaps = 34/302 (11%)
Query: 99 INKKLGQGGFGPVYKGK-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHRNLV 154
I KLG GG VY + + ++A+K + + E+ LK + EV S+L H+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 155 KLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
++ EE Y E++ +L +I L + G+ + H
Sbjct: 75 SMID---VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH 128
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
+RI+HRD+K N+L+D + KI DFG+A+A + + TN V+GT Y +PE A
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQA 184
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331
+D++S GI+L E++ G+ ++ + +++ A K + +P+ D
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPP---FNGETAVSI---AIKHIQDSVPNVTTDVRK 238
Query: 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS-ETVL--PQPKQPGYLADRKS 388
+L+ VI L ++ +R ++ M +VL + + Y D+
Sbjct: 239 DIPQSLSNVI------LRATEKDKANRY--KTIQEMKDDLSSVLHENRANEDVYELDKMK 290
Query: 389 TR 390
T
Sbjct: 291 TI 292
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 60/332 (18%), Positives = 113/332 (34%), Gaps = 84/332 (25%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 152
+F + +G+GGFG V++ K VD A+KR+ E +++ EV +KL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 153 LVKLLGCCIQGE--------EKLLIYEFMPNKSLDSFIFDQERCMILDWSK-------RF 197
+V+ ++ +++ + + + L S + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 198 HIICGTARGLLYL------HQDSRLRI--------------------------------- 218
+ + + LY+ ++ + +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 219 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN----------RVVGTYGYMAP 268
+HRDLK SN+ D K+ DFGL A DE E VGT YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 269 EYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328
E +S K D+FS G++L E++ + ++ + +
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFS------TQMERV------RIITDVRNLKFPL 293
Query: 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360
Q +++ + P +RP
Sbjct: 294 LFTQKYPQEHMMVQ------DMLSPSPTERPE 319
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 45/218 (20%), Positives = 80/218 (36%), Gaps = 22/218 (10%)
Query: 94 TNNFSINKKLGQG--GFGPVYKGK-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKL 148
+ + +G+G V + G+ + V+R L S + + L+ E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHI--IC-GTAR 205
H N+V I E ++ FM S I +D I I G +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI----CTHFMDGMNELAIAYILQGVLK 139
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-----NRVV 260
L Y+H +HR +KAS++L+ D +S + V
Sbjct: 140 ALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 261 GTYGYMAPE--YASDGQFSVKSDVFSFGILLLEIVSGK 296
+++PE + + KSD++S GI E+ +G
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 52/228 (22%), Positives = 99/228 (43%), Gaps = 35/228 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSK-----------------ISEQGLKE 137
N++ I + L QG F + + D + A+K+ K + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 138 LKNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKR 196
KNE+ + + +++ + G I +++ +IYE+M N S+ F + +++
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFV-LDKNYTCF 147
Query: 197 F------HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250
II Y+H + I HRD+K SN+L+D++ K+SDFG +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--- 202
Query: 251 ETEGNTNRVVGTYGYMAPE-YASDGQFS-VKSDVFSFGILLLEIVSGK 296
+ GTY +M PE ++++ ++ K D++S GI L +
Sbjct: 203 -VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 40/346 (11%), Positives = 79/346 (22%), Gaps = 51/346 (14%)
Query: 54 IAGYLIRKRRRNIAEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYK 113
+ GY + + A E + + + + L G V+
Sbjct: 21 LIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFL 80
Query: 114 GKLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCC--------- 160
+ V+ ++ A+K + S L+ L ++L + +
Sbjct: 81 VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140
Query: 161 -IQGEEK----------------LLIYEFMP---NKSLDSFIFDQERCMILDWSKRFHII 200
+Q + LL+ + F +
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
R L ++H N+ + D + D G
Sbjct: 201 AQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA-----SS 252
Query: 261 GTYGYMAPEY--ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318
Y E+ AS F+ + + G+ + + F + L
Sbjct: 253 VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF--LPFGLVTPGIKGSWKRPSLR 310
Query: 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSV 364
G S SC + +I L R
Sbjct: 311 VPGTDSLAFGSCTPLPDFVKTLIG----RFLNF--DRRRRLLPLEA 350
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 152
+++ + + +G G V +++A+KR++ + + + EL E+ S+ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSL-----DSFIFDQERCMILDWSKRFHIICGTARGL 207
+V + +E L+ + + S+ + + +LD S I+ GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL-ARAFGGDETEGNTNR--VVGTYG 264
YLH++ IHRD+KA N+LL +D + +I+DFG+ A G + N R VGT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 265 YMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 296
+MAPE + K+D++SFGI +E+ +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 36/229 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNL 153
N K LG G G V G+ +AVKR+ E+ +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 154 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFI----FDQERCMILDWSKRFHIICGTARGLL 208
++ C + L + E N +L + E + ++ A G+
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 209 YLHQDSRLRIIHRDLKASNVLLD-------------QDMNPKISDFGLARAFGGDET--E 253
+LH L+IIHRDLK N+L+ +++ ISDFGL + ++
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 254 GNTNRVVGTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSG 295
N N GT G+ APE + + + D+FS G + I+S
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 34/257 (13%), Positives = 73/257 (28%), Gaps = 25/257 (9%)
Query: 94 TNNFSINKKLGQGGFGPVYKGKLVD------GQEIAVKRLSKISEQGLKELKNEVILFSK 147
+ ++ LG+G F VY+ D Q+ +K + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQERCMILDWSKRFHIICGTAR 205
+K + +L+ E +L + I + ++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLL-----------DQDMNPKISDFGLARAFGGDETEG 254
+ +H IIH D+K N +L D + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHA 314
T G+ E S+ ++ + D F + ++ G ++
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM--KVKNEGGECKPEGL 298
Query: 315 WK-LWNEGMPSQLIDSC 330
++ L + M ++
Sbjct: 299 FRRLPHLDMWNEFFHVM 315
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 150
+F K LG+G F V + + A+K L K I E + + E + S+L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI-----FDQERCMILDWSKRFH---IIC 201
VKL Q +EKL + N L +I FD+ RF+ I+
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAEIVS 141
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 261
L YLH IIHRDLK N+LL++DM+ +I+DFG A+ + + N VG
Sbjct: 142 A----LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
T Y++PE ++ SD+++ G ++ ++V+G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 34/219 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 150
+ F + LG+GGFG V+ ++ ++ A K+L+K +G + E + +K+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMP---------NKSLDSFIFDQERCMILDWSKRF--- 197
R +V L + + L L+ M N D+ F + R F
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-------IFYTA 296
Query: 198 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 257
I+ G L +LHQ II+RDLK NVLLD D N +ISD GLA +T+ T
Sbjct: 297 QIVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TK 347
Query: 258 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
GT G+MAPE ++ D F+ G+ L E+++ +
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-30
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 99 INKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLV 154
+ + +G+GG G VY+ + V + +A+K +S+ S+ + ++ E +LQ ++V
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 155 KLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
+ GE +Y + L + + Q L + I+ L H
Sbjct: 98 PIHD---FGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH 151
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
HRD+K N+L+ D + DFG+A A DE VGT YMAPE
Sbjct: 152 AA---GATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMAPERF 207
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGK 296
S+ + ++D+++ +L E ++G
Sbjct: 208 SESHATYRADIYALTCVLYECLTGS 232
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-30
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 150
++F I + LG+G FG VY + +A+K L K + ++G++ L+ E+ + S L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRF------HIICGT 203
N++++ +++ L+ EF P L + + L RF +
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKE-----LQKHGRFDEQRSATFMEEL 123
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TNRVVGT 262
A L Y H ++IHRD+K N+L+ KI+DFG + + GT
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSV-----HAPSLRRRTMCGT 175
Query: 263 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
Y+ PE K D++ G+L E + G
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 49/336 (14%), Positives = 84/336 (25%), Gaps = 72/336 (21%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH------ 150
LGQ + G+ V +K++K EV+ L+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 151 ----------RNLVKLLGCCIQGEEK--------LLIYEFMPN---------KSLDSFIF 183
+LVK + L + P + L S
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 184 DQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243
+ L R + R L LH ++H L+ +++LDQ ++ F
Sbjct: 204 THKS---LVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 244 ARAFGGDETEGNTNRVVGTYGYMAPE-----YASDGQFSVKSDVFSFGILLLEIVSGKKN 298
G R A + D ++ G+ + I
Sbjct: 258 LVRD-GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD-- 314
Query: 299 RGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDR 358
G + SC + ++ G L + EDR
Sbjct: 315 LPNTDDA-------------ALGGSEWIFRSCKNIPQPVRALLE----GFL--RYPKEDR 355
Query: 359 PSMPSVILMLGSETVLPQ--PKQPGYLADRKSTRRD 392
+ E + + P Y D + TR
Sbjct: 356 LLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREG 391
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 33/217 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 150
N F + LG+GGFG V ++ ++ A K+L K +G NE + K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSL-------DSFIFDQERCMILDWSKRF---HI 199
R +V L + ++ L L+ M L F + R F I
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-------VFYAAEI 295
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 259
CG L LH R RI++RDLK N+LLD + +ISD GLA +T
Sbjct: 296 CCG----LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGR 345
Query: 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
VGT GYMAPE + +++ D ++ G LL E+++G+
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 39/209 (18%), Positives = 81/209 (38%), Gaps = 30/209 (14%)
Query: 99 INKKLGQGGFGPVYKGK--LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 155
+ + GG G +Y V+G+ + +K L + + E +++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 156 LLGCCIQGEE-----KLLIY---EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
+ E + Y E++ +SL ++ L ++ + L
Sbjct: 144 IFN---FVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQK---LPVAEAIAYLLEILPAL 195
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
YLH + +++ DLK N++L ++ K+ D G + GT G+ A
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQA 245
Query: 268 PEYASDGQFSVKSDVFSFGILLLEIVSGK 296
PE +V +D+++ G L +
Sbjct: 246 PEIVR-TGPTVATDIYTVGRTLAALTLDL 273
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 6e-29
Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 40/221 (18%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKL-- 148
N+FS+++ +G+GGFG VY + D ++ A+K L K +QG NE I+ S +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 149 -QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI-----FDQERCMILDWSKRFH--- 198
+V + +KL I + M L + F + RF+
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-------RFYAAE 300
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
II G L ++H +++RDLK +N+LLD+ + +ISD GLA F +
Sbjct: 301 IILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---- 349
Query: 259 VVGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIVSGK 296
VGT+GYMAPE G S D FS G +L +++ G
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 99 INKKLGQGGFGPVYKGK-LVDGQEIAVK----RLSKISEQGLKELKNEVILFSKLQHRNL 153
+ + LG GG V+ + L D +++AVK L++ + E + L H +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAI 74
Query: 154 VKLLGCCIQGEEKL-------LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
V + GE + ++ E++ +L + + + + +I +
Sbjct: 75 VAVYD---TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQA 128
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE-TEGNTNRVVGTYGY 265
L + H + IIHRD+K +N+++ K+ DFG+ARA + T V+GT Y
Sbjct: 129 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
++PE A +SDV+S G +L E+++G+
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 70/220 (31%), Positives = 113/220 (51%), Gaps = 35/220 (15%)
Query: 92 SATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQ------GLKELKNEVILF 145
+ +K+G+G +G VYK K G+ +A+KR+ +E ++E+ L
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS----LL 73
Query: 146 SKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRF-HIICGT 203
+L H N+V L+ I E L L++EFM K L + + + + K + + +
Sbjct: 74 KELHHPNIVSLI-DVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLL-- 129
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
RG+ + HQ RI+HRDLK N+L++ D K++DFGLARAF G T+ VV T
Sbjct: 130 -RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TL 183
Query: 264 GYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 296
Y AP+ Y++ SV D++S G + E+++GK
Sbjct: 184 WYRAPDVLMGSKKYST----SV--DIWSIGCIFAEMITGK 217
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 55/217 (25%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 153
++ K +G G FG V++ KLV+ E+A+K++ + +EL+ + ++H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94
Query: 154 VKLLGCCIQGEEKL------LIYEFMP---NKSLDSFIFDQERCMILDWSKRF-HIICGT 203
V L +K L+ E++P ++ + ++ M + K + + +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYA-KLKQTMPMLLIKLYMYQLL-- 151
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTNRVVGT 262
R L Y+H + I HRD+K N+LLD K+ DFG A+ E N + +
Sbjct: 152 -RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSR 205
Query: 263 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIVSGK 296
Y Y APE A+ ++ D++S G ++ E++ G+
Sbjct: 206 Y-YRAPELIFGAT--NYTTNIDIWSTGCVMAELMQGQ 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 73/225 (32%), Positives = 120/225 (53%), Gaps = 38/225 (16%)
Query: 91 VSATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG-----LKELKNEVIL 144
+S+++ F +KLG G + VYKG G +A+K + SE+G ++E+ L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----L 56
Query: 145 FSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPN--KSL--DSFIFDQERCMILDWSKRF-H 198
+L+H N+V+L I E KL L++EFM N K + + R + L+ K F
Sbjct: 57 MKELKHENIVRLY-DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR 258
+ +GL + H++ +I+HRDLK N+L+++ K+ DFGLARAF G ++
Sbjct: 116 QLL---QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSE 168
Query: 259 VVGTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 296
VV T Y AP+ Y++ S+ D++S G +L E+++GK
Sbjct: 169 VV-TLWYRAPDVLMGSRTYST----SI--DIWSCGCILAEMITGK 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 92 SATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKN-----EVILF 145
S + LG+G F VYK + Q +A+K++ K+ N E+ L
Sbjct: 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL 66
Query: 146 SKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRF-HIICGT 203
+L H N++ LL + + L+++FM L+ I D + K + +
Sbjct: 67 QELSHPNIIGLLDA-FGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTL-- 122
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
+GL YLHQ I+HRDLK +N+LLD++ K++DFGLA++F G T++VV T
Sbjct: 123 -QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TR 176
Query: 264 GYMAPE--YASDGQFSVKSDVFSFGILLLEIVSGK 296
Y APE + + + V D+++ G +L E++
Sbjct: 177 WYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRV 210
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-27
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 33/216 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSKL 148
+ KLG+G + VYKGK + +A+K + E+G ++E+ L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 149 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
+H N+V L I E+ L L++E++ +K L ++ D + + K F + RGL
Sbjct: 58 KHANIVTLH-DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGL 113
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
Y H+ +++HRDLK N+L+++ K++DFGLARA T+ N VV T Y
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRP 168
Query: 268 PE-------YASDGQFSVKSDVFSFGILLLEIVSGK 296
P+ Y S + D++ G + E+ +G+
Sbjct: 169 PDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 23/184 (12%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 147
+ +K+G+G +G V+K K + +A+KR+ + L+E+ L +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKE 57
Query: 148 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRF-HIICGTAR 205
L+H+N+V+L + ++KL L++EF + L + + + K F + +
Sbjct: 58 LKHKNIVRLH-DVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLL---K 112
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
GL + H ++HRDLK N+L++++ K+++FGLARAF G + VV T Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWY 167
Query: 266 MAPE 269
P+
Sbjct: 168 RPPD 171
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 18/220 (8%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 150
+ + KKLG G +G V + V E A+K + K +S +L EV + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
N++KL L+ E L I + + +D + + G+ YL
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS---GVTYL 152
Query: 211 HQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
H+ I+HRDLK N+LL ++D KI DFGL+ F + +GT Y+A
Sbjct: 153 HK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIA 206
Query: 268 PEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN 307
PE ++ K DV+S G++L +++G F +
Sbjct: 207 PE-VLRKKYDEKCDVWSIGVILFILLAGY--PPFGGQTDQ 243
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ 149
++ + + LG+G FG V K + GQE AVK +SK + + L EV L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 150 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLL 208
H N++KL + + L+ E L I ++R +D ++ + G+
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS---GIT 140
Query: 209 YLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
Y+H+ +I+HRDLK N+LL +D N +I DFGL+ F + +GT Y
Sbjct: 141 YMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYY 194
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSG 295
+APE G + K DV+S G++L ++SG
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 61/217 (28%), Positives = 110/217 (50%), Gaps = 35/217 (16%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKL 148
+ +K+G+G +G VYK + G+ A+K++ E ++E+ + +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS----ILKEL 57
Query: 149 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRF-HIICGTARG 206
+H N+VKL I +++L L++E + + L + E + +K F + G
Sbjct: 58 KHSNIVKLY-DVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLL---NG 112
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
+ Y H R++HRDLK N+L++++ KI+DFGLARAF G T+ +V T Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYR 167
Query: 267 APE-------YASDGQFSVKSDVFSFGILLLEIVSGK 296
AP+ Y++ ++ D++S G + E+V+G
Sbjct: 168 APDVLMGSKKYST----TI--DIWSVGCIFAEMVNGT 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 148
+ K+G+G +G V+K + GQ +A+K K E + E+ + +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 149 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
+H NLV LL + + +L L++E+ + ++ + +R + K T + +
Sbjct: 60 KHPNLVNLL-EVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSI--TWQTLQAV 115
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
+ H+ IHRD+K N+L+ + K+ DFG AR ++ + V T Y +
Sbjct: 116 NFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TRWYRS 170
Query: 268 PE-------YASDGQFSVKSDVFSFGILLLEIVSGK 296
PE Y V DV++ G + E++SG
Sbjct: 171 PELLVGDTQYGP----PV--DVWAIGCVFAELLSGV 200
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 5e-27
Identities = 41/311 (13%), Positives = 79/311 (25%), Gaps = 77/311 (24%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ------- 149
LGQ + G+ V +K++K EV+ L+
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 150 ------------------HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSF--IFD-QE 186
+ ++++ +Y M + +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 187 RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246
L R + R L LH ++H L+ +++LDQ ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 247 FGGDETEGNTNRVVGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIVSG 295
G + G+ PE + + D ++ G+++ I
Sbjct: 256 DGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 296 KKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNL-AEVIRCIHIGLLCVQQH 354
S+ I F+ N+ V + G L
Sbjct: 310 D--LPITKD--------------AALGGSEWI---FRSCKNIPQPVRALLE-GFLRY--P 347
Query: 355 PEDRPSMPSVI 365
EDR +
Sbjct: 348 KEDRLLPLQAM 358
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 71/217 (32%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 150
++I LG+G FG V K K + QE AVK ++K + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 151 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQERCMILDWSKRF------HIIC 201
N++KL E+ Y E L FD+ I+ KRF II
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGEL----FDE----IIK-RKRFSEHDAARIIK 128
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNR 258
G+ Y+H+ I+HRDLK N+LL ++D + KI DFGL+ F +
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKD 182
Query: 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 295
+GT Y+APE G + K DV+S G++L ++SG
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 152
N+ + K +G+G F V + ++ G+E+A+K + ++++ L++L EV + L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 153 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFH-IICGTARGLLYL 210
+VKL I+ E+ L LI E+ + ++ R + +F I+ Y
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YC 130
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
H + RI+HRDLKA N+LLD DMN KI+DFG + F + G Y APE
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPEL 184
Query: 271 ASDGQFS-VKSDVFSFGILLLEIVSGK 296
++ + DV+S G++L +VSG
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 67/217 (30%), Positives = 96/217 (44%), Gaps = 42/217 (19%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 150
++I LG+G FG V K K + QE AVK ++K + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 151 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQ--------ERCMILDWSKRFHI 199
N++KL E+ Y E L FD+ E D ++
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGEL----FDEIIKRKRFSEH----DAARIIKQ 129
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNT 256
+ G+ Y+H+ I+HRDLK N+LL ++D + KI DFGL+ F +
Sbjct: 130 VFS---GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---M 180
Query: 257 NRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 289
+GT Y+APE G + K DV+S G ILL
Sbjct: 181 KDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILL 216
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 67/251 (26%), Positives = 111/251 (44%), Gaps = 41/251 (16%)
Query: 69 KTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRL 127
EN Q I + ++ ++ +KLG G +G V K E A+K +
Sbjct: 10 GRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVI 69
Query: 128 SK-------------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFM 173
K E+ +E+ NE+ L L H N++KL + ++ L+ EF
Sbjct: 70 KKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFY 128
Query: 174 PNKSLDSFIFDQERCMILDWSKRF------HIICGTARGLLYLHQDSRLRIIHRDLKASN 227
L F+Q I++ +F +I+ G+ YLH+ I+HRD+K N
Sbjct: 129 EGGEL----FEQ----IIN-RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPEN 176
Query: 228 VLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFS 284
+LL + +N KI DFGL+ F D +GT Y+APE +++ K DV+S
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVWS 232
Query: 285 FGILLLEIVSG 295
G+++ ++ G
Sbjct: 233 CGVIMYILLCG 243
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 26/216 (12%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQH 150
+ + LG+G +G V + AVK L K G +K E+ L +L+H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 151 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQERCMILDWSKRF--HIICGTAR 205
+N+++L+ + EEK +Y E+ + E+ + + + +I G
Sbjct: 66 KNVIQLVDV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE- 123
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
YLH I+H+D+K N+LL KIS G+A A + G+ +
Sbjct: 124 ---YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 266 MAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGK 296
PE A+ G K D++S G+ L I +G
Sbjct: 178 QPPEIANGLDTFSGF---KVDIWSAGVTLYNITTGL 210
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 39/222 (17%)
Query: 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 152
+++ K +G G FG VY+ KL D G+ +A+K++ + +EL+ + KL H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108
Query: 153 LVKLLGCCIQGEEKL------LIYEFMP---NKSLDSFIFDQERCMILDWSKRF-HIICG 202
+V+L EK L+ +++P + + ++ + + + K + + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVIYVKLYMYQLF- 166
Query: 203 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTNRVVG 261
R L Y+H I HRD+K N+LLD D K+ DFG A+ E N + +
Sbjct: 167 --RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICS 219
Query: 262 TYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 296
Y Y APE Y + DV+S G +L E++ G+
Sbjct: 220 RY-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 54/245 (22%), Positives = 96/245 (39%), Gaps = 33/245 (13%)
Query: 59 IRKRRRNIAEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGK-LV 117
I + + ++ +N P +++ I+++LG G FG V++
Sbjct: 121 IVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA 180
Query: 118 DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 177
G A K + E + ++ E+ S L+H LV L E ++IYEFM
Sbjct: 181 TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240
Query: 178 LDSFIFDQERCMILDWSKRFHI-----------ICGTARGLLYLHQDSRLRIIHRDLKAS 226
L F++ + D + + +C GL ++H+ +H DLK
Sbjct: 241 L----FEK----VAD--EHNKMSEDEAVEYMRQVCK---GLCHMHE---NNYVHLDLKPE 284
Query: 227 NVLLDQDMNP--KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFS 284
N++ + K+ DFGL + + GT + APE A +D++S
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 341
Query: 285 FGILL 289
G+L
Sbjct: 342 VGVLS 346
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 148
+ +G+G +G V K + G+ +A+K K E ++ E+ L +L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 149 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
+H NLV LL + +++ L++EF+ + ++ + + +++ + G+
Sbjct: 82 RHENLVNLL-EVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKY--LFQIINGI 137
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
+ H IIHRD+K N+L+ Q K+ DFG AR E + V T Y A
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-TRWYRA 192
Query: 268 PE-------YASDGQFSVKSDVFSFGILLLEIVSGK 296
PE Y +V DV++ G L+ E+ G+
Sbjct: 193 PELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 57/245 (23%), Positives = 96/245 (39%), Gaps = 43/245 (17%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--------ISEQGLKELKNEVILFS 146
+S LG G FG V+ +E+ VK + K I + L ++ E+ + S
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 147 KLQHRNLVKLLGCCIQGEEKL-LIYEFMPN-KSLDSFIFDQERCMILDWSKRFH-IICGT 203
+++H N++K+L + + L+ E + L +FI R S F ++
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
YL IIHRD+K N+++ +D K+ DFG A E GT
Sbjct: 144 G----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTI 193
Query: 264 GYMAPEYAS----DGQFSVKSDVFSFGILLLEIVSG--------KKNRGFYH-----SDN 306
Y APE G + +++S G+ L +V + H S
Sbjct: 194 EYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKE 250
Query: 307 NLNLI 311
++L+
Sbjct: 251 LMSLV 255
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 153
++ + + LG+G +G V V + +AVK + E +K E+ + L H N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 154 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFH-IICGTARGLLYLH 211
VK G + L E+ L I D + FH ++ G YLH
Sbjct: 68 VKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH 122
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
+ I HRD+K N+LLD+ N KISDFGLA F + E N++ GT Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 272 S----DGQFSVKSDVFSFGILLLEIVSG 295
+ DV+S GI+L +++G
Sbjct: 180 KRREFHAE---PVDVWSCGIVLTAMLAG 204
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 48/211 (22%), Positives = 84/211 (39%), Gaps = 36/211 (17%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 152
+++ +G+G +G V A K++ K + + K E+ + L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 153 LVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFD--------QERCMILDWSKRFHIIC 201
+++L E+ IY E L F+ +E D ++ +
Sbjct: 68 IIRLYETF---EDNTDIYLVMELCTGGEL----FERVVHKRVFRES----DAARIMKDVL 116
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNR 258
+ Y H+ L + HRDLK N L D K+ DFGLA F +
Sbjct: 117 S---AVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRT 167
Query: 259 VVGTYGYMAPEYASDGQFSVKSDVFSFGILL 289
VGT Y++P+ +G + + D +S G+++
Sbjct: 168 KVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 56/257 (21%), Positives = 97/257 (37%), Gaps = 47/257 (18%)
Query: 60 RKRRRNIAEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGK-LVD 118
+K + TEN Q++ E L + A + +G+G V +
Sbjct: 59 KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118
Query: 119 GQEIAVKRLSK--------ISEQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLI 169
G E AVK + E+ + + E IL H +++ L+ E +
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---ESSSFM 175
Query: 170 Y---EFMPNKSLDSFIFD--------QERCMILDWSKRFHIICGTARGLLYLHQDSRLRI 218
+ + M L FD E+ + + + +LH I
Sbjct: 176 FLVFDLMRKGEL----FDYLTEKVALSEK----ETRSIMRSLLE---AVSFLHA---NNI 221
Query: 219 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE------YAS 272
+HRDLK N+LLD +M ++SDFG + E + GT GY+APE +
Sbjct: 222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDET 278
Query: 273 DGQFSVKSDVFSFGILL 289
+ + D+++ G++L
Sbjct: 279 HPGYGKEVDLWACGVIL 295
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 147
+ + KLG+G +G VYK V + +A+KR+ E+ ++E+ L +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKE 89
Query: 148 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
LQHRN+++L I +L LI+E+ L ++ ++ + + G
Sbjct: 90 LQHRNIIELK-SVIHHNHRLHLIFEYA-ENDLKKYM---DKNPDVSMRVIKSFLYQLING 144
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNP-----KISDFGLARAFGGDETEGNTNRVVG 261
+ + H R +HRDLK N+LL KI DFGLARAF G T+ ++
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII- 199
Query: 262 TYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 296
T Y PE Y++ SV D++S + E++
Sbjct: 200 TLWYRPPEILLGSRHYST----SV--DIWSIACIWAEMLMKT 235
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 49/205 (23%), Positives = 84/205 (40%), Gaps = 23/205 (11%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 152
+ + I ++LG G FG V++ G+ K ++ +KNE+ + ++L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF------HIICGTARG 206
L+ L E +LI EF+ L FD+ I + + + G
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGEL----FDR----IAAEDYKMSEAEVINYMRQACEG 161
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTNRVVGTYG 264
L ++H+ I+H D+K N++ + KI DFGLA DE T
Sbjct: 162 LKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAE 215
Query: 265 YMAPEYASDGQFSVKSDVFSFGILL 289
+ APE +D+++ G+L
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 50/252 (19%), Positives = 86/252 (34%), Gaps = 52/252 (20%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 147
+ + +GQG +G V A+K ++ +I+ + ++ +K EV L K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF---------- 197
L H N+ +L + L+ E L + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 198 ---------------------------HIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 230
+I+ L YLH I HRD+K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201
Query: 231 --DQDMNPKISDFGLARAFGGDETEGNT--NRVVGTYGYMAPE--YASDGQFSVKSDVFS 284
++ K+ DFGL++ F GT ++APE ++ + K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 285 FGILLLEIVSGK 296
G+LL ++ G
Sbjct: 262 AGVLLHLLLMGA 273
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 40/215 (18%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 152
F + LG G F V+ K + G+ A+K + K L+NE+ + K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 153 LVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQ--------ERCMILDWSKRFHIIC 201
+V L E Y + + L FD+ E+ D S +
Sbjct: 68 IVTLEDIY---ESTTHYYLVMQLVSGGEL----FDRILERGVYTEK----DASLVIQQVL 116
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNR 258
+ YLH+ I+HRDLK N+L +++ I+DFGL++ G +
Sbjct: 117 S---AVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMST 166
Query: 259 VVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 289
GT GY+APE + +S D +S G ILL
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 61/233 (26%), Positives = 107/233 (45%), Gaps = 35/233 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 150
++F I + +G+G FG V + D +++ A+K ++K + ++ + E+ + L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSL-----DSFIFDQERCMILDWSKRFHIICGTA 204
LV L Q EE + ++ + + L + F +E + I C
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV-------KLFI-CELV 125
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
L YL RIIHRD+K N+LLD+ + I+DF +A + + GT
Sbjct: 126 MALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKP 179
Query: 265 YMAPE-YASDGQ----FSVKSDVFSFGILLLEIVSGKKNRGFY-HSDNNLNLI 311
YMAPE ++S F+V D +S G+ E++ G+ R ++ S + I
Sbjct: 180 YMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGR--RPYHIRSSTSSKEI 228
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-25
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 153
++ + + LG+G +G V V + +AVK + E +K E+ + L H N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 154 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFH-IICGTARGLLYLH 211
VK G + L E+ L I D + FH ++ G YLH
Sbjct: 68 VKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH 122
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
+ I HRD+K N+LLD+ N KISDFGLA F + E N++ GT Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 272 S----DGQFSVKSDVFSFGILLLEIVSG 295
+ DV+S GI+L +++G
Sbjct: 180 KRREFHAE---PVDVWSCGIVLTAMLAG 204
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 52/206 (25%), Positives = 82/206 (39%), Gaps = 21/206 (10%)
Query: 97 FSINKKLGQGGFGPVYKGK-LVDGQEIAVK-----RLSKISEQGLKELKNEVILFSKLQH 150
+ + + +G+G F V + GQ+ AVK + + ++LK E + L+H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMIL----DWSKRFHIICGTARG 206
++V+LL +++EFM L I + + S I
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE---A 142
Query: 207 LLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
L Y H IIHRD+K VLL + K+ FG+A G VGT
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTP 197
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILL 289
+MAPE + DV+ G++L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 55/216 (25%), Positives = 86/216 (39%), Gaps = 41/216 (18%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHR 151
+ F +KLG G FG V+ + G E +K ++K Q E ++ E+ + L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 152 NLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQERCMILDWSKR------------ 196
N++K+ E+ +Y E L ++ I+ R
Sbjct: 81 NIIKIFEVF---EDYHNMYIVMETCEGGEL----LER----IVSAQARGKALSEGYVAEL 129
Query: 197 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETE 253
+ L Y H ++H+DLK N+L KI DFGLA F DE
Sbjct: 130 MKQMMN---ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH- 182
Query: 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILL 289
+ GT YMAPE + K D++S G+++
Sbjct: 183 --STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 92 SATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG---------------L 135
AT+ + ++G G +G VYK + G +A+K + + G L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 136 KELKNEVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMI 190
+ L+ +H N+V+L+ E K+ L++E + ++ L +++ D+
Sbjct: 66 RRLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPG 116
Query: 191 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250
L ++ RGL +LH + I+HRDLK N+L+ K++DFGLAR +
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
T VV T Y APE ++ D++S G + E+ K
Sbjct: 174 MA--LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 58/239 (24%), Positives = 105/239 (43%), Gaps = 51/239 (21%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK------------------------ 129
N +++ ++G+G +G V D A+K LSK
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 130 --ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFD 184
++++ E+ + KL H N+VKL+ + + +Y E + + +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----ME 127
Query: 185 --QERCMILDWSKRFH--IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 240
+ + D ++ + +I G + YLH +IIHRD+K SN+L+ +D + KI+D
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 241 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSV---KSDVFSFGILLLEIVSGK 296
FG++ F G + + VGT +MAPE S+ + DV++ G+ L V G+
Sbjct: 181 FGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 29/220 (13%)
Query: 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKN----EVILFSKL 148
+ F + + GQG FG V GK G +A+K K+ + +N + + L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQD--PRFRNRELQIMQDLAVL 76
Query: 149 QHRNLVKLLGCCIQGEEK-------LLIYEFMP---NKSLDSFIFDQERCMILDWSKRFH 198
H N+V+L E+ ++ E++P ++ ++ Q K F
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVA-PPPILIKVF- 134
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTN 257
+ R + LH S + + HRD+K NVL+++ K+ DFG A+ E N
Sbjct: 135 -LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVA 190
Query: 258 RVVGTYGYMAPEY-ASDGQFSVKSDVFSFGILLLEIVSGK 296
+ Y Y APE + ++ D++S G + E++ G+
Sbjct: 191 YICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK------ISEQGLKELKNEVILFSKL 148
+ + LG GGFG VY G + D +A+K + K + EV+L K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 149 QHR--NLVKLLGCCIQGEEKLLIYEF-MPNKSLDSFIFDQERCMILDWSKRF--HIICGT 203
+++LL + + +LI E P + L FI ++ + + ++ F ++
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEA- 161
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTNRVVGT 262
+ + H ++HRD+K N+L+D + K+ DFG + GT
Sbjct: 162 ---VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGT 211
Query: 263 YGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGK 296
Y PE+ ++ + V+S GILL ++V G
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-24
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 41/217 (18%)
Query: 94 TNNFSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 150
++N+ + ++LG+G F V + G E A K ++ +S + ++L+ E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 151 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQ--------ERCMILDWSKRFHI 199
N+V+L +E+ Y + + L F+ E D S
Sbjct: 65 PNIVRLHDSI---QEESFHYLVFDLVTGGEL----FEDIVAREFYSEA----DASHCIQQ 113
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNT 256
I + Y H I+HR+LK N+LL + K++DFGLA E
Sbjct: 114 ILE---SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---W 164
Query: 257 NRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 289
+ GT GY++PE +S D+++ G ILL
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 54/221 (24%), Positives = 85/221 (38%), Gaps = 42/221 (19%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKE---------LKNEV- 142
N+ + LG+G V + +E AVK + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 143 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ--------ERCMILDWS 194
IL H N+++L L+++ M L FD E+ +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEK----ETR 127
Query: 195 KRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254
K + + LH+ L I+HRDLK N+LLD DMN K++DFG + E
Sbjct: 128 KIMRALLE---VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-- 179
Query: 255 NTNRVVGTYGYMAPE------YASDGQFSVKSDVFSFGILL 289
V GT Y+APE + + + D++S G+++
Sbjct: 180 -LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 29/244 (11%)
Query: 61 KRRRNIAEKTENDQIQNIDLELPLFELATIVSATNNFS----INKK--LGQGGFGPVYKG 114
R + K + +I F+ + + + ++K LG G FG V+K
Sbjct: 49 TERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC 108
Query: 115 K-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173
+ G ++A K + + +E+KNE+ + ++L H NL++L + +L+ E++
Sbjct: 109 EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168
Query: 174 PNKSLDSFIFDQERCMILDWSKRF------HIICGTARGLLYLHQDSRLRIIHRDLKASN 227
L FD+ I+D S + G+ ++HQ + I+H DLK N
Sbjct: 169 DGGEL----FDR----IIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPEN 217
Query: 228 VLL-DQDMNP-KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSF 285
+L ++D KI DFGLAR + E GT ++APE + S +D++S
Sbjct: 218 ILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSV 274
Query: 286 GILL 289
G++
Sbjct: 275 GVIA 278
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 64/237 (27%), Positives = 108/237 (45%), Gaps = 62/237 (26%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 147
+ + K+GQG FG V+K + GQ++A+K++ +E+ L+E+K +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQL 72
Query: 148 LQHRNLVKLLGCCIQGEEKL--------LIYEFMPN---KSLDS----FIFDQERC---M 189
L+H N+V L+ C L+++F + L + F + + M
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 190 ILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249
+L GL Y+H++ +I+HRD+KA+NVL+ +D K++DFGLARAF
Sbjct: 133 LL-------------NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL 176
Query: 250 DETEGN---TNRVVGTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIVSGK 296
+ TNRVV T Y PE Y D++ G ++ E+ +
Sbjct: 177 AKNSQPNRYTNRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 25/211 (11%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--------ISEQGLKELKNEVIL 144
+ + ++K LG G G V +++A++ +SK ++ E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 145 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTA 204
KL H ++K+ E+ ++ E M L + +R F+ +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-- 250
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVG 261
+ YLH+ IIHRDLK NVLL ++D KI+DFG ++ G + G
Sbjct: 251 -AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 303
Query: 262 TYGYMAPE---YASDGQFSVKSDVFSFGILL 289
T Y+APE ++ D +S G++L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 48/189 (25%), Positives = 85/189 (44%), Gaps = 26/189 (13%)
Query: 99 INKKLGQGGFGPVYKGK---LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 153
K+G+G +G VYK K D ++ A+K++ IS + E+ L +L+H N+
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR----EIALLRELKHPNV 80
Query: 154 VKLLGCCIQ-GEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRF------HIICGTAR 205
+ L + + K+ L++++ L I + ++
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAFGG-DETEGNTNRVV 260
G+ YLH + ++HRDLK +N+L+ + KI+D G AR F + + + VV
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 261 GTYGYMAPE 269
T+ Y APE
Sbjct: 197 VTFWYRAPE 205
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 8e-24
Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 92 SATNNFSINKKLGQGGFGPVYKGK--LVDGQEIAVKRLSKISEQG------------LKE 137
A + ++G+G +G V+K + G+ +A+KR+ + + L+
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 138 LKNEVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILD 192
L+ +H N+V+L E KL L++E + ++ L +++ D+ +
Sbjct: 68 LETF-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVP 118
Query: 193 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252
++ RGL +LH R++HRDLK N+L+ K++DFGLAR +
Sbjct: 119 TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
T+ VV T Y APE ++ D++S G + E+ K
Sbjct: 176 L--TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--------ISEQGLKELKNEVIL 144
+ + ++K LG G G V +++A+K +SK ++ E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 145 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD--------QERCMILDWSKR 196
KL H ++K+ E+ ++ E M L FD +E
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEA----TCKLY 119
Query: 197 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETE 253
F+ + + YLH IIHRDLK NVLL ++D KI+DFG ++ G
Sbjct: 120 FYQMLL---AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 172
Query: 254 GNTNRVVGTYGYMAPE---YASDGQFSVKSDVFSFGILL 289
+ GT Y+APE ++ D +S G++L
Sbjct: 173 --MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-23
Identities = 43/205 (20%), Positives = 79/205 (38%), Gaps = 24/205 (11%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 152
+ I + LG+G FG V++ + K + +K E+ + + +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF------HIICGTARG 206
++ L EE ++I+EF+ + F++ I + +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDI----FER----INTSAFELNEREIVSYVHQVCEA 114
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTNRVVGTYG 264
L +LH I H D++ N++ + KI +FG AR + +
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPE 168
Query: 265 YMAPEYASDGQFSVKSDVFSFGILL 289
Y APE S +D++S G L+
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 37/215 (17%)
Query: 94 TNNFSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 150
++N+ + ++LG+G F V + G E A K ++ +S + ++L+ E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQ--------ERCMILDWSKRFHIIC 201
N+V+L IQ E L+++ + L F+ E D S I
Sbjct: 88 PNIVRLHD-SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEA----DASHCIQQIL 138
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNR 258
+ Y H I+HR+LK N+LL + K++DFGLA E +
Sbjct: 139 E---SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHG 189
Query: 259 VVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 289
GT GY++PE +S D+++ G ILL
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 65/314 (20%), Positives = 119/314 (37%), Gaps = 73/314 (23%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK------ISEQGLKELKNEV----IL 144
+ + LG+GGFG V+ G L D ++A+K + + EV +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 145 FSKLQHRNLVKLLGCCIQGEEKL-LIYEF-MPNKSLDSFIFDQERCMILDWSKRF--HII 200
+ H +++LL + +E L+ E +P + L +I ++ + S+ F ++
Sbjct: 92 GAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVV 149
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTNRV 259
+ + H ++HRD+K N+L+D K+ DFG +
Sbjct: 150 AA----IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDF 198
Query: 260 VGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSG--------KKNRGFYHSDNNLNL 310
GT Y PE+ S Q+ + + V+S GILL ++V G + H
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELH------- 251
Query: 311 IGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI----L 366
P+ + S + +IR C+ P RPS+ ++ +
Sbjct: 252 -----------FPAHV-------SPDCCALIRR------CLAPKPSSRPSLEEILLDPWM 287
Query: 367 MLGSETVLPQPKQP 380
+E V P +
Sbjct: 288 QTPAEDVPLNPSKG 301
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-23
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHR 151
++ + LG G FG V G+ + G ++AVK L++ I + +K E+ +H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 152 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFH-IICGTARGLLY 209
+++KL I ++ E++ L +I R ++ + F I+ Y
Sbjct: 72 HIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----Y 126
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTNRVVGTYGYM 266
H R ++HRDLK NVLLD MN KI+DFGL+ E T G+ Y
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYA 177
Query: 267 APEYASDGQFS-VKSDVFSFGILLLEIVSGK 296
APE S ++ + D++S G++L ++ G
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 49/216 (22%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 150
++F I K +G+G F V K+ ++ A+K ++K + + + E +
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFH---IICGTARG 206
R + +L Q E L L+ E+ L + + + + + RF+ I+
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA---- 174
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
+ +H+ L +HRD+K N+LLD+ + +++DFG D T + VGT Y+
Sbjct: 175 IDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYL 230
Query: 267 APE-------YASDGQFSVKSDVFSFGILLLEIVSG 295
+PE G + + D ++ G+ E+ G
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 20/207 (9%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK------ISEQGLKELKNEVILFS 146
+ + I ++LG G F V K + G E A K + K +E++ EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 147 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
++ H N++ L + +LI E + L F+ +E + + I G
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---G 127
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAFGGDETEGNTNRVVGT 262
+ YLH +I H DLK N++L P K+ DFGLA + GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGT 181
Query: 263 YGYMAPEYASDGQFSVKSDVFSFGILL 289
++APE + +++D++S G++
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-23
Identities = 49/207 (23%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK------ISEQGLKELKNEVILFS 146
+++ + ++LG G F V K + G+E A K + K +E++ EV +
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 147 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
+++H N++ L + +LI E + L F+ ++E + ++ I G
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---G 120
Query: 207 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTNRVVGT 262
+ YLH RI H DLK N++L + K+ DFG+A + GT
Sbjct: 121 VHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGT 174
Query: 263 YGYMAPEYASDGQFSVKSDVFSFGILL 289
++APE + +++D++S G++
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 5e-23
Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 20/207 (9%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKIS------EQGLKELKNEVILFS 146
+ + I ++LG G F V K + G E A K + K +E++ EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 147 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
++ H N++ L + +LI E + L F+ +E + + I G
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---G 127
Query: 207 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTNRVVGT 262
+ YLH +I H DLK N++L + K+ DFGLA + GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGT 181
Query: 263 YGYMAPEYASDGQFSVKSDVFSFGILL 289
++APE + +++D++S G++
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-23
Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK------ISEQGLKELKNEVILFS 146
+ + ++LG G F V K + G + A K + K ++++ EV +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 147 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
++QH N++ L + +LI E + L F+ ++E + ++ I G
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 207 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTNRVVGT 262
+ YLH L+I H DLK N++L KI DFGLA + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 180
Query: 263 YGYMAPEYASDGQFSVKSDVFSFGILL 289
++APE + +++D++S G++
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 87 LATIVSA--TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKELKNE 141
+ATI T + + ++LG+G F V + ++ GQE A ++ +S + ++L+ E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 142 VILFSKLQHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQ--------ERCMI 190
+ L+H N+V+L E+ Y + + L F+ E
Sbjct: 61 ARICRLLKHPNIVRLHDSI---SEEGHHYLIFDLVTGGEL----FEDIVAREYYSEA--- 110
Query: 191 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 247
D S I +L+ HQ + ++HR+LK N+LL + K++DFGLA
Sbjct: 111 -DASHCIQQILE---AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163
Query: 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 289
G++ GT GY++PE + D+++ G ILL
Sbjct: 164 EGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 54/213 (25%), Positives = 83/213 (38%), Gaps = 37/213 (17%)
Query: 100 NKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLL 157
LG+G V L+ QE AVK + K + EV + + Q HRN+++L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSFIFDQ--------ERCMILDWSKRFHIICGTARGLLY 209
+ + L++E M S+ E + S + L +
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNEL----EASVVVQDVAS---ALDF 126
Query: 210 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF--GGDETEGNTNR---VVG 261
LH I HRDLK N+L +Q KI DF L GD + +T G
Sbjct: 127 LHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 262 TYGYMAPE-----YASDGQFSVKSDVFSFGILL 289
+ YMAPE + + D++S G++L
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 150
+F I K +G+G FG V KL + ++ A+K L+K E + E +
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFH---IICGTARG 206
+ + L Q + L L+ ++ L + + E + + + RF+ ++
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVIA---- 187
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYM 266
+ +HQ L +HRD+K N+L+D + + +++DFG D T ++ VGT Y+
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYI 243
Query: 267 APE-----YASDGQFSVKSDVFSFGILLLEIVSG 295
+PE G++ + D +S G+ + E++ G
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 94 TNNFSINKKLGQGGFGPVYKG-KLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 152
T+ + + + +G G + + E AVK + K +E++ IL QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF------HIICGTARG 206
++ L G+ ++ E M L D+ IL K F ++ +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDK----ILR-QKFFSEREASAVLFTITKT 128
Query: 207 LLYLHQDSRLRIIHRDLKASNVLL-DQDMNP---KISDFGLARAFGGDETEGNTNRVVGT 262
+ YLH ++HRDLK SN+L D+ NP +I DFG A+ + T T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183
Query: 263 YGYMAPEYASDGQFSVKSDVFSFGILL 289
++APE + D++S G+LL
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 33/211 (15%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 152
++ F + +LG+G VY+ K + A+K L K ++ K ++ E+ + +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 153 LVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQ----ERCMILDWSKRFHIICGTAR 205
++KL E I E + L I ++ ER D + I
Sbjct: 110 IIKLKEIF---ETPTEISLVLELVTGGELFDRIVEKGYYSER----DAADAVKQILE--- 159
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVGT 262
+ YLH+ I+HRDLK N+L D KI+DFGL++ V GT
Sbjct: 160 AVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGT 213
Query: 263 YGYMAPEYASDGQFSVKSDVFSFG----ILL 289
GY APE + + D++S G ILL
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILL 244
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 5e-22
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHR 151
++ + LG G FG V GK + G ++AVK L++ I + ++ E+ +H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 152 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFH-IICGTARGLLY 209
+++KL I + ++ E++ L +I R + + F I+ G Y
Sbjct: 77 HIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----Y 131
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTNRVVGTYGYM 266
H R ++HRDLK NVLLD MN KI+DFGL+ E T G+ Y
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYA 182
Query: 267 APEYAS----DGQFSVKSDVFSFGILLLEIVSGK 296
APE S G + D++S G++L ++ G
Sbjct: 183 APEVISGRLYAGP---EVDIWSSGVILYALLCGT 213
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 150
N F K LG+G FG V K A+K L K +++ + E + +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSL-----DSFIFDQERCMILDWSKRFHIICGTA 204
L L Q ++L + E+ L +F ++R RF+
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RFYGAE-IV 258
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
L YLH S +++RDLK N++LD+D + KI+DFGL + D T GT
Sbjct: 259 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPE 314
Query: 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
Y+APE D + D + G+++ E++ G+
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 6e-22
Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 35/224 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 150
+ F K LG G FG V K + A+K L K LK++ NE + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI-----FDQERCMILDWSKRF---HIIC 201
LVKL + L ++ E++ + S + F + RF I+
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-------RFYAAQIVL 152
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 261
YLH L +I+RDLK N+L+DQ +++DFG A+ +G T + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCG 200
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 305
T +APE ++ D ++ G+L+ E+ +G F+
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP--FFADQ 242
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 7e-22
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 32/217 (14%)
Query: 95 NNFSINKKLGQGGFGPVY---KGKLVDGQEI-AVKRLSK--ISEQGLKELKNEVILFSKL 148
+ F + K LGQG FG V+ K D +++ A+K L K + + K E + ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 149 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSL-----DSFIFDQERCMILDWSKRFH---I 199
H +VKL Q E KL LI +F+ L +F +E +F+ +
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-------KFYLAEL 135
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 259
L +LH L II+RDLK N+LLD++ + K++DFGL++ E + +
Sbjct: 136 ALA----LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--F 186
Query: 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
GT YMAPE + + +D +SFG+L+ E+++G
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 8e-22
Identities = 52/201 (25%), Positives = 82/201 (40%), Gaps = 28/201 (13%)
Query: 100 NKKLGQGGFGPVYKG-KLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLL 157
+K LG+G F K Q AVK +SK + + E+ + H N+VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLH 72
Query: 158 GCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF------HIICGTARGLLYLH 211
L+ E + L F++ I K F +I+ + ++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGEL----FER----IKK-KKHFSETEASYIMRKLVSAVSHMH 123
Query: 212 QDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 268
+ ++HRDLK N+L + ++ KI DFG AR D T T Y AP
Sbjct: 124 D---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAP 178
Query: 269 EYASDGQFSVKSDVFSFGILL 289
E + + D++S G++L
Sbjct: 179 ELLNQNGYDESCDLWSLGVIL 199
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 150
N+F K LG+G FG V + A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSL-----DSFIFDQERCMILDWSKRFHIICGTA 204
L L Q ++L + E+ L +F +ER RF+
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RFYGAE-IV 115
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
L YLH +++RD+K N++LD+D + KI+DFGL + D T GT
Sbjct: 116 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPE 170
Query: 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
Y+APE D + D + G+++ E++ G+
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 49/205 (23%), Positives = 82/205 (40%), Gaps = 34/205 (16%)
Query: 100 NKKLGQGGFGPVYKG-KLVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNLVKLL 157
+ LG G G V + GQ+ A+K L + + EV + ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88
Query: 158 GCC---IQGEEKL-LIYEFMPNKSLDSFIFD--QERCMIL----DWSKRFHIICGTARGL 207
G+ L +I E M L F QER + ++ I +
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGT---AI 141
Query: 208 LYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
+LH I HRD+K N+L ++D K++DFG A+ T+ T
Sbjct: 142 QFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTPY 194
Query: 265 YMAPEYASDGQFSVKSDVFSFGILL 289
Y+APE ++ D++S G+++
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 32/205 (15%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR-NLVKL 156
K+LG+G F V + GQE A K L K + E+ +E+ + + ++ L
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 157 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRF---------HIICGTARGL 207
E +LI E+ + F C + + ++ I G+
Sbjct: 95 HEVYENTSEIILILEYAAGGEI----FS--LC-LPELAEMVSENDVIRLIKQILE---GV 144
Query: 208 LYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
YLHQ I+H DLK N+LL + KI DFG++R G ++GT
Sbjct: 145 YYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPE 198
Query: 265 YMAPEYASDGQFSVKSDVFSFGILL 289
Y+APE + + +D+++ GI+
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIA 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 33/214 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 150
+F I + LG G FG V+ + A+K L K LK++ +E ++ S + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI-----FDQERCMILDWSKRFH---IIC 201
++++ G Q +++ +I +++ L S + F +F+ +
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-------KFYAAEVCL 117
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVG 261
L YLH II+RDLK N+LLD++ + KI+DFG A+ T + G
Sbjct: 118 A----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCG 165
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 295
T Y+APE S ++ D +SFGIL+ E+++G
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 53/225 (23%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHR 151
+ I + LG+G FG V Q++A+K +S+ + + + ++ E+ L+H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKS------------LDSFIFDQERCMILDWSKRFH- 198
+++KL Y+ + + L +I +++R + + F
Sbjct: 70 HIIKL-------------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQ 116
Query: 199 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGN 255
IIC Y H R +I+HRDLK N+LLD ++N KI+DFGL+ T
Sbjct: 117 IICAIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT--- 166
Query: 256 TNRVVGTYGYMAPEYAS----DGQFSVKSDVFSFGILLLEIVSGK 296
G+ Y APE + G + DV+S GI+L ++ G+
Sbjct: 167 ---SCGSPNYAAPEVINGKLYAGP---EVDVWSCGIVLYVMLVGR 205
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 44/206 (21%), Positives = 83/206 (40%), Gaps = 33/206 (16%)
Query: 99 INKKLGQGGFGPVYKG-KLVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNLVKL 156
++ LG G G V + ++ A+K L + + EV + + Q ++V++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120
Query: 157 LGCC---IQGEEKL-LIYEFMPNKSLDSFIFD--QERCMIL----DWSKRFHIICGTARG 206
+ G + L ++ E + L F Q+R + S+ I
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEA--- 173
Query: 207 LLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
+ YLH + I HRD+K N+L + K++DFG A+ + T
Sbjct: 174 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTP 227
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILL 289
Y+APE ++ D++S G+++
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 149
++F K +G+G FG V + + AVK L K + ++ K + +E +L ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 150 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSL-----DSFIFDQERCMILDWSKRF---HII 200
H LV L Q +KL + +++ L F + R RF I
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RFYAAEIA 149
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
L YLH L I++RDLK N+LLD + ++DFGL + E T+
Sbjct: 150 SA----LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFC 200
Query: 261 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
GT Y+APE + D + G +L E++ G
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 51/217 (23%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 150
++ + K +G+G FG V + +++ A+K LSK I E + +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 151 RNLVKLLGCCIQGEEKL-LIYEFMPN----KSLDSFIFDQERCMILDWSKRFH---IICG 202
+V+L Q + L ++ E+MP + ++ ++ RF+ ++
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-------RFYTAEVVLA 180
Query: 203 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 262
L +H + IHRD+K N+LLD+ + K++DFG + + VGT
Sbjct: 181 ----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGT 232
Query: 263 YGYMAPE----YASDGQFSVKSDVFSFGILLLEIVSG 295
Y++PE DG + + D +S G+ L E++ G
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 52/226 (23%), Positives = 100/226 (44%), Gaps = 31/226 (13%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HR 151
+++ + +KLG+G + V++ + + +++ VK L + + K++K E+ + L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGP 91
Query: 152 NLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFI--FDQERCMILDWSKRFHI--ICGTAR 205
N++ L + L++E + N RF++ I +
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI-------RFYMYEIL---K 141
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
L Y H S I+HRD+K NV++D + ++ D+GLA + RV Y
Sbjct: 142 ALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY- 195
Query: 265 YMAPEYASDGQFSVKS-DVFSFGILLLEIVSGKKNRGFYHSDNNLN 309
+ PE D Q S D++S G +L ++ K F+H +N +
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK--EPFFHGHDNYD 239
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 95 NNFSINKKLGQGGFGPVY---KGKLVDGQEI-AVKRLSK---ISEQGLKE-LKNEVILFS 146
F + + LG+GG+G V+ K + +I A+K L K + K E +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 147 KLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSL-----DSFIFDQERCMILDWSKRF--- 197
+++H +V L+ Q KL LI E++ L IF ++ F
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-------CFYLA 128
Query: 198 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 257
I L +LHQ II+RDLK N++L+ + K++DFGL + D T +T
Sbjct: 129 EISMA----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT- 180
Query: 258 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
GT YMAPE + D +S G L+ ++++G
Sbjct: 181 -FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK--ISEQGLKELKNEV--------I 143
+NF + LG+G FG V ++ + ++ AVK L K I + ++V I
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ------DDDVECTMTEKRI 76
Query: 144 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSL-----DSFIFDQERCMILDWSKRF 197
L H L +L CC Q ++L + EF+ L S FD+ R RF
Sbjct: 77 LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-------RF 128
Query: 198 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 257
+ L++LH II+RDLK NVLLD + + K++DFG+ + + T
Sbjct: 129 YAAE-IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT- 183
Query: 258 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
GT Y+APE + + D ++ G+LL E++ G
Sbjct: 184 -FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 33/217 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 149
+F+ LG+G FG V + E+ AVK L K I + ++ E +L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 150 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSL-----DSFIFDQERCMILDWSKRFH---II 200
L +L C Q ++L + E++ L F + F+ I
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAEIA 131
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTNRV 259
G L +L II+RDLK NV+LD + + KI+DFG+ + T T
Sbjct: 132 IG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTF 181
Query: 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
GT Y+APE + + D ++FG+LL E+++G+
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 149
+F+ LG+G FG V + E+ AVK L K I + ++ E +L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 150 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSL-----DSFIFDQERCMILDWSKRFHIICGT 203
L +L C Q ++L + E++ L F + F+
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE-I 451
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTNRVVGT 262
A GL +L II+RDLK NV+LD + + KI+DFG+ + T T GT
Sbjct: 452 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGT 505
Query: 263 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
Y+APE + + D ++FG+LL E+++G+
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 149
+F + + +G+G + V +L I A+K + K ++ + ++ E +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 150 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSL-----DSFIFDQERCMILDWSKRFH---II 200
H LV L C Q E +L + E++ L +E RF+ I
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAEIS 120
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF-GGDETEGNTNRV 259
L YLH+ II+RDLK NVLLD + + K++D+G+ + +T T+
Sbjct: 121 LA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTF 170
Query: 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
GT Y+APE + D ++ G+L+ E+++G+
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 153
+ K +G G FG + + + +AVK + + + E ++ E+I L+H N+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNI 78
Query: 154 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRF--HIICGTARGLLYL 210
V+ I L +I E+ L I + R D ++ F ++ G + Y
Sbjct: 79 VRFKEV-ILTPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSGVS----YC 132
Query: 211 HQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLARAFGGDE---TEGNTNRVVGTYGY 265
H ++I HRDLK N LLD KI DFG +++ + VGT Y
Sbjct: 133 H---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS------TVGTPAY 183
Query: 266 MAPEYAS----DGQFSVKSDVFSFGILLLEIVSG 295
+APE DG+ +DV+S G+ L ++ G
Sbjct: 184 IAPEVLLRQEYDGK---IADVWSCGVTLYVMLVG 214
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 149
+F ++K LG+G FG V+ + + A+K L K + + ++ E +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 150 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSL-----DSFIFDQERCMILDWSKRFHIICGT 203
H L + C Q +E L + E++ L FD R F+
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-------TFYAAE-I 127
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF-GGDETEGNTNRVVGT 262
GL +LH I++RDLK N+LLD+D + KI+DFG+ + GD TN GT
Sbjct: 128 ILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGT 181
Query: 263 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSG 295
Y+APE +++ D +SFG+LL E++ G
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 54/247 (21%), Positives = 101/247 (40%), Gaps = 57/247 (23%)
Query: 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 152
+ +S+ K LG G FG V + ++ G+ A+K++ + +EL + L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDHVN 61
Query: 153 LVKLLGCCIQGEEKL--------------------------------------LIYEFMP 174
++KL+ ++ +I E++P
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 175 ---NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 231
+K L SFI + ++ + I R + ++H L I HRD+K N+L++
Sbjct: 122 DTLHKVLKSFIRSGRS-IPMNLISIY--IYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 232 QDMNP-KISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILL 289
N K+ DFG A+ +E + + + Y APE +++ D++S G +
Sbjct: 176 SKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 290 LEIVSGK 296
E++ GK
Sbjct: 233 GELILGK 239
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 9e-20
Identities = 38/95 (40%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT- 262
A+G+ +L + + IHRDL A N+LL + KI DFGLAR D + G
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGDA 255
Query: 263 ---YGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
+MAPE D ++++SDV+SFG+LL EI S
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 35/160 (21%), Positives = 62/160 (38%), Gaps = 19/160 (11%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 147
+ + K LG+G FG V + + +AVK L + + L +E+ +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 148 L-QHRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTAR 205
+ H N+V LLG C + G ++I EF +L +++ SKR + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245
G + + I DLK + + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 149
+F + + +G+G + V +L I A++ + K ++ + ++ E +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 150 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSL-----DSFIFDQERCMILDWSKRFH---II 200
H LV L C Q E +L + E++ L +E RF+ I
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAEIS 163
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
L YLH+ II+RDLK NVLLD + + K++D+G+ + T+
Sbjct: 164 LA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFC 214
Query: 261 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
GT Y+APE + D ++ G+L+ E+++G+
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 40/224 (17%)
Query: 95 NNFSINKKLGQGGFGPVY---KGKLVDGQEI-AVKRLSK---ISEQGLKE-LKNE-VILF 145
NF + K LG G +G V+ K D ++ A+K L K + + E + E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 146 SKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSL-----DSFIFDQERCMILDWSKRFH- 198
Q LV L Q E KL LI +++ L F + + +
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-------QIYV 165
Query: 199 --IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256
I+ L +LH+ L II+RD+K N+LLD + + ++DFGL++ F DETE
Sbjct: 166 GEIVLA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-A 217
Query: 257 NRVVGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIVSGK 296
GT YMAP+ G +V D +S G+L+ E+++G
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 146
+ +G G +G V G+++A+K+LS+ + +EL L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLK 78
Query: 147 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHII 200
+QH N++ LL + L+ FM L + + ++ ++
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQY-LV 132
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
+GL Y+H ++HRDLK N+ +++D KI DFGLAR + T V
Sbjct: 133 YQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YV 184
Query: 261 GTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 296
T Y APE S ++ D++S G ++ E+++GK
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSK 147
++ +G+G +G V ++ +A+K++S Q L+E+K + +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 148 LQHRNLVKLLGCCI-QGEEKL----LIYEFMP---NKSLDSFIFDQERCMILDWSKRFHI 199
+H N++ + E++ ++ + M K L + + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC--------YF 133
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN--TN 257
+ RGL Y+H + ++HRDLK SN+LL+ + KI DFGLAR D T
Sbjct: 134 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 258 RVVGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 296
V T Y APE + ++ D++S G +L E++S +
Sbjct: 191 YVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 31/217 (14%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 146
+ + +G G +G V G ++A+K+L + + +EL+ L
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79
Query: 147 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHII 200
++H N++ LL + L+ FM L + + L + ++
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLV 134
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
+GL Y+H IIHRDLK N+ +++D KI DFGLAR + T V
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-----YV 186
Query: 261 GTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 296
T Y APE + +++ D++S G ++ E+++GK
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 42/199 (21%), Positives = 88/199 (44%), Gaps = 33/199 (16%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 146
+ + I +G G +G V + ++ + +A+K++ ++ E L+E+ + +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILN 107
Query: 147 KLQHRNLVKLLGCCIQGEEKL-----LIYEFMP---NKSLDSFIF--DQERCMILDWSKR 196
+L H ++VK+L I + + ++ E K + ++ + +L
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLL----- 162
Query: 197 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256
++++ G+ Y+H S I+HRDLK +N L++QD + K+ DFGLAR E +
Sbjct: 163 YNLL----VGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 257 NRVVGTYGYMAPEYASDGQ 275
+ M +
Sbjct: 216 LPISPREDDMNLVTFPHTK 234
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 146
+ K +G G G V V + +A+K+LS+ + +EL L
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMK 116
Query: 147 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHII 200
+ H+N++ LL + ++ L+ E M L I + + + ++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI----QMELDHERMSY-LL 170
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
G+ +LH IIHRDLK SN+++ D KI DFGLAR + T VV
Sbjct: 171 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV 225
Query: 261 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
T Y APE + D++S G ++ E+V K
Sbjct: 226 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 146
+ +G G +G V G +AVK+LS+ + +EL+ L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLK 83
Query: 147 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHII 200
++H N++ LL + + L+ M L++ + +C L +I
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV----KCQKLTDDHVQFLI 138
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
RGL Y+H IIHRDLK SN+ +++D KI DFGLAR + T V
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-----YV 190
Query: 261 GTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 296
T Y APE + ++ D++S G ++ E+++G+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 53/232 (22%), Positives = 89/232 (38%), Gaps = 50/232 (21%)
Query: 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQG---------------LKEL 138
+ +++ + + G +G V G +G +A+KR+ G L+E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 139 KNEVILFSKLQHRNLVKLLGCCI-QGEEKL----LIYEFMPN------KSLDSFIFDQER 187
+ L + H N++ L + E + L+ E M I Q
Sbjct: 81 R----LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136
Query: 188 CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247
+ +HI+ GL LH+ ++HRDL N+LL + + I DF LAR
Sbjct: 137 QYFM-----YHIL----LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 248 GGDE--TEGNTNRVVGTYGYMAPEY-ASDGQFSVKSDVFSFGILLLEIVSGK 296
D T V Y APE F+ D++S G ++ E+ + K
Sbjct: 185 TADANKTH-----YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 146
+ K +G G G V + + +A+K+LS+ + +EL L
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMK 79
Query: 147 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFI---FDQERCMILDWSKRF 197
+ H+N++ LL + ++ ++ E M +L I D ER +
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERM-------SY 131
Query: 198 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN 257
++ G+ +LH IIHRDLK SN+++ D KI DFGLAR + T
Sbjct: 132 -LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 185
Query: 258 RVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
VV T Y APE + D++S G ++ E++ G
Sbjct: 186 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 40/228 (17%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQ 149
+ + K LG GG G V+ + +A+K KI + +K+ E+ + +L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLD 66
Query: 150 HRNLVKLL----------GCCIQGEEKL----LIYEFMP---NKSLDSFIFDQERCMILD 192
H N+VK+ + +L ++ E+M L+ +E
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA---- 122
Query: 193 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDE 251
R + RGL Y+H + ++HRDLK +N+ ++ +D+ KI DFGLAR
Sbjct: 123 ---RL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 252 TEGN--TNRVVGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIVSGK 296
+ + +V T Y +P S ++ D+++ G + E+++GK
Sbjct: 176 SHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 52/226 (23%), Positives = 98/226 (43%), Gaps = 38/226 (16%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSK 147
+++F + LG+G +G V G+ +A+K++ + L+E+K +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKH 65
Query: 148 LQHRNLVKLLGCCI-QGEEKL----LIYEFMP---NKSLDSFIFDQERCMILDWSKRFHI 199
+H N++ + E +I E M ++ + + + + ++
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-------QY-F 117
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 259
I T R + LH + +IHRDLK SN+L++ + + K+ DFGLAR + +
Sbjct: 118 IYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 260 --------VGTYGYMAPEY-ASDGQFSVKSDVFSFGILLLEIVSGK 296
V T Y APE + ++S DV+S G +L E+ +
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 43/207 (20%), Positives = 77/207 (37%), Gaps = 49/207 (23%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 146
+N+ I +G+G +G VY + +A+K+++++ E L+E+ + +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT----ILN 80
Query: 147 KLQHRNLVKLLGCCI-QGEEKL----LIYEFMP---------NKSLDS----FIFDQERC 188
+L+ +++L I K ++ E L I
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYN--- 137
Query: 189 MILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248
+L G ++H IIHRDLK +N LL+QD + K+ DFGLAR
Sbjct: 138 -LL-------------LGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 249 GDETEGNTNRVVGTYGYMAPEYASDGQ 275
++ N + Q
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQ 207
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 36/161 (22%), Positives = 65/161 (40%), Gaps = 30/161 (18%)
Query: 99 INKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNLVKL 156
++ LG G G V + ++ A+K L + + EV + + Q ++V++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76
Query: 157 LGCC---IQGEEKL-LIYEFMPNKSLDSFIFD--QERCMIL----DWSKRFHIICGTARG 206
+ G + L ++ E + L F Q+R + S+ I
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEA--- 129
Query: 207 LLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLA 244
+ YLH + I HRD+K N+L + K++DFG A
Sbjct: 130 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 57/235 (24%), Positives = 104/235 (44%), Gaps = 46/235 (19%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 146
+ + KKLG+G +G V+K G+ +AVK++ + +E+ IL
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM---ILTE 64
Query: 147 KLQHRNLVKLLGCCI--QGEEKLLIYEFMP---NKSLDSFIFDQERCMILDWSKRFHIIC 201
H N+V LL + L++++M + + + I + ++ ++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK-------QY-VVY 116
Query: 202 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV-- 259
+ + YLH S ++HRD+K SN+LL+ + + K++DFGL+R+F N +
Sbjct: 117 QLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 260 -----------------VGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 296
V T Y APE +++ D++S G +L EI+ GK
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.5 bits (174), Expect = 7e-14
Identities = 34/222 (15%), Positives = 65/222 (29%), Gaps = 63/222 (28%)
Query: 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRL--------SKISEQGLKELKNEVIL 144
T +K+G+G FG V++ D +A+K + + ++ +E+ E+I+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 145 FSKLQ---------HRNLVKLLGCCI-----------------------------QGEEK 166
+L + L +++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 226
L I +D +Q R + + I+ L LR HRDL
Sbjct: 137 LFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWG 191
Query: 227 NVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 268
NVLL + K+ ++ + + G
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVS 222
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 52/238 (21%), Positives = 89/238 (37%), Gaps = 68/238 (28%)
Query: 99 INKKLGQGGFGPVYKGK-LVDGQEIAVKRL---SKISEQGLKELK-------NEVILFSK 147
+ +KLG G F V+ K +V+ +A+K + +E E+K +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQER----CM--------ILDWSK 195
+ +++KLL D F M +L K
Sbjct: 83 MGANHILKLL---------------------DHFNHKGPNGVHVVMVFEVLGENLLALIK 121
Query: 196 RFH-------IICGTAR----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNP------KI 238
++ + ++ GL Y+H R IIH D+K NVL++ +P KI
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179
Query: 239 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
+D G A E TN + T Y +PE + +D++S L+ E+++G
Sbjct: 180 ADLGNAC----WYDEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 35/293 (11%), Positives = 80/293 (27%), Gaps = 59/293 (20%)
Query: 102 KLGQGGFGPVYKGKLVD---GQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLVK 155
G ++ +D +++A+ + + + L+E + + S++ + +
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 156 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSR 215
+L L++ E++ SL + A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA--DTS---PSPVGAIRAMQSLAAAADAAH---R 147
Query: 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ 275
+ S V + D G V+ M
Sbjct: 148 AGVALSIDHPSRVRVSID--------GDV--------------VLAYPATMPDA------ 179
Query: 276 FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM--PSQLIDSCFQD 333
+ + D+ G L ++ R + + A + P+ +
Sbjct: 180 -NPQDDIRGIGASLYALLVN---RWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI--- 232
Query: 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLPQPKQPGYLADR 386
F ++ V VQ R + + LM + V + + G + +
Sbjct: 233 PFQISAVA------ARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEA 279
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 38/165 (23%), Positives = 71/165 (43%), Gaps = 27/165 (16%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 152
N + + +K+G G FG +Y G + G+E+A+K ++ L E ++ +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQER-------CMILDWSKRFHIICGTAR 205
+ + C +G+ +++ E + SL+ R ++ D +I
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD-----QMI----S 116
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLARAF 247
+ Y+H + IHRD+K N L+ I DFGLA+ +
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 38/165 (23%), Positives = 71/165 (43%), Gaps = 27/165 (16%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 153
N F + +K+G G FG +Y G + +E+A+K + ++ L E ++ LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTG 64
Query: 154 V-KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQER-------CMILDWSKRFHIICGTAR 205
+ + ++G+ +L+ + + SL+ R M+ D +I
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQ-----MIN---- 114
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLARAF 247
+ ++H S +HRD+K N L+ I DFGLA+ +
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 42/206 (20%), Positives = 80/206 (38%), Gaps = 42/206 (20%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 153
N + + KK+G GGFG +Y ++ A + K+ Q L +E+ + ++ ++
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDC 95
Query: 154 VKLLGCCIQGEEKLLIYEFMPN---KSLDSFIFDQERCMILD-----------WSKRFHI 199
+ E K L Y +P L F R M+++ + F
Sbjct: 96 I-----KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKK 150
Query: 200 --ICGTARGLL----YLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLARAFGGDE 251
+ +L Y+H++ +H D+KA+N+LL ++ +D+GL+ + +
Sbjct: 151 STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
Query: 252 T-----EGNTNRVVGTYGYMAPEYAS 272
E GT E+ S
Sbjct: 208 NHKQYQENPRKGHNGT-----IEFTS 228
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 29/167 (17%), Positives = 74/167 (44%), Gaps = 29/167 (17%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 152
++ + +++G+G FG +++G L++ Q++A+K + S+ L++E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 67
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQER-------CMILDWSKRFHIICGTAR 205
+ + +G +L+ + + SL+ + R M ++
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAK-----QMLA---- 117
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLARAF 247
+ +H+ S +++RD+K N L+ + + + DFG+ + +
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 43/222 (19%), Positives = 80/222 (36%), Gaps = 44/222 (19%)
Query: 81 ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLS--KISEQGLKEL 138
+ + E+ T ++A + + +GQGGFG +Y + + + K+ L
Sbjct: 22 QFAVGEIITDMAA-AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPL 80
Query: 139 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN---KSLDSFIFDQERCMILDW-- 193
E+ + + ++ + L Y +P L R MI+D
Sbjct: 81 FTELKFYQRAAKPEQIQKW-----IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135
Query: 194 ----------SKRFHI--ICGTARGLL----YLHQDSRLRIIHRDLKASNVLLDQDMNPK 237
+KRF + + +L Y+H+ +H D+KASN+LL+ +
Sbjct: 136 SDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQ 192
Query: 238 I--SDFGLARAFGGDET-----EGNTNRVVGTYGYMAPEYAS 272
+ D+GLA + + GT E+ S
Sbjct: 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT-----IEFTS 229
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 60/229 (26%)
Query: 97 FSINKKLGQGGFGPVYKGK-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHR- 151
+ + K +G+G FG V K Q +A+K + + Q +E++ IL L+ +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR---IL-EHLRKQD 154
Query: 152 -----NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQERCM---ILDW 193
N++ +L C+ E LL +YE + F R IL
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ- 211
Query: 194 SKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDE 251
L LH + RIIH DLK N+LL Q K+ DFG + +
Sbjct: 212 ------------CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CY---- 251
Query: 252 TEGNTNRVVGTY----GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
++ V TY Y APE ++ + D++S G +L E+++G
Sbjct: 252 ----EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 9e-10
Identities = 54/269 (20%), Positives = 94/269 (34%), Gaps = 61/269 (22%)
Query: 57 YLIRKRRRNIAEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGK- 115
Y K ND + + + + + + I+ +G+G FG V K
Sbjct: 19 YFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKW---MDRYEIDSLIGKGSFGQVVKAYD 75
Query: 116 LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQHR------NLVKLLGC------- 159
V+ + +A+K Q E++ +L + +V L
Sbjct: 76 RVEQEWVAIKIIKNKKAFLNQAQIEVR---LL-ELMNKHDTEMKYYIVHLKRHFMFRNHL 131
Query: 160 CIQGEEKLL---IYEFMPNKSLDSFIFDQERCM---ILDWSKRFHIICGTARGLLYLHQD 213
C+ E +L +Y+ + N + + R + LL+L
Sbjct: 132 CLVFE--MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT-------------ALLFLA-T 175
Query: 214 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTNRVVGTY----GYMA 267
L IIH DLK N+LL KI DFG + G + Y Y +
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQR--------IYQYIQSRFYRS 226
Query: 268 PEYASDGQFSVKSDVFSFGILLLEIVSGK 296
PE + + D++S G +L+E+ +G+
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 41/166 (24%), Positives = 72/166 (43%), Gaps = 27/166 (16%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 152
NF + KK+G G FG + GK L + +A+K S +L E + +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHI--ICGTARGLL-- 208
+ ++ G+ ++ E + SL+ +FD C + F + + A L+
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLED-LFDL--C-----DRTFSLKTVLMIAIQLISR 117
Query: 209 --YLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLARAF 247
Y+H + +I+RD+K N L+ + N I DF LA+ +
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 52/266 (19%), Positives = 94/266 (35%), Gaps = 74/266 (27%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--- 149
+ + +KLG G F V+ + + +A+K + K +E + +E+ L ++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94
Query: 150 -----HRNLVKLLGC-CIQGEE---KLLIYEFMPNKSLDSFIFDQERCMI-LDWSKRFHI 199
+V+LL I G +++E + L +I + L K+ I
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKK--I 151
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLL----------------------------- 230
I +GL YLH ++ RIIH D+K N+LL
Sbjct: 152 IQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 231 --------------------DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
+ + KI+D G A TE + T Y + E
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEV 264
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSGK 296
++ +D++S + E+ +G
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGD 290
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 32/215 (14%), Positives = 70/215 (32%), Gaps = 57/215 (26%)
Query: 95 NNFSINKKLGQGGFGPVYKGK---------LVDGQEIAVKRLSKISEQGLKELK------ 139
+ + + G +Y+ Q+ ++K L + E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 140 --NEVILFSKLQHRNLV---KLLGCCIQGEEKLLIYEFMP----NKSLDSFIFDQERCMI 190
+V + KL L+ +G + ++ Y F+ +SL S + +
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQSALDVSPK--- 153
Query: 191 LDWSKRFHI--ICGTARGLL----YLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFG 242
+ A LL +LH++ +H ++ A N+ +D + ++ + +G
Sbjct: 154 ----HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYG 206
Query: 243 LARAFGGDET-----EGNTNRVVGTYGYMAPEYAS 272
A + EG+ + G E+ S
Sbjct: 207 FAFRYCPSGKHVAYVEGSRSPHEGD-----LEFIS 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 57/245 (23%), Positives = 90/245 (36%), Gaps = 64/245 (26%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQ 149
N F + +K+G G FG V + + + + AVK + K + E IL K+Q
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD---IL-KKIQ 89
Query: 150 HR-----NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQERCM---IL 191
+ N+VK G C+ E L +YE + + + F + + IL
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 192 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251
+ L YL ++ + H DLK N+LLD K G
Sbjct: 148 -------------KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 252 TEGNTNR--------------------VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLE 291
T ++ T Y APE + + V SD++SFG +L E
Sbjct: 192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
Query: 292 IVSGK 296
+ +G
Sbjct: 252 LYTGS 256
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 50/246 (20%), Positives = 83/246 (33%), Gaps = 70/246 (28%)
Query: 94 TNNFSINKKLGQGGFGPVYKG--KLVDGQEIAVK---RLSKISEQGLKELKNEVILFSKL 148
+ I LG+G FG V + ++A+K + K E E+ +L K+
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VL-KKI 73
Query: 149 QHR------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQERCM--- 189
+ + V + CI E LL +EF+ + + R M
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 190 ILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP------------- 236
+ L +LH ++ H DLK N+L
Sbjct: 132 LC-------------HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175
Query: 237 ------KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLL 290
+++DFG A F + + +V T Y PE + ++ DV+S G +L
Sbjct: 176 VKNTSIRVADFGSA-TFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILF 230
Query: 291 EIVSGK 296
E G
Sbjct: 231 EYYRGF 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 56/242 (23%), Positives = 88/242 (36%), Gaps = 62/242 (25%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK--LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKL 148
+ + I LG+G FG V + G+ +AVK + + E E++ +L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VL-EHL 68
Query: 149 QHR------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQERCM--- 189
V++L CI E LL Y+F+ F D R M
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENGFLPFRLDHIRKMAYQ 126
Query: 190 ILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA--- 246
I + + +LH ++ H DLK N+L Q + + + R
Sbjct: 127 IC-------------KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170
Query: 247 ----------FGG--DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS 294
FG + E + + +V T Y APE +S DV+S G +L+E
Sbjct: 171 LINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229
Query: 295 GK 296
G
Sbjct: 230 GF 231
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 7e-06
Identities = 60/446 (13%), Positives = 116/446 (26%), Gaps = 159/446 (35%)
Query: 3 FGDLIDIRYFQDGGQDLYIR--MSASELEAKGEPTTKIVVIVISSAALLAVLLIAGYLIR 60
F D D + QD + +S E++ I++S A+ L + L+
Sbjct: 29 FVDNFDCKDVQD-----MPKSILSKEEIDH----------IIMSKDAVSGTLRLFWTLLS 73
Query: 61 KRRRNIAEKTEN----------DQIQ--NIDLELPLFELATIVSATNN----FS------ 98
K+ + + E I+ + N F+
Sbjct: 74 KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR 133
Query: 99 ------INKKL------------GQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKN 140
+ + L G G GK +
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGS-----GKTW--------------------VAL 168
Query: 141 EVILFSKLQHRNLVKL----LGCCIQGEEKL-----LIYEFMPN---------------- 175
+V L K+Q + K+ L C E L L+Y+ PN
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 176 ---KSLDSFIFDQ--ERC-MILD--WSKR----FHIICGTARGLLYLHQDSRLRIIHRDL 223
L + + E C ++L + + F++ C ++ + R
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC-------------KILLTTRFK 275
Query: 224 KASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVF 283
+ ++ L D + DE + + + P
Sbjct: 276 QVTDFLSAATTTHISLDH-HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT--------- 325
Query: 284 SFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRC 343
L I++ G DN WK N + +I+S + AE +
Sbjct: 326 --NPRRLSIIAESIRDGLATWDN--------WKHVNCDKLTTIIESSL-NVLEPAEYRKM 374
Query: 344 IH-IGLLCVQQHPEDRPSMPSVILML 368
+ + P ++ ++
Sbjct: 375 FDRLSVF-----PPSAHIPTILLSLI 395
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 414 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.03 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.74 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.6 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.58 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.53 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.48 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.4 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.2 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.18 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.0 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.94 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.91 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.64 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.59 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.55 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.51 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.5 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.49 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.28 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.06 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.03 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.95 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.33 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.92 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.7 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.31 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 93.24 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.38 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.49 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.19 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-58 Score=429.49 Aligned_cols=258 Identities=28% Similarity=0.466 Sum_probs=211.9
Q ss_pred CCCCCCCeecccCCceEEEEEEc------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
++|.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+.+|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888899999999999999863 467899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhccc----------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEE
Q 043285 169 IYEFMPNKSLDSFIFDQE----------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 238 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL 238 (414)
|||||++|+|.++|.... ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 2345999999999999999999999988 999999999999999999999
Q ss_pred EeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHH
Q 043285 239 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKL 317 (414)
Q Consensus 239 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 317 (414)
+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.... ..++......
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i~~- 245 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIECITQ- 245 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHH-
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHc-
Confidence 99999987644333333444579999999999999999999999999999999999 899975432 2223322222
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
........ .. ..++.+|+.+||+.||++|||++||++.|++.
T Consensus 246 ---~~~~~~p~-----~~----~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 246 ---GRVLQRPR-----TC----PQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp ---TCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCc-----cc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111111 11 12467899999999999999999999999653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-57 Score=429.36 Aligned_cols=258 Identities=28% Similarity=0.438 Sum_probs=205.1
Q ss_pred CCCCCCCeecccCCceEEEEEEc------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
++|.+.+.||+|+||+||+|++. ++..||||+++.......+.|.+|+.+|++++|||||+++|+|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56778899999999999999864 477899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcccc------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCe
Q 043285 169 IYEFMPNKSLDSFIFDQER------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 236 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~ 236 (414)
|||||++|+|.+++..... ...+++.+++.++.|+++||+|||+++ |+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999975421 235899999999999999999999988 9999999999999999999
Q ss_pred EEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043285 237 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 237 kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 315 (414)
||+|||+++.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||.... ..++...+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---NTEAIDCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC---HHHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC---HHHHHHHHH
Confidence 9999999987654443334445679999999999999999999999999999999999 899975432 222332222
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 316 KLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
. ........ ... ..+.+|+.+||+.||++||||.||++.|+..
T Consensus 275 ~----g~~~~~p~-----~~~----~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 275 Q----GRELERPR-----ACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp H----TCCCCCCT-----TCC----HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred c----CCCCCCcc-----ccc----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 2 11111111 111 2467789999999999999999999999654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=426.96 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=210.4
Q ss_pred CCCCCCCeecccCCceEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
.++++.+.||+|+||+||+|++. +++.||||+++.. .....+.|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677789999999999999863 4678999999753 3345678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 043285 168 LIYEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 234 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~ 234 (414)
+|||||++|+|.++|..... ...+++..++.++.|+|+||+|||+++ |+||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 235899999999999999999999998 99999999999999999
Q ss_pred CeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHH
Q 043285 235 NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGH 313 (414)
Q Consensus 235 ~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~ 313 (414)
.+||+|||+++.+.............||+.|||||++.++.|+.++|||||||+||||+| |+.||.... ..++...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~---~~~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---HHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---HHHHHHH
Confidence 999999999987654433334455679999999999999999999999999999999999 888875432 2223322
Q ss_pred HHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 043285 314 AWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372 (414)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 372 (414)
+. ........+.+ ...+.+|+.+||+.||++||||.||++.|+...
T Consensus 260 i~----~~~~~~~p~~~---------~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 260 IR----NRQVLPCPDDC---------PAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HH----TTCCCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HH----cCCCCCCcccc---------hHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 22 22222222211 124678999999999999999999999997643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=419.48 Aligned_cols=259 Identities=27% Similarity=0.443 Sum_probs=199.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.+++++.+.||+|+||+||+|++. ..||||+++. ......+.|.+|+.++++++|||||+++|+|.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 367888899999999999999864 3699999864 345567789999999999999999999998854 56899999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
||++|+|.+++.... ..+++..+..++.|+|+||+|||+++ |+||||||+||||++++.+||+|||+++......
T Consensus 112 y~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999999997543 24899999999999999999999988 9999999999999999999999999998764433
Q ss_pred CccccccccccccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
........+||+.|||||++.+ +.|+.++|||||||+||||+||+.||..... ...+..........+.......
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--RDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHTTCCCCCSTTSCT
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCCCCcccccc
Confidence 3334455689999999999864 4689999999999999999999999853221 1111111111111111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
.. ...+.+++.+||+.||++||||.||++.|+..
T Consensus 265 -----~~----~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 265 -----NC----PKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp -----TS----CHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred -----cc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 23567789999999999999999999988543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-56 Score=420.50 Aligned_cols=250 Identities=23% Similarity=0.397 Sum_probs=201.3
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++|++.+.||+|+||+||+|+.. +|+.||||++.. ......+.+.+|+.+++.++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999864 589999999965 344556789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
||++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-- 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-- 177 (350)
T ss_dssp CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH--
T ss_pred CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC--
Confidence 9999999999975443 34789999999999999999999998 99999999999999999999999999986531
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
........+||+.|||||++.+..|+.++|||||||+||||+||+.||.... ...+. ........+ ..
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~---~~i~~~~~~-~~----- 245 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS---MKNLV---LKIISGSFP-PV----- 245 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHH---HHHHHTCCC-CC-----
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHH---HHHHcCCCC-CC-----
Confidence 1122345679999999999999999999999999999999999999985421 12222 222222221 11
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
....+ .++.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLHYS----YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122 24677899999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=410.73 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=208.2
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999986 46899999999752 2345678999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
|||++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999997654 3999999999999999999999998 999999999999999999999999999987544
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.........+||+.|||||++.+..|+.++||||+||++|||+||+.||... ....+...+ ..... .+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i---~~~~~--~~---- 253 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKI---IKLEY--DF---- 253 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH---HHTCC--CC----
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHH---HcCCC--CC----
Confidence 4444556678999999999999999999999999999999999999998532 222222222 22211 11
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl 365 (414)
....+ .++.+|+.+||+.||++|||++|++
T Consensus 254 -p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 -PEKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 11222 2467789999999999999999964
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-55 Score=413.06 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=206.3
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
..|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999874 58999999997654445567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+... .
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~ 224 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--V 224 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--S
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC--C
Confidence 999999998653 3899999999999999999999998 999999999999999999999999999876432 2
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||... ........+. ......+.. ..
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~----~~~~~~~~~---~~ 294 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIR----DNLPPRLKN---LH 294 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHH----HSSCCCCSC---GG
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHH----cCCCCCCCc---cc
Confidence 2344578999999999999999999999999999999999999998532 2222222221 111111111 01
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..+ ..+.+|+.+||+.||++|||++|+++
T Consensus 295 ~~s----~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVS----PSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 24677899999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=400.02 Aligned_cols=246 Identities=24% Similarity=0.395 Sum_probs=196.7
Q ss_pred CCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCeeeEEE
Q 043285 98 SINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIY 170 (414)
Q Consensus 98 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 170 (414)
++.+.||+|+||+||+|... ++..||+|++.. ......+.+.+|+.+++.++|||||+++++|.+ ....++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 66788999999999999874 588999999964 344556789999999999999999999999875 34589999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCeEEEeecCccccCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGG 249 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kL~Dfgl~~~~~~ 249 (414)
|||++|+|.+++.+.. .+++..+..++.||+.||+|||+++ ++|+||||||+|||++ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999997654 3899999999999999999999975 4599999999999998 479999999999986422
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ... ...........+...+
T Consensus 185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~--~~~----~~~~~i~~~~~~~~~~- 252 (290)
T 3fpq_A 185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAA----QIYRRVTSGVKPASFD- 252 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHH----HHHHHHTTTCCCGGGG-
T ss_pred ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC--cHH----HHHHHHHcCCCCCCCC-
Confidence 23345689999999998865 69999999999999999999999985321 111 1111122221111111
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...+ .++.+|+.+||+.||++|||++|+++
T Consensus 253 ---~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 ---KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 24667899999999999999999996
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-55 Score=416.27 Aligned_cols=266 Identities=28% Similarity=0.406 Sum_probs=212.9
Q ss_pred HHHHHHhcCCCCCCCeecccCCceEEEEEEcC------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCC-CceeeeEe
Q 043285 87 LATIVSATNNFSINKKLGQGGFGPVYKGKLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQH-RNLVKLLG 158 (414)
Q Consensus 87 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~~~~ 158 (414)
..+.....++|++.+.||+|+||+||+|++.. ++.||||++... .....+.+.+|+.+|.+++| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 33444456889999999999999999997643 357999999763 34456789999999999965 89999999
Q ss_pred EEEeC-CeeeEEEeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 043285 159 CCIQG-EEKLLIYEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 224 (414)
Q Consensus 159 ~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk 224 (414)
+|.+. +..++|||||++|+|.++|..... ...+++..++.++.|+|+||+|||+++ |+|||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence 99764 568999999999999999975432 234899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 043285 225 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYH 303 (414)
Q Consensus 225 ~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~ 303 (414)
|+|||+++++.+||+|||+++.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987755444444455679999999999999999999999999999999998 899975432
Q ss_pred CCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 304 SDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. ..+.... ..+......+. .. .++.+++.+||+.||++|||+.||++.|+.
T Consensus 293 ~~--~~~~~~i----~~g~~~~~p~~-----~~----~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 293 ID--EEFCRRL----KEGTRMRAPDY-----TT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CS--HHHHHHH----HHTCCCCCCTT-----CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH--HHHHHHH----HcCCCCCCCcc-----CC----HHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 21 1222222 22222222221 11 246778999999999999999999998854
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=410.14 Aligned_cols=250 Identities=24% Similarity=0.284 Sum_probs=200.7
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
+.|++.++||+|+||+||+|+.. +|+.||||+++.... ..+|+.+++.++|||||++++++.+++..|+|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56788889999999999999874 589999999975321 246999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CeEEEeecCccccCCCCC
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGGDET 252 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kL~Dfgl~~~~~~~~~ 252 (414)
++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||||+.+| .+||+|||+++.+.....
T Consensus 133 ~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999997654 3999999999999999999999998 99999999999999987 699999999987643322
Q ss_pred c---cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 253 E---GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 253 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
. ......+||+.|||||++.+..|+.++|||||||++|||+||+.||....... +...+. ....+..
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~---~~~~~~~---- 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKIA---SEPPPIR---- 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHHH---HSCCGGG----
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHH---cCCCCch----
Confidence 1 12334679999999999999999999999999999999999999986543322 222222 1111100
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
.+....+ ..+.+++.+||+.||++|||+.|+++.|.
T Consensus 277 ~~~~~~s----~~~~~li~~~L~~dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 277 EIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVG 312 (336)
T ss_dssp GSCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hcCccCC----HHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 0111122 24667889999999999999999998763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=393.20 Aligned_cols=245 Identities=24% Similarity=0.364 Sum_probs=189.3
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999986 46899999999652 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||| +|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 679999987654 3999999999999999999999998 999999999999999999999999999865322
Q ss_pred CCccccccccccccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
......+||+.|||||++.+..| +.++||||+||++|||+||+.||... ....+...+. .... .+
T Consensus 166 ---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i~---~~~~--~~--- 231 (275)
T 3hyh_A 166 ---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNIS---NGVY--TL--- 231 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH---HTCC--CC---
T ss_pred ---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHH---cCCC--CC---
Confidence 22345689999999999998886 57999999999999999999998532 1122222221 1111 11
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
....+ ..+.+++.+||+.||++|||++|+++
T Consensus 232 --p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 --PKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --CTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCCCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11122 24667899999999999999999997
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-54 Score=403.59 Aligned_cols=266 Identities=23% Similarity=0.319 Sum_probs=198.8
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC----eeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 170 (414)
++|.+.+.||+|+||+||+|++ +|+.||||+++..... ......|+..+..++|||||+++|+|.+.+ ..++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4678889999999999999988 6899999999753322 223345666677889999999999998754 579999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
|||++|+|.+++... .+++..+..++.|++.||+|||++ ..++|+||||||+||||+.++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999754 389999999999999999999987 12359999999999999999999999999998
Q ss_pred ccCCCCCc--cccccccccccccccccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC--------Ccc
Q 043285 246 AFGGDETE--GNTNRVVGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN--------NLN 309 (414)
Q Consensus 246 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGvil~elltg~~p~~~~~~~~--------~~~ 309 (414)
........ ......+||+.|||||++.+. .++.++|||||||+||||+||..|++...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76433221 123345799999999998764 46789999999999999999988765322211 001
Q ss_pred hHHHHHHHh-hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 310 LIGHAWKLW-NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 310 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
......... .....+.+.+ .....+....+.+|+.+||+.||++||||.||++.|+.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCG----GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCc----cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111111111 1111111111 11223445567889999999999999999999999854
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=414.79 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=206.8
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
+.|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999874 58999999997655555567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+|+.+... .
T Consensus 231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~ 301 (423)
T 4fie_A 231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--V 301 (423)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS--C
T ss_pred CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC--C
Confidence 999999998643 3899999999999999999999998 999999999999999999999999999876432 2
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||... ........+. ......+.. ..
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~----~~~~~~~~~---~~ 371 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIR----DNLPPRLKN---LH 371 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHH----HSCCCCCSC---TT
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHH----cCCCCCCcc---cc
Confidence 2344578999999999999999999999999999999999999998532 2222222221 111111111 01
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..+ ..+.+|+.+||+.||++|||+.|+++
T Consensus 372 ~~s----~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVS----PSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112 24677899999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=398.71 Aligned_cols=247 Identities=25% Similarity=0.318 Sum_probs=195.3
Q ss_pred CCCCCCCeecccCCceEEEEEEc----CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV----DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
++|++.+.||+|+||+||+|+.. .++.||||++++. .......+.+|+.+++.++|||||++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999752 4678999999652 22233467889999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
|||||++|+|.+++.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999997654 3999999999999999999999998 9999999999999999999999999998653
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
.. .......+||+.|||||++.+..|+.++|||||||++|||+||+.||... ....+...+ ..... .+
T Consensus 178 ~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i---~~~~~--~~-- 245 (304)
T 3ubd_A 178 DH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMI---LKAKL--GM-- 245 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH---HHCCC--CC--
T ss_pred CC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHH---HcCCC--CC--
Confidence 22 22334568999999999999999999999999999999999999998532 222222222 22111 11
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM-----PSVIL 366 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~ 366 (414)
....+ .++.+|+.+||+.||++|||+ +|+++
T Consensus 246 ---p~~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 246 ---PQFLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---CTTSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---CCcCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11122 246778999999999999985 67775
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=391.85 Aligned_cols=251 Identities=26% Similarity=0.404 Sum_probs=189.8
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC--------
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-------- 164 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 164 (414)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45899999999999999999864 6899999999653 3445567899999999999999999999987654
Q ss_pred ----eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEe
Q 043285 165 ----EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 240 (414)
Q Consensus 165 ----~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~D 240 (414)
..|+|||||++|+|.+++.........++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999987655455677788999999999999999998 99999999999999999999999
Q ss_pred ecCccccCCCCCc----------cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 043285 241 FGLARAFGGDETE----------GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNL 310 (414)
Q Consensus 241 fgl~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~ 310 (414)
||+++.+...... ......+||+.|||||++.+..|+.++|||||||++|||++ ||.. ..+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QMER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccHH
Confidence 9999876433221 11234579999999999999999999999999999999996 5431 1111
Q ss_pred HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 311 IGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
............+ .... .....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~p-~~~~---------~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTDVRNLKFP-PLFT---------QKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHTTCCC-HHHH---------HHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhcCCCC-CCCc---------ccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111111111 1111 11123457889999999999999999997
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=385.36 Aligned_cols=263 Identities=20% Similarity=0.320 Sum_probs=201.1
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe------CC
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GE 164 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~ 164 (414)
.++|++.+.||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999986 46899999999753 33455678899999999999999999999764 35
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
..|+|||||+ |+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 68999987644 4999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCC--CccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC
Q 043285 245 RAFGGDE--TEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG 321 (414)
Q Consensus 245 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||.... ..+....+.......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~---~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN---YVHQLQLIMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS---HHHHHHHHHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC---HHHHHHHHHHhcCCC
Confidence 8764322 12234457899999999998875 56999999999999999999999985432 222222222221111
Q ss_pred CCcccc-----------cccc-cCcCCHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 322 MPSQLI-----------DSCF-QDSFNLAE-----VIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 322 ~~~~~~-----------~~~~-~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...... .... ........ ...+.+|+.+||+.||++|||+.|+++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 100000 0000 00001111 135678999999999999999999997
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=370.11 Aligned_cols=279 Identities=36% Similarity=0.613 Sum_probs=237.5
Q ss_pred HHHhcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 90 IVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 90 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
+...+++|++.+.||+|+||.||+|+..+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 34467899999999999999999999888999999999876666678899999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 170 YEFMPNKSLDSFIFDQER-CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
|||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999865432 235899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
............||+.|+|||.+.+..++.++|||||||++|||++|+.||.............+..............+
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 33333333445689999999999999999999999999999999999999876665555555555444444555555566
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
+.............+.+++.+||+.||++|||+.|+++.|+..
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 6666666777888899999999999999999999999999643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=377.89 Aligned_cols=198 Identities=24% Similarity=0.381 Sum_probs=169.3
Q ss_pred HhcCCCCCCCeecccCCceEEEEEEc----CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCee
Q 043285 92 SATNNFSINKKLGQGGFGPVYKGKLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 166 (414)
...++|++.+.||+|+||+||+|+.. .++.||+|++.+.. ....+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34678999999999999999999753 36789999986543 335678999999988 699999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCeEEEeecCcc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLAR 245 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kL~Dfgl~~ 245 (414)
|+|||||++|+|.+++. .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999883 2889999999999999999999998 9999999999999876 799999999998
Q ss_pred ccCCCCCc--------------------------cccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCC
Q 043285 246 AFGGDETE--------------------------GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKN 298 (414)
Q Consensus 246 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p 298 (414)
........ ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65332110 112235799999999999775 589999999999999999999999
Q ss_pred CC
Q 043285 299 RG 300 (414)
Q Consensus 299 ~~ 300 (414)
|.
T Consensus 247 f~ 248 (361)
T 4f9c_A 247 FY 248 (361)
T ss_dssp SS
T ss_pred CC
Confidence 74
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=398.48 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=207.1
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
++|++.+.||+|+||+||+|+.. +|+.||+|++........+.+.+|+.+|+.++||||++++++|.+....++|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999864 58999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC--CCeEEEeecCccccCCCC
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLARAFGGDE 251 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~--~~~kL~Dfgl~~~~~~~~ 251 (414)
++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 237 ~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 237 SGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred CCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999986533 24899999999999999999999998 9999999999999854 89999999999986432
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... .......+ ...... +.....
T Consensus 311 --~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~---~~~~~~~i---~~~~~~--~~~~~~ 380 (573)
T 3uto_A 311 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNV---KSCDWN--MDDSAF 380 (573)
T ss_dssp --SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHH---HTTCCC--CCSGGG
T ss_pred --CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHH---HhCCCC--CCcccc
Confidence 23345689999999999999999999999999999999999999985322 11222221 111111 111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...+ ..+.+|+.+||+.||.+|||+.|+++
T Consensus 381 -~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 -SGIS----EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112 24668899999999999999999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=391.51 Aligned_cols=249 Identities=25% Similarity=0.339 Sum_probs=198.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHH---HHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKEL---KNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....... ..++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999874 58999999996421 1122223 3446677778999999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
|+|||||+||+|.++|.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999997654 3999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
+... .....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||..........+... ...... .
T Consensus 342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---i~~~~~--~ 412 (689)
T 3v5w_A 342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTMAV--E 412 (689)
T ss_dssp CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---HHHCCC--C
T ss_pred cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---hcCCCC--C
Confidence 6432 2345689999999999975 5799999999999999999999999865433322222211 111111 1
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS-----MPSVIL 366 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 366 (414)
+. ...+ .++.+|+.+||+.||++|++ ++|+++
T Consensus 413 ~p-----~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 413 LP-----DSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CC-----TTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CC-----ccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11 1122 24677899999999999998 678775
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=365.78 Aligned_cols=291 Identities=40% Similarity=0.678 Sum_probs=239.0
Q ss_pred CCCcCHHHHHHhcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCceeeeEeEE
Q 043285 82 LPLFELATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCC 160 (414)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 160 (414)
...+...++....++|++.+.||+|+||.||+|+..+|+.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 446788889999999999999999999999999987899999999975322 2233688999999999999999999999
Q ss_pred EeCCeeeEEEeecCCCChhHHhhcccc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEE
Q 043285 161 IQGEEKLLIYEFMPNKSLDSFIFDQER-CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 239 (414)
Q Consensus 161 ~~~~~~~lv~ey~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~ 239 (414)
.+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||++..++++||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 999999999999999999999976432 3458999999999999999999999922239999999999999999999999
Q ss_pred eecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CCCCcchHHHHHHH
Q 043285 240 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH--SDNNLNLIGHAWKL 317 (414)
Q Consensus 240 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~--~~~~~~~~~~~~~~ 317 (414)
|||++....... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .........+....
T Consensus 177 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999998764322 222334568999999999999999999999999999999999999985321 22233344444444
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
..........+..............+.+++.+||+.||.+|||+.||+++|+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 44555555666666667777888899999999999999999999999999976433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=348.21 Aligned_cols=286 Identities=35% Similarity=0.546 Sum_probs=226.5
Q ss_pred ccCCCCcCHHHHHHhcCCCCCC------CeecccCCceEEEEEEcCCCEEEEEEeccc----ChhhHHHHHHHHHHHHhc
Q 043285 79 DLELPLFELATIVSATNNFSIN------KKLGQGGFGPVYKGKLVDGQEIAVKRLSKI----SEQGLKELKNEVILFSKL 148 (414)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l 148 (414)
+...+.|.+.++...+++|... +.||+|+||.||+|.. +++.||+|++... .....+.+.+|+.+++.+
T Consensus 9 ~~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l 87 (307)
T 2nru_A 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC 87 (307)
T ss_dssp --CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC
T ss_pred CCCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc
Confidence 3345678888998888888766 8999999999999987 7889999998652 234467889999999999
Q ss_pred CCCceeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCE
Q 043285 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 228 (414)
Q Consensus 149 ~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Ni 228 (414)
+||||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||.|||+++ ++||||||+||
T Consensus 88 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Ni 164 (307)
T 2nru_A 88 QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANI 164 (307)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred CCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHE
Confidence 999999999999999999999999999999999976555556999999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 043285 229 LLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNL 308 (414)
Q Consensus 229 ll~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~ 308 (414)
+++.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..||.........
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 999999999999999987644333333344578999999998865 5899999999999999999999998754433322
Q ss_pred chHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 309 NLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
..+..... ..........+... ..........+.+++.+||+.||.+|||+.++++.|+..
T Consensus 244 ~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 244 LDIKEEIE-DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp THHHHHHH-TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHhh-hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 22111110 00111112222222 223445566788999999999999999999999999653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=348.02 Aligned_cols=260 Identities=28% Similarity=0.430 Sum_probs=210.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|.+.+.||+|+||+||++... ++..||+|++........+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367899999999999999999874 5889999999877777788999999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++|+|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999997633 24899999999999999999999998 99999999999999999999999999987643222
Q ss_pred cc------------ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhc
Q 043285 253 EG------------NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE 320 (414)
Q Consensus 253 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..|+.............. ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~ 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLDR 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHHHH
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hccccc
Confidence 11 11145789999999999999999999999999999999999998765443222111100 011111
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 043285 321 GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372 (414)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 372 (414)
..+..+. ..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 243 ~~~~~~~-------------~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 243 YCPPNCP-------------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp TCCTTCC-------------TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCC-------------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111110 13567889999999999999999999996553
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=351.80 Aligned_cols=262 Identities=27% Similarity=0.439 Sum_probs=203.8
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
..++|++.+.||+|+||+||+|+. +|+.||||++... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356899999999999999999987 6889999998753 3445678899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++........+++..++.++.|++.||+|||+++ ++++||||||+||+++.++.+||+|||++......
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999976554445899999999999999999999975 34999999999999999999999999999754322
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ........+.
T Consensus 193 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~---~~~~~~~~~~--- 261 (309)
T 3p86_A 193 --FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAV---GFKCKRLEIP--- 261 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHH---HHSCCCCCCC---
T ss_pred --ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH---HhcCCCCCCC---
Confidence 1223345789999999999999999999999999999999999999864321 1111111 1111111111
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
...+ ..+.+++.+||+.||.+|||+.|+++.|+....
T Consensus 262 --~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 262 --RNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp --TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred --ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1122 246778999999999999999999999976644
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=358.25 Aligned_cols=258 Identities=28% Similarity=0.411 Sum_probs=209.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEc--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 163 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 163 (414)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|+.+++.+ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467999999999999999999752 3457999999763 344567899999999999 899999999999999
Q ss_pred CeeeEEEeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 230 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill 230 (414)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ ++||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976432 124789999999999999999999998 9999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 043285 231 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLN 309 (414)
Q Consensus 231 ~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~ 309 (414)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---~~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GG
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---HH
Confidence 9999999999999987654433333444567889999999999999999999999999999999 9888754322 22
Q ss_pred hHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 310 LIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
...... ......... .. ...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 314 ~~~~~~----~~~~~~~~~-----~~----~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 314 LFKLLK----EGHRMDKPA-----NC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp HHHHHH----TTCCCCCCT-----TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHh----cCCCCCCCC-----CC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 222221 111111111 11 1246778999999999999999999999854
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=344.42 Aligned_cols=250 Identities=24% Similarity=0.423 Sum_probs=205.3
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|++.+.||+|+||+||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999985 46899999999765555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++|+|.+++... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence 9999999998654 3899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ... .............. .
T Consensus 171 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~---~~~~~~~~~~~~~~----~ 239 (297)
T 3fxz_A 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRA---LYLIATNGTPELQN----P 239 (297)
T ss_dssp -CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH---HHHHHHHCSCCCSC----G
T ss_pred -cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHH---HHHHHhCCCCCCCC----c
Confidence 223345799999999999999999999999999999999999999753221 111 11111111111000 0
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
... ...+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EKL----SAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccc----CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111 124667899999999999999999996
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=355.45 Aligned_cols=265 Identities=26% Similarity=0.378 Sum_probs=206.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC----eeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv 169 (414)
.++|++.+.||+|+||+||+|+. .++.||||++.... ........|+.+++.++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 46899999999999999999987 47899999997543 33345567899999999999999999998754 36999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeeeccCCCCCEEEcCCCCeEEE
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD----------SRLRIIHRDLKASNVLLDQDMNPKIS 239 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~~~~iiH~dlk~~Nill~~~~~~kL~ 239 (414)
|||+++|+|.+++.... +++..+..++.|++.||+|||+. + ++||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 99999999999996532 89999999999999999999998 7 9999999999999999999999
Q ss_pred eecCccccCCCCCccccccccccccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHH--
Q 043285 240 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIG-- 312 (414)
Q Consensus 240 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~-- 312 (414)
|||+++...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||.............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999987654444334445679999999999987 356678999999999999999999986544332211111
Q ss_pred -------HHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 313 -------HAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 313 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
................... ........+.+++.+||+.||++|||+.|+++.|+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1111111111111111111 112344568889999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=348.48 Aligned_cols=248 Identities=27% Similarity=0.412 Sum_probs=204.9
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999987 57899999999653 4455677889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++..... +++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999976543 899999999999999999999998 999999999999999999999999999865322
Q ss_pred CCccccccccccccccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
......+||+.|+|||++.+..+. .++|||||||++|||++|+.||.... ..... ......... +
T Consensus 168 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~---~~i~~~~~~--~--- 233 (328)
T 3fe3_A 168 ---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELR---ERVLRGKYR--I--- 233 (328)
T ss_dssp ---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH---HHHHHCCCC--C---
T ss_pred ---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHH---HHHHhCCCC--C---
Confidence 233456799999999999988775 89999999999999999999985432 11111 111111111 0
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.... ...+.+++.+||+.||.+|||++|+++.
T Consensus 234 --p~~~----s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 --PFYM----STDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --CTTS----CHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --CCCC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111 1246678999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=348.92 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=202.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999875 68899999986432 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999986543 3899999999999999999999998 9999999999999999999999999998654333
Q ss_pred CccccccccccccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.........||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....+ ...... ...
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~---~~~~~~--~~~- 230 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDW---KEKKTY--LNP- 230 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH---HHHHH---HTTCTT--STT-
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHH---hccccc--CCc-
Confidence 3333445679999999999988776 7899999999999999999999864332211 11111 111100 000
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
.... ...+.+++.+||+.||++|||+.|+++.-
T Consensus 231 -~~~~----~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 231 -WKKI----DSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp -GGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred -cccC----CHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 0111 12456789999999999999999999753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=358.63 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=205.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|.+.+.||+|+||.||+|+.. +++.||||.++.. .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888999999999999999885 6889999998753 33445578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999997543 24899999999999999999999998 9999999999999999999999999998653322
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.........+++.|+|||.+.++.++.++|||||||++|||++ |..||..... ...... ...........
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~~----~~~~~~~~~~~-- 338 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTREF----VEKGGRLPCPE-- 338 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHHH----HHTTCCCCCCT--
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcCCCCCCCC--
Confidence 2222222345778999999999999999999999999999998 8888754321 111111 11111111111
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. ...+.+++.+||+.||++|||+.++++.|+.
T Consensus 339 ---~~----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 339 ---LC----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp ---TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 11 1246678999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=342.31 Aligned_cols=274 Identities=21% Similarity=0.287 Sum_probs=214.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC--eeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 169 (414)
.++|++.+.||+|+||+||+|+... ++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4679999999999999999998754 8899999997532 334567889999999999999999999998765 77999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCCeEEEeecCcc
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLAR 245 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~~kL~Dfgl~~ 245 (414)
|||+++++|.+++........+++..++.++.|++.||+|||+++ ++||||||+|||+ +.++.+||+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999987655555899999999999999999999998 9999999999999 777889999999998
Q ss_pred ccCCCCCcccccccccccccccccccc--------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC-cchHHHHHH
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYAS--------DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN-LNLIGHAWK 316 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~-~~~~~~~~~ 316 (414)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........ .........
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 764322 223456899999999886 57889999999999999999999999864433221 222222221
Q ss_pred HhhcCCCcccc-----------cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 317 LWNEGMPSQLI-----------DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 317 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
.........+. ...............+.+++.+||+.||++|||+.|+++...+...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 11111110000 0001123344556677889999999999999999999999876544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=355.61 Aligned_cols=265 Identities=29% Similarity=0.407 Sum_probs=213.1
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 162 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 162 (414)
..++|.+.+.||+|+||.||+|+.. .+..||+|++... .......+.+|+.+++.+ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3478999999999999999999752 2357999999763 445567889999999999 99999999999999
Q ss_pred CCeeeEEEeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 043285 163 GEEKLLIYEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 229 (414)
Q Consensus 163 ~~~~~lv~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nil 229 (414)
.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ ++||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999976432 134899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 043285 230 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNL 308 (414)
Q Consensus 230 l~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~ 308 (414)
++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---~~ 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VE 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---HH
Confidence 99999999999999987654433334445567889999999999999999999999999999999 988875322 11
Q ss_pred chHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 043285 309 NLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLPQ 376 (414)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 376 (414)
... ............. .. ...+.+++.+||+.||++|||+.|+++.|+.......
T Consensus 301 ~~~----~~~~~~~~~~~~~-----~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 301 ELF----KLLKEGHRMDKPS-----NC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HHH----HHHHTTCCCCCCS-----SC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHH----HHHHcCCCCCCCc-----cC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 121 1122221111111 11 1246778999999999999999999999976654433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=341.68 Aligned_cols=267 Identities=24% Similarity=0.362 Sum_probs=210.1
Q ss_pred cccCCCCcCHHHHHHhcCC----------CCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHH
Q 043285 78 IDLELPLFELATIVSATNN----------FSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFS 146 (414)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~ 146 (414)
.....+.++..++..+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+++
T Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~ 97 (321)
T 2c30_A 18 LYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR 97 (321)
T ss_dssp -------CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHT
T ss_pred eeecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHH
Confidence 3344456677666655443 666789999999999999876 69999999997655566678899999999
Q ss_pred hcCCCceeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCC
Q 043285 147 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 226 (414)
Q Consensus 147 ~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~ 226 (414)
.++||||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+
T Consensus 98 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~ 170 (321)
T 2c30_A 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSD 170 (321)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred hCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 999999999999999999999999999999999988643 3899999999999999999999998 999999999
Q ss_pred CEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 043285 227 NVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306 (414)
Q Consensus 227 Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~ 306 (414)
||+++.++.+||+|||++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 171 NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~--- 245 (321)
T 2c30_A 171 SILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS--- 245 (321)
T ss_dssp GEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---
T ss_pred HEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---
Confidence 9999999999999999998764322 12334579999999999999999999999999999999999999975321
Q ss_pred CcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 307 NLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
........ .......... .... ...+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~----~~~~~~~~~~---~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 246 PVQAMKRL----RDSPPPKLKN---SHKV----SPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHH----HHSSCCCCTT---GGGS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHH----hcCCCCCcCc---cccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111 1111111111 0011 1246678899999999999999999973
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=346.69 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=204.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc----CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
.++|++.+.||+|+||.||+|+.. .+..||||+++.. .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 367889999999999999999874 3456999999763 44556789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999996543 24899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 249 GDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 249 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ........ .......
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~----~~~~~~~ 275 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVE----EGYRLPA 275 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHH----TTCCCCC
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCCCCC
Confidence 33221 12223346778999999999999999999999999999999 9999753221 12222211 1111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 372 (414)
. ... ...+.+++.+||+.||++|||+.|+++.|+...
T Consensus 276 ~-----~~~----~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 276 P-----MGC----PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp C-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-----CCc----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 111 135678899999999999999999999996543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=341.19 Aligned_cols=263 Identities=27% Similarity=0.432 Sum_probs=203.7
Q ss_pred cCCCCCCCeecccCCceEEEEEE-----cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Cee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 166 (414)
.++|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|+.+++.++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46799999999999999999984 35789999999877777778899999999999999999999998654 458
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999976432 4899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC---------CCcchHHHHHH
Q 043285 247 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSD---------NNLNLIGHAWK 316 (414)
Q Consensus 247 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~---------~~~~~~~~~~~ 316 (414)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6433221 2222345778899999999999999999999999999999999886532110 00001111111
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 317 LWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
............ .. ...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 244 ~~~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 244 LLKNNGRLPRPD-----GC----PDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHTTCCCCCCT-----TC----CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHhccCcCCCCc-----Cc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 111111111111 11 2357788999999999999999999999854
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=341.58 Aligned_cols=248 Identities=22% Similarity=0.306 Sum_probs=203.4
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||+||+++.. +|+.||+|++++. .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 67999999999999999999875 5899999999752 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|..++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999987644 3899999999999999999999998 999999999999999999999999999854221
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....... ...... .+
T Consensus 159 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~---i~~~~~--~~---- 224 (337)
T 1o6l_A 159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFEL---ILMEEI--RF---- 224 (337)
T ss_dssp --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH---HHHCCC--CC----
T ss_pred --CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHH---HHcCCC--CC----
Confidence 223345679999999999999999999999999999999999999975321 1111111 111111 11
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILM 367 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 367 (414)
....+ ..+.+++.+||+.||++|| ++.|+++.
T Consensus 225 -p~~~s----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 -PRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCC----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11122 2467788999999999999 89999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=353.04 Aligned_cols=268 Identities=28% Similarity=0.416 Sum_probs=211.5
Q ss_pred cCHHHHHHhcCCCCCCCeecccCCceEEEEEE------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeee
Q 043285 85 FELATIVSATNNFSINKKLGQGGFGPVYKGKL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKL 156 (414)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~ 156 (414)
+.........++|++.+.||+|+||.||+|++ .+++.||||+++.. .....+.+.+|+.++..+ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44455555678999999999999999999974 23578999999763 344557789999999999 79999999
Q ss_pred EeEEEeCCe-eeEEEeecCCCChhHHhhcccc------------------------------------------------
Q 043285 157 LGCCIQGEE-KLLIYEFMPNKSLDSFIFDQER------------------------------------------------ 187 (414)
Q Consensus 157 ~~~~~~~~~-~~lv~ey~~~g~L~~~l~~~~~------------------------------------------------ 187 (414)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999976432
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 188 ---------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 188 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 112889999999999999999999998 99999999999999999999999999987644333
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...... ...........
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~----~~~~~~~~~~~--- 319 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRR----LKEGTRMRAPD--- 319 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHHHHH----HHHTCCCCCCT---
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--HHHHHH----HHcCCCCCCCC---
Confidence 333445678899999999999999999999999999999998 99997543221 111111 11111111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... ..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 320 --~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 320 --YTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp --TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 111 246778999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=338.10 Aligned_cols=264 Identities=25% Similarity=0.359 Sum_probs=206.3
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.+.||+|+||.||+++.. ++..||+|.+.. ......+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999864 588999999854 3344567889999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++.... .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999997654 3899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ............+ ....
T Consensus 164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~-~~~~- 234 (294)
T 4eqm_A 164 TS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSVP-NVTT- 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSCCC-CHHH-
T ss_pred cc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhccCC-Ccch-
Confidence 22 1223345689999999999999999999999999999999999999754221 1111111112111 1100
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhcCCCCCCC
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRP-SMPSVILMLGSETVLPQ 376 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~~ 376 (414)
...... ...+.+++.+||+.||++|| +++++.+.|........
T Consensus 235 ~~~~~~----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 235 DVRKDI----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HSCTTS----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred hcccCC----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 111111 23467789999999999999 89999999976554433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=345.56 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=203.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccCh------hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
.++|++.+.||+|+||.||+++.. +|+.||+|++.+... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999875 588999999975322 1356889999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----CeEEEeec
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 242 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kL~Dfg 242 (414)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999996543 4899999999999999999999998 99999999999998877 79999999
Q ss_pred CccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+ .....
T Consensus 165 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~---~~~~~~~i---~~~~~ 235 (361)
T 2yab_A 165 LAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANI---TAVSY 235 (361)
T ss_dssp SCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHH---HTTCC
T ss_pred CceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH---HhcCC
Confidence 99876432 22334579999999999999999999999999999999999999975321 11111111 11111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 323 PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.+ +.......+ ..+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~-~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 --DF-DEEFFSQTS----ELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --CC-CHHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --CC-CchhccCCC----HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 000001111 24667899999999999999999996
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=352.87 Aligned_cols=259 Identities=29% Similarity=0.440 Sum_probs=206.3
Q ss_pred cCCCCCCCeecccCCceEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. .......+.+|+.+++.++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367899999999999999999853 3568999999753 445556788999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---CeEEE
Q 043285 167 LLIYEFMPNKSLDSFIFDQER----CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS 239 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kL~ 239 (414)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976432 235899999999999999999999998 99999999999999555 59999
Q ss_pred eecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHh
Q 043285 240 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 240 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.... .........
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~~~i~--- 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEFVT--- 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHH---
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH---
Confidence 9999986533223333344567899999999999999999999999999999998 888875422 112222111
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
........ ... ...+.+++.+||+.||++|||+.++++.|...
T Consensus 301 -~~~~~~~~-----~~~----~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 -SGGRMDPP-----KNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp -TTCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cCCCCCCC-----ccC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111111 111 12467789999999999999999999998554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=341.57 Aligned_cols=259 Identities=29% Similarity=0.420 Sum_probs=209.7
Q ss_pred hcCCCCCCCeecccCCceEEEEEE------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 165 (414)
..++|.+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 357899999999999999999975 23578999999753 44556788999999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccc---------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 043285 166 KLLIYEFMPNKSLDSFIFDQER---------------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 224 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk 224 (414)
.++||||+++++|.+++..... ...+++..++.++.|+++||.|||+++ ++|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999976432 124889999999999999999999998 9999999
Q ss_pred CCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 043285 225 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYH 303 (414)
Q Consensus 225 ~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~ 303 (414)
|+||+++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654433333344567889999999999999999999999999999999 999875432
Q ss_pred CCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 304 SDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. ........ ........ ... ...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 258 ~---~~~~~~~~----~~~~~~~~-----~~~----~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 258 P---ERLFNLLK----TGHRMERP-----DNC----SEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp G---GGHHHHHH----TTCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H---HHHHHHhh----cCCcCCCC-----ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 2 12222211 11111111 111 1356788999999999999999999998854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=335.13 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=206.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.++|++.+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 36789999999999999999999889999999997633 23467899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++....... .
T Consensus 88 ~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 161 (269)
T 4hcu_A 88 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y 161 (269)
T ss_dssp TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred CCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-c
Confidence 9999999996543 24899999999999999999999998 9999999999999999999999999998653221 1
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ....... ........ .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~----~~~~~~~~-----~ 229 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDI----STGFRLYK-----P 229 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH----HTTCCCCC-----C
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHH----hcCccCCC-----C
Confidence 12223456788999999999999999999999999999999 8888754221 1121111 11111110 1
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... ...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 230 ~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 230 RLA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 111 1246778999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=333.23 Aligned_cols=257 Identities=28% Similarity=0.405 Sum_probs=208.1
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.++|++.+.||+|+||.||+|+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46799999999999999999999888899999997533 23467899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY- 159 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence 9999999997643 24899999999999999999999998 99999999999999999999999999987543322
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... .........
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~~~~~----- 227 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EVVLKV----SQGHRLYRP----- 227 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHH----HTTCCCCCC-----
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---HHHHHH----HcCCCCCCC-----
Confidence 12223446778999999999899999999999999999999 99887543211 111111 111111100
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
...+ ..+.+++.+||+.||++|||+.|+++.|+....
T Consensus 228 ~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 HLAS----DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TTSC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CcCh----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1111 246778999999999999999999999976644
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=342.18 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=199.2
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe-------
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE------- 165 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 165 (414)
++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 57899999999999999999875 6899999999753 33456789999999999999999999999866542
Q ss_pred --------------------------------------------------eeEEEeecCCCChhHHhhcccccccCCHHH
Q 043285 166 --------------------------------------------------KLLIYEFMPNKSLDSFIFDQERCMILDWSK 195 (414)
Q Consensus 166 --------------------------------------------------~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~ 195 (414)
.++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 799999999999999998766656677888
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc----------cccccccccccc
Q 043285 196 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE----------GNTNRVVGTYGY 265 (414)
Q Consensus 196 ~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~----------~~~~~~~gt~~y 265 (414)
++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 9999999999999999998 999999999999999999999999999876543211 122345699999
Q ss_pred cccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHH
Q 043285 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIH 345 (414)
Q Consensus 266 ~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (414)
+|||.+.+..++.++|||||||++|||++|..|+. .... .............. ......+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~-~~~~~~~~~~~~~~---------~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVR-IITDVRNLKFPLLF---------TQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHH-HHHHHHTTCCCHHH---------HHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHH-HHHHhhccCCCccc---------ccCChhHHH
Confidence 99999999999999999999999999999876521 1111 11111111111110 112234577
Q ss_pred HHHhccCCCCCCCCCHHHHHHH
Q 043285 346 IGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 346 l~~~cl~~dP~~RPs~~evl~~ 367 (414)
++.+||+.||++|||+.|+++.
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCCCcCCCHHHHhhc
Confidence 8999999999999999999973
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=346.79 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=209.8
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcC------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 165 (414)
..++|++.+.||+|+||.||+|+..+ ++.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 45789999999999999999998743 478999999763 34456788999999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccc---------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 043285 166 KLLIYEFMPNKSLDSFIFDQER---------------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 224 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk 224 (414)
.++||||+++|+|.+++..... ...+++..++.++.|+++||.|||+++ ++|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 9999999999999999976321 145899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 043285 225 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYH 303 (414)
Q Consensus 225 ~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~ 303 (414)
|+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987643332233334567899999999999999999999999999999999 988875322
Q ss_pred CCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 304 SDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
....... ........... ... ..+.+++.+||+.||++|||+.++++.|+....
T Consensus 282 ---~~~~~~~----~~~~~~~~~~~-----~~~----~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 282 ---HEEVIYY----VRDGNILACPE-----NCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp ---HHHHHHH----HHTTCCCCCCT-----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---hHHHHHH----HhCCCcCCCCC-----CCC----HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 1111111 11221111111 111 256778999999999999999999999976543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=341.65 Aligned_cols=262 Identities=26% Similarity=0.355 Sum_probs=202.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||+||+|+..+|+.||+|++... .......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4789999999999999999999988999999999653 22334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++ +|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 7888776543 24899999999999999999999998 9999999999999999999999999998753221
Q ss_pred CccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc-
Q 043285 252 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS- 329 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 329 (414)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....................
T Consensus 174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGT
T ss_pred --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhhh
Confidence 22333568999999999876 568999999999999999999999986544332 22233222222211111000
Q ss_pred --------cc--cCcCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 --------CF--QDSFNLA-----EVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 --------~~--~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. ....... ...++.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 0000000 1135678999999999999999999997
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=350.36 Aligned_cols=257 Identities=28% Similarity=0.454 Sum_probs=195.1
Q ss_pred cCCCCCCCeecccCCceEEEEEEc----CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999864 4678999999753 44556789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999997543 24899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 249 GDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 249 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.... .................
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~---~~~~~~~i~~~~~~~~~--- 272 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---NQDVIKAVDEGYRLPPP--- 272 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC---HHHHHHHHHTTEECCCC---
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCC---
Confidence 32211 11222345778999999999999999999999999999998 999875322 11222221111111100
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
......+.+++.+||+.||++||++.|+++.|+..
T Consensus 273 ----------~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 273 ----------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ----------TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 01123577899999999999999999999998654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=348.78 Aligned_cols=255 Identities=22% Similarity=0.354 Sum_probs=200.1
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 168 (414)
.++|++.+.||+|+||+||+++.. +++.||+|++++. .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999875 4778999999753 223334678899999887 89999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||+++|+|..++..... +++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999976543 899999999999999999999998 9999999999999999999999999998532
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc--chHHHHHHHhhcCCCccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNL--NLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 326 (414)
. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ............... .+
T Consensus 205 ~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~ 281 (396)
T 4dc2_A 205 R--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RI 281 (396)
T ss_dssp C--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-CC
T ss_pred c--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-CC
Confidence 1 222344568999999999999999999999999999999999999998643322111 111111111111111 11
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM------PSVIL 366 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~evl~ 366 (414)
....+ ..+.+++.+||+.||++||++ +|+++
T Consensus 282 -----p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 282 -----PRSLS----VKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp -----CTTSC----HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred -----CCcCC----HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 11112 246778999999999999996 57766
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=342.50 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=198.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 168 (414)
.++|++.+.||+|+||+||+++.. +|+.||+|++++. .......+..|..+++.+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999875 5889999999752 334556788999999988 79999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||+++|+|.+++..... +++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999976543 899999999999999999999998 9999999999999999999999999997532
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ ......
T Consensus 176 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i---~~~~~~----- 242 (353)
T 3txo_A 176 C--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAI---LNDEVV----- 242 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---HHCCCC-----
T ss_pred c--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC---HHHHHHHH---HcCCCC-----
Confidence 2 1223345679999999999999999999999999999999999999985432 11222222 111111
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM------PSVIL 366 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~evl~ 366 (414)
+....+ ..+.+++.+||+.||++||++ .|+++
T Consensus 243 --~p~~~~----~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 --YPTWLH----EDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --CCTTSC----HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCCCCC----HHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 011111 246678999999999999998 77776
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=342.26 Aligned_cols=260 Identities=19% Similarity=0.222 Sum_probs=207.4
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++.+ +||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999986 4688999999865322 23578899999999 99999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC-----eEEEeecCccc
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISDFGLARA 246 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~-----~kL~Dfgl~~~ 246 (414)
|+ +++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++. +||+|||++..
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 999999997642 24899999999999999999999998 999999999999998887 99999999987
Q ss_pred cCCCCCcc-----ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC
Q 043285 247 FGGDETEG-----NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG 321 (414)
Q Consensus 247 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 64332211 1245679999999999999999999999999999999999999987654333333232222111111
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
..... .... . .+.+++.+||+.||.+||++.++++.|.+.
T Consensus 240 ~~~~~-----~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 240 PIEVL-----CENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp CHHHH-----TTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CHHHH-----hccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 10000 0001 1 577889999999999999999999988543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=344.66 Aligned_cols=263 Identities=30% Similarity=0.427 Sum_probs=207.2
Q ss_pred hcCCCCCCCeecccCCceEEEEEE------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 164 (414)
..++|.+.+.||+|+||.||+|+. .++..||+|++... .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457899999999999999999985 23567999999753 333456789999999999 8999999999999999
Q ss_pred eeeEEEeecCCCChhHHhhccccc--------------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERC--------------------MILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 224 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk 224 (414)
..++||||+++|+|.+++...... ..+++..++.++.|++.||+|||+++ ++|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999764321 23789999999999999999999998 9999999
Q ss_pred CCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 043285 225 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYH 303 (414)
Q Consensus 225 ~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~ 303 (414)
|+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||+| |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987644333333344567889999999999999999999999999999998 998875433
Q ss_pred CCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 304 SDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
.. .... ............. .. ...+.+++.+||+.||.+|||+.|+++.|+....
T Consensus 280 ~~--~~~~----~~~~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 280 VD--ANFY----KLIQNGFKMDQPF-----YA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CS--HHHH----HHHHTTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cH--HHHH----HHHhcCCCCCCCC-----CC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 21 1111 1111221111111 11 2356778999999999999999999999965433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=339.25 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=202.8
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccCh------hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
.++|.+.+.||+|+||.||+++.. +|..||+|++..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356899999999999999999875 588999999865321 2457889999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----CeEEEeec
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 242 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kL~Dfg 242 (414)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999996543 3899999999999999999999998 99999999999999887 79999999
Q ss_pred CccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......... .....
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~-~~~~~ 236 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA-VNYEF 236 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHH-TCCCC
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHHh-cCCCc
Confidence 998764222 2334579999999999999999999999999999999999999975321 1111111111 01111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 323 PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.... .... ...+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~-----~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 237 EDEY-----FSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CHHH-----HTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred Cccc-----cccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1100 0111 1246678999999999999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=342.41 Aligned_cols=260 Identities=24% Similarity=0.412 Sum_probs=191.4
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCC----EEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQ----EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
..++|++.+.||+|+||.||+|+..... .||||++... .....+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 4578999999999999999999865432 7999999753 344567899999999999999999999999887655
Q ss_pred ------eEEEeecCCCChhHHhhcccc---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeE
Q 043285 167 ------LLIYEFMPNKSLDSFIFDQER---CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 237 (414)
Q Consensus 167 ------~lv~ey~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k 237 (414)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 999999999999999865331 224899999999999999999999998 99999999999999999999
Q ss_pred EEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHH
Q 043285 238 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWK 316 (414)
Q Consensus 238 L~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 316 (414)
|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .........
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~ 254 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN---AEIYNYLIG 254 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHT
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh---HHHHHHHhc
Confidence 999999987644333333334557889999999999999999999999999999999 8888754322 222222211
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 317 LWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
........ .. ...+.+++.+||+.||++|||+.++++.|++.
T Consensus 255 ----~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 255 ----GNRLKQPP-----EC----MEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp ----TCCCCCCT-----TC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCC-----cc----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111 11 13567899999999999999999999988544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=336.29 Aligned_cols=260 Identities=24% Similarity=0.355 Sum_probs=199.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHh--cCCCceeeeEeEEEeC----Ceee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQG----EEKL 167 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~~~ 167 (414)
.++|++.+.||+|+||+||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999988 7899999998653 23455566666666 7999999999997653 4589
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeccCCCCCEEEcCCCCeEEE
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH--------QDSRLRIIHRDLKASNVLLDQDMNPKIS 239 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiH~dlk~~Nill~~~~~~kL~ 239 (414)
+||||+++|+|.+++... .+++..++.++.|++.||+||| +.+ ++||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 999999999999999543 3899999999999999999999 666 9999999999999999999999
Q ss_pred eecCccccCCCCCc--cccccccccccccccccccCC------CCCcchhHHHHHHHHHHHHhC----------CCCCCC
Q 043285 240 DFGLARAFGGDETE--GNTNRVVGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIVSG----------KKNRGF 301 (414)
Q Consensus 240 Dfgl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGvil~elltg----------~~p~~~ 301 (414)
|||++......... .......||+.|+|||++.+. .++.++|||||||++|||++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999765432221 112334789999999999876 456799999999999999999 667644
Q ss_pred CCCCCCcchHHHHHHHh-hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 302 YHSDNNLNLIGHAWKLW-NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 302 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
....... ........ .......... ..........+.+++.+||+.||++|||+.|+++.|+.
T Consensus 236 ~~~~~~~--~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 236 VVPNDPS--FEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TSCSSCC--HHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCcc--hhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 3322221 11111111 1111111111 11222345678889999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=344.40 Aligned_cols=252 Identities=20% Similarity=0.264 Sum_probs=203.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|++.+.||+|+||.||++... ++..||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999875 4788999998753 33456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC--CCCeEEEeecCccccCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLARAFGGD 250 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~--~~~~kL~Dfgl~~~~~~~ 250 (414)
+++|+|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+|||++. ++.+||+|||++......
T Consensus 83 ~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999999996533 24899999999999999999999998 999999999999987 789999999999876432
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....... ....... ....
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i---~~~~~~~--~~~~ 226 (321)
T 1tki_A 158 ---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENI---MNAEYTF--DEEA 226 (321)
T ss_dssp ---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHH---HHTCCCC--CHHH
T ss_pred ---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHH---HcCCCCC--Chhh
Confidence 223345789999999999998899999999999999999999999754221 1111111 1111110 0000
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.... ...+.+++.+||+.||.+|||+.|+++.
T Consensus 227 -~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 227 -FKEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -HTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111 1346789999999999999999999983
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=358.51 Aligned_cols=258 Identities=31% Similarity=0.444 Sum_probs=208.1
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
..++|++.+.||+|+||.||+|...++..||||+++... ...+.+.+|+.+++.++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 457789999999999999999999888999999997633 35678999999999999999999999986 6678999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++|+|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 999999999975432 23789999999999999999999998 99999999999999999999999999987532211
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.......++..|+|||++.+..++.++|||||||++|||+| |+.||.... ..+.............+ .
T Consensus 340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i~~~~~~~~~----~--- 408 (454)
T 1qcf_A 340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRALERGYRMPRP----E--- 408 (454)
T ss_dssp -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHHTCCCCCC----T---
T ss_pred -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCC----C---
Confidence 11223346788999999999999999999999999999999 999875322 22222222211111111 1
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
.. ...+.+++.+||+.||++|||+.+|++.|++...
T Consensus 409 --~~----~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 409 --NC----PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp --TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred --CC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11 1356778999999999999999999999977644
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=334.44 Aligned_cols=261 Identities=15% Similarity=0.217 Sum_probs=209.1
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999986 568899999986532 224578899999999 79999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC-----eEEEeecCccc
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISDFGLARA 246 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~-----~kL~Dfgl~~~ 246 (414)
|+ +++|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++. +||+|||++..
T Consensus 87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 999999997543 24899999999999999999999998 999999999999987776 99999999987
Q ss_pred cCCCCCc-----cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC
Q 043285 247 FGGDETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG 321 (414)
Q Consensus 247 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6443221 12345579999999999999999999999999999999999999987654443333333222221111
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
....... .. ...+.+++.+||+.||++|||+.+|++.|++.
T Consensus 241 ~~~~~~~-----~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 241 PLRELCA-----GF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHHHHTT-----TS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHHHHHh-----hC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 1111111 11 13567789999999999999999999999654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=356.24 Aligned_cols=254 Identities=23% Similarity=0.313 Sum_probs=202.4
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
..++|++.+.||+|+||.||++.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 346799999999999999999976 46889999998653 334556789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCCeEEEeecCccc
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARA 246 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~---~~~~~kL~Dfgl~~~ 246 (414)
|||+++|+|.+.+..... +++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~E~~~gg~L~~~i~~~~~---~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999876543 899999999999999999999998 99999999999998 467899999999987
Q ss_pred cCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ........... ....+...
T Consensus 163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~-~~~~~~~~ 236 (444)
T 3soa_A 163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAG-AYDFPSPE 236 (444)
T ss_dssp CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHT-CCCCCTTT
T ss_pred ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhC-CCCCCccc
Confidence 54322 22234579999999999999999999999999999999999999975321 11222221110 01111110
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. ... ...+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~-----~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 237 W-----DTV----TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp T-----TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred c-----ccC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 011 1246678999999999999999999974
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=336.04 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=198.1
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
++|++.+.||+|+||.||+++. .++.||+|.+... ...+.+.+|+.+++.++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5788999999999999999987 5789999999753 34568899999999999999999999886 45899999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC-eEEEeecCccccCCCCCc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLARAFGGDETE 253 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~-~kL~Dfgl~~~~~~~~~~ 253 (414)
+|+|.+++........++...++.++.|+++||+|||+.+..+++||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999987655556889999999999999999999943234999999999999998886 799999999764321
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+... .........
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~-~~~~~~~~~----- 227 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVH-NGTRPPLIK----- 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHH-TTCCCCCBT-----
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHh-cCCCCCccc-----
Confidence 22346899999999999999999999999999999999999998643221 111111111 111111111
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
... ..+.+++.+||+.||++|||+.|+++.|+....
T Consensus 228 ~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 228 NLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred ccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111 246678999999999999999999999966543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=342.66 Aligned_cols=256 Identities=27% Similarity=0.431 Sum_probs=198.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCC----EEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
.++|++.+.||+|+||+||+|+.. +++ .|++|.+.. ......+.+.+|+.+++.++||||++++++|.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 367999999999999999999864 344 358888754 33345678999999999999999999999998754 78
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+|+||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999997643 24899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
.............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... ....... .......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~----~~~~~~~ 240 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILE----KGERLPQ 240 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH----TTCCCCC
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HHHHHHH----cCCCCCC
Confidence 54443333444567889999999999999999999999999999999 99997643222 2222211 1111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
. .. ....+.+++.+||+.||++|||+.|+++.|+..
T Consensus 241 ~-----~~----~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 241 P-----PI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp C-----TT----BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred C-----cc----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 11 122567889999999999999999999998654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=342.77 Aligned_cols=247 Identities=22% Similarity=0.346 Sum_probs=200.7
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.+. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999986 56889999998642 122335788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+ +|+|.+++..... +++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6899988876543 899999999999999999999998 99999999999999999999999999986533
Q ss_pred CCCccccccccccccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+ ... .
T Consensus 161 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i------------~~~-~ 224 (336)
T 3h4j_B 161 G---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV------------NSC-V 224 (336)
T ss_dssp S---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC------------CSS-C
T ss_pred C---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH------------HcC-C
Confidence 2 22344579999999999988876 78999999999999999999998643322211100 000 0
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.......+ ..+.+++.+||+.||.+|||++|+++.
T Consensus 225 ~~~p~~~s----~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 YVMPDFLS----PGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCTTSC----HHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCcccCC----HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00111112 246678999999999999999999873
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=330.53 Aligned_cols=253 Identities=30% Similarity=0.487 Sum_probs=195.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccC----hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.+.||+|+||.||+|.. .++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 36789999999999999999987 58899999986532 23356789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC--------CCCeEEEee
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--------DMNPKISDF 241 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~--------~~~~kL~Df 241 (414)
|||+++++|.+++... .+++..++.++.|++.||.|||+++..+++||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999998533 3899999999999999999999987556899999999999986 678999999
Q ss_pred cCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC
Q 043285 242 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG 321 (414)
Q Consensus 242 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
|++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...........
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~ 230 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNK 230 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHTSC
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhhcCC
Confidence 9998653221 2245689999999999999999999999999999999999999754221 11111111122
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
....... .. ...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 231 ~~~~~~~-----~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 LALPIPS-----TC----PEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCc-----cc----CHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111111 11 1356788999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=354.27 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=202.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-eeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ey 172 (414)
.++|++.+.||+|+||.||+|.. .|+.||||+++... ..+.+.+|+.+++.++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 46788899999999999999988 57899999997643 4468899999999999999999999987765 78999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++|+|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 999999999976432 33789999999999999999999998 999999999999999999999999999854221
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.....+++.|+|||.+.+..++.++|||||||++|||+| |+.||...... +....... .......+
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~~----~~~~~~p~--- 409 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEK----GYKMDAPD--- 409 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---THHHHHHT----TCCCCCCT---
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc----CCCCCCCC---
Confidence 122356889999999999999999999999999999998 99997644322 22222221 11111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. ...+.+++.+||+.||++|||+.++++.|+.
T Consensus 410 --~~----~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 410 --GC----PPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp --TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --cC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11 1356778999999999999999999998854
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=333.18 Aligned_cols=262 Identities=22% Similarity=0.291 Sum_probs=199.6
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++|++.+.||+|+||+||+|+.. +++.||+|++... .......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 5889999999642 33345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++ ++.+.+.... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154 (292)
T ss_dssp CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-
Confidence 9986 5555554322 24899999999999999999999998 999999999999999999999999999876322
Q ss_pred CccccccccccccccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc-
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS- 329 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 329 (414)
........||+.|+|||++.+.. ++.++|||||||++|||++|..|+- ...........................
T Consensus 155 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~--~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp -CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC--CCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred -cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc--CCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 22233456899999999998765 7999999999999999999988852 222222233333222221111110000
Q ss_pred --------------cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 --------------CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 --------------~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.............+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000000111235678999999999999999999996
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=339.64 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=201.6
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 169 (414)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|..++..+ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 67999999999999999999875 4788999999753 344556788999999888 899999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999997644 3899999999999999999999998 99999999999999999999999999985322
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc--chHHHHHHHhhcCCCcccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNL--NLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 327 (414)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ............... .+
T Consensus 163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~- 238 (345)
T 3a8x_A 163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RI- 238 (345)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-CC-
T ss_pred C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-CC-
Confidence 1 22334567999999999999999999999999999999999999998643221110 111111111111111 11
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM------PSVIL 366 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~evl~ 366 (414)
....+ ..+.+++.+||+.||++||++ .|+++
T Consensus 239 ----p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 239 ----PRSLS----VKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ----CTTSC----HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ----CCCCC----HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 11122 246778999999999999996 66665
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=337.89 Aligned_cols=260 Identities=29% Similarity=0.419 Sum_probs=208.8
Q ss_pred hcCCCCCCCeecccCCceEEEEEE------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 164 (414)
..++|++.+.||+|+||.||+|+. .++..||+|++... .....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346899999999999999999975 24678999999753 334557889999999999 9999999999999999
Q ss_pred eeeEEEeecCCCChhHHhhcccc---------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQER---------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 229 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nil 229 (414)
..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999976432 124899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 043285 230 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNL 308 (414)
Q Consensus 230 l~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~ 308 (414)
++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 254 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--- 254 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch---
Confidence 99999999999999987654433333334567889999999999999999999999999999999 99887543321
Q ss_pred chHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 309 NLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
..... .......... .... ...+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 255 ~~~~~---~~~~~~~~~~-----~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 255 SKFYK---MIKEGFRMLS-----PEHA----PAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHHHH---HHHHTCCCCC-----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHH---HhccCCCCCC-----cccC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 11111 1111111111 0111 1356778999999999999999999999854
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=342.81 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=202.8
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.++|++.+.||+|+||.||+|... +|+.||+|++.. ......+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999874 588999999965 34445678899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---CeEEEeecCcccc
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLARAF 247 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kL~Dfgl~~~~ 247 (414)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 108 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999987543 3899999999999999999999998 99999999999998654 5999999999876
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ........... ....+....
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~~~-~~~~~~~~~ 254 (362)
T 2bdw_A 182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAG-AYDYPSPEW 254 (362)
T ss_dssp TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHT-CCCCCTTGG
T ss_pred cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhC-CCCCCcccc
Confidence 4322 2234579999999999999999999999999999999999999975321 11121111110 011111100
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
... ...+.+++.+||+.||++|||+.|+++.
T Consensus 255 -----~~~----~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 255 -----DTV----TPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----GGS----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----cCC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011 1246678999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=345.56 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=202.6
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67999999999999999999875 4788999998652 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999997644 3899999999999999999999998 999999999999999999999999999876422
Q ss_pred CCccccccccccccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||................ .... ..
T Consensus 169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~~~~--~~- 239 (384)
T 4fr4_A 169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---TTVV--TY- 239 (384)
T ss_dssp ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---HCCC--CC-
T ss_pred ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---hccc--CC-
Confidence 23345679999999999864 458999999999999999999999986544333222222211 1110 01
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS-MPSVIL 366 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~ 366 (414)
....+ ..+.+++.+||+.||.+||+ ++++++
T Consensus 240 ----p~~~s----~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 240 ----PSAWS----QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CTTSC----HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----CCcCC----HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01111 25678899999999999998 777765
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=342.72 Aligned_cols=254 Identities=23% Similarity=0.307 Sum_probs=193.9
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
..++|++.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3478999999999999999999875 68899999997532 223568899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC--eEEEeecCccccCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLARAFGG 249 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~--~kL~Dfgl~~~~~~ 249 (414)
|+++|+|.+++..... +++..+..++.|++.||+|||+++ ++||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~~~---~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999999876443 899999999999999999999998 999999999999987765 99999999874321
Q ss_pred CCCccccccccccccccccccccCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVK-SDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ .............. ...
T Consensus 171 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~~~--~~~ 243 (361)
T 3uc3_A 171 ---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVKYS--IPD 243 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTCCC--CCT
T ss_pred ---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCCCC--CCC
Confidence 222334579999999999988888665 8999999999999999999865433222 22222222111111 000
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. ... ...+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~---~~~----s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 D---IRI----SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp T---SCC----CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred c---CCC----CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 011 1346789999999999999999999974
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=340.78 Aligned_cols=252 Identities=27% Similarity=0.363 Sum_probs=196.3
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCC--CceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.+.||+|+||.||++...+++.||||++.. ......+.+.+|+.+++.++| |||+++++++.+....++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 467999999999999999999988899999999864 344556788999999999986 9999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|| +.+++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||++.....
T Consensus 88 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 55789999997654 3899999999999999999999998 99999999999997 67899999999987644
Q ss_pred CCCccccccccccccccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~ 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAII 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHHh
Confidence 333333445679999999999865 678999999999999999999999985321 1112222222
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.........+ .. ...+.+++.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~-----~~----~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 DPNHEIEFPD-----IP----EKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CTTSCCCCCC-----CS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccCCcc-----cC----CHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 2111111111 11 1246678999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=359.45 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=208.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|++.+.||+|+||.||+|.+.. +..||||.++... ...+.+.+|+.+++.++||||++++++|.+....++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4668888999999999999998865 7899999997633 3467899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++|+|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 999999999976433 34899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||.... .......... ........
T Consensus 374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~---~~~~~~~~~~----~~~~~~~~--- 442 (495)
T 1opk_A 374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEK----DYRMERPE--- 442 (495)
T ss_dssp -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHHHHT----TCCCCCCT---
T ss_pred -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHc----CCCCCCCC---
Confidence 12223446788999999999999999999999999999999 888875432 2222222221 11111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
.. ...+.+++.+||+.||++|||+.++++.|+..
T Consensus 443 --~~----~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 443 --GC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp --TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --CC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11 13567789999999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=339.54 Aligned_cols=260 Identities=28% Similarity=0.412 Sum_probs=208.1
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 162 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 162 (414)
..++|++.+.||+|+||.||+|+.. ++..||+|++... .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478999999999999999999863 4678999999753 445567889999999999 89999999999999
Q ss_pred CCeeeEEEeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 043285 163 GEEKLLIYEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 229 (414)
Q Consensus 163 ~~~~~lv~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nil 229 (414)
.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999976432 124889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 043285 230 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNL 308 (414)
Q Consensus 230 l~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~ 308 (414)
++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |+.||.... ..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~ 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VE 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---HH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC---HH
Confidence 99999999999999987654433333344567889999999999999999999999999999999 998875422 11
Q ss_pred chHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 309 NLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
...... ......... ... ...+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 267 ~~~~~~----~~~~~~~~~-----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 267 ELFKLL----KEGHRMDKP-----ANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHH----HHTCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHH----hcCCCCCCC-----ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111 111111111 111 12467789999999999999999999998654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=348.38 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=205.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999874 5889999999876666667889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC--CCCeEEEeecCccccCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLARAFGGD 250 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~--~~~~kL~Dfgl~~~~~~~ 250 (414)
+++|+|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+|||++. ++.+||+|||++......
T Consensus 130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999986543 24899999999999999999999998 999999999999974 477999999999876432
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||.... ........ ...... .....
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i---~~~~~~--~~~~~ 273 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNV---KRCDWE--FDEDA 273 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHH---HHCCCC--CCSST
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHHH---HhCCCC--CCccc
Confidence 2 2234578999999999999999999999999999999999999975422 11111111 111110 00000
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.... ...+.+++.+||+.||++|||+.|+++.
T Consensus 274 -~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 -FSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -TTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -cccC----CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0111 1246789999999999999999999984
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=341.60 Aligned_cols=254 Identities=22% Similarity=0.285 Sum_probs=201.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999864 5899999998542 1124578899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC---eEEEeecC
Q 043285 168 LIYEFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGL 243 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kL~Dfgl 243 (414)
+||||+++++|.+++.... ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886532 2234899999999999999999999998 999999999999987654 99999999
Q ss_pred ccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....... ......
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i---~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGI---IKGKYK 250 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHH---HHTCCC
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHH---HcCCCC
Confidence 98764322 12334579999999999999999999999999999999999999985421 1111111 111110
Q ss_pred cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. .+...... ...+.+++.+||+.||++|||+.|+++
T Consensus 251 ~---~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 M---NPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C---CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C---CccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00000111 135677899999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=335.61 Aligned_cols=249 Identities=23% Similarity=0.311 Sum_probs=193.2
Q ss_pred cCCCCCCCeecccCCceEEEEEE----cCCCEEEEEEecccC----hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL----VDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 165 (414)
.++|++.+.||+|+||.||+++. .+++.||+|++++.. ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999987 468999999997632 2344567889999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999997544 3889999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........ ..... .
T Consensus 170 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i---~~~~~--~ 239 (327)
T 3a62_A 170 ESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKI---LKCKL--N 239 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHH---HHTCC--C
T ss_pred ccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHH---HhCCC--C
Confidence 54221 122334578999999999999999999999999999999999999975422 11111111 11111 0
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILM 367 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 367 (414)
+ .... ...+.+++.+||+.||++|| ++.|+++.
T Consensus 240 ~-----p~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 240 L-----PPYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp C-----CTTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred C-----CCCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1 1111 12467789999999999999 78888873
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=330.94 Aligned_cols=254 Identities=28% Similarity=0.521 Sum_probs=200.1
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChh-------hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQ-------GLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 165 (414)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 47899999999999999999987 46889999998642221 1167889999999999999999999986554
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC-----eEEEe
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISD 240 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~-----~kL~D 240 (414)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ .+++||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 79999999999999886543 34899999999999999999999975 34999999999999988776 99999
Q ss_pred ecCccccCCCCCcccccccccccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043285 241 FGLARAFGGDETEGNTNRVVGTYGYMAPEYAS--DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 241 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
||++..... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||....... ........
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIR 243 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHH
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHh
Confidence 999975322 233457899999999984 4567899999999999999999999986433221 11111111
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.......+.. .. ...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 244 ~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEGLRPTIPE-----DC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSCCCCCCCT-----TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccCCCCCCCc-----cc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 2222211111 11 1356788999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=332.21 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=203.4
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
..++|++.+.||+|+||.||+++..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 346899999999999999999999888899999997633 2346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 101 MANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp CTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred cCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 99999999997633 24899999999999999999999998 9999999999999999999999999998653221
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... ........
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~~~~~----- 242 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHI----AQGLRLYR----- 242 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHH----HTTCCCCC-----
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHHH----hcccCCCC-----
Confidence 112223456788999999999999999999999999999998 99997543211 111111 11111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.... ...+.+++.+||+.||++|||+.|+++.|..
T Consensus 243 ~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 243 PHLA----SEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0111 1246778999999999999999999999853
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=355.67 Aligned_cols=258 Identities=27% Similarity=0.421 Sum_probs=202.5
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
..++|++.+.||+|+||.||+|...++..||||+++... ...+.+.+|+.+++.++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 446788999999999999999999888889999997533 335678999999999999999999999876 678999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++|+|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 999999999965322 34899999999999999999999998 99999999999999999999999999987543221
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+...... .........
T Consensus 336 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i~----~~~~~~~~~--- 404 (452)
T 1fmk_A 336 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVE----RGYRMPCPP--- 404 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHH----TTCCCCCCT---
T ss_pred -ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----cCCCCCCCC---
Confidence 12223456789999999999999999999999999999999 888875322 112222221 111111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
.. ...+.+++.+||+.||++|||+.++++.|+....
T Consensus 405 --~~----~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 405 --EC----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp --TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred --CC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 11 2356778999999999999999999999977654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=334.59 Aligned_cols=244 Identities=25% Similarity=0.363 Sum_probs=202.2
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||+++.. +|+.||+|++++. .....+.+.+|..+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67999999999999999999875 5899999999752 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 9999999999997654 3899999999999999999999998 99999999999999999999999999986532
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... ......... .+
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~---~~~i~~~~~--~~---- 222 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKT---YEKILNAEL--RF---- 222 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHH---HHHHHHCCC--CC----
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHH---HHHHHhCCC--CC----
Confidence 2334579999999999999999999999999999999999999975321 1111 112222211 01
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVIL 366 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~ 366 (414)
....+ ..+.+++.+||+.||++|| +++|+++
T Consensus 223 -p~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 -PPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11122 2466788999999999999 8999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=332.50 Aligned_cols=261 Identities=24% Similarity=0.347 Sum_probs=198.0
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|++.+.||+|+||+||+|+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999998789999999986532 22346788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++ +|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 985 8988886543 24889999999999999999999998 9999999999999999999999999998653221
Q ss_pred ccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc----
Q 043285 253 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI---- 327 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 327 (414)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ..+..................
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHHCCCChhhchhhhc
Confidence 122334689999999998764 58999999999999999999999975432 112222222211111110000
Q ss_pred ----ccccc-------CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 328 ----DSCFQ-------DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 328 ----~~~~~-------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
++.+. ..........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0000011235678999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=332.89 Aligned_cols=261 Identities=29% Similarity=0.493 Sum_probs=193.9
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
..++|++.+.||+|+||.||+|+.. ..||+|+++. ......+.+.+|+.+++.++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3478999999999999999999853 4699999864 3445567899999999999999999999965 556789999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999999986543 34899999999999999999999998 999999999999999999999999999865433
Q ss_pred CCcccccccccccccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
..........||+.|+|||.+. +..++.++||||||+++|||++|+.||...... ......... ...... .
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~---~~~~~~-~ 247 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGR---GSLSPD-L 247 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHH---TSCCCC-T
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhcc---cccCcc-h
Confidence 3333334557899999999986 667899999999999999999999997543221 111111111 111111 1
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 372 (414)
.. ..... ...+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 248 ~~-~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 248 SK-VRSNC----PKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TS-SCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hh-ccccC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 10 11111 235778999999999999999999999997543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=342.41 Aligned_cols=261 Identities=31% Similarity=0.413 Sum_probs=207.6
Q ss_pred HhcCCCCCCCeecccCCceEEEEEEcC------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeC
Q 043285 92 SATNNFSINKKLGQGGFGPVYKGKLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 163 (414)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 163 (414)
...++|++.+.||+|+||.||+|.... ...||+|.+... .....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345789999999999999999998643 247999999763 344567789999999999 899999999999999
Q ss_pred CeeeEEEeecCCCChhHHhhcccc-----------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQER-----------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 232 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~ 232 (414)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 999999999999999999975421 234789999999999999999999998 999999999999999
Q ss_pred CCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchH
Q 043285 233 DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLI 311 (414)
Q Consensus 233 ~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~ 311 (414)
++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||+| |..||...... ...
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~ 276 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN---SKF 276 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS---HHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh---HHH
Confidence 99999999999986543333223334567889999999999999999999999999999999 88887543221 111
Q ss_pred HHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 312 GHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. ............. .. ...+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 277 ~---~~~~~~~~~~~~~-----~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 277 Y---KLVKDGYQMAQPA-----FA----PKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp H---HHHHHTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H---HHHhcCCCCCCCC-----CC----CHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 1 1111111111110 11 1346778999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=330.53 Aligned_cols=249 Identities=26% Similarity=0.374 Sum_probs=193.1
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccCh--------------------------hhHHHHHHHHHHHH
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISE--------------------------QGLKELKNEVILFS 146 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 146 (414)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999864 588999999865321 12356889999999
Q ss_pred hcCCCceeeeEeEEEe--CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 043285 147 KLQHRNLVKLLGCCIQ--GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 224 (414)
Q Consensus 147 ~l~h~niv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk 224 (414)
.++||||+++++++.+ ....++||||+++++|.+++.. ..+++..+..++.|++.||+|||+++ ++|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 5678999999999999886532 24899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCC
Q 043285 225 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIVSGKKNRGF 301 (414)
Q Consensus 225 ~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGvil~elltg~~p~~~ 301 (414)
|+|||++.++.+||+|||++....... .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999998764322 1223457899999999998765 47899999999999999999999753
Q ss_pred CCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 302 YHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. .... .......... ... ....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~---~~~~---~~~~~~~~~~--~~~---~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ER---IMCL---HSKIKSQALE--FPD---QPDIA----EDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SS---HHHH---HHHHHHCCCC--CCS---SSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cc---HHHH---HHHHhcccCC--CCC---ccccC----HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 1111 1111111111 000 01111 24677899999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=341.18 Aligned_cols=258 Identities=27% Similarity=0.428 Sum_probs=197.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCE----EEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQE----IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
.++|++.+.||+|+||.||+|+.. +++. |++|.+.. ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 368999999999999999999864 3443 57777754 33445678999999999999999999999998754 78
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+|+||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999999997643 24899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
.............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... ........ ......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~~----~~~~~~ 240 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEK----GERLPQ 240 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHT----TCCCCC
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc----CCCCCC
Confidence 44333333334557889999999999999999999999999999999 99997643222 22222211 111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
. ... ...+.+++.+||+.||.+|||+.|+++.|+....
T Consensus 241 ~-----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 241 P-----PIC----TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp C-----TTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred C-----ccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 111 1246778999999999999999999999976544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=340.46 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=202.1
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 167 (414)
..++|++.+.||+|+||.||+|+.. +|+.||+|++++. .......+..|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999875 5889999999753 133456778899999877 8999999999999999999
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 95 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999997644 3899999999999999999999998 999999999999999999999999999854
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+. ... . .
T Consensus 169 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~---~~~-~-~-- 236 (345)
T 1xjd_A 169 MLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIR---MDN-P-F-- 236 (345)
T ss_dssp CCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH---HCC-C-C--
T ss_pred ccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHH---hCC-C-C--
Confidence 221 223445689999999999999999999999999999999999999975322 112222211 111 0 0
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMP-SVIL 366 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~ 366 (414)
+....+ ..+.+++.+||+.||++||++. ++++
T Consensus 237 ---~p~~~s----~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 237 ---YPRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---CCTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCcccC----HHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 111122 2467789999999999999998 7764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=340.03 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=200.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCE----EEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQE----IAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
.++|++.+.||+|+||.||+|+... +.. |++|.+... .......+.+|+.+++.++||||+++++++. ....+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 3679999999999999999998643 443 788877542 2233456778999999999999999999986 56789
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 9999999999999997642 24889999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
.............++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~----~~~~~~ 238 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPDLLEK----GERLAQ 238 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHHHHHT----TCBCCC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHHHHHc----CCCCCC
Confidence 54444434445668889999999999999999999999999999999 99998643322 22222211 111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 372 (414)
...+. ..+.+++.+||+.||.+|||+.|+++.|....
T Consensus 239 ~~~~~---------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 239 PQICT---------IDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CTTBC---------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCcCc---------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 12456888999999999999999999996554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=349.53 Aligned_cols=257 Identities=19% Similarity=0.241 Sum_probs=203.5
Q ss_pred HHHhcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 043285 90 IVSATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 90 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 165 (414)
+....++|++.+.||+|+||+||+|+.. +++.||+|++.+. .......+.+|+.+++.++||||++++++|.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3345678999999999999999999875 4889999998652 11223457889999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.++||||+++|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 99999999999999998653 3899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh-hc
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW-NE 320 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~ 320 (414)
...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .......+.... ..
T Consensus 217 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 217 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMNHKNSL 292 (410)
T ss_dssp ECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTHHHHC
T ss_pred eeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC---hhhHHHHHHhccccc
Confidence 754322 11233567999999999997765 7899999999999999999999985322 122222221111 11
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHh
Q 043285 321 GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPED--RPSMPSVILML 368 (414)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~L 368 (414)
..+.. ...+ ..+.+++.+||+.+|.+ ||+++|+++.-
T Consensus 293 ~~p~~-------~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 293 TFPDD-------NDIS----KEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp CCCTT-------CCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred cCCCc-------cccc----HHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 11110 0111 24667889999999988 99999999853
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=345.01 Aligned_cols=206 Identities=20% Similarity=0.275 Sum_probs=177.9
Q ss_pred hcCCCCCCCeeccc--CCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 93 ATNNFSINKKLGQG--GFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 93 ~~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
..++|++.+.||+| +||.||+|+.. +|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34789999999999 99999999875 5899999999653 3445677889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999976532 23899999999999999999999998 999999999999999999999999998654
Q ss_pred CCCC-----CccccccccccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 043285 248 GGDE-----TEGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNRGFY 302 (414)
Q Consensus 248 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~ 302 (414)
.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 2211 1112233478999999999987 67999999999999999999999998643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=338.30 Aligned_cols=245 Identities=22% Similarity=0.275 Sum_probs=202.8
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||+++.. +|+.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67999999999999999999875 5899999999652 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 121 e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred cCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC-
Confidence 99999999999976543 899999999999999999999998 99999999999999999999999999987532
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....... ...... .+
T Consensus 194 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~---i~~~~~--~~---- 257 (350)
T 1rdq_E 194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEK---IVSGKV--RF---- 257 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH---HHHCCC--CC----
T ss_pred ----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---HHHHHHH---HHcCCC--CC----
Confidence 2234579999999999999999999999999999999999999975321 1111111 111111 11
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPS-----MPSVILM 367 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 367 (414)
....+ ..+.+++.+||+.||.+||+ ++|+++.
T Consensus 258 -p~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 258 -PSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCC----HHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 11122 24677899999999999998 8888863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=338.39 Aligned_cols=263 Identities=28% Similarity=0.428 Sum_probs=209.0
Q ss_pred HhcCCCCCCCeecccCCceEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 043285 92 SATNNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 164 (414)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 164 (414)
...++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578999999999999999999754 3678999999753 3345567889999999999999999999999999
Q ss_pred eeeEEEeecCCCChhHHhhcccc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeE
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQER-------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 237 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k 237 (414)
..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 99999999999999999875321 134789999999999999999999998 99999999999999999999
Q ss_pred EEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHH
Q 043285 238 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWK 316 (414)
Q Consensus 238 L~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 316 (414)
|+|||++................+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ......
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~--- 252 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRF--- 252 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHH---
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHHHH---
Confidence 999999986543322223334467889999999999999999999999999999999 7888653211 111111
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 317 LWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
........... .. ...+.+++.+||+.||++|||+.|+++.|+....
T Consensus 253 -~~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 253 -VMEGGLLDKPD-----NC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -HHTTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HHcCCcCCCCC-----CC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111111111 11 1246778999999999999999999999976533
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=342.67 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=193.4
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee---
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK--- 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--- 166 (414)
.++|++.+.||+|+||.||+++. .+++.||||++... .......+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999986 56889999999753 334456788999999999999999999998876543
Q ss_pred -eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 167 -LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 167 -~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
++||||+++++|.+++.... .+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 99999999999999997644 3899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCC-ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 246 AFGGDET-EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 246 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC
Confidence 6543222 1223345689999999999999999999999999999999999999753221 11111111221111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ....... ...+.+++.+||+.||++||++.+++.
T Consensus 239 ~---~~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 239 P---SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp H---HHHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred c---ccccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0 0001111 124667899999999999997766654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=332.77 Aligned_cols=262 Identities=25% Similarity=0.389 Sum_probs=203.1
Q ss_pred CCCCCCCeecccCCceEEEEEE-----cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--Cee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-----VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 166 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 166 (414)
+.|++.+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5688999999999999999983 35889999999753 334557889999999999999999999999876 668
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999996543 24899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------CCCCcchHHHHHHH
Q 043285 247 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH--------SDNNLNLIGHAWKL 317 (414)
Q Consensus 247 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~--------~~~~~~~~~~~~~~ 317 (414)
....... .......+|..|+|||.+.+..++.++||||||+++|||++|..|+.... ..............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6433221 22334567888999999999999999999999999999999998753211 00011111111111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
........... .. ...+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 256 ~~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 LKEGKRLPCPP-----NC----PDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHTTCCCCCCT-----TC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhccCCCCCCC-----CC----CHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 12211111111 11 1356789999999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=343.12 Aligned_cols=251 Identities=27% Similarity=0.362 Sum_probs=196.7
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcC--CCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||.||++...+++.||||++.. ......+.+.+|+.+++.++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45999999999999999999987899999999864 34455678899999999996 599999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
| +.+++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||++......
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 56889999997654 3889999999999999999999998 99999999999995 589999999999876433
Q ss_pred CCccccccccccccccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN 319 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 319 (414)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...........
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~~ 282 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIID 282 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHHC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHhC
Confidence 32223345679999999999865 468999999999999999999999985321 11122222222
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 320 EGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
........ ... ...+.+++.+||+.||++|||+.|+++.
T Consensus 283 ~~~~~~~~-----~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 283 PNHEIEFP-----DIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TTSCCCCC-----CCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCCCC-----ccc----hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111111 111 1246778999999999999999999974
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=337.73 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=188.0
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3578999999999999999999864 58899999986532 234467889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhccc---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 171 EFMPNKSLDSFIFDQE---RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
||++ |+|.+++.... ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 59999886532 1234889999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc-
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ- 325 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 325 (414)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..................
T Consensus 159 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 159 GIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND---EEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCTTTC
T ss_pred CCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhHh
Confidence 3221 22234568999999999876 4689999999999999999999999864322 122222222111110000
Q ss_pred ------------c-----------ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 326 ------------L-----------IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 326 ------------~-----------~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+ ..+...... ...+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 000000111 235778999999999999999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=329.26 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=202.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.++|++.+.||+|+||.||+|... +++.||+|++.. ......+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999864 588999999864 34455678889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC---eEEEeecCcccc
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAF 247 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kL~Dfgl~~~~ 247 (414)
||+++++|.+.+.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999999887654 3899999999999999999999998 999999999999986655 999999999865
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ......... ..... ..
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~---~~~~~--~~ 227 (284)
T 3kk8_A 159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIK---AGAYD--YP 227 (284)
T ss_dssp CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH---HTCCC--CC
T ss_pred ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHHH---hcccc--CC
Confidence 4322 2234578999999999999999999999999999999999999974321 111111111 11110 00
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.+.. ...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~-~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SPEW-DTVT----PEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTT-TTSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhh-cccC----HHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 1111 24667899999999999999999997
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=330.30 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=201.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-C-------CEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-G-------QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 165 (414)
.++|++.+.||+|+||.||+|.... + ..||+|.+........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3678999999999999999997643 3 4799999987666677889999999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC--------eE
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--------PK 237 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~--------~k 237 (414)
.++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999997643 23899999999999999999999998 999999999999998887 99
Q ss_pred EEeecCccccCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH
Q 043285 238 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWK 316 (414)
Q Consensus 238 L~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 316 (414)
|+|||++.... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|..|+... ...... . .
T Consensus 162 l~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~--~~~~~~---~-~ 229 (289)
T 4fvq_A 162 LSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA--LDSQRK---L-Q 229 (289)
T ss_dssp ECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT--SCHHHH---H-H
T ss_pred eccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc--cchHHH---H-H
Confidence 99999986542 1233467899999999987 67899999999999999999966553211 111111 1 1
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 317 LWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
..... ....... ...+.+++.+||+.||++|||+.|+++.|+..-.
T Consensus 230 ~~~~~--~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 230 FYEDR--HQLPAPK---------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHTT--CCCCCCS---------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred Hhhcc--CCCCCCC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111 0111111 1135678889999999999999999999976544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=351.73 Aligned_cols=261 Identities=19% Similarity=0.241 Sum_probs=204.8
Q ss_pred HHHHHhcCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC
Q 043285 88 ATIVSATNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 163 (414)
Q Consensus 88 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 163 (414)
.++....++|++.+.||+|+||+||+|+..+ ++.||+|++.+.. ......+.+|..++..++||||++++++|.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3334456889999999999999999998765 7889999996521 12223478899999999999999999999999
Q ss_pred CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecC
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl 243 (414)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999999999999999997632 24899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH-
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL- 317 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~- 317 (414)
++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+....+...
T Consensus 222 a~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~ 297 (437)
T 4aw2_A 222 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHK 297 (437)
T ss_dssp CEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTHH
T ss_pred hhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC---hhHHHHhhhhcc
Confidence 986543221 2223457999999999987 5678999999999999999999999985322 12222222211
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPED--RPSMPSVILM 367 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~ 367 (414)
.....+... ...+ ..+.+++.+||+.+|++ ||+++|+++.
T Consensus 298 ~~~~~p~~~------~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 298 ERFQFPTQV------TDVS----ENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHCCCCSSC------CCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccCCccc------ccCC----HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 111111110 0111 24667888999988888 9999999984
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=335.32 Aligned_cols=267 Identities=28% Similarity=0.410 Sum_probs=210.4
Q ss_pred CHHHHHHhcCCCCCCCeecccCCceEEEEEE------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeE
Q 043285 86 ELATIVSATNNFSINKKLGQGGFGPVYKGKL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLL 157 (414)
Q Consensus 86 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~ 157 (414)
.........++|++.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|+.++..+ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344444568899999999999999999974 34678999999763 344556789999999999 799999999
Q ss_pred eEEEeCC-eeeEEEeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC
Q 043285 158 GCCIQGE-EKLLIYEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDL 223 (414)
Q Consensus 158 ~~~~~~~-~~~lv~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dl 223 (414)
+++...+ ..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ ++||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9998765 48999999999999999976432 122789999999999999999999998 999999
Q ss_pred CCCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 043285 224 KASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFY 302 (414)
Q Consensus 224 k~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~ 302 (414)
||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987644333333444567889999999999999999999999999999998 99887543
Q ss_pred CCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 303 HSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... ....... .......... .. ...+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 255 ~~~--~~~~~~~----~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 255 KID--EEFCRRL----KEGTRMRAPD-----YT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp CCS--HHHHHHH----HHTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred chh--HHHHHHh----ccCccCCCCC-----CC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 221 1111111 1111111111 11 1246778899999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=324.65 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=202.6
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 170 (414)
++|++.+.||+|+||.||+|+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 6789999999999999999998 5889999999753 345567899999999999999999999999887 7789999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+++ .+++||||||+||+++.++.++|+|||+.....
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred cccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 99999999999976443 34899999999999999999999875 359999999999999999999999999876432
Q ss_pred CCccccccccccccccccccccCCCCCc---chhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSV---KSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.....||+.|+|||.+.+..++. ++|||||||++|||++|+.||..... .................
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRPTIP 233 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCCCCC
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCCCCC
Confidence 12346789999999998765544 89999999999999999999753221 11111222222222211
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
. ..+ ..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 234 ~-----~~~----~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 234 P-----GIS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp T-----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-----CCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1 111 2467788999999999999999999998643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=337.93 Aligned_cols=252 Identities=24% Similarity=0.322 Sum_probs=187.8
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3467999999999999999999875 47889999997543 33567889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCeEEEeecCccccC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLARAFG 248 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kL~Dfgl~~~~~ 248 (414)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++. ++.+||+|||++....
T Consensus 129 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999987644 3899999999999999999999998 999999999999975 8899999999998653
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... ...... ....
T Consensus 203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~---i~~~~~--~~~~ 272 (349)
T 2w4o_A 203 HQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRR---ILNCEY--YFIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHH---HHTTCC--CCCT
T ss_pred cc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHH---HHhCCC--ccCC
Confidence 22 1223457899999999999999999999999999999999999997532211 111111 111111 0111
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
+. .... ...+.+++.+||+.||++|||+.|+++.
T Consensus 273 ~~-~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 PW-WDEV----SLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TT-TTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ch-hhhC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 0111 2356788999999999999999999973
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=343.93 Aligned_cols=246 Identities=24% Similarity=0.312 Sum_probs=194.7
Q ss_pred CCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCCh
Q 043285 100 NKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 178 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L 178 (414)
.+.||+|+||.||+|... +|..||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999864 5899999999876666677899999999999999999999999999999999999999999
Q ss_pred hHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE--cCCCCeEEEeecCccccCCCCCcccc
Q 043285 179 DSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL--DQDMNPKISDFGLARAFGGDETEGNT 256 (414)
Q Consensus 179 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill--~~~~~~kL~Dfgl~~~~~~~~~~~~~ 256 (414)
.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....... ..
T Consensus 174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~ 245 (373)
T 2x4f_A 174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KL 245 (373)
T ss_dssp HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BC
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cc
Confidence 99886533 24899999999999999999999998 9999999999999 567889999999998764322 22
Q ss_pred ccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCC
Q 043285 257 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFN 336 (414)
Q Consensus 257 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (414)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... ....... ...... ...+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~---i~~~~~~--~~~~~~-~~~~ 316 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AETLNN---ILACRWD--LEDEEF-QDIS 316 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHH---HHHTCCC--SCSGGG-TTSC
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH---HHhccCC--CChhhh-ccCC
Confidence 344689999999999999999999999999999999999999754321 111111 1111111 001111 1111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 337 LAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 337 ~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..+.+++.+||+.||.+|||+.|+++
T Consensus 317 ----~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 317 ----EEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 35678999999999999999999997
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=337.86 Aligned_cols=266 Identities=26% Similarity=0.374 Sum_probs=208.8
Q ss_pred cCCCCCCCeecccCCceEEEEEE-----cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEE--eCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI--QGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~ 166 (414)
.++|++.+.||+|+||.||++++ .++..||+|++........+.+.+|+.+++.++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36799999999999999999984 357889999998777777788999999999999999999999987 45568
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 999999999999999975332 4899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC--------CCcchHHHHHHH
Q 043285 247 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSD--------NNLNLIGHAWKL 317 (414)
Q Consensus 247 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~--------~~~~~~~~~~~~ 317 (414)
....... .......+|+.|+|||.+.+..++.++|||||||++|+|++|..||...... ............
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 1233446788899999999999999999999999999999999886432110 000111111111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
.......... .. ....+.+++.+||+.||++|||+.|+++.|+....
T Consensus 257 ~~~~~~~~~~-----~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 257 LEEGQRLPAP-----PA----CPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHTTCCCCCC-----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hhcccCCCCC-----Cc----ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111111 11 12356788999999999999999999999965533
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=346.64 Aligned_cols=207 Identities=28% Similarity=0.332 Sum_probs=178.7
Q ss_pred CcCHHHHHHhcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-----CCceeeeE
Q 043285 84 LFELATIVSATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----HRNLVKLL 157 (414)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~ 157 (414)
.+.+.+.....++|++.+.||+|+||+||+|+. .+++.||||++.. .......+..|+.+++.++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 344444445668999999999999999999987 4688999999975 2344566788999999986 99999999
Q ss_pred eEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-----
Q 043285 158 GCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ----- 232 (414)
Q Consensus 158 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~----- 232 (414)
+++...+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 9999999999999999 8999999976543 24899999999999999999999998 999999999999975
Q ss_pred --------------------CCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHH
Q 043285 233 --------------------DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEI 292 (414)
Q Consensus 233 --------------------~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~el 292 (414)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 78999999999986432 22345789999999999999999999999999999999
Q ss_pred HhCCCCCCC
Q 043285 293 VSGKKNRGF 301 (414)
Q Consensus 293 ltg~~p~~~ 301 (414)
++|+.||..
T Consensus 253 l~g~~pf~~ 261 (360)
T 3llt_A 253 YTGSLLFRT 261 (360)
T ss_dssp HHSSCSCCC
T ss_pred HHCCCCCCC
Confidence 999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=328.24 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=192.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC----CCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD----GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
.++|++.+.||+|+||.||+|.... +..||+|.+.. ......+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 4678999999999999999998643 45699999875 3444567889999999999999999999998 4567899
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 999999999999997543 24899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .+....... .......
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~---~~~~~~i~~----~~~~~~~ 239 (281)
T 1mp8_A 168 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIEN----GERLPMP 239 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHT----TCCCCCC
T ss_pred cccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH---HHHHHHHHc----CCCCCCC
Confidence 3221 12223456789999999999999999999999999999997 8888754322 222222211 1111111
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... ...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 240 -----~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 240 -----PNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp -----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111 1346678999999999999999999999854
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=327.82 Aligned_cols=262 Identities=19% Similarity=0.281 Sum_probs=202.9
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEE-EeCCeeeEEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC-IQGEEKLLIY 170 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 170 (414)
..++|++.+.||+|+||.||+|+. .+++.||+|++...... ..+..|+.+++.++|++++..++.+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999986 56889999987543222 3578899999999988877766655 6677889999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCCeEEEeecCcccc
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 247 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kL~Dfgl~~~~ 247 (414)
||+ +++|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+|||+ +.++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 999999987433 24899999999999999999999998 9999999999999 78899999999999876
Q ss_pred CCCCCc-----cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 248 GGDETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 248 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 443221 122355789999999999999999999999999999999999999876555444444433322211111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 323 PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
..... ...+ ..+.+++.+||+.||++|||+.++++.|++.
T Consensus 239 ~~~~~-----~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 IEVLC-----KGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHT-----TTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhhh-----ccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 11000 1111 2567889999999999999999999998654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=343.32 Aligned_cols=271 Identities=21% Similarity=0.291 Sum_probs=210.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC--eeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 169 (414)
.++|.+.+.||+|+||+||+|+... |+.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4679999999999999999998754 8999999997532 334567889999999999999999999998765 67999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCCeEEEeecCcc
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLAR 245 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~~kL~Dfgl~~ 245 (414)
|||+++|+|.+++........+++..++.++.|++.||+|||+++ ++||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999977655455899999999999999999999998 9999999999999 777889999999998
Q ss_pred ccCCCCCccccccccccccccccccccC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC-cchHHHHHH
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYASD--------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN-LNLIGHAWK 316 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~-~~~~~~~~~ 316 (414)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus 165 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 75432 22234568999999998865 5678899999999999999999999865443222 222222211
Q ss_pred HhhcCCCcccc-----------cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 317 LWNEGMPSQLI-----------DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 317 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
........... ...............+.+++.+||+.||++|||+.|+++.+..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 11000000000 0001122334556677889999999999999999999887643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=336.52 Aligned_cols=267 Identities=18% Similarity=0.230 Sum_probs=200.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEc----CCCEEEEEEecccChh-----------hHHHHHHHHHHHHhcCCCceeeeEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV----DGQEIAVKRLSKISEQ-----------GLKELKNEVILFSKLQHRNLVKLLG 158 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~ 158 (414)
.++|++.+.||+|+||.||+|... ++..||+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999875 5678999998753321 1123567888999999999999999
Q ss_pred EEEe----CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 043285 159 CCIQ----GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 234 (414)
Q Consensus 159 ~~~~----~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~ 234 (414)
++.. ....++||||+ +++|.+++.... .+++..++.++.|++.||+|||+++ ++||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 999999987654 4899999999999999999999998 99999999999999887
Q ss_pred --CeEEEeecCccccCCCCC-----ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 043285 235 --NPKISDFGLARAFGGDET-----EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN 307 (414)
Q Consensus 235 --~~kL~Dfgl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~ 307 (414)
.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-- 266 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD-- 266 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC--
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc--
Confidence 999999999987632211 11123457899999999999999999999999999999999999998532221
Q ss_pred cchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 308 LNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
...............+............ ...+.+++.+||+.||++|||+.+|++.|++...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 267 PVAVQTAKTNLLDELPQSVLKWAPSGSS----CCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHHHTTTHHHHHHSCTTSC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cHHHHHHHHhhcccccHHHHhhcccccc----HHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1112222222222222211110000011 1256778899999999999999999999987654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=335.78 Aligned_cols=262 Identities=23% Similarity=0.285 Sum_probs=197.1
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++|++.+.||+|+||+||+|+.. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999875 4899999998653 33345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++++|.+++..... +++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~~~---~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTSSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhhcC---CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999998765443 899999999999999999999998 9999999999999999999999999998754222
Q ss_pred CccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC--------
Q 043285 252 TEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM-------- 322 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 322 (414)
.......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .............
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD---QLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHHHH
T ss_pred --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhcccccccccccc
Confidence 22234568999999999876 678999999999999999999999985433221 1111111110000
Q ss_pred ----CcccccccccCcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 323 ----PSQLIDSCFQDSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 323 ----~~~~~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
......+........ .....+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000000 112346789999999999999999999963
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=354.84 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=205.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.+. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 6899999999652 223456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++|+|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999876432 34899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...........+
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p------ 409 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS------ 409 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC------
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC------
Confidence 22 223457999999999999999999999999999999999999998654333222222111111111111
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILM 367 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 367 (414)
...+ ..+.+++.+||+.||.+|| ++.|+++.
T Consensus 410 ---~~~s----~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 410 ---ERFS----PQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ---TTSC----HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ---ccCC----HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1112 2467789999999999999 78898863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=340.56 Aligned_cols=251 Identities=19% Similarity=0.242 Sum_probs=189.8
Q ss_pred CCCCCC-CeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHH-hcCCCceeeeEeEEEe----CCeee
Q 043285 95 NNFSIN-KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFS-KLQHRNLVKLLGCCIQ----GEEKL 167 (414)
Q Consensus 95 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~----~~~~~ 167 (414)
++|.+. +.||+|+||+||++... +|+.||||++... ..+.+|+.++. ..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 567665 68999999999999875 5889999998642 35667888764 4589999999999876 56789
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCeEEEeecCc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLA 244 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kL~Dfgl~ 244 (414)
+||||+++|+|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 99999999999999976432 34899999999999999999999998 999999999999997 788999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc-hHHHHHHHhhcCCC
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLN-LIGHAWKLWNEGMP 323 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 323 (414)
+..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ...... ......+
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~-~~~~~~~ 287 (400)
T 1nxk_A 212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-MGQYEFP 287 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH-HTCCCCC
T ss_pred cccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH-cCcccCC
Confidence 865322 22335678999999999999999999999999999999999999986544332211 111111 1111111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
... . ... ...+.+++.+||+.||++|||+.|+++.
T Consensus 288 ~~~----~-~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 288 NPE----W-SEV----SEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTT----T-TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Ccc----c-ccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 0 111 1246789999999999999999999984
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=326.08 Aligned_cols=261 Identities=19% Similarity=0.280 Sum_probs=205.8
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEE-EeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC-IQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... ..+.+|+.+++.++|+++++.+.++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999986 56889999998653322 4688999999999998877666655 56677899999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCCeEEEeecCccccC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFG 248 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~---~~~~~kL~Dfgl~~~~~ 248 (414)
|+ +++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 899999996433 24899999999999999999999998 99999999999994 78899999999998764
Q ss_pred CCCCc-----cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC
Q 043285 249 GDETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323 (414)
Q Consensus 249 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 43221 1224457999999999999999999999999999999999999998765544444443333221111111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
... ....+ ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 240 ~~~-----~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 240 EVL-----CKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHH-----TTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred HHH-----HhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 111 01111 2467789999999999999999999999654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=331.80 Aligned_cols=259 Identities=27% Similarity=0.375 Sum_probs=202.4
Q ss_pred CCCCCeecccCCceEEEEEEc-----CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC--CeeeE
Q 043285 97 FSINKKLGQGGFGPVYKGKLV-----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 168 (414)
Q Consensus 97 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 168 (414)
|++.+.||+|+||+||++.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 489999999999999998642 5788999999763 345567889999999999999999999999884 57899
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||+++|+|.+++.... +++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999996543 899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC--------CCcchHHHHHHHhh
Q 043285 249 GDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSD--------NNLNLIGHAWKLWN 319 (414)
Q Consensus 249 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~ 319 (414)
..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||...... ..............
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 33221 1233446788899999999999999999999999999999999987532110 00000001111111
Q ss_pred cCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 320 EGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
........ ... ...+.+++.+||+.||++|||+.|+++.|+..
T Consensus 266 ~~~~~~~~-----~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 266 RGERLPRP-----DKC----PAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp TTCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCC-----ccc----cHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111111 111 23577899999999999999999999999654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=330.00 Aligned_cols=250 Identities=18% Similarity=0.286 Sum_probs=201.8
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|++.+.||+|+||.||+|.... +..||+|++........+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4679999999999999999998754 678999999775555677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCCeEEEeecCccccCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kL~Dfgl~~~~~~ 249 (414)
+++++|.+++..... +++..+..++.|++.||+|||+++ ++||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999998876543 899999999999999999999998 9999999999999 7889999999999987543
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.. ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||..... ...... ....... ....
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~---~~~~~~~--~~~~ 229 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVMLK---IREGTFT--FPEK 229 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH---HHHCCCC--CCHH
T ss_pred cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHHH---HHhCCCC--CCch
Confidence 22 23345689999999988654 89999999999999999999999754221 111111 1111111 0000
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. ... ...+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~-~~~----~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 DW-LNV----SPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HH-TTS----CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hh-hcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 011 135677899999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=325.58 Aligned_cols=254 Identities=26% Similarity=0.434 Sum_probs=205.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.++|++.+.||+|+||.||++...+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 36788999999999999999998888899999997633 23467899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~ 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y 159 (267)
T ss_dssp TTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred CCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-c
Confidence 9999999997543 24889999999999999999999998 9999999999999999999999999998653211 1
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ........ ........ .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~i----~~~~~~~~-----~ 227 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDI----STGFRLYK-----P 227 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHH----HTTCCCCC-----C
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---HHHHHHHH----hcCCcCCC-----C
Confidence 12223456788999999999999999999999999999999 888875321 11111111 11111110 0
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... ...+.+++.+||+.||++|||+.++++.|+.
T Consensus 228 ~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 228 RLA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccC----cHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111 1246778999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=324.71 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=203.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999875 6889999998642 33445788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999986543 3899999999999999999999998 9999999999999999999999999998654332
Q ss_pred CccccccccccccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .... .+...... ...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~----~~~~~~~~--~~~- 230 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYS----DWKEKKTY--LNP- 230 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--HHHH----HHHTTCTT--STT-
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHH----Hhhhcccc--cCc-
Confidence 2223345578999999999988765 789999999999999999999986533221 1111 11111110 000
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
....+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 231 -~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 231 -WKKID----SAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -GGGSC----HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -hhhcC----HHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 01111 246678999999999999999999863
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=336.10 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=202.0
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 167 (414)
..++|++.+.||+|+||+||+++... ++.||+|++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34789999999999999999998754 788999999753 223456788899999888 7999999999999999999
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+||||+++|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999976443 899999999999999999999998 999999999999999999999999999853
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ..... .+
T Consensus 172 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i---~~~~~--~~- 240 (353)
T 2i0e_A 172 IWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSI---MEHNV--AY- 240 (353)
T ss_dssp CCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---HHCCC--CC-
T ss_pred ccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHHHHHHH---HhCCC--CC-
Confidence 221 223345679999999999999999999999999999999999999975321 11222222 11111 11
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS-----MPSVILM 367 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 367 (414)
....+ ..+.+++.+||+.||.+||+ +.++++.
T Consensus 241 ----p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 241 ----PKSMS----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ----CTTSC----HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ----CCCCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11122 24677899999999999995 5777653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=333.13 Aligned_cols=261 Identities=25% Similarity=0.412 Sum_probs=195.3
Q ss_pred HHhcCCCCCCCeecccCCceEEEEEEcC----CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 043285 91 VSATNNFSINKKLGQGGFGPVYKGKLVD----GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 164 (414)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 164 (414)
....++|.+.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 3355789999999999999999997642 447999998753 3445677899999999999999999999998765
Q ss_pred e-----eeEEEeecCCCChhHHhhcc---cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCe
Q 043285 165 E-----KLLIYEFMPNKSLDSFIFDQ---ERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 236 (414)
Q Consensus 165 ~-----~~lv~ey~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~ 236 (414)
. .++||||+++|+|.+++... .....+++..++.++.|+++||.|||+++ ++||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 3 49999999999999998532 22345899999999999999999999998 9999999999999999999
Q ss_pred EEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043285 237 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 237 kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 315 (414)
||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ........
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~ 263 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---HEMYDYLL 263 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHH
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHH
Confidence 9999999987644333233334567889999999999999999999999999999999 8888754322 22222221
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 316 KLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. ....... ... ...+.+++.+||+.||.+|||+.++++.|+.
T Consensus 264 ~----~~~~~~~-----~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 264 H----GHRLKQP-----EDC----LDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp T----TCCCCCB-----TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred c----CCCCCCC-----ccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 1111111 111 1256788999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=341.19 Aligned_cols=261 Identities=20% Similarity=0.248 Sum_probs=199.5
Q ss_pred HHHhcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC
Q 043285 90 IVSATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 163 (414)
Q Consensus 90 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 163 (414)
+....++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3445678999999999999999999874 5788999998642 344567899999999999999999999999999
Q ss_pred CeeeEEEeecCCCChhHHhhcccc-------------------------------------cccCCHHHHHHHHHHHHHH
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQER-------------------------------------CMILDWSKRFHIICGTARG 206 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~~ 206 (414)
+..++||||+++|+|.+++..... ...+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999852100 1124577788999999999
Q ss_pred HHHHHhCCCCCeeeccCCCCCEEEcCCC--CeEEEeecCccccCCCCC--ccccccccccccccccccccC--CCCCcch
Q 043285 207 LLYLHQDSRLRIIHRDLKASNVLLDQDM--NPKISDFGLARAFGGDET--EGNTNRVVGTYGYMAPEYASD--GQFSVKS 280 (414)
Q Consensus 207 l~~LH~~~~~~iiH~dlk~~Nill~~~~--~~kL~Dfgl~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~s 280 (414)
|+|||+++ ++||||||+||+++.++ .+||+|||++..+..... ........||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 899999999986532211 112334578999999999875 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCC
Q 043285 281 DVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS 360 (414)
Q Consensus 281 DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs 360 (414)
|||||||++|||++|+.||..... . .............. .+.. ... ...+.+++.+||+.||.+|||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~---~---~~~~~~~~~~~~~~--~~~~-~~~----~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVND---A---DTISQVLNKKLCFE--NPNY-NVL----SPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHCCCCTT--SGGG-GGS----CHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCh---H---HHHHHHHhcccccC--Cccc-ccC----CHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999753321 1 11222222221111 1110 011 124677899999999999999
Q ss_pred HHHHHH
Q 043285 361 MPSVIL 366 (414)
Q Consensus 361 ~~evl~ 366 (414)
+.|+++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999997
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=328.65 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=208.0
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
..++|++.+.||+|+||.||+|.... +..||+|.+... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45779999999999999999998754 788999999753 3345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999976433 34899999999999999999999998 9999999999999999999999999998764322
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
........+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ......... .......
T Consensus 166 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~---~~~~~~~~~----~~~~~~~--- 234 (288)
T 3kfa_A 166 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEK----DYRMERP--- 234 (288)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHHT----TCCCCCC---
T ss_pred -cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhc----cCCCCCC---
Confidence 222334457889999999999999999999999999999999 8888754322 222222211 1111111
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... ...+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 235 --~~~----~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 235 --EGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp --TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCC----CHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 111 1356788999999999999999999998854
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=327.75 Aligned_cols=256 Identities=26% Similarity=0.364 Sum_probs=200.7
Q ss_pred CCCCCCeecccCCceEEEEEEcC-C---CEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee-eEE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK-LLI 169 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv 169 (414)
.|.+.+.||+|+||.||+|+..+ + ..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45666899999999999997533 2 26999999763 345567889999999999999999999999877665 999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+.+|+|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999997633 34789999999999999999999998 99999999999999999999999999986543
Q ss_pred CC--CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 250 DE--TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 250 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.. .........+++.|+|||.+.+..++.++||||||+++|+|++|..|+.. ....................
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~--~~~~~~~~~~~~~~~~~~~~---- 250 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR--HIDPFDLTHFLAQGRRLPQP---- 250 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT--TSCGGGHHHHHHTTCCCCCC----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc--cCCHHHHHHHhhcCCCCCCC----
Confidence 22 11223345678999999999999999999999999999999996665322 22222222222211111110
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
... ...+.+++.+||+.||.+|||+.++++.|+..
T Consensus 251 -----~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 251 -----EYC----PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp -----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----ccc----hHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111 12467789999999999999999999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=335.88 Aligned_cols=250 Identities=22% Similarity=0.252 Sum_probs=178.0
Q ss_pred CCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEEeecCCCC
Q 043285 100 NKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKS 177 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ey~~~g~ 177 (414)
.+.||+|+||.||+|... +++.||||++.+. ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999875 5889999999653 3456788999999997 9999999999999999999999999999
Q ss_pred hhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---CeEEEeecCccccCCCCCcc
Q 043285 178 LDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 178 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kL~Dfgl~~~~~~~~~~~ 254 (414)
|.+++.... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++ .+||+|||++....... .
T Consensus 93 L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~ 164 (325)
T 3kn6_A 93 LFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q 164 (325)
T ss_dssp HHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence 999997654 3899999999999999999999998 99999999999998765 79999999998653221 2
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCc
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (414)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......................... ......
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~--- 240 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-FEGEAW--- 240 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-CCSHHH---
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-CCcccc---
Confidence 2334568999999999999999999999999999999999999986543322111111222211111110 000000
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 335 FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 335 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
......+.+++.+||+.||++|||+.|+++
T Consensus 241 --~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 --KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp --HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred --cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 001235678999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=324.80 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=198.3
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999865 4678999998642 222356788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999876543 899999999999999999999988 99999999999999999999999999865422
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....... ..... ..
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~---~~~~~--~~--- 226 (279)
T 3fdn_A 162 ----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRI---SRVEF--TF--- 226 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHH---HHTCC--CC---
T ss_pred ----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---HHHHHHH---HhCCC--CC---
Confidence 222345789999999999999999999999999999999999999753221 1111111 11111 00
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.... ...+.+++.+||+.||.+|||+.|+++.
T Consensus 227 --~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 --PDFV----TEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --CTTS----CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCcC----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111 1246678999999999999999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=347.01 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=202.8
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999875 68999999996532 22456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999997543 3899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
. ......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ........ ...... .
T Consensus 169 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i---~~~~~~--~-- 235 (476)
T 2y94_A 169 G---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH---VPTLFKKI---CDGIFY--T-- 235 (476)
T ss_dssp T---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS---SHHHHHHH---HTTCCC--C--
T ss_pred c---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC---HHHHHHHH---hcCCcC--C--
Confidence 2 22334579999999999988776 789999999999999999999985422 11122111 111110 0
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 236 ---p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 ---PQYLN----PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CccCC----HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 01111 24677899999999999999999997
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=330.70 Aligned_cols=262 Identities=22% Similarity=0.268 Sum_probs=197.7
Q ss_pred cCCCCCC-CeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSIN-KKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.+.|++. +.||+|+||.||+|.. .+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3568774 7899999999999985 46899999999776555667889999999885 7999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC---eEEEeecCcccc
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAF 247 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kL~Dfgl~~~~ 247 (414)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ ++||||||+||+++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999997654 3899999999999999999999998 999999999999998776 999999998765
Q ss_pred CCCCC-----ccccccccccccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch-------
Q 043285 248 GGDET-----EGNTNRVVGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNL------- 310 (414)
Q Consensus 248 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~------- 310 (414)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32111 111223468999999999875 5688999999999999999999999865433221000
Q ss_pred -HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 311 -IGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 311 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
............. .+..... ... ...+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~i~~~~~-~~~~~~~-~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKY-EFPDKDW-AHI----SCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCC-CCCHHHH-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCc-ccCchhc-ccC----CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0011111111111 0100000 011 1356789999999999999999999983
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=340.09 Aligned_cols=267 Identities=18% Similarity=0.212 Sum_probs=202.2
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcC------CCEEEEEEecccChhhH-----------HHHHHHHHHHHhcCCCceee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVD------GQEIAVKRLSKISEQGL-----------KELKNEVILFSKLQHRNLVK 155 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~ 155 (414)
..++|++.+.||+|+||.||+|.... ++.||||++........ ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998754 46899999876432211 12344666777888999999
Q ss_pred eEeEEEeC----CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 043285 156 LLGCCIQG----EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 231 (414)
Q Consensus 156 ~~~~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~ 231 (414)
+++++... ...++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4589999999 999999997642 34899999999999999999999998 99999999999999
Q ss_pred --CCCCeEEEeecCccccCCCCCc-----cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 043285 232 --QDMNPKISDFGLARAFGGDETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS 304 (414)
Q Consensus 232 --~~~~~kL~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~ 304 (414)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999875432111 112344599999999999999999999999999999999999999864322
Q ss_pred CCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 305 DNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
. ............. ....+.+.++..... ...+.+++.+||+.+|.+||++.++++.|...
T Consensus 267 ~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 267 D--PKYVRDSKIRYRE-NIASLMDKCFPAANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp C--HHHHHHHHHHHHH-CHHHHHHHHSCTTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred C--HHHHHHHHHHhhh-hHHHHHHHhcccccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 2 1122222211111 122233333321111 12466788899999999999999999998554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=326.02 Aligned_cols=255 Identities=31% Similarity=0.468 Sum_probs=204.3
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46789999999999999999998888899999997532 34568899999999999999999999986 45689999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++++|.+++..... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp TTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence 99999999965432 24899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ........ .........
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~----~~~~~~~~~----- 232 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEVIQNL----ERGYRMVRP----- 232 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHH----HTTCCCCCC-----
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC---HHHHHHHH----hcccCCCCc-----
Confidence 12223456788999999998899999999999999999999 888875321 11222221 111111111
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
... ...+.+++.+||+.||++|||+.++++.|++.
T Consensus 233 ~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 233 DNC----PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccc----cHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 111 13567889999999999999999999998654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=330.22 Aligned_cols=252 Identities=22% Similarity=0.310 Sum_probs=202.8
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccCh------hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
.++|++.+.||+|+||.||+++.. +|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 357999999999999999999875 588999999865321 1357889999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----CeEEEeec
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 242 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kL~Dfg 242 (414)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997543 3889999999999999999999998 99999999999999887 79999999
Q ss_pred CccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... ....... .....
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i---~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANI---TSVSY 235 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHH---HTTCC
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---Hhccc
Confidence 998764322 22345689999999999999999999999999999999999999753211 1111111 11110
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 323 PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.. +.......+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 236 --~~-~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 --DF-DEEFFSHTS----ELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --CC-CHHHHTTCC----HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --cc-ChhhhcccC----HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000001111 246778999999999999999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=328.71 Aligned_cols=244 Identities=25% Similarity=0.338 Sum_probs=190.8
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||+||+|+.. +|+.||||++... ..........|+..+..+ +||||++++++|.++...++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999876 6899999998652 233344555566655555 8999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+ +++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 679988886543 34899999999999999999999998 999999999999999999999999998875322
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.......||+.|+|||++.+ .++.++|||||||++|||++|..++... ..+........ ...
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~----~~~ 272 (311)
T 3p1a_A 211 ---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYL----PPE 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCC----CHH
T ss_pred ---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCC----Ccc
Confidence 22334568999999999876 7899999999999999999997664321 11111111111 111
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+.... ...+.+++.+||+.||++|||+.|+++
T Consensus 273 ~~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 FTAGL----SSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCC----CHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11111 235778999999999999999999996
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=334.27 Aligned_cols=265 Identities=22% Similarity=0.302 Sum_probs=204.7
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 168 (414)
.++|++.+.||+|+||.||+++. .+++.||+|++........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999987 5689999999977666777889999999999999999999999973 347899
Q ss_pred EEeecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 169 IYEFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
||||+++|+|.+++.... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999987532 2245899999999999999999999998 999999999999999999999999998764
Q ss_pred CCCCCcc-------ccccccccccccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043285 248 GGDETEG-------NTNRVVGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL 317 (414)
Q Consensus 248 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 317 (414)
....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||......... ......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~-- 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAVQ-- 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHHH--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHhh--
Confidence 2111100 112235799999999987654 689999999999999999999997532111111 111111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLP 375 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 375 (414)
...... . .... ...+.+++.+||+.||.+|||+.++++.|+......
T Consensus 262 --~~~~~~--~---~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 262 --NQLSIP--Q---SPRH----SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp --CC--CC--C---CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred --ccCCCC--c---cccC----CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 110000 0 0111 135778999999999999999999999998765533
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=327.96 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=198.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCC----CEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe-CCeee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDG----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKL 167 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 167 (414)
..+|++.+.||+|+||.||+|+..++ ..|++|.+.. ......+.+.+|+.+++.++||||+++++++.. .+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35688889999999999999986432 2589999876 344456788999999999999999999998654 55789
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 104 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999996533 34789999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCC--ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 248 GGDET--EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK-KNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 248 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
..... ........+|+.|+|||.+.+..++.++||||||+++|||++|. +|+.... .......... ....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~~~----~~~~ 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQ----GRRL 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC---TTTHHHHHHT----TCCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC---HHHHHHHHhc----CCCC
Confidence 43221 11223345788999999999999999999999999999999955 4443222 2222222211 1111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... .... ..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 252 ~~~-----~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 252 LQP-----EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp CCC-----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC-----ccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 000 1111 246778999999999999999999999854
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=346.25 Aligned_cols=248 Identities=22% Similarity=0.298 Sum_probs=192.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.+.||+|+||.||+++.. +|+.||||++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999864 5889999999752 333456678899999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||++....
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999987654 38999999999999999999998 77 9999999999999999999999999997542
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... ....... +
T Consensus 301 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~---i~~~~~~--~-- 368 (446)
T 4ejn_A 301 KD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFEL---ILMEEIR--F-- 368 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH---HHHCCCC--C--
T ss_pred CC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHH---HHhCCCC--C--
Confidence 22 2223446799999999999999999999999999999999999999753221 111111 1111111 1
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVIL 366 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~ 366 (414)
....+ ..+.+++.+||+.||.+|| |++|+++
T Consensus 369 ---p~~~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 ---PRTLG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---CTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CccCC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11111 2467789999999999999 9999997
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=340.51 Aligned_cols=259 Identities=25% Similarity=0.299 Sum_probs=188.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEe--------C
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ--------G 163 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--------~ 163 (414)
..+|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.+++.+. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999864 68899999997766667778999999999996 9999999999953 3
Q ss_pred CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecC
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl 243 (414)
...++||||++ |+|.+++........+++..++.++.|++.||.|||+++ ++++||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 45789999996 799998876444445999999999999999999999875 3599999999999999999999999999
Q ss_pred ccccCCCCCcc----------ccccccccccccccccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 043285 244 ARAFGGDETEG----------NTNRVVGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNL 310 (414)
Q Consensus 244 ~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~ 310 (414)
+.......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||....... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~ 261 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---I 261 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---h
Confidence 98764322111 11234589999999998 56778999999999999999999999975322110 0
Q ss_pred HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 311 IGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
. .........+ .. ...+.+++.+||+.||++|||+.|+++.|.....
T Consensus 262 ---~----~~~~~~~~~~-----~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 262 ---V----NGKYSIPPHD-----TQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -----------CCCCTTC-----CS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---h----cCcccCCccc-----cc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 0000000000 00 0125578889999999999999999999965543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=336.73 Aligned_cols=261 Identities=22% Similarity=0.310 Sum_probs=202.4
Q ss_pred HHHHHHhcCCCCCC-CeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcC-CCceeeeEeEEE
Q 043285 87 LATIVSATNNFSIN-KKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCI 161 (414)
Q Consensus 87 ~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 161 (414)
+.......+.|.+. +.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.+. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33444556678777 88999999999999875 5899999998752 2334678899999999994 699999999999
Q ss_pred eCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCeEE
Q 043285 162 QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKI 238 (414)
Q Consensus 162 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kL 238 (414)
+....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+||+++. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence 99999999999999999999865422 34899999999999999999999998 999999999999997 789999
Q ss_pred EeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043285 239 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 239 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... .
T Consensus 176 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~-~ 248 (327)
T 3lm5_A 176 VDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNISQ-V 248 (327)
T ss_dssp CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH-T
T ss_pred eeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHh-c
Confidence 9999998763221 22345789999999999999999999999999999999999999754221 111111111 1
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.......... .. ...+.+++.+||+.||.+|||++|+++.
T Consensus 249 ~~~~~~~~~~-----~~----~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 NVDYSEETFS-----SV----SQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCCCCTTTTT-----TS----CHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccccCchhhc-----cc----CHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111111111 11 1246678999999999999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=331.75 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=199.8
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|.+.+.||+|+||.||+++.. +|+.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467999999999999999999875 6899999999765444556788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCCeEEEeecCccccCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kL~Dfgl~~~~~~ 249 (414)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999986544 3899999999999999999999998 9999999999999 7788999999999875422
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ......... ..... ...+
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~---~~~~~--~~~~ 229 (304)
T 2jam_A 162 ----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFEKIK---EGYYE--FESP 229 (304)
T ss_dssp ----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHH---HCCCC--CCTT
T ss_pred ----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHH---cCCCC--CCcc
Confidence 22334568999999999999999999999999999999999999975322 111111111 11110 0000
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. .... ...+.+++.+||+.||++|||+.|+++
T Consensus 230 ~-~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 F-WDDI----SESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp T-TTTS----CHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred c-cccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0111 135678999999999999999999997
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=338.76 Aligned_cols=247 Identities=22% Similarity=0.292 Sum_probs=190.8
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHH-HHhcCCCceeeeEeEEEeCCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
.++|++.+.||+|+||.||+++.. ++..||+|++.+.. ......+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999875 47889999997532 2334456667766 577899999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999997644 3889999999999999999999998 9999999999999999999999999998642
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....... ...... .+
T Consensus 191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~---i~~~~~--~~-- 258 (373)
T 2r5t_A 191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDN---ILNKPL--QL-- 258 (373)
T ss_dssp CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB---HHHHHHH---HHHSCC--CC--
T ss_pred cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHH---HHhccc--CC--
Confidence 21 223445689999999999999999999999999999999999999975321 1111111 122111 11
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl 365 (414)
....+ ..+.+++.+||+.||.+||++.+.+
T Consensus 259 ---~~~~~----~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 259 ---KPNIT----NSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ---CSSSC----HHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ---CCCCC----HHHHHHHHHHcccCHHhCCCCCCCH
Confidence 11122 2466789999999999999985433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=349.60 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=203.8
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|.+.+.||+|+||+||+++.. +|+.||+|++.+. .......+..|+.+++.++||||+++++++.+....++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888999999999999999875 5899999999652 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 171 EFMPNKSLDSFIFDQER-CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999875432 345899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........... .......... .+
T Consensus 342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~--~~~~i~~~~~--~~--- 412 (543)
T 3c4z_A 342 GQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE--LKQRVLEQAV--TY--- 412 (543)
T ss_dssp TC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH--HHHHHHHCCC--CC---
T ss_pred CC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH--HHHHHhhccc--CC---
Confidence 22 123345799999999999999999999999999999999999999865432221111 1111111111 11
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM-----PSVIL 366 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~ 366 (414)
....+ ..+.+++.+||+.||++||++ .++++
T Consensus 413 --p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 413 --PDKFS----PASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --CTTSC----HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --CcccC----HHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11112 246678899999999999975 66664
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=357.95 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=206.6
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
..++|++.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|+.+|+.++||||+++++++.+ ...++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 446788999999999999999999888889999997633 335678999999999999999999999876 678999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++|+|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 343 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 417 (535)
T ss_dssp CTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred hcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence 999999999965322 34899999999999999999999998 9999999999999999999999999998653211
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
........++..|+|||.+.+..++.++|||||||+||||++ |+.||.... ..+...... .........
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~---~~~~~~~i~----~~~~~~~~~--- 487 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVE----RGYRMPCPP--- 487 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC---HHHHHHHHH----TTCCCCCCT---
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----cCCCCCCCC---
Confidence 111223346788999999999999999999999999999999 888875322 122222221 111111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
.. ...+.+++.+||+.||++|||+.+|++.|+..-.
T Consensus 488 --~~----~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 488 --EC----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp --TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred --CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 11 1246778999999999999999999999976544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=329.02 Aligned_cols=264 Identities=24% Similarity=0.330 Sum_probs=198.2
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccC-----hhhHHHHHHHHHHHHhcC---CCceeeeEeEEEeC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQG 163 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 163 (414)
..++|++.+.||+|+||+||+|+. .+++.||+|++.... ......+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999986 468899999986422 112245667777777664 99999999999876
Q ss_pred C-----eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEE
Q 043285 164 E-----EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 238 (414)
Q Consensus 164 ~-----~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL 238 (414)
. ..++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4799999997 599999876543 33899999999999999999999998 999999999999999999999
Q ss_pred EeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043285 239 SDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 239 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
+|||++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS---EADQLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS---HHHHHHHHHHHH
T ss_pred eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHh
Confidence 999999865322 22345678999999999999999999999999999999999999975432 222222222222
Q ss_pred hcCCCccccc------cccc--CcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 319 NEGMPSQLID------SCFQ--DSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 319 ~~~~~~~~~~------~~~~--~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.......... ..+. ..... .....+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1111111100 0000 00000 112356789999999999999999999963
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=329.81 Aligned_cols=266 Identities=23% Similarity=0.334 Sum_probs=197.0
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc--CCCceeeeEeEEEeC----Cee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL--QHRNLVKLLGCCIQG----EEK 166 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~----~~~ 166 (414)
..++|++.+.||+|+||.||+|+. .++.||||++.... ......|.+++... +||||+++++++... ...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 457899999999999999999987 48999999986432 23444555555554 899999999999887 678
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeccCCCCCEEEcCCCCeEEEee
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS-----RLRIIHRDLKASNVLLDQDMNPKISDF 241 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiH~dlk~~Nill~~~~~~kL~Df 241 (414)
++||||+++|+|.+++... .+++..++.++.|++.||+|||++. .++++||||||+|||++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 9999999999999999654 3899999999999999999999880 112999999999999999999999999
Q ss_pred cCccccCCCCCcc--ccccccccccccccccccCCCCCcc------hhHHHHHHHHHHHHhC----------CCCCCCCC
Q 043285 242 GLARAFGGDETEG--NTNRVVGTYGYMAPEYASDGQFSVK------SDVFSFGILLLEIVSG----------KKNRGFYH 303 (414)
Q Consensus 242 gl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwslGvil~elltg----------~~p~~~~~ 303 (414)
|++.......... ......||+.|+|||++.+..++.. +|||||||++|||++| ..||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9997654322211 1224578999999999988766655 9999999999999999 55544322
Q ss_pred CCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 304 SDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
..... ................... ..........+.+++.+||+.||++|||+.|+++.|+..
T Consensus 267 ~~~~~--~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 267 PSDPS--YEDMREIVCIKKLRPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CSSCC--HHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCc--hhhhHHHHhhhccCccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 22211 1111111111111111111 111123455678899999999999999999999999653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=331.62 Aligned_cols=257 Identities=27% Similarity=0.426 Sum_probs=198.1
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
.++|.+.+.||+|+||.||+|.... +..||+|.+... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3568888999999999999997643 235999999753 3445567899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 123 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999997542 34899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 248 GGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 248 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ....... .......
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~----~~~~~~~ 270 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAI----NDGFRLP 270 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH----HTTCCCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH----HCCCcCC
Confidence 432211 11222346788999999999999999999999999999999 9999753221 1121111 1111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
... . ....+.+++.+||+.||++||++.++++.|+..
T Consensus 271 ~~~-----~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 271 TPM-----D----CPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp CCT-----T----CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred Ccc-----c----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 1 123467789999999999999999999998654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=327.91 Aligned_cols=260 Identities=19% Similarity=0.255 Sum_probs=197.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999875 5889999999753 233457789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999997643 3899999999999999999999998 99999999999999999999999999876533
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .............. .
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~--~- 255 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIPRP--S- 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCCCG--G-
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCCCc--c-
Confidence 221 122345689999999999999999999999999999999999999754211 11111111111110 0
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhcCCCCC
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRP-SMPSVILMLGSETVL 374 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~ 374 (414)
......+ ..+.+++.+||+.||++|| |++++++.|......
T Consensus 256 ~~~~~~~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 256 TVRPGIP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp GTSTTCC----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ccCCCCC----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 0011111 2466788999999999999 999999999766543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=332.80 Aligned_cols=259 Identities=29% Similarity=0.450 Sum_probs=201.8
Q ss_pred cCCCCCCCeecccCCceEEEEEE------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
.++|++.+.||+|+||.||+|+. .++..||||.+... .......+.+|+.+++.++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 47899999999999999999974 24678999999753 445566889999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCeEEE
Q 043285 167 LLIYEFMPNKSLDSFIFDQER----CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKIS 239 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kL~ 239 (414)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976432 134889999999999999999999998 999999999999984 4469999
Q ss_pred eecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHh
Q 043285 240 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 240 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.... ........
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~~~---- 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEFV---- 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHH----
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC---HHHHHHHH----
Confidence 9999986543333333344567899999999999999999999999999999998 888875321 11111111
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
......... .... ..+.+++.+||+.||.+|||+.++++.|...
T Consensus 259 ~~~~~~~~~-----~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGRMDPP-----KNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCCCCCC-----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCCCC-----CCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111111111 1111 2467789999999999999999999998654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.59 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=203.2
Q ss_pred CCCCCCC-eecccCCceEEEEEEc---CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINK-KLGQGGFGPVYKGKLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
++|.+.+ .||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566665 9999999999999753 5778999999763 445667899999999999999999999999 56678999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999986432 34899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 250 DETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 250 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... .........
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i----~~~~~~~~~ 235 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFI----EQGKRMECP 235 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHH----HTTCCCCCC
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH----hcCCcCCCC
Confidence 3221 12223456889999999998899999999999999999998 9999754322 1222211 111111111
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
... ...+.+++.+||+.||++|||+.++++.|...
T Consensus 236 -----~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 236 -----PEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -----TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCc----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 23567789999999999999999999998543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=339.47 Aligned_cols=255 Identities=28% Similarity=0.442 Sum_probs=190.4
Q ss_pred CCCCCCeecccCCceEEEEEEcC--C--CEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe-CCeeeEE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVD--G--QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLI 169 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv 169 (414)
.|.+.+.||+|+||.||+|+..+ + ..||+|.++.. .....+.+.+|+.+++.++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46777899999999999997632 2 35899998753 34556789999999999999999999998765 4578999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++|+|.+++.... ..+++..++.++.|+++||+|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999999996543 24788999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCc--cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 250 DETE--GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 250 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
.... .......+|+.|+|||.+.+..++.++|||||||++|||+| |.+||..... .+....... ......
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~---~~~~~~~~~----~~~~~~ 317 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLLQ----GRRLLQ 317 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS---SCHHHHHHT----TCCCCC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH---HHHHHHHHc----CCCCCC
Confidence 2211 12233457789999999999999999999999999999999 5666543322 222222211 111110
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
. ... ...+.+++.+||+.||++|||+.|+++.|+..
T Consensus 318 p-----~~~----~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 318 P-----EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp C-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-----CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 111 12467789999999999999999999999654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.21 Aligned_cols=198 Identities=27% Similarity=0.390 Sum_probs=174.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||.||+++.. ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 367999999999999999999875 5889999998753 44556788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
|+++++|.+++..... +++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred CCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 9999999999976543 89999999999999999999985 6 99999999999999999999999999875421
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 301 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~ 301 (414)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 122345789999999999999999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=329.49 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=203.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|.+.+.||+|+||.||+++..+ ++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4679999999999999999998754 788999998652 344567789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999886543 3899999999999999999999998 99999999999999999999999999987532
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .... ........ .+
T Consensus 194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~---~~~~~~~~--~~--- 260 (335)
T 2owb_A 194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KETY---LRIKKNEY--SI--- 260 (335)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHH---HHHHHTCC--CC---
T ss_pred Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---HHHH---HHHhcCCC--CC---
Confidence 21 223345689999999999999999999999999999999999999754221 1111 11111111 00
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 261 --~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 --PKHIN----PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --CTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 24667889999999999999999997
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=337.18 Aligned_cols=264 Identities=25% Similarity=0.374 Sum_probs=191.8
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCC--ee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE--EK 166 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~ 166 (414)
..++|++.+.||+|+||.||+|.. .+|+.||||++.. ........+.+|+.+++.+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 347899999999999999999986 4589999999865 34455667889999999997 999999999998654 68
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++||||++ ++|..++... .++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 5899888653 3899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCC-------------------ccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 043285 247 FGGDET-------------------EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306 (414)
Q Consensus 247 ~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~ 306 (414)
+..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-- 236 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-- 236 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 532110 111234579999999999876 6789999999999999999999999854321
Q ss_pred CcchHHHHHHHhhcCCCcccc---------------------cccccCcCC------------HHHHHHHHHHHHhccCC
Q 043285 307 NLNLIGHAWKLWNEGMPSQLI---------------------DSCFQDSFN------------LAEVIRCIHIGLLCVQQ 353 (414)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~------------~~~~~~~~~l~~~cl~~ 353 (414)
......+......+....+. .......+. ......+.+|+.+||+.
T Consensus 237 -~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 -MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp -HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred -HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 12222221111111100000 000000000 00113567899999999
Q ss_pred CCCCCCCHHHHHHH
Q 043285 354 HPEDRPSMPSVILM 367 (414)
Q Consensus 354 dP~~RPs~~evl~~ 367 (414)
||++|||+.|+++.
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=338.49 Aligned_cols=260 Identities=23% Similarity=0.316 Sum_probs=193.8
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|++.+.||+|+||+||+|+.. +++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999875 6889999999653222 112345799999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
++ |+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP-- 153 (324)
T ss_dssp CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--
Confidence 97 58888886543 24899999999999999999999998 999999999999999999999999999764322
Q ss_pred ccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+................... ..
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~-~~ 229 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV---EEQLHFIFRILGTPTEETWPG-IL 229 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTT-GG
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHhchh-hh
Confidence 122234468999999999876 5789999999999999999999999854322 222222222222211111100 00
Q ss_pred cC------------cCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 332 QD------------SFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 332 ~~------------~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. .... .....+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 0000 01235678999999999999999999998
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=337.83 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=201.0
Q ss_pred CCCCCCCeecccCCceEEEEEE----cCCCEEEEEEecccC----hhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL----VDGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 165 (414)
++|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6799999999999999999987 368999999986521 22334567899999999 69999999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999997654 3899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
...... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+ .........
T Consensus 208 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~~~- 283 (355)
T 1vzo_A 208 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSEP- 283 (355)
T ss_dssp ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHCCC-
T ss_pred ecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHhccCC-
Confidence 653221 1223345799999999999863 5789999999999999999999998654333222111 111111110
Q ss_pred cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 043285 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVILML 368 (414)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L 368 (414)
.. ..... ..+.+++.+||+.||.+|| |+.|+++..
T Consensus 284 -~~-----~~~~~----~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 284 -PY-----PQEMS----ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -CC-----CTTSC----HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -CC-----CcccC----HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 01 11111 2466789999999999999 999999865
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=327.89 Aligned_cols=262 Identities=25% Similarity=0.399 Sum_probs=197.3
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.. ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 46799999999999999999986 4689999999974 2344567789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 170 YEFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999986522 2345899999999999999999999998 9999999999999999999999999988653
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... ..........
T Consensus 188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-~~~~~~~~~~ 260 (310)
T 2wqm_A 188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKI-EQCDYPPLPS 260 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHH-HTTCSCCCCT
T ss_pred CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHh-hcccCCCCcc
Confidence 221 122345689999999999999999999999999999999999999753221 111111111 1111111110
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
.... ..+.+++.+||+.||++|||+.++++.|+....
T Consensus 261 ----~~~~----~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 261 ----DHYS----EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp ----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cccC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1111 246778999999999999999999999965533
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=336.05 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=197.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.++|++.+.||+|+||.||+|+... |+.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3679999999999999999998754 889999998643 3334566789999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++++|.+++..... +++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999988755443 899999999999999999999998 999999999999999999999999999765322
Q ss_pred CCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhc---------
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE--------- 320 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 320 (414)
. .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...... ............
T Consensus 178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI---DQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHHHHHH
T ss_pred c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCChhhhhHh
Confidence 1 222345689999999999875 7899999999999999999999997543221 111111110000
Q ss_pred ---CCCcccccccccCcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 321 ---GMPSQLIDSCFQDSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 321 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
........+........ .....+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000000111111 11245778999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=321.96 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=195.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|.+.+.||+|+||.||+++.. ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367999999999999999999874 5889999998653 23356788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCCeEEEeecCcccc
Q 043285 172 FMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF 247 (414)
Q Consensus 172 y~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kL~Dfgl~~~~ 247 (414)
|+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999886532 2245899999999999999999999998 9999999999999 45678999999999765
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
... .......||+.|+|||.+. +.++.++||||||+++|||++|+.||..... ........ ........
T Consensus 178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~~~--~~~~~~~~-- 246 (285)
T 3is5_A 178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQKAT--YKEPNYAV-- 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH--HCCCCCCC--
T ss_pred CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhhhc--cCCccccc--
Confidence 332 2233456899999999886 5689999999999999999999999754321 11111111 11111100
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ..... ..+.+++.+||+.||++|||+.|+++
T Consensus 247 ~---~~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 E---CRPLT----PQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----CCCC----HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c---cCcCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00111 24667899999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=331.49 Aligned_cols=263 Identities=27% Similarity=0.432 Sum_probs=205.5
Q ss_pred cCCCCCCCeecccCCceEEEEEE-----cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC--ee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 166 (414)
.++|++.+.||+|+||.||+++. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 36789999999999999999984 358899999998766667788999999999999999999999987654 78
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999997643 24899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------CCC-cchHHHHHH
Q 043285 247 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHS--------DNN-LNLIGHAWK 316 (414)
Q Consensus 247 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~--------~~~-~~~~~~~~~ 316 (414)
....... .......++..|+|||.+.+..++.++||||||+++|||+||..|+..... ... .........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6433221 112234567789999999998999999999999999999999988653210 000 000111111
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 317 LWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
........... ... ...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 275 ~~~~~~~~~~~-----~~~----~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 275 LLKNNGRLPRP-----DGC----PDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHTTCCCCCC-----TTC----CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HhhcCCCCCCC-----Ccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111111111 111 1357789999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=345.08 Aligned_cols=260 Identities=18% Similarity=0.216 Sum_probs=203.1
Q ss_pred HHHHhcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 043285 89 TIVSATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 164 (414)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 164 (414)
+.....++|++.+.||+|+||+||+++.. +|+.||+|++++. .......+.+|..++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 33345688999999999999999999874 6899999999752 1223345788999999999999999999999999
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
..|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhh
Confidence 9999999999999999997543 24899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccccccc-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYAS-------DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL 317 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 317 (414)
........ ......+||+.|+|||++. +..++.++|||||||++|||++|+.||.... .......+...
T Consensus 210 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~ 285 (412)
T 2vd5_A 210 LKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS---TAETYGKIVHY 285 (412)
T ss_dssp EECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTH
T ss_pred eeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhc
Confidence 87643221 1223457999999999987 4578999999999999999999999985422 11222222111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCC---CCHHHHHHH
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDR---PSMPSVILM 367 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R---Ps~~evl~~ 367 (414)
......+. .....+ ..+.+++.+||+ +|.+| |+++|+++.
T Consensus 286 ~~~~~~p~-----~~~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 286 KEHLSLPL-----VDEGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHCCCC---------CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccCcCCCc-----cccCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 01111110 011111 246778899999 99998 589999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=331.84 Aligned_cols=246 Identities=28% Similarity=0.451 Sum_probs=197.6
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
+.|+..+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999986 46889999998642 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||++ |+|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9997 68888775432 34899999999999999999999998 99999999999999999999999999976532
Q ss_pred CCcccccccccccccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.....||+.|+|||++. ++.++.++|||||||++|||++|+.||.... .............+ ...
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~~~~~~~~~~~-~~~ 274 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNESP-ALQ 274 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCCC-CCC
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCCC-CCC
Confidence 22457899999999884 5678999999999999999999999975321 11111222222211 111
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. ...+ ..+.+++.+||+.||++|||+.++++.
T Consensus 275 ~----~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 S----GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp C----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C----CCCC----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 1111 246678899999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=322.51 Aligned_cols=249 Identities=27% Similarity=0.460 Sum_probs=181.6
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999987 468999999996421 22346789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++.... ..+++..+..++.|+++||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999987542 34899999999999999999999998 99999999999999999999999999987532
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... . ......
T Consensus 165 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~----~~~~~~--- 229 (278)
T 3cok_A 165 PH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------K----VVLADY--- 229 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCSSCC---
T ss_pred CC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------H----Hhhccc---
Confidence 21 12234568999999999999999999999999999999999999986433221100 0 000000
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
......+ ..+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPSFLS----IEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCccccC----HHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0111112 24667899999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=333.62 Aligned_cols=264 Identities=27% Similarity=0.367 Sum_probs=193.8
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHH--HHhcCCCceeeeEeEEEe-----CCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVIL--FSKLQHRNLVKLLGCCIQ-----GEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~-----~~~~ 166 (414)
.++|++.+.||+|+||.||+|+. +++.||||++..... ..+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 47899999999999999999977 789999999965332 333444444 555899999999986643 2356
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeeeccCCCCCEEEcCCCCeE
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD---------SRLRIIHRDLKASNVLLDQDMNPK 237 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~~~~iiH~dlk~~Nill~~~~~~k 237 (414)
++||||+++|+|.+++.... .++..++.++.|++.||+|||+. + ++||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 89999999999999996543 58889999999999999999998 6 99999999999999999999
Q ss_pred EEeecCccccCCCCC------ccccccccccccccccccccC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 043285 238 ISDFGLARAFGGDET------EGNTNRVVGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHS 304 (414)
Q Consensus 238 L~Dfgl~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGvil~elltg~~p~~~~~~ 304 (414)
|+|||++..+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643221 112224469999999999987 4567899999999999999999876532222
Q ss_pred CCC-cchHH----------HHHH-HhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 305 DNN-LNLIG----------HAWK-LWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 305 ~~~-~~~~~----------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
... ..... .... .........+.... .........+.+++.+||+.||++|||+.|+++.|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW---KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc---ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 111 11110 0011 11111111111111 11122344678899999999999999999999988554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=322.23 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=200.2
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
..++|.+.+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34789999999999999999997643 235999998764 34456788999999999999999999999864 4578
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999996543 24899999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ......... .....
T Consensus 164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~~~----~~~~~ 235 (281)
T 3cc6_A 164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLEKG----DRLPK 235 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHHHT----CCCCC
T ss_pred ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHhcC----CCCCC
Confidence 43221 12233456889999999999999999999999999999998 99997543222 222222111 11111
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. ... ...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 236 ~-----~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 236 P-----DLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp C-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C-----CCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 1 111 1246778999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=321.15 Aligned_cols=250 Identities=21% Similarity=0.325 Sum_probs=198.7
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC------hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
++|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56899999999999999999875 58999999986522 123678899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----CeEEEeecC
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGL 243 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kL~Dfgl 243 (414)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999997543 3899999999999999999999998 99999999999998877 899999999
Q ss_pred ccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
+....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....... .....
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~~~~ 228 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QETLTNI----SAVNY 228 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHH----HTTCC
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHHHHh----Hhccc
Confidence 98753321 22345689999999999999999999999999999999999999754221 1111111 11110
Q ss_pred cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. ........ ...+.+++.+||+.||++|||+.|+++
T Consensus 229 -~~-~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 -DF-DEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -CC-CHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CC-cchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00 00000111 124677899999999999999999997
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=326.07 Aligned_cols=254 Identities=28% Similarity=0.404 Sum_probs=199.8
Q ss_pred cCCCCCCC-eecccCCceEEEEEEc---CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 94 TNNFSINK-KLGQGGFGPVYKGKLV---DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 94 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
.++|.+.+ .||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 36788877 9999999999999642 36789999997532 33457889999999999999999999999 667889
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999997654 3899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 248 GGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 248 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... ........
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~~ 240 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAM----LEKGERMG 240 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHH----HHTTCCCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HHcCCCCC
Confidence 433221 11222346788999999998899999999999999999999 9999754321 111111 11111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. ... ...+.+++.+||+.||++|||+.++++.|++
T Consensus 241 ~~-----~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 241 CP-----AGC----PREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp CC-----TTC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CC-----CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11 111 2356788999999999999999999999854
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=320.81 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=198.3
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
++|.....||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455556999999999999986 458899999997765566678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCeEEEeecCccccCCCCC
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kL~Dfgl~~~~~~~~~ 252 (414)
++++|.+++........+++..+..++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999976554445788999999999999999999998 999999999999987 8999999999998754321
Q ss_pred ccccccccccccccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.......|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .. .............+
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~--~~~~~~~~~~~~~~---- 247 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---QA--AMFKVGMFKVHPEI---- 247 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---HH--HHHHHHHHCCCCCC----
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---hH--HHHhhccccccccc----
Confidence 1223456899999999987653 889999999999999999999997532211 11 11111111111111
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 248 -~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 -PESMS----AEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -CTTSC----HHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -cccCC----HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11112 24667899999999999999999996
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=334.87 Aligned_cols=252 Identities=21% Similarity=0.339 Sum_probs=198.5
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 170 (414)
..++|++.+.||+|+||.||++... +|+.||+|++.+... ...+|++++.++ +||||+++++++.++...++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3467999999999999999999875 588999999976432 234678888887 7999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC----CCeEEEeecCccc
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFGLARA 246 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~----~~~kL~Dfgl~~~ 246 (414)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ ++||||||+|||+.++ +.+||+|||++..
T Consensus 96 E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999987654 3899999999999999999999998 9999999999998543 3599999999987
Q ss_pred cCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||..........+..... ..... .
T Consensus 170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~---~~~~~--~ 242 (342)
T 2qr7_A 170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG---SGKFS--L 242 (342)
T ss_dssp CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH---HCCCC--C
T ss_pred CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc---cCCcc--c
Confidence 54322 22334578999999999998889999999999999999999999986543332222222221 11111 0
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
... .....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~-~~~~~s----~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 SGG-YWNSVS----DTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CST-TTTTSC----HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred Ccc-ccccCC----HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 001111 24667899999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.23 Aligned_cols=251 Identities=15% Similarity=0.142 Sum_probs=198.7
Q ss_pred hcCCCCCCCeecccCCceEEEEE------EcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC---CCceeeeEeEEEeC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGK------LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQG 163 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 163 (414)
..++|.+.+.||+|+||+||+|. ..+++.||+|++..... ..+..|+.+++.++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45789999999999999999993 45688999999976443 45677777777776 99999999999999
Q ss_pred CeeeEEEeecCCCChhHHhhccc--ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---------
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQE--RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--------- 232 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~--------- 232 (414)
+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999997532 2245999999999999999999999988 999999999999998
Q ss_pred --CCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 043285 233 --DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNL 310 (414)
Q Consensus 233 --~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~ 310 (414)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 899999999999765432333334456799999999999999999999999999999999999999743221100
Q ss_pred HHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHhcC
Q 043285 311 IGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDR-PSMPSVILMLGS 370 (414)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R-Ps~~evl~~L~~ 370 (414)
.....+......+ .+.+++..|++.+|.+| |+++++.+.|+.
T Consensus 294 ---------------~~~~~~~~~~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 294 ---------------KPEGLFRRLPHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp ---------------EECSCCTTCSSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred ---------------eechhccccCcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0111111112222 34567789999999998 567777776643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=334.08 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=200.0
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccC--------hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 163 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 163 (414)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346899999999999999999986 458899999987532 11334567899999999999999999999999
Q ss_pred CeeeEEEeecCCC-ChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeec
Q 043285 164 EEKLLIYEFMPNK-SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 242 (414)
Q Consensus 164 ~~~~lv~ey~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfg 242 (414)
+..++||||+.+| +|.+++..... +++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99999876543 899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCccccccccccccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG 321 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
++....... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... ...
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------~~~ 240 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------EAA 240 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------TTC
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------hhc
Confidence 998764322 2334578999999999988877 889999999999999999999985321100 000
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
... ....+ ..+.+++.+||+.||++|||+.|+++.-
T Consensus 241 ----~~~---~~~~~----~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 241 ----IHP---PYLVS----KELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp ----CCC---SSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred ----cCC---CcccC----HHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 000 01111 2467789999999999999999999853
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=319.19 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=197.2
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCeee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKL 167 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 167 (414)
+.|.+.+.||+|+||.||+|... ++..||+|.+.. ......+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45788889999999999999874 577899999864 345566788999999999999999999999876 35689
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCeEEEeecCccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARA 246 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kL~Dfgl~~~ 246 (414)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ .+++||||||+||+++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999997643 3899999999999999999999975 3599999999999998 789999999999976
Q ss_pred cCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
.... ......||+.|+|||.+. +.++.++|||||||++|+|++|+.||..... .... ............
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~-~~~~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQI-YRRVTSGVKPAS 250 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHH-HHHHTTTCCCGG
T ss_pred cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHH-HHHHhccCCccc
Confidence 4322 233456899999999886 4589999999999999999999999753221 1111 111111111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.+ .... ..+.+++.+||+.||.+|||+.|+++
T Consensus 251 ~~----~~~~----~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 FD----KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG----GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cC----CCCC----HHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 1111 24678899999999999999999996
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=321.09 Aligned_cols=248 Identities=27% Similarity=0.441 Sum_probs=201.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe----------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ---------- 162 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------- 162 (414)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 457899999999999999999875 68999999997643 246789999999999999999999864
Q ss_pred ------CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCe
Q 043285 163 ------GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 236 (414)
Q Consensus 163 ------~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~ 236 (414)
....++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 4457999999999999999975432 34899999999999999999999998 9999999999999999999
Q ss_pred EEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH
Q 043285 237 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWK 316 (414)
Q Consensus 237 kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 316 (414)
||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+.. ......
T Consensus 162 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~~ 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFFT 229 (284)
T ss_dssp EECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHHH
T ss_pred EECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHHH
Confidence 999999998764322 22344689999999999999999999999999999999999887421 111111
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 317 LWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
....... ...++ ..+.+++.+||+.||++|||+.|+++.|.....
T Consensus 230 ~~~~~~~--------~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 230 DLRDGII--------SDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHTTCC--------CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred Hhhcccc--------cccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 1111111 11122 235678899999999999999999999965544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=321.22 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=203.3
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999875 4788999998652 344567788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++.... .+++..+..++.|+++||+|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999886543 3899999999999999999999998 99999999999999999999999999987532
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.. .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ............ .+
T Consensus 168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~--~~--- 234 (294)
T 2rku_A 168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNEY--SI--- 234 (294)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCC--CC---
T ss_pred Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhhccC--CC---
Confidence 21 223345689999999999999999999999999999999999999754321 111111111111 01
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
....+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 235 --~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 --PKHIN----PVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --ccccC----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111 246678899999999999999999973
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=349.76 Aligned_cols=251 Identities=27% Similarity=0.367 Sum_probs=200.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.++|++.+.||+|+||+||+++.. +++.||||++.+. .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999875 6889999998642 2334578899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCCeEEEeecCcccc
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAF 247 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~---~~~~~kL~Dfgl~~~~ 247 (414)
||+++|+|.+.+.... .+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999887654 3899999999999999999999998 99999999999995 4567999999999865
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ........ ..........
T Consensus 175 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i---~~~~~~~~~~ 244 (486)
T 3mwu_A 175 QQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRV---ETGKYAFDLP 244 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---HHTCCCSCSG
T ss_pred CCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH---HhCCCCCCCc
Confidence 332 22334579999999999876 59999999999999999999999975322 11222221 1111111100
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.. ... ...+.+++.+||+.||++|||+.|+++.
T Consensus 245 --~~-~~~----s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 245 --QW-RTI----SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --GG-GGS----CHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --cc-CCC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 011 1246688999999999999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=355.54 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=194.8
Q ss_pred eecccCCceEEEEEEc---CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCCCC
Q 043285 102 KLGQGGFGPVYKGKLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 177 (414)
Q Consensus 102 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~ 177 (414)
.||+|+||.||+|.+. ++..||||+++.. .....+.+.+|+.+++.++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999764 4567999999763 33456789999999999999999999999976 56899999999999
Q ss_pred hhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc-ccc
Q 043285 178 LDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE-GNT 256 (414)
Q Consensus 178 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~-~~~ 256 (414)
|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++........ ...
T Consensus 422 L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 999996542 34899999999999999999999998 999999999999999999999999999876432211 112
Q ss_pred ccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcC
Q 043285 257 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSF 335 (414)
Q Consensus 257 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (414)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .+...... ......... ..
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~----~~~~~~~p~-----~~ 564 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIE----QGKRMECPP-----EC 564 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHHHHHH----TTCCCCCCT-----TC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHH----cCCCCCCCC-----cC
Confidence 22345689999999999999999999999999999998 9999754322 22222222 111111111 11
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 336 NLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 336 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
...+.+++.+||+.||++||++.++++.|+..
T Consensus 565 ----~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 565 ----PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ----CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 13567789999999999999999999998653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=323.83 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=195.1
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-CeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~ey 172 (414)
.++|++.+.||+|+||.||+++. +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+. ...++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46799999999999999999987 58899999997533 456789999999999999999999997655 478999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999975432 23789999999999999999999998 999999999999999999999999998764321
Q ss_pred ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... .........
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~----~~~~~~~~~---- 236 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV----EKGYKMDAP---- 236 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHH----TTTCCCCCC----
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----hcCCCCCCc----
Confidence 223357889999999999999999999999999999998 9998764322 1222111 111111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... ...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 237 -~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 237 -DGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp -TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -ccC----CHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 111 1356778899999999999999999998854
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=330.13 Aligned_cols=254 Identities=20% Similarity=0.334 Sum_probs=201.8
Q ss_pred HHhcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--------hhhHHHHHHHHHHHHhc-CCCceeeeEeEE
Q 043285 91 VSATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--------EQGLKELKNEVILFSKL-QHRNLVKLLGCC 160 (414)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 160 (414)
....++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 344578999999999999999999885 69999999986432 11245678999999999 799999999999
Q ss_pred EeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEe
Q 043285 161 IQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 240 (414)
Q Consensus 161 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~D 240 (414)
......++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999997543 3899999999999999999999998 99999999999999999999999
Q ss_pred ecCccccCCCCCccccccccccccccccccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHH
Q 043285 241 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASD------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHA 314 (414)
Q Consensus 241 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 314 (414)
||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ........
T Consensus 244 fG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i 317 (365)
T 2y7j_A 244 FGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRMI 317 (365)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH
T ss_pred cCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHHH
Confidence 99998764322 2334678999999998863 368899999999999999999999975321 11111111
Q ss_pred HHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 315 WKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
....... ..+.. ... ...+.+++.+||+.||++|||+.|+++
T Consensus 318 ---~~~~~~~--~~~~~-~~~----~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 ---MEGQYQF--SSPEW-DDR----SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHTCCCC--CHHHH-SSS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HhCCCCC--CCccc-ccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111110 00000 011 124677899999999999999999997
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.20 Aligned_cols=264 Identities=22% Similarity=0.324 Sum_probs=199.0
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe--------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-------- 162 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------- 162 (414)
.++|++.+.||+|+||.||+|+. .+|+.||+|++... .......+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999987 46899999998642 22234567899999999999999999999987
Q ss_pred CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeec
Q 043285 163 GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 242 (414)
Q Consensus 163 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfg 242 (414)
.+..++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999985 7777765433 23899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCC--ccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043285 243 LARAFGGDET--EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN 319 (414)
Q Consensus 243 l~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 319 (414)
++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ............
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC
Confidence 9987643221 222334578999999998876 4689999999999999999999999764322 122222222111
Q ss_pred cCCCccccccc------------ccCcCCHHH-------HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 320 EGMPSQLIDSC------------FQDSFNLAE-------VIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 320 ~~~~~~~~~~~------------~~~~~~~~~-------~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.......... ......... ...+.+++.+||+.||++|||+.|+++.
T Consensus 247 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 247 -SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp -CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1111110000 000011111 1246789999999999999999999963
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=322.38 Aligned_cols=249 Identities=26% Similarity=0.438 Sum_probs=203.8
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.+.|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467999999999999999999864 5889999998653 23456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999998642 3899999999999999999999998 9999999999999999999999999998764322
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....... .......+
T Consensus 174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~~~~~~~----- 239 (303)
T 3a7i_A 174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLI----PKNNPPTL----- 239 (303)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHH----HHSCCCCC-----
T ss_pred --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHh----hcCCCCCC-----
Confidence 123345689999999999999999999999999999999999999753221 1111111 11111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
....+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYS----KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11222 246778999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=320.72 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=197.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999875 6899999998752 334556788899999999 999999999999999999999
Q ss_pred EeecCCCChhHHhhcccc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---------------
Q 043285 170 YEFMPNKSLDSFIFDQER-CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--------------- 233 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~--------------- 233 (414)
|||+++++|.+++..... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976432 134899999999999999999999998 9999999999999844
Q ss_pred ----CCeEEEeecCccccCCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 043285 234 ----MNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNL 308 (414)
Q Consensus 234 ----~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~ 308 (414)
..+||+|||++...... ....||+.|+|||.+.+. .++.++|||||||++|+|++|..++...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------ 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------ 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------
T ss_pred cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------
Confidence 47999999999875432 223589999999999876 6678999999999999999998764321
Q ss_pred chHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 309 NLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
..... ........+. ...+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~----~~~~~~~~~~-----~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 DQWHE----IRQGRLPRIP-----QVLS----QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHHH----HHTTCCCCCS-----SCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred hHHHH----HHcCCCCCCC-----cccC----HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11111 1122211111 1112 246778999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=341.93 Aligned_cols=242 Identities=17% Similarity=0.175 Sum_probs=188.3
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc---cChhhHHHHHHHH---HHHHhcCCCceeeeE-------eE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK---ISEQGLKELKNEV---ILFSKLQHRNLVKLL-------GC 159 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~ 159 (414)
.++|++.+.||+|+||+||+|+. .+|+.||||++.. ......+.+.+|+ ..++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46789999999999999999986 4689999999963 3344567889999 455556899999998 66
Q ss_pred EEeCC-----------------eeeEEEeecCCCChhHHhhccccc----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 043285 160 CIQGE-----------------EKLLIYEFMPNKSLDSFIFDQERC----MILDWSKRFHIICGTARGLLYLHQDSRLRI 218 (414)
Q Consensus 160 ~~~~~-----------------~~~lv~ey~~~g~L~~~l~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 218 (414)
+.+.+ ..++||||+ +|+|.+++...... ..+++..++.++.|++.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 66553 278999999 68999999764321 12335888899999999999999998 9
Q ss_pred eeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCC-----------CCCcchhHHHHHH
Q 043285 219 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-----------QFSVKSDVFSFGI 287 (414)
Q Consensus 219 iH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslGv 287 (414)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986321 2334567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 288 LLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 288 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
++|||++|+.||........... +.... ...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~---------------~~~~~--~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEW---------------IFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSGG---------------GGSSC--CCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchhh---------------hhhhc--cCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999854332211111 10100 1111 24677899999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=323.22 Aligned_cols=259 Identities=26% Similarity=0.358 Sum_probs=202.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 168 (414)
.++|++.+.||+|+||.||+++.. +++.||+|.+.. ......+.+.+|+.+++.++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999875 688999999964 244556788999999999999999999998864 567899
Q ss_pred EEeecCCCChhHHhhcccc-cccCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 169 IYEFMPNKSLDSFIFDQER-CMILDWSKRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ..+++||||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999999975432 234899999999999999999999975 2349999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
...... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ........ .......
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i----~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKI----REGKFRR 235 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH----HHTCCCC
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHHHHH----hhccccc
Confidence 753221 11234568999999999999999999999999999999999999975432 11111111 1111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
+. ...+ ..+.+++.+||+.||++|||+.|+++.+..
T Consensus 236 ~~-----~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 IP-----YRYS----DELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CC-----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CC-----cccC----HHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 1111 246778999999999999999999987643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=327.48 Aligned_cols=265 Identities=22% Similarity=0.320 Sum_probs=204.3
Q ss_pred HHHhcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHh--cCCCceeeeEeEEEeCC---
Q 043285 90 IVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE--- 164 (414)
Q Consensus 90 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~--- 164 (414)
.....++|++.+.||+|+||.||+|+. +|+.||||++... ....+..|.+++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 344567899999999999999999988 6899999999653 33567788888887 78999999999998876
Q ss_pred -eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeccCCCCCEEEcCCCC
Q 043285 165 -EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH--------QDSRLRIIHRDLKASNVLLDQDMN 235 (414)
Q Consensus 165 -~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiH~dlk~~Nill~~~~~ 235 (414)
..++||||+++|+|.+++... .+++..++.++.|++.||.||| +.+ ++||||||+||+++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCC
Confidence 789999999999999999653 3899999999999999999999 666 999999999999999999
Q ss_pred eEEEeecCccccCCCCCcc--ccccccccccccccccccCC------CCCcchhHHHHHHHHHHHHhC----------CC
Q 043285 236 PKISDFGLARAFGGDETEG--NTNRVVGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIVSG----------KK 297 (414)
Q Consensus 236 ~kL~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGvil~elltg----------~~ 297 (414)
+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999999998754332111 23345789999999998776 334789999999999999999 56
Q ss_pred CCCCCCCCCCcchHHHHHHHhh-cCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 298 NRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 298 p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
||........ . ......... ......+.. ..........+.+++.+||+.||++|||+.|+++.|+..
T Consensus 266 p~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 266 PYYDLVPSDP-S-VEEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTTSCSSC-C-HHHHHHHHTTSCCCCCCCG----GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCcCcc-c-HHHHHHHHHHHHhCCCCcc----cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 6543322211 1 111111111 111111111 111234455678899999999999999999999999643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=344.35 Aligned_cols=259 Identities=25% Similarity=0.301 Sum_probs=194.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 164 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 164 (414)
.++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999764 5889999999753 4455678889999999999999999999997553
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
..++||||++++ |.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999764 6555532 2889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC-
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP- 323 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 323 (414)
+..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ..+....+......+.+
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~---~~~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD---YIDQWNKVIEQLGTPCPE 285 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCSCCHH
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCHH
Confidence 875322 22344679999999999999999999999999999999999999985432 11122222111111000
Q ss_pred -------------------c-----cc-ccccccCcCC--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 324 -------------------S-----QL-IDSCFQDSFN--LAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 324 -------------------~-----~~-~~~~~~~~~~--~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. .. .+........ ......+.+|+.+||+.||++|||++|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00 0000000000 1113467889999999999999999999984
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=319.78 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=201.3
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.+.||+|+||.||+|+.. ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999875 4778999998642 122346788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999997654 3899999999999999999999998 99999999999999999999999999876532
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ... ......... .
T Consensus 167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~---~~~~~~~~~--~---- 230 (284)
T 2vgo_A 167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---TET---HRRIVNVDL--K---- 230 (284)
T ss_dssp S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHH---HHHHHTTCC--C----
T ss_pred c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---hHH---HHHHhcccc--C----
Confidence 1 22345689999999999999999999999999999999999999754221 111 111111110 0
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+....+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 231 -~~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 -FPPFLS----DGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -CCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCCcCC----HHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111111 24667899999999999999999997
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=338.45 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=190.3
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--------hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 163 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 163 (414)
..++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4578999999999999999999764 57899999986421 112235789999999999999999999985 5
Q ss_pred CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---CeEEEe
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISD 240 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kL~D 240 (414)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++ .+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 56899999999999999886544 3899999999999999999999998 99999999999997544 599999
Q ss_pred ecCccccCCCCCccccccccccccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043285 241 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL 317 (414)
Q Consensus 241 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 317 (414)
||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .......
T Consensus 286 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~-- 358 (419)
T 3i6u_A 286 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT-- 358 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHH--
T ss_pred cccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHh--
Confidence 9999875422 22334679999999999864 578899999999999999999999986433221 1211111
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
..... ..... .... ...+.+++.+||+.||++|||+.|+++.
T Consensus 359 --~~~~~-~~~~~-~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 359 --SGKYN-FIPEV-WAEV----SEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --TTCCC-CCHHH-HTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --cCCCC-CCchh-hccc----CHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11110 00000 0011 1356789999999999999999999973
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=330.12 Aligned_cols=263 Identities=23% Similarity=0.304 Sum_probs=193.0
Q ss_pred HhcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 92 SATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
...++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999764 68899999997532 2234567899999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-----CCCCeEEEeecC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-----QDMNPKISDFGL 243 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-----~~~~~kL~Dfgl 243 (414)
||||+++ +|.+++..... +++..+..++.|++.||.|||+++ ++||||||+|||++ .++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999984 99999876543 899999999999999999999998 99999999999994 445699999999
Q ss_pred ccccCCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
+....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ..+.............
T Consensus 184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS---EIDQLFKIFEVLGLPD 258 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCC
T ss_pred ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC---HHHHHHHHHHHhCCCc
Confidence 98753221 222344679999999999875 58999999999999999999999975422 1222222222211111
Q ss_pred Cccccc--------cccc--CcCCHH------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 323 PSQLID--------SCFQ--DSFNLA------EVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 323 ~~~~~~--------~~~~--~~~~~~------~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...... .... ...... ....+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 100000 0000 000011 1135678999999999999999999997
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=340.64 Aligned_cols=196 Identities=26% Similarity=0.415 Sum_probs=155.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-----Ce
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 165 (414)
.++|++.+.||+|+||+||+|+.. +++.||||++.. ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999764 688999999965 3344567889999999999999999999999543 56
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 68999886543 3899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCc-------------------------cccccccccccccccccc-cCCCCCcchhHHHHHHHHHHHHhCC
Q 043285 246 AFGGDETE-------------------------GNTNRVVGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGK 296 (414)
Q Consensus 246 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslGvil~elltg~ 296 (414)
........ ......+||+.|+|||++ .+..++.++|||||||++|||++|.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 76422111 122345789999999976 5667999999999999999999943
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=329.97 Aligned_cols=255 Identities=28% Similarity=0.454 Sum_probs=199.2
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCE--EEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQE--IAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 169 (414)
++|++.+.||+|+||.||+|+.. ++.. +++|.+... .....+.+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999764 4554 499988652 334456788999999999 899999999999999999999
Q ss_pred EeecCCCChhHHhhccc-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCe
Q 043285 170 YEFMPNKSLDSFIFDQE-------------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 236 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~ 236 (414)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997543 1235899999999999999999999998 9999999999999999999
Q ss_pred EEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHH
Q 043285 237 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 237 kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 315 (414)
||+|||++.... .........+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... .. ..
T Consensus 182 kL~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~----~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AE----LY 251 (327)
T ss_dssp EECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HH----HH
T ss_pred EEcccCcCcccc---ccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HH----HH
Confidence 999999987432 1112233456889999999998899999999999999999998 9999753221 11 11
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 316 KLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
............ ... ...+.+++.+||+.||.+|||+.|+++.|...
T Consensus 252 ~~~~~~~~~~~~-----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 252 EKLPQGYRLEKP-----LNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHGGGTCCCCCC-----TTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhcCCCCCCC-----CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111111111 111 13567889999999999999999999988543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=351.25 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=198.8
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccCh-------------hhHHHHHHHHHHHHhcCCCceeeeEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISE-------------QGLKELKNEVILFSKLQHRNLVKLLG 158 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~ 158 (414)
..++|.+.+.||+|+||+||+|+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999875 478999999865321 33567889999999999999999999
Q ss_pred EEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---C
Q 043285 159 CCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---N 235 (414)
Q Consensus 159 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~ 235 (414)
++.+....++|||||++|+|.+++..... +++..+..++.|++.||.|||+++ ++||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999876543 899999999999999999999998 99999999999998776 6
Q ss_pred eEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH
Q 043285 236 PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 236 ~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 315 (414)
+||+|||++...... .......||+.|+|||++. +.++.++|||||||++|+|++|..||..... ........
T Consensus 188 ~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~ 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---QDIIKKVE 260 (504)
T ss_dssp EEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred EEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence 999999999876432 2233457999999999987 4689999999999999999999999864321 12222211
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 316 KLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
........ +.. ...+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 261 ---~~~~~~~~--~~~-~~~s----~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 261 ---KGKYYFDF--NDW-KNIS----DEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp ---HCCCCCCH--HHH-TTSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---cCCCCCCc--ccc-CCCC----HHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111000 000 0111 34678899999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=316.86 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=196.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC----hhhHHHHHHHHHHHHhcCCCceeeeEeEEE--eCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCI--QGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~ 166 (414)
.++|++.+.||+|+||.||++... ++..||+|++.... ......+.+|+.+++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999874 58899999997532 234578899999999999999999999984 45578
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++||||++++ |.+++..... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 7777655332 34899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
..............||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... ........ .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i----~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFENI----GKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHH----HHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHH----hcCCC-
Confidence 64433333334556899999999987654 3789999999999999999999975421 11111111 11111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.+ ..... ..+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~-----~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 AI-----PGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC-----CSSSC----HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC-----CCccC----HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01 11111 246678999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=336.76 Aligned_cols=199 Identities=25% Similarity=0.430 Sum_probs=167.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-----Ce
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 165 (414)
.++|++.+.||+|+||.||+|+.. +++.||||++.. ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999864 478899999975 3344567889999999999999999999999876 56
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999996 59999986543 3899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCc--------------------cccccccccccccccccc-cCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 043285 246 AFGGDETE--------------------GNTNRVVGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIVSGKKNR 299 (414)
Q Consensus 246 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslGvil~elltg~~p~ 299 (414)
........ ......+||+.|+|||++ .+..++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76432211 122456789999999986 5667999999999999999999876554
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.99 Aligned_cols=250 Identities=25% Similarity=0.335 Sum_probs=195.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.++|++.+.||+|+||+||+|+.. ++..||+|++.+. .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356999999999999999999875 5889999998753 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CCeEEEeecCcccc
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARAF 247 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kL~Dfgl~~~~ 247 (414)
|||++|+|.+++..... +++..+..++.|++.||.|||+++ ++||||||+|||++.. +.+||+|||++...
T Consensus 116 e~~~~g~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999998876543 899999999999999999999998 9999999999999764 45999999999876
Q ss_pred CCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
... .......||+.|+|||++. +.++.++|||||||++|+|++|..||..... ........ ...... .
T Consensus 190 ~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~---~~~~~~--~ 257 (494)
T 3lij_A 190 ENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVE---KGKYTF--D 257 (494)
T ss_dssp BTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH---HTCCCC--C
T ss_pred CCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH---hCCCCC--C
Confidence 432 2233457999999999886 5699999999999999999999999854321 12222221 111110 0
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.+.. ...+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 258 ~~~~-~~~s----~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEW-KNVS----EGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGG-TTSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhc-ccCC----HHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1110 1111 24667899999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=317.07 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=194.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|.+.+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999875 6899999998652 223456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++..... +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999976543 899999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCccccccccccccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
.. ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... ........ ..... ..
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~----~~~~~-~~-- 230 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKI----RGGVF-YI-- 230 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH----HHCCC-CC--
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHh----hcCcc-cC--
Confidence 21 2234568999999999988766 689999999999999999999975321 11111111 11110 00
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
....+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 231 ---~~~~~----~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ---PEYLN----RSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---chhcC----HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111 246678999999999999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=332.11 Aligned_cols=261 Identities=16% Similarity=0.230 Sum_probs=202.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC---------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceee---------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD---------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK--------- 155 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 155 (414)
.++|++.+.||+|+||.||+|+... ++.||+|.+... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999998753 788999998753 35788999999999999988
Q ss_pred ------eEeEEEe-CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCE
Q 043285 156 ------LLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 228 (414)
Q Consensus 156 ------~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Ni 228 (414)
+++++.. ....++||||+ +++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 67889999999 9999999976522 34999999999999999999999998 99999999999
Q ss_pred EEcCCC--CeEEEeecCccccCCCCC-----ccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 043285 229 LLDQDM--NPKISDFGLARAFGGDET-----EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 301 (414)
Q Consensus 229 ll~~~~--~~kL~Dfgl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~ 301 (414)
|++.++ .+||+|||++..+..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 899999999986543211 1122344789999999999999999999999999999999999999865
Q ss_pred CCCCCCcchHHHHHHHhhcCCCccccccccc-CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 302 YHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ-DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
..... .........+... ...+...+.. ...+ ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 271 ~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 271 CLPNT--EDIMKQKQKFVDK-PGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GTTCH--HHHHHHHHHHHHS-CCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcCH--HHHHHHHHhccCC-hhhhhhhccccCCCc----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 43221 1121221111111 1122221111 0111 3467788999999999999999999999654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=327.85 Aligned_cols=265 Identities=26% Similarity=0.339 Sum_probs=197.0
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccCh-----hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
..++|++.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999874 589999999864221 1124678999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++||||+++ +|.+++.... ..+++..+..++.|+++||.|||+++ ++||||||+|||++.++.+||+|||++..
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 8888886533 34888899999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
..... .......||+.|+|||.+.+. .++.++|||||||++|||++|..||... ...+................
T Consensus 162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~---~~~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD---SDLDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCTTT
T ss_pred ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHHcCCCChhh
Confidence 53222 223345789999999998764 5899999999999999999999886532 22222222222222111111
Q ss_pred cccccc---------cCcCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 043285 326 LIDSCF---------QDSFNLA-----EVIRCIHIGLLCVQQHPEDRPSMPSVILML 368 (414)
Q Consensus 326 ~~~~~~---------~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 368 (414)
..+.+. ....... ....+.+++.+||+.||++|||+.|+++.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 111000 0000111 124577899999999999999999999854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=339.53 Aligned_cols=260 Identities=19% Similarity=0.283 Sum_probs=204.5
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC-CceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||.||+|+. .+++.||||++...... ..+..|+.+++.++| +++..+..++......++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999986 46899999987653222 357889999999987 456666667778888999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCCeEEEeecCccccC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFG 248 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kL~Dfgl~~~~~ 248 (414)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++...
T Consensus 84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 999999997533 24899999999999999999999998 9999999999999 588999999999998764
Q ss_pred CCCCc-----cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC
Q 043285 249 GDETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323 (414)
Q Consensus 249 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
..... .......||+.|+|||.+.+..++.++|||||||+||||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 43221 1223567999999999999999999999999999999999999998765544333333332222111111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
..+.. .+ ...+.+++.+||+.+|++||++.+|++.|+.
T Consensus 238 ~~l~~-----~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 238 EALCR-----GY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp HHHHT-----TS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHhc-----CC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 11111 11 1357789999999999999999999998854
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=338.14 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=193.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe------ee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE------KL 167 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~ 167 (414)
..+|++.+.||+|+||.||+|+...+..||+|++..... ...+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357999999999999999999987777899998865322 12369999999999999999999965443 78
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCeEEEeecCccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARA 246 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kL~Dfgl~~~ 246 (414)
+||||++++.+............+++..+..++.|++.||+|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987655444332223345899999999999999999999998 99999999999999 789999999999987
Q ss_pred cCCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC---
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM--- 322 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 322 (414)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+...........+.
T Consensus 192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG---IDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHH
T ss_pred ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHH
Confidence 53222 22345689999999998765 589999999999999999999999864321 111211111111000
Q ss_pred ------------CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 323 ------------PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 323 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
........+...+.......+.+++.+||+.||++|||+.|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000000000001112357789999999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=350.33 Aligned_cols=250 Identities=28% Similarity=0.368 Sum_probs=201.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.+.||+|+||.||+++.. +|+.||||++... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999875 6899999998642 234567889999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCCeEEEeecCccc
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARA 246 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kL~Dfgl~~~ 246 (414)
|||+.+|+|.+++..... +++..+..++.|++.||.|||+++ ++||||||+|||+ +.++.+||+|||++..
T Consensus 105 ~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTCSC---CBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999999876543 899999999999999999999998 9999999999999 5678999999999987
Q ss_pred cCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ........ .........
T Consensus 179 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i---~~~~~~~~~ 248 (484)
T 3nyv_A 179 FEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKV---EKGKYTFEL 248 (484)
T ss_dssp BCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---HHCCCCCCS
T ss_pred cccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHHHH---HcCCCCCCC
Confidence 6432 22334579999999999876 69999999999999999999999975422 11222222 111111110
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+.. ... ...+.+++.+||+.||++|||+.|+++
T Consensus 249 --~~~-~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 249 --PQW-KKV----SESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp --GGG-GGS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --ccc-ccC----CHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000 011 124667899999999999999999996
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=321.40 Aligned_cols=253 Identities=27% Similarity=0.427 Sum_probs=197.5
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
..++|++.+.||+|+||.||+|+.. ++..||+|++........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4478999999999999999999875 488999999977666667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 169 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-- 169 (302)
T ss_dssp CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--
T ss_pred eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc--
Confidence 999999999886533 23899999999999999999999998 99999999999999999999999998754211
Q ss_pred Cccccccccccccccccccc-----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYA-----SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
.........||+.|+|||.+ .+..++.++||||||+++|+|++|+.||..... ................
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~ 243 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDPPTLL 243 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCCCCS
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCCcccC
Confidence 01112234689999999988 467789999999999999999999999754321 1111111112111111
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. ...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~----~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 TP----SKWS----VEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SG----GGSC----HHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred Cc----cccC----HHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11 1111 24677899999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=324.40 Aligned_cols=264 Identities=24% Similarity=0.402 Sum_probs=185.4
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4578999999999999999999753 68899999986532 334567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcc-----cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 171 EFMPNKSLDSFIFDQ-----ERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 171 ey~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
||+++++|.+++... .....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998641 12235899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCC---ccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC
Q 043285 246 AFGGDET---EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG 321 (414)
Q Consensus 246 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
....... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... .............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM---KVLMLTLQNDPPS 246 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHTSSCCC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh---hHHHHHhccCCCc
Confidence 6543211 112234568999999999876 57899999999999999999999998643321 1111111100000
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
......+......+. ..+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 011111111111122 34677899999999999999999996
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=354.64 Aligned_cols=247 Identities=29% Similarity=0.399 Sum_probs=194.0
Q ss_pred CeecccCCceEEEEEEc---CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLV---DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
+.||+|+||.||+|.+. .++.||||+++.. .....+.+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 3578999999753 3345678999999999999999999999996 4568899999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC-cc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET-EG 254 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~-~~ 254 (414)
|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999997544 3899999999999999999999998 99999999999999999999999999987643322 12
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ........ .........
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~----~~~~~~~p~----- 595 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLE----KGERMGCPA----- 595 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHH----TTCCCCCCT-----
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH----cCCCCCCCC-----
Confidence 2223456789999999999999999999999999999998 9999754321 12222221 121111111
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. ...+.+++.+||+.||++|||+.+|++.|++
T Consensus 596 ~~----~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 596 GC----PREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp TC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 1356788999999999999999999999853
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=334.85 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=193.2
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 164 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 164 (414)
.++|++.+.||+|+||.||+|.. .+|+.||||++.. ......+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 47899999999999999999987 4689999999965 23445567889999999999999999999998763
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
..++||||+ +++|.+++... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 78999998653 3899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
+.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+.........
T Consensus 176 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 176 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTPPA 247 (367)
T ss_dssp EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCH
T ss_pred ccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence 87532 2234578999999999877 6899999999999999999999999754321 1111111111100000
Q ss_pred ------------------cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 324 ------------------SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 324 ------------------~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.......+.. ........+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000000 000112356788999999999999999999983
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=321.63 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=200.7
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC---------hhhHHHHHHHHHHHHhcC-CCceeeeEeEEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLGCCI 161 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 161 (414)
..++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999875 57899999986432 123456789999999995 999999999999
Q ss_pred eCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEee
Q 043285 162 QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 241 (414)
Q Consensus 162 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Df 241 (414)
+....++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999997643 3899999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCCCcccccccccccccccccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH
Q 043285 242 GLARAFGGDETEGNTNRVVGTYGYMAPEYAS------DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 242 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 315 (414)
|++....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||.... ........
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~- 241 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMI- 241 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH-
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHHHHH-
Confidence 9998754322 233456899999999885 4578899999999999999999999975322 11111111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 316 KLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...... ...+.. ... ...+.+++.+||+.||++|||+.|+++
T Consensus 242 --~~~~~~--~~~~~~-~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 --MSGNYQ--FGSPEW-DDY----SDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --HHTCCC--CCTTTG-GGS----CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --hcCCcc--cCcccc-ccc----CHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111111 000000 011 234678899999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=331.46 Aligned_cols=261 Identities=20% Similarity=0.262 Sum_probs=200.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC--------CCceeeeEeEEE---
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--------HRNLVKLLGCCI--- 161 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~--- 161 (414)
.++|++.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 5788999999753 445567889999999985 788999999998
Q ss_pred -eCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCC-----
Q 043285 162 -QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDM----- 234 (414)
Q Consensus 162 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~~~~----- 234 (414)
+....++||||+ +++|.+.+..... ..+++..+..++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 556789999999 5566666654322 3489999999999999999999998 7 99999999999999775
Q ss_pred --------------------------------------------CeEEEeecCccccCCCCCcccccccccccccccccc
Q 043285 235 --------------------------------------------NPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270 (414)
Q Consensus 235 --------------------------------------------~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~ 270 (414)
.+||+|||++...... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999875322 233468999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchH---HHHHHHhhcCCCc----------ccccc--------
Q 043285 271 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLI---GHAWKLWNEGMPS----------QLIDS-------- 329 (414)
Q Consensus 271 ~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~----------~~~~~-------- 329 (414)
+.+..++.++|||||||++|||++|+.||............ ....... ...+. .+...
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL-GKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHH-CSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhc-CCCChHHhhcccccccccCCcccccccc
Confidence 99999999999999999999999999998754443322111 1111111 11000 00000
Q ss_pred --c---------ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 --C---------FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 --~---------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ............+.+|+.+||+.||++|||+.|+++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 001223445567889999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=325.08 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=196.0
Q ss_pred HHHHhcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEe----
Q 043285 89 TIVSATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ---- 162 (414)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~---- 162 (414)
++....++|++.+.||+|+||.||+|+. .+++.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3344568899999999999999999987 468899999986532 2346788999999999 79999999999987
Q ss_pred --CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEe
Q 043285 163 --GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 240 (414)
Q Consensus 163 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~D 240 (414)
....++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence 4678999999999999999976432 34899999999999999999999998 99999999999999999999999
Q ss_pred ecCccccCCCCCcccccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH
Q 043285 241 FGLARAFGGDETEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 241 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 315 (414)
||++...... ........|++.|+|||++. +..++.++|||||||++|+|++|+.||..... .....
T Consensus 173 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~ 244 (326)
T 2x7f_A 173 FGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALF 244 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHH
T ss_pred CcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHH
Confidence 9998865322 11233456899999999987 56789999999999999999999999753221 11111
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 316 KLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
........ .... ...+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~-~~~~----~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 245 LIPRNPAP-RLKS----KKWS----KKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHSCCC-CCSC----SCSC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhcCccc-cCCc----cccC----HHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111111 1111 1111 24677899999999999999999997
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=350.53 Aligned_cols=248 Identities=24% Similarity=0.322 Sum_probs=202.3
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 168 (414)
.++|++.+.||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467999999999999999999875 4788999999752 233456778899999887 79999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||+++|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 420 V~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEeCcCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999976543 899999999999999999999998 9999999999999999999999999998642
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
.. .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ..++...+ ..... .+
T Consensus 494 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~~~~i---~~~~~--~~-- 561 (674)
T 3pfq_A 494 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSI---MEHNV--AY-- 561 (674)
T ss_dssp CT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---HSSCC--CC--
T ss_pred cC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC---HHHHHHHH---HhCCC--CC--
Confidence 22 223445689999999999999999999999999999999999999985421 12222222 11111 11
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM-----PSVIL 366 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~ 366 (414)
....+ ..+.+|+.+||+.||++||++ +||++
T Consensus 562 ---p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 562 ---PKSMS----KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---CTTSC----HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---CccCC----HHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11122 246778999999999999998 77765
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=320.38 Aligned_cols=254 Identities=26% Similarity=0.348 Sum_probs=196.0
Q ss_pred HhcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcC--CCceeeeEeEEEeCCeee
Q 043285 92 SATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~ 167 (414)
...++|++.+.||+|+||.||++...+++.||+|++.. ......+.+.+|+.+++.++ ||||+++++++.+....+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 34578999999999999999999988899999999864 34456678899999999997 599999999999999999
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+||| +.+++|.+++.... .+++..+..++.|+++||.|||+++ ++||||||+||++++ +.+||+|||++...
T Consensus 105 lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9999 56789999997654 3899999999999999999999998 999999999999964 89999999999876
Q ss_pred CCCCCccccccccccccccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWK 316 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 316 (414)
.............|++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... .......
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~ 251 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHA 251 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHH
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHH
Confidence 43333223344578999999999875 4788999999999999999999999753221 1111122
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 317 LWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.........+. ... ...+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~-----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 252 IIDPNHEIEFP-----DIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHCTTSCCCCC-----CCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhcccccCCc-----ccc----hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 22111111111 111 1246778899999999999999999963
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=316.65 Aligned_cols=251 Identities=26% Similarity=0.439 Sum_probs=197.4
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
..++|++.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999875 48999999997532 34678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999986322 34899999999999999999999998 9999999999999999999999999998754321
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .......... .......
T Consensus 180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-~~~~~~~--- 247 (314)
T 3com_A 180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIPTN-PPPTFRK--- 247 (314)
T ss_dssp --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS-CCCCCSS---
T ss_pred --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcC-CCcccCC---
Confidence 223345689999999999999999999999999999999999999753221 1111111111 1111110
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.... ...+.+++.+||+.||.+|||+.++++
T Consensus 248 ~~~~----~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 PELW----SDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGGS----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0111 124677899999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=324.56 Aligned_cols=256 Identities=19% Similarity=0.301 Sum_probs=197.0
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEe--CCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ--GEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv 169 (414)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46799999999999999999976 568899999997533 357889999999997 9999999999988 5678999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CeEEEeecCccccC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFG 248 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kL~Dfgl~~~~~ 248 (414)
|||+++++|.+++.. ++...+..++.|++.||+|||+++ ++||||||+|||++.++ .+||+|||++....
T Consensus 112 ~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999998742 788999999999999999999998 99999999999999776 89999999998754
Q ss_pred CCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh---------
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW--------- 318 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------- 318 (414)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ............
T Consensus 183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHHH
T ss_pred CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCCchhhhHH
Confidence 322 2334568999999999877 6789999999999999999999999743221 111111111100
Q ss_pred ---hcCCC-----------cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 319 ---NEGMP-----------SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 319 ---~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..... ...................+.+++.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0000000000000011235778999999999999999999997
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=319.23 Aligned_cols=258 Identities=27% Similarity=0.386 Sum_probs=194.8
Q ss_pred cCCCCCCCeecccCCceEEEEEEc--CCC--EEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV--DGQ--EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
.++|++.+.||+|+||.||+|++. +++ .||+|+++.. .....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 367999999999999999999753 233 6899988653 3345678899999999999999999999998765 8
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999997543 24899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 247 FGGDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 247 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
....... .......+|..|+|||.+.+..++.++||||||+++|+|++ |+.||..... .... ..........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~---~~~~~~~~~~ 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQIL---HKIDKEGERL 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH---HHHHTSCCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHH---HHHHccCCCC
Confidence 6433221 12233457788999999998899999999999999999999 9999754321 1111 1111111111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 372 (414)
... ... ...+.+++.+||+.||++|||+.++++.|....
T Consensus 245 ~~~-----~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 PRP-----EDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC-----cCc----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 110 111 235778899999999999999999999996544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=333.68 Aligned_cols=254 Identities=10% Similarity=0.047 Sum_probs=179.3
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhc--CCCceeeeE-------eEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKL--QHRNLVKLL-------GCC 160 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~ 160 (414)
..+|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345889999999999999999864 68899999997633 23455677885555444 699988755 444
Q ss_pred EeC-----------------CeeeEEEeecCCCChhHHhhcccccccCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 043285 161 IQG-----------------EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKR------FHIICGTARGLLYLHQDSRLR 217 (414)
Q Consensus 161 ~~~-----------------~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~ 217 (414)
... ...++||||++ |+|.+++..... .+....+ ..++.|++.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 33799999999 899999976432 2455555 678899999999999998
Q ss_pred eeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccC--CCCCcchhHHHHHHHHHHHHhC
Q 043285 218 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSG 295 (414)
Q Consensus 218 iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg 295 (414)
|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999986532 1213456799999999987 6899999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 296 KKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 296 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+.||........... ........................+.+++.+||+.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999875433211100 000000000000000000011235677899999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=334.78 Aligned_cols=198 Identities=22% Similarity=0.284 Sum_probs=171.1
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc------CCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL------QHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~ 166 (414)
..+|++.+.||+|+||+||+|... +++.||||++... ......+.+|+.+++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999765 4789999999753 33446677888888877 577999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC--eEEEeecCc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLA 244 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~--~kL~Dfgl~ 244 (414)
++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 699998876443 33899999999999999999999998 999999999999999887 999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFY 302 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~ 302 (414)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 250 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 76432 223457899999999999999999999999999999999999997543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=325.33 Aligned_cols=259 Identities=21% Similarity=0.304 Sum_probs=199.8
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC-----ee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 166 (414)
.++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999864 5788999999753 3444577899999999999999999999997653 68
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++||||++ |+|.+++... .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 5899988653 3899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCC-ccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC-
Q 043285 247 FGGDET-EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP- 323 (414)
Q Consensus 247 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 323 (414)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +..............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG---GHHHHHHHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH---HHHHHHHHHhCCCCHH
Confidence 543221 112234578999999998654 45899999999999999999999997543322 222222211111100
Q ss_pred --------------------cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 324 --------------------SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 324 --------------------~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
............ ...+.+++.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNA----DSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCC----CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000111 1356789999999999999999999973
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=317.55 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=185.5
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc-Chh-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI-SEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.++|++.+.||+|+||.||+++. .+|+.||+|++... ... ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999987 46889999999753 222 2334455566688889999999999999999999999
Q ss_pred eecCCCChhHHhhcc-cccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 171 EFMPNKSLDSFIFDQ-ERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 171 ey~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||++ |+|.+++... .....+++..+..++.|++.||+|||++ + ++||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 4888877542 2234589999999999999999999997 7 9999999999999999999999999998653
Q ss_pred CCCCccccccccccccccccccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYA----SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
.. .......||+.|+|||.+ .+..++.++|||||||++|||++|+.||..... . ..............
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~---~~~~~~~~~~~~~~ 233 (290)
T 3fme_A 162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--P---FQQLKQVVEEPSPQ 233 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--H---HHHHHHHHHSCCCC
T ss_pred cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--h---HHHHHHHhccCCCC
Confidence 32 122334689999999996 566789999999999999999999999753221 1 11111122222111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
... ...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 234 -~~~----~~~~----~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 -LPA----DKFS----AEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -CCT----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -ccc----ccCC----HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111 1111 24678899999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=325.08 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=201.3
Q ss_pred cCCCCCCCeecccCCceEEEEEE--cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCc------eeeeEeEEEeCCe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL--VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN------LVKLLGCCIQGEE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 165 (414)
.++|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.+++.++|+| ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 35789999999753 344567889999999987664 9999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-------------
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ------------- 232 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~------------- 232 (414)
.++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 8899999876542 34889999999999999999999998 999999999999987
Q ss_pred ------CCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 043285 233 ------DMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306 (414)
Q Consensus 233 ------~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~ 306 (414)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~- 240 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK- 240 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH-
T ss_pred ccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-
Confidence 67899999999986432 223457899999999999999999999999999999999999998643221
Q ss_pred CcchHHHHHHHhhcCCCccccc------------------------------ccc-cCcCCHHHHHHHHHHHHhccCCCC
Q 043285 307 NLNLIGHAWKLWNEGMPSQLID------------------------------SCF-QDSFNLAEVIRCIHIGLLCVQQHP 355 (414)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~-~~~~~~~~~~~~~~l~~~cl~~dP 355 (414)
.......... ...+..... ... ...........+.+++.+||+.||
T Consensus 241 --~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 241 --EHLAMMERIL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp --HHHHHHHHHH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred --HHHHHHHHHh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 1111111111 111100000 000 001112334567889999999999
Q ss_pred CCCCCHHHHHH
Q 043285 356 EDRPSMPSVIL 366 (414)
Q Consensus 356 ~~RPs~~evl~ 366 (414)
.+|||+.|+++
T Consensus 318 ~~Rpt~~ell~ 328 (339)
T 1z57_A 318 AKRITLREALK 328 (339)
T ss_dssp TTSCCHHHHTT
T ss_pred ccccCHHHHhc
Confidence 99999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=333.41 Aligned_cols=268 Identities=21% Similarity=0.293 Sum_probs=196.8
Q ss_pred HHHHHHhcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccC-----------hhhHHHHHHHHHHHHhcCCCceee
Q 043285 87 LATIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKIS-----------EQGLKELKNEVILFSKLQHRNLVK 155 (414)
Q Consensus 87 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~ 155 (414)
..++....++|++.+.||+|+||.||+|...+|..||||++.... ....+.+.+|+.+++.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 345666789999999999999999999998889999999986421 122478899999999999999999
Q ss_pred eEeEEEeC-----CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 043285 156 LLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 230 (414)
Q Consensus 156 ~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill 230 (414)
+++++... ...++||||++ |+|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99999643 35799999998 58888876433 34899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 043285 231 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLN 309 (414)
Q Consensus 231 ~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~ 309 (414)
+.++.+||+|||++...... .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~ 241 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF---YN 241 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HH
T ss_pred cCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH---HH
Confidence 99999999999999754322 22334568999999999877 6789999999999999999999999754321 11
Q ss_pred hHHHHHHHhhcCC-------------------CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 310 LIGHAWKLWNEGM-------------------PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 310 ~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
............. .......... .........+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1221111111100 0000000000 0000012346789999999999999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=322.16 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=194.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC--------hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 164 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 164 (414)
.++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467999999999999999999875 47899999986421 122345789999999999999999999987654
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC---eEEEee
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDF 241 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kL~Df 241 (414)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 899999999999999886543 3899999999999999999999998 999999999999987664 999999
Q ss_pred cCccccCCCCCcccccccccccccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043285 242 GLARAFGGDETEGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 242 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
|++...... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||....... .+...... .
T Consensus 162 g~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~-~ 235 (322)
T 2ycf_A 162 GHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS-G 235 (322)
T ss_dssp TTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHH-T
T ss_pred ccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHh-C
Confidence 999875322 1223456899999999874 5678999999999999999999999986433221 12211111 0
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
........ .... ...+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~-----~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 KYNFIPEV-----WAEV----SEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCCCCHHH-----HTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccCchh-----hhhc----CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000000 0111 135678999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=325.88 Aligned_cols=261 Identities=24% Similarity=0.339 Sum_probs=201.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChh-----------------hHHHHHHHHHHHHhcCCCceeee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQ-----------------GLKELKNEVILFSKLQHRNLVKL 156 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~~ 156 (414)
.++|++.+.||+|+||.||+|+. +|+.||+|++...... ..+.+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999998 9999999998642211 12788999999999999999999
Q ss_pred EeEEEeCCeeeEEEeecCCCChhHH------hhcccccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEE
Q 043285 157 LGCCIQGEEKLLIYEFMPNKSLDSF------IFDQERCMILDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVL 229 (414)
Q Consensus 157 ~~~~~~~~~~~lv~ey~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dlk~~Nil 229 (414)
++++.+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||.|||+ ++ ++||||+|+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 54321 3458999999999999999999999 87 999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 043285 230 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSV-KSDVFSFGILLLEIVSGKKNRGFYHSDNN 307 (414)
Q Consensus 230 l~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwslGvil~elltg~~p~~~~~~~~~ 307 (414)
++.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++|||||||++|||++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 999999999999999875332 23345689999999999887 6766 999999999999999999997643221
Q ss_pred cchHHHHHHHhhcCCCcc---ccccccc---CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 308 LNLIGHAWKLWNEGMPSQ---LIDSCFQ---DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.......... ....+.. ....... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111100 0000000 0000000 0000111235678999999999999999999997
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=330.59 Aligned_cols=258 Identities=24% Similarity=0.339 Sum_probs=182.4
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------C
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------E 164 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 164 (414)
.++|++.+.||+|+||.||+|.. .+|+.||||++.. ......+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999976 4588999999965 2344567788999999999999999999999754 5
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
..++|+||+ +++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 68999988642 3899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+......+..
T Consensus 180 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 180 RHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCH
T ss_pred ccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCH
Confidence 86432 2234578999999999877 6889999999999999999999999854321 1222222211111000
Q ss_pred c---ccc--------cccc-cCcCCHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 324 S---QLI--------DSCF-QDSFNLAE-----VIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 324 ~---~~~--------~~~~-~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. .+. .... ........ ...+.+|+.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 000 0000 00001111 1346789999999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.82 Aligned_cols=261 Identities=20% Similarity=0.270 Sum_probs=192.8
Q ss_pred HhcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-------
Q 043285 92 SATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------- 163 (414)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 163 (414)
...++|++.+.||+|+||.||+|+. .+|+.||+|++..... ...+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999986 4689999999865322 224699999999999999999998543
Q ss_pred -------------------------------CeeeEEEeecCCCChhHHhhcc-cccccCCHHHHHHHHHHHHHHHHHHH
Q 043285 164 -------------------------------EEKLLIYEFMPNKSLDSFIFDQ-ERCMILDWSKRFHIICGTARGLLYLH 211 (414)
Q Consensus 164 -------------------------------~~~~lv~ey~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH 211 (414)
...++||||++ |+|.+.+... .....+++..+..++.|++.||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34789999998 5887777542 22245899999999999999999999
Q ss_pred hCCCCCeeeccCCCCCEEEc-CCCCeEEEeecCccccCCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHH
Q 043285 212 QDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILL 289 (414)
Q Consensus 212 ~~~~~~iiH~dlk~~Nill~-~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil 289 (414)
+.+ ++||||||+||+++ .++.+||+|||++....... ......+|+.|+|||.+.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 99999999999997 68899999999998753322 22345689999999998775 589999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC---------------cccccccccCcCCHHHHHHHHHHHHhccCCC
Q 043285 290 LEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP---------------SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQH 354 (414)
Q Consensus 290 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d 354 (414)
|||++|+.||..... .+...........+.. ...................+.+++.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~---~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETS---IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999764322 1222222111111100 0000000000001111234778999999999
Q ss_pred CCCCCCHHHHHH
Q 043285 355 PEDRPSMPSVIL 366 (414)
Q Consensus 355 P~~RPs~~evl~ 366 (414)
|++|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=319.50 Aligned_cols=262 Identities=22% Similarity=0.308 Sum_probs=192.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEE-----------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI----------- 161 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----------- 161 (414)
.++|++.+.||+|+||.||+|.... ++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4789999999999999999998764 8899999998766777788999999999999999999999874
Q ss_pred ---eCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCeE
Q 043285 162 ---QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPK 237 (414)
Q Consensus 162 ---~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~k 237 (414)
+....++||||++ |+|.+++... .+++..+..++.|++.||+|||+++ ++||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 6999988542 3889999999999999999999998 99999999999997 567999
Q ss_pred EEeecCccccCCCCC-ccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH
Q 043285 238 ISDFGLARAFGGDET-EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 238 L~Dfgl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 315 (414)
|+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ........
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence 999999987532211 122334467899999998865 6789999999999999999999999764321 11111111
Q ss_pred HHhhcC----------CCccccccccc-CcCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 316 KLWNEG----------MPSQLIDSCFQ-DSFNLA-----EVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 316 ~~~~~~----------~~~~~~~~~~~-~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...... ........... ...... ....+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 110000 00000000000 000000 1235778999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=328.97 Aligned_cols=267 Identities=21% Similarity=0.329 Sum_probs=183.6
Q ss_pred CCCCC-CCeecccCCceEEEEEEc---CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCeeeE
Q 043285 95 NNFSI-NKKLGQGGFGPVYKGKLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLL 168 (414)
Q Consensus 95 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 168 (414)
+.|++ .++||+|+||+||+|+.. ++..||+|++..... ...+.+|+.+++.++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34665 468999999999999865 478899999975322 2467899999999999999999999965 668899
Q ss_pred EEeecCCCChhHHhhccc------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCCeEE
Q 043285 169 IYEFMPNKSLDSFIFDQE------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKI 238 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~~kL 238 (414)
||||+++ +|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999974 7887775322 1224899999999999999999999998 9999999999999 67789999
Q ss_pred EeecCccccCCCCC-ccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC------Ccch
Q 043285 239 SDFGLARAFGGDET-EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN------NLNL 310 (414)
Q Consensus 239 ~Dfgl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~------~~~~ 310 (414)
+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..+.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987643211 1223446789999999999874 58999999999999999999999986433211 1122
Q ss_pred HHHHHHHhhcCCCcccccc---------------cccCcCCHHH---------HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 311 IGHAWKLWNEGMPSQLIDS---------------CFQDSFNLAE---------VIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~---------~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+.................- .......... ...+.+|+.+||+.||.+|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 2222222211111100000 0000000000 235678999999999999999999998
Q ss_pred H
Q 043285 367 M 367 (414)
Q Consensus 367 ~ 367 (414)
.
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=325.66 Aligned_cols=259 Identities=24% Similarity=0.295 Sum_probs=190.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 164 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 164 (414)
.++|++.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999864 588999999965 23445567889999999999999999999997665
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
..++||||+++ +|.+++.. .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999975 78877742 3889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhc----
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE---- 320 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 320 (414)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .............
T Consensus 175 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTPCPE 248 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCCCCHH
T ss_pred cccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHH
Confidence 865322 122345789999999999999999999999999999999999999754321 1111111110000
Q ss_pred --------------CCCc---c----ccccc-ccCc--CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 321 --------------GMPS---Q----LIDSC-FQDS--FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 321 --------------~~~~---~----~~~~~-~~~~--~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
..+. . ..... .... ........+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 0 00000 0000 001124567889999999999999999999983
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=318.66 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=197.3
Q ss_pred hcCCCCCCCeecccCCceEEEEEE--cCCCEEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCceeeeEeEEE----
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL--VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCI---- 161 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~---- 161 (414)
..++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 357889999986422 12223456677777666 8999999999997
Q ss_pred -eCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEe
Q 043285 162 -QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 240 (414)
Q Consensus 162 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~D 240 (414)
.....++||||++ |+|.+++..... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 699999876443 23899999999999999999999998 99999999999999999999999
Q ss_pred ecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhc
Q 043285 241 FGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE 320 (414)
Q Consensus 241 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
||++..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .............
T Consensus 164 fg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred CcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCC
Confidence 999976532 1223345689999999999999999999999999999999999999754321 1222222221111
Q ss_pred CCCccccc------ccc-------cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 321 GMPSQLID------SCF-------QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 321 ~~~~~~~~------~~~-------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
........ ..+ ...........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 10000000 000 00000011234667899999999999999999995
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=317.91 Aligned_cols=251 Identities=26% Similarity=0.362 Sum_probs=199.9
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3478999999999999999999875 6889999998652 334567889999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CCeEEEeecCccc
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARA 246 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kL~Dfgl~~~ 246 (414)
+||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999999886544 3899999999999999999999998 9999999999999754 4699999999986
Q ss_pred cCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
..... ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... ....... ..........
T Consensus 174 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~---~~~~~~~~~~ 243 (287)
T 2wei_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKR---VETGKYAFDL 243 (287)
T ss_dssp BCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH---HHHCCCCCCS
T ss_pred ecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHH---HHcCCCCCCc
Confidence 54322 2233468899999998875 48999999999999999999999975422 1111111 1111111110
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. .. ... ...+.+++.+||+.||++|||+.|+++
T Consensus 244 ~--~~-~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 P--QW-RTI----SDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp G--GG-TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h--hh-hhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 00 111 124677899999999999999999997
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=320.25 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=197.4
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
..++|++.+.||+|+||.||+|+..+ .|++|+++.. .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45789999999999999999998743 4999998642 2233456778999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++ ++.+||+|||++......
T Consensus 109 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 9999999999996543 34889999999999999999999998 99999999999998 679999999998764321
Q ss_pred C---CccccccccccccccccccccC---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh
Q 043285 251 E---TEGNTNRVVGTYGYMAPEYASD---------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 251 ~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
. .........|++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... .... ...
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~---~~~- 255 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAII---WQM- 255 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHH---HHH-
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH---HHh-
Confidence 1 1122334468999999999864 4578999999999999999999999754221 1111 111
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCCC
Q 043285 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVL 374 (414)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 374 (414)
........... ... ..+.+++.+||+.||++|||+.++++.|+.....
T Consensus 256 ~~~~~~~~~~~----~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 256 GTGMKPNLSQI----GMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HTTCCCCCCCS----SCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ccCCCCCCCcC----CCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111111 111 1366788999999999999999999999877653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.82 Aligned_cols=259 Identities=22% Similarity=0.278 Sum_probs=190.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------eee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------EKL 167 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~ 167 (414)
.+|++.+.||+|+||.||+|+.. +|+.||||++..... ...+|+.+++.++||||++++++|.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46899999999999999999875 589999999865322 2346999999999999999999986422 367
Q ss_pred EEEeecCCCChhHHhhc-ccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CCeEEEeecCcc
Q 043285 168 LIYEFMPNKSLDSFIFD-QERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLAR 245 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kL~Dfgl~~ 245 (414)
+||||+++ +|.+++.. ......+++..+..++.|+++||+|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 66665543 122345899999999999999999999998 9999999999999965 568999999998
Q ss_pred ccCCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC---
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG--- 321 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 321 (414)
.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+.+..+.......
T Consensus 206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCCHH
T ss_pred hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHH
Confidence 753322 22345789999999998765 789999999999999999999999754321 11222221111100
Q ss_pred -------CCcccccccccC-----cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 322 -------MPSQLIDSCFQD-----SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 322 -------~~~~~~~~~~~~-----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
....+..+.+.. .+.......+.+|+.+||+.||.+|||+.|+++.
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000000000000 0001112357789999999999999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=321.07 Aligned_cols=252 Identities=21% Similarity=0.260 Sum_probs=170.9
Q ss_pred cCCCCCCC-eecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCeee
Q 043285 94 TNNFSINK-KLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKL 167 (414)
Q Consensus 94 ~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 167 (414)
.++|.+.+ .||+|+||.||+|+.. +|+.||||++... .. ...+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46788854 6999999999999875 5899999998652 11 22223334667799999999999976 44589
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCeEEEeecCc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLA 244 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kL~Dfgl~ 244 (414)
+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999976543 34899999999999999999999998 999999999999986 455999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........................
T Consensus 179 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3fhr_A 179 KETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred eeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence 86532 22234568999999999999999999999999999999999999985433221111000000000000000
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+.. ... ...+.+++.+||+.||++|||+.|+++
T Consensus 255 ----~~~-~~~----~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 255 ----PEW-SEV----SEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ----TTS-TTC----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----hhh-ccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 011 234677899999999999999999998
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.11 Aligned_cols=261 Identities=21% Similarity=0.307 Sum_probs=198.1
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-----------CCceeeeEeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCI 161 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 161 (414)
.++|++.+.||+|+||.||+|+. .+++.||||++.. .......+.+|+.+++.++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999986 4688999999975 3334567888999998886 899999999998
Q ss_pred eCC----eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEc-----
Q 043285 162 QGE----EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLD----- 231 (414)
Q Consensus 162 ~~~----~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~----- 231 (414)
... ..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||++ + ++||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 8899999876433 2389999999999999999999998 7 99999999999994
Q ss_pred -CCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc--
Q 043285 232 -QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNL-- 308 (414)
Q Consensus 232 -~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~-- 308 (414)
..+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 445799999999986532 223346899999999999999999999999999999999999998654332211
Q ss_pred -chHHHHHHHhhcCCCcc----------------cccc-------------cccCcCCHHHHHHHHHHHHhccCCCCCCC
Q 043285 309 -NLIGHAWKLWNEGMPSQ----------------LIDS-------------CFQDSFNLAEVIRCIHIGLLCVQQHPEDR 358 (414)
Q Consensus 309 -~~~~~~~~~~~~~~~~~----------------~~~~-------------~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 358 (414)
.......... ...+.. .... .............+.+++.+||+.||++|
T Consensus 247 ~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 247 DDHIAQIIELL-GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHH-CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHHhc-CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 1111111110 000000 0000 00012234455678899999999999999
Q ss_pred CCHHHHHH
Q 043285 359 PSMPSVIL 366 (414)
Q Consensus 359 Ps~~evl~ 366 (414)
||+.|+++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999998
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=323.56 Aligned_cols=268 Identities=21% Similarity=0.255 Sum_probs=186.9
Q ss_pred HHHHhcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe--
Q 043285 89 TIVSATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-- 165 (414)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 165 (414)
......++|++.+.||+|+||.||+|+.. +|..||||++.... .......+++..++.++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34456689999999999999999999874 58899999986532 223456678888899999999999999976443
Q ss_pred -----eeEEEeecCCCChhHHhhc-ccccccCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeeccCCCCCEEEcC-CCCe
Q 043285 166 -----KLLIYEFMPNKSLDSFIFD-QERCMILDWSKRFHIICGTARGLLYLH--QDSRLRIIHRDLKASNVLLDQ-DMNP 236 (414)
Q Consensus 166 -----~~lv~ey~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~iiH~dlk~~Nill~~-~~~~ 236 (414)
.++||||+++ +|...+.. ......+++..+..++.|++.||.||| +.+ ++||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999987 44444332 223345889999999999999999999 777 999999999999996 8999
Q ss_pred EEEeecCccccCCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHH
Q 043285 237 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 237 kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 315 (414)
||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ........
T Consensus 172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~~~ 245 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS---AGQLHEIV 245 (360)
T ss_dssp EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh---HHHHHHHH
Confidence 999999998764322 22345689999999998665 489999999999999999999999754321 12222221
Q ss_pred HHhhcCC------------Cccccc------ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 316 KLWNEGM------------PSQLID------SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 316 ~~~~~~~------------~~~~~~------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
....... ...... ..............+.+++.+||+.||.+|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111000 000000 000001111123467889999999999999999999973
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=319.11 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=196.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-----Cee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 166 (414)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999875 5889999999753 344456788999999999999999999998764 678
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++||||++ ++|.+++... .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 5899988653 3899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcc--------ccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043285 247 FGGDETEG--------NTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL 317 (414)
Q Consensus 247 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 317 (414)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR---HQLLLIFGI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHH
Confidence 64322111 1223468999999998764 68899999999999999999999998643211 111111111
Q ss_pred hhcCCCccccc------------cccc-CcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 318 WNEGMPSQLID------------SCFQ-DSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 318 ~~~~~~~~~~~------------~~~~-~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
........... .... ..... .....+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11110000000 0000 00000 11235678999999999999999999997
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=314.08 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=190.3
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe----------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ---------- 162 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------- 162 (414)
.++|++.+.||+|+||.||+|+.. +++.||+|++.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467899999999999999999864 689999999965 34456788999999999999999999999865
Q ss_pred ---CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEE
Q 043285 163 ---GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 239 (414)
Q Consensus 163 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~ 239 (414)
....++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 356799999999999999997533 24788899999999999999999998 9999999999999999999999
Q ss_pred eecCccccCCCCC------------ccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 043285 240 DFGLARAFGGDET------------EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306 (414)
Q Consensus 240 Dfgl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~ 306 (414)
|||++........ ........||+.|+|||.+.+. .++.++|||||||++|||++ |+...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---- 231 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---- 231 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----
Confidence 9999986532210 1122345689999999999865 78999999999999999998 33210
Q ss_pred CcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 307 NLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
...... ........ ..+. ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 232 -~~~~~~-~~~~~~~~-~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 -MERVNI-LKKLRSVS-IEFP-----PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HHHHHH-HHHHHSTT-CCCC-----TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -hhHHHH-HHhccccc-cccC-----ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 011111 11111111 0111 11111122346678999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.67 Aligned_cols=200 Identities=24% Similarity=0.335 Sum_probs=169.5
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CC-----ceeeeEeEEEeCCe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HR-----NLVKLLGCCIQGEE 165 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~ 165 (414)
..++|++.+.||+|+||+||+|+.. +++.||||+++. .......+..|+.+++.++ |+ +++++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999865 578899999975 3344567778888888875 44 49999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc--CCCCeEEEeecC
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGL 243 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~--~~~~~kL~Dfgl 243 (414)
.++||||++ ++|.+++..... ..+++..+..++.|++.||.|||++. .+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 599999876532 23899999999999999999999531 2499999999999995 477899999999
Q ss_pred ccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 301 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~ 301 (414)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9875322 2345789999999999999999999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=345.13 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=199.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
.++|++.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.+++.++||||+++++++. .+..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 4678888999999999999998643 457999998753 4445578899999999999999999999984 567899
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 468 v~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 999999999999997543 24899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.... ..+....... .......
T Consensus 543 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~---~~~~~~~i~~----~~~~~~~ 614 (656)
T 2j0j_A 543 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRIEN----GERLPMP 614 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHH----TCCCCCC
T ss_pred CCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHc----CCCCCCC
Confidence 3221 12223456789999999999999999999999999999997 888875322 1222222211 1111111
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. .. ...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 615 ~-----~~----~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 615 P-----NC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp T-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c-----cc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 11 1356778999999999999999999998854
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=320.72 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=194.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee----
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK---- 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---- 166 (414)
.++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 478999999999999999999864 5889999999753 344467888999999999999999999999877765
Q ss_pred --eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 167 --LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 167 --~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
++||||++ ++|.+++.. .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 588877632 2899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
..... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ..+............ .
T Consensus 192 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~-~ 262 (371)
T 4exu_A 192 RHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---YLDQLTQILKVTGVP-G 262 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCC-C
T ss_pred ccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCC-c
Confidence 86432 2234568999999999887 688999999999999999999999985432 111111111111000 0
Q ss_pred cccccc------------ccc-CcCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 324 SQLIDS------------CFQ-DSFNL-----AEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 324 ~~~~~~------------~~~-~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
...... ... ..... .....+.+++.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000 000 00000 012357789999999999999999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=318.48 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=176.4
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHH-HHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.++|++.+.||+|+||.||+|... +|+.||||++... .......+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 378999999999999999999874 5889999999763 3334445556665 677789999999999999999999999
Q ss_pred eecCCCChhHHhhcc--cccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 171 EFMPNKSLDSFIFDQ--ERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 171 ey~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
||+++ +|.+++... .....+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 888777531 1123589999999999999999999998 7 999999999999999999999999999865
Q ss_pred CCCCCccccccccccccccccccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYA----SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
.... ......||+.|+|||.+ .+..++.++|||||||++|||++|+.||........ ..... .....
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~-~~~~~ 247 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQV-VKGDP 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCC-CCSCC
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHH-hcCCC
Confidence 3221 12234689999999998 456789999999999999999999999864321100 00000 00111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..+.. ...... ...+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~-~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQLSN-SEEREF----SPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCC-CSSCCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCC-cccccC----CHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11110 000112 235778899999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=319.44 Aligned_cols=258 Identities=19% Similarity=0.280 Sum_probs=198.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CC-CEEEEEEecccChhhHHHHHHHHHHHHhcCCCc------eeeeEeEEEeCCe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DG-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRN------LVKLLGCCIQGEE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 165 (414)
.++|++.+.||+|+||.||+|... ++ ..||+|+++.. ....+.+.+|+.+++.++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999874 34 68999999753 344567888999999997766 8999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---------------
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL--------------- 230 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill--------------- 230 (414)
.++||||+ ++++.+++..... ..+++..+..++.|++.||.|||+++ ++||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 5677777655432 34899999999999999999999998 9999999999999
Q ss_pred ----cCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 043285 231 ----DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306 (414)
Q Consensus 231 ----~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~ 306 (414)
+.++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~- 245 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR- 245 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred cccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 5678999999999986432 223457899999999999999999999999999999999999998643221
Q ss_pred CcchHHHHHHHhhcCCCccccc------------------------------c-cccCcCCHHHHHHHHHHHHhccCCCC
Q 043285 307 NLNLIGHAWKLWNEGMPSQLID------------------------------S-CFQDSFNLAEVIRCIHIGLLCVQQHP 355 (414)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~------------------------------~-~~~~~~~~~~~~~~~~l~~~cl~~dP 355 (414)
.......... ...+..... . .............+.+++.+||+.||
T Consensus 246 --~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 246 --EHLVMMEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp --HHHHHHHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred --HHHHHHHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 1111111111 111100000 0 00001112234567889999999999
Q ss_pred CCCCCHHHHHH
Q 043285 356 EDRPSMPSVIL 366 (414)
Q Consensus 356 ~~RPs~~evl~ 366 (414)
++|||+.|+++
T Consensus 323 ~~Rpt~~e~l~ 333 (355)
T 2eu9_A 323 AQRITLAEALL 333 (355)
T ss_dssp TTSCCHHHHTT
T ss_pred hhCcCHHHHhc
Confidence 99999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=327.95 Aligned_cols=253 Identities=23% Similarity=0.297 Sum_probs=185.8
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEEeec
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++.+....++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445667889999999998776678999999998652 234678899999876 8999999999999999999999999
Q ss_pred CCCChhHHhhcccccc----cCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-------------CCe
Q 043285 174 PNKSLDSFIFDQERCM----ILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-------------MNP 236 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-------------~~~ 236 (414)
+ |+|.+++....... ...+..++.++.|++.||+|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999997643211 1123345789999999999999998 9999999999999754 479
Q ss_pred EEEeecCccccCCCCCc--cccccccccccccccccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 043285 237 KISDFGLARAFGGDETE--GNTNRVVGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDN 306 (414)
Q Consensus 237 kL~Dfgl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~ 306 (414)
||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~- 246 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR- 246 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence 99999999876433221 12234579999999999876 678999999999999999999 88887532211
Q ss_pred CcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 307 NLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. .. ......... .............+.+++.+||+.||++|||+.|+++
T Consensus 247 ---~-~~---i~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ---E-SN---IIRGIFSLD----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---H-HH---HHHTCCCCC----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---H-HH---HhcCCCCcc----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 11 111111100 0111122334457788999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=321.21 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=194.0
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe-----
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 165 (414)
.++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999874 5889999999652 33445678899999999999999999999987654
Q ss_pred -eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 166 -KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 166 -~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
.++||||++ ++|.+++.. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 588877632 2899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhc---
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE--- 320 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 320 (414)
..... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||..... .+...........
T Consensus 174 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 174 RHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGT 245 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHCBCCH
T ss_pred cCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCH
Confidence 76432 1234568999999999877 6789999999999999999999999764321 1111111111000
Q ss_pred ----------------CCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 321 ----------------GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 321 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.... .....+.. ........+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQ-TPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCB-CSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhHHHHHHHHhCcC-CCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 00000000 000112357789999999999999999999963
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=311.63 Aligned_cols=244 Identities=24% Similarity=0.404 Sum_probs=188.6
Q ss_pred HHhcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccCh------hhHHHHHHHHHHHHhc----CCCceeeeEeE
Q 043285 91 VSATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISE------QGLKELKNEVILFSKL----QHRNLVKLLGC 159 (414)
Q Consensus 91 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~~~~~ 159 (414)
....++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.++..+ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34567899999999999999999976 4688999999965322 1223456789999888 89999999999
Q ss_pred EEeCCeeeEEEee-cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCeE
Q 043285 160 CIQGEEKLLIYEF-MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPK 237 (414)
Q Consensus 160 ~~~~~~~~lv~ey-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~k 237 (414)
+.+.+..++|+|| +.+++|.+++.... .+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 78999999997644 3899999999999999999999998 99999999999999 889999
Q ss_pred EEeecCccccCCCCCccccccccccccccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHH
Q 043285 238 ISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWK 316 (414)
Q Consensus 238 L~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 316 (414)
|+|||++...... ......|+..|+|||++.+..+. .++|||||||++|||++|+.||... ...
T Consensus 181 l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---------~~~-- 245 (312)
T 2iwi_A 181 LIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---------QEI-- 245 (312)
T ss_dssp ECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HHH--
T ss_pred EEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---------HHH--
Confidence 9999999876432 22345689999999999877664 5899999999999999999997531 011
Q ss_pred HhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 317 LWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
..... .+ ....+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 246 -~~~~~--~~-----~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 -LEAEL--HF-----PAHVS----PDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -HHTCC--CC-----CTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -hhhcc--CC-----cccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01100 00 11111 246778999999999999999999973
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=311.99 Aligned_cols=251 Identities=23% Similarity=0.397 Sum_probs=177.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hh-hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... .. ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 367888999999999999999875 68999999997532 22 2334455556788889999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
||+ ++.+..+..... ..+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 455555543322 3489999999999999999999985 7 99999999999999999999999999976532
Q ss_pred CCCcccccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
.. ......|++.|+|||.+. +..++.++|||||||++|||++|+.||..... ....... ..... ..
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~---~~~~~-~~ 248 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTK---VLQEE-PP 248 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHH---HHHSC-CC
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHH---HhccC-CC
Confidence 21 223456899999999984 55788999999999999999999999753221 1111111 11111 11
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..... ...+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~---~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 LLPGH---MGFS----GDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCSS---SCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCcc---CCCC----HHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11100 0111 24667889999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=314.24 Aligned_cols=242 Identities=24% Similarity=0.392 Sum_probs=196.0
Q ss_pred hcCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccCh------hhHHHHHHHHHHHHhcC--CCceeeeEeEEEeC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ--HRNLVKLLGCCIQG 163 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~ 163 (414)
..++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+++.++ |+||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 457899999999999999999976 4688999999865321 12245677999999996 59999999999999
Q ss_pred CeeeEEEeecCC-CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCeEEEee
Q 043285 164 EEKLLIYEFMPN-KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDF 241 (414)
Q Consensus 164 ~~~~lv~ey~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kL~Df 241 (414)
+..++|+||+.+ ++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+|||++ +++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999976 89999987643 3899999999999999999999998 99999999999999 7899999999
Q ss_pred cCccccCCCCCccccccccccccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhc
Q 043285 242 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE 320 (414)
Q Consensus 242 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
|++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... . ....
T Consensus 195 g~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~---~~~~ 258 (320)
T 3a99_A 195 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------E---IIRG 258 (320)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------H---HHHC
T ss_pred ccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------h---hhcc
Confidence 999876432 2234568999999999987766 688999999999999999999975311 0 0111
Q ss_pred CCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 321 GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
... ...... ..+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~-------~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 QVF-------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCC-------CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccc-------ccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 100 011111 246788999999999999999999973
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=333.05 Aligned_cols=265 Identities=23% Similarity=0.335 Sum_probs=196.1
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe------CCe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GEE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~ 165 (414)
.++|++.+.||+|+||.||+|.. .+|+.||||++.. ......+.+.+|+.+++.++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 37899999999999999999976 4588999999875 345556788999999999999999999998765 667
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCC---eEEEeec
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFG 242 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kL~Dfg 242 (414)
.++||||+++|+|.+++........+++..++.++.|++.||+|||+.+ ++||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999987655456899999999999999999999998 999999999999997765 9999999
Q ss_pred CccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC--cchHHHH-HHHhh
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN--LNLIGHA-WKLWN 319 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~--~~~~~~~-~~~~~ 319 (414)
++....... ......||+.|+|||.+.+..++.++|||||||++|||++|..||........ ....... .....
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 998764322 22345789999999999999999999999999999999999999853210000 0000000 00000
Q ss_pred cC-CCccc-ccccc--cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 043285 320 EG-MPSQL-IDSCF--QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSV 364 (414)
Q Consensus 320 ~~-~~~~~-~~~~~--~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev 364 (414)
.. ..... ..... ...........+.+++.+||+.||++|||+.|+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00 00000 00000 111222234567889999999999999999663
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=318.01 Aligned_cols=250 Identities=24% Similarity=0.321 Sum_probs=184.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
..+|.+.+.||+|+||+|+.....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 356888899999999997665566899999999965322 2356799999999 799999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-----CCCeEEEeecCcccc
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLARAF 247 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-----~~~~kL~Dfgl~~~~ 247 (414)
++ |+|.+++..... ......+..++.|++.||.|||+++ |+||||||+|||++. ...+||+|||++...
T Consensus 100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 599999875442 2444456789999999999999998 999999999999953 235889999999876
Q ss_pred CCCCC-cccccccccccccccccccc---CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 248 GGDET-EGNTNRVVGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 248 ~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
..... ........||+.|+|||++. ...++.++|||||||++|||++ |..||+..... ..... ....
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~-~~~~ 245 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANIL-LGAC 245 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHH-TTCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHH-hccC
Confidence 43221 12234467999999999997 4567889999999999999999 88887532111 11111 1111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 323 PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...... ........+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111111 11122334678999999999999999999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=335.52 Aligned_cols=236 Identities=19% Similarity=0.318 Sum_probs=188.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEc--CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe-----
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV--DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 165 (414)
.++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999875 5889999998653 34455678899999999999999999999987665
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.|+||||+++++|.+++.. .+++..++.++.|++.||.|||+++ |+||||||+|||++.+ .+||+|||++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987643 3899999999999999999999998 9999999999999886 89999999998
Q ss_pred ccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..|+...... ...
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------~~~-- 285 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------------GLP-- 285 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------------SCC--
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------------ccc--
Confidence 75322 3456899999999987654 89999999999999999998775421111 000
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHh
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS-MPSVILML 368 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~~L 368 (414)
...........+.+++.+||+.||++||+ ++++.+.|
T Consensus 286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 323 (681)
T 2pzi_A 286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL 323 (681)
T ss_dssp ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence 00000111235678999999999999995 45555544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=295.13 Aligned_cols=230 Identities=12% Similarity=0.081 Sum_probs=180.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
.++|++.+.||+|+||.||+|+... ++.||||++... .....+.+.+|+..+..++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3679999999999999999998754 889999999753 234457889999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++... ....++..++.|++.||+|||+++ ++||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999998532 355578889999999999999998 9999999999999999999997443
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc-
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID- 328 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 328 (414)
|++| ++.++|||||||++|||+||+.||............. .........
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~ 225 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------RDTAGQPIEP 225 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-------BCTTSCBCCH
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-------HHhccCCCCh
Confidence 3333 6889999999999999999999986543322110000 000000000
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSET 372 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 372 (414)
....... ...+.+++.+||+.||++| |+.|+++.|....
T Consensus 226 ~~~~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 226 ADIDRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHCTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhcccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0001111 1346788999999999999 9999999996643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=296.24 Aligned_cols=227 Identities=20% Similarity=0.270 Sum_probs=176.0
Q ss_pred CCCCCC-CeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHH-HhcCCCceeeeEeEEEe----CCeee
Q 043285 95 NNFSIN-KKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILF-SKLQHRNLVKLLGCCIQ----GEEKL 167 (414)
Q Consensus 95 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~~ 167 (414)
++|.+. +.||+|+||.||++.. .+++.||+|++... ..+.+|+.++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567776 7899999999999987 46889999998642 3566788887 56699999999999987 67789
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCeEEEeecCc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLA 244 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kL~Dfgl~ 244 (414)
+||||+++|+|.+++..... ..+++..+..++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999976542 34899999999999999999999998 999999999999998 788999999998
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
.... +..++.++|||||||++|||++|+.||......... .....
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~ 212 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKT 212 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHH
Confidence 6532 244678999999999999999999998543221100 00000
Q ss_pred ccccccccCcCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 325 QLIDSCFQDSFNL----AEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 325 ~~~~~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
.+..... .... .....+.+++.+||+.||++|||+.|+++.
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000 0000 012356789999999999999999999973
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=309.36 Aligned_cols=241 Identities=17% Similarity=0.183 Sum_probs=176.2
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCC-Cce----------ee----
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQH-RNL----------VK---- 155 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~ni----------v~---- 155 (414)
..|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.+++.++| +|. +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4577788999999999999985 46899999998742 22335778999999999977 221 11
Q ss_pred -------eEeEEEe-----CCeeeEEEeecCCCChhHHhhcc----cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 043285 156 -------LLGCCIQ-----GEEKLLIYEFMPNKSLDSFIFDQ----ERCMILDWSKRFHIICGTARGLLYLHQDSRLRII 219 (414)
Q Consensus 156 -------~~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii 219 (414)
+..++.. ....+++|+++ +++|.+++... .....+++..++.++.|+++||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1111111 12356677765 67999988521 11234778899999999999999999998 99
Q ss_pred eccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccc----------cCCCCCcchhHHHHHHHH
Q 043285 220 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA----------SDGQFSVKSDVFSFGILL 289 (414)
Q Consensus 220 H~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwslGvil 289 (414)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999998864321 334567 999999999 566789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 290 LEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 290 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
|||++|+.||.......... ...... .... ..+.+++.+||+.||++|||+.|+++
T Consensus 308 ~elltg~~Pf~~~~~~~~~~---------------~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSE---------------WIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSG---------------GGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhhHH---------------HHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999986433221111 111111 0111 35778899999999999999777654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=300.28 Aligned_cols=241 Identities=15% Similarity=0.115 Sum_probs=181.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccC--------hhhHHHHHHHHHHHHhcC---------CCceeee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQ---------HRNLVKL 156 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~~ 156 (414)
.++|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999988 78999999997532 233477889999998886 6666666
Q ss_pred EeEEE-----------------e-------------CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHH
Q 043285 157 LGCCI-----------------Q-------------GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206 (414)
Q Consensus 157 ~~~~~-----------------~-------------~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 206 (414)
.+.+. + ....++||||+++|++.+.+.+ ..+++..+..++.|++.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 66543 2 6789999999999977766643 238999999999999999
Q ss_pred HHHHH-hCCCCCeeeccCCCCCEEEcCCC--------------------CeEEEeecCccccCCCCCccccccccccccc
Q 043285 207 LLYLH-QDSRLRIIHRDLKASNVLLDQDM--------------------NPKISDFGLARAFGGDETEGNTNRVVGTYGY 265 (414)
Q Consensus 207 l~~LH-~~~~~~iiH~dlk~~Nill~~~~--------------------~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y 265 (414)
|+||| +++ |+||||||+|||++.++ .+||+|||+++.... ....||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence 99999 888 99999999999999887 899999999987532 234799999
Q ss_pred cccccccCCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCCCCCcchHHHHH-HHhhcCCCcccccccccCcCCHHHHHHH
Q 043285 266 MAPEYASDGQFSVKSDVFSFGIL-LLEIVSGKKNRGFYHSDNNLNLIGHAW-KLWNEGMPSQLIDSCFQDSFNLAEVIRC 343 (414)
Q Consensus 266 ~aPE~~~~~~~~~~sDvwslGvi-l~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (414)
+|||++.+.. +.++||||+|++ .+++++|..||... ....... .......... .............+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFKT----KCNTPAMKQIKRKI 312 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCSS----CCCSHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccCc----ccchhhhhhcCHHH
Confidence 9999998766 899999998777 77788898885310 0000011 1111111100 00011112234567
Q ss_pred HHHHHhccCCCCCCCCCHHHHH
Q 043285 344 IHIGLLCVQQHPEDRPSMPSVI 365 (414)
Q Consensus 344 ~~l~~~cl~~dP~~RPs~~evl 365 (414)
.+|+.+||+.| |++|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 88999999976 999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=269.49 Aligned_cols=183 Identities=17% Similarity=0.178 Sum_probs=128.8
Q ss_pred ecccCCceEEEEE-EcCCCEEEEEEeccc----------ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEEE
Q 043285 103 LGQGGFGPVYKGK-LVDGQEIAVKRLSKI----------SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 103 lg~G~~g~V~~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 170 (414)
.+.|++|.+..++ .--|+.+++|++.+. .....+++.+|+++|+++ .|+||+++++++.+....||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666555442 224788999998642 123446799999999999 7999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||++|++|.++|..... ++.. .|+.||+.||+|+|++| |+||||||+|||++.+|.+||+|||+++.....
T Consensus 322 Eyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999976543 5554 47899999999999999 999999999999999999999999999876432
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK 297 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~ 297 (414)
. ......+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 393 ~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 C--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred C--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 2 23345689999999999875 46778999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=247.69 Aligned_cols=185 Identities=18% Similarity=0.200 Sum_probs=145.8
Q ss_pred CCCCeecccCCceEEEEEEcCCCEEEEEEecccC---h-----hhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 98 SINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKIS---E-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 98 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
...+.||+|+||+||+|.. .+..+++|+..... . ...+.+.+|+.++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 67889998864311 1 1234579999999999999999777777788889999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++++|.+++.. +..++.|+++||.|||+++ |+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999864 4579999999999999998 999999999999998 999999999987643
Q ss_pred CCCcc-----ccccccccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 043285 250 DETEG-----NTNRVVGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIVSGKKNR 299 (414)
Q Consensus 250 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~ 299 (414)
..... ......||+.|||||++.+ ..|+..+|+|+..+-..+-+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 21111 1235679999999999987 57888899999999999888877654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.9e-25 Score=202.71 Aligned_cols=151 Identities=19% Similarity=0.138 Sum_probs=121.3
Q ss_pred HHHHhcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccCh------------------hhHHHHHHHHHHHHhcCC
Q 043285 89 TIVSATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISE------------------QGLKELKNEVILFSKLQH 150 (414)
Q Consensus 89 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h 150 (414)
.+......|.+.+.||+|+||.||+|...+|+.||+|.++.... .....+.+|+.+++.++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 33444566777899999999999999987799999999964221 13456889999999999
Q ss_pred CceeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 043285 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 230 (414)
Q Consensus 151 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill 230 (414)
| +++.+++. .+..++||||+++++|.+ +.. .....++.|++.||.|||+++ ++||||||+|||+
T Consensus 163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 5 66666554 356799999999999988 421 123469999999999999998 9999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCCcccccccccccccccccccc
Q 043285 231 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 272 (414)
Q Consensus 231 ~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 272 (414)
+ ++.+||+|||++.. +..++|||++.
T Consensus 227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9 99999999999864 34578899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.1e-20 Score=169.10 Aligned_cols=138 Identities=16% Similarity=0.172 Sum_probs=106.7
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCE--EEEEEecccCh------------------------hhHHHHHHHHHHHHh
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQE--IAVKRLSKISE------------------------QGLKELKNEVILFSK 147 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~ 147 (414)
.-|.+.+.||+|+||.||+|.. .+|+. ||||+++.... .....+.+|+..+..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467789999999999999987 67888 99998754211 112367889999999
Q ss_pred cCCCce--eeeEeEEEeCCeeeEEEeecCC-C----ChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHH-hCCCCCee
Q 043285 148 LQHRNL--VKLLGCCIQGEEKLLIYEFMPN-K----SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH-QDSRLRII 219 (414)
Q Consensus 148 l~h~ni--v~~~~~~~~~~~~~lv~ey~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ii 219 (414)
+.|+++ ..++++ ...++||||+.+ | +|.++... .++.....++.|++.||.||| +.+ ++
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 988764 334432 367899999942 4 66665432 223456789999999999999 887 99
Q ss_pred eccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 220 HRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 220 H~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
||||||.|||++. .++|+|||++...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1e-17 Score=159.89 Aligned_cols=140 Identities=12% Similarity=0.154 Sum_probs=99.9
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccC--------------hhhHHH--------HHHHHHHHHhcCC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKIS--------------EQGLKE--------LKNEVILFSKLQH 150 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~--------~~~E~~~l~~l~h 150 (414)
...-|.+...||.|+||.||+|...+|+.||||+++... ...... ...|...|.++.+
T Consensus 93 rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 93 RKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 334489999999999999999998899999999875310 000111 2346666666654
Q ss_pred CceeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 043285 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 230 (414)
Q Consensus 151 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill 230 (414)
.++.-..-+.. ...++||||+++++|..+... .....++.|++.+|.|||+.+ +|||||||.|||+
T Consensus 173 ~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl 238 (397)
T 4gyi_A 173 EGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILI 238 (397)
T ss_dssp TTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred cCCCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence 44321111111 234799999999888665321 123467899999999999998 9999999999999
Q ss_pred cCCCC----------eEEEeecCccc
Q 043285 231 DQDMN----------PKISDFGLARA 246 (414)
Q Consensus 231 ~~~~~----------~kL~Dfgl~~~ 246 (414)
++++. +.|+||+-+-.
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred eCCCCcccccccccceEEEEeCCccc
Confidence 88763 89999997654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=7.1e-13 Score=121.02 Aligned_cols=144 Identities=16% Similarity=0.061 Sum_probs=112.3
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.+.|.+...++.|+++.||+... +++.+++|............+.+|+.+++.+. +.++.++++++.+.+..++||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 35688888889899999999975 47899999986522122346888999999884 67788899999988899999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS-------------------------------------- 214 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------- 214 (414)
++|.+|.+.+.. ......++.+++++++.||+..
T Consensus 92 i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999998876321 1123467889999999999821
Q ss_pred ------------------CCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 215 ------------------RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 215 ------------------~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998765667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=7.1e-12 Score=113.86 Aligned_cols=137 Identities=17% Similarity=0.132 Sum_probs=99.9
Q ss_pred CCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCc--eeeeEeEEEeCCeeeEEEeec
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~ey~ 173 (414)
.+.+....+.|..+.||+....+|..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34443333456669999998777888999997653 2245778999999886545 456888888877889999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS--------------------------------------- 214 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 214 (414)
+|.+|. ... .+. ..++.++++.+..||+..
T Consensus 98 ~G~~l~--~~~------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 98 PGQDLL--SSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SSEETT--TSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCcccC--cCc------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 998884 211 111 256677778888888643
Q ss_pred ----------------CCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 215 ----------------RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 215 ----------------~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
...++|+|++|.||++++++.+.|+||+.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.6e-10 Score=110.31 Aligned_cols=141 Identities=17% Similarity=0.224 Sum_probs=105.8
Q ss_pred CCeecccCCceEEEEEEcCCCEEEEEEec--ccC-hhhHHHHHHHHHHHHhcC--CCceeeeEeEEEeC---CeeeEEEe
Q 043285 100 NKKLGQGGFGPVYKGKLVDGQEIAVKRLS--KIS-EQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQG---EEKLLIYE 171 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e 171 (414)
.+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. ...++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 468999999999999874 5688888775 321 122356788999999997 45578888888776 34799999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS------------------------------------- 214 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------- 214 (414)
|++|..+.+... ..++......++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999987754211 12677788889999999999999731
Q ss_pred ------------------CCCeeeccCCCCCEEEcCCCC--eEEEeecCccc
Q 043285 215 ------------------RLRIIHRDLKASNVLLDQDMN--PKISDFGLARA 246 (414)
Q Consensus 215 ------------------~~~iiH~dlk~~Nill~~~~~--~kL~Dfgl~~~ 246 (414)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.03 E-value=2.2e-10 Score=106.85 Aligned_cols=182 Identities=19% Similarity=0.196 Sum_probs=119.7
Q ss_pred CCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCc--eeeeEeEEEeCC---eeeEEEeec
Q 043285 100 NKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRN--LVKLLGCCIQGE---EKLLIYEFM 173 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~ey~ 173 (414)
.+.++.|.+..||+.. ..+++|..... .....+.+|+.+++.+. +.. +.+++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3678999999999863 56888886532 34567889999998884 333 334444433333 348999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD---------------------------------------- 213 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------- 213 (414)
+|.++.+... ..++..+...++.+++..++.||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988875432 1256677778888888888888862
Q ss_pred ---------------CCCCeeeccCCCCCEEEcC--CCCeEEEeecCccccCCCCCccccccccccccc---cccccccC
Q 043285 214 ---------------SRLRIIHRDLKASNVLLDQ--DMNPKISDFGLARAFGGDETEGNTNRVVGTYGY---MAPEYASD 273 (414)
Q Consensus 214 ---------------~~~~iiH~dlk~~Nill~~--~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~ 273 (414)
....++|+|++|.||++++ +..+.|+||+.+...... .+ ......+ ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~D----l~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--ND----FISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--HH----HHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--HH----HHHHHhhccccCHHHHHH
Confidence 1235899999999999998 456889999998753210 00 0000111 22221110
Q ss_pred -----CCC---------CcchhHHHHHHHHHHHHhCCCC
Q 043285 274 -----GQF---------SVKSDVFSFGILLLEIVSGKKN 298 (414)
Q Consensus 274 -----~~~---------~~~sDvwslGvil~elltg~~p 298 (414)
+.. ....+.|++|.++|.+.+|..+
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHH
Confidence 111 1236899999999999999865
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=5.7e-07 Score=83.69 Aligned_cols=135 Identities=21% Similarity=0.165 Sum_probs=92.0
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC---ceeeeEeEEE-eCCeeeEEEeecCCC
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCI-QGEEKLLIYEFMPNK 176 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~ey~~~g 176 (414)
+.++.|....||+. |..+++|+.. .......+..|+.+++.+.+. .+.+++.++. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 56888888899987 5678888753 233456789999999999753 3556666664 344578999999998
Q ss_pred ChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 043285 177 SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD------------------------------------------- 213 (414)
Q Consensus 177 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------- 213 (414)
++.+.... .++......++.++++.|+.||+.
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88763211 123333444444444444444432
Q ss_pred --------------CCCCeeeccCCCCCEEEcC---CCC-eEEEeecCccc
Q 043285 214 --------------SRLRIIHRDLKASNVLLDQ---DMN-PKISDFGLARA 246 (414)
Q Consensus 214 --------------~~~~iiH~dlk~~Nill~~---~~~-~kL~Dfgl~~~ 246 (414)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999997 455 48999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=8.1e-07 Score=80.87 Aligned_cols=136 Identities=16% Similarity=0.151 Sum_probs=96.1
Q ss_pred CeecccCCc-eEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEEeecCCCC
Q 043285 101 KKLGQGGFG-PVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKS 177 (414)
Q Consensus 101 ~~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ey~~~g~ 177 (414)
+.+..|..| .||+.... ++..+++|+-.. .....+..|...|+.+. +-.+.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556555 58987654 466789998653 23456788999998884 3346778899999999999999999988
Q ss_pred hhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 043285 178 LDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS------------------------------------------- 214 (414)
Q Consensus 178 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------- 214 (414)
+.+...... .....+..+++..|+-||+..
T Consensus 107 ~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 876543211 112345555666666666431
Q ss_pred ------------CCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 215 ------------RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 215 ------------~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
...++|+|+.+.||++++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12279999999999999877778999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=4.5e-07 Score=86.18 Aligned_cols=79 Identities=5% Similarity=-0.016 Sum_probs=55.0
Q ss_pred Cee-cccCCceEEEEEEc-------CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCC---CceeeeEeEEEeC---
Q 043285 101 KKL-GQGGFGPVYKGKLV-------DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQH---RNLVKLLGCCIQG--- 163 (414)
Q Consensus 101 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~--- 163 (414)
+.| +.|....+|+.... ++..+++|...... ......+..|+.+++.+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88889999988764 26678898765422 0012456788888888842 3566788777655
Q ss_pred CeeeEEEeecCCCChh
Q 043285 164 EEKLLIYEFMPNKSLD 179 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~ 179 (414)
...++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=5.2e-06 Score=80.02 Aligned_cols=75 Identities=12% Similarity=0.185 Sum_probs=49.6
Q ss_pred CCeecccCCceEEEEEEc-CCCEEEEEEecccCh-------hhHHHHHHHHHHHHhcCC--Ccee-eeEeEEEeCCeeeE
Q 043285 100 NKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISE-------QGLKELKNEVILFSKLQH--RNLV-KLLGCCIQGEEKLL 168 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~~~~~~~~~~~~~l 168 (414)
.+.||.|.++.||++... ++..+++|....... .....+..|..+++.+.. +..+ +++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 368999999999999754 468899998653211 123456778888887742 4443 45543 4556789
Q ss_pred EEeecCCC
Q 043285 169 IYEFMPNK 176 (414)
Q Consensus 169 v~ey~~~g 176 (414)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.18 E-value=8.4e-06 Score=76.57 Aligned_cols=141 Identities=16% Similarity=0.215 Sum_probs=79.7
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC--CceeeeEe------EEEeCCeeeEEEee
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLG------CCIQGEEKLLIYEF 172 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~------~~~~~~~~~lv~ey 172 (414)
+.|+.|..+.||+....+| .+++|+.... . ..+..|..+++.+.. -.+.+++. +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987544 5889988752 2 234445555555531 12333332 12346678999999
Q ss_pred cCCCChh-----------H---Hhhcccc-c----------ccCCHHHH-------------------------------
Q 043285 173 MPNKSLD-----------S---FIFDQER-C----------MILDWSKR------------------------------- 196 (414)
Q Consensus 173 ~~~g~L~-----------~---~l~~~~~-~----------~~l~~~~~------------------------------- 196 (414)
++|.++. . .++.... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 0 1121100 0 00122111
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 197 FHIICGTARGLLYLHQ----------DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 197 ~~i~~~i~~~l~~LH~----------~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
..+...+..++.+|++ .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223345666653 1234599999999999998888999999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.00 E-value=2.8e-05 Score=71.33 Aligned_cols=79 Identities=16% Similarity=0.198 Sum_probs=57.2
Q ss_pred CCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC---ceeeeEeEEEeCCeeeEEEee
Q 043285 96 NFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~lv~ey 172 (414)
...-.+.+|.|..+.||+.+..+|+.|++|+...........+..|+..|+.+... .+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 44455789999999999999999999999987653333334578899999888432 234455432 34789999
Q ss_pred cCCCCh
Q 043285 173 MPNKSL 178 (414)
Q Consensus 173 ~~~g~L 178 (414)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.94 E-value=0.00011 Score=68.24 Aligned_cols=138 Identities=16% Similarity=0.128 Sum_probs=92.1
Q ss_pred CCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC---CCceeeeEeEEEeCCeeeEEEeecCCC
Q 043285 100 NKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMPNK 176 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ey~~~g 176 (414)
.+.|+.|.+..+|+... ++..+++|..... ....+..|+..|+.+. ...+.+++.++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 36799999999999976 5778899987542 3456788999988884 356788888888888899999999987
Q ss_pred ChhH-----------Hhhcccc---c----------------ccCCHHHHHH---HH----------------HHHHHHH
Q 043285 177 SLDS-----------FIFDQER---C----------------MILDWSKRFH---II----------------CGTARGL 207 (414)
Q Consensus 177 ~L~~-----------~l~~~~~---~----------------~~l~~~~~~~---i~----------------~~i~~~l 207 (414)
.+.. .|+.... . -.-+|..... +. ..+++.+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 1222111 0 0123433220 11 1112122
Q ss_pred -HHHHh-CCCCCeeeccCCCCCEEEcCCCCeEEEeec
Q 043285 208 -LYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFG 242 (414)
Q Consensus 208 -~~LH~-~~~~~iiH~dlk~~Nill~~~~~~kL~Dfg 242 (414)
..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23432 2346799999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.91 E-value=5.6e-05 Score=73.38 Aligned_cols=78 Identities=13% Similarity=0.045 Sum_probs=48.5
Q ss_pred CCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccccccc-cccccccccccccCC---CCCcchhHHHHHHHHHH
Q 043285 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV-VGTYGYMAPEYASDG---QFSVKSDVFSFGILLLE 291 (414)
Q Consensus 216 ~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~sDvwslGvil~e 291 (414)
..++|||+++.||+++.++ ++++||+.+..-.. ..+..... .-...|++|+..... .-....++......+|+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p--~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM--GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECH--HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCch--HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 4599999999999998876 99999999875310 00000000 012346666655321 11234566688888888
Q ss_pred HHhCC
Q 043285 292 IVSGK 296 (414)
Q Consensus 292 lltg~ 296 (414)
.+++.
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.64 E-value=0.0001 Score=71.70 Aligned_cols=72 Identities=19% Similarity=0.320 Sum_probs=49.5
Q ss_pred CeecccCCceEEEEEEcC--------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeeEEEe
Q 043285 101 KKLGQGGFGPVYKGKLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 171 (414)
+.|+.|....+|+....+ +..+++|+..... ....+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 578889999999998753 5789999884421 11345578888888854444 566665532 38999
Q ss_pred ecCCCCh
Q 043285 172 FMPNKSL 178 (414)
Q Consensus 172 y~~~g~L 178 (414)
|++|.++
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00019 Score=68.38 Aligned_cols=141 Identities=18% Similarity=0.266 Sum_probs=82.5
Q ss_pred CeecccCCceEEEEEEc--------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeeEEEe
Q 043285 101 KKLGQGGFGPVYKGKLV--------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 171 (414)
+.|..|-...+|+.... ++..+++|+.... ........+|..+++.+...++ .++++++.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 57878888999998764 2478999986432 2234566789999988853333 556666543 29999
Q ss_pred ecCCCChhHH-----------------hhcccc--cccCC--HHHHHHHHHHHHH-------------------HHHH--
Q 043285 172 FMPNKSLDSF-----------------IFDQER--CMILD--WSKRFHIICGTAR-------------------GLLY-- 209 (414)
Q Consensus 172 y~~~g~L~~~-----------------l~~~~~--~~~l~--~~~~~~i~~~i~~-------------------~l~~-- 209 (414)
|++|.+|..- ++.... ..... +.++.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998655321 111100 01112 3344444433321 1222
Q ss_pred --HHhC-CCCCeeeccCCCCCEEEcCC----CCeEEEeecCccc
Q 043285 210 --LHQD-SRLRIIHRDLKASNVLLDQD----MNPKISDFGLARA 246 (414)
Q Consensus 210 --LH~~-~~~~iiH~dlk~~Nill~~~----~~~kL~Dfgl~~~ 246 (414)
|... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3222 23458999999999999876 7899999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.0002 Score=66.05 Aligned_cols=138 Identities=12% Similarity=0.106 Sum_probs=76.1
Q ss_pred CCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeeEEEeec-CCCC
Q 043285 100 NKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFM-PNKS 177 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ey~-~~g~ 177 (414)
.+.|+.|....+|+. ..+++|+........ .....|+..++.+...++ .+++++ +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578999999999998 568888876422111 123467777777743333 345543 344568999999 6655
Q ss_pred hhHH------------------hhccccc--ccCCH-HHHHHHHH--------------HHHHHHH----HHHh-CCCCC
Q 043285 178 LDSF------------------IFDQERC--MILDW-SKRFHIIC--------------GTARGLL----YLHQ-DSRLR 217 (414)
Q Consensus 178 L~~~------------------l~~~~~~--~~l~~-~~~~~i~~--------------~i~~~l~----~LH~-~~~~~ 217 (414)
+... ++..... ...+. ..+..+.. .+.+.+. .+.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4321 0111000 00111 11111100 0111111 1111 22345
Q ss_pred eeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 218 IIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 218 iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
++|+|+.+.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667789999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00026 Score=69.26 Aligned_cols=73 Identities=16% Similarity=0.108 Sum_probs=47.8
Q ss_pred CeecccCCceEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeeEEEeecCCCCh
Q 043285 101 KKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMPNKSL 178 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ey~~~g~L 178 (414)
+.|+.|-...+|+....+ +..+++|+........ -....|..+++.+...++ .++++.+. + .+|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 578889999999998754 4788898875422111 112578888988875555 46676662 2 259999987554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00035 Score=64.95 Aligned_cols=143 Identities=16% Similarity=0.116 Sum_probs=78.5
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCc--eeeeEeE------EEeCCeeeEEEee
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYEF 172 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~ey 172 (414)
+.|+.|....+|+....+| .+++|...... ....+..|+.+++.+...+ +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577788899999987555 68889886521 1134556777777764222 2233311 1234567899999
Q ss_pred cCCCChhH--------------Hhhccc-c--cc---cC---CHHHHHH------------HHHHHHHHHHHHHhC----
Q 043285 173 MPNKSLDS--------------FIFDQE-R--CM---IL---DWSKRFH------------IICGTARGLLYLHQD---- 213 (414)
Q Consensus 173 ~~~g~L~~--------------~l~~~~-~--~~---~l---~~~~~~~------------i~~~i~~~l~~LH~~---- 213 (414)
++|..+.. .++... . .. .. .|...+. +...+.+.++.++..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98865421 011110 0 00 00 1211100 001134445555432
Q ss_pred CCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 214 ~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
....++|+|+.+.||+++++..+.++||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234599999999999999876668999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00086 Score=62.63 Aligned_cols=141 Identities=15% Similarity=0.090 Sum_probs=72.6
Q ss_pred CeecccCCce-EEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC--CceeeeEeEEEeCCeeeEEEeecCCCC
Q 043285 101 KKLGQGGFGP-VYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMPNKS 177 (414)
Q Consensus 101 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~ey~~~g~ 177 (414)
+.|+.|.... +|+....+|..+++|....... ..+..|+.+++.+.. -.+.+++.+.. ..-+++||++++..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 4566565544 6677654477788876543221 234456666666642 23455665532 23378999998766
Q ss_pred hhHHhhccc-----------------------ccccCCHHHHH-------H-H------------HHHHHHHHHHHH---
Q 043285 178 LDSFIFDQE-----------------------RCMILDWSKRF-------H-I------------ICGTARGLLYLH--- 211 (414)
Q Consensus 178 L~~~l~~~~-----------------------~~~~l~~~~~~-------~-i------------~~~i~~~l~~LH--- 211 (414)
+.+.+.... ....++..... . + ...+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 654432110 00112211100 0 0 001111222221
Q ss_pred hCCCCCeeeccCCCCCEEEcCC----CCeEEEeecCccc
Q 043285 212 QDSRLRIIHRDLKASNVLLDQD----MNPKISDFGLARA 246 (414)
Q Consensus 212 ~~~~~~iiH~dlk~~Nill~~~----~~~kL~Dfgl~~~ 246 (414)
......++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123469999999999999875 6799999998875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0019 Score=60.10 Aligned_cols=142 Identities=14% Similarity=0.145 Sum_probs=80.8
Q ss_pred CeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCc--eeeeEeE-----EEeCCeeeEEEeec
Q 043285 101 KKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGC-----CIQGEEKLLIYEFM 173 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv~ey~ 173 (414)
..++ |....||+....+|+.+++|...... .....+..|..+++.+.... +.+++.. ....+..+++|+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4577 88889999877677789999986321 12346667888887774222 3444432 22244567899999
Q ss_pred CCCChhH-----------H---hhccc------ccccCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 043285 174 PNKSLDS-----------F---IFDQE------RCMILDWSKR----FHI---------------ICGTARGLLYLHQ-- 212 (414)
Q Consensus 174 ~~g~L~~-----------~---l~~~~------~~~~l~~~~~----~~i---------------~~~i~~~l~~LH~-- 212 (414)
+|..+.. . ++... .....++... ..+ ...+...++.+..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8754321 0 11100 0011222111 000 0011112222221
Q ss_pred --CCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 213 --DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 213 --~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
.....++|+|+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999999 4 899999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00038 Score=66.19 Aligned_cols=73 Identities=15% Similarity=0.210 Sum_probs=44.2
Q ss_pred CeecccCCceEEEEEEcC---------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeeEEE
Q 043285 101 KKLGQGGFGPVYKGKLVD---------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 170 (414)
+.|+.|....+|+....+ +..+++|+....... ......|..+++.+...++ .++++.. . -++|+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 567888889999997644 268888887542221 1123578888887753333 4565543 2 37899
Q ss_pred eecCCCCh
Q 043285 171 EFMPNKSL 178 (414)
Q Consensus 171 ey~~~g~L 178 (414)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0021 Score=60.24 Aligned_cols=31 Identities=26% Similarity=0.349 Sum_probs=27.6
Q ss_pred CCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 216 LRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 216 ~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0086 Score=51.72 Aligned_cols=103 Identities=13% Similarity=0.069 Sum_probs=66.5
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCccc
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 255 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~ 255 (414)
-+|.++|.... .++++.++|.++.|.+.+|.-+-... .+ ..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 47889886543 35999999999999999987762211 01 1333457899999999887764 1110
Q ss_pred cccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 043285 256 TNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN 298 (414)
Q Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p 298 (414)
.....+.|||... ...+.+.-|||||+++|.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122466888653 3457889999999999999875444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0044 Score=59.85 Aligned_cols=73 Identities=19% Similarity=0.226 Sum_probs=48.2
Q ss_pred CeecccCCceEEEEEEcC--------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeeEEEe
Q 043285 101 KKLGQGGFGPVYKGKLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 171 (414)
+.+..|-...+|+....+ +..+++|+....... .-...+|..+++.+...++ .++++.+ . -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 567788899999998753 578999987543221 1223578888888753333 4555433 2 378999
Q ss_pred ecCCCCh
Q 043285 172 FMPNKSL 178 (414)
Q Consensus 172 y~~~g~L 178 (414)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.92 E-value=0.1 Score=49.91 Aligned_cols=30 Identities=23% Similarity=0.375 Sum_probs=25.4
Q ss_pred CeeeccCCCCCEEE------cCCCCeEEEeecCccc
Q 043285 217 RIIHRDLKASNVLL------DQDMNPKISDFGLARA 246 (414)
Q Consensus 217 ~iiH~dlk~~Nill------~~~~~~kL~Dfgl~~~ 246 (414)
.++|+|+.+.||++ +++..+.++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4457799999999864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.70 E-value=0.017 Score=35.85 Aligned_cols=31 Identities=23% Similarity=0.415 Sum_probs=14.2
Q ss_pred CCcceEEEEeeehHHHHHHHHH-HHHHHhhhc
Q 043285 33 EPTTKIVVIVISSAALLAVLLI-AGYLIRKRR 63 (414)
Q Consensus 33 ~~~~~i~~iv~~~~~~~~~~~~-~~~~~~~rr 63 (414)
++...|+..|++.+++++++++ +++++|+|+
T Consensus 8 s~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 8 PKIPSIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp SCSSSSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred CCcceEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 4445555555554444433333 344444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.31 E-value=0.017 Score=35.77 Aligned_cols=33 Identities=18% Similarity=0.209 Sum_probs=15.4
Q ss_pred CCCcceEEEEeeehHHHHHHHHH-HHHHHhhhcc
Q 043285 32 GEPTTKIVVIVISSAALLAVLLI-AGYLIRKRRR 64 (414)
Q Consensus 32 ~~~~~~i~~iv~~~~~~~~~~~~-~~~~~~~rr~ 64 (414)
+++...|+..|++.++++++++. .++++|+|++
T Consensus 6 ~s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 6 HARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp SCSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred CCCcceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 44555555555554444433333 3444444443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=93.24 E-value=0.015 Score=35.93 Aligned_cols=32 Identities=25% Similarity=0.505 Sum_probs=14.8
Q ss_pred CcceEEEEeeehHHHHHHHHHHHHHHhhhccc
Q 043285 34 PTTKIVVIVISSAALLAVLLIAGYLIRKRRRN 65 (414)
Q Consensus 34 ~~~~i~~iv~~~~~~~~~~~~~~~~~~~rr~~ 65 (414)
+...++.+++++.+++++++++++++|||+.+
T Consensus 10 ~~~~Ia~~vVGvll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 10 PLTSIISAVVGILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred cccchHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence 33445555555333333444445555555443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.38 E-value=1.1 Score=38.36 Aligned_cols=116 Identities=11% Similarity=0.090 Sum_probs=78.6
Q ss_pred cCCCceeeeEeEEEeCCeeeEEEeecCCC-ChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCC
Q 043285 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNK-SLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 226 (414)
Q Consensus 148 l~h~niv~~~~~~~~~~~~~lv~ey~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~ 226 (414)
..||++++. ..-.+.+.+.+.++.-+.+ ++.. + ...+...+++++.+|+....+++. -+|--|.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 368888877 4555666555555554322 2222 2 237888999999999988866654 478889999
Q ss_pred CEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 043285 227 NVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 300 (414)
Q Consensus 227 Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~ 300 (414)
|++++.++.+++.=.|+-..+ +|. ..+...=.-.+=|++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877764322 221 11222334477888999999987764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.49 E-value=1.4 Score=37.99 Aligned_cols=115 Identities=8% Similarity=0.027 Sum_probs=75.3
Q ss_pred CCCceeeeEeEEEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeeccCCCCC
Q 043285 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLL-YLHQDSRLRIIHRDLKASN 227 (414)
Q Consensus 149 ~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~iiH~dlk~~N 227 (414)
.||++ -...-.+.+.+.+.++.-+++.=...+. .++...+++++.+|+.... +++. -+|--+.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57887 3334456666666666654432222332 2788899999988887666 5543 5788899999
Q ss_pred EEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 043285 228 VLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRG 300 (414)
Q Consensus 228 ill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~ 300 (414)
++++.++.+++.-.|+-.. ++|.-+ +..-=.-.+=|++..++.++..|+
T Consensus 115 L~f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKES-------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTT-------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCccc-------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999987776432 233211 122223367788888888877653
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.19 E-value=0.11 Score=50.59 Aligned_cols=62 Identities=15% Similarity=0.186 Sum_probs=18.7
Q ss_pred CCCCeecccCCceEEEEEEcC-CCEEEE------EEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe
Q 043285 98 SINKKLGQGGFGPVYKGKLVD-GQEIAV------KRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 162 (414)
Q Consensus 98 ~~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 162 (414)
.+.+.|| ||.||+|.+.. ..+||+ |..+. ...+....+.+|..+++.++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3446676 99999998754 357888 66543 223334567889999999999999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 414 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-75 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-69 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-68 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-62 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-61 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-59 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-58 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-52 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-24 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (598), Expect = 1e-75
Identities = 71/277 (25%), Positives = 133/277 (48%), Gaps = 20/277 (7%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
++ +++G G FG VYKGK + + ++ + Q L+ KNEV + K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+G + ++ ++ SL + E + K I TA+G+ YLH S
Sbjct: 68 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA--- 271
IIHRDLK++N+ L +D+ KI DFGLA ++ G+ +MAPE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331
+S +SDV++FGI+L E+++G+ + + +N +I + + S++ +C
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+ + C+++ ++RP P ++ +
Sbjct: 240 KA---------MKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 3e-70
Identities = 81/274 (29%), Positives = 128/274 (46%), Gaps = 22/274 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ ++LG G FG V+ G ++AVK L + E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+L Q E +I E+M N SL F+ + L +K + A G+ ++ + +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
IHRDL+A+N+L+ ++ KI+DFGLAR +E + APE + G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 275 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334
F++KSDV+SFGILL EIV+ + Y N +I + G D+C ++
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVI----QNLERGYRMVRPDNCPEE- 238
Query: 335 FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+ LC ++ PEDRP+ + +L
Sbjct: 239 --------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 1e-69
Identities = 67/275 (24%), Positives = 124/275 (45%), Gaps = 24/275 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ + +++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+L G C++ L++EFM + L + + + + + G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
+IHRDL A N L+ ++ K+SDFG+ R D+ ++ + +PE S
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 275 QFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333
++S KSDV+SFG+L+ E+ S GK + + I ++L+ + S
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST-------- 229
Query: 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
I C ++ PEDRP+ ++ L
Sbjct: 230 --------HVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-68
Identities = 74/288 (25%), Positives = 129/288 (44%), Gaps = 23/288 (7%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ + KLGQG FG V+ G +A+K L + E + KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+L + E ++ E+M SL F+ + + + + A G+ Y+ +
Sbjct: 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER-- 131
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
+ +HRDL+A+N+L+ +++ K++DFGLAR +E + APE A G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 275 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334
+F++KSDV+SFGILL E+ + + Y N ++ + + P + +S
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGYRMPCPPECPES----- 242
Query: 335 FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLPQPK-QPG 381
+ C ++ PE+RP+ + L +P+ QPG
Sbjct: 243 --------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (536), Expect = 5e-66
Identities = 71/302 (23%), Positives = 127/302 (42%), Gaps = 46/302 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGKL------VDGQEIAVKRLSK-ISEQGLKELKNEVILFSK 147
NN + +G+G FG V++ + +AVK L + S + + E L ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMI----------------- 190
+ N+VKLLG C G+ L++E+M L+ F+ +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 191 ----LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246
L +++ I A G+ YL + + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 247 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306
+ +M PE +++ +SDV+++G++L EI S Y+
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMA 247
Query: 307 NLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366
+ +I +G ++C + ++ LC + P DRPS S+
Sbjct: 248 HEEVI----YYVRDGNILACPENC---------PLELYNLMRLCWSKLPADRPSFCSIHR 294
Query: 367 ML 368
+L
Sbjct: 295 IL 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 9e-66
Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 22/274 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ + K+LG G FG V GK ++A+K + + E E + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+L G C + +I E+M N L +++ + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
+ +HRDL A N L++ K+SDFGL+R DE + + PE
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176
Query: 275 QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334
+FS KSD+++FG+L+ EI S K ++ + ++ I +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221
Query: 335 FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+ I C + ++RP+ ++ +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 3e-65
Identities = 64/292 (21%), Positives = 120/292 (41%), Gaps = 28/292 (9%)
Query: 99 INKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 158
+ + +G+G FG V++GK G+E+AVK S E+ + E+ L+H N++ +
Sbjct: 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIA 64
Query: 159 CCIQGEEKL----LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD- 213
+ L+ ++ + SL ++ + + TA GL +LH +
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEI 120
Query: 214 ----SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTNRVVGTYGYMA 267
+ I HRDLK+ N+L+ ++ I+D GLA D + N VGT YMA
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 268 PEYASD------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN----NLNLIGHAWKL 317
PE D + ++D+++ G++ EI G + +L + +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIH-IGLLCVQQHPEDRPSMPSVILML 368
+ + Q + + + E +R + I C + R + + L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (528), Expect = 7e-65
Identities = 73/301 (24%), Positives = 128/301 (42%), Gaps = 37/301 (12%)
Query: 85 FELATIVSATNNFS---------INKKLGQGGFGPVYKGKLV----DGQEIAVKRLSK-I 130
F A F+ I + +G G FG V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 131 SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMI 190
+E+ ++ +E + + H N++ L G + ++I EFM N SLDSF+ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 191 LDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250
+ ++ G A G+ YL + +HRDL A N+L++ ++ K+SDFGL+R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 251 ETEGNTNRVVG---TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN 307
++ +G + APE +F+ SDV+S+GI++ E++S + Y N
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMTN 239
Query: 308 LNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367
++I I+ ++ + + L C Q+ RP ++
Sbjct: 240 QDVI-------------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 368 L 368
L
Sbjct: 287 L 287
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 9e-65
Identities = 71/275 (25%), Positives = 113/275 (41%), Gaps = 28/275 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ + +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 155 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
+LLG ++ + L ++ E+M SL ++ + R +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 273
+HRDL A NVL+ +D K+SDFGL + + G + APE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174
Query: 274 GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333
+FS KSDV+SFGILL EI S + Y +++ +G D C
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVV----PRVEKGYKMDAPDGCPPA 228
Query: 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+ C RPS + L
Sbjct: 229 ---------VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (525), Expect = 1e-64
Identities = 71/275 (25%), Positives = 124/275 (45%), Gaps = 22/275 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 153
+ ++ KLG G +G VY+G +AVK L + ++E E + +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
V+LLG C + +I EFM +L ++ + R + ++ + + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE-- 132
Query: 214 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASD 273
+ IHRDL A N L+ ++ K++DFGL+R GD + + APE +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190
Query: 274 GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333
+FS+KSDV++FG+LL EI + + Y + + ++L + + + C +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQV----YELLEKDYRMERPEGCPEK 244
Query: 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+ C Q +P DRPS +
Sbjct: 245 ---------VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-64
Identities = 74/305 (24%), Positives = 134/305 (43%), Gaps = 31/305 (10%)
Query: 74 QIQNIDLELPLFELATIVSATNNFSIN--KKLGQGGFGPVYKGKLVD----GQEIAVKRL 127
+ ++ EL + + +V ++ ++ + +G+G FG VY G L+D AVK L
Sbjct: 5 DLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63
Query: 128 SKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEK-LLIYEFMPNKSLDSFIFDQ 185
++I++ G + + E I+ H N++ LLG C++ E L++ +M + L +FI ++
Sbjct: 64 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123
Query: 186 ERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245
+ F + + + + +HRDL A N +LD+ K++DFGLAR
Sbjct: 124 THNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 246 AFGGDETEGNTNR--VVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYH 303
E + N+ +MA E +F+ KSDV+SFG+LL E+++ Y
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYP 236
Query: 304 SDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPS 363
N ++ + + P D + L C E RPS
Sbjct: 237 DVNTFDITVYLLQGRRLLQPEYCPDP-------------LYEVMLKCWHPKAEMRPSFSE 283
Query: 364 VILML 368
++ +
Sbjct: 284 LVSRI 288
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-64
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 11/206 (5%)
Query: 93 ATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQH 150
++F +LG G G V+K G +A K + I ++ E+ + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
+V G E + E M SLD + R + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
+ +I+HRD+K SN+L++ K+ DFG++ + N VGT YM+PE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSGK 296
+SV+SD++S G+ L+E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 7e-64
Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 27/282 (9%)
Query: 93 ATNNFSI-NKKLGQGGFGPVYKGKLV---DGQEIAVKRLSKISEQG-LKELKNEVILFSK 147
+N I + +LG G FG V +G ++A+K L + +E+ +E+ E + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
L + +V+L+G C Q E +L+ E L F+ + + S ++ + G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TNRVVGTYGYM 266
YL + +HRDL A NVLL KISDFGL++A G D++ + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326
APE + +FS +SDV+S+G+ + E +S + Y ++ +G +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVM----AFIEQGKRMEC 233
Query: 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
C + + C EDRP +V +
Sbjct: 234 PPECPPE---------LYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-63
Identities = 77/305 (25%), Positives = 117/305 (38%), Gaps = 45/305 (14%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVD------GQEIAVKRLSKISEQG-LKELKNEVILFSK 147
N K LG G FG V ++AVK L + ++ + L +E+ + ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 148 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ--------------------E 186
L H N+V LLG C LI+E+ L +++ + E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 187 RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246
+L + A+G+ +L +HRDL A NVL+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 247 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDN 306
D +MAPE +G +++KSDV+S+GILL EI S +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272
Query: 307 NLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366
+ N +KL G ++ I C RPS P++
Sbjct: 273 DANF----YKLIQNGFKMDQPFYATEE---------IYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 367 MLGSE 371
LG +
Sbjct: 320 FLGCQ 324
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 9e-63
Identities = 68/273 (24%), Positives = 118/273 (43%), Gaps = 23/273 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRN 152
++ + + LG+G +G V V + +AVK + + + +K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
+VK G +G + L E+ L I + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 272
+ I HRD+K N+LLD+ N KISDFGLA F + E N++ GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 273 DGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331
+F + DV+S GI+L +++G+ + ++ + P + IDS
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236
Query: 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSV 364
++ + ++P R ++P +
Sbjct: 237 LA------LLHK------ILVENPSARITIPDI 257
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-62
Identities = 72/275 (26%), Positives = 113/275 (41%), Gaps = 28/275 (10%)
Query: 100 NKKLGQGGFGPVYKGKLVD---GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLV 154
+K+LG G FG V KG + +AVK L EL E + +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
+++G C + E +L+ E L+ ++ + ++ + G+ YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES- 126
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTN-RVVGTYGYMAPEYASD 273
+HRDL A NVLL KISDFGL++A DE + APE +
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 274 GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333
+FS KSDV+SFG+L+ E S + Y + + +G C ++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVT----AMLEKGERMGCPAGCPRE 238
Query: 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+ LC E+RP +V L L
Sbjct: 239 ---------MYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-62
Identities = 75/297 (25%), Positives = 112/297 (37%), Gaps = 40/297 (13%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKISEQG-LKELKNEVILFSK 147
N S K LG G FG V + +AVK L + + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 148 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMI---------------L 191
L H N+V LLG C G L+I E+ L +F+ + I L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 192 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251
D A+G+ +L IHRDL A N+LL KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLI 311
+MAPE + ++ +SDV+S+GI L E+ S + ++
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255
Query: 312 GHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+K+ EG + + I C P RP+ ++ ++
Sbjct: 256 -KFYKMIKEGFRMLSPEHAPAE---------MYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-62
Identities = 72/282 (25%), Positives = 117/282 (41%), Gaps = 26/282 (9%)
Query: 92 SATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKL 148
S ++ + +G G +G K + DG+ + K L ++E + L +EV L +L
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 149 QHRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQER-CMILDWSKRFHIICGTAR 205
+H N+V+ I L + E+ L S I + LD ++
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 206 GLLYLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTY 263
L H+ D ++HRDLK +NV LD N K+ DFGLAR D + VGT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTP 178
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323
YM+PE + ++ KSD++S G LL E+ + + + + L EG
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELA----GKIREGKF 231
Query: 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365
++ S L E+I + RPS+ ++
Sbjct: 232 RRIPYRY---SDELNEIITR------MLNLKDYHRPSVEEIL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-62
Identities = 78/320 (24%), Positives = 128/320 (40%), Gaps = 43/320 (13%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDG---QEIAVKRLSKI-SEQGLKELKNEVILFSKL-Q 149
N+ +G+G FG V K ++ + A+KR+ + S+ ++ E+ + KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-------------FDQERCMILDWSKR 196
H N++ LLG C L E+ P+ +L F+ L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 197 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 256
H ARG+ YL Q + IHRDL A N+L+ ++ KI+DFGL+R E
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 257 NRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWK 316
+MA E + ++ SDV+S+G+LL EIVS Y L +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQ 241
Query: 317 LWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLPQ 376
+ P D + C ++ P +RPS +++ L +L +
Sbjct: 242 GYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSL--NRMLEE 286
Query: 377 PKQPGYLADRKSTRRDYSSI 396
K Y+ + Y+ I
Sbjct: 287 RKT--YVNTTLYEKFTYAGI 304
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 4e-62
Identities = 73/298 (24%), Positives = 136/298 (45%), Gaps = 29/298 (9%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 148
+ + K +G G FG VYKG L +A+K L +E+ + E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 149 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLL 208
H N+++L G + + ++I E+M N +LD F+ +++ + ++ G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 124
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-NRVVGTYGYMA 267
YL + +HRDL A N+L++ ++ K+SDFGL+R D T + + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 268 PEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327
PE S +F+ SDV+SFGI++ E+++ + + S++ + + I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MKAI 226
Query: 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLPQPKQPGYLAD 385
+ F+ + + + C QQ RP ++ +L + ++ P LAD
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL--DKLIRAPDSLKTLAD 282
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-61
Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 33/302 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSK 147
+++++LGQG FG VY+G +A+K +++ S + E NE + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMI-------LDWSKRFHII 200
++V+LLG QG+ L+I E M L S++ M SK +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 201 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVV 260
A G+ YL+ + + +HRDL A N ++ +D KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 261 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE 320
+M+PE DG F+ SDV+SFG++L EI + + Y +N + + E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQV----LRFVME 250
Query: 321 GMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLPQPKQP 380
G D+C + +C Q +P+ RPS +I + E + P ++
Sbjct: 251 GGLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIISSI-KEEMEPGFREV 300
Query: 381 GY 382
+
Sbjct: 301 SF 302
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (507), Expect = 1e-61
Identities = 70/272 (25%), Positives = 122/272 (44%), Gaps = 34/272 (12%)
Query: 97 FSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRN 152
FS +++G G FG VY + + + + +A+K++S S + +++ EV KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
++ GC ++ L+ E+ + D ++ L + + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHS 133
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA- 271
+IHRD+KA N+LL + K+ DFG A N VGT +MAPE
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184
Query: 272 --SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329
+GQ+ K DV+S GI +E+ + + N ++ + + + P+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAER---KPPLFNMNAMSAL---YHIAQNESPALQSGH 238
Query: 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361
S + C+Q+ P+DRP+
Sbjct: 239 W---SEYFRNFVDS------CLQKIPQDRPTS 261
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-61
Identities = 72/277 (25%), Positives = 129/277 (46%), Gaps = 27/277 (9%)
Query: 91 VSATNNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ 149
++ + + I +LG G FG VYK + + A K + SE+ L++ E+ + +
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209
H N+VKLL ++ EF ++D+ + + ER L S+ + T L Y
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNY 125
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 269
LH +IIHRDLKA N+L D + K++DFG++ ++ +GT +MAPE
Sbjct: 126 LHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPE 180
Query: 270 YA-----SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324
D + K+DV+S GI L+E+ + +H N + ++ K+ P+
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVL---LKIAKSEPPT 234
Query: 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361
S + S N + ++ C++++ + R +
Sbjct: 235 LAQPSRW--SSNFKDFLKK------CLEKNVDARWTT 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 8e-61
Identities = 75/282 (26%), Positives = 116/282 (41%), Gaps = 28/282 (9%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSK 147
+ + +KLG G FG V +G+ +AVK L + + + EV
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
L HRNL++L G + K+ + E P SL + + +L R+ + A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGM 124
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-NTNRVVGTYGYM 266
YL R IHRDL A N+LL KI DFGL RA ++ + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 267 APEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326
APE FS SD + FG+ L E+ + + + N ++ K+ EG
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQIL---HKIDKEGERLPR 236
Query: 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+ C QD ++ + C PEDRP+ ++ L
Sbjct: 237 PEDCPQD---------IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 1e-60
Identities = 61/277 (22%), Positives = 117/277 (42%), Gaps = 31/277 (11%)
Query: 97 FSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 153
+ ++G+G F VYKG + E+A L +++ + K E + LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 154 VKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209
V+ + +L+ E M + +L +++ + + +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQF 127
Query: 210 LHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAP 268
LH + IIHRDLK N+ + + KI D GLA V+GT +MAP
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182
Query: 269 EYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328
E + ++ DV++FG+ +LE+ + + + N + ++ G+ D
Sbjct: 183 EMY-EEKYDESVDVYAFGMCMLEMATSE--YPYSECQNAAQI----YRRVTSGVKPASFD 235
Query: 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365
+ E+I C++Q+ ++R S+ ++
Sbjct: 236 KVA--IPEVKEIIEG------CIRQNKDERYSIKDLL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-60
Identities = 75/322 (23%), Positives = 130/322 (40%), Gaps = 31/322 (9%)
Query: 97 FSINKKLGQGGFGPVYKGKLVDGQE-----IAVKRLSKI-SEQGLKELKNEVILFSKLQH 150
F K LG G FG VYKG + E +A+K L + S + KE+ +E + + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
++ +LLG C+ LI + MP L ++ + + + + A+G+ YL
Sbjct: 71 PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYL 127
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
R++HRDL A NVL+ + KI+DFGLA+ G +E E + +MA E
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330
++ +SDV+S+G+ + E+++ Y + + +G C
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEIS----SILEKGERLPQPPIC 238
Query: 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLPQPKQPGYLADRKSTR 390
D I + C + RP +I+ PQ YL + R
Sbjct: 239 TID---------VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR----YLVIQGDER 285
Query: 391 RDYSSIMPESCSTNTITVSGLE 412
S + + ++
Sbjct: 286 MHLPSPTDSNFYRALMDEEDMD 307
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-60
Identities = 67/282 (23%), Positives = 133/282 (47%), Gaps = 27/282 (9%)
Query: 84 LFELATIVSA---TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELK 139
L +L +IVS ++ +K+GQG G VY + GQE+A+++++ + + +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 140 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHI 199
NE+++ + ++ N+V L + G+E ++ E++ SL + + D + +
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAV 121
Query: 200 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRV 259
+ L +LH ++IHRD+K+ N+LL D + K++DFG +++ + +
Sbjct: 122 CRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTM 176
Query: 260 VGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN 319
VGT +MAPE + + K D++S GI+ +E++ G+ Y ++N L + + +
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL---YLIAT 230
Query: 320 EGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361
G P S + + C+ E R S
Sbjct: 231 NGTPELQNPEKL--SAIFRDFLNR------CLDMDVEKRGSA 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-59
Identities = 66/275 (24%), Positives = 105/275 (38%), Gaps = 31/275 (11%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 150
+F I + LG+G FG VY + +A+K L K +L+ EV + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
N+++L G LI E+ P ++ + + D + I A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330
K D++S G+L E + GK I + + + D
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-- 233
Query: 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365
+I ++ +P RP + V+
Sbjct: 234 ---------LISR------LLKHNPSQRPMLREVL 253
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (487), Expect = 1e-58
Identities = 73/298 (24%), Positives = 114/298 (38%), Gaps = 39/298 (13%)
Query: 95 NNFSINKKLGQGGFGPVYKG------KLVDGQEIAVKRLSKISEQGLKE--LKNEVILFS 146
+ + K LG+G FG V + K + +AVK L + + + IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 147 KLQHRNLVKLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQERCMI-------------LD 192
H N+V LLG C + L++ EF +L +++ + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 193 WSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252
A+G+ +L + IHRDL A N+LL + KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 253 EGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIG 312
+MAPE D ++++SDV+SFG+LL EI S + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDE 244
Query: 313 HAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370
+ EG + D + L C P RP+ ++ LG+
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-56
Identities = 77/297 (25%), Positives = 123/297 (41%), Gaps = 41/297 (13%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV--------DGQEIAVKRLSK-ISEQGLKELKNEVILF 145
+ + K LG+G FG V + + ++AVK L +E+ L +L +E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 146 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMI-------------L 191
+ +H+N++ LLG C Q +I E+ +L ++ + + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 192 DWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251
ARG+ YL + IHRDL A NVL+ +D KI+DFGLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLI 311
T +MAPE D ++ +SDV+SFG+LL EI + + Y L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEEL- 246
Query: 312 GHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+KL EG +C + + C P RP+ ++ L
Sbjct: 247 ---FKLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-56
Identities = 66/289 (22%), Positives = 115/289 (39%), Gaps = 29/289 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVD----GQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 149
+ + +G+G FG V++G + +A+K + ++E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209
H ++VKL+G + +I E L SF+ R LD + + L Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAY 123
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 269
L R +HRD+ A NVL+ + K+ DFGL+R + D T ++ +MAPE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPE 179
Query: 270 YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329
+ +F+ SDV+ FG+ + EI+ +N++ G + +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPPN 233
Query: 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETVLPQPK 378
C ++L C P RP + L T+L + K
Sbjct: 234 CPPTLYSLM---------TKCWAYDPSRRPRFTELKAQL--STILEEEK 271
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 186 bits (472), Expect = 6e-56
Identities = 63/315 (20%), Positives = 118/315 (37%), Gaps = 32/315 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 153
+++ I+++LG G FG V++ G A K + E + ++ E+ S L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
V L E ++IYEFM L + D+ + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 214 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
+H DLK N++ + K+ DFGL ++ GT + APE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 197
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331
+D++S G+L ++SG + +N+ + K + M
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLS---PFGGENDDETL-RNVKSCDWNMDDSAFSGI- 252
Query: 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSV--------ILMLGSETVLPQPKQPGYL 383
S + + IR + P R ++ G ++ +P +
Sbjct: 253 --SEDGKDFIRK------LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 304
Query: 384 ADRKSTRRDYSSIMP 398
K+ + +P
Sbjct: 305 DSIKTKYDAWPEPLP 319
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-54
Identities = 65/272 (23%), Positives = 105/272 (38%), Gaps = 31/272 (11%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHR 151
+F K LG+G F V + L +E A+K L K I E + + E + S+L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
VKL E+ + N L +I D + L YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH 125
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
IIHRDLK N+LL++DM+ +I+DFG A+ + + N VGT Y++PE
Sbjct: 126 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN--LNLIGHAWKLWNEGMPSQLIDS 329
++ SD+++ G ++ ++V+G F + I + E + D
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL--PPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD- 239
Query: 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361
++ + R
Sbjct: 240 ----------LVEK------LLVLDATKRLGC 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 175 bits (445), Expect = 6e-52
Identities = 57/270 (21%), Positives = 106/270 (39%), Gaps = 24/270 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 153
+ + I ++LG G FG V++ G+ K ++ +KNE+ + ++L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
+ L E +LI EF+ L I + ++ + + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 214 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
I+H D+K N++ + KI DFGLA DE T + APE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331
+D+++ G+L ++SG + +++L + K + S
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS---PFAGEDDLETL-QNVKRCDWEFDEDAFSSV- 255
Query: 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361
S + I+ +Q+ P R ++
Sbjct: 256 --SPEAKDFIKN------LLQKEPRKRLTV 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (430), Expect = 1e-49
Identities = 70/276 (25%), Positives = 117/276 (42%), Gaps = 28/276 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSK---ISEQGLKELKNEVI---LFSK 147
N+FS+++ +G+GGFG VY + D G+ A+K L K +QG NE I L S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
+V + ++ I + M L + + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGL 120
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
++H +++RDLK +N+LLD+ + +ISD GLA F + + VGT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 268 PEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ- 325
PE G + +D FS G +L +++ G H + + I +P
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 326 ------LIDSCFQDSFNLAEVIRCIHIGLLCVQQHP 355
L++ Q ++ + C+ G V++ P
Sbjct: 233 SPELRSLLEGLLQ--RDVNRRLGCLGRGAQEVKESP 266
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 168 bits (426), Expect = 1e-49
Identities = 66/270 (24%), Positives = 120/270 (44%), Gaps = 24/270 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 150
+F I + LG G FG V+ + +G+ A+K L K + + ++ +E ++ S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
++++ G ++ +I +++ L S + +R +C L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
II+RDLK N+LLD++ + KI+DFG A+ + GT Y+APE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN--LNLIGHAWKLWNEGMPSQ--- 325
S ++ D +SFGIL+ E+++G FY S+ I +A +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
Query: 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHP 355
L+ +L++ + + G V+ HP
Sbjct: 231 LLSRLIT--RDLSQRLGNLQNGTEDVKNHP 258
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 2e-49
Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 30/277 (10%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK---ISEQGLKELKNEV-ILFSKLQ 149
+F ++K LG+G FG V+ + Q A+K L K + + ++ E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 150 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLY 209
H L + E + E++ L I + D S+ GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 210 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 269
LH I++RDLK N+LLD+D + KI+DFG+ + + + NT GT Y+APE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 270 YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329
+++ D +SFG+LL E++ G+ +H + L H+ ++ N P L
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEEELF-HSIRMDNPFYPRWL--- 226
Query: 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366
+++ + PE R + I
Sbjct: 227 ----EKEAKDLLVK------LFVREPEKRLGVRGDIR 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (419), Expect = 6e-49
Identities = 59/282 (20%), Positives = 119/282 (42%), Gaps = 28/282 (9%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ 149
++ + + + LG GG V+ + L +++AVK L + E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 150 HRNLVKLLGCCI----QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTAR 205
H +V + G ++ E++ +L + + + + +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-NTNRVVGTYG 264
L + H + IIHRD+K +N+++ K+ DFG+ARA T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324
Y++PE A +SDV+S G +L E+++G+ + D+ +++ + + PS
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVA-YQHVREDPIPPS 235
Query: 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366
+ S +L V+ + ++PE+R + +
Sbjct: 236 ARHEGL---SADLDAVVLK------ALAKNPENRYQTAAEMR 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-47
Identities = 52/269 (19%), Positives = 103/269 (38%), Gaps = 25/269 (9%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+ I + LG+G FG V++ + K + K+ +K E+ + + +HRN++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNIL 64
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
L EE ++I+EF+ + I L+ + + L +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS-- 120
Query: 215 RLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYAS 272
I H D++ N++ + KI +FG AR + N + Y APE
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176
Query: 273 DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332
S +D++S G L+ ++SG + + I +A ++E ++
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI------ 230
Query: 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361
S + + + + + R +
Sbjct: 231 -SIEAMDFVDR------LLVKERKSRMTA 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 3e-47
Identities = 62/296 (20%), Positives = 119/296 (40%), Gaps = 31/296 (10%)
Query: 89 TIVSATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG-LKELKNEVILFS 146
+ ++ +G+G +G V V+ +A+K++S Q + E+ +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 147 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARG 206
+ +H N++ + + + ++ + + ++ + L + + RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 207 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-NRVVGTYGY 265
L Y+H ++HRDLK SN+LL+ + KI DFGLAR D V T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 266 MAPEYASDGQFSVKS-DVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324
APE + + KS D++S G +L E++S + + + L+ + H + G PS
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYLDQLNHILGI--LGSPS 233
Query: 325 QLIDSCFQDSFNLAEVIRCIH-----------------IGLL--CVQQHPEDRPSM 361
Q +C + ++ H + LL + +P R +
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 3e-47
Identities = 49/283 (17%), Positives = 93/283 (32%), Gaps = 25/283 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 153
N + + +K+G G FG +Y G + G+E+A+K ++ +L E ++ +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
+ + C + ++ + SL+ R + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120
Query: 214 SRLRIIHRDLKASNVL---LDQDMNPKISDFGLARAFGGDETEGN-----TNRVVGTYGY 265
IHRD+K N L + I DFGLA+ + T + + GT Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325
+ + S + D+ S G +L+ G + +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
L A + C +D+P + +
Sbjct: 240 LCKGY---PSEFATYLNF------CRSLRFDDKPDYSYLRQLF 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 5e-47
Identities = 56/270 (20%), Positives = 103/270 (38%), Gaps = 21/270 (7%)
Query: 94 TNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQG-LKELKNEVILFSKLQHR 151
+ + LG G F V + + +A+K ++K + +G ++NE+ + K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
N+V L G LI + + L I ++ +I + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
+ + LD+D ISDFGL++ + GT GY+APE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331
+ +S D +S G++ ++ G ++ +N+ L S D
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLF-EQILKAEYEFDSPYWDDI- 236
Query: 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361
S + + IR +++ PE R +
Sbjct: 237 --SDSAKDFIRH------LMEKDPEKRFTC 258
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (398), Expect = 6e-46
Identities = 58/283 (20%), Positives = 110/283 (38%), Gaps = 39/283 (13%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK---------ISEQGLKELKNEVILF 145
N+ + LG+G V + +E AVK + ++ + EV +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 146 SKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTA 204
K+ H N+++L L+++ M L ++ ++ L + I+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALL 120
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
+ LH +L I+HRDLK N+LLD DMN K++DFG + E V GT
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPS 174
Query: 265 YMAPEYASDGQ------FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW 318
Y+APE + + D++S G+++ +++G + + ++
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMS-G 230
Query: 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361
N S D S + +++ + P+ R +
Sbjct: 231 NYQFGSPEWDDY---SDTVKDLVSR------FLVVQPQKRYTA 264
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 157 bits (398), Expect = 8e-46
Identities = 39/285 (13%), Positives = 103/285 (36%), Gaps = 27/285 (9%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 153
++ + +++G+G FG +++G L++ Q++A+K + S+ +L++E + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 154 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD 213
+ + Q ++ + SL+ + R + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHE- 119
Query: 214 SRLRIIHRDLKASNVLLDQDMNP-----KISDFGLARAFGGDETEGN-----TNRVVGTY 263
+++RD+K N L+ + + + DFG+ + + T+ + + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323
YM+ + S + D+ + G + + + G + N ++ +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---ERIGEKKQS 234
Query: 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILML 368
+ L + C + + + P + +
Sbjct: 235 TPLRELCAGFPEEFYKYMHY------ARNLAFDATPDYDYLQGLF 273
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-44
Identities = 70/282 (24%), Positives = 114/282 (40%), Gaps = 23/282 (8%)
Query: 96 NFSINKKLGQGGFGPVYKGK-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 152
NF +K+G+G +G VYK + + G+ +A+K RL +E E+ L +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
+VKLL + L++EF+ D + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YA 271
R++HRDLK N+L++ + K++DFGLARAFG V T Y APE
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE-------GMPS 324
+S D++S G + E+V+ + + L I +E MP
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 325 QLIDSCFQDSFNLAEVIRCIHIGLL-----CVQQHPEDRPSM 361
+ ++V+ + + P R S
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-44
Identities = 60/292 (20%), Positives = 113/292 (38%), Gaps = 32/292 (10%)
Query: 93 ATNNFSINKKLGQGGFGPVYKGKLV--DGQEIAVKRLSK--ISEQGLKELKNEVILFSKL 148
A + ++G+G +G V+K + + G+ +A+KR+ E EV + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 149 ---QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS---FIFDQERCMILDWSKRFHIICG 202
+H N+V+L C + + +D D+ + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 203 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGT 262
RGL +LH R++HRDLK N+L+ K++DFGLAR + + VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 263 YGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL----- 317
Y APE ++ D++S G + E+ K + ++++ +G +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPG 235
Query: 318 ---WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLL-----CVQQHPEDRPSM 361
W + + + + + + I C+ +P R S
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 152 bits (384), Expect = 9e-44
Identities = 62/282 (21%), Positives = 112/282 (39%), Gaps = 23/282 (8%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 152
+ +K+G+G +G VYK + G+ A+K RL K E E+ + +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 153 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
+VKL + +L++E + + L+ + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 213 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE-YA 271
R++HRDLK N+L++++ KI+DFGLARAF + T Y AP+
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLM 173
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG-------MPS 324
++S D++S G + E+V+G + L I N +P
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 325 QLIDSCFQDSFNLAEVIRCIHIGLL-----CVQQHPEDRPSM 361
+ + ++ + + ++ P R +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-43
Identities = 59/278 (21%), Positives = 109/278 (39%), Gaps = 33/278 (11%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKIS------EQGLKELKNEVILFSK 147
+ + ++LG G F V K + G + A K + K ++++ EV + +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
+QH N++ L + +LI E + L F+ ++E + + G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT---EEEATEFLKQILNGV 126
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAFGGDETEGNTNRVVGTY 263
YLH L+I H DLK N++L P KI DFGLA + GT
Sbjct: 127 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 264 GYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323
++APE + +++D++S G++ ++SG L + + +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361
S S + IR + + P+ R ++
Sbjct: 241 SNT-------SALAKDFIRR------LLVKDPKKRMTI 265
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-43
Identities = 68/282 (24%), Positives = 117/282 (41%), Gaps = 32/282 (11%)
Query: 101 KKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKE-----LKNEVILFSKLQHRNLV 154
LG+G F VYK + Q +A+K++ K+ E+ L +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 155 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS 214
LL L+++FM ++ ++L S + T +GL YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDG 274
I+HRDLK +N+LLD++ K++DFGLA++FG V T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGA 175
Query: 275 Q-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333
+ + V D+++ G +L E++ F D++L+ + ++ Q D C
Sbjct: 176 RMYGVGVDMWAVGCILAELLLR---VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 334 SFNLAEVIRCIHIGLL--------------CVQQHPEDRPSM 361
+ + I + + +P R +
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-42
Identities = 54/268 (20%), Positives = 100/268 (37%), Gaps = 17/268 (6%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 150
N+F K LG+G FG V + G+ A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
L L + + E+ L + R + + A + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
+++RD+K N++LD+D + KI+DFGL + D GT Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 176
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ---LI 327
D + D + G+++ E++ G+ + LI + + + L+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 236
Query: 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHP 355
+ + + + V +H
Sbjct: 237 AGLLK--KDPKQRLGGGPSDAKEVMEHR 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-42
Identities = 62/282 (21%), Positives = 104/282 (36%), Gaps = 43/282 (15%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKN------EVILFSK 147
+ + + LG GGFG VY G + D +A+K + K EL N EV+L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 148 LQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTAR 205
+ +++LL + + +LI E + L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLE 121
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
+ + H ++HRD+K N+L+D + K+ DFG + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174
Query: 265 YMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323
Y PE+ ++ + V+S GILL ++V G F H + I + + +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEE----IIRGQVFFRQRVS 228
Query: 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365
S+ +IR C+ P DRP+ +
Sbjct: 229 SECQH-----------LIRW------CLALRPSDRPTFEEIQ 253
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-42
Identities = 62/289 (21%), Positives = 109/289 (37%), Gaps = 35/289 (12%)
Query: 96 NFSINKKLGQGGFGPVYKGKLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 154
+++ K +G G FG VY+ KL D G+ +A+K++ + E+ + KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76
Query: 155 KLLGCCIQGEEK------LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLL 208
+L EK L+ +++P L + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 209 YLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTNRVVGTYGYMA 267
Y+H I HRD+K N+LLD D K+ DFG A+ E N + + Y
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAP 191
Query: 268 PEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL---------- 317
++ DV+S G +L E++ G+ + D+ ++ + K+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 318 -----WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361
+ E Q+ + F I + ++ P R +
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-41
Identities = 57/299 (19%), Positives = 112/299 (37%), Gaps = 41/299 (13%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 151
+ + K+GQG FG V+K + GQ++A+K++ E E+ + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 152 NLVKLLGCCIQGEEK--------LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGT 203
N+V L+ C L+++F + + + + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 204 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR--VVG 261
L L+ R +I+HRD+KA+NVL+ +D K++DFGLARAF + V
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 262 TYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNE 320
T Y PE + + D++ G ++ E+ + + + + +L
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP---IMQGNTEQHQLALISQLCGS 240
Query: 321 GMPSQLIDSCFQDSFNLAEVIRCIHIGLL------------------CVQQHPEDRPSM 361
P + + + E+++ + + P R
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-40
Identities = 56/285 (19%), Positives = 114/285 (40%), Gaps = 27/285 (9%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 151
+ +K+G+G +G V+K K + +A+KR+ E E+ L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 152 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLH 211
N+V+L ++ L++EF F + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH 118
Query: 212 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYA 271
++HRDLK N+L++++ K+++FGLARAFG + VV +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLF 174
Query: 272 SDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN----------EG 321
+S D++S G + E+ + R + ++ + + ++L
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAG--RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLL-----CVQQHPEDRPSM 361
+P + + +L V+ ++ ++ +P R S
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-40
Identities = 51/272 (18%), Positives = 102/272 (37%), Gaps = 30/272 (11%)
Query: 99 INKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNLVKL 156
++ LG G G V + ++ A+K L + + EV + + Q ++V++
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 70
Query: 157 LGCCIQGEEK----LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ 212
+ L++ E + L S I D+ + I+ + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS 129
Query: 213 DSRLRIIHRDLKASNVLLDQDMNP---KISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 269
+ I HRD+K N+L K++DFG A+ + T Y+APE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPE 183
Query: 270 YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329
++ D++S G+++ ++ G ++S++ L + G
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361
+ S + +IR ++ P R ++
Sbjct: 241 WSEVSEEVKMLIRN------LLKTEPTQRMTI 266
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 8e-39
Identities = 59/268 (22%), Positives = 101/268 (37%), Gaps = 20/268 (7%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 150
+ F K LG G FG V K G A+K L K + + ++ NE + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 151 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
LVKL ++ E++ + S + R YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEY 270
H L +I+RDLK N+L+DQ +++DFG A+ +G T + GT +APE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 271 ASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ---LI 327
++ D ++ G+L+ E+ +G I + S L+
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHP 355
+ Q +L + + G+ ++ H
Sbjct: 270 RNLLQ--VDLTKRFGNLKNGVNDIKNHK 295
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-36
Identities = 62/290 (21%), Positives = 119/290 (41%), Gaps = 35/290 (12%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 151
+ + +G G +G V G ++A+K+L + SE K E+ L ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 152 NLVKLLGCCIQGEEKLLIYEF-MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
N++ LL E +F + + + + + L + ++ +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 211 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE- 269
H IIHRDLK N+ +++D KI DFGLAR + + V T Y APE
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189
Query: 270 YASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329
+ +++ D++S G ++ E+++GK + ++L+ + K+ P++ +
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKT---LFKGSDHLDQLKEIMKVTGT-PPAEFVQR 245
Query: 330 CFQDSF-------------NLAEVIRCIH---IGLL--CVQQHPEDRPSM 361
D + A ++ + LL + E R +
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-35
Identities = 64/278 (23%), Positives = 113/278 (40%), Gaps = 31/278 (11%)
Query: 95 NNFSINKKLGQGGFGPVYKGKLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFS 146
NF + K LG G +G V+ + + G+ A+K L K + + + + E +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 147 KLQHR-NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTAR 205
++ LV L + LI +++ L + + +ER + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
+L L +L II+RD+K N+LLD + + ++DFGL++ F DETE GT Y
Sbjct: 139 -VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 266 MAPEYASDGQ--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323
MAP+ G D +S G+L+ E+++G N+ I P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256
Query: 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSM 361
++ S ++I+ + + P+ R
Sbjct: 257 QEM-------SALAKDLIQR------LLMKDPKKRLGC 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (321), Expect = 3e-34
Identities = 50/242 (20%), Positives = 104/242 (42%), Gaps = 23/242 (9%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRN 152
+++ + +KLG+G + V++ + + +++ VK L + + K++K E+ + L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 153 LVKLLGCCIQGEEKL--LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYL 210
++ L + L++E + N L + + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 211 HQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPE 269
H + I+HRD+K NV++D + ++ D+GLA + + N V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199
Query: 270 YASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328
D Q + D++S G +L ++ K+ F+H +N + + K+ ID
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYID 257
Query: 329 SC 330
Sbjct: 258 KY 259
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 5e-33
Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 95 NNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 151
+ K +G G G V V + +A+K+LS+ ++ K E++L + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 152 NLVKLLGCCI------QGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTAR 205
N++ LL + ++ L+ E M + D + +++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 206 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGY 265
G+ +LH IIHRDLK SN+++ D KI DFGLAR G V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 266 MAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
APE + D++S G ++ E+V K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 3e-32
Identities = 62/291 (21%), Positives = 111/291 (38%), Gaps = 25/291 (8%)
Query: 89 TIVSATNNFSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSK--ISEQGLKELKNEVILF 145
TI + +G G +G V G +AVK+LS+ S K E+ L
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 146 SKLQHRNLVKLLGCCIQGEE-KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTA 204
++H N++ LL + ++ + + + + +C L +I
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 205 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYG 264
RGL Y+H IIHRDLK SN+ +++D KI DFGLAR + T R +
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WY 184
Query: 265 YMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324
+ ++ D++S G ++ E+++G+ + L LI +
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 325 QLIDSCFQD---------SFNLAEVIRCIH---IGLL--CVQQHPEDRPSM 361
++ ++ N A V + + LL + + R +
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (296), Expect = 1e-30
Identities = 46/215 (21%), Positives = 88/215 (40%), Gaps = 18/215 (8%)
Query: 97 FSINKKLGQGGFGPVYKGK-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 155
+ + +KLG G F V+ K +V+ +A+K + + + ++E+ L ++ + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 156 LLGCCIQGEEKLLIY--EFMPNKSLDSFIFDQERCMILDWSKRF-----------HIICG 202
KLL + PN +F+ +L K++ I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 203 TARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGDETEGNTNRVVG 261
GL Y+H+ R IIH D+K NVL++ D + +A + + +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 262 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK 296
T Y +PE + +D++S L+ E+++G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.0 bits (238), Expect = 5e-24
Identities = 39/205 (19%), Positives = 69/205 (33%), Gaps = 27/205 (13%)
Query: 98 SINKKLGQGGFGPVYKGKLVDGQEIAVK--RLSKIS--------EQGLKELKNEVILFSK 147
+I K +G+G V+ E VK ++ S + G I ++
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 148 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGL 207
+ R L KL G + +Y + N L I +E + + ++ +
Sbjct: 63 NEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEV 116
Query: 208 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTNR-VVGTYGYM 266
+ I+H DL NVL+ + I DF + G + R V Y
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 267 APEYASDGQFSVKSDVFSFGILLLE 291
+ Y + D+ S +L+
Sbjct: 173 SRTY------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 414 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.77 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.16 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.27 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.98 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.39 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=399.78 Aligned_cols=259 Identities=28% Similarity=0.444 Sum_probs=200.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||+||+|+.. ..||||+++. ......+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 468999999999999999999863 4699999864 34556788999999999999999999999875 456899999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
||++|+|.+++..... .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999965432 4899999999999999999999988 9999999999999999999999999998765443
Q ss_pred CccccccccccccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
.........||+.|||||++.+ ..|+.++|||||||++|||+||+.||..... ..............+......
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--~~~~~~~~~~~~~~p~~~~~~- 235 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPDLSKVR- 235 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHHTSCCCCGGGSC-
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCCCcchhcc-
Confidence 3344455689999999999864 3589999999999999999999999754321 111111221111111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
... ...+.+++.+||+.||++|||++|+++.|+..
T Consensus 236 ----~~~----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 236 ----SNC----PKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp ----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----ccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 13567789999999999999999999998643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=398.78 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=202.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 367999999999999999999874 68999999986532 2344678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
||++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999986543 4999999999999999999999998 9999999999999999999999999998765443
Q ss_pred CccccccccccccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
........+||+.|||||++.+..+ +.++|||||||++|||+||+.||....... ...... ..........
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~---~~~~~~~~~~--- 229 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDW---KEKKTYLNPW--- 229 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHH---HTTCTTSTTG---
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHHH---hcCCCCCCcc---
Confidence 3334455789999999999988876 578999999999999999999986433221 111111 1111110000
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...+ ..+.+++.+||+.||++|||++|+++
T Consensus 230 --~~~s----~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 --KKID----SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --GGSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 24567889999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=395.82 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=197.6
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
++|++.+.||+|+||+||+|++.+++.||||+++.. ....+++.+|+.+++.++||||++++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 678999999999999999999988889999999763 3345689999999999999999999999999999999999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 157 (263)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence 999999986543 34889999999999999999999998 99999999999999999999999999987643322 2
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCc
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (414)
......||+.|+|||++.+..|+.++|||||||++|||+|+..|+.. ............. ........ .
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~--~~~~~~~~~~i~~----~~~~~~p~-----~ 226 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE--NRSNSEVVEDIST----GFRLYKPR-----L 226 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC--SCCHHHHHHHHHH----TCCCCCCT-----T
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC--CCCHHHHHHHHHh----cCCCCCcc-----c
Confidence 22345689999999999999999999999999999999996544321 1222222222222 11111111 1
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 335 FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 335 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. ..++.+++.+||+.||++|||++||++.|+.
T Consensus 227 ~----~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 227 A----STHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c----CHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1 1256789999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=392.67 Aligned_cols=249 Identities=24% Similarity=0.432 Sum_probs=205.6
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.+++.++||||+++++++.+.+..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999986 468999999997655555678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-- 170 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence 999999987643 3899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......+||+.|+|||++.+..++.++|||||||++|||+||+.||.... ...... .......+. +.. ..
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~---~~~~~~~~~-~~~---~~ 240 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PLRALY---LIATNGTPE-LQN---PE 240 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHH---HHHHHCSCC-CSS---GG
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC---HHHHHH---HHHhCCCCC-CCC---cc
Confidence 23345679999999999999999999999999999999999999985322 111121 111221111 100 01
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..+ ..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~s----~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLS----AIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSC----HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 24677899999999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-54 Score=396.42 Aligned_cols=254 Identities=31% Similarity=0.458 Sum_probs=204.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.++|++.+.||+|+||+||+|++.+++.||||+++.. ....+.+.+|+.++++++||||++++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3678889999999999999999988889999999753 3345689999999999999999999998854 5679999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++|+|.+++..... ..+++..++.++.|+++||.|||+++ |+||||||+||||++++.+||+|||+++.+.....
T Consensus 90 ~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~- 164 (272)
T d1qpca_ 90 ENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (272)
T ss_dssp TTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence 99999998765433 34899999999999999999999988 99999999999999999999999999987643322
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
.......||+.|+|||++.++.++.++|||||||++|||+||..|+.. ............ ........+
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~--~~~~~~~~~~i~----~~~~~~~p~----- 233 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP--GMTNPEVIQNLE----RGYRMVRPD----- 233 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHHHHHH----TTCCCCCCT-----
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC--CCCHHHHHHHHH----hcCCCCCcc-----
Confidence 223345689999999999999999999999999999999997666422 122222222222 221111111
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
... ..+.+++.+||+.||++|||+.||++.|+
T Consensus 234 ~~~----~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 234 NCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCh----HHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 111 24678899999999999999999999885
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=390.50 Aligned_cols=245 Identities=26% Similarity=0.374 Sum_probs=203.8
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||+||+|+.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 5889999998642 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
|||++|+|.+++..... +++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp ECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred eecCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC-
Confidence 99999999999976543 899999999999999999999998 99999999999999999999999999986532
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........ ..... .+
T Consensus 159 ---~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i---~~~~~--~~---- 223 (263)
T d2j4za1 159 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRI---SRVEF--TF---- 223 (263)
T ss_dssp ---CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHH---HTTCC--CC----
T ss_pred ---CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC---HHHHHHHH---HcCCC--CC----
Confidence 22345679999999999999999999999999999999999999985321 11222211 11111 11
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
....+ ..+.+++.+||+.||++|||++|+++
T Consensus 224 -p~~~s----~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 -PDFVT----EGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CccCC----HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11112 24667899999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-54 Score=399.04 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=208.3
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
..++|++.+.||+|+||+||+|++. +|+.||||+++.. ....+++.+|+.+++.++||||++++++|.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3467899999999999999999875 4888999998753 3345789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
||++|+|.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 9999999999876433 35899999999999999999999998 9999999999999999999999999998764322
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
. .......|++.|+|||++.+..|+.++|||||||++|||++|..|+.. ......+ .............+
T Consensus 170 ~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~--~~~~~~~----~~~i~~~~~~~~~~--- 239 (287)
T d1opja_ 170 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP--GIDLSQV----YELLEKDYRMERPE--- 239 (287)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST--TCCHHHH----HHHHHTTCCCCCCT---
T ss_pred c-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC--cchHHHH----HHHHhcCCCCCCCc---
Confidence 2 222334688999999999999999999999999999999998776432 1111111 12222222222211
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
..+ ..+.+|+.+||+.||++|||+.|+++.|+.
T Consensus 240 --~~~----~~l~~li~~cl~~dP~~Rps~~ei~~~L~~ 272 (287)
T d1opja_ 240 --GCP----EKVYELMRACWQWNPSDRPSFAEIHQAFET 272 (287)
T ss_dssp --TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --cch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111 257789999999999999999999998854
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-53 Score=384.61 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=209.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.++|++.+.||+|+||+||+|+..+++.||||++++.. ...+++.+|+.++++++||||++++|+|.+.+..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 36899999999999999999999888899999997633 34468999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++|+|.+++..... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~- 155 (258)
T d1k2pa_ 82 ANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 155 (258)
T ss_dssp TTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-
T ss_pred CCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-
Confidence 99999999765443 4889999999999999999999998 99999999999999999999999999987644322
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
.......||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... .++..... .........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~----~~~~~~~p~---- 224 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIA----QGLRLYRPH---- 224 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHH----TTCCCCCCT----
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHH----hCCCCCCcc----
Confidence 22334568999999999999999999999999999999998 7888764432 22222222 221111111
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... ..+.+++.+||+.||++|||++|+++.|.+
T Consensus 225 -~~~----~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 -LAS----EKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -TCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -ccc----HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 111 356789999999999999999999998853
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-53 Score=395.17 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=194.7
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-C---CEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-G---QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
++|++.+.||+|+||+||+|+... + ..||||.+.. ......+.+.+|+.+|++++|||||+++|+|.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 567888999999999999998743 2 2589998865 4455667899999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
||||++|+|.+++.... ..+++.+++.++.|+++||.|||+++ ++||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999886543 24899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcc---ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 250 DETEG---NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 250 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
..... ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.... ..++...... .....
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~---~~~~~~~i~~----~~~~~ 253 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---NQDVINAIEQ----DYRLP 253 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHT----TCCCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC---HHHHHHHHHc----CCCCC
Confidence 32221 1223457899999999999999999999999999999998 888875432 1222222221 11111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
... . ....+.+++.+||+.||++|||+.||++.|+
T Consensus 254 ~~~-----~----~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 254 PPM-----D----CPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288 (299)
T ss_dssp CCT-----T----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCc-----c----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 111 1 1235677899999999999999999999885
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=391.62 Aligned_cols=254 Identities=27% Similarity=0.372 Sum_probs=193.4
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe--CCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 169 (414)
++|++.+.||+|+||+||+|+.. +|+.||+|++.. ..+...+.+.+|+.++++++||||+++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999864 688999999865 344556778999999999999999999999975 4568999
Q ss_pred EeecCCCChhHHhhccc-ccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 170 YEFMPNKSLDSFIFDQE-RCMILDWSKRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
||||++|+|.+++.+.. ....+++..++.++.|++.||+|||+++ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986532 2345999999999999999999999864 23499999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 326 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (414)
+.... .......||+.|+|||++.+..|+.++|||||||++|||+||+.||.... ..++...+. ......+
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i~----~~~~~~~ 234 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIR----EGKFRRI 234 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHH----HTCCCCC
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHHH----cCCCCCC
Confidence 64322 22345679999999999999999999999999999999999999985322 122222221 1211111
Q ss_pred ccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 327 IDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ..++ .++.+++.+||+.||++|||+.|+++
T Consensus 235 ~-----~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 P-----YRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C-----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-----cccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 1122 24677889999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=398.59 Aligned_cols=258 Identities=30% Similarity=0.423 Sum_probs=204.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEcCC------CEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 165 (414)
.++|++.+.||+|+||+||+|+.... ..||+|.+... .......+.+|+.++.++ +|||||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 46799999999999999999986432 26999998653 334456788999999998 89999999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccc--------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC
Q 043285 166 KLLIYEFMPNKSLDSFIFDQER--------------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKA 225 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~ 225 (414)
.++|||||++|+|.+++..... ...+++..++.++.|+++||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999975432 134889999999999999999999998 99999999
Q ss_pred CCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 043285 226 SNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHS 304 (414)
Q Consensus 226 ~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~ 304 (414)
+|||++.++.+||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987644333333345678999999999999999999999999999999998 8998754322
Q ss_pred CCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 305 DNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
. .... ............. .. ...+.+|+.+||+.||++|||++||+++|+
T Consensus 273 ~---~~~~---~~~~~~~~~~~p~-----~~----~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 D---ANFY---KLIQNGFKMDQPF-----YA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp S---HHHH---HHHHTTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H---HHHH---HHHhcCCCCCCCC-----cC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2 1111 1122222111111 11 125678999999999999999999999984
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=392.33 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=201.6
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999987 46899999998642 2344567899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
|||++|+|.+++..... +++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999998876543 899999999999999999999998 999999999999999999999999999877544
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+...+ ..... .+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i---~~~~~--~~---- 229 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKI---IKLEY--DF---- 229 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH---HTTCC--CC----
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHH---HcCCC--CC----
Confidence 4444445568999999999999999999999999999999999999998532 112222221 11111 11
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVI 365 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl 365 (414)
....+ .++.+|+.+||+.||++|||++|++
T Consensus 230 -p~~~s----~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 230 -PEKFF----PKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp -CTTCC----HHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred -CccCC----HHHHHHHHHHccCCHhHCcCHHHHc
Confidence 11122 2467899999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-53 Score=390.38 Aligned_cols=252 Identities=27% Similarity=0.391 Sum_probs=204.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.+.|++.+.||+|+||+||+|+.. +|..||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 356899999999999999999874 5889999999876666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
|++|+|.+++.+.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..... .
T Consensus 91 ~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~ 163 (288)
T d2jfla1 91 CAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 163 (288)
T ss_dssp CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--H
T ss_pred CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--C
Confidence 99999999886543 24899999999999999999999998 99999999999999999999999999976421 1
Q ss_pred cccccccccccccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 253 EGNTNRVVGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
........||+.|+|||++. +..|+.++|||||||++|||+||+.||.... ..+...... ....+ .+.
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~---~~~~~~~i~---~~~~~-~~~ 236 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN---PMRVLLKIA---KSEPP-TLA 236 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC---GGGHHHHHH---HSCCC-CCS
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC---HHHHHHHHH---cCCCC-CCC
Confidence 11233467999999999984 4568999999999999999999999985432 222222222 12111 111
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.+ ...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~---~~~s----~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 QP---SRWS----SNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SG---GGSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc---ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 1111 24677899999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=400.54 Aligned_cols=198 Identities=27% Similarity=0.390 Sum_probs=176.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++.. .....+.+.+|+.+++.++||||++++++|.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 478999999999999999999864 5889999999753 34445788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
|+++|+|.+++.+... +++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+|.....
T Consensus 85 y~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp CCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred cCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 9999999999976543 89999999999999999999974 6 99999999999999999999999999986532
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGF 301 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~ 301 (414)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||..
T Consensus 158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 223456899999999999999999999999999999999999999854
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-52 Score=381.19 Aligned_cols=246 Identities=24% Similarity=0.397 Sum_probs=195.8
Q ss_pred CCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe----CCeeeEEE
Q 043285 98 SINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIY 170 (414)
Q Consensus 98 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 170 (414)
++.+.||+|+||+||+|+.. ++..||+|++.. ......+.+.+|++++++++||||+++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 66778999999999999875 578999999865 344556788999999999999999999999875 34579999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCCeEEEeecCccccCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGG 249 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kL~Dfgl~~~~~~ 249 (414)
||+++|+|.+++.+.. .+++..+..++.|+++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999997654 3899999999999999999999975 4599999999999997 578999999999986422
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
.......||+.|||||++.+ .++.++|||||||++|||++|+.||.... .... ..........+..
T Consensus 168 ----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~----~~~~i~~~~~~~~--- 233 (270)
T d1t4ha_ 168 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQ----IYRRVTSGVKPAS--- 233 (270)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHH----HHHHHTTTCCCGG---
T ss_pred ----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--cHHH----HHHHHHcCCCCcc---
Confidence 23345689999999999875 59999999999999999999999985321 1111 1111122211111
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
+..... .++.+++.+||++||++|||++|+++
T Consensus 234 -~~~~~~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 -FDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -GGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cCccCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111112 23667899999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=386.74 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=198.0
Q ss_pred CCCCCCCeecccCCceEEEEEEcCC-----CEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDG-----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
+.|+..+.||+|+||+||+|.+.++ ..||||+++. ........+.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688889999999999999986542 3699999965 344455678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||+.++++.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999876543 24899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 249 GDETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 249 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
..... .......||+.|+|||++.++.++.++|||||||++|||++|..|+... .....+... ..........
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~--~~~~~~~~~----i~~~~~~~~~ 235 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE--LSNHEVMKA----INDGFRLPTP 235 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHH----HHTTCCCCCC
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc--CCHHHHHHH----HhccCCCCCc
Confidence 33222 2223456899999999999999999999999999999999977664322 112222222 2222221111
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.. ....+.+|+.+||+.||++|||+.||++.|+.
T Consensus 236 ~~---------~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 236 MD---------CPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp TT---------CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred hh---------hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 11 11356789999999999999999999999854
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=386.78 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=203.5
Q ss_pred CCCCCCC-eecccCCceEEEEEEc---CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINK-KLGQGGFGPVYKGKLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 169 (414)
++|.+.+ .||+|+||+||+|.+. ++..||||+++.. .....+.+.+|+.++++++||||++++|+|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999763 3457999999753 44556789999999999999999999999864 568999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
||||++|+|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999885433 24899999999999999999999998 99999999999999999999999999987754
Q ss_pred CCCc-cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 250 DETE-GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 250 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.... ..++...+. .+......
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~---~~~~~~~i~----~~~~~~~p 234 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFIE----QGKRMECP 234 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---THHHHHHHH----TTCCCCCC
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC---HHHHHHHHH----cCCCCCCC
Confidence 3322 22334568999999999999999999999999999999998 899976432 222222222 22222221
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. ..+ ..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 235 ~-----~~~----~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 235 P-----ECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp T-----TCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred C-----cCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 111 246788999999999999999999998853
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=386.90 Aligned_cols=257 Identities=27% Similarity=0.401 Sum_probs=202.2
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecC
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 174 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~ 174 (414)
++|++.+.||+|+||+||+|++.+++.||||+++.. ....+.+.+|+.++++++|||||+++|+|. .+..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 679999999999999999999988889999999753 334578999999999999999999999985 456899999999
Q ss_pred CCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCcc
Q 043285 175 NKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 254 (414)
Q Consensus 175 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~ 254 (414)
+|+|..++..... ..+++..++.++.||+.||+|||+++ ++||||||+||||+.++.+||+|||+++....... .
T Consensus 95 ~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 95 KGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp TCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence 9999998875432 34899999999999999999999998 99999999999999999999999999987643322 2
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccCc
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQDS 334 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (414)
......||+.|+|||++.++.++.++|||||||++|||++|..|+... ....+....... ........ .
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~--~~~~~~~~~i~~----~~~~~~~~-----~ 238 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVER----GYRMPCPP-----E 238 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHT----TCCCCCCT-----T
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC--CCHHHHHHHHHh----cCCCCCCc-----c
Confidence 233456899999999999999999999999999999999977664322 222222222221 21111111 1
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 043285 335 FNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSETV 373 (414)
Q Consensus 335 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 373 (414)
.+ .++.+++.+||+.||++|||+.+|+++|+..-.
T Consensus 239 ~~----~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 239 CP----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp SC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred cC----HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 11 256789999999999999999999999976544
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=384.07 Aligned_cols=247 Identities=29% Similarity=0.402 Sum_probs=195.7
Q ss_pred CeecccCCceEEEEEEcC---CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeecCC
Q 043285 101 KKLGQGGFGPVYKGKLVD---GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 175 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~~~ 175 (414)
++||+|+||+||+|.+.+ ++.||||+++.. .....+.+.+|+.++++++||||++++|+|.+ +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999997643 457999999652 33345689999999999999999999999964 567899999999
Q ss_pred CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc-c
Q 043285 176 KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE-G 254 (414)
Q Consensus 176 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~-~ 254 (414)
|+|.+++..... +++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~~~~~---l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhccC---CCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999876543 899999999999999999999998 999999999999999999999999999876433222 2
Q ss_pred ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccccC
Q 043285 255 NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQD 333 (414)
Q Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (414)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..++..... .+.......
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---~~~~~~~i~----~~~~~~~p~----- 233 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLE----KGERMGCPA----- 233 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHH----TTCCCCCCT-----
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC---HHHHHHHHH----cCCCCCCCc-----
Confidence 2334568999999999999999999999999999999998 899975432 122222222 222211111
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 334 SFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 334 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
..+ ..+.+|+.+||+.||++|||+++|+++|+.
T Consensus 234 ~~~----~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 234 GCP----REMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ccC----HHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 111 256789999999999999999999988853
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-52 Score=392.86 Aligned_cols=256 Identities=22% Similarity=0.321 Sum_probs=190.9
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
.+.|++.+.||+|+||+||+|+.. +|+.||||++.+.. ......+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 366999999999999999999874 58899999997532 2334567899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCCeEEEeecCccccC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFG 248 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~---~~~~~kL~Dfgl~~~~~ 248 (414)
||++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||++. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999997644 3999999999999999999999998 99999999999995 57899999999998653
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 328 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (414)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ....... ........ ..
T Consensus 162 ~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~---i~~~~~~~--~~ 230 (307)
T d1a06a_ 162 PG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLFEQ---ILKAEYEF--DS 230 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHH---HHTTCCCC--CT
T ss_pred CC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHHHH---HhccCCCC--CC
Confidence 22 22334679999999999999999999999999999999999999985321 1112111 11211111 00
Q ss_pred ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HhcCC
Q 043285 329 SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL--MLGSE 371 (414)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~ 371 (414)
+ .....+ ..+.+++.+||+.||++|||++|+++ ++.+.
T Consensus 231 ~-~~~~~s----~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 231 P-YWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp T-TTTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred c-cccCCC----HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 0 011111 24678899999999999999999998 45543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.3e-52 Score=395.42 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=207.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999864 6889999999876666778899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC--CCCeEEEeecCccccCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLARAFGGD 250 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~--~~~~kL~Dfgl~~~~~~~ 250 (414)
|++|+|.+++.... ..+++..+..++.||+.||.|||+++ ++||||||+|||++. ++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999986533 24899999999999999999999998 999999999999964 578999999999876432
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.......||+.|||||++.+..++.++|||||||++|||++|+.||.... ..+....+ ....... ....
T Consensus 180 ---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i---~~~~~~~--~~~~ 248 (350)
T d1koaa2 180 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNV---KSCDWNM--DDSA 248 (350)
T ss_dssp ---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---HHTCCCS--CCGG
T ss_pred ---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHH---HhCCCCC--Cccc
Confidence 23345679999999999999999999999999999999999999985332 12222222 1111110 0000
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. ...+ ..+.+++.+||+.||++|||++|+++.
T Consensus 249 ~-~~~s----~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 F-SGIS----EDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp G-GGCC----HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred c-cCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 1111 246778999999999999999999984
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-52 Score=388.36 Aligned_cols=260 Identities=27% Similarity=0.410 Sum_probs=208.3
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 165 (414)
..++|++.+.||+|+||+||+|+.. ++..||||+++.. .....+.+.+|+.+++.++||||++++++|.+...
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4578999999999999999999863 3568999999753 34456679999999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccc---------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 043285 166 KLLIYEFMPNKSLDSFIFDQER---------------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLK 224 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk 224 (414)
.+++|||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ ++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 9999999999999999864321 234889999999999999999999998 9999999
Q ss_pred CCCEEEcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCC
Q 043285 225 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK-NRGFYH 303 (414)
Q Consensus 225 ~~Nill~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~-p~~~~~ 303 (414)
|+|||++.++.+||+|||+++...............|++.|+|||.+.+..|+.++|||||||++|||++|.. ||...
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~- 246 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM- 246 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC-
Confidence 9999999999999999999987644433334445678899999999999999999999999999999999964 54332
Q ss_pred CCCCcchHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 304 SDNNLNLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
...+..... .........+ ... .++.+|+.+||+.||++||||.||+++|+..
T Consensus 247 --~~~e~~~~v----~~~~~~~~p~-----~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 247 --AHEEVIYYV----RDGNILACPE-----NCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp --CHHHHHHHH----HTTCCCCCCT-----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred --CHHHHHHHH----HcCCCCCCCc-----cch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 222222222 2222222211 111 2567899999999999999999999999753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.3e-52 Score=393.76 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=208.5
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
++|++.+.||+|+||+||+|+. .+|+.||||+++.........+.+|+.+++.++||||+++++++.+++..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 6799999999999999999986 468999999998766666678899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc--CCCCeEEEeecCccccCCCC
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~--~~~~~kL~Dfgl~~~~~~~~ 251 (414)
++|+|.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..+...
T Consensus 109 ~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 109 SGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp CCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred CCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 9999998875433 24899999999999999999999998 99999999999998 6789999999999876432
Q ss_pred CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC--Ccccccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM--PSQLIDS 329 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 329 (414)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+ ..... +....
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i---~~~~~~~~~~~~-- 252 (352)
T d1koba_ 183 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNV---KRCDWEFDEDAF-- 252 (352)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHH---HHCCCCCCSSTT--
T ss_pred --CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH---HhCCCCCCcccc--
Confidence 23345678999999999999999999999999999999999999985322 12222222 12111 11111
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hcCC
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM--LGSE 371 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 371 (414)
...+ ..+.+|+.+||+.||.+|||+.|+++. +.+.
T Consensus 253 ---~~~s----~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 253 ---SSVS----PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ---TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ---cCCC----HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1111 246789999999999999999999983 5443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-51 Score=384.11 Aligned_cols=245 Identities=29% Similarity=0.468 Sum_probs=199.3
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
+.|+..+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34889999999999999999864 5888999998653 2344567899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
|||++|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999987665443 3899999999999999999999998 99999999999999999999999999986432
Q ss_pred CCccccccccccccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
.....||+.|||||++.+ +.|+.++|||||||++|||++|+.||.... .... .........+. ..
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~~~~---~~~i~~~~~~~-~~ 235 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSA---LYHIAQNESPA-LQ 235 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHH---HHHHHHSCCCC-CS
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---HHHH---HHHHHhCCCCC-CC
Confidence 234579999999999864 468999999999999999999999975321 1111 22222222211 11
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ...+ ..+.+++.+||+.||++|||++|+++
T Consensus 236 ~----~~~s----~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 S----GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C----CCCC----HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 1112 24677899999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-51 Score=378.59 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=203.6
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc------ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
.++|++.+.||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999987 46899999998642 122457899999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----CeEEEeec
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 242 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kL~Dfg 242 (414)
++|||||++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999997654 3999999999999999999999998 99999999999998776 49999999
Q ss_pred CccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCC
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGM 322 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.... ......
T Consensus 163 ~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~---i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLAN---VSAVNY 233 (293)
T ss_dssp TCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH---HHTTCC
T ss_pred hhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC---HHHHHHH---HHhcCC
Confidence 99876322 22334578999999999999999999999999999999999999975322 1111111 111111
Q ss_pred CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 323 PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. .... ..... ...+.+++.+||+.||++|||++|+++
T Consensus 234 ~--~~~~-~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E--FEDE-YFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C--CCHH-HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--CCch-hcCCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 0000 00111 124678999999999999999999997
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=378.14 Aligned_cols=247 Identities=22% Similarity=0.300 Sum_probs=204.6
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.+|+.++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 6799999999999999999986 46899999999752 2334577889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
|||++|+|.+++..... +++..+..++.|++.||+|||+++ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 85 ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999876554 899999999999999999999998 999999999999999999999999999865322
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ...+.... ..... .+
T Consensus 159 --~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~i---~~~~~--~~---- 224 (337)
T d1o6la_ 159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELI---LMEEI--RF---- 224 (337)
T ss_dssp --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---HHCCC--CC----
T ss_pred --CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHHHHH---hcCCC--CC----
Confidence 223445689999999999999999999999999999999999999975432 11222221 11111 11
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPS-----MPSVIL 366 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 366 (414)
....+ .++.+|+.+||++||++||+ ++|+++
T Consensus 225 -p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 -PRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11222 24667899999999999995 788876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=381.14 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=198.5
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCC----EEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
++|++.+.||+|+||+||+|.+. +|+ .||+|+++. ......+.+.+|+.++++++||||++++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 56999999999999999999864 343 589998865 3445667899999999999999999999999865 5678
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
++||+.+|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 899999999999886543 34899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
............||+.|+|||.+.++.++.++|||||||++|||+| |..||..... ..+........+...+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~---~~~~~~i~~~~~~~~p---- 235 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEKGERLPQP---- 235 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG---GGHHHHHHHTCCCCCC----
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCCCCC----
Confidence 5444444445578999999999999999999999999999999999 6777654322 2222222221111111
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. .. ...+.+++.+||+.||++|||+.|+++.|..
T Consensus 236 ~-----~~----~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 236 P-----IC----TIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp T-----TB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c-----cc----CHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 1 11 1246789999999999999999999998754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=373.45 Aligned_cols=248 Identities=28% Similarity=0.414 Sum_probs=195.5
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-CeeeEEEeec
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEFM 173 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~ey~ 173 (414)
++|++.+.||+|+||.||+|++ .|+.||||++++. ...+.+.+|+.++++++||||++++|+|.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5688889999999999999998 5789999999753 3446789999999999999999999999654 5689999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++|+|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~---- 155 (262)
T d1byga_ 84 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---- 155 (262)
T ss_dssp TTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC----
Confidence 99999999975432 24899999999999999999999988 99999999999999999999999999986432
Q ss_pred cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccccc
Q 043285 254 GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCFQ 332 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (414)
......+|+.|+|||.+.++.++.++|||||||++|||+| |+.|+... ...++...+.. .....+..
T Consensus 156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~i~~----~~~~~~~~---- 223 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEK----GYKMDAPD---- 223 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHHHTT----TCCCCCCT----
T ss_pred -CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHc----CCCCCCCc----
Confidence 2233467899999999999999999999999999999998 67765433 22233333321 11112211
Q ss_pred CcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 333 DSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 333 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... ..+.+++.+||+.||.+|||+.|++++|+.
T Consensus 224 -~~~----~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 224 -GCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp -TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -cCC----HHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111 256789999999999999999999999853
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=378.13 Aligned_cols=260 Identities=28% Similarity=0.413 Sum_probs=197.3
Q ss_pred hcCCCCCCCeecccCCceEEEEEEc------CCCEEEEEEecc-cChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCC
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 164 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 164 (414)
..++|++.+.||+|+||.||+|+.. +++.||||+++. ......+.+..|...+.++ +|+||+.+++++.+.+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 4478999999999999999999753 246799999975 3344556778888888777 6899999999987654
Q ss_pred -eeeEEEeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 043285 165 -EKLLIYEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 230 (414)
Q Consensus 165 -~~~lv~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill 230 (414)
..++|||||++|+|.+++..... ...+++..+..++.|+++||.|||+++ |+||||||+||||
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 68999999999999999975432 234889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCCCCcc
Q 043285 231 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK-NRGFYHSDNNLN 309 (414)
Q Consensus 231 ~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~-p~~~~~~~~~~~ 309 (414)
++++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+||.. ||..... ...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~--~~~ 245 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEE 245 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC--SHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 9999999999999987654444444555679999999999999999999999999999999999764 5532221 111
Q ss_pred hHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 310 LIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.... ...+......+. .. .++.+++.+||+.||++|||+.|+++.|+.
T Consensus 246 ~~~~----~~~~~~~~~~~~-----~~----~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 246 FCRR----LKEGTRMRAPDY-----TT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HHHH----HHHTCCCCCCTT-----CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH----HhcCCCCCCCcc-----CC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2222 222222222221 11 246788999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=372.89 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=193.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEcC----CCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeE
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLVD----GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 168 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 168 (414)
.++|++.+.||+|+||+||+|+... +..||||.++. ......+.+.+|+.++++++||||++++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3679999999999999999997643 34689999865 34445678999999999999999999999995 567899
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccC
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 248 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~ 248 (414)
||||+++|+|.+++.... ..+++..++.++.|+++||.|||+++ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 85 v~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999999876543 34899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc
Q 043285 249 GDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 327 (414)
Q Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (414)
... ........||+.|+|||.+.+..++.++|||||||++|||+| |.+||.... ..++...... .....+.
T Consensus 160 ~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~---~~~~~~~i~~----~~~~~~~ 231 (273)
T d1mp8a_ 160 DST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRIEN----GERLPMP 231 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHHHT----TCCCCCC
T ss_pred CCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC---HHHHHHHHHc----CCCCCCC
Confidence 322 222334568999999999999999999999999999999998 788875432 2233333222 1111111
Q ss_pred cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 328 DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
. ..+ ..+.+|+.+||+.||++|||+.||++.|+
T Consensus 232 ~-----~~~----~~~~~li~~cl~~dp~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 232 P-----NCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLS 264 (273)
T ss_dssp T-----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C-----CCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1 111 25678899999999999999999999885
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-51 Score=373.70 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=195.2
Q ss_pred CCCCCCCeecccCCceEEEEEEcC--C--CEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD--G--QEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 167 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 167 (414)
++|++.+.||+|+||.||+|+... + ..||||++.+. .....+.+.+|+.++++++||||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 679999999999999999997632 2 36899998652 34456789999999999999999999999965 4678
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
+||||+++|++.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999999886543 24899999999999999999999988 999999999999999999999999999986
Q ss_pred CCCCCcc-ccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 248 GGDETEG-NTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 248 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
....... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||... ...+.. ...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~---~~~~~~---~~i~~~~~~~~ 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQIL---HKIDKEGERLP 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHH---HHHHTSCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc---CHHHHH---HHHHhCCCCCC
Confidence 4433222 2334467889999999999999999999999999999998 89887532 112222 22222322222
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
... ... ..+.+++.+||+.||++|||+.||++.|++
T Consensus 236 ~~~-----~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 236 RPE-----DCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCT-----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Ccc-----ccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111 111 246789999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-49 Score=377.10 Aligned_cols=244 Identities=22% Similarity=0.269 Sum_probs=203.4
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999874 6899999998642 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
||+.+|+|..++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 121 e~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred ccccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 99999999999976543 899999999999999999999998 99999999999999999999999999987642
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
......||+.|||||++.+..++.++|||||||++|||+||+.||... ........+ ...... .
T Consensus 194 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i---~~~~~~--~---- 257 (350)
T d1rdqe_ 194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKI---VSGKVR--F---- 257 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH---HHCCCC--C----
T ss_pred ----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHH---hcCCCC--C----
Confidence 233467999999999999999999999999999999999999998532 112222222 222111 1
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVIL 366 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~ 366 (414)
....+ .++.+++.+||+.||.+|+ |++|+++
T Consensus 258 -p~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 -PSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11111 2467789999999999994 8999987
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.7e-50 Score=375.00 Aligned_cols=244 Identities=26% Similarity=0.380 Sum_probs=202.9
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 170 (414)
++|++.+.||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999987 45899999999642 2334578899999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 250 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~ 250 (414)
|||++|+|..++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc-
Confidence 99999999998876554 788899999999999999999998 99999999999999999999999999987532
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
.....+||+.|||||++.+..|+.++|||||||++|||+||+.||... ........ ...... .+
T Consensus 157 ----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~---i~~~~~--~~---- 220 (316)
T d1fota_ 157 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEK---ILNAEL--RF---- 220 (316)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHH---HHHCCC--CC----
T ss_pred ----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHHH---HHcCCC--CC----
Confidence 233468999999999999999999999999999999999999998532 11222222 222211 11
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRP-----SMPSVIL 366 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~ 366 (414)
....+ .++.+++.+||+.||.+|| |++|+++
T Consensus 221 -p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 221 -PPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11112 2466788999999999996 8999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=375.47 Aligned_cols=258 Identities=28% Similarity=0.394 Sum_probs=208.1
Q ss_pred cCCCCCCCeecccCCceEEEEEE------cCCCEEEEEEecc-cChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL------VDGQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 165 (414)
.++|++.+.||+|+||.||+|++ .+++.||||+++. ........+.+|+.+++.+ +||||++++++|.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 47889999999999999999975 2356899999976 3344556789999999999 69999999999999999
Q ss_pred eeEEEeecCCCChhHHhhccc---------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 043285 166 KLLIYEFMPNKSLDSFIFDQE---------------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 230 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill 230 (414)
.++|||||++|+|.+++.... ....+++..+..++.||+.||+|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999997543 1235889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCCCCCcc
Q 043285 231 DQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKN-RGFYHSDNNLN 309 (414)
Q Consensus 231 ~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p-~~~~~~~~~~~ 309 (414)
+.++.+|++|||+++...............||+.|+|||.+.++.++.++|||||||++|||+|++.| +.... ...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~---~~~ 255 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---VDS 255 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---SSH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC---HHH
Confidence 99999999999999987554444444556899999999999999999999999999999999995555 33222 112
Q ss_pred hHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 043285 310 LIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLG 369 (414)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 369 (414)
.+.. ....+....... .. ...+.+|+.+||+.||++|||+.||+++|+
T Consensus 256 ~~~~---~i~~~~~~~~~~-----~~----~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 256 KFYK---MIKEGFRMLSPE-----HA----PAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp HHHH---HHHHTCCCCCCT-----TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH---HHhcCCCCCCcc-----cc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 2221 122222211111 11 135778999999999999999999999985
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=377.53 Aligned_cols=255 Identities=28% Similarity=0.430 Sum_probs=199.2
Q ss_pred CCCCCCCeecccCCceEEEEEEcC-CC--EEEEEEecc-cChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVD-GQ--EIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 169 (414)
++|++.+.||+|+||+||+|++.+ |. .||||+++. ......+.+.+|+.+++++ +||||++++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678899999999999999998754 33 478888764 3344566899999999998 799999999999999999999
Q ss_pred EeecCCCChhHHhhcc-------------cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCe
Q 043285 170 YEFMPNKSLDSFIFDQ-------------ERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 236 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~ 236 (414)
|||+++|+|.+++... .....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999654 22346899999999999999999999998 9999999999999999999
Q ss_pred EEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCCCCcchHHHHH
Q 043285 237 KISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKK-NRGFYHSDNNLNLIGHAW 315 (414)
Q Consensus 237 kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~-p~~~~~~~~~~~~~~~~~ 315 (414)
||+|||+++.... ........||..|+|||.+.++.++.++|||||||++|||++|.. ||... ....+...+
T Consensus 167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~~~~i- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYEKL- 239 (309)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHG-
T ss_pred EEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHHHHHH-
Confidence 9999999976432 222234568999999999999999999999999999999999765 44322 122222221
Q ss_pred HHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 316 KLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
.......... .. ..++.+|+.+||+.||++||||.||++.|+..
T Consensus 240 ---~~~~~~~~~~-----~~----~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 240 ---PQGYRLEKPL-----NC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp ---GGTCCCCCCT-----TB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HhcCCCCCCc-----cC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1221111111 11 12577889999999999999999999988554
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.8e-50 Score=371.99 Aligned_cols=257 Identities=22% Similarity=0.346 Sum_probs=197.9
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCe----
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE---- 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 165 (414)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.. .......+.+|+.+++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999986 46889999999753 33445678999999999999999999999986543
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.|+||||+++++|.+++..... +++.++..++.|++.||+|||+++ ++||||||+|||++.++..+++|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999998866543 899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCC-CccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 246 AFGGDE-TEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 246 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
...... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.... .. .............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~---~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PV---SVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HH---HHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC---HH---HHHHHHHhcCCCC
Confidence 653322 2223345679999999999999999999999999999999999999985321 11 1122222222111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhc
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRP-SMPSVILMLG 369 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~ 369 (414)
. .......+ ..+.+++.+||++||++|| |++++++.|.
T Consensus 234 ~---~~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 234 P---SARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp G---GGTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred C---chhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 0 01111111 2466789999999999999 8999887763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-50 Score=372.75 Aligned_cols=259 Identities=29% Similarity=0.414 Sum_probs=205.4
Q ss_pred hcCCCCCCCeecccCCceEEEEEEcC--------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCceeeeEeEEEe
Q 043285 93 ATNNFSINKKLGQGGFGPVYKGKLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 162 (414)
Q Consensus 93 ~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 162 (414)
..++|++.+.||+|+||.||+|+... +..||||++++. .......+.+|...+.++ +||||++++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 34789999999999999999997532 246999999763 344567888899999888 79999999999999
Q ss_pred CCeeeEEEeecCCCChhHHhhcccc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 043285 163 GEEKLLIYEFMPNKSLDSFIFDQER-------------CMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 229 (414)
Q Consensus 163 ~~~~~lv~ey~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nil 229 (414)
+...++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ ++||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 9999999999999999999965431 235899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 043285 230 LDQDMNPKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDNNL 308 (414)
Q Consensus 230 l~~~~~~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~ 308 (414)
++.++.+||+|||++................+|+.|+|||.+.++.|+.++|||||||++|||++ |..||..... .
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~ 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---H
Confidence 99999999999999997765554445556678999999999999999999999999999999998 6777643221 1
Q ss_pred chHHHHHHHhhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 309 NLIGHAWKLWNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
. ............... ... ..+.+|+.+||+.||++|||+.||++.|+.
T Consensus 245 ~----~~~~i~~~~~~~~p~-----~~~----~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 245 E----LFKLLKEGHRMDKPS-----NCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp H----HHHHHHTTCCCCCCS-----SCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H----HHHHHHcCCCCCCCc-----cch----HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1 222222222222211 111 247789999999999999999999999954
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-50 Score=375.21 Aligned_cols=259 Identities=28% Similarity=0.437 Sum_probs=209.5
Q ss_pred cCCCCCCCeecccCCceEEEEEEc------CCCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV------DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
.++|++.+.||+|+||+||+|.+. ++..||||+++. ........+.+|+.++++++||||++++|+|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 378899999999999999999763 257899999975 3444556789999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHhhccc-------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEE
Q 043285 167 LLIYEFMPNKSLDSFIFDQE-------RCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 239 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~ 239 (414)
++||||+++|+|.+++.... ....+++..+..++.|+++||.|||+++ |+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999986432 2234789999999999999999999987 9999999999999999999999
Q ss_pred eecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCCcchHHHHHHHh
Q 043285 240 DFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGK-KNRGFYHSDNNLNLIGHAWKLW 318 (414)
Q Consensus 240 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 318 (414)
|||+++.+.............||+.|+|||.+.++.++.++|||||||++|||+||. .|+... ..........
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~~~~i~--- 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFVM--- 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHHHHHHH---
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---CHHHHHHHHH---
Confidence 999998765444444445567899999999999999999999999999999999986 554322 2222222221
Q ss_pred hcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 319 NEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
........+. .. ..+.+++.+||+.+|++|||+.||+++|+..
T Consensus 250 -~~~~~~~p~~-----~~----~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 250 -EGGLLDKPDN-----CP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp -TTCCCCCCTT-----CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred -hCCCCCCccc-----ch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1211111111 11 2577899999999999999999999999765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.8e-50 Score=368.89 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=201.0
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccC---------hhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeC
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG 163 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 163 (414)
++|++.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999986 468899999986522 112346789999999997 99999999999999
Q ss_pred CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecC
Q 043285 164 EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 243 (414)
Q Consensus 164 ~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl 243 (414)
+..|+|||||++|+|.+++.... .+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999997644 3899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH
Q 043285 244 ARAFGGDETEGNTNRVVGTYGYMAPEYASD------GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL 317 (414)
Q Consensus 244 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 317 (414)
++.+.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.... ....... .
T Consensus 157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~~---i 227 (277)
T d1phka_ 157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRM---I 227 (277)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH---H
T ss_pred eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHHHH---H
Confidence 98764322 2334679999999998853 357889999999999999999999986432 1111111 1
Q ss_pred hhcCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 318 WNEGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
....... ..+.. ...+ .++.+++.+||++||++|||++|+++
T Consensus 228 ~~~~~~~--~~~~~-~~~s----~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSGNYQF--GSPEW-DDYS----DTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHTCCCC--CTTTG-GGSC----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhCCCCC--CCccc-ccCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2221110 01000 1111 25778999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.7e-49 Score=378.24 Aligned_cols=249 Identities=26% Similarity=0.328 Sum_probs=197.6
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHH---HHHHHHHHhcCCCceeeeEeEEEeCCee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKEL---KNEVILFSKLQHRNLVKLLGCCIQGEEK 166 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~ 166 (414)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+. .......+ ..++.+++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999875 5899999998642 11122233 3446777778899999999999999999
Q ss_pred eEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 167 LLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 167 ~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
|+|||||++|+|.+++..... +++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999976543 889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 247 FGGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
+... ......||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.......... ..... ......
T Consensus 157 ~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~~~~~--~~~~~~ 227 (364)
T d1omwa3 157 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMT--LTMAVE 227 (364)
T ss_dssp CSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH---HHHHS--SSCCCC
T ss_pred cCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhc--ccCCCC
Confidence 6432 2344579999999999875 568999999999999999999999986543332211 11111 111111
Q ss_pred cccccccCcCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 043285 326 LIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS-----MPSVIL 366 (414)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 366 (414)
+. ...+ ..+.+++.+||+.||++||| ++|+++
T Consensus 228 ~~-----~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 228 LP-----DSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CC-----SSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CC-----CCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11 1122 24678899999999999999 688875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=371.40 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=199.4
Q ss_pred CCeecccCCceEEEEEEcCC----CEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-CeeeEEEeec
Q 043285 100 NKKLGQGGFGPVYKGKLVDG----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEFM 173 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~ey~ 173 (414)
.++||+|+||+||+|++.++ ..||||+++. ......+.+.+|++++++++||||++++|++.+. ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999987543 2589999975 4555678899999999999999999999998764 5789999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
++|+|.+++.... ...++..++.++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999987543 24778889999999999999999998 999999999999999999999999999876443222
Q ss_pred --cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccccc
Q 043285 254 --GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSCF 331 (414)
Q Consensus 254 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (414)
.......||+.|+|||.+.+..++.++||||||+++|||+||+.||.... ...+....... +......+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~--~~~~~~~~i~~----g~~~~~p~--- 257 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQ----GRRLLQPE--- 257 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT----TCCCCCCT---
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC--CHHHHHHHHHc----CCCCCCcc---
Confidence 22233568999999999999999999999999999999999888764322 12222222221 11111111
Q ss_pred cCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 332 QDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
.. ...+.+++.+||+.||++|||+.||++.|+..
T Consensus 258 --~~----~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 258 --YC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp --TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cC----cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 12467889999999999999999999998654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=372.66 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=200.1
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHH-hcCCCceeeeEeEEEeCCeeeEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFS-KLQHRNLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv 169 (414)
++|++.+.||+|+||+||+|+.. +|+.||||++++. .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999874 5889999999652 2334456666776654 68999999999999999999999
Q ss_pred EeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCC
Q 043285 170 YEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 249 (414)
Q Consensus 170 ~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~ 249 (414)
|||+++|+|.+++..... +++..+..++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999976544 899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS 329 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (414)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+. ... + .+
T Consensus 156 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~---~~~-~-~~--- 222 (320)
T d1xjda_ 156 G--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIR---MDN-P-FY--- 222 (320)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH---HCC-C-CC---
T ss_pred c--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHH---cCC-C-CC---
Confidence 2 223345679999999999999999999999999999999999999985322 122222221 111 1 11
Q ss_pred cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 043285 330 CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMP-SVIL 366 (414)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~ 366 (414)
....+ ..+.+|+.+||+.||++|||+. |+++
T Consensus 223 --p~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 --PRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CccCC----HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11122 2467889999999999999996 7764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=370.56 Aligned_cols=267 Identities=23% Similarity=0.297 Sum_probs=198.2
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC----eeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 170 (414)
++|.+.+.||+|+||+||+|+. +|+.||||+++.... .......|+..+..++||||++++++|.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4677889999999999999987 789999999965322 1122334555666789999999999998654 578999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
|||++|+|.+++.+. .+++..++.++.|++.||+|||+. ..++|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999754 389999999999999999999974 12359999999999999999999999999998
Q ss_pred ccCCCCC--ccccccccccccccccccccCCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC--------cc
Q 043285 246 AFGGDET--EGNTNRVVGTYGYMAPEYASDGQ------FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNN--------LN 309 (414)
Q Consensus 246 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslGvil~elltg~~p~~~~~~~~~--------~~ 309 (414)
....... ........||+.|+|||++.+.. ++.++|||||||+||||+||..|++....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 7643322 12334567999999999987643 67799999999999999999887653222111 11
Q ss_pred hHHHHHHHhhcCCC-cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 043285 310 LIGHAWKLWNEGMP-SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGSE 371 (414)
Q Consensus 310 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 371 (414)
...........+.. +.+.. ..........+.+++.+||+.||++|||+.||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCG----GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCc----ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11222222222111 11111 111223455678899999999999999999999998643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=375.10 Aligned_cols=251 Identities=21% Similarity=0.296 Sum_probs=203.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
.++|++.+.||+|+||+||+|... +|+.||||+++.... ....+.+|+.+|+.++||||+++++++.+.+..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367999999999999999999875 588899999976433 345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC--CCeEEEeecCccccCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLARAFGGD 250 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~--~~~kL~Dfgl~~~~~~~ 250 (414)
|++|+|.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||++.....
T Consensus 83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~- 156 (321)
T d1tkia_ 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc-
Confidence 99999999996543 24899999999999999999999998 9999999999999854 5799999999987532
Q ss_pred CCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccccc
Q 043285 251 ETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDSC 330 (414)
Q Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (414)
........+|+.|+|||.+.+..++.++|||||||++|+|++|+.||.... ..+.... ....... +....
T Consensus 157 --~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~---~~~~~~~---i~~~~~~--~~~~~ 226 (321)
T d1tkia_ 157 --GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIEN---IMNAEYT--FDEEA 226 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHH---HHHTCCC--CCHHH
T ss_pred --CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC---HHHHHHH---HHhCCCC--CChhh
Confidence 223345678999999999999999999999999999999999999985432 1122222 1221111 00100
Q ss_pred ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 331 FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
. ...+ .++.+++.+||+.||++|||+.|+++
T Consensus 227 ~-~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 F-KEIS----IEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp H-TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-cCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 1111 24678999999999999999999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=374.72 Aligned_cols=251 Identities=20% Similarity=0.214 Sum_probs=194.6
Q ss_pred CCCCCCC-eecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHh-cCCCceeeeEeEEEe----CCeee
Q 043285 95 NNFSINK-KLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ----GEEKL 167 (414)
Q Consensus 95 ~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~~~ 167 (414)
++|.+.. .||+|+||+||+|+. .+++.||||++++. ..+.+|+.++.+ .+||||++++++|.+ ....|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 6788764 699999999999986 46899999998642 356789988655 489999999999976 45689
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCeEEEeecCc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLA 244 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kL~Dfgl~ 244 (414)
+|||||++|+|.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 86 ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 99999999999999975432 34899999999999999999999998 999999999999985 467999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
+..... .......||+.|+|||++.+..|+.++|||||||++|+|+||+.||........... ..... ...
T Consensus 162 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i---~~~ 232 (335)
T d2ozaa1 162 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRI---RMG 232 (335)
T ss_dssp EECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CC---CSC
T ss_pred eeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHH---hcC
Confidence 876432 223456799999999999999999999999999999999999999864332211110 00000 000
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. .+..........++.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 QY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SS---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 0000000111235778999999999999999999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=366.57 Aligned_cols=260 Identities=25% Similarity=0.299 Sum_probs=195.8
Q ss_pred CCeecccCCceEEEEEEc-CCCEEEEEEecccChh-----hHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEeec
Q 043285 100 NKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQ-----GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 173 (414)
Q Consensus 100 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey~ 173 (414)
.+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999864 5899999998652211 2346889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCCc
Q 043285 174 PNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 253 (414)
Q Consensus 174 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~~ 253 (414)
.++++..+..... .+++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-- 154 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-- 154 (299)
T ss_dssp SEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--
T ss_pred cchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc--
Confidence 9887776654333 4888999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccccc---
Q 043285 254 GNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDS--- 329 (414)
Q Consensus 254 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 329 (414)
......+||+.|+|||++.+. .|+.++|||||||++|||+||..||.... ..+....+.............+.
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~---~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---DLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC---HHHHHHHHHHhcCCCChhhccchhcc
Confidence 223345789999999988654 67999999999999999999999875332 22233333322211111111000
Q ss_pred ----cc--cCcCCHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHH--HhcC
Q 043285 330 ----CF--QDSFNLAE-----VIRCIHIGLLCVQQHPEDRPSMPSVIL--MLGS 370 (414)
Q Consensus 330 ----~~--~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~ 370 (414)
.. ........ ...+.+|+.+||+.||++|||++|+++ ++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 00 00111111 235788999999999999999999997 4644
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=363.09 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=198.0
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999986 468999999996532 2345688999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
|+.++ +..++.... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~- 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 155 (298)
T ss_dssp CCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-
T ss_pred ecCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC-
Confidence 99765 444443322 234899999999999999999999998 999999999999999999999999999876432
Q ss_pred CccccccccccccccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc---ccc
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS---QLI 327 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 327 (414)
........||+.|+|||.+.... ++.++|||||||++|+|++|+.||.... ..+............... ...
T Consensus 156 -~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 156 -VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS---EIDQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp -SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC---HHHHHHHHHHhcCCCchhhccccc
Confidence 22334457999999999877765 4889999999999999999999985322 122222222211111100 000
Q ss_pred ---c--ccc--cCcCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 328 ---D--SCF--QDSFNLA-----EVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 328 ---~--~~~--~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
+ ... ....... ....+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 000 0000000 11356788999999999999999999984
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-48 Score=362.66 Aligned_cols=261 Identities=22% Similarity=0.316 Sum_probs=199.3
Q ss_pred CCCCCCCeecccCCceEEEEEEcCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ey 172 (414)
++|++.+.||+|+||+||+|+..+|+.||||+++.. .....+.+.+|+.+++.++||||+++++++.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999988999999999653 233457889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 252 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~~ 252 (414)
+.++.+..+..... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 98877777665443 4999999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCccccc---
Q 043285 253 EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID--- 328 (414)
Q Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 328 (414)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.... ..+..................+
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC---HHHHHHHHHHhhCCCChhhccchhh
Confidence 223344689999999998765 56999999999999999999999985432 1222222222111111000000
Q ss_pred ------------ccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 329 ------------SCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 329 ------------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..............+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000001135678999999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=357.11 Aligned_cols=240 Identities=25% Similarity=0.389 Sum_probs=193.7
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccCh------hhHHHHHHHHHHHHhcC--CCceeeeEeEEEeCC
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGE 164 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 164 (414)
.++|++.+.||+|+||+||+|+. .+|+.||||++.+... .....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36799999999999999999986 4689999999864211 11234678999999996 899999999999999
Q ss_pred eeeEEEeecCC-CChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCCeEEEeec
Q 043285 165 EKLLIYEFMPN-KSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFG 242 (414)
Q Consensus 165 ~~~lv~ey~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kL~Dfg 242 (414)
..++||||+.+ +++.+++.... .+++..+..++.|+++||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 57778776544 3899999999999999999999998 999999999999985 4799999999
Q ss_pred CccccCCCCCccccccccccccccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC
Q 043285 243 LARAFGGDETEGNTNRVVGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG 321 (414)
Q Consensus 243 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
++..... .......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... .. ....
T Consensus 157 ~a~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i---~~~~ 220 (273)
T d1xwsa_ 157 SGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EI---IRGQ 220 (273)
T ss_dssp TCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HH---HHCC
T ss_pred cceeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HH---hhcc
Confidence 9986532 22334679999999999987766 577899999999999999999985311 11 1111
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. +....+ .++.+++.+||+.||++|||++|+++
T Consensus 221 ~~-------~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 VF-------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CC-------CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cC-------CCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 10 111122 24678899999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=355.74 Aligned_cols=258 Identities=23% Similarity=0.318 Sum_probs=194.2
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-C-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhc---CCCceeeeEeEEEe----
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-D-GQEIAVKRLSKI--SEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQ---- 162 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~---- 162 (414)
.++|++.+.||+|+||+||+|+.. + ++.||||+++.. .......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999873 4 567999998642 222233456777777665 79999999999864
Q ss_pred -CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEee
Q 043285 163 -GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 241 (414)
Q Consensus 163 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Df 241 (414)
....+++|||++++++....... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 34679999999987766544332 234899999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC
Q 043285 242 GLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG 321 (414)
Q Consensus 242 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
|++.... .........||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ..+............
T Consensus 161 g~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 161 GLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS---DVDQLGKILDVIGLP 234 (305)
T ss_dssp CSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCC
T ss_pred hhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC---HHHHHHHHHHhhCCC
Confidence 9987642 2233445689999999999999999999999999999999999999985432 222222222211111
Q ss_pred CCcccc-----------------cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 322 MPSQLI-----------------DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 322 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
...... ...+.... ...+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDI----DELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSC----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccC----CHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 100000 00001111 134667899999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=355.76 Aligned_cols=265 Identities=22% Similarity=0.294 Sum_probs=197.1
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe--------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-------- 162 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------- 162 (414)
.++|++.+.||+|+||+||+|+. .+|+.||||++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999987 4689999999854 233445678899999999999999999999865
Q ss_pred CCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeec
Q 043285 163 GEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 242 (414)
Q Consensus 163 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfg 242 (414)
....++||||+.++++........ .++...+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 346799999998877665543333 3889999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCC--ccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh
Q 043285 243 LARAFGGDET--EGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN 319 (414)
Q Consensus 243 l~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 319 (414)
++........ ........||+.|+|||.+.+. .++.++|||||||++|||++|+.||.... .............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~---~~~~~~~i~~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT---EQHQLALISQLCG 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC---HHHHHHHHHHhcC
Confidence 9987643322 2223345799999999998765 68999999999999999999999985422 1222222222211
Q ss_pred cCCCc---cccc--------ccccCcCCHHH-------HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 320 EGMPS---QLID--------SCFQDSFNLAE-------VIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 320 ~~~~~---~~~~--------~~~~~~~~~~~-------~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
..... .... ........... ...+.+|+.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11110 0000 00000111111 1345689999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=358.69 Aligned_cols=258 Identities=23% Similarity=0.280 Sum_probs=191.2
Q ss_pred CCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC------CeeeE
Q 043285 96 NFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EEKLL 168 (414)
Q Consensus 96 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l 168 (414)
+|+..++||+|+||+||+|+.. +|+.||||++.+... ...+|+.++++++||||++++++|... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999875 589999999975332 234799999999999999999998643 24789
Q ss_pred EEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CeEEEeecCcccc
Q 043285 169 IYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAF 247 (414)
Q Consensus 169 v~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kL~Dfgl~~~~ 247 (414)
|||||+++.+..+.........+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987655554433333345999999999999999999999998 99999999999999775 8999999999876
Q ss_pred CCCCCccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH---------
Q 043285 248 GGDETEGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL--------- 317 (414)
Q Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 317 (414)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... +........
T Consensus 174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~---~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCCCHHHH
T ss_pred cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH---HHHHHHHHHhCCChHHhh
Confidence 4322 2334578999999998765 57899999999999999999999998543221 111111111
Q ss_pred --hhcCC----CcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 318 --WNEGM----PSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 318 --~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
..... ...................++.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00000000000001111235678899999999999999999996
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-46 Score=347.76 Aligned_cols=259 Identities=19% Similarity=0.272 Sum_probs=194.4
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCceee-eEeEEEeCCeeeEEEee
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK-LLGCCIQGEEKLLIYEF 172 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~ey 172 (414)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+..|+++++.++|+|++. +.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 6799999999999999999986 4588999998865322 235788999999998776554 55566778889999999
Q ss_pred cCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCCeEEEeecCccccCC
Q 043285 173 MPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLARAFGG 249 (414)
Q Consensus 173 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kL~Dfgl~~~~~~ 249 (414)
++ +++...+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+++.+..
T Consensus 85 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 56666554332 24899999999999999999999998 999999999999864 45799999999997654
Q ss_pred CCCc-----cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 250 DETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 250 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
.... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3221 12345679999999999999999999999999999999999999987655444333332222111111111
Q ss_pred ccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 325 QLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
.... ..+ .++.+++.+||+.+|++||++.++.+.|+.
T Consensus 239 ~~~~-----~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 239 VLCK-----GYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HHTT-----TSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred Hhcc-----CCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1111 111 246678899999999999999998887754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=350.65 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=195.2
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC----eee
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKL 167 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 167 (414)
+++|++++.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999976 57999999999753 3445668899999999999999999999997654 235
Q ss_pred EEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcccc
Q 043285 168 LIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 247 (414)
Q Consensus 168 lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~ 247 (414)
++++|+.+|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 556677799999999653 3899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCC-ccccccccccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcc
Q 043285 248 GGDET-EGNTNRVVGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 325 (414)
Q Consensus 248 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
..... ........||+.|+|||++.. ..++.++||||+||++|||++|+.||..... .+................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY---LDQLNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH---HHHHHHHhhhccCCChhh
Confidence 33222 222345679999999999855 4678999999999999999999999754321 111111111110000000
Q ss_pred c-----------cccc-ccCcCCHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 326 L-----------IDSC-FQDSFNLAE-----VIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 326 ~-----------~~~~-~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
. .... ......... ..++.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000 000000000 1246789999999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=350.39 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=200.9
Q ss_pred CCCCCCCeecccCCceEEEEEEc----CCCEEEEEEeccc----ChhhHHHHHHHHHHHHhcCC-CceeeeEeEEEeCCe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEE 165 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 165 (414)
++|++.+.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999752 4789999998642 22334567899999999976 899999999999999
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.+++|||+.+|+|.+++..... +++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999976654 788899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCC
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 323 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
.+.... ........|++.|+|||.+.+. .++.++|||||||+||||++|+.||...........+...........+
T Consensus 178 ~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 256 (322)
T d1vzoa_ 178 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256 (322)
T ss_dssp ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred hhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc
Confidence 654322 2233456799999999998765 4688999999999999999999998655444433332222211111111
Q ss_pred cccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 043285 324 SQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPS-----MPSVIL 366 (414)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 366 (414)
. .. ...+.+++.+||++||++||| ++|+++
T Consensus 257 ~---------~~----s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 257 Q---------EM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp T---------TS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred c---------cC----CHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1 11 135677899999999999994 789986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-45 Score=341.24 Aligned_cols=260 Identities=15% Similarity=0.230 Sum_probs=203.7
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCC-CceeeeEeEEEeCCeeeEEEe
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 171 (414)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+|++.++.++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999864 588999998865322 2356788899999975 899999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-----CCCeEEEeecCccc
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLARA 246 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-----~~~~kL~Dfgl~~~ 246 (414)
|+ +++|.+++..... .++...+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 6899998865432 4899999999999999999999998 999999999999974 57899999999987
Q ss_pred cCCCCCc-----cccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcC
Q 043285 247 FGGDETE-----GNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEG 321 (414)
Q Consensus 247 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
....... .......||+.|||||++.+..++.++|||||||++|||+||+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6433221 12334679999999999999999999999999999999999999987554444333322222211111
Q ss_pred CCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 043285 322 MPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILMLGS 370 (414)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 370 (414)
...++.. ... .++.+++..|++.+|++||+++.+.+.|++
T Consensus 236 ~~~~l~~-----~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLRELCA-----GFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHHHHTT-----TSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChHHhcC-----CCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111111 111 246678889999999999999888877754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=349.11 Aligned_cols=257 Identities=24% Similarity=0.336 Sum_probs=193.1
Q ss_pred cCCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCC------
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 164 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 164 (414)
.++|++++.||+|+||+||+|+.. +|+.||||++++ ......+.+.+|+.+|+.++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999864 589999999975 34445678899999999999999999999998655
Q ss_pred eeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCc
Q 043285 165 EKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 244 (414)
Q Consensus 165 ~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~ 244 (414)
..++||||+ +.+|..++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 55777766433 3999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhh----
Q 043285 245 RAFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWN---- 319 (414)
Q Consensus 245 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 319 (414)
..... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||..... ............
T Consensus 169 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 169 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTPPA 240 (346)
T ss_dssp EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCH
T ss_pred eccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh---HHHHHHHHhccCCCcH
Confidence 87532 23345789999999998764 568999999999999999999999754321 111111111000
Q ss_pred ------------------cCCCcccccccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hcCC
Q 043285 320 ------------------EGMPSQLIDSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM--LGSE 371 (414)
Q Consensus 320 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 371 (414)
........... ....+ ..+.+|+.+||+.||++|||++|+++. +++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s----~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASI-LTNAS----PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGT-CTTCC----HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHh-ccCCC----HHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00000000001 01112 246789999999999999999999984 5543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=341.58 Aligned_cols=262 Identities=22% Similarity=0.277 Sum_probs=202.8
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeCCeeeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 171 (414)
++|++.+.||+|+||+||+|+. .+|+.||||+++. ........+.+|+.+++.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999987 4688999999864 233456788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCccccCCCC
Q 043285 172 FMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 251 (414)
Q Consensus 172 y~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~~~~~~ 251 (414)
++.+++|..++.... .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.+.......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888776544 3889999999999999999999998 9999999999999999999999999998764322
Q ss_pred CccccccccccccccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCcccc---
Q 043285 252 TEGNTNRVVGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI--- 327 (414)
Q Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 327 (414)
.......+++.|+|||.+.+.. ++.++|||||||++|||++|+.||.. ..+..+..................
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred --ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC--CCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 2223345778899999887665 69999999999999999999998632 222223333332222211110000
Q ss_pred -----------cc-cccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 328 -----------DS-CFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 328 -----------~~-~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.. .............+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000000111235678899999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.8e-45 Score=342.92 Aligned_cols=255 Identities=18% Similarity=0.301 Sum_probs=194.1
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeC--CeeeEEE
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIY 170 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~ 170 (414)
++|++.+.||+|+||+||+|+. .+|+.||||+++... .+.+.+|+.+|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6799999999999999999987 468899999997543 357889999999995 99999999999854 4689999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-CeEEEeecCccccCC
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGG 249 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kL~Dfgl~~~~~~ 249 (414)
|||++++|..+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++.....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999977642 3899999999999999999999998 99999999999998655 699999999987643
Q ss_pred CCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHH-----------
Q 043285 250 DETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKL----------- 317 (414)
Q Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----------- 317 (414)
. .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...... ..........
T Consensus 183 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~--~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 183 G---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp T---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHH
T ss_pred C---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh--HHHHHHHHHHHCCchhhhhhh
Confidence 2 223445789999999998765 5799999999999999999999997543321 1111111100
Q ss_pred -hhcCCCcccc-----------cccccCcCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043285 318 -WNEGMPSQLI-----------DSCFQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMPSVIL 366 (414)
Q Consensus 318 -~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 366 (414)
.......... ..............++.+|+.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001100000 000000000111235678999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=342.39 Aligned_cols=258 Identities=25% Similarity=0.295 Sum_probs=188.3
Q ss_pred CCCCCCCeecccCCceEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCceeeeEeEEEe------CCe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GEE 165 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~ 165 (414)
++|++.+.||+|+||+||+|+.. +|+.||||++.+ ........+.+|+.+++.++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999875 589999999975 334455678999999999999999999999964 367
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.|+|||||.++.+. .+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999765554 342 23889999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHh-------
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLW------- 318 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------- 318 (414)
.... ........+|+.|+|||++.+..++.++||||+||++|||++|+.||..... ...........
T Consensus 168 ~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~---~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 168 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHH
T ss_pred cccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH---HHHHHHHHHhccCCCHHH
Confidence 6532 2233455789999999999999999999999999999999999999753221 11111111000
Q ss_pred -----------hcCCC-------cccccccccCcC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043285 319 -----------NEGMP-------SQLIDSCFQDSF---NLAEVIRCIHIGLLCVQQHPEDRPSMPSVILM 367 (414)
Q Consensus 319 -----------~~~~~-------~~~~~~~~~~~~---~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 367 (414)
..... ............ .......+.+|+.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 000000000111 11234567889999999999999999999964
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=345.61 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=195.6
Q ss_pred cCCCCCCCeecccCCceEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCceeeeEeEEEeC-----Ce
Q 043285 94 TNNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 165 (414)
Q Consensus 94 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 165 (414)
.++|++.+.||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.+++.++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999986 46899999999753 344556788999999999999999999999643 34
Q ss_pred eeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEEeecCcc
Q 043285 166 KLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 245 (414)
Q Consensus 166 ~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~ 245 (414)
.+++++|+.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 57778888899999998543 3899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCccccccccccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHHHHHHhhcCCCc
Q 043285 246 AFGGDETEGNTNRVVGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 324 (414)
Q Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
... .......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||..... ............. ...
T Consensus 170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~---~~~~~~i~~~~~~-~~~ 240 (348)
T d2gfsa1 170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGT-PGA 240 (348)
T ss_dssp CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC-CCH
T ss_pred ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCC-CCh
Confidence 542 233445789999999987665 468999999999999999999999753221 1111111111100 000
Q ss_pred cccc------------cccc-CcCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHH--HhcCC
Q 043285 325 QLID------------SCFQ-DSFNLA-----EVIRCIHIGLLCVQQHPEDRPSMPSVIL--MLGSE 371 (414)
Q Consensus 325 ~~~~------------~~~~-~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~ 371 (414)
.... .... ...... ....+.+|+.+||+.||++|||++|+++ ++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0000 0000 000000 1134678999999999999999999998 45543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.1e-40 Score=314.06 Aligned_cols=280 Identities=19% Similarity=0.203 Sum_probs=198.2
Q ss_pred CCCCCCCeecccCCceEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-----------CCceeeeEeEEEe
Q 043285 95 NNFSINKKLGQGGFGPVYKGKL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCIQ 162 (414)
Q Consensus 95 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 162 (414)
++|++++.||+|+||+||+|+. .+|+.||||++++. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4599999999999999999986 46899999999763 233456788998888875 5789999988864
Q ss_pred C--CeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCC----
Q 043285 163 G--EEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMN---- 235 (414)
Q Consensus 163 ~--~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dlk~~Nill~~~~~---- 235 (414)
. ...+++++++..+..............+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4667777777666544444444444558999999999999999999998 66 999999999999986653
Q ss_pred --eEEEeecCccccCCCCCccccccccccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchH--
Q 043285 236 --PKISDFGLARAFGGDETEGNTNRVVGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIVSGKKNRGFYHSDNNLNLI-- 311 (414)
Q Consensus 236 --~kL~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~-- 311 (414)
++++|||.+.... .......||+.|+|||++.+..++.++||||+||+++||++|+.||............
T Consensus 169 ~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccc-----cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 9999999987642 2233457999999999999999999999999999999999999998644332211111
Q ss_pred -HHHHHHhhc------------------C-CCccccccc---------ccCcCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 043285 312 -GHAWKLWNE------------------G-MPSQLIDSC---------FQDSFNLAEVIRCIHIGLLCVQQHPEDRPSMP 362 (414)
Q Consensus 312 -~~~~~~~~~------------------~-~~~~~~~~~---------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 362 (414)
......... . ....+.... ............+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 111111000 0 000000000 01122344556788999999999999999999
Q ss_pred HHHHH--hcCCC---CCCCCCCCCcc
Q 043285 363 SVILM--LGSET---VLPQPKQPGYL 383 (414)
Q Consensus 363 evl~~--L~~~~---~~~~~~~~~~~ 383 (414)
|+|+. +++.. ....|..+.+.
T Consensus 324 e~L~Hp~f~~~~~~~~~~~p~~~~~~ 349 (362)
T d1q8ya_ 324 GLVNHPWLKDTLGMEEIRVPDRELYG 349 (362)
T ss_dssp HHHTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred HHhcCcccCCCCCcccCCCCCcccCC
Confidence 99984 54332 23445555443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.5e-24 Score=187.37 Aligned_cols=164 Identities=18% Similarity=0.163 Sum_probs=119.7
Q ss_pred CCCCeecccCCceEEEEEEcCCCEEEEEEecccC------------------hhhHHHHHHHHHHHHhcCCCceeeeEeE
Q 043285 98 SINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKIS------------------EQGLKELKNEVILFSKLQHRNLVKLLGC 159 (414)
Q Consensus 98 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~~~~~ 159 (414)
.++++||+|+||+||+|+..+|+.||||+++... .........|...+..+.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4568999999999999998889999999875210 0112234568889999999999988765
Q ss_pred EEeCCeeeEEEeecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCCeEEE
Q 043285 160 CIQGEEKLLIYEFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 239 (414)
Q Consensus 160 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kL~ 239 (414)
. ..+++|||+++..+.. ++......++.|++++++|||+++ ++||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 3479999998865543 333445678999999999999998 9999999999999965 48999
Q ss_pred eecCccccCCCCCcccccccccccccccc--c---cccCCCCCcchhHHHHHHHH
Q 043285 240 DFGLARAFGGDETEGNTNRVVGTYGYMAP--E---YASDGQFSVKSDVFSFGILL 289 (414)
Q Consensus 240 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~sDvwslGvil 289 (414)
|||++......... .|... + .+..+.|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99998764321110 11110 0 01135678899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.77 E-value=2.5e-08 Score=88.29 Aligned_cols=146 Identities=16% Similarity=0.076 Sum_probs=99.4
Q ss_pred HhcCCCCCCCeecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCceeeeEeEEEeCCeeeEEE
Q 043285 92 SATNNFSINKKLGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 170 (414)
Q Consensus 92 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 170 (414)
.....|+..+..+.++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.++.+++..++||
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 3345666655555455578998865 66778889886544444445678888887774 434567888888888999999
Q ss_pred eecCCCChhHHhhcccccccCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 043285 171 EFMPNKSLDSFIFDQERCMILDWSKRFHIICGTARGLLYLHQDS------------------------------------ 214 (414)
Q Consensus 171 ey~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 214 (414)
+++++.++.+...... . ...++.++++.++.||+..
T Consensus 90 ~~l~G~~~~~~~~~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 90 SEADGVLCSEEYEDEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHTTTCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred Eecccccccccccccc-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 9999988765442211 1 1223445555555555421
Q ss_pred --------------------CCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 215 --------------------RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 215 --------------------~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11279999999999999876677999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.16 E-value=4.9e-06 Score=72.64 Aligned_cols=142 Identities=17% Similarity=0.135 Sum_probs=85.4
Q ss_pred eecccCC-ceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC--ceeeeEeEEEeCCeeeEEEeecCCCCh
Q 043285 102 KLGQGGF-GPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGCCIQGEEKLLIYEFMPNKSL 178 (414)
Q Consensus 102 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~ey~~~g~L 178 (414)
.+..|.. +.||+....++..+++|....... ..+..|...++.+... .+.+++.+..+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 678999887788889998754332 2466788888777433 356678888888889999999988665
Q ss_pred hHHh-----------------hccc--ccc-cCCHHHHHHHHH--------------------HHHHHHHHHHhC----C
Q 043285 179 DSFI-----------------FDQE--RCM-ILDWSKRFHIIC--------------------GTARGLLYLHQD----S 214 (414)
Q Consensus 179 ~~~l-----------------~~~~--~~~-~l~~~~~~~i~~--------------------~i~~~l~~LH~~----~ 214 (414)
.+.. +... ... .-.......-.. .....+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 4311 0000 000 000000000000 011122333222 1
Q ss_pred CCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 215 RLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 215 ~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
...++|+|+.|.||+++++..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 12379999999999999876678999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.90 E-value=2.8e-05 Score=72.44 Aligned_cols=75 Identities=11% Similarity=0.150 Sum_probs=48.5
Q ss_pred CeecccCCceEEEEEEcC-CCEEEEEEeccc-------ChhhHHHHHHHHHHHHhcC-C-C-ceeeeEeEEEeCCeeeEE
Q 043285 101 KKLGQGGFGPVYKGKLVD-GQEIAVKRLSKI-------SEQGLKELKNEVILFSKLQ-H-R-NLVKLLGCCIQGEEKLLI 169 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h-~-niv~~~~~~~~~~~~~lv 169 (414)
+.||.|....||+....+ ++.++||.-... .+....+...|+..|+.+. + | .+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999997654 678999975321 1112334566888887663 2 3 34455543 56677899
Q ss_pred EeecCCCC
Q 043285 170 YEFMPNKS 177 (414)
Q Consensus 170 ~ey~~~g~ 177 (414)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.27 E-value=0.00037 Score=64.68 Aligned_cols=72 Identities=19% Similarity=0.327 Sum_probs=49.7
Q ss_pred CeecccCCceEEEEEEcC--------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCce-eeeEeEEEeCCeeeEEEe
Q 043285 101 KKLGQGGFGPVYKGKLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYE 171 (414)
Q Consensus 101 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 171 (414)
+.|+.|-.-.+|+....+ ...|++++.... .......+|..+++.+.-.++ .++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 678889999999998654 346777776532 223456689999988854444 46777763 268999
Q ss_pred ecCCCCh
Q 043285 172 FMPNKSL 178 (414)
Q Consensus 172 y~~~g~L 178 (414)
|+++.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.98 E-value=0.00092 Score=60.09 Aligned_cols=136 Identities=13% Similarity=0.102 Sum_probs=77.7
Q ss_pred CceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCce--eeeE-----eEEEeCCeeeEEEeecCCCChhH
Q 043285 108 FGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL--VKLL-----GCCIQGEEKLLIYEFMPNKSLDS 180 (414)
Q Consensus 108 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~ey~~~g~L~~ 180 (414)
--.||+.+..+|..+++|+.+.. ....+++..|...+..|...++ +..+ ..+......+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 45899999989999999987642 2234667888888888753322 1111 12334556788999997643321
Q ss_pred -----H---------hhcc------cccccCCHH----------------------HHHHHHHHHHHHHHHH-HhCCCCC
Q 043285 181 -----F---------IFDQ------ERCMILDWS----------------------KRFHIICGTARGLLYL-HQDSRLR 217 (414)
Q Consensus 181 -----~---------l~~~------~~~~~l~~~----------------------~~~~i~~~i~~~l~~L-H~~~~~~ 217 (414)
+ ++.. ......+.. .....+..+...+.-+ .+.....
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 1110 000111111 1112222233222222 1222345
Q ss_pred eeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 218 IIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 218 iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999743 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.39 E-value=0.012 Score=52.14 Aligned_cols=158 Identities=15% Similarity=0.027 Sum_probs=80.3
Q ss_pred CHHHHHHhcCCCCCCCe-----ecccCCceEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCce--eeeEe
Q 043285 86 ELATIVSATNNFSINKK-----LGQGGFGPVYKGKLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL--VKLLG 158 (414)
Q Consensus 86 ~~~~~~~~~~~~~~~~~-----lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~ 158 (414)
+.+++.....+|.+++. |..|---+.|+.+..+| .+++|+..... ...++..|+.++..+...++ ...+-
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 34455555667776543 44566678899987655 48899886532 22345566777777643222 11110
Q ss_pred ------EEEeCCeeeEEEeecCCCChhHH--------------hhcc------cccc------------------cCCHH
Q 043285 159 ------CCIQGEEKLLIYEFMPNKSLDSF--------------IFDQ------ERCM------------------ILDWS 194 (414)
Q Consensus 159 ------~~~~~~~~~lv~ey~~~g~L~~~--------------l~~~------~~~~------------------~l~~~ 194 (414)
+.........++.+..+...... ++.. .... .....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11223445566666655332210 0000 0000 00011
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCCeEEEeecCccc
Q 043285 195 KRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 246 (414)
Q Consensus 195 ~~~~i~~~i~~~l~~LH~-~~~~~iiH~dlk~~Nill~~~~~~kL~Dfgl~~~ 246 (414)
.....+......+.-.+. .-+.++||+|+.+.||+++.+...-+.||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 111122222222222222 1233599999999999999887778999998864
|